Citrus Sinensis ID: 017411

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370--
Protein Sequence
MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLKSC
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccEEcccccccHHHHHHHHHHHHHcccEEEcccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHcccccccccccccccccEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEEccccEEEEEEEccccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEcccccccccccccccccccccccccccccccccccccEEEccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHcccHEEcccccccccEEEEcccccEEEEEEEcccccccccccccEEEEEcccHccccccEEcccccEEccEEccccccccccccccccccccccccccccccccEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccEcHHHHHHHHccccccccccccccccEEEEEcccccEEEEEEEEEccccccHHHHHHHHHHHHHHHHHcHHHHEEEEcccccEEEEEEEEcccccHHHHHccccccccccccccHHHHHHHHHHHHHHHHHHHHHcccEEEcccccHHHEEEcccccEEEccccccEEcccccccccEEEEEEcccccccccHHHHccccc
Coil and Loop (DISEMBL)
mgfsqdtyskssqhnelyassivsdnyceykVYNKHYNELKIKTLLRKMIWDFglscflpslsnnhnnrindddekskgsnlehNKAWLLAEsggaeltstdpqsvhssfrfslcsqvelesmnigasASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHnfskgrvlgrGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAsslhhpnivplvgfcidpeQGLFLIYKYVsggslerhlhekkkgvrgnstlpwSVRYKVALGIAESVAYLHNgtercvvhrdikpsnillsskkipklcdfglatwtsapsvpflcktvkgtfgqnpfcIEEWQRLKSC
Flexible Loop (DISEMBL)
mgfsqdtyskssqhneLYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQslersispvaNSLIRLSYGEILAATHNFSKGRVLGRGALSfvfkgkvgllrtsvaikrldkedkesSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHlhekkkgvrgnstlpwSVRYKVALGIAESVAYLHNGTERCVVHRDikpsnillsskKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLKSC
Low Complexity Region (SEG)
MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLKSC
Disordered region (IsUnstruct)
****************LYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPS************************************************FRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL********KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQ*****
Disordered Region (DISOPRED)
*************HNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLS*****************NLEHNKAWLLAESG*****************************NIGASASATVLMVNLENGLCD************************LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE**ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLK**
Disordered Region (DISEMBL)
*************HNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAE************FRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLKSC
Disordered Region (DISPRO)
**********SSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHS*********VELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLK*C
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLKSC
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	372	2.2.26 [Sep-21-2011]
Q5XF57	579	Probable receptor-like se	no	no	0.526	0.338	0.385	5e-32
Q9FE20	456	Serine/threonine-protein	no	no	0.505	0.412	0.374	3e-31
Q9LSL5	675	L-type lectin-domain cont	no	no	0.543	0.299	0.376	9e-31
Q9LXA5	651	L-type lectin-domain cont	no	no	0.615	0.351	0.349	1e-30
O65472	690	Putative cysteine-rich re	no	no	0.494	0.266	0.363	6e-30
Q9LQQ8	423	Probable serine/threonine	no	no	0.505	0.444	0.384	6e-30
Q9SFT7	414	Serine/threonine-protein	no	no	0.510	0.458	0.375	1e-29
Q9LK03	717	Proline-rich receptor-lik	no	no	0.473	0.245	0.404	6e-29
Q9CAH1	450	Putative receptor-like pr	no	no	0.481	0.397	0.406	9e-29
Q9SCZ4	895	Receptor-like protein kin	no	no	0.483	0.201	0.354	1e-28

>sp|Q5XF57|Y5576_ARATH Probable receptor-like serine/threonine-protein kinase At5g57670 OS=Arabidopsis thaliana GN=At5g57670 PE=2 SV=1

 Score =  138 bits (348), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 81/210 (38%), Positives = 118/210 (56%), Gaps = 14/210 (6%)

Query: 151 KWRKIQSLERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTS 209
           KWR  ++  +   P    LI+  +Y EI  AT++F +G ++G G  S V++G +   R  
Sbjct: 236 KWRGSETKNK---PKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGR-R 291

Query: 210 VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           +A+KRL KE  D    K F  EL I S + HPN   L+G C+  E+GL+L++++   G+L
Sbjct: 292 IAVKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGCCV--EKGLYLVFRFSENGTL 349

Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              LHE + G     +L W VRYK+A+G+A  + YLH      ++HRDIK SN+LL    
Sbjct: 350 YSALHENENG-----SLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDY 404

Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            P++ DFGLA W            V+GTFG
Sbjct: 405 EPQITDFGLAKWLPNKWTHHAVIPVEGTFG 434

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1

 Score =  136 bits (342), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 73/195 (37%), Positives = 110/195 (56%), Gaps = 7/195 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            ++ E+ AAT NF     LG G    V+KG++      VA+K+LD+   + ++ F  E++
Sbjct: 74  FAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFLVEVL 133

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + S LHHPN+V L+G+C D +Q L L+Y+++  GSLE HLH+          L W++R K
Sbjct: 134 MLSLLHHPNLVNLIGYCADGDQRL-LVYEFMPLGSLEDHLHDLPP---DKEALDWNMRMK 189

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +A G A+ + +LH+     V++RD K SNILL     PKL DFGLA          +   
Sbjct: 190 IAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVSTR 249

Query: 352 VKGTFGQNPFCIEEW 366
           V GT+G   +C  E+
Sbjct: 250 VMGTYG---YCAPEY 261

Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LSL5|LRK92_ARATH L-type lectin-domain containing receptor kinase IX.2 OS=Arabidopsis thaliana GN=LECRK92 PE=2 SV=1

 Score =  134 bits (338), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 84/223 (37%), Positives = 124/223 (55%), Gaps = 21/223 (9%)

Query: 125 IGASASATVL---MVNLENGLCDSRAQELKWRKIQS-------LERSISPVANSLIRLSY 174
           IG SAS  V    MV     +   + ++ K R I++       LER   P      + SY
Sbjct: 286 IGISASGFVFLTFMVITTVVVWSRKQRKKKERDIENMISINKDLEREAGPR-----KFSY 340

Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 234
            ++++AT+ FS  R LG G    V++G +  + T VA+K+L  + ++    F  E+ I S
Sbjct: 341 KDLVSATNRFSSHRKLGEGGFGAVYEGNLKEINTMVAVKKLSGDSRQGKNEFLNEVKIIS 400

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L H N+V L+G+C +  + L LIY+ V  GSL  HL  K+  +     L W +RYK+ L
Sbjct: 401 KLRHRNLVQLIGWCNEKNEFL-LIYELVPNGSLNSHLFGKRPNL-----LSWDIRYKIGL 454

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           G+A ++ YLH   ++CV+HRDIK SNI+L S+   KL DFGLA
Sbjct: 455 GLASALLYLHEEWDQCVLHRDIKASNIMLDSEFNVKLGDFGLA 497

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LXA5|LRK91_ARATH L-type lectin-domain containing receptor kinase IX.1 OS=Arabidopsis thaliana GN=LECRK91 PE=2 SV=1

 Score =  134 bits (336), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 88/252 (34%), Positives = 129/252 (51%), Gaps = 23/252 (9%)

Query: 116 SQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQ----------SLERSISPV 165
           SQ + + M IG S S  VL+      L     ++ + +K +           LER   P 
Sbjct: 262 SQNDKKGMIIGISVSGFVLLTFFITSLIVFLKRKQQKKKAEETENLTSINEDLERGAGPR 321

Query: 166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
                + +Y ++ +A +NF+  R LG G    V++G +  L   VAIK+     K+  + 
Sbjct: 322 -----KFTYKDLASAANNFADDRKLGEGGFGAVYRGYLNSLDMMVAIKKFAGGSKQGKRE 376

Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           F  E+ I SSL H N+V L+G+C + ++   +IY+++  GSL+ HL  KK        L 
Sbjct: 377 FVTEVKIISSLRHRNLVQLIGWCHEKDE-FLMIYEFMPNGSLDAHLFGKKP------HLA 429

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           W VR K+ LG+A ++ YLH   E+CVVHRDIK SN++L S    KL DFGLA        
Sbjct: 430 WHVRCKITLGLASALLYLHEEWEQCVVHRDIKASNVMLDSNFNAKLGDFGLARLMDHELG 489

Query: 346 PFLCKTVKGTFG 357
           P     + GTFG
Sbjct: 490 P-QTTGLAGTFG 500

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2

 Score =  132 bits (331), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 69/190 (36%), Positives = 109/190 (57%), Gaps = 6/190 (3%)

Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL 230
           +L +  I  AT NF+K   LG+G    V+KG + +  T VA+KRL K  ++ ++ F  E+
Sbjct: 354 QLDFKTIEVATENFAKTNKLGQGGFGEVYKGTL-VNGTEVAVKRLSKTSEQGAQEFKNEV 412

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ + L H N+V L+G+C++PE+ + L+Y++V   SL+  L +  K       L W+ RY
Sbjct: 413 VLVAKLQHRNLVKLLGYCLEPEEKI-LVYEFVPNKSLDYFLFDPTK----QGQLDWTKRY 467

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
            +  GI   + YLH  +   ++HRD+K SNILL +  IPK+ DFG+A  +         K
Sbjct: 468 NIIGGITRGILYLHQDSRLTIIHRDLKASNILLDADMIPKIADFGMARISGIDQSVANTK 527

Query: 351 TVKGTFGQNP 360
            + GTFG  P
Sbjct: 528 RIAGTFGYMP 537

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1

 Score =  131 bits (330), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 75/195 (38%), Positives = 106/195 (54%), Gaps = 7/195 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            ++ E+  AT NF     LG G    VFKG +  L   VAIK+LD+   +  + F  E++
Sbjct: 91  FTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVVEVL 150

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
             S   HPN+V L+GFC + +Q L L+Y+Y+  GSLE HLH    G +    L W+ R K
Sbjct: 151 TLSLADHPNLVKLIGFCAEGDQRL-LVYEYMPQGSLEDHLHVLPSGKK---PLDWNTRMK 206

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +A G A  + YLH+     V++RD+K SNILL     PKL DFGLA    +     +   
Sbjct: 207 IAAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTR 266

Query: 352 VKGTFGQNPFCIEEW 366
           V GT+G   +C  ++
Sbjct: 267 VMGTYG---YCAPDY 278

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1

 Score =  130 bits (328), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 74/197 (37%), Positives = 111/197 (56%), Gaps = 7/197 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            S+ E+  AT NF +  ++G G    V+KGK+      VA+K+LD+   + +K F  E++
Sbjct: 67  FSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGLQGNKEFIVEVL 126

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + S LHH ++V L+G+C D +Q L L+Y+Y+S GSLE HL +          L W  R +
Sbjct: 127 MLSLLHHKHLVNLIGYCADGDQRL-LVYEYMSRGSLEDHLLDLTP---DQIPLDWDTRIR 182

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           +ALG A  + YLH+     V++RD+K +NILL  +   KL DFGLA          +   
Sbjct: 183 IALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGDKQHVSSR 242

Query: 352 VKGTFGQNPFCIEEWQR 368
           V GT+G   +C  E+QR
Sbjct: 243 VMGTYG---YCAPEYQR 256

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  128 bits (322), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 76/188 (40%), Positives = 110/188 (58%), Gaps = 12/188 (6%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRE 229
            +Y E+  AT+ FS+  +LG+G   +VFKG   +LR    VA+K+L +   +  + F  E
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKG---MLRNGKEVAVKQLKEGSSQGEREFQAE 398

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
           + I S +HH ++V LVG+CI   Q L L+Y++V   +LE HLH K     G  T+ WS R
Sbjct: 399 VGIISRVHHRHLVALVGYCIADAQRL-LVYEFVPNNTLEFHLHGK-----GRPTMEWSSR 452

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
            K+A+G A+ ++YLH      ++HRDIK SNIL+  K   K+ DFGLA   S  +   + 
Sbjct: 453 LKIAVGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVS 511

Query: 350 KTVKGTFG 357
             V GTFG
Sbjct: 512 TRVMGTFG 519

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAH1|Y1725_ARATH Putative receptor-like protein kinase At1g72540 OS=Arabidopsis thaliana GN=At1g72540 PE=2 SV=1

 Score =  127 bits (320), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 78/192 (40%), Positives = 107/192 (55%), Gaps = 13/192 (6%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKG------KVGLLRTSVAIKRLDKEDKESSKA 225
            +Y E+   T  FSK   LG G    V+KG      K GL    VA+K L +E  +  + 
Sbjct: 72  FTYEELKTITQGFSKYNFLGEGGFGEVYKGFVDDSLKTGLKDQPVAVKALKREGGQGHRE 131

Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           +  E++I   L HP++V LVG+C + ++ L L+Y+Y+  G+LE HL +K  G      LP
Sbjct: 132 WLAEVIILGQLKHPHLVNLVGYCCEDDERL-LVYEYMERGNLEDHLFQKYGG-----ALP 185

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           W  R K+ LG A+ + +LH   E+ V++RD KPSNILLSS    KL DFGLAT  S    
Sbjct: 186 WLTRVKILLGAAKGLEFLHK-QEKPVIYRDFKPSNILLSSDFSSKLSDFGLATDGSEEED 244

Query: 346 PFLCKTVKGTFG 357
               K+V GT G
Sbjct: 245 SNFTKSVMGTEG 256

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SCZ4|FERON_ARATH Receptor-like protein kinase FERONIA OS=Arabidopsis thaliana GN=FER PE=1 SV=1

 Score =  127 bits (320), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 66/186 (35%), Positives = 106/186 (56%), Gaps = 6/186 (3%)

Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
            S+ EI AAT NF + RVLG G    V++G++    T VAIKR +   ++    F  E+ 
Sbjct: 524 FSFAEIKAATKNFDESRVLGVGGFGKVYRGEIDGGTTKVAIKRGNPMSEQGVHEFQTEIE 583

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + S L H ++V L+G+C +    + L+Y Y++ G++  HL++ +     N +LPW  R +
Sbjct: 584 MLSKLRHRHLVSLIGYC-EENCEMILVYDYMAHGTMREHLYKTQ-----NPSLPWKQRLE 637

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           + +G A  + YLH G +  ++HRD+K +NILL  K + K+ DFGL+          +   
Sbjct: 638 ICIGAARGLHYLHTGAKHTIIHRDVKTTNILLDEKWVAKVSDFGLSKTGPTLDHTHVSTV 697

Query: 352 VKGTFG 357
           VKG+FG
Sbjct: 698 VKGSFG 703

Receptor-like protein kinase that mediates the female control of male gamete delivery during fertilization, including growth cessation of compatible pollen tubes ensuring a reproductive isolation barriers. Required for cell elongation during vegetative growth, mostly in a brassinosteroids- (BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
359488192	519	PREDICTED: probable receptor-like serine	0.938	0.672	0.715	1e-147
449445086	519	PREDICTED: proline-rich receptor-like pr	0.916	0.657	0.733	1e-145
224065170	523	predicted protein [Populus trichocarpa]	0.930	0.661	0.735	1e-144
363807838	508	uncharacterized protein LOC100808074 [Gl	0.913	0.669	0.710	1e-144
224079445	520	predicted protein [Populus trichocarpa]	0.841	0.601	0.779	1e-143
356569560	511	PREDICTED: proline-rich receptor-like pr	0.916	0.667	0.700	1e-140
356552025	509	PREDICTED: proline-rich receptor-like pr	0.881	0.644	0.673	1e-125
356499093	469	PREDICTED: proline-rich receptor-like pr	0.798	0.633	0.722	1e-123
297805364	539	kinase family protein [Arabidopsis lyrat	0.838	0.578	0.681	1e-118
110738055	548	protein kinase like protein [Arabidopsis	0.846	0.574	0.665	1e-118

>gi|359488192|ref|XP_002274329.2| PREDICTED: probable receptor-like serine/threonine-protein kinase At5g57670-like [Vitis vinifera] gi|296087159|emb|CBI33533.3| unnamed protein product [Vitis vinifera]

 Score =  528 bits (1360), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 261/365 (71%), Positives = 310/365 (84%), Gaps = 16/365 (4%)

Query: 1   MGFSQ----DTYSKSSQHNELYASSIVSDNY-CEYKVYNKHYNELKIKTLLRKMIWDFGL 55
           MG SQ    DT       N  YASS+ +D++ C++       +EL++K+LL+KM+W+FGL
Sbjct: 1   MGCSQGACTDTRKAFDGPNASYASSVTADDHSCDH-------DELRVKSLLKKMVWEFGL 53

Query: 56  SCFLPSLSNNHNNRINDDDEKSKGSN-LEHNKAWLLAESGG--AELTSTDPQSVHSSFRF 112
            C  P ++   ++    + ++ KG N LEHNKAWLLAESGG  AEL++ DPQSVHSSFRF
Sbjct: 54  GCVYP-VNRRRSSGGKGEMQRDKGKNSLEHNKAWLLAESGGCGAELSNADPQSVHSSFRF 112

Query: 113 SLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRL 172
           S CSQVELES+N+ +S +ATVLMVNL+NGL  SR++ELKWR+I+SLERSISPVAN+LIR 
Sbjct: 113 SFCSQVELESLNMSSSTAATVLMVNLDNGLTQSRSKELKWRRIESLERSISPVANTLIRF 172

Query: 173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
            Y EI++AT NF+KGRVLGRGALS VF+G+VG LRT+VAIKRLDKEDKES+KAFCRELMI
Sbjct: 173 GYAEIVSATRNFNKGRVLGRGALSCVFRGRVGFLRTAVAIKRLDKEDKESAKAFCRELMI 232

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           ASSL +PNIVPLVGFCIDPE+GLFL+YKYVSGGSLERHLHEKK+GV+G S+LPWSVRYKV
Sbjct: 233 ASSLQNPNIVPLVGFCIDPEEGLFLVYKYVSGGSLERHLHEKKRGVKGYSSLPWSVRYKV 292

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A+G+AESVAYLH+GT+RCVVHRDIKPSNILLSSKKIPKLCDFGLATWT APSVPFLCKTV
Sbjct: 293 AVGVAESVAYLHSGTDRCVVHRDIKPSNILLSSKKIPKLCDFGLATWTPAPSVPFLCKTV 352

Query: 353 KGTFG 357
           KGTFG
Sbjct: 353 KGTFG 357

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449445086|ref|XP_004140304.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus] gi|449479863|ref|XP_004155731.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Cucumis sativus]

 Score =  521 bits (1341), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 256/349 (73%), Positives = 297/349 (85%), Gaps = 8/349 (2%)

Query: 17  LYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDE- 75
           L   SI  +   E   ++  YNELKIKTLLRKMIW+ G +C LP       N+   D+E 
Sbjct: 5   LGTCSIQRETPLELDHHHCRYNELKIKTLLRKMIWELGFACILPPARFRRKNQGIQDEEH 64

Query: 76  ---KSKGSNLEHNKAWLLAESG--GAELTSTDPQSVHSSFRFSLCSQVELESMNIGASAS 130
              + +  NLEHNKAWLLAESG  G EL +TDPQSVHSSFRFS CSQVELE+MNIG+S +
Sbjct: 65  PNVEGQNKNLEHNKAWLLAESGAGGGELLNTDPQSVHSSFRFSFCSQVELETMNIGSSTT 124

Query: 131 A-TVLMVNLENGL-CDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGR 188
           A TVLMVNL+NG+  ++  +ELKWR+I+SLE+SISPVA++LIR  Y EIL+AT NFSKGR
Sbjct: 125 AATVLMVNLDNGMMAEALTKELKWRRIESLEKSISPVAHTLIRFRYREILSATRNFSKGR 184

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLGRGALS VF+G+VG LRT+VAIKRLDKEDKES+KAFCRELMIASSLH+PNIVPLVGFC
Sbjct: 185 VLGRGALSCVFRGRVGFLRTAVAIKRLDKEDKESAKAFCRELMIASSLHNPNIVPLVGFC 244

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           IDPE+GLFL+YKYVSGGSLERHLHEKK+G++G  +LPWSVR+K+ALGIAE+VAYLHNGTE
Sbjct: 245 IDPEEGLFLVYKYVSGGSLERHLHEKKRGMKGRFSLPWSVRFKIALGIAEAVAYLHNGTE 304

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           RCVVHRDIKPSNILL+SKK+PKLCDFGLATWT+APSVPFLCKTVKGTFG
Sbjct: 305 RCVVHRDIKPSNILLTSKKMPKLCDFGLATWTAAPSVPFLCKTVKGTFG 353

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224065170|ref|XP_002301698.1| predicted protein [Populus trichocarpa] gi|222843424|gb|EEE80971.1| predicted protein [Populus trichocarpa]

 Score =  517 bits (1331), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 273/371 (73%), Positives = 309/371 (83%), Gaps = 25/371 (6%)

Query: 1   MGFSQDTY------SKSSQHNELYASSIVS-DNYCEYKVYNKHYNELKIKTLLRKMIWDF 53
           MGF Q T       S SS  + L AS+I++ D+  +Y       NELK+K  L KM W  
Sbjct: 1   MGFCQGTCRNTKEPSNSSTCDALSASTIIAKDHSFDYD------NELKMKGFLSKMFWQS 54

Query: 54  GLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGG----AELTSTDPQSVHSS 109
           GL+CFLP+ S+    + N+     K  +LEHNKAWLLAESGG    +ELT+ DP SVHSS
Sbjct: 55  GLACFLPNESDETIKKSNN-----KNGSLEHNKAWLLAESGGCGSGSELTNADPHSVHSS 109

Query: 110 FRFSLCSQVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSL 169
           FRFSLCSQVELESMN+ +SASATVLMVNL+NGL ++RA+ELKWR+IQSLERSISPVANSL
Sbjct: 110 FRFSLCSQVELESMNMNSSASATVLMVNLDNGLNETRAKELKWRRIQSLERSISPVANSL 169

Query: 170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
           +R SY EILAAT+NFSKGRVLGRGALSFVF+GKVG LRT+VAIKRLDKEDKE+SKAFCRE
Sbjct: 170 VRFSYSEILAATNNFSKGRVLGRGALSFVFRGKVGFLRTAVAIKRLDKEDKEASKAFCRE 229

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE---KKKGVRGNSTLPW 286
           LMIASSL+H NIVPLVGFCIDPE+GLFL+YKYVSGGSLERHLH+    K GV+G+S L W
Sbjct: 230 LMIASSLYHSNIVPLVGFCIDPEEGLFLVYKYVSGGSLERHLHDKKKVKVGVKGSSGLSW 289

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           SVRYKVALGIA+++AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP
Sbjct: 290 SVRYKVALGIAQAIAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 349

Query: 347 FLCKTVKGTFG 357
           FLCKTVKGTFG
Sbjct: 350 FLCKTVKGTFG 360

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807838|ref|NP_001242440.1| uncharacterized protein LOC100808074 [Glycine max] gi|255635407|gb|ACU18056.1| unknown [Glycine max]

 Score =  516 bits (1330), Expect = e-144,   Method: Compositional matrix adjust.
 Identities = 255/359 (71%), Positives = 304/359 (84%), Gaps = 19/359 (5%)

Query: 1   MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLP 60
           MGFSQD  + S+      +S++V D+YC+Y       ++LK KT LRKM W+FGL+C   
Sbjct: 1   MGFSQDPCTDSNAPTST-SSTLVVDHYCDY-------DKLKFKTFLRKMFWEFGLAC--- 49

Query: 61  SLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGG--AELTSTDPQSVHSSFRFSLCSQV 118
            ++N    R +  D   K +N+E+NKAWLLAESGG  AELT+ DPQSVHSSFRFS CSQV
Sbjct: 50  -VANPSQRRRSSGD--GKKTNMENNKAWLLAESGGCGAELTNADPQSVHSSFRFSFCSQV 106

Query: 119 ELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL 178
           ELES+N+ +SA+ATVLMVNL+NG+ +SRA E+KWR+++SLE+SISPV ++LIR SYGEI+
Sbjct: 107 ELESLNMSSSAAATVLMVNLDNGVSESRANEMKWRRMESLEKSISPVVHTLIRFSYGEIM 166

Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +AT NFSKGRVLGRGALS VF+G+VG+LRT+VAIKRLDKEDKES+KAFCRELMIASSLH 
Sbjct: 167 SATRNFSKGRVLGRGALSCVFRGRVGILRTAVAIKRLDKEDKESAKAFCRELMIASSLHS 226

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            N+VPL+GFCIDPE+GLFL+YKYVSGGSLERHLH +KK   G+S LPW VRYKVA+GIAE
Sbjct: 227 SNVVPLLGFCIDPEEGLFLVYKYVSGGSLERHLHGRKK---GSSPLPWPVRYKVAIGIAE 283

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           +VAYLH+GTERCVVHRDIKPSNILLSS+K PKLCDFGLATWTSAPSVPFLCKTVKGTFG
Sbjct: 284 AVAYLHSGTERCVVHRDIKPSNILLSSRKTPKLCDFGLATWTSAPSVPFLCKTVKGTFG 342

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224079445|ref|XP_002305868.1| predicted protein [Populus trichocarpa] gi|222848832|gb|EEE86379.1| predicted protein [Populus trichocarpa]

 Score =  515 bits (1326), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 262/336 (77%), Positives = 294/336 (87%), Gaps = 23/336 (6%)

Query: 33  YNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSN-----LEHNKA 87
           Y +H+ E K+K  L KM W FGL+CF+P          N+ DE SKGSN     LEHNKA
Sbjct: 34  YFEHHYERKMKAFLSKMFWQFGLACFVP----------NESDETSKGSNKKNADLEHNKA 83

Query: 88  WLLAESGG---AELTSTDPQSVHSSFRFSLCSQVELESMNIGASASATVLMVNLENGLCD 144
           WLLAESGG   AELT+ DPQSVHSSFRFSLCSQVELESMN+  ++SATVLMVNL+NGL +
Sbjct: 84  WLLAESGGCGGAELTNADPQSVHSSFRFSLCSQVELESMNM--NSSATVLMVNLDNGLNE 141

Query: 145 SRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVG 204
           +RA+ELKWR+IQSLERSISPVANSL+R SY EILAAT+NFSKGRVLGRGALSFVF+GKVG
Sbjct: 142 TRAKELKWRRIQSLERSISPVANSLVRFSYREILAATNNFSKGRVLGRGALSFVFRGKVG 201

Query: 205 LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG 264
            LRT+VAIKRLDKEDKE+SKAFCRELMIASSL+H NIVPLVGFCIDP++GLFL+Y+YVSG
Sbjct: 202 FLRTAVAIKRLDKEDKEASKAFCRELMIASSLYHSNIVPLVGFCIDPDEGLFLVYRYVSG 261

Query: 265 GSLERHLHE---KKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI 321
           GSLERHLH+    K GV+G+S LPWSVRYKVALGIA+++AYLHNGTERCVVHRDIKPSNI
Sbjct: 262 GSLERHLHDKKKGKGGVKGSSGLPWSVRYKVALGIAQAIAYLHNGTERCVVHRDIKPSNI 321

Query: 322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           LLSSKK+PKLCDFGLATWTSAPSVPFLCKTVKGTFG
Sbjct: 322 LLSSKKVPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356569560|ref|XP_003552967.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Glycine max]

 Score =  504 bits (1298), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 253/361 (70%), Positives = 303/361 (83%), Gaps = 20/361 (5%)

Query: 1   MGFSQDTYSKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLP 60
           MG SQ   + S   +   A ++V D+YC+Y       N+LK +T LRKM W+FGL+C   
Sbjct: 1   MGLSQGPCTDSRDLSN--APTLVVDHYCDY-------NKLKFRTFLRKMFWEFGLAC--- 48

Query: 61  SLSNNHNNRINDDDEKSKG--SNLEHNKAWLLAESGG--AELTSTDPQSVHSSFRFSLCS 116
            ++N    R + +   + G  +NLEHNKAWLLAESGG  AELT+ DPQSVHSSFRFS CS
Sbjct: 49  -VANPSRRRRSSERSSAYGKKTNLEHNKAWLLAESGGCGAELTNADPQSVHSSFRFSFCS 107

Query: 117 QVELESMNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGE 176
           QVELES+N+ +S++ATVLMVNL+NG+ +SRA+E+KWR+++SLE+SISPVA+SLIR SYGE
Sbjct: 108 QVELESLNMSSSSAATVLMVNLDNGMSESRAREMKWRRMESLEKSISPVAHSLIRFSYGE 167

Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           I++AT NFSKGRVLGRGALS VF+G+VG+LRT+VAIKRLDKE KES+KAFCRELMIASSL
Sbjct: 168 IMSATRNFSKGRVLGRGALSCVFRGRVGILRTAVAIKRLDKESKESAKAFCRELMIASSL 227

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  N+VPL+GFCIDPE+GLFL+YKYVSGGSLERHLH +KK   G+S L W VRYKVA+GI
Sbjct: 228 HSSNVVPLLGFCIDPEEGLFLVYKYVSGGSLERHLHGRKK---GSSPLLWPVRYKVAIGI 284

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           AE+VAYLH+GTERCVVHRDIKPSNILLSS+KIPKLCDFGLATWTSAPS+PFLCKTVKGTF
Sbjct: 285 AEAVAYLHSGTERCVVHRDIKPSNILLSSRKIPKLCDFGLATWTSAPSLPFLCKTVKGTF 344

Query: 357 G 357
           G
Sbjct: 345 G 345

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356552025|ref|XP_003544372.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Glycine max]

 Score =  454 bits (1167), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 237/352 (67%), Positives = 281/352 (79%), Gaps = 24/352 (6%)

Query: 11  SSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCF--LPSLSNNHNN 68
           S   N L +SS V ++  +YK +N      K+ T L+K +W++  +C   +P   NN   
Sbjct: 11  SGDTNALVSSSAVGNDPSDYKRHNN-----KLMTFLKKTMWEYAFACVGVVPCGGNN--- 62

Query: 69  RINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIG-- 126
               D    + + L+HNKAWLLA+SG AEL S DP+SVHSSFRFS CSQVE+ES N+   
Sbjct: 63  ----DLNGQRKATLKHNKAWLLADSG-AELASADPRSVHSSFRFSFCSQVEVESFNMSYS 117

Query: 127 -ASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFS 185
            ++A+AT LMVNL+    +S+ +ELKWR+IQS E+S+SPVAN+LIR SY EIL+ATHNFS
Sbjct: 118 ASAAAATFLMVNLDY---ESQVKELKWRRIQSPEKSLSPVANTLIRFSYDEILSATHNFS 174

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           K RVLGRGALS VF+G+VG+ RTSVAIKRLDKEDKE  KAFCRELMIASSLH+ N+VPLV
Sbjct: 175 KERVLGRGALSCVFRGRVGIWRTSVAIKRLDKEDKECVKAFCRELMIASSLHNTNVVPLV 234

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           GFCID E+GLFL+YKYVSGGSLE HLH +KK   G+S LPWSVRYKVA+GIAE+VAYLH+
Sbjct: 235 GFCIDSEEGLFLVYKYVSGGSLEHHLHGRKK---GSSPLPWSVRYKVAIGIAEAVAYLHH 291

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA+WTSAPSVPFLCKTVKGTFG
Sbjct: 292 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLASWTSAPSVPFLCKTVKGTFG 343

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499093|ref|XP_003518378.1| PREDICTED: proline-rich receptor-like protein kinase PERK13-like [Glycine max]

 Score =  446 bits (1148), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 227/314 (72%), Positives = 265/314 (84%), Gaps = 17/314 (5%)

Query: 50  IWDFGLSCF--LPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVH 107
           +W++ L+C   +P   NN       D    + + LEHNKAWLLA+SG AEL S DP+SVH
Sbjct: 1   MWEYALACVGVVPCGGNN-------DLNGQRKTTLEHNKAWLLADSG-AELASADPRSVH 52

Query: 108 SSFRFSLCSQVELESMNIG----ASASATVLMVNLENGLCDSRAQELKWRKIQSLERSIS 163
           SSFRFS CSQVE+ES N+     A+A+AT LMVNL+    +S+ +ELKWR+IQSLE+S+S
Sbjct: 53  SSFRFSFCSQVEVESFNMSYSASAAAAATFLMVNLDY---ESQVRELKWRRIQSLEKSLS 109

Query: 164 PVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS 223
           PVAN+LIR SY EIL+AT NFSK RVLGRGALS VF+G+VG+ RT+VAIKRLDKEDKE +
Sbjct: 110 PVANTLIRFSYDEILSATRNFSKERVLGRGALSCVFRGRVGIWRTAVAIKRLDKEDKECA 169

Query: 224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST 283
           KAFCRELMIASSL+  N+VPLVGFCID E+GLFL+YKYVSGGSLE HLH +KKGV+G+S 
Sbjct: 170 KAFCRELMIASSLNDTNVVPLVGFCIDSEEGLFLVYKYVSGGSLEHHLHGRKKGVKGSSP 229

Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           LPWSVRY+VA+GIAE+VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA+WTSAP
Sbjct: 230 LPWSVRYEVAIGIAEAVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLASWTSAP 289

Query: 344 SVPFLCKTVKGTFG 357
           SVPFLCKTVKGTFG
Sbjct: 290 SVPFLCKTVKGTFG 303

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297805364|ref|XP_002870566.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297316402|gb|EFH46825.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  432 bits (1111), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 227/333 (68%), Positives = 266/333 (79%), Gaps = 21/333 (6%)

Query: 42  IKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTST 101
           IKTLL+KMI+D G +CFLP L+ N  N        S     E+NKAWLLAE+   E  + 
Sbjct: 45  IKTLLKKMIFDLGFACFLPPLAENSGNNNGGAGGGS--GGGENNKAWLLAETA-PENMNP 101

Query: 102 DPQSVHSSFRFSLCSQVELESM--------------NIGASA-SATVLMVNLENGLCDSR 146
           DP SVHSSFRFSLCSQ+ELE M              N+  S  S TVLMVNLENG+ ++ 
Sbjct: 102 DPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSVSGGSTTVLMVNLENGVKET- 160

Query: 147 AQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLL 206
             +L+W + +SLE+SISPVAN+L+R SYGEI+AAT NFSKGRVLGRGA S+VF+GK+G+ 
Sbjct: 161 TDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRNFSKGRVLGRGACSYVFRGKIGMW 220

Query: 207 RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
           RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVPL+GFCIDPE+GLFL+YKYVSGGS
Sbjct: 221 RTTLAIKRLDKEDKESPKSFCRELMIASSLHSFNIVPLLGFCIDPEEGLFLVYKYVSGGS 280

Query: 267 LERHLHE--KKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
           LE +LH+  KKKGV+    LPWS RYKVALGIA+++AYLHNGTE+CVVHRDIKPSNILLS
Sbjct: 281 LEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLS 340

Query: 325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           SKKIPKLCDFGLATWT+APS+PFLCKTVKGTFG
Sbjct: 341 SKKIPKLCDFGLATWTAAPSIPFLCKTVKGTFG 373

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|110738055|dbj|BAF00962.1| protein kinase like protein [Arabidopsis thaliana]

 Score =  431 bits (1109), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 227/341 (66%), Positives = 267/341 (78%), Gaps = 26/341 (7%)

Query: 42  IKTLLRKMIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHN-----KAWLLAESGGA 96
           IKTLL++MI+D G +CFLP LS+  N+  N+    S G           KAWLLAE+   
Sbjct: 43  IKTLLKRMIFDLGFACFLPPLSSTENSGNNNGGGTSGGGGGGGGGGENNKAWLLAETA-P 101

Query: 97  ELTSTDPQSVHSSFRFSLCSQVELESM--------------NIGASA-SATVLMVNLENG 141
           E  + DP SVHSSFRFSLCSQ+ELE M              N+  S  S TVLMVNLENG
Sbjct: 102 ENMNPDPHSVHSSFRFSLCSQIELEKMKGEEPSLSASSSCRNLSVSGGSTTVLMVNLENG 161

Query: 142 LCDSRA---QELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFV 198
           + ++      +L+W + +SLE+SISPVAN+L+R SYGEI+AAT NFSKGRVLGRGA S+V
Sbjct: 162 VKETTGNATDDLRWTRARSLEKSISPVANTLVRFSYGEIVAATRNFSKGRVLGRGACSYV 221

Query: 199 FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI 258
           F+GK+G+ RT++AIKRLDKEDKES K+FCRELMIASSLH  NIVPL+GFCIDPE+GLFL+
Sbjct: 222 FRGKIGMWRTALAIKRLDKEDKESPKSFCRELMIASSLHSSNIVPLLGFCIDPEEGLFLV 281

Query: 259 YKYVSGGSLERHLHE--KKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI 316
           YKYVSGGSLE +LH+  KKKGV+    LPWS RYKVALGIA+++AYLHNGTE+CVVHRDI
Sbjct: 282 YKYVSGGSLEHYLHDKKKKKGVKAAFGLPWSARYKVALGIADAIAYLHNGTEQCVVHRDI 341

Query: 317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           KPSNILLSSKKIPKLCDFGLATWT+APSVPFLCKTVKGTFG
Sbjct: 342 KPSNILLSSKKIPKLCDFGLATWTAAPSVPFLCKTVKGTFG 382

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	372
TAIR|locus:2156050	552	AT5G37790 [Arabidopsis thalian	0.655	0.442	0.724	3.2e-119
TAIR|locus:2028967	467	AT1G66460 [Arabidopsis thalian	0.782	0.623	0.636	7.4e-98
TAIR|locus:2195975	794	AT1G77280 [Arabidopsis thalian	0.534	0.250	0.422	2.1e-35
TAIR|locus:2026957	756	AT1G21590 [Arabidopsis thalian	0.526	0.259	0.410	3.7e-34
TAIR|locus:2151191	378	CDL1 "CDG1-like 1" [Arabidopsi	0.580	0.571	0.371	3.2e-33
TAIR|locus:2171342	636	AT5G16500 [Arabidopsis thalian	0.486	0.284	0.403	5e-32
TAIR|locus:2087263	363	AT3G24790 [Arabidopsis thalian	0.532	0.545	0.378	7.7e-32
TAIR|locus:504954886	1113	AT5G56890 [Arabidopsis thalian	0.524	0.175	0.408	1.6e-31
TAIR|locus:2172555	579	AT5G57670 [Arabidopsis thalian	0.529	0.340	0.389	2.4e-31
TAIR|locus:2091980	432	CDG1 "CONSTITUTIVE DIFFERENTIA	0.5	0.430	0.376	4.2e-31

TAIR|locus:2156050 AT5G37790 [Arabidopsis thaliana (taxid:3702)]

 Score = 948 (338.8 bits), Expect = 3.2e-119, Sum P(2) = 3.2e-119
 Identities = 181/250 (72%), Positives = 216/250 (86%)

Query:   113 SLCSQVELESMNIGASASATVLMVNLENGLCDSRAQ---ELKWRKIQSLERSISPVANSL 169
             SL +     ++++ +  S TVLMVNLENG+ ++      +L+W + +SLE+SISPVAN+L
Sbjct:   138 SLSASSSCRNLSV-SGGSTTVLMVNLENGVKETTGNATDDLRWTRARSLEKSISPVANTL 196

Query:   170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
             +R SYGEI+AAT NFSKGRVLGRGA S+VF+GK+G+ RT++AIKRLDKEDKES K+FCRE
Sbjct:   197 VRFSYGEIVAATRNFSKGRVLGRGACSYVFRGKIGMWRTALAIKRLDKEDKESPKSFCRE 256

Query:   230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWS 287
             LMIASSLH  NIVPL+GFCIDPE+GLFL+YKYVSGGSLE +LH+KKK  GV+    LPWS
Sbjct:   257 LMIASSLHSSNIVPLLGFCIDPEEGLFLVYKYVSGGSLEHYLHDKKKKKGVKAAFGLPWS 316

Query:   288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
              RYKVALGIA+++AYLHNGTE+CVVHRDIKPSNILLSSKKIPKLCDFGLATWT+APSVPF
Sbjct:   317 ARYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLSSKKIPKLCDFGLATWTAAPSVPF 376

Query:   348 LCKTVKGTFG 357
             LCKTVKGTFG
Sbjct:   377 LCKTVKGTFG 386

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2028967 AT1G66460 [Arabidopsis thaliana (taxid:3702)]

 Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
 Identities = 205/322 (63%), Positives = 241/322 (74%)

Query:    49 MIWDFGLSCFLPSLSNNHNNRINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHS 108
             MI D G  CF+P                 + S+ E NKAWLLAE+   +L  ++  S+ S
Sbjct:     1 MILDLGFPCFVPP----------------RTSSREDNKAWLLAETE-PKLIDSEQHSLQS 43

Query:   109 SFRFSLCSQVELESM----------NIGAS-ASATVLMVNLENGLCDSRAQELKWRKIQS 157
             SFRFSLCSQ+ELE +          N   S  S TVL+VNLEN   +    E+ W +  S
Sbjct:    44 SFRFSLCSQLELEKIKKEKPSLSYRNFPVSEGSETVLLVNLENETGELTG-EMNWSRGLS 102

Query:   158 LERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK 217
             LE+SISPVA+SLIR SY E+L AT NFSK RVLGRGA S+VFKG++G+ R +VAIKRLDK
Sbjct:   103 LEKSISPVADSLIRFSYRELLTATRNFSKRRVLGRGACSYVFKGRIGIWRKAVAIKRLDK 162

Query:   218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
             +DKES K+FCRELMIASSL+ PN+VPL+GFCIDP+QGLFL+YKYVSGGSLER LH+KKK 
Sbjct:   163 KDKESPKSFCRELMIASSLNSPNVVPLLGFCIDPDQGLFLVYKYVSGGSLERFLHDKKKK 222

Query:   278 VRGNS--TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
                 +   LPWS RYKVALGIA+++AYLHNGTE+CVVHRDIKPSNILLSS KIPKLCDFG
Sbjct:   223 KSRKTPLNLPWSTRYKVALGIADAIAYLHNGTEQCVVHRDIKPSNILLSSNKIPKLCDFG 282

Query:   336 LATWTSAPSVPFLCKTVKGTFG 357
             LATWT+APSVPFLCKTVKGTFG
Sbjct:   283 LATWTAAPSVPFLCKTVKGTFG 304

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2195975 AT1G77280 [Arabidopsis thaliana (taxid:3702)]

 Score = 391 (142.7 bits), Expect = 2.1e-35, P = 2.1e-35
 Identities = 87/206 (42%), Positives = 123/206 (59%)

Query:   153 RKI-QSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVA 211
             RK+ + LE      +++     Y E+++ T NFS    +G+G  S VF+G +   R  VA
Sbjct:   413 RKLPEELEGLYERFSSTCRFFKYKELVSVTSNFSADNFIGKGGSSRVFRGCLSNGRV-VA 471

Query:   212 IKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL 271
             +K L K+ ++    F  E+ I ++LHH NI+ L+GFC + +  L L+Y Y+S GSLE +L
Sbjct:   472 VKIL-KQTEDVLNDFVAEIEIITTLHHKNIISLLGFCFE-DHNLLLVYNYLSRGSLEENL 529

Query:   272 HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL 331
             H  KK         WS RYKVA+G+AE++ YLHN   + V+HRD+K SNILLS    P+L
Sbjct:   530 HGNKKDPLA---FCWSERYKVAVGVAEALDYLHNTASQPVIHRDVKSSNILLSDDFEPQL 586

Query:   332 CDFGLATWTSAPSVPFLCKTVKGTFG 357
              DFGLA W S  +   +C  V GTFG
Sbjct:   587 SDFGLARWASISTTHIICSDVAGTFG 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2026957 AT1G21590 [Arabidopsis thaliana (taxid:3702)]

 Score = 379 (138.5 bits), Expect = 3.7e-34, P = 3.7e-34
 Identities = 83/202 (41%), Positives = 121/202 (59%)

Query:   156 QSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL 215
             +++E   + ++ S    +Y E+++ T NF     +G+G  S VF+G +   R  VA+K L
Sbjct:   381 ENVEGLQARISTSCQFFTYKELVSVTSNFCADNFIGKGGSSRVFRGYLPNGR-EVAVKIL 439

Query:   216 DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
              K  +   K F  E+ I ++LHH N++ L+G+C +    L L+Y Y+S GSLE +LH  K
Sbjct:   440 -KRTECVLKDFVAEIDIITTLHHKNVISLLGYCFE-NNNLLLVYNYLSRGSLEENLHGNK 497

Query:   276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             K +       W+ RYKVA+GIAE++ YLHN   + V+HRD+K SNILLS    P+L DFG
Sbjct:   498 KDL---VAFRWNERYKVAVGIAEALDYLHNDAPQPVIHRDVKSSNILLSDDFEPQLSDFG 554

Query:   336 LATWTSAPSVPFLCKTVKGTFG 357
             LA W S  +   +C  V GTFG
Sbjct:   555 LAKWASESTTQIICSDVAGTFG 576

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 362 (132.5 bits), Expect = 3.2e-33, P = 3.2e-33
 Identities = 84/226 (37%), Positives = 123/226 (54%)

Query:   143 CDSRAQELKWRKIQSLERSISPVANSLIR--LSYGEILAATHNFSKGRVLGRGALSFVFK 200
             C     E K R   SL  S S  ++ ++    ++ E+  AT NF K  ++G G    V+K
Sbjct:    31 CSVSTSE-KSRAKSSLSESKSKGSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYK 89

Query:   201 GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK 260
             G +     + AIK+LD    + ++ F  E+++ S LHHPN+V L+G+C D +Q L L+Y+
Sbjct:    90 GYLASTSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRL-LVYE 148

Query:   261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN 320
             Y+  GSLE HLH+   G      L W+ R K+A G A+ + YLH+ T   V++RD+K SN
Sbjct:   149 YMPLGSLEDHLHDISPG---KQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSN 205

Query:   321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
             ILL     PKL DFGLA          +   V GT+G   +C  E+
Sbjct:   206 ILLDDDYFPKLSDFGLAKLGPVGDKSHVSTRVMGTYG---YCAPEY 248

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

GO:0045892 "negative regulation of transcription, DNA-dependent" evidence=RCA

TAIR|locus:2171342 AT5G16500 [Arabidopsis thaliana (taxid:3702)]

 Score = 357 (130.7 bits), Expect = 5.0e-32, P = 5.0e-32
 Identities = 75/186 (40%), Positives = 110/186 (59%)

Query:   173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
             ++ E+  AT NF +  +LG G    V+KG +      VA+K+LDK     +K F  E++ 
Sbjct:    63 NFRELATATKNFRQECLLGEGGFGRVYKGTLQSTGQLVAVKQLDKHGLHGNKEFLAEVLS 122

Query:   233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
              + L HPN+V L+G+C D +Q L L+++YVSGGSL+ HL+E+K G +    + W  R K+
Sbjct:   123 LAKLEHPNLVKLIGYCADGDQRL-LVFEYVSGGSLQDHLYEQKPGQK---PMDWITRMKI 178

Query:   293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP-FLCKT 351
             A G A+ + YLH+     V++RD+K SNILL ++  PKLCDFGL           FL   
Sbjct:   179 AFGAAQGLDYLHDKVTPAVIYRDLKASNILLDAEFYPKLCDFGLHNLEPGTGDSLFLSSR 238

Query:   352 VKGTFG 357
             V  T+G
Sbjct:   239 VMDTYG 244

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)]

 Score = 349 (127.9 bits), Expect = 7.7e-32, P = 7.7e-32
 Identities = 78/206 (37%), Positives = 120/206 (58%)

Query:   164 PVANSLIRL-SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES 222
             P  N   R+ ++ E+  AT NF +  ++G G    V+KGK+      VA+K+LD+   + 
Sbjct:    26 PSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKGKLENPAQVVAVKQLDRNGLQG 85

Query:   223 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS 282
              + F  E+++ S LHH N+V L+G+C D +Q L L+Y+Y+  GSLE HL + + G +   
Sbjct:    86 QREFLVEVLMLSLLHHRNLVNLIGYCADGDQRL-LVYEYMPLGSLEDHLLDLEPGQK--- 141

Query:   283 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
              L W+ R K+ALG A+ + YLH+  +  V++RD+K SNILL  + + KL DFGLA     
Sbjct:   142 PLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDPEYVAKLSDFGLAKLGPV 201

Query:   343 PSVPFLCKTVKGTFGQNPFCIEEWQR 368
                  +   V GT+G   +C  E+QR
Sbjct:   202 GDTLHVSSRVMGTYG---YCAPEYQR 224

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)]

 Score = 358 (131.1 bits), Expect = 1.6e-31, P = 1.6e-31
 Identities = 83/203 (40%), Positives = 117/203 (57%)

Query:   157 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
             S E SI+P   S    +  EI+ AT+NF + RVLG G    V++G V    T VA+K L 
Sbjct:   696 SFESSIAPFTLSAKTFTASEIMKATNNFDESRVLGEGGFGRVYEG-VFDDGTKVAVKVLK 754

Query:   217 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
             ++D++ S+ F  E+ + S LHH N+V L+G CI+ ++   L+Y+ +  GS+E HLH    
Sbjct:   755 RDDQQGSREFLAEVEMLSRLHHRNLVNLIGICIE-DRNRSLVYELIPNGSVESHLH---- 809

Query:   277 GV-RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             G+ + +S L W  R K+ALG A  +AYLH  +   V+HRD K SNILL +   PK+ DFG
Sbjct:   810 GIDKASSPLDWDARLKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLENDFTPKVSDFG 869

Query:   336 LA-TWTSAPSVPFLCKTVKGTFG 357
             LA           +   V GTFG
Sbjct:   870 LARNALDDEDNRHISTRVMGTFG 892

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2172555 AT5G57670 [Arabidopsis thaliana (taxid:3702)]

 Score = 349 (127.9 bits), Expect = 2.4e-31, P = 2.4e-31
 Identities = 81/208 (38%), Positives = 116/208 (55%)

Query:   153 RKIQSLERSISPVANSLIR-LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVA 211
             RK +  E    P    LI+  +Y EI  AT++F +G ++G G  S V++G +   R  +A
Sbjct:   235 RKWRGSETKNKPKPQPLIQCFTYNEISKATNDFHQGNIVGIGGYSEVYRGDLWDGRR-IA 293

Query:   212 IKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
             +KRL KE  D    K F  EL I S + HPN   L+G C+  E+GL+L++++   G+L  
Sbjct:   294 VKRLAKESGDMNKEKEFLTELGIISHVSHPNTALLLGCCV--EKGLYLVFRFSENGTLYS 351

Query:   270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
              LHE + G     +L W VRYK+A+G+A  + YLH      ++HRDIK SN+LL     P
Sbjct:   352 ALHENENG-----SLDWPVRYKIAVGVARGLHYLHKRCNHRIIHRDIKSSNVLLGPDYEP 406

Query:   330 KLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             ++ DFGLA W            V+GTFG
Sbjct:   407 QITDFGLAKWLPNKWTHHAVIPVEGTFG 434

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002238 "response to molecule of fungal origin" evidence=RCA

TAIR|locus:2091980 CDG1 "CONSTITUTIVE DIFFERENTIAL GROWTH 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 342 (125.4 bits), Expect = 4.2e-31, P = 4.2e-31
 Identities = 73/194 (37%), Positives = 116/194 (59%)

Query:   173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
             SY E+  AT++F    ++GRG    V+KG++   + ++A+K LD+   +  K F  E+++
Sbjct:    63 SYRELAIATNSFRNESLIGRGGFGTVYKGRLSTGQ-NIAVKMLDQSGIQGDKEFLVEVLM 121

Query:   233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
              S LHH N+V L G+C + +Q L ++Y+Y+  GS+E HL++  +G      L W  R K+
Sbjct:   122 LSLLHHRNLVHLFGYCAEGDQRL-VVYEYMPLGSVEDHLYDLSEG---QEALDWKTRMKI 177

Query:   293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
             ALG A+ +A+LHN  +  V++RD+K SNILL     PKL DFGLA +  +  +  +   V
Sbjct:   178 ALGAAKGLAFLHNEAQPPVIYRDLKTSNILLDHDYKPKLSDFGLAKFGPSDDMSHVSTRV 237

Query:   353 KGTFGQNPFCIEEW 366
              GT G   +C  E+
Sbjct:   238 MGTHG---YCAPEY 248

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0040007 "growth" evidence=IMP

GO:0004672 "protein kinase activity" evidence=IDA

GO:1900459 "positive regulation of brassinosteroid mediated signaling pathway" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	372
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-38
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-36
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-35
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-35
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	7e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-23
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-22
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-19
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-18
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-18
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	9e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-17
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-17
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-17
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	9e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-15
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	8e-15
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-14
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-14
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-14
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-13
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-13
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	6e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	8e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-12
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-12
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-12
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-12
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-12
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-12
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-11
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-11
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-11
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	3e-11
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-11
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-11
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-10
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-10
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	8e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	9e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-09
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-09
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-09
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-09
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-09
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-08
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-08
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-08
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-08
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-08
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-08
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-08
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-08
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-08
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	5e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-08
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	6e-08
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-08
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	8e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-08
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-07
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-07
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	7e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	8e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-07
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-06
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-06
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-06
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-06
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-06
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-06
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-05
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-05
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	9e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-04
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-04
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-04
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-04
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-04
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.001
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.001
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	0.002
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	0.002
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.003
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.003
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	0.003
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  136 bits (345), Expect = 2e-38
 Identities = 62/170 (36%), Positives = 80/170 (47%), Gaps = 14/170 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 248
           LG G    V+  +       VAIK + KED  S      RE+ I   L+HPNIV L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
            D    L+L+ +Y  GGSL+  L E +        L      ++ L I E + YLH    
Sbjct: 61  EDENH-LYLVMEYCEGGSLKDLLKENEGK------LSEDEILRILLQILEGLEYLH---S 110

Query: 309 RCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             ++HRD+KP NILL S     KL DFGL+      S   L KT+ GT  
Sbjct: 111 NGIIHRDLKPENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPA 158

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  131 bits (331), Expect = 6e-36
 Identities = 50/156 (32%), Positives = 72/156 (46%), Gaps = 12/156 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 242
           +     LG G+   V+  +       VAIK + K+  K+  +   RE+ I   L HPNIV
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L     D ++ L+L+ +Y  GG L   L ++ +       L           I  ++ Y
Sbjct: 61  RLYDVFEDEDK-LYLVMEYCEGGDLFDLLKKRGR-------LSEDEARFYLRQILSALEY 112

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           LH    + +VHRD+KP NILL      KL DFGLA 
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLAR 145

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  129 bits (326), Expect = 3e-35
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 14/158 (8%)

Query: 185 SKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHP 239
           + G+ LG GA   V+KG            VA+K L ++  ++  + F RE  I   L HP
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L+G C + E  L ++ +Y+ GG L  +L + +        L  S     AL IA  
Sbjct: 62  NIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNR-----PKELSLSDLLSFALQIARG 115

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + YL     +  +HRD+   N L+    + K+ DFGL+
Sbjct: 116 MEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLS 150

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  128 bits (325), Expect = 5e-35
 Identities = 54/159 (33%), Positives = 79/159 (49%), Gaps = 17/159 (10%)

Query: 185 SKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHH 238
           + G+ LG GA   V+KGK     G  +  VA+K L KED      + F RE  I   L H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL-KEDASEQQIEEFLREARIMRKLDH 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PN+V L+G C + E  L+++ +Y+ GG L  +L + +        L  S     AL IA 
Sbjct: 61  PNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + YL     +  +HRD+   N L+    + K+ DFGL+
Sbjct: 114 GMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLS 149

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (324), Expect = 7e-35
 Identities = 59/174 (33%), Positives = 79/174 (45%), Gaps = 15/174 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK--AFCRELMIASSLHHPNI 241
           +   R LG G+   V+K K       VA+K L K  ++S K     RE+ I   L HPNI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+    D +  L+L+ +Y  GG L  +L            L      K+AL I   + 
Sbjct: 61  VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGGP-------LSEDEAKKIALQILRGLE 112

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           YLH      ++HRD+KP NILL    + K+ DFGLA      S      T  GT
Sbjct: 113 YLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGT 161

Length = 260

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  125 bits (317), Expect = 7e-34
 Identities = 64/176 (36%), Positives = 87/176 (49%), Gaps = 13/176 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            +++G +LGRG+   V+          +A+K   L  + +E  +A  RE+ I SSL HPN
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV   G   D E+    I+ +YVSGGSL   L +  K       LP  V  K    I E 
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-------LPEPVIRKYTRQILEG 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +AYLH      +VHRDIK +NIL+ S  + KL DFG A             +V+GT
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 1e-32
 Identities = 54/157 (34%), Positives = 79/157 (50%), Gaps = 12/157 (7%)

Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIV 242
           + LG GA   V+KGK+       T VA+K L KED      K F +E  +   L HPN+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKDFLKEARVMKKLGHPNVV 59

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN--STLPWSVRYKVALGIAESV 300
            L+G C + E  L+L+ +Y+ GG L  +L + +        STL        A+ IA+ +
Sbjct: 60  RLLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N L+    + K+ DFGL+
Sbjct: 119 EYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (295), Expect = 1e-30
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 15/159 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH 238
              G+ LG GA   V+KG +        T VA+K L +   +E  + F  E  I   L H
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L+G C    + L+++ +Y+ GG L   L +          L      ++AL IA+
Sbjct: 61  PNIVRLLGVCTQ-GEPLYIVTEYMPGGDLLDFLRKHG------EKLTLKDLLQMALQIAK 113

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + YL     +  VHRD+   N L++   + K+ DFGL+
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLS 149

Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.7 bits (244), Expect = 6e-23
 Identities = 67/182 (36%), Positives = 91/182 (50%), Gaps = 20/182 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSL-HH 238
           ++   R LG G+   V+  +    R  VA+K L K+ +  SK    F RE+ I +SL H 
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L  F  D    L+L+ +YV GGSLE  L +  +       L  S    +   I  
Sbjct: 58  PNIVKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGR----KGPLSESEALFILAQILS 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW----TSAPSVPFLCKTVK 353
           ++ YLH    + ++HRDIKP NILL    ++ KL DFGLA       S  S+P L  T  
Sbjct: 113 ALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV 169

Query: 354 GT 355
           GT
Sbjct: 170 GT 171

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 10/155 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           F     +G+G    V+K +       VAIK +  E KE  +    E+ I     HPNIV 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             G     +  L+++ ++ SGGSL+  L    +      TL  S    V   + + + YL
Sbjct: 62  YYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQ------TLTESQIAYVCKELLKGLEYL 114

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           H+     ++HRDIK +NILL+S    KL DFGL+ 
Sbjct: 115 HS--NG-IIHRDIKAANILLTSDGEVKLIDFGLSA 146

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 94.2 bits (235), Expect = 3e-22
 Identities = 58/161 (36%), Positives = 88/161 (54%), Gaps = 19/161 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+  G ++GRGA   V+KG        VAIK++  E  +    K+  +E+ +  +L HPN
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA--- 297
           IV  +G  I+    L++I +Y   GSL + +  KK G       P S+   VA+ +    
Sbjct: 61  IVKYIGS-IETSDSLYIILEYAENGSLRQII--KKFG-----PFPESL---VAVYVYQVL 109

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           + +AYLH   E+ V+HRDIK +NIL +   + KL DFG+AT
Sbjct: 110 QGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVAT 147

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.0 bits (234), Expect = 6e-22
 Identities = 50/162 (30%), Positives = 82/162 (50%), Gaps = 22/162 (13%)

Query: 184 FSKGRVLGRGALSFVFKG-------KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASS 235
             K +VLG GA   V+KG       KV +    VAIK L ++   +++K    E  + +S
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKI---PVAIKVLREETSPKANKEILDEAYVMAS 65

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP++V L+G C      + LI + +  G L  ++   K  +     L W V+      
Sbjct: 66  VDHPHVVRLLGIC--LSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------ 117

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           IA+ ++YL    E+ +VHRD+   N+L+ + +  K+ DFGLA
Sbjct: 118 IAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 63/173 (36%), Positives = 80/173 (46%), Gaps = 22/173 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR-LDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           LG GA   V K ++       A+K      + +  K   REL I  S   P IV   G  
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68

Query: 249 IDPEQG-LFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGIAESV----AY 302
           +D     + +  +Y  GGSL+    + KK+G R           KV   IAESV    +Y
Sbjct: 69  LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE--------KVLGKIAESVLKGLSY 120

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           LH    R ++HRDIKPSNILL+ K   KLCDFG+    S   V  L  T  GT
Sbjct: 121 LH---SRKIIHRDIKPSNILLTRKGQVKLCDFGV----SGELVNSLAGTFTGT 166

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.2 bits (225), Expect = 1e-20
 Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 13/156 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   LG G    V+K +       VA+K  RLD E++       RE+ +   L HPNI
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+       + L+L+++Y     L+++L ++   +  N      ++  +   +   +A
Sbjct: 61  VKLLDVIHTERK-LYLVFEYCDM-DLKKYLDKRPGPLSPNL-----IKS-IMYQLLRGLA 112

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           Y H      ++HRD+KP NIL++   + KL DFGLA
Sbjct: 113 YCH---SHRILHRDLKPQNILINRDGVLKLADFGLA 145

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 87.9 bits (219), Expect = 5e-20
 Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 17/173 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFC-RELMIASSLHHPNIVPLV 245
           + +G+G+   V+  +         +K +D     E  +     E+ I   L+HPNI+   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG---NSTLPWSVRYKVALGIAESVAY 302
               + +  L ++ +Y  GG L + + ++KK  +       L W V+      +  ++ Y
Sbjct: 66  ESFEE-KGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------LCLALKY 118

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           LH    R ++HRDIKP NI L+S  + KL DFG++   S+     L KTV GT
Sbjct: 119 LH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGT 166

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 85.2 bits (211), Expect = 8e-19
 Identities = 48/164 (29%), Positives = 76/164 (46%), Gaps = 13/164 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           + +  R LG GA   V++G             VA+K L +   E  ++ F  E +I S  
Sbjct: 7   SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           +H NIV L+G   +     F++ + ++GG L+  L E +      S+L        A  +
Sbjct: 67  NHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           A+   YL    E   +HRDI   N LL+ K   ++ K+ DFG+A
Sbjct: 126 AKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA 166

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 22/158 (13%)

Query: 188 RVLGRGALSFVFK------GKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPN 240
             LG G    V K      GK+      +A+K +  E ++   K   REL I    + P 
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKI------MAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV   G   +    + +  +Y+ GGSL++ L E +  +      P  +  K+A+ + + +
Sbjct: 61  IVGFYGAFYN-NGDISICMEYMDGGSLDKILKEVQGRI------PERILGKIAVAVLKGL 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            YLH   +  ++HRD+KPSNIL++S+   KLCDFG++ 
Sbjct: 114 TYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG 149

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 51/171 (29%), Positives = 76/171 (44%), Gaps = 19/171 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-----EDKESSKAFCRELMIASSL 236
            +F  G+++G G+ S V   K        AIK LDK     E K   K    E  + + L
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKV--KYVKIEKEVLTRL 58

Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
             HP I+ L     D E  L+ + +Y   G L +++ +      G+     +  Y  A  
Sbjct: 59  NGHPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFY--AAE 110

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           I  ++ YLH+   + ++HRD+KP NILL      K+ DFG A      S P
Sbjct: 111 ILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 19/161 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G    V+K +       VA+K  R++ E +       RE+ +   L HPNIV L   
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66

Query: 248 CIDPEQG-LFLIYKYVS---GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                +G ++++++Y+     G L+    +         T    ++      + E + YL
Sbjct: 67  VTSKGKGSIYMVFEYMDHDLTGLLDSPEVK--------FTES-QIKC-YMKQLLEGLQYL 116

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           H+     ++HRDIK SNIL+++  + KL DFGLA   +  +
Sbjct: 117 HS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 81.9 bits (203), Expect = 9e-18
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 23/163 (14%)

Query: 183 NFSKGRVLGRGALSFVFK------GKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASS 235
           +  + +VLG+G+   V+K      GK+       A+K++    D+E  K   REL    S
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKI------YALKKIHVDGDEEFRKQLLRELKTLRS 55

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
              P +V   G      + + ++ +Y+ GGSL   L +K   +      P  V   +A  
Sbjct: 56  CESPYVVKCYGAFYKEGE-ISIVLEYMDGGSLAD-LLKKVGKI------PEPVLAYIARQ 107

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           I + + YLH  T+R ++HRDIKPSN+L++SK   K+ DFG++ 
Sbjct: 108 ILKGLDYLH--TKRHIIHRDIKPSNLLINSKGEVKIADFGISK 148

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 53/163 (32%), Positives = 78/163 (47%), Gaps = 15/163 (9%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           V+G GA   V K +       VAIK+    ++D++  K   RE+ +   L H NIV L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 305
                +  L+L+++YV    LE  L     G+      P +VR      + +++AY H +
Sbjct: 68  AFRR-KGRLYLVFEYVERTLLE-LLEASPGGLP-----PDAVR-SYIWQLLQAIAYCHSH 119

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
                ++HRDIKP NIL+S   + KLCDFG A    A     L
Sbjct: 120 N----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPL 158

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 82.1 bits (203), Expect = 1e-17
 Identities = 53/157 (33%), Positives = 85/157 (54%), Gaps = 11/157 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           +++K   +G G    V+KG+       VA+K  RL+ E++       RE+ +   L HPN
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L    +  E  L+LI++++S   L+++L    KG   ++ L  S  Y++  GI    
Sbjct: 61  IVCLQDVLMQ-ESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGIL--- 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + H    R V+HRD+KP N+L+ +K + KL DFGLA
Sbjct: 116 -FCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 47/156 (30%), Positives = 76/156 (48%), Gaps = 15/156 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           + LG G    V   +   L  +    VA+K L+   +E  ++ F RE+ I  +L H NIV
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 243 PLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
              G C  P  + L LI +Y+  GSL  +L   +  +     L   + +  +  I + + 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQI-NLKRL---LLF--SSQICKGMD 123

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL +   +  +HRD+   NIL+ S+ + K+ DFGLA
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLA 156

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.2 bits (198), Expect = 3e-17
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 19/175 (10%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELMIASSLHHPN 240
           KG +LG G+   V++G         A+K +      +  +E+ K   +E+ + S L HPN
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN 63

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV  +G   + E  L++  + V GGSL + L  KK G     + P  V       I   +
Sbjct: 64  IVQYLGTERE-EDNLYIFLELVPGGSLAKLL--KKYG-----SFPEPVIRLYTRQILLGL 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
            YLH+   R  VHRDIK +NIL+ +  + KL DFG+A      S     K+ KG+
Sbjct: 116 EYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGS 164

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 32/183 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
            + KG+ LG G  + V+K +       VAIK++   +++ +K      A  RE+ +   L
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTAL-REIKLLQEL 59

Query: 237 HHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA-- 293
            HPNI+ L+  F       + L+++++    LE+ + +K            S+    A  
Sbjct: 60  KHPNIIGLLDVFGHK--SNINLVFEFMET-DLEKVIKDK------------SIVLTPADI 104

Query: 294 ----LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
               L     + YLH+     ++HRD+KP+N+L++S  + KL DFGLA    +P+     
Sbjct: 105 KSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTH 161

Query: 350 KTV 352
           + V
Sbjct: 162 QVV 164

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 62/184 (33%), Positives = 92/184 (50%), Gaps = 26/184 (14%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS--VAIKR--LDKEDKESSKAFCRELM----IASS 235
           ++KG VLG+GA   V+    GL      +A+K+  LD  +  +++    +L     +  S
Sbjct: 2   WTKGEVLGKGAYGTVY---CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKS 58

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H NIV  +G C+D +  + +  ++V GGS+   L   + G      LP  V  K    
Sbjct: 59  LKHVNIVQYLGTCLD-DNTISIFMEFVPGGSISSIL--NRFG-----PLPEPVFCKYTKQ 110

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSAP-SVPFLCKT 351
           I + VAYLHN    CVVHRDIK +N++L    I KL DFG A    W     +   + K+
Sbjct: 111 ILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 352 VKGT 355
           + GT
Sbjct: 168 MHGT 171

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 12/152 (7%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
            G  +G+G    V  G        VA+K L K+D  +++AF  E  + ++L HPN+V L+
Sbjct: 10  LGATIGKGEFGDVMLGD--YRGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLL 66

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G  +     L+++ +Y++ GSL  +L       RG + +  + +   AL + E + YL  
Sbjct: 67  GVVLQ-GNPLYIVTEYMAKGSLVDYLRS-----RGRAVITLAQQLGFALDVCEGMEYLE- 119

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E+  VHRD+   N+L+S   + K+ DFGLA
Sbjct: 120 --EKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 54/151 (35%), Positives = 73/151 (48%), Gaps = 11/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            R LG G    V+ G      T VA+K L K    S +AF +E  I   L H  +V L  
Sbjct: 11  ERKLGAGQFGEVWMG-TWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C + E  ++++ +Y+S GSL   L   K G      LP  V   +A  IAE +AYL   
Sbjct: 69  VCSEEEP-IYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLV--DMAAQIAEGMAYLE-- 120

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             R  +HRD+   NIL+    + K+ DFGLA
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLA 150

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 77.5 bits (191), Expect = 2e-16
 Identities = 44/151 (29%), Positives = 73/151 (48%), Gaps = 12/151 (7%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLVG 246
             +G+G    V+KG +    T VA+K          K  F +E  I     HPNIV L+G
Sbjct: 1   EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C+  +Q ++++ + V GGSL   L +KK  +     L      +++L  A  + YL + 
Sbjct: 60  VCVQ-KQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLL------QMSLDAAAGMEYLES- 111

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +  +HRD+   N L+    + K+ DFG++
Sbjct: 112 --KNCIHRDLAARNCLVGENNVLKISDFGMS 140

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 77.4 bits (191), Expect = 3e-16
 Identities = 47/151 (31%), Positives = 69/151 (45%), Gaps = 19/151 (12%)

Query: 211 AIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
           A+K  R+   D ++ K    E+ +   L HPN+V   G  +  E+ +++  +Y SGG+LE
Sbjct: 29  AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFMEYCSGGTLE 87

Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +        L   V     L + E +AYLH      +VHRDIKP+NI L    +
Sbjct: 88  ELLEHGR-------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGV 137

Query: 329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQN 359
            KL DFG A      +      T  G   Q+
Sbjct: 138 IKLGDFGCAVKLKNNT------TTMGEEVQS 162

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.8 bits (192), Expect = 5e-16
 Identities = 56/178 (31%), Positives = 84/178 (47%), Gaps = 23/178 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            F K   +G G    V++ +       VA+K  R+D E      +  RE+ +  +L HPN
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 241 IVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV-RYK-VAL 294
           IV L    VG  +D    +FL+ +Y      E+ L      +  N   P+S  + K + L
Sbjct: 68  IVELKEVVVGKHLD---SIFLVMEYC-----EQDL----ASLLDNMPTPFSESQVKCLML 115

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
            +   + YLH   E  ++HRD+K SN+LL+ K   K+ DFGLA     P+ P   K V
Sbjct: 116 QLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 52/155 (33%), Positives = 84/155 (54%), Gaps = 16/155 (10%)

Query: 188 RVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIV 242
           +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ HP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+ + Y
Sbjct: 73  RLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMY 124

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           L    ER +VHRD+   N+L+ S    K+ DFGLA
Sbjct: 125 LE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.1 bits (187), Expect = 9e-16
 Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 16/157 (10%)

Query: 186 KGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPN 240
           K ++LG G    V KG    +   ++  VAIK + D+  +++ +     ++   SL H  
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+G C  P   L L+ +    GSL  H+ + +  +     L W V+      IA+ +
Sbjct: 71  IVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGM 122

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    E  +VHR++   NILL S  I ++ DFG+A
Sbjct: 123 YYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 47/169 (27%), Positives = 85/169 (50%), Gaps = 19/169 (11%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPN 240
           + K   +G G    V+K +  L    VAIK++ K   ES    K   RE+ +   L+HPN
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAES 299
           I+ L+      +  L+L+++++          +  K ++     LP S+       + + 
Sbjct: 60  IIKLLD-VFRHKGDLYLVFEFM--------DTDLYKLIKDRQRGLPESLIKSYLYQLLQG 110

Query: 300 VAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
           +A+ H +G    ++HRD+KP N+L++++ + KL DFGLA    +P  P+
Sbjct: 111 LAFCHSHG----ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY 155

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 75.2 bits (186), Expect = 2e-15
 Identities = 58/174 (33%), Positives = 83/174 (47%), Gaps = 26/174 (14%)

Query: 190 LGRGALSFVFKGKVGLLR---TSV--AIKRLDKE---DKESSKAFCRELMIASSLHHPNI 241
           LG+G  SF   GKV L+R   T    A+K L K+    ++  +    E  I S ++HP I
Sbjct: 1   LGKG--SF---GKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L  +    E+ L+L+ +Y  GG L  HL +      G  +   +  Y  A  I  ++ 
Sbjct: 56  VKLH-YAFQTEEKLYLVLEYAPGGELFSHLSK-----EGRFSEERARFY--AAEIVLALE 107

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           YLH+     +++RD+KP NILL +    KL DFGLA      S      T  GT
Sbjct: 108 YLHS---LGIIYRDLKPENILLDADGHIKLTDFGLA--KELSSEGSRTNTFCGT 156

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 6/112 (5%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           E+ I   L HPNIV      ID   Q L+++ +Y  GG L + +   +K  +    +   
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI---QKCKKERKYIEEE 105

Query: 288 VRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +++   +  ++   HN +     V+HRD+KP+NI L +    KL DFGLA
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 48/160 (30%), Positives = 77/160 (48%), Gaps = 16/160 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHP 239
           +F   RV+G+GA   V   +    +   A+K ++K+    K S +    E  I   L+HP
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 240 NIVPL-VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            +V L   F    E+ ++L+   + GG L  HL +K K           V++ +   I  
Sbjct: 61  FLVNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFSEE------QVKFWIC-EIVL 111

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           ++ YLH    + ++HRDIKP NILL  +    + DF +AT
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIAT 148

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 18/162 (11%)

Query: 183 NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           N+ +G++LG+GA   V+       G+  L    V       E K+   A   E+ +  +L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGR-ELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H  IV   G C+  ++ L +  +Y+ GGS++  L       +    L  +V  K    I
Sbjct: 62  QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-------KAYGALTETVTRKYTRQI 113

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            E V YLH+     +VHRDIK +NIL  S    KL DFG + 
Sbjct: 114 LEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 53/163 (32%), Positives = 80/163 (49%), Gaps = 19/163 (11%)

Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVP 243
           LG GA   V+KG++      L  TSVAIK L +  + +  + F +E  + S L HPNIV 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTLPWSVRY----KVAL 294
           L+G C   EQ   ++++Y++ G L   L     H       G+ T+  S+       +A+
Sbjct: 73  LLGVCTK-EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            IA  + YL   +    VHRD+   N L+      K+ DFGL+
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 73.1 bits (179), Expect = 8e-15
 Identities = 47/156 (30%), Positives = 82/156 (52%), Gaps = 14/156 (8%)

Query: 188 RVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + +G+G    V    +G  R   VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 12  QTIGKGEFGDVM---LGDYRGNKVAVKCI-KNDA-TAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL   
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEAN 121

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
                VHRD+   N+L+S   + K+ DFGL    S+
Sbjct: 122 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNIVPL 244
              +G GA   VFK K      +VA+K++     E        RE+    +  HP +V L
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 245 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           +   + P   G  L+ +Y+    L   L ++++       LP +        + + VAY+
Sbjct: 65  LD--VFPHGSGFVLVMEYM-PSDLSEVLRDEER------PLPEAQVKSYMRMLLKGVAYM 115

Query: 304 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           H NG    ++HRD+KP+N+L+S+  + K+ DFGLA
Sbjct: 116 HANG----IMHRDLKPANLLISADGVLKIADFGLA 146

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 16/162 (9%)

Query: 188 RVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
             LG GA   V++G        G     VA+K L K   +  K  F +E  + S+ +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+G C+  E   ++I + + GG L  +L + +    G   L       + L +A+  
Sbjct: 61  IVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDFGLA 337
            YL    +   +HRD+   N L+S K     ++ K+ DFGLA
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 44/151 (29%), Positives = 78/151 (51%), Gaps = 14/151 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           G ++G G    V +G+    + +V   + D     +++AF  E  + + LHH N+V L+G
Sbjct: 11  GEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLG 66

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             +    GL+++ + +S G+L   L       RG + +      + +L +AE + YL + 
Sbjct: 67  VIL--HNGLYIVMELMSKGNLVNFLR-----TRGRALVSVIQLLQFSLDVAEGMEYLES- 118

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             + +VHRD+   NIL+S   + K+ DFGLA
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 65/203 (32%), Positives = 98/203 (48%), Gaps = 30/203 (14%)

Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           E++W+ I+S+  +    I P      +L Y        +N S G+ LG GA   V +   
Sbjct: 2   EVRWKVIESINGNEYVYIDP-----TQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATA 56

Query: 204 -GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCI--DPEQG 254
            GL ++   +K   K  K ++     +A   EL I S L +H NIV L+G C    P   
Sbjct: 57  YGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP--- 113

Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           + +I +Y   G L   L  K++       L  S  Y+VA G+A    +L   ++ C+ HR
Sbjct: 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDL-LSFSYQVAKGMA----FL--ASKNCI-HR 165

Query: 315 DIKPSNILLSSKKIPKLCDFGLA 337
           D+   N+LL+  KI K+CDFGLA
Sbjct: 166 DLAARNVLLTHGKIVKICDFGLA 188

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 20/170 (11%)

Query: 191 GRGALSFVFK--GKVGLLRTSVAIKRLDKEDKES----SKAFCRELMIASSLHHPNIVPL 244
           GRG    V+K   K G      AIK+  K DKE     S++ CRE+ +   L H N+V L
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 245 VGFCIDP-EQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           V   ++  ++ ++L++ Y      +    H + K V    ++  S+ +++  G+     Y
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGV----HY 123

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFL 348
           LH      V+HRD+KP+NIL+  +       K+ D GLA   +AP  P  
Sbjct: 124 LH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 72.2 bits (178), Expect = 2e-14
 Identities = 61/185 (32%), Positives = 82/185 (44%), Gaps = 41/185 (22%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA---FCRELMIAS 234
           +F   + LG G  SF   G+V L+R        A+K L K      K       E  I  
Sbjct: 2   DFEFIKTLGTG--SF---GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ 56

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KV 292
           S+ HP +V L G   D    L+L+ +YV GG L  HL  +K G       P +  Y  +V
Sbjct: 57  SIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHL--RKSG---RFPEPVARFYAAQV 110

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVP 346
            L +     YLH+     +V+RD+KP N+LL S    K+ DFG A      T+T      
Sbjct: 111 VLALE----YLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT------ 157

Query: 347 FLCKT 351
            LC T
Sbjct: 158 -LCGT 161

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 43/129 (33%), Positives = 67/129 (51%), Gaps = 10/129 (7%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     E  + F RE+ I  SL H NIV   G C     + L L+ +Y+  GSL 
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLR 95

Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + ++ +     L ++ +      I + + YL  G++R  VHRD+   NIL+ S+  
Sbjct: 96  DYLQKHRERLDHRKLLLYASQ------ICKGMEYL--GSKRY-VHRDLATRNILVESENR 146

Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 147 VKIGDFGLT 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 16/151 (10%)

Query: 190 LGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 245
           LG G    V KG           VA+K L +E   + K  F RE  + + L HP IV L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C      L L+ +    G L ++L       +    +P S   ++A  +A  +AYL  
Sbjct: 63  GVCKGE--PLMLVMELAPLGPLLKYL-------KKRREIPVSDLKELAHQVAMGMAYLE- 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
              +  VHRD+   N+LL ++   K+ DFG+
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 71.4 bits (175), Expect = 3e-14
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 10/148 (6%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 73  R-EPPFYIITEFMTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLE---KK 123

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD+   N L+    + K+ DFGL+
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLS 151

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.3 bits (175), Expect = 4e-14
 Identities = 48/152 (31%), Positives = 69/152 (45%), Gaps = 16/152 (10%)

Query: 190 LGRGALSFVFKGK---VGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPL 244
           LG G+   V +G+    G     VA+K L K DK  +    F +E  I  SL H N++ L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCL-KSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G  +     L ++ +    GSL   L +   G         S     A+ IA  + YL 
Sbjct: 62  YGVVLTHP--LMMVTELAPLGSLLDRLRKDALGH-----FLISTLCDYAVQIANGMRYLE 114

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             ++R + HRD+   NILL+S    K+ DFGL
Sbjct: 115 --SKRFI-HRDLAARNILLASDDKVKIGDFGL 143

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 51/154 (33%), Positives = 74/154 (48%), Gaps = 13/154 (8%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPLVG- 246
           V+G GA + V+          VAIKR+D E  ++S     +E+   S  +HPN+V     
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 305
           F +  E  L+L+  Y+SGGSL   L   K        L  ++   V   + + + YLH N
Sbjct: 68  FVVGDE--LWLVMPYLSGGSL---LDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN 121

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           G     +HRDIK  NILL      K+ DFG++  
Sbjct: 122 GQ----IHRDIKAGNILLGEDGSVKIADFGVSAS 151

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 70.3 bits (172), Expect = 8e-14
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 17/177 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
            + K RV+GRGA   V   +    +  V IK++  E   K+   A   E  +   L HPN
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 241 IVPLV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           I+     F  D  + L ++ +Y  GG+L  ++ +     R NS L         + I  +
Sbjct: 61  IIEYYENFLED--KALMIVMEYAPGGTLAEYIQK-----RCNSLLDEDTILHFFVQILLA 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + ++H    + ++HRD+K  NILL   K + K+ DFG++   S+ S  +   TV GT
Sbjct: 114 LHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY---TVVGT 164

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 70.5 bits (173), Expect = 9e-14
 Identities = 49/157 (31%), Positives = 77/157 (49%), Gaps = 13/157 (8%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           ++G G+   V K K       VAIK+    ++DK   K   RE+ +   L H N+V L+ 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ L+L++++V    L+    + +K   G   L  S   K    I   + + H+ 
Sbjct: 68  VF-RRKKRLYLVFEFVDHTVLD----DLEKYPNG---LDESRVRKYLFQILRGIEFCHSH 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
               ++HRDIKP NIL+S   + KLCDFG A   +AP
Sbjct: 120 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 44/156 (28%), Positives = 75/156 (48%), Gaps = 17/156 (10%)

Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVP 243
           RV+G+G    V+ G +      +   A+K L++  D E  + F +E +I     HPN++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVA 301
           L+G C+  E    ++  Y+  G L R+       +R  +  P +V+  +  G  +A+ + 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL-RNF------IRSETHNP-TVKDLIGFGLQVAKGME 112

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL     +  VHRD+   N +L      K+ DFGLA
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLA 145

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 14/156 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           N  K   +G GA   V+K         VAIK++    +        E++I     HPNIV
Sbjct: 23  NLEK---IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII-NEILIMKDCKHPNIV 78

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 +  ++ L+++ +Y+ GGSL   + +          +       V   + + + Y
Sbjct: 79  DYYDSYLVGDE-LWVVMEYMDGGSLTDIITQNFV------RMNEPQIAYVCREVLQGLEY 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           LH+   + V+HRDIK  NILLS     KL DFG A 
Sbjct: 132 LHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAA 164

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 56/159 (35%), Positives = 82/159 (51%), Gaps = 16/159 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF +   LG G  + V+KG+       VA+K   LD E+   S A  RE+ +   L H N
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKHEN 59

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG--NSTLPWSVRYKVALGIAE 298
           IV L    I  E  L L+++Y+    L++++     GVRG  +     S  Y++  GIA 
Sbjct: 60  IVRLHD-VIHTENKLMLVFEYMDK-DLKKYM--DTHGVRGALDPNTVKSFTYQLLKGIA- 114

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + H   E  V+HRD+KP N+L++ +   KL DFGLA
Sbjct: 115 ---FCH---ENRVLHRDLKPQNLLINKRGELKLADFGLA 147

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 14/166 (8%)

Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--SKAFCRELM 231
           +G +   T+ +   + +G GA   V   +  L   +VAIK++ K       +K   REL 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           +   L H NI+ L    I P + ++ + + + G  L R L  +             ++Y 
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP-------LEKQFIQY- 112

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               I   + Y+H+     VVHRD+KPSNIL++     K+CDFGLA
Sbjct: 113 FLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 13/150 (8%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLG+G    V+  +    +  +AIK + + D    +    E+ + S L H NIV  +G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74

Query: 249 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 306
              E G F I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH  
Sbjct: 75  S--ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLH-- 125

Query: 307 TERCVVHRDIKPSNILLSS-KKIPKLCDFG 335
            +  +VHRDIK  N+L+++   + K+ DFG
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFG 154

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 23/163 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED---KESSKAFCRELMIAS 234
           ++   RVLG+GA      G+  L R +     V  K ++      KE   A   E++I S
Sbjct: 1   HYIPIRVLGKGAF-----GEATLYRRTEDDSLVVWKEVNLTRLSEKERRDAL-NEIVILS 54

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HPNI+      +D +  L +  +Y +GG+L   +  +K  +     + W        
Sbjct: 55  LLQHPNIIAYYNHFMD-DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLF 108

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            I  +V+Y+H   +  ++HRDIK  NI L+   + KL DFG++
Sbjct: 109 QIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGIS 148

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 3e-13
 Identities = 44/152 (28%), Positives = 70/152 (46%), Gaps = 16/152 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V+K +       VAIK +  E  +  +   +E+ +     HPNIV   G  +
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV---AYLHNG 306
             ++ L+++ +Y  GGSL+               L      ++A    E++   AYLH  
Sbjct: 71  RRDK-LWIVMEYCGGGSLQDIYQV------TRGPLS---ELQIAYVCRETLKGLAYLH-- 118

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            E   +HRDIK +NILL+     KL DFG++ 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSA 149

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.5 bits (167), Expect = 3e-13
 Identities = 50/151 (33%), Positives = 76/151 (50%), Gaps = 14/151 (9%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVG 246
           +LG+G    VFKG +   +T VA+K   KED  +E    F  E  I     HPNIV L+G
Sbjct: 2   LLGKGNFGEVFKGTLKD-KTPVAVKTC-KEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C    Q ++++ + V GG     L +KK  ++    +      K AL  A  +AYL   
Sbjct: 60  VCTQ-RQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV------KFALDAAAGMAYLE-- 110

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++ C +HRD+   N L+    + K+ DFG++
Sbjct: 111 SKNC-IHRDLAARNCLVGENNVLKISDFGMS 140

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 68.6 bits (168), Expect = 3e-13
 Identities = 54/172 (31%), Positives = 75/172 (43%), Gaps = 24/172 (13%)

Query: 189 VLGRGALSFVFKGK-----VGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIV 242
            LGRG    VF  K          T V +K L K   E+ +  F REL +   L H N+V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C + E   ++I +Y   G L++ L   K         P S + KVAL   IA  +
Sbjct: 72  RLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
            +L N      VHRD+   N L+SS++  K+            S+  L K V
Sbjct: 131 DHLSNAR---FVHRDLAARNCLVSSQREVKV------------SLLSLSKDV 167

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 17/171 (9%)

Query: 177 ILAATHNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELM 231
           IL  T  F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  
Sbjct: 3   ILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + +S+ +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+  
Sbjct: 62  VMASVDNPHVCRLLGICL--TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ-- 117

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
               IA+ + YL    ER +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 118 ----IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 68.4 bits (168), Expect = 5e-13
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 27/138 (19%)

Query: 210 VAIKRLDKEDKESSKAF----CRELMIASSLHHPNIVPL----VGFCIDPEQGLFLIYKY 261
           VA+K+L K +KE    F     RE+ I   L HPNIV +    VG  +D    ++++ +Y
Sbjct: 33  VALKKL-KMEKEKE-GFPITSLREINILLKLQHPNIVTVKEVVVGSNLDK---IYMVMEY 87

Query: 262 VSGGSLERHLHEKKKGVRGNSTLPWSV--RYKVALGIAESVAYLHNGTERCVVHRDIKPS 319
           V     E  L    K +      P+       + L +   VA+LH   +  ++HRD+K S
Sbjct: 88  V-----EHDL----KSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTS 135

Query: 320 NILLSSKKIPKLCDFGLA 337
           N+LL+++ I K+CDFGLA
Sbjct: 136 NLLLNNRGILKICDFGLA 153

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.3 bits (167), Expect = 5e-13
 Identities = 54/171 (31%), Positives = 81/171 (47%), Gaps = 25/171 (14%)

Query: 188 RVLGRGALSFVFKGKV-GLL----RTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 241
           R +G+GA   VF+ +  GLL     T VA+K L +E     +A F RE  + +   HPNI
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRY---------- 290
           V L+G C   +  + L+++Y++ G L   L H   +     S    S R           
Sbjct: 71  VKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 291 ----KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+
Sbjct: 130 TEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 177

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 68.2 bits (167), Expect = 5e-13
 Identities = 43/157 (27%), Positives = 73/157 (46%), Gaps = 15/157 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V++G        + +VA+K        S +  F +E  I     HP+IV
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G   +    ++++ +    G L  +L   K       +L  +     +  ++ ++AY
Sbjct: 71  KLIGVITENP--VWIVMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAY 122

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           L   ++R V HRDI   N+L+SS    KL DFGL+ +
Sbjct: 123 LE--SKRFV-HRDIAARNVLVSSPDCVKLGDFGLSRY 156

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 54/161 (33%), Positives = 71/161 (44%), Gaps = 32/161 (19%)

Query: 189 VLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED------KESSKAFCRELMIASSLH 237
           VLGRG       GKV L          AIK L K D       ES     R    A+S  
Sbjct: 6   VLGRGHF-----GKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--VALG 295
           HP +V L   C   E  +  + +Y +GG L  H+H          + P +V Y   V LG
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDV------FSEPRAVFYAACVVLG 113

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           +     YLH   E  +V+RD+K  N+LL ++   K+ DFGL
Sbjct: 114 LQ----YLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 68.7 bits (169), Expect = 6e-13
 Identities = 46/171 (26%), Positives = 68/171 (39%), Gaps = 47/171 (27%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V           VAIK++    +D   +K   RE+ +   L H NI+ L+
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65

Query: 246 GFCIDPEQGLF----------------LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
                P    F                +I    S   L    H               ++
Sbjct: 66  DILRPPSPEDFNDVYIVTELMETDLHKVIK---SPQPLT-DDH---------------IQ 106

Query: 290 ---YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              Y++  G+     YLH+     V+HRD+KPSNIL++S    K+CDFGLA
Sbjct: 107 YFLYQILRGL----KYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLA 150

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 49/157 (31%), Positives = 81/157 (51%), Gaps = 12/157 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+   I  E  L+L+++++    L++ +          S +P  +       + + +
Sbjct: 61  IVKLLD-VIHTENKLYLVFEFLHQ-DLKKFMDASPL-----SGIPLPLIKSYLFQLLQGL 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ H  + R V+HRD+KP N+L++++   KL DFGLA
Sbjct: 114 AFCH--SHR-VLHRDLKPQNLLINTEGAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 22/155 (14%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELMIASSL-HHPNIVP 243
           LG+GA   V+K      +  VA+K++     +  D  + + F RE+M    L  HPNIV 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATD--AQRTF-REIMFLQELGDHPNIVK 71

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L+     + ++ ++L+++Y     +E  LH     +R N       RY +   + +++ Y
Sbjct: 72  LLNVIKAENDKDIYLVFEY-----METDLHAV---IRANILEDVHKRY-IMYQLLKALKY 122

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +H+G    V+HRD+KPSNILL+S    KL DFGLA
Sbjct: 123 IHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 67.6 bits (166), Expect = 8e-13
 Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 18/155 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL----HHPNIVP 243
           + LG G    V+  +       VAIK++ K  K  S   C  L    SL     HPNIV 
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVK 62

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L     + ++ L+ +++Y     +E +L++  K  R       SV   +   I + +A++
Sbjct: 63  LKEVFRENDE-LYFVFEY-----MEGNLYQLMKD-RKGKPFSESVIRSIIYQILQGLAHI 115

Query: 304 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           H +G      HRD+KP N+L+S  ++ K+ DFGLA
Sbjct: 116 HKHG----FFHRDLKPENLLVSGPEVVKIADFGLA 146

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 67.7 bits (165), Expect = 9e-13
 Identities = 52/180 (28%), Positives = 80/180 (44%), Gaps = 31/180 (17%)

Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIAS 234
           N   G+ LG G       A +F  KG+ G   T+VA+K L +    S  +    E  +  
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGY--TTVAVKMLKENASSSELRDLLSEFNLLK 58

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLP 285
            ++HP+++ L G C      L LI +Y   GSL   L E +K         G R +S L 
Sbjct: 59  QVNHPHVIKLYGACSQDG-PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 286 WSVRYKVALG--------IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                 + +G        I+  + YL    E  +VHRD+   N+L++  +  K+ DFGL+
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 12/150 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G    V+K +  L    VA+K  RL+ ED+       RE+ +   L+HPNIV L+  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
               E  L+L+++++    L++++            +  S  Y++  GIA    Y H+  
Sbjct: 67  VHS-ENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIK-SYLYQLLQGIA----YCHS-- 117

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              V+HRD+KP N+L+  +   KL DFGLA
Sbjct: 118 -HRVLHRDLKPQNLLIDREGALKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 11/150 (7%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           R LG G    V++G +    T VA+K L K      K F  E  I   L HP ++ L   
Sbjct: 12  RKLGAGQFGEVWEG-LWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
           C   E+ ++++ + +  GSL  +L            LP  +   +A  +A  +AYL    
Sbjct: 70  CTL-EEPIYIVTELMKYGSLLEYLQGGAGR---ALKLPQLI--DMAAQVASGMAYLE--- 120

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  +HRD+   N+L+    I K+ DFGLA
Sbjct: 121 AQNYIHRDLAARNVLVGENNICKVADFGLA 150

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 53/163 (32%), Positives = 83/163 (50%), Gaps = 26/163 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHH--- 238
           + +  ++GRGA   V++GK       VA+K   LD  D + S    RE+ + S L     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQ-REVALLSQLRQSQP 61

Query: 239 PNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           PNI    G +   P   L++I +Y  GGS+ R L +           P + +Y +++ I 
Sbjct: 62  PNITKYYGSYLKGPR--LWIIMEYAEGGSV-RTLMKAG---------PIAEKY-ISVIIR 108

Query: 298 E---SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E   ++ Y+H      V+HRDIK +NIL+++    KLCDFG+A
Sbjct: 109 EVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVA 148

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 14/152 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + LG G    V  GK    +  VAIK + +E   S   F  E  +   L HPN+V L G
Sbjct: 9   LKELGSGQFGVVHLGK-WRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYG 66

Query: 247 FCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
            C   +Q  +F++ +Y++ G L  +L E+K  +     L       +   + E++ YL  
Sbjct: 67  VCT--KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL------DMCSDVCEAMEYLE- 117

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                 +HRD+   N L+    + K+ DFGLA
Sbjct: 118 --SNGFIHRDLAARNCLVGEDNVVKVSDFGLA 147

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 44/165 (26%), Positives = 84/165 (50%), Gaps = 10/165 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHP 239
           NF   + +GRG  S V++    L    VA+K++   D  D ++     +E+ +   L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++      I+ +  L ++ +    G L R +   KK  R    +P    +K  + +  +
Sbjct: 63  NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKR---LIPEKTVWKYFVQLCSA 118

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 40/159 (25%), Positives = 80/159 (50%), Gaps = 10/159 (6%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLH 237
             NF   + +G+G  S V+K    L    VA+K++   +  D ++ +   +E+ +   L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++  +   I+  + L ++ +    G L R +   KK  R    +P    +K  + + 
Sbjct: 61  HPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKR---LIPERTIWKYFVQLC 116

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            ++ ++H    + ++HRDIKP+N+ +++  + KL D GL
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 14/153 (9%)

Query: 188 RVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +V+G G    V +G++ L       VAIK L     +  +  F  E  I     HPNI+ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +   + + +I +Y+  GSL++ L E       +          +  GIA  + YL
Sbjct: 70  LEG-VVTKSRPVMIITEYMENGSLDKFLREN------DGKFTVGQLVGMLRGIASGMKYL 122

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
              +E   VHRD+   NIL++S  + K+ DFGL
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGL 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 39/114 (34%), Positives = 60/114 (52%), Gaps = 21/114 (18%)

Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE-RHLHEKKKGVRGNSTLP 285
           CRE+ I   ++HPN+V       D    + ++ +++ GGSLE  H+              
Sbjct: 120 CREIEILRDVNHPNVVKCHDM-FDHNGEIQVLLEFMDGGSLEGTHI-------------- 164

Query: 286 WSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              ++   VA  I   +AYLH    R +VHRDIKPSN+L++S K  K+ DFG++
Sbjct: 165 ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVS 215

Length = 353

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 47/166 (28%), Positives = 87/166 (52%), Gaps = 12/166 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHP 239
           NF   + +GRG  S V++    L R  VA+K++   +  D ++ +   +E+ +   L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 240 NIVP-LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           N++  L  F  D E  L ++ +    G L + +   KK  R    +P    +K  + +  
Sbjct: 63  NVIKYLDSFIEDNE--LNIVLELADAGDLSQMIKYFKKQKR---LIPERTVWKYFVQLCS 117

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           +V ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+ +
Sbjct: 118 AVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 13/157 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   +G G    V+K +  +   ++A+K  RL++ED+       RE+ +   + H NI
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L    +  E+ L+L+++Y+    L++H+       + N  L  +  Y++  GI    A
Sbjct: 64  VRLQD-VVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAK-NPRLIKTYLYQILRGI----A 116

Query: 302 YLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLA 337
           Y H+     V+HRD+KP N+L+       KL DFGLA
Sbjct: 117 YCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150

Length = 294

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 65.4 bits (160), Expect = 3e-12
 Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 26/157 (16%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
            LG G+   V+K         VAIK +    +E  +   +E+ I      P IV   G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKYYG-S 66

Query: 249 IDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
                 L+++ +Y   GS+        + L E++            + Y+   G+     
Sbjct: 67  YFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA---------ILYQTLKGLE---- 113

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           YLH+      +HRDIK  NILL+ +   KL DFG++ 
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSG 147

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.8 bits (160), Expect = 4e-12
 Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 13/151 (8%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           V+G GA   V K +    +  VAIK+    +E++E  +   REL +  +L   NIV L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                   L+L+++YV    LE  L E   GV      P  VR  +   + +++ + H  
Sbjct: 68  -AFRRRGKLYLVFEYVEKNMLEL-LEEMPNGV-----PPEKVRSYI-YQLIKAIHWCHKN 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               +VHRDIKP N+L+S   + KLCDFG A
Sbjct: 120 D---IVHRDIKPENLLISHNDVLKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 45/163 (27%), Positives = 86/163 (52%), Gaps = 20/163 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL------DKEDKESSKAFCRELMIASSL 236
            + KG+ LG GA S  ++ +     T +A+K++        E +E  +A  +E+ + + L
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 237 HHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +HP+I+ ++G  C D    LF+  ++++GGS+   L   K G    +     + Y     
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLS--KYGAFKEAV---IINY--TEQ 111

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLA 337
           +   ++YLH   E  ++HRD+K +N+L+ S+ +  ++ DFG A
Sbjct: 112 LLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 17/152 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G+   VFK +       VAIK+    ++D    K   RE+ +   L HPN+V L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE- 67

Query: 248 CIDPEQGLFLIYKYVSGGSLERH--LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               ++ L L+++Y        H  L+E +K  RG   +P  +  K+     ++V + H 
Sbjct: 68  VFRRKRKLHLVFEYCD------HTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCH- 117

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               C+ HRD+KP NIL++ +   KLCDFG A
Sbjct: 118 -KHNCI-HRDVKPENILITKQGQIKLCDFGFA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 14/157 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G  + VFKG+  L    VA+K  RL+ E+     A  RE+ +  +L H NIV L   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKNLKHANIVTLHDI 71

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E+ L L+++Y+    L+++L        GN     +V+      +   ++Y H   
Sbjct: 72  -IHTERCLTLVFEYLDS-DLKQYLDNC-----GNLMSMHNVKI-FMFQLLRGLSYCH--- 120

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           +R ++HRD+KP N+L++ K   KL DFGLA   S P+
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 50/176 (28%), Positives = 71/176 (40%), Gaps = 22/176 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR---ELMIASSLHHPNIVPLVG 246
           + +GA   VF  K        AIK + K D        +   E  I S    P +V L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-N 305
           +    ++ L+L+ +Y+ GG L   L     G      L   V       I  ++ YLH N
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLE--NVGS-----LDEDVARIYIAEIVLALEYLHSN 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW------TSAPSVPFLCKTVKGT 355
           G    ++HRD+KP NIL+ S    KL DFGL+         +        K + GT
Sbjct: 113 G----IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGT 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 53/164 (32%), Positives = 80/164 (48%), Gaps = 26/164 (15%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            LG G+ + V+KG+  L    VA+K  RL+ E+     A  RE  +   L H NIV L  
Sbjct: 12  KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAI-REASLLKDLKHANIVTLHD 70

Query: 247 FCIDPEQGLFLIYKYVS---GGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESV 300
             I  ++ L L+++Y+       ++           G      +VR   +++  G+A   
Sbjct: 71  I-IHTKKTLTLVFEYLDTDLKQYMDDC---------GGGLSMHNVRLFLFQLLRGLA--- 117

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            Y H   +R V+HRD+KP N+L+S +   KL DFGLA   S PS
Sbjct: 118 -YCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 30/167 (17%)

Query: 183 NFSKGRVLGRGALSFVF------KGKVGLLRTSVAIKRLDKED---KESSKAFC--RELM 231
           +F   +V+GRGA   V+       G+V       A+K L K D   +         R+++
Sbjct: 2   DFEVIKVIGRGAFGEVWLVRDKDTGQV------YAMKVLRKSDMIKRNQIAHVRAERDIL 55

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
             +    P IV L  +    E+ L+L+ +Y+ GG L   L   +K V    T  +   Y 
Sbjct: 56  ADA--DSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEETARF---Y- 106

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               IAE V  L +  +   +HRDIKP NIL+ +    KL DFGL  
Sbjct: 107 ----IAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCK 149

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 64.8 bits (158), Expect = 7e-12
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 188 RVLGRGALSFVFKGKVGLL-----RTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNI 241
           R LG GA   VF G+   L     +  VA+K L +    ++ K F RE  + ++  H NI
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNST--LPWSVRYKVAL 294
           V   G C + +    ++++Y+  G L + L              +    L  S   ++A+
Sbjct: 71  VKFYGVCTEGDP-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            IA  + YL     +  VHRD+   N L+    + K+ DFG++
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 64.9 bits (159), Expect = 7e-12
 Identities = 44/161 (27%), Positives = 65/161 (40%), Gaps = 23/161 (14%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNIV 242
           F+    +G+G+   V+K         VAIK +D E+ E       +E+   S    P I 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
              G  +     L++I +Y  GGS         L E                  +   + 
Sbjct: 63  KYYGSFLK-GSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------------ILREVL 108

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
             + YLH   E   +HRDIK +NILLS +   KL DFG++ 
Sbjct: 109 LGLEYLHE--EG-KIHRDIKAANILLSEEGDVKLADFGVSG 146

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 66.8 bits (163), Expect = 7e-12
 Identities = 47/135 (34%), Positives = 72/135 (53%), Gaps = 16/135 (11%)

Query: 210 VAIK--RLDKEDKESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
           VAIK  R D  ++E  +A F RE  + + L+HPNIV L+     P   LF +++YV G +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
           L   L     G      LP     ++ L + +++A  HN   + +VHRD+KP NI++S  
Sbjct: 66  LREVL--AADGA-----LPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQT 115

Query: 327 KI---PKLCDFGLAT 338
            +    K+ DFG+ T
Sbjct: 116 GVRPHAKVLDFGIGT 130

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 14/157 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G  + V+KG+  L    VA+K  RL+ E+     A  RE+ +   L H NIV L   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E+ L L+++Y+    L+++L +      GNS    +V+  +   +   + Y H   
Sbjct: 73  -IHTEKSLTLVFEYLDK-DLKQYLDDC-----GNSINMHNVKLFL-FQLLRGLNYCH--- 121

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            R V+HRD+KP N+L++ +   KL DFGLA   S P+
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (155), Expect = 1e-11
 Identities = 52/159 (32%), Positives = 80/159 (50%), Gaps = 16/159 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 237
           N+  G++LGRGA   V+          +A+K++  D + +E+SK   A   E+ +  +L 
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62

Query: 238 HPNIVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  IV   G   DPE+    I+ +Y+ GGS++  L       +    L  +V  +    I
Sbjct: 63  HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-------KAYGALTENVTRRYTRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
            + V+YLH+     +VHRDIK +NIL  S    KL DFG
Sbjct: 116 LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           F+  R LG G    V++G     R  VAIK L  +D    + F +E+     L H +++ 
Sbjct: 8   FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   E  +++I + +  GSL   L   +  V   ++L       +A  +AE +AYL
Sbjct: 67  LFAVCSVGEP-VYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYL 120

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               E+  +HRD+   NIL+    + K+ DFGLA
Sbjct: 121 E---EQNSIHRDLAARNILVGEDLVCKVADFGLA 151

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.1 bits (156), Expect = 1e-11
 Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 27/163 (16%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTS---------VAIKRLDKED-KESSKAFCRELMIASS 235
           K RVLG G       GKV L             VA+K L +E  ++++  + +E+ I  +
Sbjct: 8   KIRVLGEGHF-----GKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62

Query: 236 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L+H NIV   G C +   +GL LI +YV  GSL  +L + K  +        +     A 
Sbjct: 63  LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL--------AQLLLFAQ 114

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            I E +AYLH+   +  +HRD+   N+LL + ++ K+ DFGLA
Sbjct: 115 QICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLA 154

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 52/165 (31%), Positives = 76/165 (46%), Gaps = 23/165 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSL-HHPN 240
           F    V+G G    V+K +       VAIK +D  ++++E  K    E  I     +HPN
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHPN 64

Query: 241 IVPLVGFCIDP-----EQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKV 292
           I    G  I       +  L+L+ +   GGS   L + L +K K ++      W + Y +
Sbjct: 65  IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEE----W-IAY-I 118

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                  +AYLH   E  V+HRDIK  NILL+     KL DFG++
Sbjct: 119 LRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 46/161 (28%), Positives = 78/161 (48%), Gaps = 20/161 (12%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESS--KAFCRELMIASSL 236
           KG ++G G+   V+ G        +A+K++         +D++ S   A  RE+ +   L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H NIV  +G  +D +  L +  +YV GGS+   L+              ++       I
Sbjct: 64  QHENIVQYLGSSLDADH-LNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + YLHN   R ++HRDIK +NIL+ +K   K+ DFG++
Sbjct: 116 LKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGIS 153

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 11/149 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLVGFC 248
           +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
              +Q ++++ + V GG     L  +   ++    +      ++    A  + YL +   
Sbjct: 63  TQ-KQPIYIVMELVQGGDFLTFLRTEGPRLKVKELI------QMVENAAAGMEYLES--- 112

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  +HRD+   N L++ K + K+ DFG++
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMS 141

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 20/160 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G  + VFKG+  L    VA+K  RL+ E+     A  RE+ +   L H NIV L   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHDI 72

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLH 304
            +  ++ L L+++Y     L++ L +      GN     +V+   Y++  G+A    Y H
Sbjct: 73  -VHTDKSLTLVFEY-----LDKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLA----YCH 121

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
               R V+HRD+KP N+L++ +   KL DFGLA   S P+
Sbjct: 122 ---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 63.0 bits (153), Expect = 3e-11
 Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 12/148 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V+ G   L +  VAIK + +E   S + F  E  +   L HP +V L G C 
Sbjct: 12  IGSGQFGLVWLGY-WLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           +    + L+++++  G L  +L   ++G     TL       + L + E +AYL      
Sbjct: 70  E-RSPICLVFEFMEHGCLSDYL-RAQRGKFSQETL-----LGMCLDVCEGMAYLE---SS 119

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            V+HRD+   N L+   ++ K+ DFG+ 
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMT 147

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 46/163 (28%), Positives = 81/163 (49%), Gaps = 22/163 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLH 237
            +   + +G G+   ++  K         IK +D       +KE+SK   +E+++ + + 
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMK 57

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--RGNSTLPWSVRYKVALG 295
           HPNIV            LF++ +Y  GG L + +  +++GV    +  L W V  +++LG
Sbjct: 58  HPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFV--QISLG 113

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLA 337
           +     ++H   +R ++HRDIK  NI LS    + KL DFG+A
Sbjct: 114 LK----HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.7 bits (152), Expect = 3e-11
 Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 16/159 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 237
           N+  G++LG+GA   V+          +A+K++  D E  E+SK   A   E+ +  +L 
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  IV   G   DP E+ L +  +++ GGS++  L       +    L  +V  K    I
Sbjct: 63  HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-------KSYGALTENVTRKYTRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
            E V+YLH+     +VHRDIK +NIL  S    KL DFG
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 62.4 bits (152), Expect = 4e-11
 Identities = 54/176 (30%), Positives = 84/176 (47%), Gaps = 33/176 (18%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-----DKEDKESSKAFCRELM---IA-SSLHHPN 240
           LGRGA   V K +     T +A+KR+      +E K       R LM   I+  S+  P 
Sbjct: 9   LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-------RLLMDLDISMRSVDCPY 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLE---RHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            V   G      +G   I   V   SL+   + +++K        T+P  +  K+A+ I 
Sbjct: 62  TVTFYGALF--REGDVWICMEVMDTSLDKFYKKVYDKGL------TIPEDILGKIAVSIV 113

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK 353
           +++ YLH  ++  V+HRD+KPSN+L++     KLCDFG+    S   V  + KT+ 
Sbjct: 114 KALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI----SGYLVDSVAKTID 163

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 62.5 bits (152), Expect = 4e-11
 Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 12/149 (8%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFC 248
           LG GA   V+K +        A K +  E +E  + F  E+ I S   HPNIV L   + 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
            + +  L+++ ++  GG+L+  + E ++G+    T P  +RY V   + E++ +LH+   
Sbjct: 73  YENK--LWILIEFCDGGALDSIMLELERGL----TEP-QIRY-VCRQMLEALNFLHS--- 121

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V+HRD+K  NILL+     KL DFG++
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.4 bits (151), Expect = 5e-11
 Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 14/164 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           ++ K   LG G+ + V+KGK  +    VA+K  RL +E+     A  RE  +   L H N
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAI-REASLLKGLKHAN 64

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+   I  ++ L L+++YV    L +++ +   G+      P +V+  +   +   +
Sbjct: 65  IV-LLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLH-----PENVKLFL-FQLLRGL 116

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           +Y+H   +R ++HRD+KP N+L+S     KL DFGLA   S PS
Sbjct: 117 SYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 51/160 (31%), Positives = 75/160 (46%), Gaps = 25/160 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS---------VAIKRLDKEDKESSKA-FCRELMIASSLH 237
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 10  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 238 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C  D   G+ LI +++  GSL+ +L   K  +     L ++V+      I
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQ------I 118

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL
Sbjct: 119 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 155

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 37/138 (26%), Positives = 69/138 (50%), Gaps = 24/138 (17%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSL- 267
           VA+K++D   ++  +    E++I     HPNIV +   + +  E  L+++ +++ GG+L 
Sbjct: 47  VAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE--LWVVMEFLEGGALT 104

Query: 268 ----ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL 323
                  ++E++                V L + +++++LH    + V+HRDIK  +ILL
Sbjct: 105 DIVTHTRMNEEQIAT-------------VCLAVLKALSFLHA---QGVIHRDIKSDSILL 148

Query: 324 SSKKIPKLCDFGLATWTS 341
           +S    KL DFG     S
Sbjct: 149 TSDGRVKLSDFGFCAQVS 166

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 50/147 (34%), Positives = 75/147 (51%), Gaps = 16/147 (10%)

Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVG-FCID 250
           G++S V     G   T +A K +    K S  K   REL I      P IV   G F  +
Sbjct: 19  GSVSKVKHIPTG---TVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75

Query: 251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 310
               + +  +++  GSL+R    KK G      +P  +  K+A+ + E + YL+N     
Sbjct: 76  NN--ICMCMEFMDCGSLDRIY--KKGG-----PIPVEILGKIAVAVVEGLTYLYN--VHR 124

Query: 311 VVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++HRDIKPSNIL++S+   KLCDFG++
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 7e-11
 Identities = 39/111 (35%), Positives = 64/111 (57%), Gaps = 12/111 (10%)

Query: 228 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L E K+       +P 
Sbjct: 52  RELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKR-------IPE 102

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  KV++ +   +AYL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 103 EILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 15/144 (10%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           V+ RG     +KGK         +K ++  +   S            L HPNIV L+G C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLIGLC 752

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
              E+G +LI++Y+ G +L   L            L W  R K+A+GIA+++ +LH    
Sbjct: 753 -RSEKGAYLIHEYIEGKNLSEVL----------RNLSWERRRKIAIGIAKALRFLHCRCS 801

Query: 309 RCVVHRDIKPSNILLSSKKIPKLC 332
             VV  ++ P  I++  K  P L 
Sbjct: 802 PAVVVGNLSPEKIIIDGKDEPHLR 825

Length = 968

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 19/161 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           R++G+G +  V+     +    VA+K++ +   E+    K F RE  IA+ L HP IVP+
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--------I 296
              C D +  ++    Y+ G +L+  L    K V    +L   +  K ++G        I
Sbjct: 68  YSICSDGDP-VYYTMPYIEGYTLKSLL----KSVWQKESLSKELAEKTSVGAFLSIFHKI 122

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++ Y+H+   + V+HRD+KP NILL       + D+G A
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAA 160

Length = 932

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 13/157 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPN 240
            + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H N
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L    +  ++ L L+++Y      ++ L  KK     N  +   +       + + +
Sbjct: 61  IVRLYD-VLHSDKKLTLVFEYC-----DQDL--KKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ H      V+HRD+KP N+L++     KL DFGLA
Sbjct: 113 AFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLA 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 50/149 (33%), Positives = 77/149 (51%), Gaps = 14/149 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K      +AF +E  I   L H  +VPL  + +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ ++++ +++  GSL   L   K+G      LP  V   +A  IA+ +AY+    ER
Sbjct: 70  VSEEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLV--DMAAQIADGMAYI----ER 120

Query: 310 C-VVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +HRD++ +NIL+    + K+ DFGLA
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 39/131 (29%), Positives = 59/131 (45%), Gaps = 9/131 (6%)

Query: 210 VAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS-- 266
           VA+K L       + + F +E+ I S L  PNI  L+G C      L +I +Y+  G   
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGDLN 107

Query: 267 --LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
             L++H+ E       + +L +S    +A  IA  + YL        VHRD+   N L+ 
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVG 164

Query: 325 SKKIPKLCDFG 335
                K+ DFG
Sbjct: 165 KNYTIKIADFG 175

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 24/155 (15%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 71

Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             E++ Y
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-------------EALNY 118

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH   E  ++HRD+K  NIL +     KL DFG++
Sbjct: 119 LH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 28/160 (17%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCREL-MIASSLHHPNIVPLVG- 246
           +GRGA   V K       T +A+KR+    D++  K    +L ++  S   P IV   G 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 247 --------FCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
                    C++  +  L   YKYV         +E        S +P  +  K+A+   
Sbjct: 72  LFREGDCWICMELMDISLDKFYKYV---------YEVL-----KSVIPEEILGKIAVATV 117

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +++ YL    E  ++HRD+KPSNILL      KLCDFG++
Sbjct: 118 KALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.3 bits (146), Expect = 2e-10
 Identities = 41/130 (31%), Positives = 67/130 (51%), Gaps = 11/130 (8%)

Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VAIK L K+   S +AF  E  +   L HP +V L  + +  ++ +++I +Y+  GSL
Sbjct: 31  TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAVVTQEPIYIITEYMENGSL 87

Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +        L  +    +A  IAE +A++     +  +HRD++ +NIL+S   
Sbjct: 88  VDFLKTPE-----GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETL 139

Query: 328 IPKLCDFGLA 337
             K+ DFGLA
Sbjct: 140 CCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 12/153 (7%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIVPLV 245
           RV+G+G+   V   +         IK+L+  +      KA  +E  + S L HPNIV   
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPWSVRYKVALGIAESVAYLH 304
                 +  L+++  +  GG L   L E+K K +  N  + W V+      IA ++ YLH
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQ------IAMALQYLH 119

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              E+ ++HRD+K  N+ L+   I K+ D G+A
Sbjct: 120 ---EKHILHRDLKTQNVFLTRTNIIKVGDLGIA 149

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 60.8 bits (148), Expect = 2e-10
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 45/170 (26%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G    V+K +       VA+K++   +++D     A  RE+ I   L HPN+VPL+ 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL-REIKILKKLKHPNVVPLID 74

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKK-------------KGVRGNSTLPWSVRYKVA 293
             ++                 ++   ++               G+  N     SV+   +
Sbjct: 75  MAVERP---------------DKSKRKRGSVYMVTPYMDHDLSGLLENP----SVKLTES 115

Query: 294 ------LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                 L + E + YLH   E  ++HRDIK +NIL+ ++ I K+ DFGLA
Sbjct: 116 QIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA 162

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 25/158 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           +VLG+G  SF   GKV L          A+K L K+    D +       + ++A +  H
Sbjct: 1   KVLGKG--SF---GKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C   +  LF + +YV+GG L  H+    +        P +  Y  A  I  
Sbjct: 56  PFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR-----FDEPRARFY--AAEIVL 107

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            + +LH   ER +++RD+K  N+LL S+   K+ DFG+
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 50/185 (27%), Positives = 83/185 (44%), Gaps = 41/185 (22%)

Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K L K    S +AF  E  +  +L H  +V L    +  E+ +++I +Y++ GSL
Sbjct: 31  TKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VVTKEEPIYIITEYMAKGSL 88

Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   K    G   LP  + +     IAE +AY+     +  +HRD++ +N+L+S   
Sbjct: 89  LDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIE---RKNYIHRDLRAANVLVSESL 140

Query: 328 IPKLCDFGLA------------------TWTSAPSVPFLCKTVKG-------------TF 356
           + K+ DFGLA                   WT+  ++ F   T+K              T+
Sbjct: 141 MCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200

Query: 357 GQNPF 361
           G+ P+
Sbjct: 201 GKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 15/167 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           HN    R LG GA   VF  +   L     +  VA+K L      + K F RE  + ++L
Sbjct: 5   HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGN--STLPWSVRY 290
            H +IV   G C++ +  L ++++Y+  G L + L            GN  + L  S   
Sbjct: 65  QHEHIVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +A  IA  + YL     +  VHRD+   N L+    + K+ DFG++
Sbjct: 124 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 60/210 (28%)

Query: 187 GRVLGRGALSFVFKGK-VGLLRTS----VAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+ LGRGA   V +    G+ +++    VA+K L KE   +S  KA   EL I   + HH
Sbjct: 12  GKPLGRGAFGKVIQASAFGIEKSASCRTVAVKML-KEGATASEYKALMTELKILIHIGHH 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNSTLPWSVR- 289
            N+V L+G C  P   L +I +Y   G+L  +L  K+        K  R         + 
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130

Query: 290 -----------------------------------YKVALGIAESVAY---LHNGTE--- 308
                                              YK  L + + ++Y   +  G E   
Sbjct: 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLA 190

Query: 309 -RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            R  +HRD+   NILLS   + K+CDFGLA
Sbjct: 191 SRKCIHRDLAARNILLSENNVVKICDFGLA 220

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 45/153 (29%), Positives = 77/153 (50%), Gaps = 15/153 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           RV+GRG+ + V   ++       A+K + KE    D++       + +   + +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+ ++ YL
Sbjct: 61  LHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEISLALNYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H   ER +++RD+K  N+LL S+   KL D+G+
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 51/166 (30%), Positives = 77/166 (46%), Gaps = 26/166 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED---KESSKAFCRELMIA 233
            +F   +V+GRGA      G+V L++        A+K+L K +   KE       E  I 
Sbjct: 1   DDFESIKVIGRGAF-----GEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL 55

Query: 234 SSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           +   +P +V L  +     E  L+LI +Y+ GG +   L  KK       T  +      
Sbjct: 56  AEADNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEEETRFY------ 106

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              IAE++  + +  +   +HRDIKP N+LL +K   KL DFGL T
Sbjct: 107 ---IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 44/151 (29%), Positives = 72/151 (47%), Gaps = 14/151 (9%)

Query: 190 LGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           LG G    V  GK  G  +  VAIK + KE   S   F  E  +   L H  +V L G C
Sbjct: 12  LGTGQFGVVKYGKWRG--QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
              ++ ++++ +Y+S G L  +L E  K  + +  L      ++   + E +AYL +   
Sbjct: 69  -TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL------EMCKDVCEGMAYLES--- 118

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           +  +HRD+   N L+  +   K+ DFGL+ +
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRY 149

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.1 bits (143), Expect = 8e-10
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 20/161 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           F+  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            +  G  
Sbjct: 77  TIEYKG-CYLREHTAWLVMEYCLGSASDILEVH----KKPLQEVEIA------AICHGAL 125

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           + +AYLH+      +HRDIK  NILL+     KL DFG A+
Sbjct: 126 QGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSAS 163

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 58.9 bits (142), Expect = 8e-10
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 14  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L   L + +               STL        A  
Sbjct: 74  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 171

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 38/111 (34%), Positives = 64/111 (57%), Gaps = 12/111 (10%)

Query: 228 RELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           REL +    + P IV   G F  D E  + +  +++ GGSL++ L  KK G      +P 
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPE 98

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++  K+++ +   + YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 99  NILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 44/163 (26%), Positives = 70/163 (42%), Gaps = 19/163 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G+G    VFK +    +  VA+K+  ++ E +       RE+ I   L H N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 248 CIDPEQG-------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           C              +L++++     L   L  K      N     S   KV   +   +
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNK------NVKFTLSEIKKVMKMLLNGL 132

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            Y+H      ++HRD+K +NIL++   I KL DFGLA   S  
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLS 172

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 53/159 (33%), Positives = 78/159 (49%), Gaps = 16/159 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSK---AFCRELMIASSLH 237
           N+ +G++LG+GA   V+          +A K++  D E  E+SK   A   E+ +  +L 
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62

Query: 238 HPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H  IV   G   D  E+ L +  +Y+ GGS++  L       +    L  SV  K    I
Sbjct: 63  HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-------KAYGALTESVTRKYTRQI 115

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
            E ++YLH+     +VHRDIK +NIL  S    KL DFG
Sbjct: 116 LEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 20/161 (12%)

Query: 190 LGRGALSFVFK-GKVGLLRTSVAIKRLD-------KEDKESSKAF---CREL-MIASSLH 237
           LG GA   V+K  K    +  +A+K ++       K+ +E  K+      E+ +I   L 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           HPNIV      ++ ++ L+++   + G  L  H +  K+K  R      W++  ++ L  
Sbjct: 68  HPNIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL-- 124

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++ YLH   E+ +VHRD+ P+NI+L       + DFGLA
Sbjct: 125 --ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 42/151 (27%), Positives = 71/151 (47%), Gaps = 14/151 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHH-PNIVPLVG- 246
           +G G    V+K +       +A+K++ +   KE +K    +L +    H  P IV   G 
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           F  D +     I   +    L++ L   +  +      P  +  K+ + I +++ YL   
Sbjct: 83  FITDSD---VFICMELMSTCLDKLLKRIQGPI------PEDILGKMTVAIVKALHYLK-- 131

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  V+HRD+KPSNILL +    KLCDFG++
Sbjct: 132 EKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 57.7 bits (139), Expect = 1e-09
 Identities = 49/149 (32%), Positives = 74/149 (49%), Gaps = 14/149 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K    S ++F  E  I   L H  +V L  + +
Sbjct: 14  LGNGQFGEVWMGTWNG-NTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ ++++ +Y+S GSL   L   K G      LP  V   +A  +A  +AY+    ER
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLV--DMAAQVAAGMAYI----ER 120

Query: 310 C-VVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +HRD++ +NIL+    + K+ DFGLA
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 18/164 (10%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           R LG GA   VF  +   L  +     VA+K L      + K F RE  + ++L H +IV
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHE---------KKKGVRGNSTLPWSVRYKVA 293
              G C D +  L ++++Y+  G L + L             +  +    L  S    +A
Sbjct: 71  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             IA  + YL     +  VHRD+   N L+ +  + K+ DFG++
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 15/153 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +V+G+G+   V   K        A+K L K+     KE         ++  ++ HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +       L+ +  YV+GG L  HL  ++         P       A  IA ++ YL
Sbjct: 61  L-HYSFQTADKLYFVLDYVNGGELFFHLQRERS-------FPEPRARFYAAEIASALGYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H      +++RD+KP NILL S+    L DFGL
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 58.0 bits (141), Expect = 2e-09
 Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 35/172 (20%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIAS-----SLHHPNIV 242
           +G GA   V+K +       VA+K++     E     +  RE  IA      S  HPNIV
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLRE--IALLKQLESFEHPNIV 64

Query: 243 PLVGFC----IDPEQGLFLIYKYVSGGSLERHLH---EK--KKGVRGNSTLPWSVRYKVA 293
            L+  C     D E  L L++++V     ++ L     K  K G+      P +++  + 
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHV-----DQDLATYLSKCPKPGLP-----PETIK-DLM 113

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA---TWTSA 342
             +   V +LH+     +VHRD+KP NIL++S    K+ DFGLA   ++  A
Sbjct: 114 RQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA 162

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 6   DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65

Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 66  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 116

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 117 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS 151

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 11/159 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHP 239
           +F   + LG+G+   V+K K        A+K +D      KE   A   E+ I +S++HP
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAV-NEIRILASVNHP 59

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+      +D  + L ++ +Y   G L + + ++KK  +    +P    +++ + +   
Sbjct: 60  NIISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRK---LIPEQEIWRIFIQLLRG 115

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           +  LH   E+ ++HRD+K +NILL +  + K+ D G++ 
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISK 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 14/151 (9%)

Query: 190 LGRGALSFVFKG--KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G    V KG  K+   +  VAIK L ++ +K       RE  I   L +P IV ++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C    + L L+ +  SGG L + L  KK  +  ++ +   + ++V++G+     YL   
Sbjct: 63  VC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMK----YLE-- 112

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +  VHRD+   N+LL ++   K+ DFGL+
Sbjct: 113 -GKNFVHRDLAARNVLLVNQHYAKISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 30/180 (16%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            +G G    V+K +       VA+K  RLD E +       RE+ I   L+H NIV L  
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 247 FCIDPEQGL---------FLIYKYVSG---GSLERHL-HEKKKGVRGNSTLPWSVRYKVA 293
              D +  L         +L+++Y+     G LE  L H  +  ++              
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-----------SFM 122

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTV 352
             + E + Y H    +  +HRDIK SNILL++K   KL DFGLA  + S  S P+  K +
Sbjct: 123 KQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI 179

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 17/166 (10%)

Query: 177 ILAATHNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELM 231
           IL  T    K +VLG GA   V+KG        ++  VAIK L +    +++K    E  
Sbjct: 3   ILKETE-LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAY 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + + +  P +  L+G C+     + L+ + +  G L  ++ E K  +     L W V+  
Sbjct: 62  VMAGVGSPYVCRLLGICL--TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ-- 117

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               IA+ ++YL    E  +VHRD+   N+L+ S    K+ DFGLA
Sbjct: 118 ----IAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLA 156

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 57.3 bits (138), Expect = 2e-09
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 21/163 (12%)

Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLER---------HLHEKKKGVR-GNSTLPWSVRYKVAL 294
            G C +    L ++++Y+  G L R          +    + V  G  TL   +   +A 
Sbjct: 73  YGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML--AIAS 129

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            IA  + YL        VHRD+   N L+    + K+ DFG++
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 18/159 (11%)

Query: 185 SKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
           +K +V+G G    VF+G +   G    +VAIK L     E  +  F  E  I     H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL--GIAE 298
           I+ L G  +   +   +I +Y+  G+L+++L +            +S    V +  GIA 
Sbjct: 68  IIRLEG-VVTKFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAA 118

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + YL   ++   VHRD+   NIL++S    K+ DFGL+
Sbjct: 119 GMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLS 154

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 38/172 (22%), Positives = 78/172 (45%), Gaps = 21/172 (12%)

Query: 190 LGRGALSFVFK------GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G+G+   VFK       +V  ++  + + ++++ ++E +     E  + + L    I+ 
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMK-QIDLSKMNRREREEA---IDEARVLAKLDSSYIIR 63

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                +D +  L ++ +Y   G L + L   ++G        W    ++ LG+A    +L
Sbjct: 64  YYESFLD-KGKLNIVMEYAENGDLHKLLK-MQRGRPLPEDQVWRFFIQILLGLA----HL 117

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           H+   + ++HRDIK  N+ L +    K+ D G+A   S  +      T+ GT
Sbjct: 118 HS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGT 164

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.3 bits (139), Expect = 3e-09
 Identities = 50/158 (31%), Positives = 72/158 (45%), Gaps = 32/158 (20%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSL-HHPNIVPLVGF 247
           +G G  S V K +        AIK + K  K   +    RE+     L  HPNI+ L+  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 248 CIDPEQG-LFLI--------YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
             D + G L L+        Y+ + G   +R L EK+  V+       S  Y+    + +
Sbjct: 67  LFDRKTGRLALVFELMDMNLYELIKG--RKRPLPEKR--VK-------SYMYQ----LLK 111

Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           S+ ++H NG    + HRDIKP NIL+    I KL DFG
Sbjct: 112 SLDHMHRNG----IFHRDIKPENILI-KDDILKLADFG 144

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 14/154 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   VF          VAIK+++ + +   +    E+++   L +PNIV 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 244 LV-GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +  F +  E  LF++ +Y++GGSL   + E        + +  +    V     +++ +
Sbjct: 81  FLDSFLVGDE--LFVVMEYLAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEF 130

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH      V+HRDIK  N+LL      KL DFG 
Sbjct: 131 LHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.6 bits (136), Expect = 3e-09
 Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 16/150 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 14  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V    A  IA  +AY+    E
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR----LPQLVDM--AAQIASGMAYV----E 119

Query: 309 RC-VVHRDIKPSNILLSSKKIPKLCDFGLA 337
           R   VHRD++ +NIL+    + K+ DFGLA
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLA 149

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 57.0 bits (137), Expect = 3e-09
 Identities = 37/132 (28%), Positives = 68/132 (51%), Gaps = 12/132 (9%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K++D   ++  +    E++I    HH N+V +    +  ++ L+++ +++ GG+L  
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVMEFLEGGALTD 108

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +   +      +T        V L +  +++YLHN   + V+HRDIK  +ILL+S    
Sbjct: 109 IVTHTRMNEEQIAT--------VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRI 157

Query: 330 KLCDFGLATWTS 341
           KL DFG     S
Sbjct: 158 KLSDFGFCAQVS 169

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 22/168 (13%)

Query: 187 GRVLGRGALSFVFKGK-VGLL----RTSVAIKRL--DKEDKESSKAFCRELMIASSLHHP 239
           G+ LG GA   V K + VGL      ++VA+K L  D  +K+ S       M+     H 
Sbjct: 17  GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76

Query: 240 NIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPWSVRYKV----- 292
           NI+ L+G C   ++G L+++ +Y + G+L   L  ++  G   +   P      +     
Sbjct: 77  NIINLLGVCT--QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 293 ---ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              A  +A  + +L   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 135 VSFAYQVARGMEFL--ASKKCI-HRDLAARNVLVTEDHVMKIADFGLA 179

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 54/179 (30%), Positives = 86/179 (48%), Gaps = 19/179 (10%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   V+KG     +  VAIK +D E+ E   +   +E+ + S    P I 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +   + L++I +Y+ GGS    L   K G    + +   +R      I + + Y
Sbjct: 66  RYYGSYLKGTK-LWIIMEYLGGGSA---LDLLKPGPLEETYIATILRE-----ILKGLDY 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPF 361
           LH  +ER  +HRDIK +N+LLS +   KL DFG+A   +   +       + TF   PF
Sbjct: 117 LH--SER-KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK------RNTFVGTPF 166

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 9/133 (6%)

Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
           VA+K L ++ +K +   F +E+ I S L  PNI+ L+  CI  +  L +I +Y+  G L 
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDP-LCMITEYMENGDLN 107

Query: 269 ----RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
               RH  ++        T+ +S    +A  IA  + YL   +    VHRD+   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164

Query: 325 SKKIPKLCDFGLA 337
                K+ DFG++
Sbjct: 165 KNYTIKIADFGMS 177

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 15/153 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +V+G+G+   V   K     +  A+K L K+     KE +       ++  +L HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +     + L+ +  YV+GG L  HL  ++  +      P +  Y  A  +A ++ YL
Sbjct: 61  L-HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-----PRARFY--AAEVASAIGYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H+     +++RD+KP NILL S+    L DFGL
Sbjct: 113 HSLN---IIYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 27/168 (16%)

Query: 183 NFSKGRVLGRGALSFVFKG------------KVGLLRTSVAIKRLDKEDKESSKAFCREL 230
            + KG ++G+G    V+              +V L  T     R D   K+  KA   E+
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATI--AGRHDSRQKDMVKALRSEI 59

Query: 231 MIASSLHHPNIVPLVGFCIDPEQ-GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
                L H NIV  +GF    E   +FL  +YV GGS+   L   +   R    L     
Sbjct: 60  ETLKDLDHLNIVQYLGFETTEEYLSIFL--EYVPGGSIGSCL---RTYGRFEEQLVRFFT 114

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +V  G+A    YLH+   + ++HRD+K  N+L+ +  I K+ DFG++
Sbjct: 115 EQVLEGLA----YLHS---KGILHRDLKADNLLVDADGICKISDFGIS 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 15/153 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           RV+GRG+ + V   ++   R   A+K + KE    D++       + +  ++ +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   E  LF + ++VSGG L  H+  ++K       LP       +  I+ ++ +L
Sbjct: 61  LHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRK-------LPEEHARFYSAEISLALNFL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H   ER +++RD+K  N+LL ++   KL D+G+
Sbjct: 113 H---ERGIIYRDLKLDNVLLDAEGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)

Query: 188 RVLGRGALSFVFKGKVGLLRT--SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           + LG G    V  GK    R    VAIK +  E   S + F  E  +   L HP +V L 
Sbjct: 10  KELGSGQFGVVHLGK---WRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C   ++ L+++ +++  G L  +L +++  +  +  L       +   + E + YL  
Sbjct: 66  GVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLER 118

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
            +    +HRD+   N L+SS  + K+ DFG+  +
Sbjct: 119 NS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY 149

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 55.6 bits (134), Expect = 8e-09
 Identities = 41/132 (31%), Positives = 71/132 (53%), Gaps = 20/132 (15%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFCIDPEQG-LFLIYKYVSGGSL 267
           + I ++  +++E S+   +E+ + S++ HPNIV     F    E G L+++  Y  GG L
Sbjct: 33  INISKMSPKEREESR---KEVAVLSNMKHPNIVQYQESF---EENGNLYIVMDYCEGGDL 86

Query: 268 ERHLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 325
            + ++  ++GV    +  L W V+  +AL       ++H   +R ++HRDIK  NI L+ 
Sbjct: 87  YKKIN-AQRGVLFPEDQILDWFVQICLAL------KHVH---DRKILHRDIKSQNIFLTK 136

Query: 326 KKIPKLCDFGLA 337
               KL DFG+A
Sbjct: 137 DGTIKLGDFGIA 148

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 56.1 bits (135), Expect = 8e-09
 Identities = 52/156 (33%), Positives = 75/156 (48%), Gaps = 18/156 (11%)

Query: 195 LSFVFKGKVGL-LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ 253
           L F F  + G  L  +V I R D  +K +   F +E+ I S L  PNI+ L+G C+D E 
Sbjct: 35  LQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVD-ED 92

Query: 254 GLFLIYKYVSGGSLE-----RHLHEKKK----GVRGNSTLP---WSVRYKVALGIAESVA 301
            L +I +Y+  G L       HL +K++     V     LP   +S    VAL IA  + 
Sbjct: 93  PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL   +    VHRD+   N L+      K+ DFG++
Sbjct: 153 YL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 56.0 bits (135), Expect = 1e-08
 Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 36/165 (21%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-------EDKESSKAFCRELMI 232
           +VLG+G       GKV  +R           A+K L K       +D   +KA   E  I
Sbjct: 2   KVLGKGGY-----GKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKA---ERNI 53

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             ++ HP IV L+ +       L+LI +Y+SGG L  HL  +++G+    T         
Sbjct: 54  LEAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHL--EREGIFMEDTA------CF 104

Query: 293 ALG-IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            L  I+ ++ +LH   ++ +++RD+KP NILL ++   KL DFGL
Sbjct: 105 YLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGL 146

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 46/154 (29%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 192 RGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------KAFCRELMIASSLHHPNIVPLV 245
           +GA   V+  K        AIK L K D  +       KA    +MI      P +  L 
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE--SPYVAKLY 63

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYL 303
            +    +  L+L+ +Y++GG     +  K  G      LP  W+ +Y     IAE V  +
Sbjct: 64  -YSFQSKDYLYLVMEYLNGGDCASLI--KTLGG-----LPEDWAKQY-----IAEVVLGV 110

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  +R ++HRDIKP N+L+      KL DFGL+
Sbjct: 111 EDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 19/158 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D E+ E   +   +E+ + S    P + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---S 299
              G  +   + L++I +Y+ GGS    L   + G       P+   +++A  + E    
Sbjct: 66  KYYGSYLKGTK-LWIIMEYLGGGSA---LDLLRAG-------PFD-EFQIATMLKEILKG 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + YLH+  +   +HRDIK +N+LLS +   KL DFG+A
Sbjct: 114 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 13/155 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D E+ E   +   +E+ + S    P + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 66  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILRE-----ILKGLDY 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+  +   +HRDIK +N+LLS     KL DFG+A
Sbjct: 117 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 24/163 (14%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK----EDKESSKAFCRELMIASSLHHPNIVPLV 245
           LG G    V   KV     + A+K + K    E  +    F  E  I    +HP IV L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS-EKEILEECNHPFIVKLY 59

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D ++ ++++ +Y  GG L   L ++  G+    T     R+ +A  +  +  YLHN
Sbjct: 60  RTFKD-KKYIYMLMEYCLGGELWTILRDR--GLFDEYT----ARFYIA-CVVLAFEYLHN 111

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA--------TWT 340
              R +++RD+KP N+LL S    KL DFG A        TWT
Sbjct: 112 ---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.4 bits (133), Expect = 1e-08
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 15/153 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +V+G+G+   V   K  L     A+K L K+     KE         ++  ++ HP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +     + L+ +  +V+GG L  HL  ++       + P       A  IA ++ YL
Sbjct: 61  L-HYSFQTTEKLYFVLDFVNGGELFFHLQRER-------SFPEPRARFYAAEIASALGYL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H+     +V+RD+KP NILL S+    L DFGL
Sbjct: 113 HSIN---IVYRDLKPENILLDSQGHVVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V+K +        AIK +  E  E      +E+++     H NIV   G  +
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ L++  ++  GGSL+   H    G    S + +  R  +     + + YLH+  + 
Sbjct: 77  RRDK-LWICMEFCGGGSLQDIYH--VTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
             +HRDIK +NILL+     KL DFG++   +A
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITA 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 55.5 bits (133), Expect = 1e-08
 Identities = 49/171 (28%), Positives = 80/171 (46%), Gaps = 21/171 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           F+  R +G G+   V+  +       VAIK++    K+S++ +    +E+     + HPN
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            +  G  
Sbjct: 87  SIEYKG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AITHGAL 135

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           + +AYLH+     ++HRDIK  NILL+     KL DFG A+  S P+  F+
Sbjct: 136 QGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-PANSFV 182

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 1e-08
 Identities = 47/156 (30%), Positives = 79/156 (50%), Gaps = 12/156 (7%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 248
           LG G+ + V+KG   +    VA+K +  + +E       RE  +   L H NIV L+   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIV-LLHDI 71

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           I  ++ L  +++Y+    L +++ +   G+      P++VR      +   +AY+H    
Sbjct: 72  IHTKETLTFVFEYMHT-DLAQYMIQHPGGLH-----PYNVRL-FMFQLLRGLAYIHG--- 121

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + ++HRD+KP N+L+S     KL DFGLA   S PS
Sbjct: 122 QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 29/167 (17%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC----RELMIASSLH 237
             +     +G GA   V           VAIK++   + ++   FC    RE+ I     
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFK 61

Query: 238 HPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRY 290
           H NI+ ++     P       ++++ +      +E  L+   K ++   T   S   ++Y
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQEL-----METDLY---KLIK---TQHLSNDHIQY 110

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +   I   + Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 111 FL-YQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.1 bits (132), Expect = 1e-08
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 13/170 (7%)

Query: 186 KGRVLGRGALSFVFKG--KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G  +GRG    V+K   K G      A+K++  E    S + CRE+ +   L HPN++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIA 62

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           L   F    ++ ++L++ Y           H   K  +    LP S+   +   I + + 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 302 YLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPF 347
           YLH      V+HRD+KP+NIL+      +   K+ D G A   ++P  P 
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 54.9 bits (132), Expect = 1e-08
 Identities = 39/153 (25%), Positives = 73/153 (47%), Gaps = 12/153 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAIK+++ + +   +    E+++     HPNIV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
            +   +  ++ L+++ +Y++GGSL   + E        + +       V     +++ +L
Sbjct: 81  YLDSYLVGDE-LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFL 131

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H+     V+HRDIK  NILL      KL DFG 
Sbjct: 132 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 49/183 (26%), Positives = 90/183 (49%), Gaps = 29/183 (15%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++ +HP IV L+G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-AF 78

Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             +  L+++ ++  GG+++  + E  +G+    T P  ++  +   + E++ YLH+    
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGL----TEP-QIQV-ICRQMLEALQYLHS---M 129

Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLAT-----------------WTSAPSVPFLCKTV 352
            ++HRD+K  N+LL+     KL DFG++                  W  AP V  +C+T+
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM-APEV-VMCETM 187

Query: 353 KGT 355
           K T
Sbjct: 188 KDT 190

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 52/164 (31%), Positives = 74/164 (45%), Gaps = 23/164 (14%)

Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ S L HPNIV 
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----------HEKKKGVRGNSTLPWSVRYKV 292
           L+G  +  EQ L +I+ Y S   L   L            +  K V+  STL  +    +
Sbjct: 73  LLGV-VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK--STLEPADFVHI 129

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
              IA  + +L   +   VVH+D+   N+L+  K   K+ D GL
Sbjct: 130 VTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 47/154 (30%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +V+G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +   + + ++ +Y+  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 70  LEG-VVTKSKPVMIVTEYMENGSLDAFLRKHD----GQFTVIQLV--GMLRGIASGMKYL 122

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLS 153

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 21/171 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 125

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV 172

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 50/158 (31%), Positives = 73/158 (46%), Gaps = 25/158 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMIASSLHH 238
           +V+G+G+      GKV L R        A+K L K+     KE         ++  ++ H
Sbjct: 1   KVIGKGSF-----GKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +V L  F       L+ +  Y++GG L  HL       R    L    R+  A  IA 
Sbjct: 56  PFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAA-EIAS 107

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           ++ YLH+     +V+RD+KP NILL S+    L DFGL
Sbjct: 108 ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL 142

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 23/160 (14%)

Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAFC--RELMIA---SSLHHPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +     +  HPN+
Sbjct: 9   IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66

Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           V L   C     D E  L L++++V    L  +L +          +P      +   + 
Sbjct: 67  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVP-----EPGVPTETIKDMMFQLL 120

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             + +LH+     VVHRD+KP NIL++S    KL DFGLA
Sbjct: 121 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 44/164 (26%), Positives = 68/164 (41%), Gaps = 14/164 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS---VAIK--RLDKEDKESSKAFCRELMIASSLHH 238
              G++LG G    V +G++     S   VA+K  +LD       + F  E        H
Sbjct: 1   LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60

Query: 239 PNIVPLVGFCIDPE--QGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           PN++ L+G C +    Q +    +I  ++  G L   L   + G      LP     K  
Sbjct: 61  PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFM 119

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + IA  + YL N   R  +HRD+   N +L       + DFGL+
Sbjct: 120 VDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 53.9 bits (129), Expect = 3e-08
 Identities = 40/131 (30%), Positives = 71/131 (54%), Gaps = 13/131 (9%)

Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 31  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 87

Query: 268 ERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
              L    K   G+   LP  + +     IAE +A++    +R  +HRD++ +NIL+S+ 
Sbjct: 88  LDFL----KSDEGSKQPLPKLIDFSAQ--IAEGMAFIE---QRNYIHRDLRAANILVSAS 138

Query: 327 KIPKLCDFGLA 337
            + K+ DFGLA
Sbjct: 139 LVCKIADFGLA 149

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 32/114 (28%), Positives = 58/114 (50%), Gaps = 6/114 (5%)

Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
             +E  +   L H NI+P++  CI+  +  F++Y Y++ G+L+  L + + G   N    
Sbjct: 55  LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ-A 113

Query: 286 WSVRYKVALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            S +  V +   IA  ++YLH    R V+H+DI   N ++  +   K+ D  L+
Sbjct: 114 LSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALS 164

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 46/181 (25%), Positives = 90/181 (49%), Gaps = 21/181 (11%)

Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +   ++  G ++G G+   V++         VAIK++ ++ +  +    REL+I  +L+H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN----RELLIMKNLNH 118

Query: 239 PNIVPLVGF----CIDP-EQGLFL--IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
            NI+ L  +    C    E+ +FL  + +++   ++ +++   K   R N  LP  +   
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYM---KHYARNNHALPLFLVKL 174

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT--WTSAPSVPFL 348
            +  +  ++AY+H+   + + HRD+KP N+L+       KLCDFG A        SV ++
Sbjct: 175 YSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYI 231

Query: 349 C 349
           C
Sbjct: 232 C 232

Length = 440

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 46/138 (33%), Positives = 69/138 (50%), Gaps = 19/138 (13%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           E  +   + HP I+ L  F  + +Q  L+++ +YV GG L  +L  +  G   NST    
Sbjct: 51  EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNST---G 103

Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTS 341
           + Y  A  I  ++ YLH+   + +V+RD+KP NILL  +   KL DFG A      TWT 
Sbjct: 104 LFY--ASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL 158

Query: 342 APSVPFLCKTVKGTFGQN 359
             +  +L   V  + G N
Sbjct: 159 CGTPEYLAPEVIQSKGHN 176

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 54.4 bits (131), Expect = 3e-08
 Identities = 49/175 (28%), Positives = 66/175 (37%), Gaps = 28/175 (16%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD----KEDKESSKAFC----------RELM 231
           KG  LG G    V K    L    VAIK++       D    +             REL 
Sbjct: 13  KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72

Query: 232 IASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           I + + H NI+ LV  +    E     +   +    L       KK V     L  S   
Sbjct: 73  IMNEIKHENIMGLVDVYV---EGDFINLVMDIMASDL-------KKVVDRKIRLTESQVK 122

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
            + L I   +  LH       +HRD+ P+NI ++SK I K+ DFGLA     P  
Sbjct: 123 CILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPY 174

Length = 335

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 10/150 (6%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPLVG-F 247
           LG+G    V+K        ++A+K +  E  ES       EL I      P IV   G F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E  +++  +Y+  GSL++ L+       G   +P  V  ++   + + + +L    
Sbjct: 69  FI--EGAVYMCMEYMDAGSLDK-LYAGGVATEG---IPEDVLRRITYAVVKGLKFLKE-- 120

Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E  ++HRD+KP+N+L++     KLCDFG++
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 58/211 (27%), Positives = 83/211 (39%), Gaps = 61/211 (28%)

Query: 187 GRVLGRGALSFVFKGKV-GLLRTS----VAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+VLG GA   V +    G+ + S    VA+K L KE   +S  KA   EL I   + +H
Sbjct: 12  GKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML-KEGATASEHKALMSELKILIHIGNH 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV-------------------- 278
            N+V L+G C  P   L +I ++   G+L   L  K++                      
Sbjct: 71  LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQ 130

Query: 279 ----------------------RGNSTLPWSVR---YKVALGIAESVAY---LHNGTE-- 308
                                    ST P       +K  L + + + Y   +  G E  
Sbjct: 131 SRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL 190

Query: 309 --RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             R  +HRD+   NILLS   + K+CDFGLA
Sbjct: 191 ASRKCIHRDLAARNILLSENNVVKICDFGLA 221

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 49/164 (29%), Positives = 73/164 (44%), Gaps = 24/164 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGL--LRTS---VAIKRLDKEDKESSKA---FCRELMIA 233
            +F  G  LG G  SF   G+V +   + +    AIK L K +    K      +E  I 
Sbjct: 18  SDFEMGETLGTG--SF---GRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSIL 72

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
             L HP IV ++    D E  ++ + ++V GG L  HL       R     P  V     
Sbjct: 73  MELSHPFIVNMMCSFQD-ENRVYFLLEFVVGGELFTHL-------RKAGRFPNDVAKFYH 124

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +  +  YLH+     +++RD+KP N+LL +K   K+ DFG A
Sbjct: 125 AELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFA 165

Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 4e-08
 Identities = 52/177 (29%), Positives = 73/177 (41%), Gaps = 30/177 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKEDKESSKAFCR---ELMIA 233
            +F K ++LG+G +     G+V L+R        A+K LDK++        R   E  I 
Sbjct: 1   KHFKKIKLLGKGDV-----GRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEIL 55

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           ++L HP +  L       E  L L+  Y  GG L R L  +         L   V     
Sbjct: 56  ATLDHPFLPTLYA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKC-----LSEEV---AR 106

Query: 294 LGIAESVA---YLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
              AE +    YLH  G    +V+RD+KP NILL       L DF L+  +     P
Sbjct: 107 FYAAEVLLALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 14/153 (9%)

Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIVPL 244
           V+G G    V +G++   G     VAIK L     E   + F  E  I     HPNI+ L
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G  +   + + +I +++  G+L+  L +      G  T+   V   +  GIA  + YL 
Sbjct: 71  EGV-VTKSRPVMIITEFMENGALDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL- 122

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +E   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 123 --SEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.5 bits (128), Expect = 5e-08
 Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 21/165 (12%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           +G G+   V+          VA+K++    K+  E  +   +E+     L HPN +   G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 247 FCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
            C   E   +L+ +Y  G +   LE H    KK ++            +  G  + +AYL
Sbjct: 89  -CYLKEHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AITHGALQGLAYL 137

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           H+     ++HRDIK  NILL+     KL DFG A+  S+P+  F+
Sbjct: 138 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSAS-KSSPANSFV 178

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 18/157 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH---HPNIVPL 244
           +G GA   V+K +       VA+K +  +  E        RE+ +   L    HPNIV L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 245 VGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +  C     D E  + L++++V    L  +L +          LP      +       +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP-----PGLPAETIKDLMRQFLRGL 121

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +LH     C+VHRD+KP NIL++S    KL DFGLA
Sbjct: 122 DFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLA 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 35/167 (20%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED--KESSKAFC---RELM 231
            +F   +V+GRGA      G+V L+R        A+K L K +  K S  AF    R++M
Sbjct: 43  EDFDVIKVIGRGAF-----GEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 232 I-ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSV 288
             A+S     IV L  +    ++ L+++ +Y+ GG L   +         N  +P  W+ 
Sbjct: 98  AHANS---EWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--------SNYDIPEKWAR 145

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
            Y      AE V  L        +HRD+KP N+LL      KL DFG
Sbjct: 146 FY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 32/192 (16%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 136

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T    F
Sbjct: 137 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTACTNF 177

Query: 357 GQNPFCIEEWQR 368
              P+ +  + R
Sbjct: 178 MMTPYVVTRYYR 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.3 bits (123), Expect = 6e-08
 Identities = 24/103 (23%), Positives = 44/103 (42%), Gaps = 14/103 (13%)

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
                VP V    + +   +L+ +++ G +L+    E+K+               +A  +
Sbjct: 50  RKGLPVPKVLASGESDGWSYLLMEWIEGETLDEVSEEEKE--------------DIAEQL 95

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           AE +A LH      + H D+ P NIL+   KI  + D+  A +
Sbjct: 96  AELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 9/151 (5%)

Query: 190 LGRGALSFVFKGKV--GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           +G G    V  G+   G+ +  V +K L      +    F +E+     L+HPN++  +G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            CI+      L+ ++   G L+ +L   +  V   +     V  ++A  +A  + +LH  
Sbjct: 63  QCIESIP-YLLVLEFCPLGDLKNYLRSNRGMVAQMAQK--DVLQRMACEVASGLLWLHQA 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                +H D+   N  L++    K+ D+GLA
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 57/216 (26%), Positives = 83/216 (38%), Gaps = 66/216 (30%)

Query: 187 GRVLGRGALSFVFKG------KVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HH 238
           G+ LGRGA   V +       K    RT VA+K L +    S  +A   EL I   + HH
Sbjct: 12  GKPLGRGAFGQVIEADAFGIDKTATCRT-VAVKMLKEGATHSEHRALMSELKILIHIGHH 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------------KGVRGNSTL 284
            N+V L+G C  P   L +I ++   G+L  +L  K+              +G  G   +
Sbjct: 71  LNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDI 130

Query: 285 PWSVR------------------------------------YKVALGIAESVAY---LHN 305
              ++                                    YK  L + + + Y   +  
Sbjct: 131 SEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAK 190

Query: 306 GTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           G E    R  +HRD+   NILLS   + K+CDFGLA
Sbjct: 191 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA 226

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 15/153 (9%)

Query: 188 RVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           RV+GRG+ + V     K    +    V  K L  +D++       + +   +  +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C      LFL+ +YV+GG L  H+  ++K       LP       A  I  ++ +L
Sbjct: 61  LHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRK-------LPEEHARFYAAEICIALNFL 112

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H   ER +++RD+K  N+LL +    KL D+G+
Sbjct: 113 H---ERGIIYRDLKLDNVLLDADGHIKLTDYGM 142

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 43/138 (31%), Positives = 71/138 (51%), Gaps = 18/138 (13%)

Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCI--DPEQGLFLIYKYVSGGS 266
           VA+K L  +  K +   F +E+ I S L +PNI+ L+G C+  DP   L +I +Y+  G 
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDP---LCMITEYMENGD 103

Query: 267 LERHLHEKK---KGVRGNSTLPWSVRYK----VALGIAESVAYLHNGTERCVVHRDIKPS 319
           L + L +++        N+ +P SV       +A+ IA  + YL +      VHRD+   
Sbjct: 104 LNQFLSQREIESTFTHANN-IP-SVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR 158

Query: 320 NILLSSKKIPKLCDFGLA 337
           N L+ +    K+ DFG++
Sbjct: 159 NCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 52.7 bits (127), Expect = 7e-08
 Identities = 37/160 (23%), Positives = 69/160 (43%), Gaps = 13/160 (8%)

Query: 187 GRVLGRGALSFVFKG-----KVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPN 240
            R LG+G+   V++G       G   T VAIK +++      +  F  E  +    +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLE---RHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +V L+G      Q   ++ + ++ G L+   R    + +   G          ++A  IA
Sbjct: 71  VVRLLGVVST-GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +AYL     +  VHRD+   N +++     K+ DFG+ 
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 21/161 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +GRGA   V   K       VAIK++    +++  +K   RE+ +   L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD- 71

Query: 248 CIDPEQ-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS-VRYKVALGIAESVA 301
            + P        ++++Y+      ++  LH+    +R + TL     +Y +   +   + 
Sbjct: 72  IMPPPHREAFNDVYIVYEL-----MDTDLHQI---IRSSQTLSDDHCQYFL-YQLLRGLK 122

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           Y+H+     V+HRD+KPSN+LL++    K+CDFGLA  TS 
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    +G+ +       +VA+K L  D  DK+ S       M+     
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 288
           H NI+ L+G C   +  L+++ +Y S G+L  +L  ++  G+             L +  
Sbjct: 77  HKNIINLLGACTQ-DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 136 LVSCAYQVARGMEYL--ASQKCI-HRDLAARNVLVTEDNVMKIADFGLA 181

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 46/170 (27%), Positives = 76/170 (44%), Gaps = 13/170 (7%)

Query: 186 KGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G  +GRG    V+K K   G      A+K++  E    S + CRE+ +   L HPN++ 
Sbjct: 5   EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVIS 62

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           L   F    ++ ++L++ Y           H   K  +    LP  +   +   I + + 
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122

Query: 302 YLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPF 347
           YLH      V+HRD+KP+NIL+      +   K+ D G A   ++P  P 
Sbjct: 123 YLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (127), Expect = 9e-08
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHH-PNIVP 243
           +G+G    V++ +    R   A+K L K++  + K        R +++ + L   P IV 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  F    +  L+L+  Y+SGG L  HL ++ +              +    IAE V  L
Sbjct: 61  L-KFSFQTDSDLYLVTDYMSGGELFWHLQKEGR----------FSEDRAKFYIAELVLAL 109

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  +  +V+RD+KP NILL +     LCDFGL+
Sbjct: 110 EHLHKYDIVYRDLKPENILLDATGHIALCDFGLS 143

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 18/152 (11%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG- 246
           +LG G    V+K    L R  +A+K +  +   E  K    EL I      P I+   G 
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           F +  E  + +  +++ GGSL+ +             +P  V  ++A+ + + + YL + 
Sbjct: 68  FFV--ENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSL 114

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               ++HRD+KPSN+L++++   KLCDFG++T
Sbjct: 115 K---ILHRDVKPSNMLVNTRGQVKLCDFGVST 143

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 15/133 (11%)

Query: 210 VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           VA+K++    ++  S K   REL +     H N++  +     P    F    YV    +
Sbjct: 28  VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFE-EIYVVTELM 86

Query: 268 ERHLHEKKKGVRGNSTLPWSVR---YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS 324
           +  LH  K  V         V+   Y++  G    + YLH+     ++HRDIKP N+L++
Sbjct: 87  QSDLH--KIIVSPQPLSSDHVKVFLYQILRG----LKYLHSAG---ILHRDIKPGNLLVN 137

Query: 325 SKKIPKLCDFGLA 337
           S  + K+CDFGLA
Sbjct: 138 SNCVLKICDFGLA 150

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 11/152 (7%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--FCRELMIASSLHHPNIVPLVG 246
           V+G+G+   V           VAIK+++   +  S A    RE+ +   L HP+IV +  
Sbjct: 7   VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESVAYLHN 305
             + P +  F    YV    +E  LH+    ++ N  L     ++  L  +  ++ Y+H 
Sbjct: 67  IMLPPSRREFKDI-YVVFELMESDLHQV---IKANDDLT-PEHHQFFLYQLLRALKYIHT 121

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                V HRD+KP NIL ++    K+CDFGLA
Sbjct: 122 AN---VFHRDLKPKNILANADCKLKICDFGLA 150

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 187 GRVLGRGALSFVFKGK-VGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G    V   + +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK------ 291
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++         P  V  +      
Sbjct: 83  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141

Query: 292 ---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 142 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 187

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 47/190 (24%), Positives = 88/190 (46%), Gaps = 40/190 (21%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84

Query: 248 -----CIDPEQGLFLIYKYVSGG---SLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAE 298
                 ++  Q ++L+ + +       ++  L HE+             + Y++  GI  
Sbjct: 85  FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQMLCGI-- 132

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQ 358
              +LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T   +F  
Sbjct: 133 --KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMM 175

Query: 359 NPFCIEEWQR 368
            P+ +  + R
Sbjct: 176 TPYVVTRYYR 185

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 11/108 (10%)

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E  + + ++ P IVPL  F     + L+L+  +++GG L  HL  + +            
Sbjct: 43  ERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHLQREGR----------FD 91

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             +     AE +  L N  +  V++RD+KP NILL  +    LCDFGL
Sbjct: 92  LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGL 139

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 30/173 (17%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G    V + +  G+ +       +VA+K L  +  DK+ +       ++     
Sbjct: 17  GKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK 76

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK-----------KGVRGNSTLP- 285
           H NI+ L+G C   E  L++I +Y + G+L   L  ++           K      +   
Sbjct: 77  HKNIINLLGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   + RC+ HRD+   N+L++   + K+ DFGLA
Sbjct: 136 LVSCAYQVARGME----YLE--SRRCI-HRDLAARNVLVTEDNVMKIADFGLA 181

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 17/162 (10%)

Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HHPNIVPL 244
           V+G G    V +  +    L+ + AIK L +   E+  + F  EL +   L HHPNI+ L
Sbjct: 9   VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKK---------KGVRGNSTLPWSVRYKVALG 295
           +G C +    L++  +Y   G+L   L + +         K     STL      + A  
Sbjct: 69  LGAC-ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +A  + YL   +E+  +HRD+   N+L+      K+ DFGL+
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLS 166

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 16/152 (10%)

Query: 190 LGRGALSFVFKGKVGLLRT--SVAIKRLDKEDKESS--KAFCRELMIASSLHHPNIVPLV 245
           LG G    V KG   + ++  +VA+K L  ++ + +      RE  +   L +P IV ++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L + L + K     N T    + ++V++G+     YL  
Sbjct: 63  GIC--EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT---ELVHQVSMGMK----YLE- 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 113 --ETNFVHRDLAARNVLLVTQHYAKISDFGLS 142

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 11/161 (6%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           H++   + +G G    V+K +        A+K +  E  +      +E+ +     H NI
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V   G  +  E+ L++  +Y  GGSL+   H    G      + +  R  +     + +A
Sbjct: 69  VAYFGSYLSREK-LWICMEYCGGGSLQDIYH--VTGPLSELQIAYVCRETL-----QGLA 120

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           YLH+   +  +HRDIK +NILL+     KL DFG+A   +A
Sbjct: 121 YLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITA 158

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 39/156 (25%), Positives = 66/156 (42%), Gaps = 21/156 (13%)

Query: 187 GRVLGRG--ALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIV 242
             ++G+    L  V   K     T VA+K+  LD   KE  K   +E++ +  L HPNI+
Sbjct: 3   LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNIL 62

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P V      +  L+++   ++ GS    L+ H             LP      +   +  
Sbjct: 63  PYV-TSFIVDSELYVVSPLMAYGSCEDLLKTHF---------PEGLPELAIAFILKDVLN 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 334
           ++ Y+H+  +   +HR +K S+ILLS      L   
Sbjct: 113 ALDYIHS--KGF-IHRSVKASHILLSGDGKVVLSGL 145

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 51.4 bits (123), Expect = 3e-07
 Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 19/155 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNI 241
           RVLG+G+   V   ++       A+K L K+      D E +    R L +A +  HP +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN--HPFL 58

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
             L   C      LF + ++V+GG L  H+ + ++     +          A  I  ++ 
Sbjct: 59  TQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEITSALM 110

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           +LH   ++ +++RD+K  N+LL  +   KL DFG+
Sbjct: 111 FLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 41/158 (25%), Positives = 80/158 (50%), Gaps = 22/158 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V      +   +VAIK+L +  ++   +K   REL++   ++H NI+ L+
Sbjct: 22  KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81

Query: 246 GFCIDPE------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
                P+      Q ++L+ +      ++ +L +  +    +  + + + Y++  GI   
Sbjct: 82  N-VFTPQKSLEEFQDVYLVMEL-----MDANLCQVIQMDLDHERMSYLL-YQMLCGIK-- 132

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +LH+     ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 133 --HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 19/162 (11%)

Query: 184 FSKGRVLGRGALSFVFKG---KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F    V+G G    V+KG   K G L    AIK +D  + E  +      M+    HH N
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQL---AAIKVMDVTEDEEEEIKLEINMLKKYSHHRN 74

Query: 241 IVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           I    G  I       +  L+L+ ++   GS+     +  K  +GN+     + Y +   
Sbjct: 75  IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT----DLVKNTKGNALKEDWIAY-ICRE 129

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           I   +A+LH      V+HRDIK  N+LL+     KL DFG++
Sbjct: 130 ILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 51.2 bits (123), Expect = 3e-07
 Identities = 42/154 (27%), Positives = 66/154 (42%), Gaps = 14/154 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VAIK++    +    +K   REL I     H NI+ + 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS-VRYKVALG-IAESVAYL 303
              + P    F    YV    +E  LH     +  +  L    +RY   L  +   + Y+
Sbjct: 71  DI-LRPPGADF-KDVYVVMDLMESDLHHI---IHSDQPLTEEHIRY--FLYQLLRGLKYI 123

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           H+     V+HRD+KPSN+L++     ++ DFG+A
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 14/164 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESS--KAFCRELMIASSLHH 238
           F+ GR+LG+G    V + ++     S   VA+K L  +   SS  + F RE        H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 239 PNIVPLVGFCID--PEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           PN++ L+G  +    +  L    +I  ++  G L   L   + G     TLP     +  
Sbjct: 61  PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFM 119

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + IA  + YL +   +  +HRD+   N +L+      + DFGL+
Sbjct: 120 IDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLS 160

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 14/153 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV-GFC 248
           +G G+   V    V      VA+K++D   ++  +    E++I     H N+V +   + 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           +  E  L+++ +++ GG+L   +   +      +         V L + ++++ LH    
Sbjct: 88  VGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLKALSVLH---A 134

Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
           + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 135 QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 46/190 (24%), Positives = 88/190 (46%), Gaps = 40/190 (21%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 91

Query: 248 -----CIDPEQGLFLIYKYVSGG---SLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAE 298
                 ++  Q ++++ + +       ++  L HE+             + Y++  GI  
Sbjct: 92  FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLYQMLCGIK- 140

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQ 358
              +LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T   +F  
Sbjct: 141 ---HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMM 182

Query: 359 NPFCIEEWQR 368
            P+ +  + R
Sbjct: 183 TPYVVTRYYR 192

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 29/168 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR--------TSVAIKRLDK-----EDKESSKAFCRE 229
           NF   RVLG GA      GKV L+R           A+K L K     + K +       
Sbjct: 1   NFELLRVLGTGAY-----GKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTER 55

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
            ++ +    P +V L  +    +  L LI  YV+GG L  HL++     R + T      
Sbjct: 56  QVLEAVRRCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQ-----REHFTE----- 104

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +V + IAE V  L +  +  +++RDIK  NILL S+    L DFGL+
Sbjct: 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 37/120 (30%), Positives = 59/120 (49%), Gaps = 14/120 (11%)

Query: 252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 311
           +  L LI +Y SGG L + + ++ K       LP+   Y+V L   + V  L     R +
Sbjct: 137 DDKLLLIMEYGSGGDLNKQIKQRLK-----EHLPFQ-EYEVGLLFYQIVLALDEVHSRKM 190

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLAT-WTSAPSVPFLCKTVKGTFGQNPFCI--EEWQR 368
           +HRD+K +NI L    I KL DFG +  ++ + S+      V  +F   P+ +  E W+R
Sbjct: 191 MHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL-----DVASSFCGTPYYLAPELWER 245

Length = 478

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 40/142 (28%), Positives = 73/142 (51%), Gaps = 19/142 (13%)

Query: 190 LGRGALSFVFKGK---VG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           LG+G  + +FKG    VG    L +T V +K LDK  +  S++F     + S L H ++V
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G C+  ++ + ++ +YV  GSL+ +L + K  +     + W       L +A+ +A+
Sbjct: 63  LNYGVCVCGDESI-MVQEYVKFGSLDTYLKKNKNLI----NISWK------LEVAKQLAW 111

Query: 303 -LHNGTERCVVHRDIKPSNILL 323
            LH   ++ + H ++   N+LL
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 9e-07
 Identities = 62/266 (23%), Positives = 99/266 (37%), Gaps = 88/266 (33%)

Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGK- 202
           E++W+ I++ E +    I P      +L Y E       N   G+ LG GA   V +   
Sbjct: 5   EIRWKIIEAAEGNNYTFIDPT-----QLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATA 59

Query: 203 VGLLR----TSVAIKRLD-KEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG-- 254
            GL +      VA+K L      +  +A   EL I S L  H NIV L+G C     G  
Sbjct: 60  FGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT---HGGP 116

Query: 255 LFLIYKYVSGGSL---------------------------ERHLHEKKKGVRGNSTL--- 284
           + +I +Y   G L                            +++  +KK +R +S     
Sbjct: 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQ 176

Query: 285 ---------PWSVRYKVALG------------------------IAESVAYLHNGTERCV 311
                    P S     +                          +A+ + +L   ++ C+
Sbjct: 177 GSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFL--ASKNCI 234

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLA 337
            HRD+   N+LL+  ++ K+CDFGLA
Sbjct: 235 -HRDVAARNVLLTDGRVAKICDFGLA 259

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 41/143 (28%), Positives = 71/143 (49%), Gaps = 15/143 (10%)

Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK-KGVRGNSTLPW 286
           +E ++ + + HPNIV       + +  L+++ +Y  GG L + +  ++ K    ++ L W
Sbjct: 47  KEAVLLAKMKHPNIVAFKE-SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
            V  ++ LG    V ++H   E+ V+HRDIK  NI L+     KL DFG A   ++P   
Sbjct: 106 FV--QMCLG----VQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155

Query: 347 FLCKTVKGTFGQNPFCIEEWQRL 369
           + C  V   +   P   E W+ +
Sbjct: 156 YACTYVGTPYYVPP---EIWENM 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 47/163 (28%), Positives = 77/163 (47%), Gaps = 19/163 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTS----VAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG  A   ++KG + L        VAIK L D  + +    F +E  + + LHHPNIV L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK----GVRGN------STLPWSVRYKVAL 294
           +G  +  EQ + ++++Y++ G L   L  +      G   +      S+L       +A+
Sbjct: 73  LG-VVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            IA  + YL   +    VH+D+   NIL+  +   K+ D GL+
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLS 171

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 24/163 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHH 238
           +F   +++  GA   V+  +    R   A+K+++K++     +  + F  E  I +   +
Sbjct: 2   DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAEN 60

Query: 239 PNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           P +V +  FC  + ++ L ++ +YV GG     L  K  G      LP  +     +  A
Sbjct: 61  PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL--KNIG-----ALPVDM---ARMYFA 108

Query: 298 ESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E+V    YLHN     +VHRD+KP N+L++S    KL DFGL+
Sbjct: 109 ETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 34/132 (25%), Positives = 65/132 (49%), Gaps = 12/132 (9%)

Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +D   ++  +    E++I     H N+V +    +  E+ L+++ +++ GG+L  
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-LWVLMEFLQGGALTD 107

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            + + +      +T        V   + +++ YLH+   + V+HRDIK  +ILL+     
Sbjct: 108 IVSQTRLNEEQIAT--------VCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRV 156

Query: 330 KLCDFGLATWTS 341
           KL DFG     S
Sbjct: 157 KLSDFGFCAQIS 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 14/159 (8%)

Query: 183 NFSKGRVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
           +F   +V+GRGA      V K   G +     +++ D  +KE       E  I       
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V +  +    +  L+LI +++ GG +   L +K        TL      +    IAE+
Sbjct: 62  WVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKK-------DTL---TEEETQFYIAET 110

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           V  + +  +   +HRDIKP N+LL SK   KL DFGL T
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 52/165 (31%), Positives = 72/165 (43%), Gaps = 27/165 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS------VAIKRLDK----EDKESSKAFCRELMI 232
           +F+  R LG G+      G+V L          VAIKR +K    + K+    F  E  I
Sbjct: 31  DFNFIRTLGTGSF-----GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
            + ++HP  V L G   D E  L+L+ ++V GG     L       R N   P  V    
Sbjct: 85  LNYINHPFCVNLYGSFKD-ESYLYLVLEFVIGGEFFTFL-------RRNKRFPNDVGCFY 136

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A  I     YL +     +V+RD+KP N+LL      K+ DFG A
Sbjct: 137 AAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFA 178

Length = 340

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 22/144 (15%)

Query: 190 LGRGALSFVFKG----------KVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
           LG+G  + ++KG                 SV +K L   D   S AF     + S L H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHK 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           ++V L G C+  E    ++ +YV  G L+  LH +K  V    +L W  +  VA  +A +
Sbjct: 62  HLVKLYGVCVRDEN--IMVEEYVKFGPLDVFLHREKNNV----SLHW--KLDVAKQLASA 113

Query: 300 VAYLHNGTERCVVHRDIKPSNILL 323
           + YL +     +VH ++   NIL+
Sbjct: 114 LHYLEDKK---LVHGNVCGKNILV 134

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 14/159 (8%)

Query: 183 NFSKGRVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
           +F   +V+GRGA      V K   G +     +++ D  +KE       E  I       
Sbjct: 2   DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V +  +    ++ L+LI +++ GG +   L +K        TL           IAE+
Sbjct: 62  WVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKK-------DTLS---EEATQFYIAET 110

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           V  +    +   +HRDIKP N+LL +K   KL DFGL T
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCT 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 14/152 (9%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG+G    V   +V       A K+LDK+    K   K    E  I   ++ P IV L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           +  + +  L L+   ++GG L+ H+ +  ++G+     + +S +      I   + +LH 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLH- 112

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                +V+RD+KP N+LL  +   +L D GLA
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLA 142

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 42/154 (27%), Positives = 75/154 (48%), Gaps = 17/154 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           ++LG+G+   VF  ++       AIK L K+    D +       + +++ +  HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 244 LVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L  +C    ++ LF + +Y++GG L  H+    K       LP +  Y  A  I   + +
Sbjct: 61  L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-----FDLPRATFY--AAEIICGLQF 111

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+   + +V+RD+K  NILL +    K+ DFG+
Sbjct: 112 LHS---KGIVYRDLKLDNILLDTDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 17/154 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +VLG+G+   V   ++       AIK L K+    D +       + ++A +  HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L   C   +  LF + +YV+GG L   +   +K     S      R+  A  +  ++ +L
Sbjct: 61  LHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS------RFYAA-EVTLALMFL 112

Query: 304 H-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H +G    V++RD+K  NILL ++   KL DFG+
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 44/143 (30%), Positives = 66/143 (46%), Gaps = 15/143 (10%)

Query: 206 LRTSVAIKRLDKEDKESS-KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS 263
           LR   AIKR+ +   +   + F  EL +   L HHPNI+ L+G C +    L+L  +Y  
Sbjct: 21  LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-EHRGYLYLAIEYAP 79

Query: 264 GGSL------ERHLHEKKKGVRGN---STLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
            G+L       R L         N   STL        A  +A  + YL   +++  +HR
Sbjct: 80  HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHR 136

Query: 315 DIKPSNILLSSKKIPKLCDFGLA 337
           D+   NIL+    + K+ DFGL+
Sbjct: 137 DLAARNILVGENYVAKIADFGLS 159

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 45/179 (25%), Positives = 73/179 (40%), Gaps = 18/179 (10%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG+G    V   +V       A K+LDK+    ++  +    E  I   +    IV L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           +  + +  L L+   ++GG L+ H++       G    P +     A  I   + +LH  
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYN-----VGEPGFPEARAIFYAAQIICGLEHLHQ- 113

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE 365
             R +V+RD+KP N+LL      ++ D GLA            K +KG  G   +   E
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------KKIKGRAGTPGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 48.2 bits (114), Expect = 3e-06
 Identities = 44/159 (27%), Positives = 72/159 (45%), Gaps = 13/159 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           F    ++G G    V+KG+        AIK +D    E  +      M+    HH NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 244 LVGFCI--DP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
             G  I  +P   +  L+L+ ++   GS+   +    K  +GN+     + Y +   I  
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAY-ICREILR 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +++LH   +  V+HRDIK  N+LL+     KL DFG++
Sbjct: 123 GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 158

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 47.9 bits (114), Expect = 3e-06
 Identities = 53/163 (32%), Positives = 80/163 (49%), Gaps = 32/163 (19%)

Query: 188 RVLGRGALSFVFKGKVGLLR--------TSVAIKRLDK-----EDKESSKAFCRELMIAS 234
           +VLG+G  SF   GKV L+R           A+K L K      D+  +K    E  I +
Sbjct: 2   KVLGQG--SF---GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILA 53

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            ++HP IV L  +    E  L+LI  ++ GG L   L    K V         V++ +A 
Sbjct: 54  EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEE---DVKFYLA- 105

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +A ++ +LH+     +++RD+KP NILL  +   KL DFGL+
Sbjct: 106 ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 145

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 22/169 (13%)

Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    +G+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-------GVRGNSTLPWSVRY 290
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++         +        + + 
Sbjct: 80  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138

Query: 291 KVALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            V+    +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 139 LVSCTYQVARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 184

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 39/132 (29%), Positives = 58/132 (43%), Gaps = 14/132 (10%)

Query: 210 VAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
           VA+KR+ K         +    E  I ++     +V L+    D E  L+L  +YV GG 
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-LYLAMEYVPGGD 87

Query: 267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
             R L      +  +       R+ +A    E+V  LH   E   +HRD+KP N L+ + 
Sbjct: 88  F-RTLLNNLGVLSEDHA-----RFYMAEMF-EAVDALH---ELGYIHRDLKPENFLIDAS 137

Query: 327 KIPKLCDFGLAT 338
              KL DFGL+ 
Sbjct: 138 GHIKLTDFGLSK 149

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 31/159 (19%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED---KESSKAFCRELMIASSLHHP 239
           +V+GRGA      G+V L+R        A+K L K +   +  S  F  E  I +  + P
Sbjct: 49  KVIGRGAF-----GEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 240 NIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGI 296
            +V L  FC    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      
Sbjct: 104 WVVQL--FCAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKFYT----- 148

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           AE V  L       ++HRD+KP N+LL      KL DFG
Sbjct: 149 AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HRDIK  NILL      KL DFG 
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 47.0 bits (111), Expect = 6e-06
 Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAIK+++ + +   +    E+++     +PNIV 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 81  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDF 130

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HRDIK  NILL      KL DFG 
Sbjct: 131 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 161

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 47.1 bits (112), Expect = 6e-06
 Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 29/165 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLL--RTS---VAIKRLDK------EDKESSKAFCRELM 231
           +F+   VLG+G  SF   GKV L   + +    AIK L K      +D E +    R L 
Sbjct: 1   DFNFLMVLGKG--SF---GKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLA 55

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           +      P  +  +  C      L+ + +YV+GG L  H+ +      G    P +V Y 
Sbjct: 56  LPGK---PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPHAVFY- 106

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            A  IA  + +LH+   + +++RD+K  N++L ++   K+ DFG+
Sbjct: 107 -AAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 41/157 (26%), Positives = 69/157 (43%), Gaps = 21/157 (13%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNI 241
           +VLG+G+   V   ++       AIK L K+      D E +    R L +A    HP +
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFL 58

Query: 242 VPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
             L  FC    ++ LF + +Y++GG L  H+    +     +          A  I   +
Sbjct: 59  THL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARF-------YAAEIICGL 109

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +LH    + +++RD+K  N+LL      K+ DFG+ 
Sbjct: 110 QFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMC 143

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 29/85 (34%), Positives = 50/85 (58%), Gaps = 14/85 (16%)

Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVV 312
           ++L+ +Y+ GG ++  LH     + G      +V+Y  +VAL    ++ YLH      ++
Sbjct: 79  VYLVMEYLIGGDVKSLLH-----IYGYFDEEMAVKYISEVAL----ALDYLH---RHGII 126

Query: 313 HRDIKPSNILLSSKKIPKLCDFGLA 337
           HRD+KP N+L+S++   KL DFGL+
Sbjct: 127 HRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSL-HHPNIVPLVG 246
           +G+G    V+K       +  A+K LD   +  E  +A   E  I  SL +HPN+V   G
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEA---EYNILQSLPNHPNVVKFYG 86

Query: 247 FCIDPEQ----GLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAESVA 301
                ++     L+L+ +  +GGS+   +      G R +  +   + Y   LG+     
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ---- 142

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL-ATWTSA 342
           +LHN     ++HRD+K +NILL+++   KL DFG+ A  TS 
Sbjct: 143 HLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTST 181

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 19/157 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VAIK+L +  +    +K   REL +   + H N++ L+
Sbjct: 21  SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80

Query: 246 G-FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
             F         Q ++L+   + G  L   +  +K            +++ V   I   +
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD-------HIQFLV-YQILRGL 131

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            Y+H+     ++HRD+KPSNI ++     K+ DFGLA
Sbjct: 132 KYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 13/158 (8%)

Query: 188 RVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +    +  ++
Sbjct: 12  RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIAE 298
           V L+G  +   Q   +I + ++ G L+ +L   +  +  N            ++A  IA+
Sbjct: 72  VRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +AYL+       VHRD+   N +++     K+ DFG+
Sbjct: 131 GMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 165

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 21/157 (13%)

Query: 190 LGRGALSFV--FKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPL 244
           LG+GA   V   +        +VAIK++      K  +K   REL +      H NI  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 245 VGFCI---DPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAESV 300
               I        L+L Y+ +    +E  LH+  + G         S  Y++  G+    
Sbjct: 68  YDMDIVFPGNFNELYL-YEEL----MEADLHQIIRSGQPLTDAHFQSFIYQILCGLK--- 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            Y+H+     V+HRD+KP N+L+++    K+CDFGLA
Sbjct: 120 -YIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 1e-05
 Identities = 37/160 (23%), Positives = 68/160 (42%), Gaps = 13/160 (8%)

Query: 187 GRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           G+ LG G    V +G++     +L+ +V   ++    +   + F  E +      HPN++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 243 PLVGFCIDPEQ-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L+G C+   +        +I  ++  G L   L   + G      LP  +  K    IA
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIA 122

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             + YL   + +  +HRD+   N +L+      + DFGL+
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLS 159

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 46/168 (27%), Positives = 72/168 (42%), Gaps = 27/168 (16%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKED--KESSKAFCR-ELMIASS 235
           F K + +G GA      G+V L+R        A+K L K D    +  A  + E  I + 
Sbjct: 3   FVKIKTIGIGAF-----GEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE 57

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
             +  +V L  +    +  L+ +  Y+ GG +   L   + G+          R+ +A  
Sbjct: 58  ADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMMSLL--IRLGIFEEDL----ARFYIA-E 109

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT---WT 340
           +  ++  +H       +HRDIKP NIL+      KL DFGL T   WT
Sbjct: 110 LTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 44/153 (28%), Positives = 67/153 (43%), Gaps = 19/153 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPL 244
           +V+GRGA   V   +    R   A+K L K +   +  S  F  E  I +  + P +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAY 302
             +    ++ L+++ +Y+ GG L          +  N  +P  W+  Y      AE V  
Sbjct: 109 F-YAFQDDRYLYMVMEYMPGGDL--------VNLMSNYDVPEKWARFYT-----AEVVLA 154

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           L        +HRD+KP N+LL      KL DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 22/158 (13%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD-----KEDKESSKAFCRELMIASSLHHPNIVPL 244
           +G+G    VFK       +  A+K LD      E+ E+     + L       HPN+V  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS-----DHPNVVKF 80

Query: 245 VG--FCIDPEQG--LFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 299
            G  +  D + G  L+L+ +  +GGS+   +    K+G R    +   + ++  +G+   
Sbjct: 81  YGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ-- 138

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +LH       +HRD+K +NILL+++   KL DFG++
Sbjct: 139 --HLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS 171

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 41/154 (26%), Positives = 69/154 (44%), Gaps = 19/154 (12%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHHPNIV 242
           VLG+G+   V   +        AIK L K+      D E +     E  + +    P  +
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV---EKRVLALQDKPPFL 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             +  C      L+ + +YV+GG L  H+ +      G    P +V Y  A  I+  + +
Sbjct: 64  TQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFY--AAEISVGLFF 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH    R +++RD+K  N++L S+   K+ DFG+
Sbjct: 117 LH---RRGIIYRDLKLDNVMLDSEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 22/173 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHH-P 239
            + K   +G G    V+K +       VA+K  RL+ +++       RE+ +   L    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 240 NIVPLVGFCID------PEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYK 291
            IV L+   ++       +  L+L+++Y+    L++ +  + +  G    +    S  Y+
Sbjct: 62  YIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLATWTSAP 343
           +  G    VA+ H   +  V+HRD+KP N+L+   K + K+ D GL    S P
Sbjct: 119 LLKG----VAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP 164

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 10/156 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 241
           F + RVLG+G    V   +V       A KRL+K+  +  K     L     L   N   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V  + +  + +  L L+   ++GG L+ H++       GN   P     +     AE + 
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM-----GN---PGFEEERALFYAAEILC 113

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            L +      V+RD+KP NILL      ++ D GLA
Sbjct: 114 GLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA 149

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 27/167 (16%)

Query: 183 NFSKGRVLGRGALSFVF---------KGKV---GLLRTSVAIKRLDKEDKESSKAFCREL 230
           NF   +VLG GA   VF          GK+    +L+ +  +++    +   ++    E 
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S    P +V L  +    E  L LI  YVSGG +  HL+++             VR+
Sbjct: 61  VRQS----PFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED------EVRF 109

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                I  ++ +LH   +  +V+RDIK  NILL S+    L DFGL+
Sbjct: 110 YSG-EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 42/162 (25%), Positives = 67/162 (41%), Gaps = 17/162 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKAFCR-ELMIASS 235
           NF   +VLG GA   VF  +       G L     +K+     K  +    R E  +   
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +     +  + +    +  L LI  Y++GG L  HL ++++              +V + 
Sbjct: 61  IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER----------FKEQEVQIY 110

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E V  L +  +  +++RDIK  NILL S     L DFGL+
Sbjct: 111 SGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 44/158 (27%), Positives = 68/158 (43%), Gaps = 12/158 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPN 240
           F   RVLG+G    V   +V       A K+L+K+  +  K       E  I   ++   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L  +  + +  L L+   ++GG L+ H++       GN           A  I   +
Sbjct: 62  VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYN-----MGNPGFDEERAVFYAAEITCGL 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
             LH   ER +V+RD+KP NILL      ++ D GLA 
Sbjct: 116 EDLH--RER-IVYRDLKPENILLDDYGHIRISDLGLAV 150

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 43.9 bits (103), Expect = 6e-05
 Identities = 49/176 (27%), Positives = 75/176 (42%), Gaps = 16/176 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 241
           F + RVLG+G    V   +V       A K+L+K+  +  K     L     L   N   
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V  + +  + +  L L+   ++GG L+ H++       G +          A  I   + 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM-----GEAGFEEGRAVFYAAEICCGLE 116

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            LH   ER +V+RD+KP NILL      ++ D GLA       VP   +T+KG  G
Sbjct: 117 DLHQ--ER-IVYRDLKPENILLDDHGHIRISDLGLAV-----HVP-EGQTIKGRVG 163

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.9 bits (103), Expect = 7e-05
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 26/174 (14%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +    +  L  + +YV+GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT------RFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT--WTSAPSVPFLCKT 351
           + YLH+G    +V+RD+K  N++L      K+ DFGL     T A ++   C T
Sbjct: 108 LDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 43.9 bits (103), Expect = 8e-05
 Identities = 45/140 (32%), Positives = 68/140 (48%), Gaps = 18/140 (12%)

Query: 149 ELKWRKIQSLERSISPVANSLIRLSYGEI-LAATHNFSK-----GRVLGRGALSFVFKGK 202
           E++WR I+S    ISP  +  I +   ++   +   F +     GR+LG GA   V +G 
Sbjct: 2   EIRWRVIES----ISPDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGT 57

Query: 203 V-GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGL 255
             GL R+     VA+K L    + S K A   EL I + L  H NIV L+G C      +
Sbjct: 58  AYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-SGPI 116

Query: 256 FLIYKYVSGGSLERHLHEKK 275
           ++I +Y   G L  +LH+ +
Sbjct: 117 YIITEYCFYGDLVNYLHKNR 136

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.7 bits (103), Expect = 9e-05
 Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 32/168 (19%)

Query: 183 NFSKGRVLGRGA---LSFVFK---GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           +F   +V+G+GA   +  V K   GK+  ++T +  +   K+     KA  R+++  S  
Sbjct: 2   DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAE-RDVLAESD- 59

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---- 292
             P +V L  +     Q L+LI +++ GG L   L                ++Y      
Sbjct: 60  -SPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTML----------------IKYDTFSED 101

Query: 293 --ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                +AE V  +    +   +HRDIKP NIL+      KL DFGL+T
Sbjct: 102 VTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLST 149

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 41/158 (25%), Positives = 73/158 (46%), Gaps = 15/158 (9%)

Query: 183 NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A S   
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      L+ + +YV+GG L   + +      G    P +V Y  A  IA 
Sbjct: 61  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYQIQQV-----GRFKEPHAVFY--AAEIAI 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            + +LH+   + +++RD+K  N++L S+   K+ DFG+
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 147

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 51/202 (25%), Positives = 80/202 (39%), Gaps = 41/202 (20%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKA----------F----CR 228
           RVLG GA   V   K        A+K +D E     DK  ++A          F    C 
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCH 97

Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E        +P  V ++   +D          Y + G L + +  + K  R         
Sbjct: 98  EDFAKKDPRNPENVLMIALVLD----------YANAGDLRQEIKSRAKTNRT------FR 141

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
            ++  L   + +  +H+   + ++HRDIK +NILL S  + KL DFG +   +A     +
Sbjct: 142 EHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAAT----V 197

Query: 349 CKTVKGTFGQNPFCI--EEWQR 368
              V  TF   P+ +  E W+R
Sbjct: 198 SDDVGRTFCGTPYYVAPEIWRR 219

Length = 496

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.9 bits (102), Expect = 1e-04
 Identities = 33/125 (26%), Positives = 51/125 (40%), Gaps = 25/125 (20%)

Query: 229 ELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGN 281
           E M+   +  +PN + L  + +   +G  LI  Y+  G L      E  L E +      
Sbjct: 58  EPMVHQLMKDNPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAE------ 110

Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWT 340
                 V+ K+   + E++  LH      ++H DIK  N+L    K    LCD+GL    
Sbjct: 111 ------VK-KIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160

Query: 341 SAPSV 345
             PS 
Sbjct: 161 GTPSC 165

Length = 267

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 41/157 (26%), Positives = 65/157 (41%), Gaps = 10/157 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--I 241
           F   RVLG+G    V   +V       A K+L+K+  +  K     L     L   N   
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V  + +  + +  L L+   ++GG L+ H++       GN         +     AE   
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYN-----MGNPGFD---EQRAIFYAAELCC 113

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            L +     +V+RD+KP NILL  +   ++ D GLA 
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAV 150

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 17/155 (10%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIA--SSLHHPNIV 242
           ++GRG    V+  +        A+K LDK+     +  + A    +M++  S+   P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +      P++ L  I   ++GG L  H H  + GV     + +      A  I   + +
Sbjct: 61  CMTYAFHTPDK-LCFILDLMNGGDL--HYHLSQHGVFSEKEMRF-----YATEIILGLEH 112

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +HN   R VV+RD+KP+NILL      ++ D GLA
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 17/155 (10%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIA--SSLHHPNIV 242
           ++GRG    V+  +        A+K LDK+     +  + A    +M++  S+   P IV
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +      P++ L  I   ++GG L  H H  + GV   + + +    ++ LG+     +
Sbjct: 61  CMSYAFHTPDK-LSFILDLMNGGDL--HYHLSQHGVFSEAEMRFYAA-EIILGLE----H 112

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +HN   R VV+RD+KP+NILL      ++ D GLA
Sbjct: 113 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.8 bits (98), Expect = 2e-04
 Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 9/151 (5%)

Query: 190 LGRGALSFVFKGKV--GLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           +G G    V  G+V  G     V +K L      +    F  E     SL H N++  +G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C +    L L+ ++   G L+ +L   +K      T   +   ++A  IA  + +LH  
Sbjct: 63  QCTEVTPYL-LVMEFCPLGDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKN 119

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                +H D+   N LL++    K+ D+GL+
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 22/51 (43%), Positives = 33/51 (64%), Gaps = 7/51 (13%)

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           S  Y+VA G++    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA
Sbjct: 218 SFSYQVAKGMS----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLA 261

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 45/155 (29%), Positives = 65/155 (41%), Gaps = 11/155 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 2   DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       IAE V
Sbjct: 62  WITTLHYAFQDENYLYLVMDYYVGGDLLTLLS------KFEDRLPEDM---ARFYIAEMV 112

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             +H+  +   VHRDIKP N+LL      +L DFG
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 41.5 bits (97), Expect = 5e-04
 Identities = 24/51 (47%), Positives = 33/51 (64%), Gaps = 7/51 (13%)

Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           S  Y+VA G+ E +A     ++ CV HRD+   N+LL+  KI K+CDFGLA
Sbjct: 241 SFTYQVARGM-EFLA-----SKNCV-HRDLAARNVLLAQGKIVKICDFGLA 284

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 10/151 (6%)

Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPNIVPLVG 246
           LG+G    V   ++       A K+L+K+  +  K +     E  I + +H   IV L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           +    +  L L+   ++GG L  H++   +   G    P +  Y     I   + +LH  
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPE-PRACFY--TAQIISGLEHLH-- 114

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +R +++RD+KP N+LL +    ++ D GLA
Sbjct: 115 -QRRIIYRDLKPENVLLDNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 24/157 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +       L  + +Y +GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA------RFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 44/157 (28%), Positives = 67/157 (42%), Gaps = 24/157 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L+R        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +       L  + +Y +GG L  HL   ++ V          R+  A  I  +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSED----RARFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + YLH      VV+RD+K  N++L      K+ DFGL
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGL 141

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 21/60 (35%), Positives = 30/60 (50%), Gaps = 3/60 (5%)

Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           V  +  LP      +   + E++AYLH    R ++HRD+K  NI L   +   L DFG A
Sbjct: 176 VDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAA 232

Length = 392

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 37/154 (24%), Positives = 71/154 (46%), Gaps = 17/154 (11%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVP 243
           +VLG+G+   V   ++       A+K L K+    D +       + ++A +  +P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 244 LVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L  +C    ++ LF + ++++GG L  H+ +K     G   L     Y+     AE V  
Sbjct: 61  L--YCTFQTKEHLFFVMEFLNGGDLMFHIQDK-----GRFDL-----YRATFYAAEIVCG 108

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           L     + +++RD+K  N++L      K+ DFG+
Sbjct: 109 LQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGM 142

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 39.8 bits (93), Expect = 0.002
 Identities = 19/42 (45%), Positives = 25/42 (59%)

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +AE V  +H+  +   VHRDIKP N+L+      KL DFG A
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 26/159 (16%)

Query: 193 GALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLVGF-- 247
           G +      + G     VAIK+L +    +  + +A+ REL +   + H N++ L+    
Sbjct: 29  GTVCSALDRRTG---AKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLDVFT 84

Query: 248 ---CIDPEQGLFLIYKYVSGGSLERHL-HEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
               +D     +L+  ++ G  L + + HEK    R        +++ V   + + + Y+
Sbjct: 85  PDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDR--------IQFLV-YQMLKGLKYI 134

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           H      ++HRD+KP N+ ++     K+ DFGLA  T +
Sbjct: 135 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 36/119 (30%), Positives = 52/119 (43%), Gaps = 28/119 (23%)

Query: 229 ELMIASSLHHPNIVPLVG-------FCIDPEQGLFLIYKYVSGGSLERHLHEKKKG---V 278
           E  + S L HP IV           FCI        I +Y  G  L+  L E K     +
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCI--------ITEYCEGRDLDCKLEELKHTGKTL 103

Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             N    W +  ++ LG    V Y+H   +R ++HRD+K  NI L    + K+ DFG++
Sbjct: 104 SENQVCEWFI--QLLLG----VHYMH---QRRILHRDLKAKNIFL-KNNLLKIGDFGVS 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 40/160 (25%), Positives = 77/160 (48%), Gaps = 17/160 (10%)

Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 70

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVR--YKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N    P +++   ++A  I
Sbjct: 71  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+
Sbjct: 129 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGM 165

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 11/155 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L + +  +  +    +     +A+   +SV
Sbjct: 62  WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI---DSV 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             LH       VHRDIKP NIL+      +L DFG
Sbjct: 119 HQLH------YVHRDIKPDNILMDMNGHIRLADFG 147

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 38.9 bits (90), Expect = 0.003
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 23/157 (14%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++LG+G       GKV L++        A+K L KE    K+       E  +  +  HP
Sbjct: 1   KLLGKGTF-----GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L  +       L  + +Y +GG L  HL  ++      +      R+  A  I  +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA------RFYGA-EIVSA 107

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + YLH  +E+ VV+RD+K  N++L      K+ DFGL
Sbjct: 108 LDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGL 142

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 38.3 bits (89), Expect = 0.003
 Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 11/97 (11%)

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PN+V L  + +  E  +FL+ ++  GG L  H+  K   +       W+    VAL    
Sbjct: 45  PNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVKRWAAEMVVALDA-- 100

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
               LH      +V RD+ P+NILL  +   +L  F 
Sbjct: 101 ----LH---REGIVCRDLNPNNILLDDRGHIQLTYFS 130

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 37.6 bits (88), Expect = 0.004
 Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 17/100 (17%)

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           VP V + +DPE  + ++ +Y+ G  L+  ++                  +++  I   V 
Sbjct: 63  VPAV-YFVDPENFI-IVMEYIEGEPLKDLINSNGME-----------ELELSREIGRLVG 109

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            LH+     ++H D+  SN++LS  KI  L DFGLA ++ 
Sbjct: 110 KLHSAG---IIHGDLTTSNMILSGGKI-YLIDFGLAEFSK 145

Length = 211

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	372
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.97
KOG0198	313	consensus MEKK and related serine/threonine protei	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.96
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.96
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.96
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.96
PTZ00267	478	NIMA-related protein kinase; Provisional	99.96
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.96
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.96
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.96
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.96
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.96
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.96
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.96
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.96
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.96
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.96
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.96
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.95
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.95
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.95
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.95
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.95
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.95
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.95
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.95
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.95
KOG0589	426	consensus Serine/threonine protein kinase [General	99.95
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.95
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.95
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.95
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.95
KOG0586	596	consensus Serine/threonine protein kinase [General	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.95
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.95
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
KOG0584	632	consensus Serine/threonine protein kinase [General	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.95
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.95
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.95
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
PHA02988	283	hypothetical protein; Provisional	99.95
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.94
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.94
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.94
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.94
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.94
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.94
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.94
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.94
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.94
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.94
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.94
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.94
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.94
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.94
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.94
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.94
PHA03209	357	serine/threonine kinase US3; Provisional	99.94
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.94
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.94
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.94
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.94
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.94
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.94
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.94
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.94
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.94
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.94
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.94
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.94
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.94
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.94
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.94
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.94
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.94
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.94
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.94
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.93
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.93
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.93
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.93
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.93
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.93
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.93
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.93
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.93
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.93
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.93
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.93
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.93
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.93
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.93
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.93
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.93
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.93
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.93
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.93
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.93
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.93
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.93
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.93
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.93
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.93
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.93
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.93
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.93
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.93
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.93
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.93
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.93
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.93
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.93
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.93
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.93
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.93
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.93
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.93
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.93
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.93
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.93
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.93
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.93
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.92
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.92
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.92
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.92
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.92
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.92
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.92
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.92
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.92
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.92
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.92
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.92
PLN00009	294	cyclin-dependent kinase A; Provisional	99.92
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.92
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.92
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.92
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.92
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.92
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.92
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.92
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.92
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.92
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.92
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.92
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.92
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.92
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.92
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.92
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.92
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.92
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.92
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.92
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.92
KOG1152	772	consensus Signal transduction serine/threonine kin	99.92
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.92
PHA03210	501	serine/threonine kinase US3; Provisional	99.92
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.92
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.92
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.92
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.92
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.91
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.91
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.91
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.91
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.91
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.91
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.91
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.91
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.91
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.91
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.91
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.91
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.91
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.91
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.91
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.9
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.9
PHA02882	294	putative serine/threonine kinase; Provisional	99.9
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.9
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.9
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.9
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.9
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.9
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.9
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.9
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.89
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.89
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.89
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.89
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.89
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.89
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.88
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.87
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.87
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.86
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.86
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.85
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.85
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.85
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.85
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.84
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.81
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.81
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
smart00090	237	RIO RIO-like kinase.	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.78
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.78
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.78
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.77
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.76
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.75
PRK12274	218	serine/threonine protein kinase; Provisional	99.75
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.74
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.65
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.6
PLN00181	793	protein SPA1-RELATED; Provisional	99.55
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.54
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.51
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.42
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.37
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.33
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.32
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.25
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.24
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.13
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.13
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.11
KOG3087	229	consensus Serine/threonine protein kinase [General	99.11
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.09
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.07
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.97
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.87
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	98.82
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.79
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.78
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.75
KOG1243	690	consensus Protein kinase [General function predict	98.64
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.59
PRK09902	216	hypothetical protein; Provisional	98.5
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.45
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.37
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.32
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.18
PF01636	239	APH: Phosphotransferase enzyme family This family	98.17
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.13
PLN02876	822	acyl-CoA dehydrogenase	98.11
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.07
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.01
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.97
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.96
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.85
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.79
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.68
PRK10593	297	hypothetical protein; Provisional	97.56
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.53
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.43
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.38
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.36
PRK05231	319	homoserine kinase; Provisional	97.3
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.26
COG4248	637	Uncharacterized protein with protein kinase and he	97.15
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.05
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.99
PLN02236	344	choline kinase	96.82
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.79
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.38
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.12
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.7
PRK12396	409	5-methylribose kinase; Reviewed	95.63
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.6
PLN02756	418	S-methyl-5-thioribose kinase	95.5
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.11
KOG2270	520	consensus Serine/threonine protein kinase involved	94.84
PRK06148	1013	hypothetical protein; Provisional	94.4
COG2334	331	Putative homoserine kinase type II (protein kinase	94.21
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	94.18
PTZ00384	383	choline kinase; Provisional	94.16
PRK11768	325	serine/threonine protein kinase; Provisional	93.98
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	93.41
PTZ00296	442	choline kinase; Provisional	92.75
KOG2137	700	consensus Protein kinase [Signal transduction mech	91.78
PRK10271	188	thiK thiamine kinase; Provisional	90.5
PF03109	119	ABC1: ABC1 family; InterPro: IPR004147 This entry	89.96
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	89.55

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-40  Score=323.66  Aligned_cols=187  Identities=43%  Similarity=0.707  Sum_probs=162.1

Q ss_pred             ccccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeee
Q 017411          168 SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF  247 (372)
Q Consensus       168 ~~~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~  247 (372)
                      ....|+|.+|..+|++|...+.||+|+||.||+|.... +..||||++.....+..++|.+|++++.+++|||||+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            56789999999999999999999999999999999976 48999998876543314569999999999999999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       248 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      |.+.+...+||||||++|+|.++|+....     ..++|..|++|+.++|+||+|||..+.++||||||||+|||||+++
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~-----~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~  214 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKG-----EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF  214 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCC-----CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence            99866347899999999999999987542     1789999999999999999999999988999999999999999999


Q ss_pred             cEEEEecccccccCC-CCCCccccccccCCCccCcc
Q 017411          328 IPKLCDFGLATWTSA-PSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       328 ~~KL~DFGla~~~~~-~~~~~~~~~~~GT~gy~ape  362 (372)
                      ++||+|||+|+.... ...  ......||.||+|||
T Consensus       215 ~aKlsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PE  248 (361)
T KOG1187|consen  215 NAKLSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPE  248 (361)
T ss_pred             CEEccCccCcccCCccccc--eeeecCCCCccCChh
Confidence            999999999976654 222  111118999999954

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=298.38  Aligned_cols=171  Identities=30%  Similarity=0.511  Sum_probs=153.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ..+|...+.||+|+||+||+|+++.++..||||.+.+.  .....+.+..|+.+|+.|+|||||.+++++.+ ++.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence            35888889999999999999999999999999999876  56667778999999999999999999998766 5569999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC------CcEEEE
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK------KIPKLC  332 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~------~~~KL~  332 (372)
                      ||||.||+|.++|+..       ..+++..++.++.|||.||++||+.+   ||||||||+||||+..      -.+||+
T Consensus        88 MEyC~gGDLs~yi~~~-------~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRR-------GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             EEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEec
Confidence            9999999999999986       47999999999999999999999988   9999999999999865      468999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |||+||.+....   ...+.+|++-|||||+-.
T Consensus       158 DFGfAR~L~~~~---~a~tlcGSplYMAPEV~~  187 (429)
T KOG0595|consen  158 DFGFARFLQPGS---MAETLCGSPLYMAPEVIM  187 (429)
T ss_pred             ccchhhhCCchh---HHHHhhCCccccCHHHHH
Confidence            999999998554   567899999999988764

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-35  Score=278.43  Aligned_cols=173  Identities=29%  Similarity=0.353  Sum_probs=152.4

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..++|+..++||+|+||+||.++.+++++.+|+|++++..   ....+...+|..+|.+++||+||+++-.|.+ ...+|
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLy  101 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLY  101 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEE
Confidence            3469999999999999999999999999999999998752   2345667899999999999999999987665 55699


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||+||+.||.|..+|++.       ..+++..+.-++.+|+.||.|||+.+   ||||||||+|||||.+|+++|+||||
T Consensus       102 lVld~~~GGeLf~hL~~e-------g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL  171 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQRE-------GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGL  171 (357)
T ss_pred             EEEeccCCccHHHHHHhc-------CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEecccc
Confidence            999999999999999876       57999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ++..-....  .+.+.+||+.|||||+-.
T Consensus       172 ~k~~~~~~~--~t~tfcGT~eYmAPEil~  198 (357)
T KOG0598|consen  172 CKEDLKDGD--ATRTFCGTPEYMAPEILL  198 (357)
T ss_pred             chhcccCCC--ccccccCCccccChHHHh
Confidence            996544433  346689999999988643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-35  Score=279.54  Aligned_cols=170  Identities=31%  Similarity=0.432  Sum_probs=147.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .+.|...+.||+|+||.|-+|..+.+++.||||++++...       .....+.+|+++|++|+|||||++++++..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3567888999999999999999999999999999986421       122335799999999999999999999877554


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPK  330 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~K  330 (372)
                       .|+||||++||+|.+.+-..       ..+.+..-..++.|++.|+.|||+.+   |+||||||+|||+..+   ..+|
T Consensus       251 -~YmVlE~v~GGeLfd~vv~n-------k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  251 -SYMVLEYVEGGELFDKVVAN-------KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             -eEEEEEEecCccHHHHHHhc-------cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEE
Confidence             79999999999999999876       45777777889999999999999988   9999999999999766   7899


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+|+.....+   ...+.+||+.|.|||+-
T Consensus       320 ItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl  350 (475)
T KOG0615|consen  320 ITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVL  350 (475)
T ss_pred             ecccchhhccccce---ehhhhcCCccccChhhe
Confidence            99999999987443   45788999999998864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-34  Score=287.94  Aligned_cols=170  Identities=28%  Similarity=0.384  Sum_probs=154.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ..|..++.||+|||+.||++++..+|+.||+|++.+.   .....+.+.+||++.+.|+|||||+++++|.+. +++|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs-~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS-NNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC-CceEEE
Confidence            4799999999999999999999889999999999874   455667889999999999999999999988775 459999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      +|+|++++|..++++.       ..+++.+++.++.||+.||.|||+.+   |||||||..|++|++++++||+|||||+
T Consensus        97 LELC~~~sL~el~Krr-------k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRR-------KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             EEecCCccHHHHHHhc-------CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceee
Confidence            9999999999999854       57999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .+..+...  ..+.+|||.|+|||+-
T Consensus       167 ~le~~~Er--k~TlCGTPNYIAPEVl  190 (592)
T KOG0575|consen  167 QLEYDGER--KKTLCGTPNYIAPEVL  190 (592)
T ss_pred             eecCcccc--cceecCCCcccChhHh
Confidence            99876542  3678999999998863

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=274.29  Aligned_cols=167  Identities=31%  Similarity=0.418  Sum_probs=149.3

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +.+....||+|..|+||+++++.+++.+|+|.+... ++...+++.+|++++++.+||+||.++|.|+.....+.++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            445568999999999999999999999999999654 5667789999999999999999999999998755348999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |.+|+|++++...       ..+++...-.|+.+|++||.|||+ .+   ||||||||+|||++..|.+||||||.++.+
T Consensus       160 MDgGSLd~~~k~~-------g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~l  229 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-------GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGIL  229 (364)
T ss_pred             cCCCCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHh
Confidence            9999999999865       468999999999999999999996 55   999999999999999999999999999988


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+.    .+.+.+||..||+||-
T Consensus       230 vnS----~a~tfvGT~~YMsPER  248 (364)
T KOG0581|consen  230 VNS----IANTFVGTSAYMSPER  248 (364)
T ss_pred             hhh----hcccccccccccChhh
Confidence            755    5678899999999763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-34  Score=279.96  Aligned_cols=172  Identities=39%  Similarity=0.608  Sum_probs=146.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeE-EEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTS-VAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~-vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++...+.||+|+||+||+|.++.  +. ||||++....  ....+.|.+|+.+|.+++|||||+++|+|.++....++||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g--~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVt  119 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRG--TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVT  119 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCC--ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEE
Confidence            34445669999999999999984  45 9999998643  2226689999999999999999999999988664589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGla~  338 (372)
                      |||++|+|.++++....     ..+++..++.++.|||+||+|||+...  ||||||||+|||++.++ ++||+|||+++
T Consensus       120 Ey~~~GsL~~~l~~~~~-----~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  120 EYMPGGSLSVLLHKKRK-----RKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EeCCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccce
Confidence            99999999999987421     679999999999999999999998763  99999999999999998 99999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .......  ..+...||+.|||||+-+
T Consensus       193 ~~~~~~~--~~~~~~GT~~wMAPEv~~  217 (362)
T KOG0192|consen  193 EKVISKT--SMTSVAGTYRWMAPEVLR  217 (362)
T ss_pred             eeccccc--cccCCCCCccccChhhhc
Confidence            8764321  223478999999988765

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-34  Score=264.54  Aligned_cols=178  Identities=25%  Similarity=0.386  Sum_probs=154.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe-EEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG-LFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~-~~lV  258 (372)
                      .+|++.++||.|+||.||++....++..||.|.++-.  +....+.+..|+.+|++|+|||||+++++.+..+.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3788899999999999999999999999999988743  556677899999999999999999999954443443 8899


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-ceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER-CVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~-~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||.+|+|.++++..++.   ...+++..+++++.|++.||.++|+.-++ .|+||||||.||+|+.+|.+||+||||+
T Consensus        99 mE~c~~GDLsqmIk~~K~q---kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQ---KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHhhcccCHHHHHHHHHhc---cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhH
Confidence            9999999999999876543   26899999999999999999999984322 2999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++.....  .+.+.+|||.||.||.-
T Consensus       176 r~l~s~~t--fA~S~VGTPyYMSPE~i  200 (375)
T KOG0591|consen  176 RFLSSKTT--FAHSLVGTPYYMSPERI  200 (375)
T ss_pred             hHhcchhH--HHHhhcCCCcccCHHHH
Confidence            99987654  56778999999998754

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-33  Score=256.59  Aligned_cols=168  Identities=27%  Similarity=0.354  Sum_probs=150.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||.|+||+|.+++.+.++.-+|+|++++...   ...+...+|..+|+.+.||+++++++.|.+. ..+|+|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-SNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-CeEEEE
Confidence            488899999999999999999999999999999988643   3445677899999999999999999988774 459999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||++||.|..+|++.       .++++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+
T Consensus       123 meyv~GGElFS~Lrk~-------~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK  192 (355)
T KOG0616|consen  123 MEYVPGGELFSYLRKS-------GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAK  192 (355)
T ss_pred             EeccCCccHHHHHHhc-------CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceE
Confidence            9999999999999876       57999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .....     +.+.+|||.|+|||+-.
T Consensus       193 ~v~~r-----T~TlCGTPeYLAPEii~  214 (355)
T KOG0616|consen  193 RVSGR-----TWTLCGTPEYLAPEIIQ  214 (355)
T ss_pred             EecCc-----EEEecCCccccChHHhh
Confidence            87643     46789999999987643

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.1e-33  Score=271.54  Aligned_cols=172  Identities=25%  Similarity=0.353  Sum_probs=148.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~l  257 (372)
                      .+.|+..++||+|.||.||+|++..+|+.||+|++...  .+.......|||.||++|+||||++|.+...+. ...+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            35788889999999999999999999999999998754  355666778999999999999999999988776 446999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |+|||+. ||.-++....      ..+++.++..++.||+.||+|+|+.+   |+|||||.+|||||.+|.+||+|||||
T Consensus       196 VFeYMdh-DL~GLl~~p~------vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLA  265 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPG------VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLA  265 (560)
T ss_pred             EEecccc-hhhhhhcCCC------cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccce
Confidence            9999976 8988887542      57999999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++........ +..+-|..|.|||.
T Consensus       266 r~y~~~~~~~~-T~rVvTLWYRpPEL  290 (560)
T KOG0600|consen  266 RFYTPSGSAPY-TSRVVTLWYRPPEL  290 (560)
T ss_pred             eeccCCCCccc-ccceEEeeccChHH
Confidence            98876554322 34456888888663

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=2e-32  Score=254.62  Aligned_cols=153  Identities=29%  Similarity=0.467  Sum_probs=133.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +.|+...++|+|+||.||+|+++.+|+.||||++...  ++...+--+||+++|++++|+|+|.|+.+|.. ...++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence            4577788999999999999999999999999998654  34555667899999999999999999999866 45699999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||.. ++.+-|....      ..++...+..++.|++.|+.|+|+++   ||||||||+||||+.+|.+||||||+||.
T Consensus        81 E~~dh-TvL~eLe~~p------~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~  150 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYP------NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFART  150 (396)
T ss_pred             eecch-HHHHHHHhcc------CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHh
Confidence            99976 5555555543      45888899999999999999999988   99999999999999999999999999999


Q ss_pred             cCCCCC
Q 017411          340 TSAPSV  345 (372)
Q Consensus       340 ~~~~~~  345 (372)
                      +..+..
T Consensus       151 L~~pgd  156 (396)
T KOG0593|consen  151 LSAPGD  156 (396)
T ss_pred             hcCCcc
Confidence            876543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=1.1e-31  Score=245.85  Aligned_cols=168  Identities=27%  Similarity=0.375  Sum_probs=145.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..|...+.||+|.||.||+|++..+++.||||+++...  .......+||+..|+.++|+||+.++++|...+ .+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-NLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-ceEEEE
Confidence            36777899999999999999999999999999997642  222446789999999999999999999876644 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||+ .+|+..+++..      ..++..++..++.++++||+|||...   |+||||||.|+|++.+|.+||+|||+|+.
T Consensus        81 Efm~-tdLe~vIkd~~------i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~  150 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKN------IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARF  150 (318)
T ss_pred             Eecc-ccHHHHhcccc------cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhc
Confidence            9996 49999998764      67899999999999999999999988   99999999999999999999999999999


Q ss_pred             cCCCCCCccccccccCCCccCcc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      +.++.....  ..+-|..|.|||
T Consensus       151 f~~p~~~~~--~~V~TRWYRAPE  171 (318)
T KOG0659|consen  151 FGSPNRIQT--HQVVTRWYRAPE  171 (318)
T ss_pred             cCCCCcccc--cceeeeeccChH
Confidence            988776432  225677888866

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=265.77  Aligned_cols=175  Identities=29%  Similarity=0.384  Sum_probs=150.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..++|..++.||+|+|++|++|+...++++||||++.+.   .....+.+.+|-.+|.+| .||.|++|+--|.+ +..+
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~sL  149 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EESL  149 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-ccce
Confidence            446999999999999999999999999999999999875   334445677899999999 89999999988776 4559


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      |+|+||+++|+|.++|.+.       ..+++..++.++.+|+.||+|||+.+   ||||||||+|||||.+|++||+|||
T Consensus       150 YFvLe~A~nGdll~~i~K~-------Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKY-------GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             EEEEEecCCCcHHHHHHHh-------CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecc
Confidence            9999999999999999886       57999999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCC-----------ccccccccCCCccCccccc
Q 017411          336 LATWTSAPSVP-----------FLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       336 la~~~~~~~~~-----------~~~~~~~GT~gy~apeaPE  365 (372)
                      .|+.+......           ..+.+.+||..|.+||.--
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~  260 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLN  260 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhc
Confidence            99987533221           1125689999999977543

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=260.47  Aligned_cols=172  Identities=32%  Similarity=0.464  Sum_probs=149.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC----Ch-hhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~----~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~  253 (372)
                      ....|..++.||+|+||+|+.|.+..++..||||++++.    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            456899999999999999999999999999999987764    22 23456678999999999 9999999999876555


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLC  332 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~  332 (372)
                       +++||||+.+|+|.+++...       ..+.+..+..++.|++.|++|||+.+   |+||||||+|||+|.+ +++||+
T Consensus        95 -~~ivmEy~~gGdL~~~i~~~-------g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   95 -IYIVMEYCSGGDLFDYIVNK-------GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             -EEEEEEecCCccHHHHHHHc-------CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEe
Confidence             99999999999999999883       57889999999999999999999888   9999999999999999 999999


Q ss_pred             ecccccccC-CCCCCccccccccCCCccCccccc
Q 017411          333 DFGLATWTS-APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       333 DFGla~~~~-~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |||++.... ...   ...+.+||+.|+|||.-.
T Consensus       164 DFG~s~~~~~~~~---~l~t~cGsp~Y~aPEvl~  194 (370)
T KOG0583|consen  164 DFGLSAISPGEDG---LLKTFCGSPAYAAPEVLS  194 (370)
T ss_pred             ccccccccCCCCC---cccCCCCCcccCCHHHhC
Confidence            999999874 222   456788999999976544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=7.9e-31  Score=251.67  Aligned_cols=175  Identities=34%  Similarity=0.454  Sum_probs=149.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-eEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-~~~lV~E  260 (372)
                      .++..++.||+|+||.||++....++...|||.+...+....+.+.+|+.+|++++|||||+++|.....+. .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            467888999999999999999988899999999977643336778999999999999999999996433333 5789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~  339 (372)
                      |+++|+|.+++.+..      ..|++..+..+++||++||.|||+++   ||||||||+|||++. ++.+||+|||+++.
T Consensus        97 y~~~GsL~~~~~~~g------~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG------GKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             ccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccc
Confidence            999999999998753      25999999999999999999999888   999999999999999 79999999999987


Q ss_pred             cCC-CCCCccccccccCCCccCccccc
Q 017411          340 TSA-PSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~-~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ... ...........||+.|||||+-+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~  194 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIR  194 (313)
T ss_pred             cccccccccccccccCCccccCchhhc
Confidence            764 11112334678999999988765

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=1.1e-31  Score=266.14  Aligned_cols=170  Identities=32%  Similarity=0.475  Sum_probs=152.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|.+.+.||+|+||.||||+.+.+.+.||+|.+.+.  .....+.+.+|++++++++|||||.++++|.. ...+|+|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence            4788889999999999999999999999999999875  34456778999999999999999999998766 44599999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+.| +|..+|...       ..+++..++.|+.|+..||.|||+..   |+|||+||.|||++..|.+|++|||+||.
T Consensus        81 e~a~g-~L~~il~~d-------~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~  149 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQD-------GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARA  149 (808)
T ss_pred             hhhhh-hHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhh
Confidence            99976 999999875       56999999999999999999999988   99999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .+...  .+.+.+.||+-|||||.-|
T Consensus       150 m~~~t--~vltsikGtPlYmAPElv~  173 (808)
T KOG0597|consen  150 MSTNT--SVLTSIKGTPLYMAPELVE  173 (808)
T ss_pred             cccCc--eeeeeccCcccccCHHHHc
Confidence            87654  3677899999999988766

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=3.4e-31  Score=249.15  Aligned_cols=170  Identities=27%  Similarity=0.379  Sum_probs=146.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~lV  258 (372)
                      ++|+..+.|++|+||.||+|+++.+++.||+|+++...  ....-.-+||+.+|.+++|||||.+..+.+.. -+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            47888999999999999999999999999999997542  22333568999999999999999998876543 2348999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||||+. +|..++....      .++...++..++.|+++||+|||...   |+||||||+|+|++..|.+||+||||||
T Consensus       156 Me~~Eh-DLksl~d~m~------q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR  225 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK------QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAR  225 (419)
T ss_pred             HHHHHh-hHHHHHHhcc------CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhh
Confidence            999975 9999998764      57889999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .++.+..+.  +..+-|..|.|||.
T Consensus       226 ~ygsp~k~~--T~lVVTLWYRaPEL  248 (419)
T KOG0663|consen  226 EYGSPLKPY--TPLVVTLWYRAPEL  248 (419)
T ss_pred             hhcCCcccC--cceEEEeeecCHHH
Confidence            998885543  44567888988763

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=2.4e-31  Score=255.18  Aligned_cols=170  Identities=29%  Similarity=0.393  Sum_probs=151.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|.+.+.||+|.||+|-++.....|+.||||.+++.   +.+..-.+.+|++||+.|+||||+.++.+|.+.+ .+.|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkd-KIvi  130 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKD-KIVI  130 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCc-eEEE
Confidence            35788889999999999999999888999999999765   5566667899999999999999999999987654 5899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||..+|.|++++.++       ..|++..+..+++||..|+.|+|.+.   ++|||||.+|||||.++++||+||||+
T Consensus       131 vMEYaS~GeLYDYiSer-------~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLS  200 (668)
T KOG0611|consen  131 VMEYASGGELYDYISER-------GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLS  200 (668)
T ss_pred             EEEecCCccHHHHHHHh-------ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchh
Confidence            99999999999999987       57999999999999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      -.+....   ...+++|++-|..||+-
T Consensus       201 Nly~~~k---fLqTFCGSPLYASPEIv  224 (668)
T KOG0611|consen  201 NLYADKK---FLQTFCGSPLYASPEIV  224 (668)
T ss_pred             hhhcccc---HHHHhcCCcccCCcccc
Confidence            8886554   35678999999887653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=261.66  Aligned_cols=170  Identities=25%  Similarity=0.332  Sum_probs=143.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHH-HHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~-~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|...+.||.|+||.||+|+...++..||||+|++.-....+ .=+||+..|++|. |||||++.+++.+.+..+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346899999999999999999999999999999999865322222 2368999999998 99999999999987767999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |||||. .+|+++++++.      ..+++..++.|+.||++||+|+|.++   +.|||+||+|||+.....+||+|||||
T Consensus        88 VfE~Md-~NLYqLmK~R~------r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDRN------RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             eHHhhh-hhHHHHHhhcC------CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccc
Confidence            999995 59999998873      68999999999999999999999888   999999999999998889999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      |......-   -+..+.|..|.|||
T Consensus       158 Rev~SkpP---YTeYVSTRWYRAPE  179 (538)
T KOG0661|consen  158 REVRSKPP---YTEYVSTRWYRAPE  179 (538)
T ss_pred             cccccCCC---cchhhhcccccchH
Confidence            98753321   13344555566644

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.8e-31  Score=241.28  Aligned_cols=172  Identities=32%  Similarity=0.464  Sum_probs=151.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      -++|..++.||+|-||.||.|+.+.++..||+|++.+.   ..+..+++.+|+++-+.|+||||++++++|.+.. ++||
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~-riyL   99 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK-RIYL   99 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc-eeEE
Confidence            35899999999999999999999999999999999765   2344567899999999999999999999998754 5999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ++||.++|+|...|...+.     ..+++.....++.|+|.||.|+|..+   ||||||||+|+|++..+.+||+|||-+
T Consensus       100 ilEya~~gel~k~L~~~~~-----~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGws  171 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRM-----KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWS  171 (281)
T ss_pred             EEEecCCchHHHHHHhccc-----ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCce
Confidence            9999999999999986543     56788888899999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .......    -.+.+||.-|+|||.-|
T Consensus       172 V~~p~~k----R~tlcgt~dyl~pEmv~  195 (281)
T KOG0580|consen  172 VHAPSNK----RKTLCGTLDYLPPEMVE  195 (281)
T ss_pred             eecCCCC----ceeeecccccCCHhhcC
Confidence            7665332    35788999999988765

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=1.8e-30  Score=256.87  Aligned_cols=150  Identities=29%  Similarity=0.358  Sum_probs=136.4

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ...++|+.+.+||+|+||.||+|+.+.+|..+|+|++++..   ....+.++.|-.+|....+|+||+|+-.|.+ ..++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~L  216 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYL  216 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCee
Confidence            35679999999999999999999999999999999998863   3445667889999999999999999988766 4569


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ||||||++||++..+|...       ..|++..+..++.+++.|++-||..+   +|||||||+|+|||..|++||+|||
T Consensus       217 YLiMEylPGGD~mTLL~~~-------~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRK-------DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             EEEEEecCCccHHHHHHhc-------CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccc
Confidence            9999999999999999876       67999999999999999999999888   9999999999999999999999999


Q ss_pred             cccc
Q 017411          336 LATW  339 (372)
Q Consensus       336 la~~  339 (372)
                      |++.
T Consensus       287 Ls~g  290 (550)
T KOG0605|consen  287 LSTG  290 (550)
T ss_pred             ccch
Confidence            9864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.97  E-value=4.2e-30  Score=249.69  Aligned_cols=181  Identities=27%  Similarity=0.356  Sum_probs=145.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~  252 (372)
                      ..++|++.+.||+|+||.||+|.+.     .++..||||++.... ....+.+.+|+.++.++ +||||++++++|...+
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            4468999999999999999999752     335689999997542 34456789999999999 8999999999988766


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCC------------------------------------------------------
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGV------------------------------------------------------  278 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~------------------------------------------------------  278 (372)
                      ..+++||||+++|+|.+++.......                                                      
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            66899999999999999997642110                                                      


Q ss_pred             -CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCC
Q 017411          279 -RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG  357 (372)
Q Consensus       279 -~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~g  357 (372)
                       .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............+++.
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence             00135788899999999999999999877   99999999999999999999999999987643322222234456778


Q ss_pred             ccCccc
Q 017411          358 QNPFCI  363 (372)
Q Consensus       358 y~apea  363 (372)
                      |+|||.
T Consensus       242 y~aPE~  247 (338)
T cd05102         242 WMAPES  247 (338)
T ss_pred             ccCcHH
Confidence            888774

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=9.4e-30  Score=250.47  Aligned_cols=149  Identities=31%  Similarity=0.340  Sum_probs=132.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++....+++.||||++.+..   ......+.+|+.++.+++||||+++++.+.+ ....|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence            47899999999999999999999889999999997642   2334567889999999999999999998776 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~  149 (363)
T cd05628          80 MEFLPGGDMMTLLMKK-------DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCT  149 (363)
T ss_pred             EcCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcc
Confidence            9999999999999764       46899999999999999999999887   9999999999999999999999999997


Q ss_pred             ccC
Q 017411          339 WTS  341 (372)
Q Consensus       339 ~~~  341 (372)
                      ...
T Consensus       150 ~~~  152 (363)
T cd05628         150 GLK  152 (363)
T ss_pred             ccc
Confidence            653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-30  Score=251.07  Aligned_cols=175  Identities=29%  Similarity=0.355  Sum_probs=141.4

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------------hhhHHHHHHHHHHHHhCCCCCeece
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------------KESSKAFCRELMIASSLHHPNIVPL  244 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------------~~~~~~~~~Ev~iL~~l~HpnIv~l  244 (372)
                      ..-++|.+.+.||+|.||.|-+|+...+++.||||++++..              ....+.+.+|+.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            45578999999999999999999999999999999997631              1123578899999999999999999


Q ss_pred             eeeEEcCC-CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          245 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       245 ~g~~~~~~-~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      +.+.-++. ..+|||+|||..|.+...-...       ..+++.+++.|++++..||+|||.++   ||||||||+|+||
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~-------~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK-------PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCc-------ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence            99765443 3489999999988875432111       23899999999999999999999998   9999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCCCc---cccccccCCCccCccc
Q 017411          324 SSKKIPKLCDFGLATWTSAPSVPF---LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       324 d~~~~~KL~DFGla~~~~~~~~~~---~~~~~~GT~gy~apea  363 (372)
                      +++|++||+|||.+-.+.+.....   ......||+.++|||+
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~  286 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPEL  286 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHh
Confidence            999999999999998764332111   1223568888888664

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-29  Score=248.76  Aligned_cols=149  Identities=32%  Similarity=0.368  Sum_probs=133.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++++..+++.||||++.+.   .......+.+|+.++..++||||+++++++.+ +...++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence            4789999999999999999999988999999999753   23344567899999999999999999998876 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~  149 (364)
T cd05599          80 MEYLPGGDMMTLLMKK-------DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCT  149 (364)
T ss_pred             ECCCCCcHHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccce
Confidence            9999999999999764       45899999999999999999999887   9999999999999999999999999997


Q ss_pred             ccC
Q 017411          339 WTS  341 (372)
Q Consensus       339 ~~~  341 (372)
                      .+.
T Consensus       150 ~~~  152 (364)
T cd05599         150 GLK  152 (364)
T ss_pred             ecc
Confidence            653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=1.5e-29  Score=250.33  Aligned_cols=173  Identities=24%  Similarity=0.324  Sum_probs=147.4

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ...++|+..+.||+|+||.||++++..+++.||+|++.+.   .......+.+|+.+++.++||||+++++++.+ +...
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEE
Confidence            3457899999999999999999999988999999998653   22334567899999999999999999998766 4558


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      |+||||+++|+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       119 ~lv~Ey~~gg~L~~~l~~--------~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN--------YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecc
Confidence            999999999999999964        34788899999999999999999887   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|+....... ..+.+..||++|+|||.-
T Consensus       188 ~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~  215 (370)
T cd05621         188 TCMKMDETGM-VRCDTAVGTPDYISPEVL  215 (370)
T ss_pred             cceecccCCc-eecccCCCCcccCCHHHH
Confidence            9987653322 123456799999998853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=2.3e-29  Score=249.43  Aligned_cols=147  Identities=27%  Similarity=0.317  Sum_probs=131.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .|...+.||+|+||.||+|++..+++.||||++.+..   ......+.+|+.++++++||||+++++++.+. ...++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEE
Confidence            6888999999999999999999999999999997542   33456788999999999999999999988764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.+++...       ..+++..+..++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~  150 (381)
T cd05626          81 DYIPGGDMMSLLIRM-------EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG  150 (381)
T ss_pred             ecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence            999999999999764       45889999999999999999999877   99999999999999999999999999864


Q ss_pred             c
Q 017411          340 T  340 (372)
Q Consensus       340 ~  340 (372)
                      +
T Consensus       151 ~  151 (381)
T cd05626         151 F  151 (381)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=2.1e-29  Score=244.81  Aligned_cols=167  Identities=28%  Similarity=0.369  Sum_probs=145.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|...+.||+|+||.||+|++..+++.||||++.+.   .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEEE
Confidence            5899999999999999999999988999999999754   223446788999999999999999999988764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        97 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~  166 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-------GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAK  166 (329)
T ss_pred             EcCCCCChHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCce
Confidence            9999999999999764       46888999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......     .+..||+.|+|||.-
T Consensus       167 ~~~~~~-----~~~~gt~~y~aPE~~  187 (329)
T PTZ00263        167 KVPDRT-----FTLCGTPEYLAPEVI  187 (329)
T ss_pred             EcCCCc-----ceecCChhhcCHHHH
Confidence            764332     345789999997753

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-29  Score=248.33  Aligned_cols=147  Identities=29%  Similarity=0.328  Sum_probs=131.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|...+.||+|+||.||++....+++.||||++.+.   .....+.+.+|++++++++||||+++++++.+. ...|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEE
Confidence            4788999999999999999999989999999998653   233456788999999999999999999988764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~  149 (377)
T cd05629          80 MEFLPGGDLMTMLIKY-------DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLST  149 (377)
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccc
Confidence            9999999999999754       46889999999999999999999887   9999999999999999999999999996


Q ss_pred             c
Q 017411          339 W  339 (372)
Q Consensus       339 ~  339 (372)
                      .
T Consensus       150 ~  150 (377)
T cd05629         150 G  150 (377)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.4e-30  Score=259.50  Aligned_cols=172  Identities=26%  Similarity=0.333  Sum_probs=149.5

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      ..-++|...++||+|.||+|+++..+.+++.+|||++++.   ..+..+..+.|.+|+... +||.++.|+..|. ...+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-T~~~  443 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-TKEH  443 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-cCCe
Confidence            3456899999999999999999999999999999999986   345567788899988877 5999999998654 5666


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      +|+||||+.||++..+++.        ..+++..+..++..|+.||.|||.++   ||+||||.+|||||.+|.+||+||
T Consensus       444 l~fvmey~~Ggdm~~~~~~--------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADF  512 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT--------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADF  512 (694)
T ss_pred             EEEEEEecCCCcEEEEEec--------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccc
Confidence            9999999999996666543        46999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||++.--....  .+.+.+||+.|||||+-
T Consensus       513 GlcKe~m~~g~--~TsTfCGTpey~aPEil  540 (694)
T KOG0694|consen  513 GLCKEGMGQGD--RTSTFCGTPEFLAPEVL  540 (694)
T ss_pred             ccccccCCCCC--ccccccCChhhcChhhh
Confidence            99987653332  46789999999998864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=3.5e-29  Score=242.50  Aligned_cols=164  Identities=25%  Similarity=0.280  Sum_probs=139.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.||+|+||.||+++...+++.||||++++.   .......+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            4699999999999999988999999999754   23344567899999999999999999998776 4458999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |+|.+++...       ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          80 GELFFHLSRE-------RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            9999998764       46899999999999999999999887   9999999999999999999999999998643222


Q ss_pred             CCccccccccCCCccCcccc
Q 017411          345 VPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apeaP  364 (372)
                      .  ......||+.|+|||.-
T Consensus       150 ~--~~~~~~gt~~y~aPE~~  167 (323)
T cd05571         150 A--TMKTFCGTPEYLAPEVL  167 (323)
T ss_pred             C--cccceecCccccChhhh
Confidence            1  22446799999997753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=3.1e-29  Score=243.53  Aligned_cols=167  Identities=26%  Similarity=0.297  Sum_probs=145.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++++..   ....+.+.+|++++..++||||+++++++.+ ....|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence            37899999999999999999999889999999997542   2345678899999999999999999998876 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~g~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~  149 (333)
T cd05600          80 MEYVPGGDFRTLLNNL-------GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSK  149 (333)
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCc
Confidence            9999999999999754       46889999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....     ......||+.|+|||.-
T Consensus       150 ~~~~-----~~~~~~gt~~y~aPE~~  170 (333)
T cd05600         150 GIVT-----YANSVVGSPDYMAPEVL  170 (333)
T ss_pred             cccc-----ccCCcccCccccChhHh
Confidence            6644     22445799999997753

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=3.7e-29  Score=247.72  Aligned_cols=146  Identities=28%  Similarity=0.348  Sum_probs=130.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .|+..+.||+|+||.||+|+...+++.||||++.+..   ......+.+|+.++++++||||+++++.+.+. ...++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEE
Confidence            6889999999999999999999889999999997542   23455788999999999999999999988764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.+++.+.       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 E~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~  150 (382)
T cd05625          81 DYIPGGDMMSLLIRM-------GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG  150 (382)
T ss_pred             eCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence            999999999999764       45788899999999999999999887   99999999999999999999999999864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-29  Score=239.99  Aligned_cols=167  Identities=25%  Similarity=0.311  Sum_probs=144.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+ +...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence            47888999999999999999999889999999997532   2345668899999999999999999998766 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~  149 (291)
T cd05612          80 MEYVPGGELFSYLRNS-------GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAK  149 (291)
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcch
Confidence            9999999999999764       46889999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......     ....||+.|+|||.-
T Consensus       150 ~~~~~~-----~~~~gt~~y~aPE~~  170 (291)
T cd05612         150 KLRDRT-----WTLCGTPEYLAPEVI  170 (291)
T ss_pred             hccCCc-----ccccCChhhcCHHHH
Confidence            764322     235689999997753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.96  E-value=4.1e-29  Score=246.73  Aligned_cols=147  Identities=26%  Similarity=0.315  Sum_probs=130.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .+|++.+.||+|+||.||+++...+++.||||++.+..   ......+.+|+++|++++||||+++++.+.+ ++.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence            37899999999999999999999889999999997532   2234568899999999999999999998876 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|.
T Consensus        80 ~E~~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~  149 (376)
T cd05598          80 MDYIPGGDMMSLLIRL-------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT  149 (376)
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence            9999999999999764       45888889999999999999999887   9999999999999999999999999985


Q ss_pred             c
Q 017411          339 W  339 (372)
Q Consensus       339 ~  339 (372)
                      .
T Consensus       150 ~  150 (376)
T cd05598         150 G  150 (376)
T ss_pred             c
Confidence            3

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.96  E-value=7.6e-29  Score=235.48  Aligned_cols=170  Identities=24%  Similarity=0.284  Sum_probs=143.1

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .|+..+.||+|+||.||++.+..+++.||+|.+.+..   ......+.+|+.++.+++|+||+++++++.+. ...++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEE
Confidence            3778899999999999999998889999999987542   22334678999999999999999999987664 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        80 e~~~~g~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~  151 (285)
T cd05631          80 TIMNGGDLKFHIYNMGN-----PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQ  151 (285)
T ss_pred             EecCCCcHHHHHHhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEE
Confidence            99999999988865422     46899999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   .....||..|+|||.-
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~  173 (285)
T cd05631         152 IPEGET---VRGRVGTVGYMAPEVI  173 (285)
T ss_pred             cCCCCe---ecCCCCCCCccCHhhh
Confidence            643321   2345688999997753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9e-30  Score=253.34  Aligned_cols=168  Identities=27%  Similarity=0.410  Sum_probs=151.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ..|.....||+|+.|.||.+....+++.||||++........+-+++|+.+|+..+|+|||.+++.+.-. +.+|+||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence            4677778999999999999999999999999999987777777889999999999999999999987765 449999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |++|+|.+.+..        ..+++.++..|++++++||+|||..+   |||||||.+|||++.+|.+||+|||++..+.
T Consensus       352 m~ggsLTDvVt~--------~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  352 MEGGSLTDVVTK--------TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQIS  420 (550)
T ss_pred             cCCCchhhhhhc--------ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence            999999999976        35899999999999999999999988   9999999999999999999999999999887


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  .-.+.+||+.|||||+
T Consensus       421 ~~~~--KR~TmVGTPYWMAPEV  440 (550)
T KOG0578|consen  421 EEQS--KRSTMVGTPYWMAPEV  440 (550)
T ss_pred             cccC--ccccccCCCCccchhh
Confidence            5553  3356789999999775

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=6.3e-29  Score=245.87  Aligned_cols=177  Identities=24%  Similarity=0.319  Sum_probs=149.4

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      .++....++|+..+.||+|+||.||++.+..+++.||+|++.+.   .....+.+.+|+.+++.++||||+++++.+.+ 
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-  114 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  114 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence            34445568999999999999999999999999999999998653   22334567889999999999999999998766 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      +...++||||+++|+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~--------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEE
Confidence            4568999999999999999865        34788888899999999999999887   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++....... .......||+.|+|||.-
T Consensus       184 ~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l  215 (371)
T cd05622         184 ADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVL  215 (371)
T ss_pred             EeCCceeEcCcCCc-ccccCcccCccccCHHHH
Confidence            99999987654322 123456799999998853

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=2.3e-29  Score=239.11  Aligned_cols=173  Identities=27%  Similarity=0.387  Sum_probs=144.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCC-eeceeeeEEcCCC-----
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQ-----  253 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~~~~~~-----  253 (372)
                      ..|...+.||+|+||+||+|+...+|+.||+|++.....  .....-.+|+.+|++++|+| ||.|++++.....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            467777889999999999999999999999999876432  34455689999999999999 9999999877553     


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      .+++|+||+. -+|..++.......   ..++...++.+++||+.||+|||+++   |+||||||+||||+.+|.+||+|
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~---~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaD  163 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKP---QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLAD  163 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeec
Confidence            6899999995 59999998764211   24666889999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|+.+.-+...  -+...+|.-|.|||+
T Consensus       164 FGlAra~~ip~~~--yt~evvTlWYRaPEv  191 (323)
T KOG0594|consen  164 FGLARAFSIPMRT--YTPEVVTLWYRAPEV  191 (323)
T ss_pred             cchHHHhcCCccc--ccccEEEeeccCHHH
Confidence            9999987755543  244567878888765

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=1.1e-28  Score=236.03  Aligned_cols=178  Identities=26%  Similarity=0.353  Sum_probs=143.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECC----------------CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeece
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGL----------------LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPL  244 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~----------------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l  244 (372)
                      ++|...+.||+|+||.||+|.+..                .+..||+|.+... .......|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            578889999999999999997532                3457999998764 34445679999999999999999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceE
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  312 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~Ii  312 (372)
                      ++++.+.+ ..++||||+++|+|.+++.......            .....++|..++.++.||+.||.|||+.+   |+
T Consensus        85 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          85 LGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            99987754 4899999999999999997542110            11135788899999999999999999887   99


Q ss_pred             EcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          313 HRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       313 HrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||.
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWEC  211 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHH
Confidence            999999999999999999999999987654433223334456778888764

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.96  E-value=9.4e-29  Score=240.26  Aligned_cols=163  Identities=26%  Similarity=0.311  Sum_probs=139.2

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.||+|+||.||++....+++.||||++.+.   .......+.+|+.+++.++||||+++++++.. +...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            4699999999999999988999999999754   23445678899999999999999999998766 4558999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          80 GELFFHLSRE-------RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc
Confidence            9999988654       46899999999999999999999887   9999999999999999999999999998643222


Q ss_pred             CCccccccccCCCccCccc
Q 017411          345 VPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apea  363 (372)
                      .  ......||+.|+|||.
T Consensus       150 ~--~~~~~~gt~~y~aPE~  166 (328)
T cd05593         150 A--TMKTFCGTPEYLAPEV  166 (328)
T ss_pred             c--ccccccCCcCccChhh
Confidence            1  2234679999999775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=5.8e-29  Score=243.34  Aligned_cols=168  Identities=29%  Similarity=0.362  Sum_probs=143.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC-eEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|.+..++ ..||+|++.+.   .....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~  107 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLY  107 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEE
Confidence            357999999999999999999876544 68999998653   233456788999999999999999999998764 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       108 lv~Ey~~~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~  177 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN-------KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGF  177 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCC
Confidence            999999999999999764       46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.....     .....||+.|+|||.-
T Consensus       178 a~~~~~~-----~~~~~gt~~y~aPE~~  200 (340)
T PTZ00426        178 AKVVDTR-----TYTLCGTPEYIAPEIL  200 (340)
T ss_pred             CeecCCC-----cceecCChhhcCHHHH
Confidence            9876432     2345799999998753

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.96  E-value=1e-28  Score=242.73  Aligned_cols=148  Identities=30%  Similarity=0.350  Sum_probs=132.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++....+++.||||++++.   .......+.+|+.++..++||||+++++.+.+ ....++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            4788999999999999999999988999999999753   23345578889999999999999999998766 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~  149 (360)
T cd05627          80 MEFLPGGDMMTLLMKK-------DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCT  149 (360)
T ss_pred             EeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCc
Confidence            9999999999999764       46899999999999999999999887   9999999999999999999999999987


Q ss_pred             cc
Q 017411          339 WT  340 (372)
Q Consensus       339 ~~  340 (372)
                      .+
T Consensus       150 ~~  151 (360)
T cd05627         150 GL  151 (360)
T ss_pred             cc
Confidence            55

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=1e-28  Score=239.32  Aligned_cols=171  Identities=26%  Similarity=0.267  Sum_probs=146.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|...+.||+|+||.||++....+++.||||++++..   ....+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEE
Confidence            47899999999999999999999899999999997642   23456688999999999999999999987764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~  150 (330)
T cd05601          80 MEYQPGGDLLSLLNRYE------DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAA  150 (330)
T ss_pred             ECCCCCCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCe
Confidence            99999999999997653      46899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+...... ......||+.|+|||.
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~  174 (330)
T cd05601         151 RLTANKMV-NSKLPVGTPDYIAPEV  174 (330)
T ss_pred             ECCCCCce-eeecccCCccccCHHH
Confidence            77544321 2234578999999775

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-28  Score=239.58  Aligned_cols=172  Identities=26%  Similarity=0.264  Sum_probs=145.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+++...+++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++.+. ...|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEE
Confidence            4789999999999999999999988999999999753   223445688999999999999999999987764 558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~g~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~  150 (331)
T cd05597          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCL  150 (331)
T ss_pred             EecCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCcee
Confidence            99999999999997642      46889999999999999999999887   9999999999999999999999999997


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ........ ......||++|+|||.-
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~~  175 (331)
T cd05597         151 RLLADGTV-QSNVAVGTPDYISPEIL  175 (331)
T ss_pred             ecCCCCCc-cccceeccccccCHHHH
Confidence            66543321 12234699999998753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.8e-29  Score=238.37  Aligned_cols=162  Identities=25%  Similarity=0.324  Sum_probs=138.6

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||+|+||.||++++..+++.||+|++.+.   .......+.+|+.++.+++||||+++++++.+ ....++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            69999999999999988999999998753   23445678899999999999999999998776 455899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        80 L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  148 (312)
T cd05585          80 LFHHLQRE-------GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-  148 (312)
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-
Confidence            99999764       46899999999999999999999887   99999999999999999999999999986433222 


Q ss_pred             ccccccccCCCccCcccc
Q 017411          347 FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       347 ~~~~~~~GT~gy~apeaP  364 (372)
                       ......||+.|+|||.-
T Consensus       149 -~~~~~~gt~~y~aPE~~  165 (312)
T cd05585         149 -KTNTFCGTPEYLAPELL  165 (312)
T ss_pred             -ccccccCCcccCCHHHH
Confidence             23456799999997753

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-30  Score=255.95  Aligned_cols=180  Identities=28%  Similarity=0.419  Sum_probs=152.4

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEE
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~  249 (372)
                      .+..++....+.+.+...||+|.||+||+|++.+   .||||+++..  .++..+.|.+|+.++++-+|.||+-+.|||.
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            4445666666777888999999999999999874   6999999865  4567789999999999999999999999998


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcE
Q 017411          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       250 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                      .+.  ..+|..+|+|-+|+.+|+..+      ..+.....+.|+.||++|+.|||..+   |||||||..||++.+++.+
T Consensus       459 ~p~--~AIiTqwCeGsSLY~hlHv~e------tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  459 NPP--LAIITQWCEGSSLYTHLHVQE------TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             CCc--eeeeehhccCchhhhhccchh------hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcE
Confidence            755  489999999999999998765      56888899999999999999999988   9999999999999999999


Q ss_pred             EEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ||+||||+.....-..........|...|||||+-.
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIR  563 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIR  563 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHh
Confidence            999999997654333333344556888888876543

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.96  E-value=5.7e-29  Score=245.98  Aligned_cols=171  Identities=26%  Similarity=0.318  Sum_probs=145.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..++|+..+.||+|+||.||++++..+++.||+|++++.   .....+.+.+|+.+++.++||||+++++++.+ +...+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence            456899999999999999999999989999999999753   22334557889999999999999999988765 45589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       120 lv~Ey~~gg~L~~~l~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~  188 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN--------YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (370)
T ss_pred             EEEcCCCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999999999865        24778888899999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++........ ......||+.|+|||.
T Consensus       189 ~~~~~~~~~~-~~~~~~gt~~y~aPE~  214 (370)
T cd05596         189 CMKMDANGMV-RCDTAVGTPDYISPEV  214 (370)
T ss_pred             eeeccCCCcc-cCCCCCCCcCeECHHH
Confidence            9876543221 2234679999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.96  E-value=9.7e-29  Score=239.53  Aligned_cols=164  Identities=26%  Similarity=0.281  Sum_probs=139.2

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.||+|+||.||+++...+++.||+|++.+.   .......+.+|++++++++||||+++++++... ...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCC
Confidence            4699999999999999888999999999754   233445678899999999999999999987764 468999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          80 GELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             CcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC
Confidence            9999988754       46899999999999999999999887   9999999999999999999999999987643322


Q ss_pred             CCccccccccCCCccCcccc
Q 017411          345 VPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apeaP  364 (372)
                      .  ......||+.|+|||.-
T Consensus       150 ~--~~~~~~gt~~y~aPE~~  167 (323)
T cd05595         150 A--TMKTFCGTPEYLAPEVL  167 (323)
T ss_pred             C--ccccccCCcCcCCcccc
Confidence            2  22345799999997753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=1.7e-28  Score=238.62  Aligned_cols=171  Identities=26%  Similarity=0.271  Sum_probs=145.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|.+.+.||+|+||.||+++...+++.||+|.+.+.   .......+.+|+.++..++|+||+++++++.+ +...|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            4789999999999999999999988999999998753   22334557889999999999999999998766 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~Ey~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~  150 (331)
T cd05624          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCL  150 (331)
T ss_pred             EeCCCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEecccee
Confidence            99999999999997642      46889999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ........ ......||++|+|||.
T Consensus       151 ~~~~~~~~-~~~~~~gt~~y~aPE~  174 (331)
T cd05624         151 KMNQDGTV-QSSVAVGTPDYISPEI  174 (331)
T ss_pred             eccCCCce-eeccccCCcccCCHHH
Confidence            76543321 2234569999999774

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.96  E-value=1.8e-28  Score=237.52  Aligned_cols=163  Identities=26%  Similarity=0.283  Sum_probs=137.9

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.||+|+||.||++....+++.||+|++.+.   .......+.+|++++..++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            4699999999999999888999999999754   23344567889999999999999999998766 4558999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      |+|..++...       ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~  149 (325)
T cd05594          80 GELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  149 (325)
T ss_pred             CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC
Confidence            9999988754       468999999999999999999996 56   999999999999999999999999999764322


Q ss_pred             CCCccccccccCCCccCccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apea  363 (372)
                      ..  ......||+.|+|||.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~  167 (325)
T cd05594         150 GA--TMKTFCGTPEYLAPEV  167 (325)
T ss_pred             Cc--ccccccCCcccCCHHH
Confidence            22  2234579999999775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=248.59  Aligned_cols=183  Identities=27%  Similarity=0.377  Sum_probs=148.3

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      +.+......+...+.||+|.||.|+.|.+.. ...||+|.++.. ....+.|.+|+.+|++|+|+|||+++++|...+ .
T Consensus       199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-p  275 (468)
T KOG0197|consen  199 DPWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-P  275 (468)
T ss_pred             CCeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-c
Confidence            3344444556677899999999999999975 358999999764 334568999999999999999999999998755 5


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      ++||||||+.|+|.++|+....     ..+...+.+.++.|||+|++||.+++   +|||||...||||+++..+||+||
T Consensus       276 iyIVtE~m~~GsLl~yLr~~~~-----~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  276 IYIVTEYMPKGSLLDYLRTREG-----GLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             eEEEEEecccCcHHHHhhhcCC-----CccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccc
Confidence            9999999999999999987322     57888999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccccccccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRL  369 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaPE~~~~  369 (372)
                      ||||....... .......-.+-|.||||--+..+
T Consensus       348 GLAr~~~d~~Y-~~~~~~kfPIkWtAPEa~~~~~F  381 (468)
T KOG0197|consen  348 GLARLIGDDEY-TASEGGKFPIKWTAPEALNYGKF  381 (468)
T ss_pred             ccccccCCCce-eecCCCCCCceecCHHHHhhCCc
Confidence            99995544432 11222223356889887665443

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=249.58  Aligned_cols=174  Identities=22%  Similarity=0.229  Sum_probs=147.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCC-CeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLL-RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~-~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .|...+.||+|+||.||+|....+ +..||+|.+..........+.+|+++|+.++|||||++++++... +..|+||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEEC
Confidence            499999999999999999988766 788999988766666666788999999999999999999998764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|+|.+++......   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       147 ~~gg~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~  220 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKE---HLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS  220 (478)
T ss_pred             CCCCCHHHHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence            9999999988653221   146889999999999999999999877   9999999999999999999999999998775


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ............||++|+|||.
T Consensus       221 ~~~~~~~~~~~~gt~~y~aPE~  242 (478)
T PTZ00267        221 DSVSLDVASSFCGTPYYLAPEL  242 (478)
T ss_pred             CccccccccccCCCccccCHhH
Confidence            4433223455679999999774

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.1e-28  Score=240.49  Aligned_cols=172  Identities=27%  Similarity=0.318  Sum_probs=146.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|.+.+.||+|+||.||+|....+++.||||++++..   ......+.+|+.++..++||||+++++++.+ +...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence            47899999999999999999999889999999997542   2345678899999999999999999998776 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++...       ..+++..+..++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~  149 (350)
T cd05573          80 MEYMPGGDLMNLLIRK-------DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCK  149 (350)
T ss_pred             EcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCc
Confidence            9999999999999764       46889999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCC---------------------------CCccccccccCCCccCcccc
Q 017411          339 WTSAPS---------------------------VPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~---------------------------~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......                           .........||+.|+|||.-
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (350)
T cd05573         150 KMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL  202 (350)
T ss_pred             cCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            765433                           01123345789999997753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.96  E-value=1.8e-28  Score=233.25  Aligned_cols=169  Identities=28%  Similarity=0.420  Sum_probs=142.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|+||.||+|....++..||+|.++... ......+.+|+.++++++||||+++++++.. +...++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEe
Confidence            57999999999999999999999889999999987542 2334567899999999999999999998765 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        84 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~  153 (288)
T cd07871          84 YLD-SDLKQYLDNCG------NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAK  153 (288)
T ss_pred             CCC-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeec
Confidence            997 59999887542      35788999999999999999999887   999999999999999999999999999865


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......||+.|+|||.
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~  174 (288)
T cd07871         154 SVPTK--TYSNEVVTLWYRPPDV  174 (288)
T ss_pred             cCCCc--cccCceecccccChHH
Confidence            43322  1233467888999774

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.96  E-value=2.5e-28  Score=233.78  Aligned_cols=170  Identities=28%  Similarity=0.378  Sum_probs=142.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|...+.||+|+||.||+|+...+++.||||++.... ......+.+|+.++++++||||+++++++.+. ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEE
Confidence            468999999999999999999998889999999987543 22334678899999999999999999988764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+. ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  152 (303)
T cd07869          83 EYVH-TDLCQYMDKHP------GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA  152 (303)
T ss_pred             ECCC-cCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCccee
Confidence            9995 68888886542      45888899999999999999999887   99999999999999999999999999986


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  ......||+.|+|||+
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~  174 (303)
T cd07869         153 KSVPSH--TYSNEVVTLWYRPPDV  174 (303)
T ss_pred             ccCCCc--cCCCCcccCCCCChHH
Confidence            543322  2234568889999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=3.8e-28  Score=236.12  Aligned_cols=171  Identities=26%  Similarity=0.273  Sum_probs=144.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+++...+++.||+|++.+.   .......+.+|+.++..++|+||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEE
Confidence            4788999999999999999999988999999998653   223344578899999999999999999987664 558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~ey~~~g~L~~~l~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~  150 (332)
T cd05623          80 MDYYVGGDLLTLLSKFE------DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCL  150 (332)
T ss_pred             EeccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchhe
Confidence            99999999999997643      46899999999999999999999887   9999999999999999999999999997


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....... .......||+.|+|||.
T Consensus       151 ~~~~~~~-~~~~~~~gt~~y~aPE~  174 (332)
T cd05623         151 KLMEDGT-VQSSVAVGTPDYISPEI  174 (332)
T ss_pred             ecccCCc-ceecccccCccccCHHH
Confidence            6543322 12234579999999774

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.5e-28  Score=237.04  Aligned_cols=175  Identities=25%  Similarity=0.324  Sum_probs=151.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ...+|...+.||.|.-++||+|+...+++.||||+++.+.. .....+++|+..|+.++||||++++..|.. +..+|+|
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvV  102 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVV  102 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEe
Confidence            44689999999999999999999998899999999986533 235789999999999999999999988776 4559999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |.||.+|++.+++...-.     ..+++..+..|.+++++||.|||.++   .||||||+.||||+.+|.+||+|||.+.
T Consensus       103 mpfMa~GS~ldIik~~~~-----~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYP-----DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             ehhhcCCcHHHHHHHHcc-----ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeee
Confidence            999999999999987643     45899999999999999999999888   9999999999999999999999999877


Q ss_pred             ccCCCCCC-ccc-cccccCCCccCccc
Q 017411          339 WTSAPSVP-FLC-KTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~-~~~-~~~~GT~gy~apea  363 (372)
                      .+-..... ... .+.+||+.|||||+
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEv  201 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEV  201 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHH
Confidence            65433221 122 56789999999887

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=3.7e-28  Score=239.30  Aligned_cols=165  Identities=30%  Similarity=0.441  Sum_probs=140.5

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      ++||+|.||+||-|.++.+|+.||||++++.  ......++++|+.||++++||.||.+.--|.. .+++++|||-+ +|
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKL-HG  647 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhh-cc
Confidence            7899999999999999999999999999874  33444678999999999999999999877665 45599999999 55


Q ss_pred             CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEEEEecccccccCC
Q 017411          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLATWTSA  342 (372)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~KL~DFGla~~~~~  342 (372)
                      ++.+.|-...+     .+|++.....++.||+.||.|||..+   |+|+||||+|||+...   .++||||||+||.++.
T Consensus       648 DMLEMILSsEk-----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  648 DMLEMILSSEK-----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hHHHHHHHhhc-----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            66666654433     67999999999999999999999988   9999999999999643   5799999999999976


Q ss_pred             CCCCccccccccCCCccCccccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ..   ...+++||+.|+|||+-.
T Consensus       720 ks---FRrsVVGTPAYLaPEVLr  739 (888)
T KOG4236|consen  720 KS---FRRSVVGTPAYLAPEVLR  739 (888)
T ss_pred             hh---hhhhhcCCccccCHHHHh
Confidence            54   346789999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.2e-29  Score=251.17  Aligned_cols=170  Identities=30%  Similarity=0.413  Sum_probs=150.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .-|+.++.||.|+-|.|.+|++..||+.+|||++.+.   .......+.+|+.+|+-|.|||++++++++.+ ...+|+|
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylv   90 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLV   90 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEE
Confidence            3578899999999999999999999999999999875   22334567899999999999999999999876 4459999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      .||+++|.|.+++-++       ..+++.++.++++||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|.
T Consensus        91 lEyv~gGELFdylv~k-------G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAs  160 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK-------GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMAS  160 (786)
T ss_pred             EEecCCchhHHHHHhh-------CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceee
Confidence            9999999999999876       57999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .-..+.   ...+.+|++.|.+||+--
T Consensus       161 Le~~gk---lLeTSCGSPHYA~PEIV~  184 (786)
T KOG0588|consen  161 LEVPGK---LLETSCGSPHYAAPEIVS  184 (786)
T ss_pred             cccCCc---cccccCCCcccCCchhhc
Confidence            765544   456779999999988654

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.96  E-value=1.3e-28  Score=243.82  Aligned_cols=182  Identities=26%  Similarity=0.345  Sum_probs=144.2

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      ...++|+..+.||+|+||.||+|....     +...||||+++.. .......+.+|+++++.+ +||||++++++|...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            344589999999999999999998643     3357999999754 334456788999999999 899999999998775


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccC------------------------------------------------------
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKG------------------------------------------------------  277 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~------------------------------------------------------  277 (372)
                      . ..++||||+++|+|.+++......                                                      
T Consensus       115 ~-~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         115 G-PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             C-CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            4 489999999999999999753210                                                      


Q ss_pred             ---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCcc
Q 017411          278 ---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL  348 (372)
Q Consensus       278 ---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~  348 (372)
                               ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..........
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                     001135788999999999999999999877   99999999999999999999999999987654432222


Q ss_pred             ccccccCCCccCcccc
Q 017411          349 CKTVKGTFGQNPFCIE  364 (372)
Q Consensus       349 ~~~~~GT~gy~apeaP  364 (372)
                      .....++..|+|||.-
T Consensus       271 ~~~~~~~~~y~aPE~~  286 (374)
T cd05106         271 KGNARLPVKWMAPESI  286 (374)
T ss_pred             ccCCCCccceeCHHHh
Confidence            2334456678887743

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.96  E-value=5.4e-28  Score=234.10  Aligned_cols=169  Identities=23%  Similarity=0.271  Sum_probs=140.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCC-CeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP-NIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~Hp-nIv~l~g~~~~~~~~~~lV  258 (372)
                      +|+..+.||+|+||.||+|....+++.||||++.+.   .....+.+..|++++..++|+ +|+.+++++.+ .+..|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            578889999999999999999988999999999753   234456788899999999765 57778877655 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05587          80 MEYVNGGDLMYHIQQV-------GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK  149 (324)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcce
Confidence            9999999999998754       45889999999999999999999877   9999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......  ......||+.|+|||.-
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~  173 (324)
T cd05587         150 ENIFGGK--TTRTFCGTPDYIAPEII  173 (324)
T ss_pred             ecCCCCC--ceeeecCCccccChhhh
Confidence            5432221  22446799999997754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.96  E-value=1.6e-29  Score=232.42  Aligned_cols=170  Identities=28%  Similarity=0.359  Sum_probs=149.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----C---hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----D---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~  252 (372)
                      ..|...+.||.|..+.|.++.++.++.++|+|++...     .   ....++-++|+.+|+++ .||+|+++.+++. .+
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye-s~   95 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE-SD   95 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc-Cc
Confidence            4677889999999999999999999999999998642     1   12234456899999998 5999999999865 46


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ..+++|+|.|+.|.|.++|...       ..+++....+|++|+.+|++|||..+   ||||||||+|||+|++.++||+
T Consensus        96 sF~FlVFdl~prGELFDyLts~-------VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSK-------VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhh-------eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence            6789999999999999999875       67999999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |||+|+.+..+..   ....+|||||+|||.-+
T Consensus       166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtik  195 (411)
T KOG0599|consen  166 DFGFACQLEPGEK---LRELCGTPGYLAPETIK  195 (411)
T ss_pred             ccceeeccCCchh---HHHhcCCCcccChhhee
Confidence            9999999877663   46789999999988765

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=4.7e-28  Score=234.47  Aligned_cols=170  Identities=22%  Similarity=0.382  Sum_probs=141.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----CeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~~~  256 (372)
                      +|++.+.||+|+||.||+|.+..++..||||++...  .......+.+|++++++++||||+++++++....    ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999999888999999998743  2334457889999999999999999999876432    2379


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+. ++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~~-~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-------DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcc
Confidence            9999995 6899988754       45899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCC-CccccccccCCCccCccc
Q 017411          337 ATWTSAPSV-PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~-~~~~~~~~GT~gy~apea  363 (372)
                      ++....... ........||+.|+|||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~  177 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPEL  177 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHH
Confidence            986533221 112234578999999775

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.96  E-value=8.5e-28  Score=233.54  Aligned_cols=171  Identities=27%  Similarity=0.349  Sum_probs=147.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|+..+.||+|+||.||++++..++..||+|.+... .....+.+.+|++++++++||||+++++++... ...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEe
Confidence            36899999999999999999999989999999998764 344556799999999999999999999988764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          83 EHMDGGSLDQVLKEA-------KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            999999999999764       45889999999999999999999742  399999999999999999999999999986


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .....    .....||..|+|||.-.
T Consensus       154 ~~~~~----~~~~~g~~~y~aPE~~~  175 (331)
T cd06649         154 LIDSM----ANSFVGTRSYMSPERLQ  175 (331)
T ss_pred             ccccc----cccCCCCcCcCCHhHhc
Confidence            64332    23456899999977543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.96  E-value=5.2e-28  Score=234.10  Aligned_cols=169  Identities=24%  Similarity=0.268  Sum_probs=141.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      +|...+.||+|+||.||+|....+++.||||++.+..   ....+.+..|..++..+ +|++|+++++++.+ ....++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence            5788899999999999999999889999999997542   23344567788888877 58899999887765 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~E~~~~g~L~~~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~  149 (323)
T cd05616          80 MEYVNGGDLMYQIQQV-------GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EcCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCce
Confidence            9999999999998764       45889999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......  ......||+.|+|||.-
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~  173 (323)
T cd05616         150 ENMWDGV--TTKTFCGTPDYIAPEII  173 (323)
T ss_pred             ecCCCCC--ccccCCCChhhcCHHHh
Confidence            6542221  23456789999997753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.96  E-value=4.3e-28  Score=235.58  Aligned_cols=164  Identities=29%  Similarity=0.369  Sum_probs=139.2

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||++.+..+++.||||++++.   .....+.+.+|..++.++ +||||+++++++.+ ....|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            4699999999999999988999999999764   233455688999999998 79999999998776 455899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          80 GGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP  149 (329)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC
Confidence            99999988654       46899999999999999999999887   999999999999999999999999999753322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (329)
T cd05588         150 GD--TTSTFCGTPNYIAPEIL  168 (329)
T ss_pred             CC--ccccccCCccccCHHHH
Confidence            21  23456799999997753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.96  E-value=5.4e-28  Score=235.05  Aligned_cols=164  Identities=29%  Similarity=0.368  Sum_probs=138.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||++.+..+++.||+|++++.   .......+.+|+.++.++ +||||+++++++.. ....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            4799999999999999988999999999764   334455678899988877 79999999998766 455899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~  149 (329)
T cd05618          80 GGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  149 (329)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC
Confidence            99999988654       46899999999999999999999887   999999999999999999999999999764322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (329)
T cd05618         150 GD--TTSTFCGTPNYIAPEIL  168 (329)
T ss_pred             CC--ccccccCCccccCHHHH
Confidence            22  23456799999998754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.96  E-value=5.7e-28  Score=234.36  Aligned_cols=170  Identities=29%  Similarity=0.251  Sum_probs=141.8

Q ss_pred             CeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCC----ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE----DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~----~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      +|++.+.||+|+||.||+++..   .+++.||+|++.+.    .....+.+.+|+.++..+ +||||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            5888999999999999998863   46789999998753    223345678899999999 59999999988765 455


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Df  149 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQR-------DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDF  149 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeC
Confidence            89999999999999999764       46899999999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........ ......||+.|+|||.-
T Consensus       150 G~~~~~~~~~~~-~~~~~~gt~~y~aPE~~  178 (332)
T cd05614         150 GLSKEFLSEEKE-RTYSFCGTIEYMAPEII  178 (332)
T ss_pred             cCCccccccCCC-ccccccCCccccCHHHh
Confidence            999875433321 22345799999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.96  E-value=4.9e-28  Score=234.08  Aligned_cols=164  Identities=26%  Similarity=0.313  Sum_probs=138.2

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|+...+++.||||++.+.   .....+.+..|.+++..+ +||||+++++++... ...|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCC
Confidence            4699999999999999988999999999753   233445677899998876 799999999988764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          80 GGDLMFQIQRS-------RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            99999998754       46889999999999999999999887   999999999999999999999999999865333


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (321)
T cd05591         150 GV--TTTTFCGTPDYIAPEIL  168 (321)
T ss_pred             Cc--cccccccCccccCHHHH
Confidence            22  23456789999997753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.96  E-value=5.5e-28  Score=234.05  Aligned_cols=166  Identities=27%  Similarity=0.327  Sum_probs=137.9

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHH---HhCCCCCeeceeeeEEcCCCeEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIA---SSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL---~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      |++.+.||+|+||.||++.+..+++.||||++++..   ....+.+.+|++++   +.++||||+++++++... ...|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEE
Confidence            567899999999999999999889999999997542   23345566776655   566899999999987764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|..++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        80 v~E~~~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~  148 (324)
T cd05589          80 VMEYAAGGDLMMHIHT--------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLC  148 (324)
T ss_pred             EEcCCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCC
Confidence            9999999999988754        35899999999999999999999887   999999999999999999999999998


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.......  ......||+.|+|||.
T Consensus       149 ~~~~~~~~--~~~~~~g~~~y~aPE~  172 (324)
T cd05589         149 KEGMGFGD--RTSTFCGTPEFLAPEV  172 (324)
T ss_pred             ccCCCCCC--cccccccCccccCHhH
Confidence            75432222  2345679999999774

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-28  Score=240.14  Aligned_cols=171  Identities=33%  Similarity=0.438  Sum_probs=149.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh---hHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~  255 (372)
                      ....|++.+.||.|.||.||+++.+.+|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+++++.+.. .+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~-~~  111 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD-SV  111 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC-eE
Confidence            345799999999999999999999999999999999876432   4468899999999998 999999999987755 58


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC----CcEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKL  331 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~----~~~KL  331 (372)
                      ++|||++.||.|.+.+...        .+++..+..++.|++.++.|||+.+   |+||||||+|+|+...    +.+|+
T Consensus       112 ~lvmEL~~GGeLfd~i~~~--------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~  180 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK--------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKL  180 (382)
T ss_pred             EEEEEecCCchHHHHHHHc--------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEE
Confidence            9999999999999999764        2899999999999999999999977   9999999999999643    47999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +|||+|.......   ....++||++|+|||+--
T Consensus       181 ~DFGla~~~~~~~---~~~~~~Gtp~y~APEvl~  211 (382)
T KOG0032|consen  181 IDFGLAKFIKPGE---RLHTIVGTPEYVAPEVLG  211 (382)
T ss_pred             eeCCCceEccCCc---eEeeecCCccccCchhhc
Confidence            9999999887632   456789999999987644

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.95  E-value=6.4e-28  Score=228.27  Aligned_cols=171  Identities=28%  Similarity=0.370  Sum_probs=142.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||.||++++..+++.||||++...  .....+.+.+|+.++++++||||+++++++.. +...++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence            4789999999999999999999988999999998754  23345678899999999999999999998765 45589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++++.+..+....       ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+++.
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~  149 (287)
T cd07848          80 EYVEKNMLELLEEMP-------NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN  149 (287)
T ss_pred             ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccc
Confidence            999987776554321       45889999999999999999999877   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....... ......||+.|+|||.-
T Consensus       150 ~~~~~~~-~~~~~~~~~~y~aPE~~  173 (287)
T cd07848         150 LSEGSNA-NYTEYVATRWYRSPELL  173 (287)
T ss_pred             ccccccc-cccccccccccCCcHHH
Confidence            6543221 22345789999997753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=8.2e-28  Score=232.90  Aligned_cols=164  Identities=29%  Similarity=0.352  Sum_probs=136.7

Q ss_pred             eeEcccCceEEEEEEEC---CCCeEEEEEEecCC----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          188 RVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.||+|+||.||+++..   .+++.||||++++.    .......+.+|+++|+.++||||+++++++.. +...|+|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence            68999999999999863   46789999999753    22334567889999999999999999998776 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (323)
T cd05584          81 YLSGGELFMHLERE-------GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES  150 (323)
T ss_pred             CCCCchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence            99999999999764       45788888899999999999999887   999999999999999999999999999754


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....  ......||+.|+|||.-
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~  172 (323)
T cd05584         151 IHEGT--VTHTFCGTIEYMAPEIL  172 (323)
T ss_pred             ccCCC--cccccCCCccccChhhc
Confidence            33222  23445799999997753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.95  E-value=7.7e-28  Score=233.25  Aligned_cols=169  Identities=24%  Similarity=0.290  Sum_probs=140.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      +|+..+.||+|+||.||++....+++.||||++.+.   .....+.+..|..++..+. |++|+++++++.+ ....|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            467789999999999999999988999999999753   2234456788999998886 5677778877655 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        80 ~Ey~~~g~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~  149 (323)
T cd05615          80 MEYVNGGDLMYHIQQV-------GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK  149 (323)
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccc
Confidence            9999999999998764       46899999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......  ......||+.|+|||.-
T Consensus       150 ~~~~~~~--~~~~~~gt~~y~aPE~~  173 (323)
T cd05615         150 EHMVDGV--TTRTFCGTPDYIAPEII  173 (323)
T ss_pred             ccCCCCc--cccCccCCccccCHHHH
Confidence            6533322  23445689999997753

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.95  E-value=7.5e-28  Score=232.62  Aligned_cols=163  Identities=29%  Similarity=0.364  Sum_probs=134.3

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHH-HHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|++..+++.||+|++.+..   ......+.+|.. +++.++||||+++++++.+. ...++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            46999999999999999889999999997532   222344555554 67889999999999987664 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +++|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          80 GGELFFHLQRE-------RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP  149 (321)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC
Confidence            99999888654       45788889999999999999999887   999999999999999999999999999764332


Q ss_pred             CCCccccccccCCCccCccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apea  363 (372)
                      ..  ......||+.|+|||.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~  167 (321)
T cd05603         150 EE--TTSTFCGTPEYLAPEV  167 (321)
T ss_pred             CC--ccccccCCcccCCHHH
Confidence            22  2344578999999775

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=7.2e-28  Score=232.75  Aligned_cols=163  Identities=24%  Similarity=0.316  Sum_probs=135.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.+..+++.||||++++.   .....+.+..|..++..+ +||||+++++++.. +...++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            4699999999999999988999999999753   223344566777777654 89999999998766 445899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 gg~L~~~~~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          80 GGDLMFHIQSS-------GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            99999998764       45889999999999999999999877   999999999999999999999999999865433


Q ss_pred             CCCccccccccCCCccCccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apea  363 (372)
                      ..  ......||+.|+|||.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~  167 (316)
T cd05592         150 EG--KASTFCGTPDYIAPEI  167 (316)
T ss_pred             CC--ccccccCCccccCHHH
Confidence            22  2345679999999775

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=9.1e-28  Score=231.38  Aligned_cols=171  Identities=27%  Similarity=0.390  Sum_probs=141.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe----EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.++.. .....+.+.+|+.+++.++||||++++++|...  ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence            479999999999999999998755444    4899998754 345567899999999999999999999998763  367


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+++|+|.+++....      ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~  155 (316)
T cd05108          85 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (316)
T ss_pred             eeeecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccc
Confidence            9999999999999998643      45889999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++...............++..|+|||.
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~  182 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALES  182 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHH
Confidence            998765443222222334567887664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=4e-28  Score=233.85  Aligned_cols=148  Identities=27%  Similarity=0.309  Sum_probs=133.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      +.|...+.||.|.-|+||+++++.++..+|+|++++...   ....+...|-+||+.++||.++.||..+. .+...|||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-t~~~~cl~  155 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-TDKYSCLV  155 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-ccceeEEE
Confidence            467788999999999999999999999999999998643   33445677999999999999999999865 46779999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||||+||+|..+++++..     ..+++..++.++.+|+-||+|||..+   ||+|||||+||||.++|++.|+||.|+.
T Consensus       156 meyCpGGdL~~LrqkQp~-----~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPG-----KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             EecCCCccHHHHHhhCCC-----CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccc
Confidence            999999999999988754     68999999999999999999999988   9999999999999999999999999974

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=8.4e-28  Score=246.74  Aligned_cols=183  Identities=24%  Similarity=0.231  Sum_probs=151.5

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-  253 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-  253 (372)
                      +....++|.+.+.||+|+||.||+++...+++.||||++...  .......+.+|+.++..++|+||+++...+...+. 
T Consensus        27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            344567999999999999999999999888999999998754  34556678899999999999999998876643221 


Q ss_pred             ------eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          254 ------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       254 ------~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                            .+++||||+++|+|.+++......   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~---~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKT---NRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence                  267999999999999999764321   256899999999999999999999877   99999999999999999


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .+||+|||+++...............||+.|+|||.-.
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  218 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWR  218 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhC
Confidence            99999999998775443333345567999999977643

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.95  E-value=7.9e-29  Score=235.89  Aligned_cols=166  Identities=28%  Similarity=0.416  Sum_probs=134.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC----eEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~----~~~lV  258 (372)
                      .|...+++|.|+||.||+|....+++.||||+.-....    .--+|+++|++++|||||+|.-+|.....    ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            57778999999999999999998899999998865432    22379999999999999999887764322    24589


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEecccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLA  337 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DFGla  337 (372)
                      |||||. +|.+.++....   .+..++...+.-++.||.+||.|||+.+   |+||||||+|+|+|.+ |.+||||||.|
T Consensus       101 leymP~-tL~~~~r~~~~---~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTR---ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHhchH-HHHHHHHHHhh---cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcc
Confidence            999976 99999986321   1256888888899999999999999977   9999999999999987 99999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      +.+...+..   .+..-|.-|.|||
T Consensus       174 K~L~~~epn---iSYicSRyYRaPE  195 (364)
T KOG0658|consen  174 KVLVKGEPN---ISYICSRYYRAPE  195 (364)
T ss_pred             eeeccCCCc---eeEEEeccccCHH
Confidence            988655431   2233455677755

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=5.9e-28  Score=239.16  Aligned_cols=179  Identities=27%  Similarity=0.357  Sum_probs=142.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~  253 (372)
                      .++|+..+.||+|+||.||+|..     ..++..||||+++.. .....+.+.+|+.++..+ +||||++++++|.+.+ 
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~-  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG-  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC-
Confidence            45789999999999999999974     345678999999754 234456788999999999 8999999999987754 


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCC-------------------------------------------------------
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGV-------------------------------------------------------  278 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~-------------------------------------------------------  278 (372)
                      ..++||||+++|+|.+++.......                                                       
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            4899999999999999997542100                                                       


Q ss_pred             -------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 017411          279 -------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (372)
Q Consensus       279 -------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~  345 (372)
                                   .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                         01135789999999999999999999877   99999999999999999999999999987654432


Q ss_pred             CccccccccCCCccCccc
Q 017411          346 PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       346 ~~~~~~~~GT~gy~apea  363 (372)
                      ........++..|+|||.
T Consensus       270 ~~~~~~~~~~~~y~aPE~  287 (375)
T cd05104         270 YVVKGNARLPVKWMAPES  287 (375)
T ss_pred             ccccCCCCCCcceeChhH
Confidence            222223345667888764

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.5e-27  Score=226.66  Aligned_cols=170  Identities=25%  Similarity=0.285  Sum_probs=143.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +|+..+.||+|+||.||++....+++.||+|.+....   ......+.+|+.++++++||||+++++.+.+. ...++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEE
Confidence            4778899999999999999998889999999987532   22335678899999999999999999987664 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.
T Consensus        80 e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN-----PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVE  151 (285)
T ss_pred             eccCCCcHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCcee
Confidence            99999999998865422     46899999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   .....|++.|+|||.-
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~  173 (285)
T cd05605         152 IPEGET---IRGRVGTVGYMAPEVV  173 (285)
T ss_pred             cCCCCc---cccccCCCCccCcHHh
Confidence            643322   1334688889987753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.95  E-value=9.8e-28  Score=232.18  Aligned_cols=163  Identities=30%  Similarity=0.369  Sum_probs=134.7

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHH-HHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.+..+++.||||++.+..   ....+.+.+|.. +++.++||||+++++++.+. ...++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCC
Confidence            46999999999999999899999999997532   222344555554 56789999999999987764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          80 GGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH  149 (323)
T ss_pred             CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC
Confidence            99999998764       46889999999999999999999887   999999999999999999999999999764332


Q ss_pred             CCCccccccccCCCccCccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apea  363 (372)
                      ..  ......||+.|+|||.
T Consensus       150 ~~--~~~~~~gt~~y~aPE~  167 (323)
T cd05575         150 SK--TTSTFCGTPEYLAPEV  167 (323)
T ss_pred             CC--ccccccCChhhcChhh
Confidence            22  2344579999999775

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.95  E-value=8.8e-28  Score=232.72  Aligned_cols=164  Identities=30%  Similarity=0.383  Sum_probs=135.5

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHH-HHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||++....+++.||||++.+.   .......+.+|.. +++.++||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCC
Confidence            4699999999999999888999999999754   2233345566654 56779999999999987764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~  149 (325)
T cd05604          80 GGELFFHLQRE-------RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC
Confidence            99999888654       46899999999999999999999887   999999999999999999999999999754322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (325)
T cd05604         150 SD--TTTTFCGTPEYLAPEVI  168 (325)
T ss_pred             CC--CcccccCChhhCCHHHH
Confidence            21  23456799999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=8.6e-28  Score=231.92  Aligned_cols=164  Identities=27%  Similarity=0.270  Sum_probs=138.2

Q ss_pred             eeEcccCceEEEEEEE---CCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~---~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      +.||+|+||.||+++.   ..+++.||+|++.+..  ......+.+|++++++++||||+++++++.+ +...|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence            5799999999999876   3568899999997642  2233457789999999999999999998876 45589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  150 (318)
T cd05582          81 RGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID  150 (318)
T ss_pred             CCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence            999999999654       46899999999999999999999887   99999999999999999999999999987644


Q ss_pred             CCCCccccccccCCCccCcccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...  ......||+.|+|||.-
T Consensus       151 ~~~--~~~~~~g~~~y~aPE~~  170 (318)
T cd05582         151 HEK--KAYSFCGTVEYMAPEVV  170 (318)
T ss_pred             CCC--ceecccCChhhcCHHHH
Confidence            322  23446789999998754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=7.6e-28  Score=232.97  Aligned_cols=164  Identities=26%  Similarity=0.323  Sum_probs=137.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|++..+++.||||++.+.   .....+.+.+|..++..+ +||||+++++++.. ....|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            4699999999999999988999999998753   223445677888888876 69999999998766 455899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..+..++.|++.||.|||..+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~i~~~-------~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          80 GGDLMFHIQKS-------RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             CchHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            99999998764       46889999999999999999999887   999999999999999999999999998764322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (320)
T cd05590         150 GK--TTSTFCGTPDYIAPEIL  168 (320)
T ss_pred             CC--cccccccCccccCHHHH
Confidence            21  23445799999997753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3.1e-28  Score=243.99  Aligned_cols=178  Identities=31%  Similarity=0.427  Sum_probs=144.7

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCC---eE-EEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeE
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLR---TS-VAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFC  248 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~---~~-vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~  248 (372)
                      .|+...++-...++||+|+||.||+|++...+   .. ||||..+..   .....++|++|+++|++++|||||+++|++
T Consensus       151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa  230 (474)
T KOG0194|consen  151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA  230 (474)
T ss_pred             ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            34445556666799999999999999986432   23 899998852   466778999999999999999999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      .... .+++|||+|.||+|.++|++..      ..++..+++.++.++|.||+|||..+   +|||||-.+|+|++.++.
T Consensus       231 ~~~~-Pl~ivmEl~~gGsL~~~L~k~~------~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~  300 (474)
T KOG0194|consen  231 VLEE-PLMLVMELCNGGSLDDYLKKNK------KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGV  300 (474)
T ss_pred             cCCC-ccEEEEEecCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCe
Confidence            8744 4899999999999999998864      35899999999999999999999988   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +||+||||++.-..-...  ...-.-...|+|||...
T Consensus       301 vKISDFGLs~~~~~~~~~--~~~~klPirWLAPEtl~  335 (474)
T KOG0194|consen  301 VKISDFGLSRAGSQYVMK--KFLKKLPIRWLAPETLN  335 (474)
T ss_pred             EEeCccccccCCcceeec--cccccCcceecChhhhc
Confidence            999999998765411110  00112346788887765

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.95  E-value=1.6e-27  Score=232.17  Aligned_cols=170  Identities=27%  Similarity=0.358  Sum_probs=145.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|+..+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++++++||||++++++|.+. +..++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEE
Confidence            46899999999999999999999988999999998764 334456789999999999999999999998774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~  153 (333)
T cd06650          83 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (333)
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence            999999999999764       45889999999999999999999732  299999999999999999999999999976


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....    .....||..|+|||.-
T Consensus       154 ~~~~~----~~~~~~~~~y~aPE~~  174 (333)
T cd06650         154 LIDSM----ANSFVGTRSYMSPERL  174 (333)
T ss_pred             hhhhc----cccCCCCccccCHHHh
Confidence            64322    2335688899987754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.95  E-value=5.8e-28  Score=236.73  Aligned_cols=164  Identities=28%  Similarity=0.401  Sum_probs=138.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +|+..+.||+|+||.||++.+..+++.||||++... .......+.+|++++++++|+||+++++++.. +...++||||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~  153 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLEF  153 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEec
Confidence            566678999999999999999888999999998654 33445678999999999999999999998765 4558999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +.+|+|...           ..+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       154 ~~~~~L~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~  219 (353)
T PLN00034        154 MDGGSLEGT-----------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA  219 (353)
T ss_pred             CCCCccccc-----------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence            999998643           23567778889999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  .+....||..|+|||.
T Consensus       220 ~~~~--~~~~~~gt~~y~aPE~  239 (353)
T PLN00034        220 QTMD--PCNSSVGTIAYMSPER  239 (353)
T ss_pred             cccc--cccccccCccccCccc
Confidence            4322  2234578999999875

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.95  E-value=1.3e-27  Score=226.43  Aligned_cols=166  Identities=24%  Similarity=0.287  Sum_probs=138.1

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||+|+||+||++.+..+++.||+|.+.+..   ....+.+..|++++++++||||+++.+++.. +...++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            699999999999999889999999987542   2234567889999999999999999988765 455899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |..++.....   ....+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+++.+..... 
T Consensus        80 L~~~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-  152 (280)
T cd05608          80 LRYHIYNVDE---ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-  152 (280)
T ss_pred             HHHHHHhccc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-
Confidence            9988864321   1246899999999999999999999887   99999999999999999999999999987654332 


Q ss_pred             ccccccccCCCccCcccc
Q 017411          347 FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       347 ~~~~~~~GT~gy~apeaP  364 (372)
                       ......||+.|+|||.-
T Consensus       153 -~~~~~~g~~~y~aPE~~  169 (280)
T cd05608         153 -KTKGYAGTPGFMAPELL  169 (280)
T ss_pred             -cccccCCCcCccCHHHh
Confidence             22345789999997753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.95  E-value=1.5e-27  Score=231.68  Aligned_cols=164  Identities=28%  Similarity=0.343  Sum_probs=138.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||++....+++.||+|++++.   .....+.+.+|+.++.++ +||||+.+++++.+ ....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            4799999999999999988999999999764   233455688999999888 69999999998765 455899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          80 GGDLMFHMQRQ-------RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP  149 (327)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC
Confidence            99999988754       46899999999999999999999887   999999999999999999999999999754322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (327)
T cd05617         150 GD--TTSTFCGTPNYIAPEIL  168 (327)
T ss_pred             CC--ceecccCCcccCCHHHH
Confidence            22  23456799999997754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.7e-28  Score=242.10  Aligned_cols=174  Identities=30%  Similarity=0.365  Sum_probs=155.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|..++++|+|+||.++..+++..++.|++|.+...  .....+....|+.++++++|||||.+.+.|++.+...+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5788899999999999999999988999999998754  33344467899999999999999999999988777699999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      +||+||+|.+.|.+.+.     ..+++..+..++.|++.|+.|||...   |+|||||+.||+++.++.+||.|||+|+.
T Consensus        84 ~Y~eGg~l~~~i~~~k~-----~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG-----VLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eecCCCCHHHHHHHHhh-----ccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhh
Confidence            99999999999998763     57899999999999999999999777   99999999999999999999999999999


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +..+..  ...++.||+-||.||.-+
T Consensus       156 l~~~~~--~a~tvvGTp~YmcPEil~  179 (426)
T KOG0589|consen  156 LNPEDS--LASTVVGTPYYMCPEILS  179 (426)
T ss_pred             cCCchh--hhheecCCCcccCHHHhC
Confidence            987763  457889999999987654

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.95  E-value=1.5e-27  Score=231.13  Aligned_cols=164  Identities=28%  Similarity=0.346  Sum_probs=134.1

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHH-HHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCREL-MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev-~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||++++..+++.||+|++.+..   ......+.+|. .+++.++||||+++++++.+. ...++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCC
Confidence            46999999999999999889999999997532   12223444454 456789999999999987764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~  149 (325)
T cd05602          80 GGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  149 (325)
T ss_pred             CCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC
Confidence            99999999764       45778888889999999999999887   999999999999999999999999999864332


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (325)
T cd05602         150 NG--TTSTFCGTPEYLAPEVL  168 (325)
T ss_pred             CC--CcccccCCccccCHHHH
Confidence            22  23456799999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=1.7e-27  Score=237.44  Aligned_cols=164  Identities=24%  Similarity=0.261  Sum_probs=138.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|++.+.||+|+||.||++.+..+++.||+|....      ..+.+|++++++++||||+++++++.. +...++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEec
Confidence            579999999999999999999999999999997542      356789999999999999999998766 4458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +. ++|..++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus       165 ~~-~~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~  233 (391)
T PHA03212        165 YK-TDLYCYLAAK-------RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV  233 (391)
T ss_pred             CC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence            95 7898888654       45889999999999999999999887   9999999999999999999999999997643


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..... ......||+.|+|||.-
T Consensus       234 ~~~~~-~~~~~~gt~~y~aPE~~  255 (391)
T PHA03212        234 DINAN-KYYGWAGTIATNAPELL  255 (391)
T ss_pred             ccccc-ccccccCccCCCChhhh
Confidence            22211 22345789999987753

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=234.05  Aligned_cols=171  Identities=25%  Similarity=0.337  Sum_probs=143.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeeEEcCC---CeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPE---QGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~~~---~~~~  256 (372)
                      ...+..++||+|.||.||+|.+.  ++.||||++..   +..+.|+.|-+|.+.  ++|+||++++++-.-..   ..++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            35566789999999999999986  58999999965   455678888888775  58999999998743222   2479


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCceEEcCCCCCCEEEcCCCcEE
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG------TERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                      ||+||.+.|+|.++|..        ..++|....+|+.-+++||+|||..      .+++|+|||||+.||||..|+++.
T Consensus       285 LVt~fh~kGsL~dyL~~--------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTcc  356 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKA--------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCC  356 (534)
T ss_pred             EEeeeccCCcHHHHHHh--------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEE
Confidence            99999999999999987        4689999999999999999999963      356799999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+|||||..+........+...+||..|||||+-|
T Consensus       357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLE  391 (534)
T KOG3653|consen  357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLE  391 (534)
T ss_pred             eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHh
Confidence            99999998876544333344478999999999887

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=1.5e-27  Score=230.52  Aligned_cols=164  Identities=22%  Similarity=0.287  Sum_probs=136.7

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|++..+++.||+|.+++..   ......+..|.+++..+ +||||+++++++.+ ....|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            46999999999999999899999999997532   23345567788888764 89999999998876 446899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~i~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          80 GGDLMFHIQDK-------GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC
Confidence            99999998764       45889999999999999999999887   999999999999999999999999998754322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (316)
T cd05620         150 DN--RASTFCGTPDYIAPEIL  168 (316)
T ss_pred             CC--ceeccCCCcCccCHHHH
Confidence            21  23456799999997754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.95  E-value=1.9e-27  Score=229.93  Aligned_cols=164  Identities=26%  Similarity=0.307  Sum_probs=136.6

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.+..+++.||||++++..   ......+..|..++..+ +||||+++++++.+. ...++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCC
Confidence            46999999999999999889999999997642   23345567788888764 899999999988764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          80 GGDLMFHIQSC-------HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG  149 (316)
T ss_pred             CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCC
Confidence            99999999764       45889999999999999999999877   999999999999999999999999999764322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (316)
T cd05619         150 DA--KTCTFCGTPDYIAPEIL  168 (316)
T ss_pred             CC--ceeeecCCccccCHHHH
Confidence            21  22345789999997753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=2.3e-28  Score=248.39  Aligned_cols=173  Identities=32%  Similarity=0.435  Sum_probs=147.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----CeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~~~~  256 (372)
                      .+...+.||+|+||.||+|+++.+|+.||||.+++. .....+...+|+++|++++|||||+++++-.+..     ....
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            345568899999999999999999999999999764 3455677899999999999999999998743322     1257


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc--CCC--cEEEE
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKK--IPKLC  332 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld--~~~--~~KL~  332 (372)
                      +|||||.+|||+..|.+..+.    ..|++...+.+..+++.||.|||.++   |+||||||.||++-  ++|  .-||+
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~----~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENA----YGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeee
Confidence            999999999999999876432    57999999999999999999999887   99999999999994  334  36999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |||.||.++..+   .+.++.||..|++|+.-|
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E  196 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYE  196 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHh
Confidence            999999998776   578899999999988766

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=232.69  Aligned_cols=175  Identities=25%  Similarity=0.332  Sum_probs=146.1

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecC--CChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc----CC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCID----PE  252 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~  252 (372)
                      .....|...+.||+|+||.|..+.+..+++.||||.+..  ......++-.||+.+|+.++|+||+.+++.+..    .-
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            345677778999999999999999999999999999873  456667788999999999999999999998754    12


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      +.+|+|+|+| ..+|.+.++..       ..|+......++.|+++||.|+|+.+   |+||||||+|+|++.+..+||+
T Consensus        99 ~DvYiV~elM-etDL~~iik~~-------~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQ-------QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcC-------ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEec
Confidence            3489999999 66999999875       45899999999999999999999999   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||||||...........+..+-|..|.|||.-
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPEll  199 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELL  199 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHH
Confidence            99999988644222223444556666665543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.95  E-value=2e-28  Score=253.47  Aligned_cols=190  Identities=24%  Similarity=0.353  Sum_probs=155.2

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      ......+....+.||+|+||+||+|+..     .....||||.++... .+..++|+||+++|..++|||||+|+|+|.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            3445567777899999999999999863     234689999998764 4478899999999999999999999999988


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCC---C----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVR---G----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~---~----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      ++. +++|+|||..|||.++|........   .    ..+|+..+.+.||.|||.|++||-++.   +|||||-..|+||
T Consensus       561 ~~P-~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV  636 (774)
T KOG1026|consen  561 GDP-LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV  636 (774)
T ss_pred             CCe-eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence            554 8999999999999999987543211   1    234889999999999999999999888   9999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCCCccccccccCCCccCcccccccccc
Q 017411          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLK  370 (372)
Q Consensus       324 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE~~~~~  370 (372)
                      .++..+||+||||+|..-..+.........-...|||||+-.|.++.
T Consensus       637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT  683 (774)
T KOG1026|consen  637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT  683 (774)
T ss_pred             ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence            99999999999999976444332222222334689999998887664

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-28  Score=245.70  Aligned_cols=164  Identities=29%  Similarity=0.385  Sum_probs=144.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      -|+..+.||.|+||.||-+++..+.+.||||.+.-.   .....+.+++|+..|.+++|||+|.+.|++.- +...||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHH
Confidence            477788999999999999999999999999999743   44556789999999999999999999997654 66689999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||| -|+-.+++...+      .++.+..+..|+.+.+.||.|||+++   .||||||..|||+++.|.+||+|||.|..
T Consensus       106 EYC-lGSAsDlleVhk------KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHH-hccHHHHHHHHh------ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhh
Confidence            999 568889888765      46888889999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..+.      .+++|||.|||||+
T Consensus       176 ~~PA------nsFvGTPywMAPEV  193 (948)
T KOG0577|consen  176 MAPA------NSFVGTPYWMAPEV  193 (948)
T ss_pred             cCch------hcccCCccccchhH
Confidence            6533      45789999999876

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=3.8e-27  Score=221.26  Aligned_cols=171  Identities=20%  Similarity=0.308  Sum_probs=140.2

Q ss_pred             CCeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.++.. .......|.+|+.++.+++||||+++++++... ...++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcEE
Confidence            57899999999999999999864   34578999999765 334456789999999999999999999988764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||+|||..+   ++||||||+|||++.++.+|++|||++
T Consensus        84 v~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~  154 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE------GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL  154 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence            999999999999997642      46899999999999999999999877   999999999999999999999999987


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ........ .......++..|+|||.
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~  179 (266)
T cd05064         155 QEDKSEAI-YTTMSGKSPVLWAAPEA  179 (266)
T ss_pred             ccccccch-hcccCCCCceeecCHHH
Confidence            65432211 11122345567888764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=3.6e-27  Score=223.44  Aligned_cols=171  Identities=29%  Similarity=0.367  Sum_probs=138.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECC-CCeEEEEEEecCCC--hhhHHHHHHHHHHHHhC---CCCCeeceeeeEEc----C
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCID----P  251 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~----~  251 (372)
                      ++|+..+.||+|+||.||+|++.. .+..||+|.++...  ......+.+|+.+++.+   +||||++++++|..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368889999999999999999853 46889999986532  22334566788777765   69999999998852    2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      ...+++||||+. ++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEE
Confidence            345899999996 699999875432     45899999999999999999999887   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++......   ......||+.|+|||.-
T Consensus       152 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~  181 (290)
T cd07862         152 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVL  181 (290)
T ss_pred             ccccceEeccCCc---ccccccccccccChHHH
Confidence            9999998765432   23445789999998753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.7e-27  Score=229.56  Aligned_cols=162  Identities=27%  Similarity=0.312  Sum_probs=134.0

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC---CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      ||+|+||.||+|++..+++.||||++.+..   ......+..|..++..+   +||||+++++++.+. ...|+||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCC
Confidence            699999999999999889999999996532   22233455677777665   699999999987764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~g~L~~~l~~~-------~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          80 GGELFWHLQKE-------GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD  149 (330)
T ss_pred             CChHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC
Confidence            99999998754       46899999999999999999999887   999999999999999999999999999764332


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~gt~~y~aPE~~  168 (330)
T cd05586         150 NK--TTNTFCGTTEYLAPEVL  168 (330)
T ss_pred             CC--CccCccCCccccCHHHH
Confidence            22  23456799999998754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.95  E-value=4.3e-27  Score=225.80  Aligned_cols=169  Identities=28%  Similarity=0.416  Sum_probs=141.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|...+.||+|+||.||+|+...+++.||+|.++... ......+.+|++++++++||||+++++++... ...++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence            57999999999999999999998889999999987542 22334678899999999999999999988764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++ +|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  154 (309)
T cd07872          85 YLDK-DLKQYMDDCG------NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (309)
T ss_pred             CCCC-CHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceec
Confidence            9974 8888886542      45788999999999999999999877   999999999999999999999999999865


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......+|+.|+|||.
T Consensus       155 ~~~~~--~~~~~~~~~~y~aPE~  175 (309)
T cd07872         155 SVPTK--TYSNEVVTLWYRPPDV  175 (309)
T ss_pred             CCCcc--ccccccccccccCCHH
Confidence            44332  1223467888998774

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.95  E-value=3.2e-27  Score=228.29  Aligned_cols=164  Identities=25%  Similarity=0.322  Sum_probs=138.2

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||++.+..+++.||||++++.   .......+.+|.+++..+ +||||+++++++... ...++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCC
Confidence            4699999999999999988999999999754   233455678899999888 699999999987764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|..++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        80 ~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          80 GGDLMFHIQRS-------GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG  149 (318)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC
Confidence            99999998764       46899999999999999999999887   999999999999999999999999999764322


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       150 ~~--~~~~~~g~~~y~aPE~~  168 (318)
T cd05570         150 GV--TTSTFCGTPDYIAPEIL  168 (318)
T ss_pred             CC--cccceecCccccCHHHh
Confidence            21  22345789999997753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=2e-27  Score=238.50  Aligned_cols=169  Identities=30%  Similarity=0.390  Sum_probs=149.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ...|.+...||+|.|+.|.++++..++..||||.+++.  +....+.+.+|+++|..|+|||||+++.+... ...+|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeEEE
Confidence            46899999999999999999999999999999999875  34445568999999999999999999998655 5559999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+.+|.+++++...       ..+.+..+..++.|+..|++|||..+   |+|||||.+||||+.++++||+|||++.
T Consensus       134 ~eya~~ge~~~yl~~~-------gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH-------GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             EEeccCchhHHHHHhc-------ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence            9999999999999876       45666888899999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++....   ...+.+|++.|.|||.
T Consensus       204 ~~~~~~---~lqt~cgsppyAaPEl  225 (596)
T KOG0586|consen  204 FFDYGL---MLQTFCGSPPYAAPEL  225 (596)
T ss_pred             eecccc---cccccCCCCCccChHh
Confidence            987443   4567889999998765

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=3.8e-27  Score=235.70  Aligned_cols=182  Identities=29%  Similarity=0.364  Sum_probs=144.4

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEc
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLH-HPNIVPLVGFCID  250 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~  250 (372)
                      ....+.|.+++.||+|+||.||+|.+...     ...||||++... .....+.+.+|+++++++. ||||++++++|.+
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            34567899999999999999999986432     347999999754 3344567999999999996 9999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC----------------------------------------------------
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV----------------------------------------------------  278 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~----------------------------------------------------  278 (372)
                      . ...++||||+++|+|.++|.......                                                    
T Consensus       113 ~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         113 S-GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             C-CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            4 45899999999999999997642100                                                    


Q ss_pred             -------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          279 -------------------------------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       279 -------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                                                           .....+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence                                                 00134788899999999999999999877   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |++.++.+||+|||+++...............++..|+|||.
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~  310 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPES  310 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhh
Confidence            999999999999999987654332222233456777888764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=6.2e-27  Score=219.04  Aligned_cols=169  Identities=27%  Similarity=0.331  Sum_probs=144.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|++.+.||+|+||.||+|....+++.||+|++..........+.+|+.++++++||||+++++++... ...++|+||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e~   87 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICMEY   87 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEeC
Confidence            5799999999999999999999888999999999765444556788999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        88 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  157 (267)
T cd06646          88 CGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT  157 (267)
T ss_pred             CCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence            9999999998653       45889999999999999999999877   9999999999999999999999999998664


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......|+..|+|||.
T Consensus       158 ~~~~--~~~~~~~~~~y~~PE~  177 (267)
T cd06646         158 ATIA--KRKSFIGTPYWMAPEV  177 (267)
T ss_pred             cccc--ccCccccCccccCHhH
Confidence            3221  1123468888998774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.95  E-value=8.9e-27  Score=218.09  Aligned_cols=173  Identities=27%  Similarity=0.405  Sum_probs=143.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|+..+.||+|+||.||+|.+...   ...||||.++.. .......|.+|+.++++++||||+++++++.+. ...++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceEE
Confidence            5789999999999999999988543   458999998754 344456789999999999999999999987664 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~  153 (266)
T cd05033          83 ITEYMENGSLDKFLREND------GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchh
Confidence            999999999999997643      36899999999999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +...............++..|+|||..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~  180 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAI  180 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhh
Confidence            987633332222333456678887754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.95  E-value=4.7e-27  Score=229.56  Aligned_cols=180  Identities=26%  Similarity=0.371  Sum_probs=142.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~  253 (372)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||+++... ......+.+|+.++.++ +||||++++++|...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45799999999999999999974     2356789999997542 33456788999999999 68999999998877666


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCC-------------------------------------------------------
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGV-------------------------------------------------------  278 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~-------------------------------------------------------  278 (372)
                      ..++||||+++|+|.+++.......                                                       
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6899999999999999997532100                                                       


Q ss_pred             -----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccc
Q 017411          279 -----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVK  353 (372)
Q Consensus       279 -----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~  353 (372)
                           .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                 00124788899999999999999999877   9999999999999999999999999998764332211222334


Q ss_pred             cCCCccCccc
Q 017411          354 GTFGQNPFCI  363 (372)
Q Consensus       354 GT~gy~apea  363 (372)
                      +++.|+|||.
T Consensus       243 ~~~~y~aPE~  252 (343)
T cd05103         243 LPLKWMAPET  252 (343)
T ss_pred             CCcceECcHH
Confidence            5667888664

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.95  E-value=3.3e-27  Score=230.47  Aligned_cols=181  Identities=27%  Similarity=0.359  Sum_probs=144.4

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~  252 (372)
                      ..++|++.+.||+|+||.||+|....     +++.||+|+++.. .....+.+.+|+.++.++ +|+||++++++|...+
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            34578999999999999999997533     3578999998754 233456788999999999 8999999999988777


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCC------------------------------------------------------
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGV------------------------------------------------------  278 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~------------------------------------------------------  278 (372)
                      ..++++|||+++++|.+++.......                                                      
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            77899999999999999997532110                                                      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCc
Q 017411          279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQ  358 (372)
Q Consensus       279 ~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy  358 (372)
                      .....++|..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence            00136899999999999999999999877   999999999999999999999999999876443322222344566778


Q ss_pred             cCccc
Q 017411          359 NPFCI  363 (372)
Q Consensus       359 ~apea  363 (372)
                      +|||.
T Consensus       242 ~aPE~  246 (337)
T cd05054         242 MAPES  246 (337)
T ss_pred             cCcHH
Confidence            88663

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=6.2e-27  Score=220.63  Aligned_cols=181  Identities=20%  Similarity=0.247  Sum_probs=143.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .+++|+..+.||+|+||.||+|.+..     ++..||||.+... .......+.+|+.+++.++||||+++++++.+. .
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-Q   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-C
Confidence            45789999999999999999998642     3567999998653 234456789999999999999999999988654 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVR---GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                      ..++||||+++++|.+++........   ....+++..++.++.|++.||.|||..+   ++||||||+||+++.++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            58999999999999999976432111   1135688899999999999999999877   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+++...............+++.|+|||.-
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESL  193 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHh
Confidence            9999999866443322222233456788887753

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=5.3e-28  Score=243.06  Aligned_cols=168  Identities=26%  Similarity=0.329  Sum_probs=146.4

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEecC----CChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-eEEEEEe
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK----EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIYK  260 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~----~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-~~~lV~E  260 (372)
                      ...+||+|+|-+||+|.+..+|.+||--.++.    ..+...++|..|+++|+.|+|||||+++.++.+... .+-+|.|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            34689999999999999998899988765543    356667899999999999999999999999987654 3679999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DFGla~~  339 (372)
                      .+..|+|..++.+.       ..++......|++||++||.|||++. |||||||||.+||+|+.+ |.+||+|+|||+.
T Consensus       124 L~TSGtLr~Y~kk~-------~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  124 LFTSGTLREYRKKH-------RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             cccCCcHHHHHHHh-------ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999999999987       45888899999999999999999986 789999999999999865 8999999999998


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ......    ..+.|||.+||||.-|
T Consensus       196 ~r~s~a----ksvIGTPEFMAPEmYE  217 (632)
T KOG0584|consen  196 LRKSHA----KSVIGTPEFMAPEMYE  217 (632)
T ss_pred             hhcccc----ceeccCccccChHHHh
Confidence            876643    4589999999977655

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=8.5e-27  Score=228.82  Aligned_cols=168  Identities=24%  Similarity=0.346  Sum_probs=140.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----C
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~  253 (372)
                      .++|+..+.||+|+||.||++.+..++..||||.+...  .......+.+|+.+++.++||||+++++++....     .
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            46899999999999999999999888999999999653  3445567889999999999999999999875432     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..|+||||+.+ +|.+.+.         ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       100 ~~~lv~e~~~~-~l~~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~D  166 (359)
T cd07876         100 DVYLVMELMDA-NLCQVIH---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  166 (359)
T ss_pred             eeEEEEeCCCc-CHHHHHh---------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEec
Confidence            47899999965 6766664         24788888999999999999999887   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++......   ......||+.|+|||.-
T Consensus       167 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~  194 (359)
T cd07876         167 FGLARTACTNF---MMTPYVVTRYYRAPEVI  194 (359)
T ss_pred             CCCccccccCc---cCCCCcccCCCCCchhc
Confidence            99998654322   22345789999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.95  E-value=6e-27  Score=231.15  Aligned_cols=169  Identities=24%  Similarity=0.341  Sum_probs=141.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----CeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~~~  256 (372)
                      +|+..+.||+|+||.||++.+..+++.||||.+...  .....+.+.+|+++++.++||||+++++++....    ...|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999888999999998653  3345567889999999999999999999887644    2579


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+. ++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        81 lv~e~~~-~~l~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-------QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccc
Confidence            9999996 5888887543       46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++........ ......+|..|+|||.
T Consensus       150 a~~~~~~~~~-~~~~~~~~~~y~aPE~  175 (372)
T cd07853         150 ARVEEPDESK-HMTQEVVTQYYRAPEI  175 (372)
T ss_pred             eeecccCccc-cCCCCCcCCCcCCHHH
Confidence            9876433221 2233467888998774

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.95  E-value=1.5e-26  Score=219.69  Aligned_cols=168  Identities=26%  Similarity=0.292  Sum_probs=141.7

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      |+..+.||+|+||.||++.+..+++.||+|.+....   ......+.+|++++++++|+||+.+.+.+.. +...++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEE
Confidence            667789999999999999998889999999987542   2234457889999999999999999988766 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          81 IMNGGDLKFHIYNMGN-----PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             eccCccHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            9999999998875432     46899999999999999999999877   999999999999999999999999999765


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....   .....|+..|+|||.
T Consensus       153 ~~~~~---~~~~~g~~~~~aPE~  172 (285)
T cd05632         153 PEGES---IRGRVGTVGYMAPEV  172 (285)
T ss_pred             CCCCc---ccCCCCCcCccChHH
Confidence            43321   234568889998775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.95  E-value=1.5e-26  Score=222.21  Aligned_cols=168  Identities=26%  Similarity=0.349  Sum_probs=144.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++++++||||+++++++.+ +...++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence            4789999999999999999999888999999998754 33445678899999999999999999998876 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||++..
T Consensus        80 y~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (308)
T cd06615          80 HMDGGSLDQVLKKA-------GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  149 (308)
T ss_pred             ccCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccc
Confidence            99999999999764       458899999999999999999997 35   99999999999999999999999999876


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....    .....|+..|+|||.-
T Consensus       150 ~~~~~----~~~~~~~~~~~aPE~~  170 (308)
T cd06615         150 LIDSM----ANSFVGTRSYMSPERL  170 (308)
T ss_pred             ccccc----cccCCCCcCccChhHh
Confidence            54332    2345688889987753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-27  Score=245.05  Aligned_cols=183  Identities=26%  Similarity=0.319  Sum_probs=149.4

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEE-c--CC---
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCI-D--PE---  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~-~--~~---  252 (372)
                      ...+.++.++|.+|||+.||.|++...+..||+|++-..+....+.+.+||++|++|+ |+|||.+++... .  .+   
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            4567888999999999999999998877999999998888889999999999999997 999999999322 1  11   


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      -.++|.||||.+|.|-+++..+..     ..|++.++++|+.|+++|+.+||... ++|||||||-|||||+.++..|||
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq-----~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQ-----TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHh-----ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeC
Confidence            136799999999999999987654     45999999999999999999999886 779999999999999999999999


Q ss_pred             ecccccccCCCC-CCccc------cccccCCCccCcccccccc
Q 017411          333 DFGLATWTSAPS-VPFLC------KTVKGTFGQNPFCIEEWQR  368 (372)
Q Consensus       333 DFGla~~~~~~~-~~~~~------~~~~GT~gy~apeaPE~~~  368 (372)
                      |||-|.-....- .....      -...-|+.|.+||.-..|+
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys  231 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS  231 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc
Confidence            999986543221 11100      0123567788877666554

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=1.4e-26  Score=218.86  Aligned_cols=173  Identities=27%  Similarity=0.333  Sum_probs=141.9

Q ss_pred             CCeeeceeEcccCceEEEEEEE----CCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~  256 (372)
                      .+|+..+.||+|+||.||++..    ..++..||+|.+........+.+.+|++++++++||||+++++++...+ ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            5788899999999999999974    3457899999998776667788999999999999999999999876433 3478


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+++++|.+++....      ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~  154 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKHR------ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGL  154 (284)
T ss_pred             EEEEecCCCCHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcc
Confidence            9999999999999997542      35899999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccc-cccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLC-KTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~-~~~~GT~gy~apea  363 (372)
                      ++........... ....++..|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  182 (284)
T cd05081         155 TKVLPQDKEYYKVREPGESPIFWYAPES  182 (284)
T ss_pred             cccccCCCcceeecCCCCCceEeeCHHH
Confidence            9877543322111 11123344777654

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=1.5e-26  Score=219.91  Aligned_cols=170  Identities=25%  Similarity=0.304  Sum_probs=142.3

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .|+..+.||+|+||.||++....+++.||+|.+.+..   ......+.+|+.++++++|++|+.+++.+.+. ...++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEE
Confidence            3677789999999999999999999999999986532   23345678899999999999999999988764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..
T Consensus        80 e~~~g~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~  151 (285)
T cd05630          80 TLMNGGDLKFHIYHMGE-----AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVH  151 (285)
T ss_pred             EecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceee
Confidence            99999999999865432     45899999999999999999999877   99999999999999999999999999976


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   .....||..|+|||+-
T Consensus       152 ~~~~~~---~~~~~g~~~y~aPE~~  173 (285)
T cd05630         152 VPEGQT---IKGRVGTVGYMAPEVV  173 (285)
T ss_pred             cCCCcc---ccCCCCCccccChHHH
Confidence            543322   1234688899987753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.95  E-value=1.3e-26  Score=219.22  Aligned_cols=162  Identities=28%  Similarity=0.300  Sum_probs=135.5

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||+|+||.||++....+++.||+|.+....   ....+.+..|++++++++||||+++++++.+ +...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            699999999999999889999999986532   1223456679999999999999999998766 455899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus        80 L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~-  150 (277)
T cd05607          80 LKYHIYNVGE-----RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-  150 (277)
T ss_pred             HHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce-
Confidence            9998865432     45889999999999999999999877   99999999999999999999999999987654321 


Q ss_pred             ccccccccCCCccCccc
Q 017411          347 FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       347 ~~~~~~~GT~gy~apea  363 (372)
                        .....|+..|+|||+
T Consensus       151 --~~~~~~~~~y~aPE~  165 (277)
T cd05607         151 --ITQRAGTNGYMAPEI  165 (277)
T ss_pred             --eeccCCCCCccCHHH
Confidence              233468888998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=1.1e-26  Score=215.42  Aligned_cols=144  Identities=27%  Similarity=0.494  Sum_probs=127.6

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      +.||+|+||.||+|.+..+++.||+|.+... .......+.+|++++++++||||++++++|.... ..++||||+++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC-CeEEEEeeccCCc
Confidence            3699999999999999888999999988654 3445567999999999999999999999987654 5899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        80 L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  145 (252)
T cd05084          80 FLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE  145 (252)
T ss_pred             HHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence            999997532      45889999999999999999999877   9999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=6.3e-27  Score=218.98  Aligned_cols=170  Identities=27%  Similarity=0.330  Sum_probs=146.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||+|....+++.||+|.++.........+.+|+.+++.++||||+++++++... ...++|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEec
Confidence            4788889999999999999999888999999999876555556788999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++....
T Consensus        88 ~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd06645          88 CGGGSLQDIYHVT-------GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT  157 (267)
T ss_pred             cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence            9999999998754       46899999999999999999999887   9999999999999999999999999987664


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  ......|+..|+|||.-
T Consensus       158 ~~~~--~~~~~~~~~~y~aPE~~  178 (267)
T cd06645         158 ATIA--KRKSFIGTPYWMAPEVA  178 (267)
T ss_pred             Cccc--ccccccCcccccChhhh
Confidence            3221  12345688999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.95  E-value=1.2e-26  Score=219.27  Aligned_cols=183  Identities=22%  Similarity=0.286  Sum_probs=150.6

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      +.++++..+.++|+..+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445666778899999999999999999999998889999999886532 2235678899999999 69999999998753


Q ss_pred             ----CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          251 ----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       251 ----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                          .+...++||||+++++|.+++......   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~  160 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKR---GERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTE  160 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhcc---CccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCC
Confidence                234589999999999999988653211   146889999999999999999999877   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.+||+|||+++.......  ......|++.|+|||.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  195 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEV  195 (286)
T ss_pred             CCEEEccCCceeecccCCC--ccccccCCCcccChhh
Confidence            9999999999987653322  2234568999999774

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.95  E-value=1.2e-26  Score=218.80  Aligned_cols=173  Identities=25%  Similarity=0.343  Sum_probs=142.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCe----EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .++|+..+.||+|+||.||+|.+..++.    .||+|.+... .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--Cc
Confidence            4589999999999999999998765554    4899998754 344566789999999999999999999998753  36


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++++||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG  154 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK------DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFG  154 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCC
Confidence            79999999999999997642      46899999999999999999999887   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++...............+++.|+|||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (279)
T cd05109         155 LARLLDIDETEYHADGGKVPIKWMALESI  183 (279)
T ss_pred             ceeecccccceeecCCCccchhhCCHHHh
Confidence            99877544332222223446678887754

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=8.3e-27  Score=237.07  Aligned_cols=167  Identities=22%  Similarity=0.237  Sum_probs=140.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ...|.+.+.||+|+||.||++.+..+++.||||....      ..+.+|+++|++++|+|||++++++... ...++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~-~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVG-GLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEE
Confidence            4589999999999999999999998899999996432      3457899999999999999999988764 45889999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      ++. ++|..++....      ..++|..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus       241 ~~~-~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~  310 (461)
T PHA03211        241 KYR-SDLYTYLGARL------RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFA  310 (461)
T ss_pred             ccC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceec
Confidence            994 78988886542      46899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .............||+.|+|||.-
T Consensus       311 ~~~~~~~~~~~~~GT~~Y~APE~~  334 (461)
T PHA03211        311 RGSWSTPFHYGIAGTVDTNAPEVL  334 (461)
T ss_pred             ccccccccccccCCCcCCcCHHHH
Confidence            543322222345789999997753

>PHA02988 hypothetical protein; Provisional

Probab=99.95  E-value=1.1e-26  Score=221.10  Aligned_cols=174  Identities=17%  Similarity=0.222  Sum_probs=141.0

Q ss_pred             cccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeecee
Q 017411          169 LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLV  245 (372)
Q Consensus       169 ~~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~  245 (372)
                      +..+++.+|     +......||+|++|.||+|...  ++.||||+++....   ...+.|.+|+.+|++++||||++++
T Consensus        12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             ceecCHHHc-----CCCCCeEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            344455555     2222368999999999999984  78999999976432   2256788999999999999999999


Q ss_pred             eeEEc--C-CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCE
Q 017411          246 GFCID--P-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNI  321 (372)
Q Consensus       246 g~~~~--~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NI  321 (372)
                      +++.+  . ....++||||+++|+|.+++...       ..+++.....++.|++.||.|||.. +   ++||||||+||
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~ni  154 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-------KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSF  154 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-------CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhE
Confidence            98865  2 23578999999999999999764       4688999999999999999999974 5   78999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |++.++.+||+|||+++....+.     ....||..|+|||.-
T Consensus       155 ll~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~  192 (283)
T PHA02988        155 LVTENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKML  192 (283)
T ss_pred             EECCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHh
Confidence            99999999999999998765432     234578888887754

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.95  E-value=1.3e-26  Score=219.33  Aligned_cols=172  Identities=26%  Similarity=0.368  Sum_probs=141.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|+..+.||+|+||.||+|.+..++.    .|++|.+.... .....++..|+.++++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccE
Confidence            478888999999999999999866555    47788775432 3344677888889999999999999998753  3368


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +++||+++|+|.+++....      ..+++..+..++.||+.||.|||+.+   ++||||||+|||++.++.+||+|||+
T Consensus        85 ~i~e~~~~gsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~  155 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHR------DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGV  155 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCcc
Confidence            9999999999999997643      46899999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++...............++..|+|||.-
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~  183 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESI  183 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHh
Confidence            9876544333333455677788887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=1.7e-26  Score=219.23  Aligned_cols=179  Identities=26%  Similarity=0.374  Sum_probs=145.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .++|.+.+.||+|+||.||++...     .++..+|+|.+........+.+.+|++++++++||||+++++++... ...
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-Ccc
Confidence            358899999999999999999852     34567999999876666677899999999999999999999998764 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccC------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKG------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                      ++||||+++++|.+++......      ......+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence            9999999999999999754310      011135899999999999999999999877   9999999999999999999


Q ss_pred             EEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|||+++...............++..|+|||.
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  193 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  193 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHH
Confidence            9999999987644332222333445677888664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-28  Score=227.54  Aligned_cols=173  Identities=26%  Similarity=0.282  Sum_probs=149.4

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..++|...++||+|.||+|.+++.+.+++.+|||++++.-   ......-+.|-++|+..+||.+..|.-.| +...++|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-Qt~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-QTQDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-ccCceEE
Confidence            4568999999999999999999999999999999998762   33344456789999999999998886554 4566799


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||..||.|.-+|.+.       ..+++.....+...|..||.|||+.+   ||.||||.+|+|+|.+|++||+||||
T Consensus       245 FVMeyanGGeLf~HLsre-------r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGL  314 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRE-------RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGL  314 (516)
T ss_pred             EEEEEccCceEeeehhhh-------hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeeccc
Confidence            999999999999999876       56888888889999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ++.--....  ...+.+|||.|+|||+-|
T Consensus       315 CKE~I~~g~--t~kTFCGTPEYLAPEVle  341 (516)
T KOG0690|consen  315 CKEEIKYGD--TTKTFCGTPEYLAPEVLE  341 (516)
T ss_pred             chhcccccc--eeccccCChhhcCchhhc
Confidence            986432222  457889999999999887

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.94  E-value=1.1e-26  Score=215.57  Aligned_cols=167  Identities=34%  Similarity=0.473  Sum_probs=142.7

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHH--HHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK--AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~--~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      |+..+.||+|+||+||++....+++.||+|.+.........  ...+|+.++++++||||+++++++.+ ....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            67889999999999999999999999999999876543332  34569999999999999999999877 5558999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++...       ..+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.++|+|||++....
T Consensus        80 ~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   80 CPGGSLQDYLQKN-------KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS  149 (260)
T ss_dssp             ETTEBHHHHHHHH-------SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST
T ss_pred             ccccccccccccc-------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc
Confidence            9999999999843       46899999999999999999999987   9999999999999999999999999998652


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......++..|+|||.
T Consensus       150 ~~~~--~~~~~~~~~~y~aPE~  169 (260)
T PF00069_consen  150 ENNE--NFNPFVGTPEYMAPEV  169 (260)
T ss_dssp             STTS--EBSSSSSSGGGSCHHH
T ss_pred             cccc--cccccccccccccccc
Confidence            2221  3345678888988665

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=1.5e-26  Score=218.60  Aligned_cols=179  Identities=25%  Similarity=0.303  Sum_probs=142.8

Q ss_pred             CCeeeceeEcccCceEEEEEEEC----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|+..+.||+|+||.||+|...    ..+..||+|.+... .......+.+|++++++++||||+++++++... ...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceE
Confidence            47888899999999999999852    34578999999753 344456789999999999999999999987764 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          257 LIYKYVSGGSLERHLHEKKKGV----------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      +||||+++++|.+++.......          .....+++...+.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            9999999999999996432100          01135789999999999999999999877   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.+||+|||+++...............++..|+|||.-
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAI  198 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHh
Confidence            99999999999876544332223344566778887643

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=1.3e-26  Score=217.24  Aligned_cols=170  Identities=21%  Similarity=0.291  Sum_probs=132.9

Q ss_pred             eeEcccCceEEEEEEECC--CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVGL--LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.||+|+||.||+|....  ....+|+|.+... .......+.+|+++++.++||||+++++.+.+.. ..++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~-~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESI-PYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCC-ceEEEEEeCCC
Confidence            358999999999997532  3457899987654 3344567889999999999999999999887654 48999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |+|.+++.......  ....++.....++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          80 GDLKNYLRSNRGMV--AQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPED  154 (269)
T ss_pred             CcHHHHHHhccccc--cccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccch
Confidence            99999997753211  134567888899999999999999887   9999999999999999999999999987643322


Q ss_pred             CCccccccccCCCccCccc
Q 017411          345 VPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apea  363 (372)
                      .........++..|+|||.
T Consensus       155 ~~~~~~~~~~~~~y~aPE~  173 (269)
T cd05042         155 YYITKDCHAVPLRWLAPEL  173 (269)
T ss_pred             heeccCCCCCcccccCHHH
Confidence            1111223345667888665

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=1.8e-26  Score=247.26  Aligned_cols=178  Identities=24%  Similarity=0.351  Sum_probs=145.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...   .....+.|.+|++++++++||||+++++++.+. +..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEE
Confidence            4799999999999999999999888999999999753   234456799999999999999999999988764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          259 YKYVSGGSLERHLHEKKKGV----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      |||+++|+|.+++.......    .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDF  157 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW  157 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEec
Confidence            99999999999997532110    01134677888999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCC----------------CccccccccCCCccCccc
Q 017411          335 GLATWTSAPSV----------------PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~----------------~~~~~~~~GT~gy~apea  363 (372)
                      |+++.......                ........||+.|+|||.
T Consensus       158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~  202 (932)
T PRK13184        158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER  202 (932)
T ss_pred             CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHH
Confidence            99987621110                001123569999999775

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=2.5e-26  Score=215.27  Aligned_cols=175  Identities=26%  Similarity=0.337  Sum_probs=146.0

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|++++++++|+||+++++++... ...+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~   81 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFK   81 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEE
Confidence            344566777778999999999999999888899999999877666777899999999999999999999988764 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEe
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTL--PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCD  333 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~D  333 (372)
                      +|+||+++++|.+++....      ..+  ++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|
T Consensus        82 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~d  152 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW------GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISD  152 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc------ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEec
Confidence            9999999999999997642      234  78888899999999999999877   999999999999986 67999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||++........  ......|+..|+|||.
T Consensus       153 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~  180 (268)
T cd06624         153 FGTSKRLAGINP--CTETFTGTLQYMAPEV  180 (268)
T ss_pred             chhheecccCCC--ccccCCCCccccChhh
Confidence            999976643222  1223457888888764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.1e-26  Score=216.33  Aligned_cols=179  Identities=20%  Similarity=0.257  Sum_probs=144.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++|.+.+.||+|+||.||+|.....     +..||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CC
Confidence            35889999999999999999987543     478999998754 334456788999999999999999999998765 45


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGV---RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      .++||||+++|+|.+++.......   .....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            899999999999999997643211   11235789999999999999999999877   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|||+++...............++..|+|||.
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHH
Confidence            99999987654432222233456778888764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=233.98  Aligned_cols=169  Identities=23%  Similarity=0.374  Sum_probs=136.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-------CC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------EQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-------~~  253 (372)
                      ..+|+..+.||+|+||.||+|....+++.||||++....    ....+|+.+|+.++||||+++++++...       ..
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            458999999999999999999998889999999886532    2345799999999999999998876432       12


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLC  332 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~  332 (372)
                      .+++||||+++ +|.+++.....   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++ .+||+
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~---~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYAR---NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence            36789999974 78777754321   1156899999999999999999999887   99999999999999665 79999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+|+.+.....   .....||+.|+|||.
T Consensus       214 DFGla~~~~~~~~---~~~~~~t~~y~aPE~  241 (440)
T PTZ00036        214 DFGSAKNLLAGQR---SVSYICSRFYRAPEL  241 (440)
T ss_pred             ccccchhccCCCC---cccCCCCcCccCHHH
Confidence            9999987654332   234568899999774

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.94  E-value=2e-26  Score=217.35  Aligned_cols=178  Identities=29%  Similarity=0.374  Sum_probs=143.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCC-----eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+... .......|.+|+.++.+++||||+++++++.+. ...
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-Cce
Confidence            37888899999999999999875444     67999998754 344456789999999999999999999988764 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVR---------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      +++|||+++++|.+++........         ....+++..++.++.|++.||.|||..+   |+||||||+||+++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            999999999999999976422110         1145788999999999999999999887   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.+||+|||+++...............+++.|+|||.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEA  197 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHH
Confidence            9999999999987644332222333456778888663

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.94  E-value=1e-28  Score=229.74  Aligned_cols=170  Identities=25%  Similarity=0.314  Sum_probs=150.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +-|.+..+||+|+||.||++.++.+|+.||||.+...  ...+++.+|+.+|++++.|++|++||.++...+ +|+||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhh
Confidence            3578889999999999999999999999999999764  345789999999999999999999998876444 9999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |..|++.+.++.++      .+|.+..+..+.+.-++||+|||...   -||||||..|||++.+|.+||+|||+|-.+.
T Consensus       110 CGAGSiSDI~R~R~------K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLT  180 (502)
T KOG0574|consen  110 CGAGSISDIMRARR------KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLT  180 (502)
T ss_pred             cCCCcHHHHHHHhc------CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhh
Confidence            99999999998765      57999999999999999999999876   7999999999999999999999999998775


Q ss_pred             CCCCCccccccccCCCccCccccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ....  ...++.||+-|||||+-|
T Consensus       181 DTMA--KRNTVIGTPFWMAPEVI~  202 (502)
T KOG0574|consen  181 DTMA--KRNTVIGTPFWMAPEVIE  202 (502)
T ss_pred             hhHH--hhCccccCcccccHHHHH
Confidence            4332  235788999999999876

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.94  E-value=1.3e-26  Score=227.01  Aligned_cols=169  Identities=24%  Similarity=0.346  Sum_probs=141.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----  252 (372)
                      ..++|+..+.||+|+||.||++.+..+++.||||.+...  .....+.+.+|+.+++.++||||+++++++....     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457999999999999999999999888999999999753  3444567889999999999999999999875432     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++||||+++ +|.+.+..         .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~  161 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  161 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEe
Confidence            236899999964 67776642         4788889999999999999999887   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++......   ......||..|+|||.-
T Consensus       162 Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~  190 (355)
T cd07874         162 DFGLARTAGTSF---MMTPYVVTRYYRAPEVI  190 (355)
T ss_pred             eCcccccCCCcc---ccCCccccCCccCHHHH
Confidence            999998764332   22345789999997754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.94  E-value=3.5e-26  Score=211.89  Aligned_cols=170  Identities=23%  Similarity=0.327  Sum_probs=145.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||++....+++.|++|.+...  .......+.+|++++++++||||+++++++.+. ...++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEE
Confidence            577889999999999999999888999999998643  345567889999999999999999999988764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~  151 (256)
T cd08529          80 YAENGDLHKLLKMQRG-----RPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLL  151 (256)
T ss_pred             eCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceec
Confidence            9999999999986422     46899999999999999999999877   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|++.|+|||.
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~  172 (256)
T cd08529         152 SDNTN--FANTIVGTPYYLSPEL  172 (256)
T ss_pred             cCccc--hhhccccCccccCHHH
Confidence            54432  1234567888888664

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=1.3e-26  Score=225.71  Aligned_cols=168  Identities=21%  Similarity=0.300  Sum_probs=141.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----  252 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||.+....  ....+.+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999998889999999987542  234456789999999999999999998775322     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++++|++ +++|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC--------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEc
Confidence            2368999988 7899888753        35899999999999999999999887   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++......     ....||..|+|||..
T Consensus       161 Dfg~~~~~~~~~-----~~~~~t~~y~aPE~~  187 (343)
T cd07878         161 DFGLARQADDEM-----TGYVATRWYRAPEIM  187 (343)
T ss_pred             CCccceecCCCc-----CCccccccccCchHh
Confidence            999998765332     334688999998764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.94  E-value=3.3e-26  Score=217.52  Aligned_cols=167  Identities=31%  Similarity=0.381  Sum_probs=145.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.+.   .....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEE
Confidence            4789999999999999999999888999999998753   233456788999999999999999999988764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||+++
T Consensus        80 ~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~  149 (290)
T cd05580          80 MEYVPGGELFSHLRKS-------GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAK  149 (290)
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCcc
Confidence            9999999999999764       46889999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....     .....|++.|+|||.-
T Consensus       150 ~~~~~-----~~~~~~~~~y~aPE~~  170 (290)
T cd05580         150 RVKGR-----TYTLCGTPEYLAPEII  170 (290)
T ss_pred             ccCCC-----CCCCCCCccccChhhh
Confidence            76544     2345688999998754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.94  E-value=4.6e-26  Score=211.42  Aligned_cols=172  Identities=27%  Similarity=0.342  Sum_probs=145.8

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||++....+++.||+|.+...  .....+.+.+|++++++++|||++++++.+...+...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            478899999999999999999888899999998653  334456788999999999999999999877655556789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++.+++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~~l~~~l~~~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          81 FCEGGDLYHKLKEQKG-----KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             ccCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            9999999999976432     46899999999999999999999887   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....  ......|++.|+|||.-
T Consensus       153 ~~~~~--~~~~~~~~~~y~aPE~~  174 (257)
T cd08223         153 ENQCD--MASTLIGTPYYMSPELF  174 (257)
T ss_pred             cccCC--ccccccCCcCccChhHh
Confidence            54332  22345688899997753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=232.86  Aligned_cols=172  Identities=26%  Similarity=0.304  Sum_probs=147.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+.|...++||+|+||.||-++.+.+|+.+|+|.+.+..   .+....-++|-.+|.+++.+.||.+--.+.. ...++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEE
Confidence            457888899999999999999999999999999987642   2333456789999999999999998766555 455999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |+..|.||+|.-+|.....     ..+++..++.++.+|+.||++||...   ||.|||||+|||||+.|+++|+|+|||
T Consensus       263 VLtlMNGGDLkfHiyn~g~-----~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLA  334 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-----PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLA  334 (591)
T ss_pred             EEEeecCCceeEEeeccCC-----CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceE
Confidence            9999999999999987643     57999999999999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..+.....   ....+||.||||||+-
T Consensus       335 vei~~g~~---~~~rvGT~GYMAPEvl  358 (591)
T KOG0986|consen  335 VEIPEGKP---IRGRVGTVGYMAPEVL  358 (591)
T ss_pred             EecCCCCc---cccccCcccccCHHHH
Confidence            98876553   2334899999999864

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.94  E-value=3.1e-26  Score=216.43  Aligned_cols=168  Identities=26%  Similarity=0.340  Sum_probs=144.7

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      |++.+.||+|+||.||++....++..+++|.+........+.+.+|+++++.++||||+++++++... ...++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecC
Confidence            56678899999999999999988999999999876666677899999999999999999999988764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +++|..++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        86 ~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~  156 (282)
T cd06643          86 GGAVDAVMLELE------RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  156 (282)
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccc
Confidence            999999886532      46899999999999999999999877   999999999999999999999999998765432


Q ss_pred             CCCccccccccCCCccCccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apea  363 (372)
                      ..  ......|+..|+|||.
T Consensus       157 ~~--~~~~~~~~~~y~aPE~  174 (282)
T cd06643         157 IQ--RRDSFIGTPYWMAPEV  174 (282)
T ss_pred             cc--ccccccccccccCHhh
Confidence            21  1234568889999774

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-26  Score=218.61  Aligned_cols=171  Identities=28%  Similarity=0.327  Sum_probs=148.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|++.+.||+|+||.||++....++..||+|.+........+.+.+|++++++++||||+++++++.+ +...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEee
Confidence            4578899999999999999999988889999999987766677789999999999999999999999876 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~~~~~L~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~  153 (280)
T cd06611          83 FCDGGALDSIMLELE------RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN  153 (280)
T ss_pred             ccCCCcHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhh
Confidence            999999999987643      46899999999999999999999887   999999999999999999999999998765


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|++.|++||.
T Consensus       154 ~~~~~--~~~~~~~~~~y~~PE~  174 (280)
T cd06611         154 KSTLQ--KRDTFIGTPYWMAPEV  174 (280)
T ss_pred             ccccc--ccceeecchhhcCHHH
Confidence            43322  1234568888998775

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.94  E-value=4.1e-26  Score=213.44  Aligned_cols=173  Identities=29%  Similarity=0.354  Sum_probs=143.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~  255 (372)
                      ++|+..+.||+|+||.||++....++..||||.+...     .....+.+.+|+.++++++||||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5899999999999999999999888999999988532     1234567889999999999999999999876543 457


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-------GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCc
Confidence            8999999999999998754       35788889999999999999999887   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      +++......... ......|+..|+|||.-
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  181 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVI  181 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhh
Confidence            998664322111 12234688888887753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.94  E-value=2.4e-26  Score=214.84  Aligned_cols=173  Identities=25%  Similarity=0.416  Sum_probs=144.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|+...+++.||||.++..   .......+.+|+++++.++||||+++++++.+.+ ..++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN-ELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC-eEEEE
Confidence            4789999999999999999999888999999987642   3444567899999999999999999999887644 58999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      +||+++++|.+++......   ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~  154 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQ---KRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCcHHHHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccce
Confidence            9999999999998653221   145788999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......|++.|+|||.
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~  177 (267)
T cd08228         155 FFSSKTT--AAHSLVGTPYYMSPER  177 (267)
T ss_pred             eccchhH--HHhcCCCCccccChhh
Confidence            7654322  1233467888888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.94  E-value=1.2e-26  Score=217.42  Aligned_cols=173  Identities=25%  Similarity=0.329  Sum_probs=145.4

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC-----CC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP-----EQ  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~-----~~  253 (372)
                      ++..|+..+.||+|+||.||+|....+++.||+|.+.... .....+.+|+.++.++ +||||+++++++...     ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            5567888899999999999999998889999999987543 3345788999999998 699999999998653     23


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEcc
Confidence            47899999999999999976432     46899999999999999999999877   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++.......  ......|+..|+|||.
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~  182 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEV  182 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhH
Confidence            999986643221  2244578889999774

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.94  E-value=2.3e-26  Score=218.30  Aligned_cols=179  Identities=24%  Similarity=0.332  Sum_probs=145.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC----------------eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeec
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR----------------TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVP  243 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~----------------~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~  243 (372)
                      ..+|.+.+.||+|+||.||++.....+                ..||+|.+... .....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357889999999999999998875432                56899998765 3445678999999999999999999


Q ss_pred             eeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCC
Q 017411          244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (372)
Q Consensus       244 l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~  319 (372)
                      +++++... ...++|+||+++++|.+++.......    .....+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus        84 ~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~  159 (296)
T cd05051          84 LLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATR  159 (296)
T ss_pred             EEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchh
Confidence            99988764 45899999999999999997653110    01136899999999999999999999877   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++.++.++|+|||+++...............++..|+|||.
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  203 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWES  203 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHH
Confidence            99999999999999999987654433223344556778888764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=4.2e-26  Score=212.44  Aligned_cols=171  Identities=31%  Similarity=0.384  Sum_probs=143.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|...+.||+|+||.||++....+++.||+|.+....     ....+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDE-TLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCC-eEE
Confidence            57899999999999999999998889999999986432     223456889999999999999999999987654 689


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.++|+|||+
T Consensus        81 ~v~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~  150 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAY-------GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA  150 (263)
T ss_pred             EEEEECCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            999999999999999764       45888999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCcc-ccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFL-CKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~-~~~~~GT~gy~apea  363 (372)
                      ++.......... .....|+..|+|||.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  178 (263)
T cd06625         151 SKRLQTICSSGTGMKSVTGTPYWMSPEV  178 (263)
T ss_pred             ceeccccccccccccCCCcCccccCcce
Confidence            976543221111 123457788888765

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.94  E-value=4.1e-26  Score=216.87  Aligned_cols=171  Identities=24%  Similarity=0.315  Sum_probs=147.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .+.|++.+.||+|+||.||+|++..+++.|++|.+........+.+.+|+.++++++||||+++++.+... ...++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-GKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-CeEEEEEe
Confidence            35788999999999999999999888999999999877777778899999999999999999999987764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|..++....      ..+++..+..++.|++.+|.|||..+   |+||||||+||+++.++.+||+|||++...
T Consensus        90 ~~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          90 FCPGGAVDAIMLELD------RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             cCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence            999999998886543      45899999999999999999999877   999999999999999999999999998764


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......++..|+|||.
T Consensus       161 ~~~~~--~~~~~~~~~~y~aPE~  181 (292)
T cd06644         161 VKTLQ--RRDSFIGTPYWMAPEV  181 (292)
T ss_pred             ccccc--ccceecCCccccCcee
Confidence            33221  2234567888888774

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.6e-26  Score=227.30  Aligned_cols=165  Identities=21%  Similarity=0.269  Sum_probs=139.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ...+|.+.+.||+|+||.||+|....++..||+|.....      ....|+.++++++||||+++++++.... ..++|+
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGA-ITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCC-eeEEEE
Confidence            345899999999999999999999888899999986543      2356999999999999999999987754 478999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+. ++|.+++....      ..+++..++.|+.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++.
T Consensus       137 e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        137 PHYS-SDLYTYLTKRS------RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             EccC-CcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccc
Confidence            9994 68988886543      46899999999999999999999887   99999999999999999999999999976


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....   ......||+.|+|||.-
T Consensus       207 ~~~~~---~~~~~~gt~~y~aPE~~  228 (357)
T PHA03209        207 PVVAP---AFLGLAGTVETNAPEVL  228 (357)
T ss_pred             cccCc---ccccccccccccCCeec
Confidence            43222   12345689999997753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.94  E-value=6.4e-28  Score=239.41  Aligned_cols=171  Identities=27%  Similarity=0.405  Sum_probs=143.9

Q ss_pred             cccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeE
Q 017411          169 LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC  248 (372)
Q Consensus       169 ~~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~  248 (372)
                      +..+.|++|.       .++.||.|+.|.||+|++.  ++.||||+++...       ..+|..|++|+|||||.+.|+|
T Consensus       118 ~WeiPFe~Is-------ELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVC  181 (904)
T KOG4721|consen  118 LWEIPFEEIS-------ELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVC  181 (904)
T ss_pred             hccCCHHHhh-------hhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeee
Confidence            3445555554       3578999999999999987  6899999885422       2578889999999999999999


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ....- +|||||||+.|.|+.+|+..       ..+.......+..+||.|+.|||.+.   |||||||.-||||+.+..
T Consensus       182 tqsPc-yCIiMEfCa~GqL~~VLka~-------~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~  250 (904)
T KOG4721|consen  182 TQSPC-YCIIMEFCAQGQLYEVLKAG-------RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDV  250 (904)
T ss_pred             cCCce-eEEeeeccccccHHHHHhcc-------CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccce
Confidence            87655 79999999999999999875       46777888899999999999999988   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccccccccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRL  369 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE~~~~  369 (372)
                      +||+|||.++......   ....+.||+.|||||+..-.++
T Consensus       251 VKIsDFGTS~e~~~~S---TkMSFaGTVaWMAPEvIrnePc  288 (904)
T KOG4721|consen  251 VKISDFGTSKELSDKS---TKMSFAGTVAWMAPEVIRNEPC  288 (904)
T ss_pred             EEeccccchHhhhhhh---hhhhhhhhHhhhCHHHhhcCCc
Confidence            9999999999886553   2356789999999887654443

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=2.9e-26  Score=217.60  Aligned_cols=181  Identities=22%  Similarity=0.345  Sum_probs=145.4

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      ...++|+..+.||+|+||.||++.....     ...+|+|.+... .......+.+|+.++.++ +||||+++++++...
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            3456899999999999999999987533     368999998754 334456788999999999 799999999998764


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NIL  322 (372)
                      . ..+++|||+++|+|.+++......         ......+++..++.++.|++.||.|||+.+   |+||||||+||+
T Consensus        89 ~-~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          89 G-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             C-CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            4 589999999999999999764210         012356899999999999999999999877   999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       323 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.++.+||+|||+++...............++..|+|||.
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  205 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEA  205 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHH
Confidence            99999999999999987755433222333345667888764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.7e-26  Score=215.55  Aligned_cols=171  Identities=27%  Similarity=0.394  Sum_probs=141.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+|+..+.||+|+||.||+|....++.    .||+|.+.... ......+.+|+.++++++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            578889999999999999998765543    68999887653 4455678999999999999999999999876  3478


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~  155 (279)
T cd05057          85 LITQLMPLGCLLDYVRNHK------DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGL  155 (279)
T ss_pred             EEEecCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcc
Confidence            9999999999999997643      45899999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++...............++..|++||.
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (279)
T cd05057         156 AKLLDVDEKEYHAEGGKVPIKWMALES  182 (279)
T ss_pred             cccccCcccceecCCCcccccccCHHH
Confidence            987764433222222233556887664

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=2.8e-26  Score=217.80  Aligned_cols=181  Identities=19%  Similarity=0.243  Sum_probs=142.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .+++|++.+.||+|+||.||+|..+.     .+..||+|.++... ......+.+|+.++++++||||+++++++.+.. 
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ-   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC-
Confidence            45789999999999999999997642     34589999986543 334456889999999999999999999877654 


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGV---RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~---~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                      ..++||||+++|+|.+++.......   .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            5899999999999999997643211   11234577888899999999999999877   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+++...............++..|+|||..
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~  193 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL  193 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHh
Confidence            9999999866433322122223456678886643

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.94  E-value=3.7e-26  Score=216.00  Aligned_cols=163  Identities=28%  Similarity=0.398  Sum_probs=139.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+... .....+.+.+|+.++++++||||+++++++... ...++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEe
Confidence            3677889999999999999999888999999998754 344556799999999999999999999998774 45889999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|..+           ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~~~l~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~  145 (279)
T cd06619          80 FMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL  145 (279)
T ss_pred             cCCCCChHHh-----------hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceec
Confidence            9999999654           24678888899999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....    .....||..|+|||.
T Consensus       146 ~~~~----~~~~~~~~~y~aPE~  164 (279)
T cd06619         146 VNSI----AKTYVGTNAYMAPER  164 (279)
T ss_pred             cccc----ccCCCCChhhcCcee
Confidence            5432    234568888998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=3.3e-26  Score=214.80  Aligned_cols=172  Identities=21%  Similarity=0.255  Sum_probs=136.2

Q ss_pred             eeEcccCceEEEEEEEC--CCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVG--LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.||+|+||.||+|...  .++..+|+|.++... ......+.+|+.++++++||||+++++++.+.. ..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVT-PYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC-CcEEEEECCCC
Confidence            36899999999999864  345679999987643 334457889999999999999999999887644 47999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |+|.+++......  .....++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++......
T Consensus        80 g~L~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          80 GDLKGYLRSCRKA--ELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             CcHHHHHHHhhhc--ccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9999999764321  1135677888899999999999999877   9999999999999999999999999997654332


Q ss_pred             CCccccccccCCCccCccccc
Q 017411          345 VPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .........|+..|+|||..+
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~  175 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVD  175 (269)
T ss_pred             eeecCCCcCCcccccCHhHhc
Confidence            211222345677888877653

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.94  E-value=3.4e-26  Score=215.78  Aligned_cols=180  Identities=27%  Similarity=0.356  Sum_probs=143.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .+++|++.+.||+|+||.||+|.+..     ++..||+|.+.... ......|.+|+.++++++|+||+++++++.+.. 
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-
Confidence            34689999999999999999999876     67889999987543 344567999999999999999999999887754 


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC---cEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPK  330 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~---~~K  330 (372)
                      ..++||||+++++|.+++............+++..++.++.||+.||.|||+.+   ++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceE
Confidence            478999999999999999876432222246899999999999999999999887   99999999999998764   699


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+|||+++................+..|+|||.
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEA  192 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHH
Confidence            999999987643222111122233456777654

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.94  E-value=1.8e-26  Score=230.95  Aligned_cols=184  Identities=27%  Similarity=0.350  Sum_probs=144.6

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEE
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLH-HPNIVPLVGFCI  249 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~  249 (372)
                      +....++|.+.+.||+|+||.||+|++.     ..+..||||+++.. .....+.+.+|+.+|.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3344567888899999999999999864     23568999999754 2333457899999999997 999999999987


Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhhccCC---------------------------------------------------
Q 017411          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGV---------------------------------------------------  278 (372)
Q Consensus       250 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------------------------------------------------  278 (372)
                      ... ..++||||+++|+|.++++......                                                   
T Consensus       112 ~~~-~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 KGG-PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             cCC-CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence            644 5899999999999999997642100                                                   


Q ss_pred             ----------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCC
Q 017411          279 ----------------------------------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (372)
Q Consensus       279 ----------------------------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp  318 (372)
                                                              .....+++..++.++.|++.||.|||+.+   |+||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence                                                    01135788889999999999999999876   99999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          319 SNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       319 ~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||++.++.+||+|||+++...............++..|+|||..
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  313 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESI  313 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHh
Confidence            9999999999999999999876433221122334567788887754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.94  E-value=2.9e-26  Score=216.82  Aligned_cols=169  Identities=28%  Similarity=0.375  Sum_probs=137.2

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhC---CCCCeeceeeeEEcC----CC
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCIDP----EQ  253 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~~----~~  253 (372)
                      +|+..+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|+++++.+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788899999999999999999899999999987532  22233556777777665   699999999987542    23


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPP-----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECc
Confidence            4789999997 589998875432     35899999999999999999999887   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++.......   .....||..|+|||.
T Consensus       152 fg~~~~~~~~~~---~~~~~~~~~y~aPE~  178 (288)
T cd07863         152 FGLARIYSCQMA---LTPVVVTLWYRAPEV  178 (288)
T ss_pred             cCccccccCccc---CCCccccccccCchH
Confidence            999987654322   234568888999774

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=3.6e-26  Score=214.14  Aligned_cols=175  Identities=22%  Similarity=0.356  Sum_probs=137.3

Q ss_pred             eeceeEcccCceEEEEEEECCCCe--EEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----CeE
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----QGL  255 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~~~  255 (372)
                      .+.+.||+|+||.||+|.....+.  .||+|.++..  .....+.+.+|++++++++||||+++++++....     ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999876554  6899988754  3455678899999999999999999999875422     236


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      +++|||+++|+|.+++...... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLG-DCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhccc-CCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            8999999999999988543211 11245899999999999999999999877   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++...............+++.|++||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~  185 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIES  185 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHH
Confidence            9987654332111122334556777654

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=3e-26  Score=214.87  Aligned_cols=170  Identities=35%  Similarity=0.520  Sum_probs=137.3

Q ss_pred             eeceeEcccCceEEEEEEEC----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          185 SKGRVLGRGALSFVFKGKVG----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ...+.||.|.||.||+|.+.    ..+..|+||.++.. .....+.|.+|++.+++++||||++++|+|...+. .++|+
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-ccccc
Confidence            35689999999999999987    34578999999653 44457889999999999999999999999985444 89999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.++|.....     ..+++..+..|+.||+.||.|||+.+   |+|+||+++||+++.++.+||+|||+++.
T Consensus        81 e~~~~g~L~~~L~~~~~-----~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~  152 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNK-----EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRP  152 (259)
T ss_dssp             E--TTEBHHHHHHHTCT-----TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEE
T ss_pred             ccccccccccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence            99999999999988622     57899999999999999999999987   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..............+...|+|||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~  176 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEV  176 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHH
T ss_pred             cccccccccccccccccccccccc
Confidence            743332222333456667787664

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.94  E-value=3.1e-26  Score=225.23  Aligned_cols=169  Identities=23%  Similarity=0.343  Sum_probs=141.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----  252 (372)
                      ..++|+..+.||+|+||.||++.+..+++.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            346899999999999999999999888999999999753  3344567889999999999999999999875322     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...|+||||+++ +|.+.+..         .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEE
Confidence            347999999964 77777742         4788889999999999999999877   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++......   ......||..|+|||.-
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~  197 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVI  197 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHH
Confidence            999998764332   22345688999997754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=4.1e-26  Score=213.46  Aligned_cols=172  Identities=23%  Similarity=0.377  Sum_probs=143.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|+..+.||+|+||.||+|.....++.||+|.+.... .....+.+|++++++++||||+++++++... ...+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEe
Confidence            46888899999999999999998888999999987543 3456789999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++.....     ..+++..++.++.|++.||.|||..+   ++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~  155 (263)
T cd05052          84 MTYGNLLDYLRECNR-----QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT  155 (263)
T ss_pred             CCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccc
Confidence            999999999976432     46899999999999999999999877   9999999999999999999999999998775


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..... ......++.+|+|||.-
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~  177 (263)
T cd05052         156 GDTYT-AHAGAKFPIKWTAPESL  177 (263)
T ss_pred             cceee-ccCCCCCccccCCHHHh
Confidence            44321 11122345568876643

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.94  E-value=3.7e-26  Score=218.30  Aligned_cols=169  Identities=28%  Similarity=0.416  Sum_probs=141.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|...+.||+|+||.||+|.+..+++.||+|.+.... ......+.+|+.++++++||||+++++++.. +...++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEe
Confidence            57999999999999999999998889999999987542 2334567889999999999999999999876 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||+++..
T Consensus        85 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  154 (301)
T cd07873          85 YLD-KDLKQYLDDCG------NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAK  154 (301)
T ss_pred             ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhcc
Confidence            996 58999887643      45789999999999999999999877   999999999999999999999999999865


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..+..  ......+++.|+|||.
T Consensus       155 ~~~~~--~~~~~~~~~~y~~PE~  175 (301)
T cd07873         155 SIPTK--TYSNEVVTLWYRPPDI  175 (301)
T ss_pred             CCCCC--cccccceeecccCcHH
Confidence            43332  1223456888888774

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.2e-26  Score=218.15  Aligned_cols=178  Identities=24%  Similarity=0.345  Sum_probs=141.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCC--------------CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceee
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLL--------------RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG  246 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~--------------~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g  246 (372)
                      ++|++.+.||+|+||.||++....+              ...||+|.++.. .......|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788999999999999999886432              235899998764 3444567999999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhhccC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKG-----VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       247 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~-----~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      ++... ...++||||+++++|.+++......     ......+++..++.++.|++.||.|||+.+   ++||||||+||
T Consensus        85 ~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          85 VCVSD-DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEcCC-CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            98764 4589999999999999999653210     001134789999999999999999999887   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++.++.+||+|||+++...............++..|+|||.
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  202 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES  202 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhh
Confidence            999999999999999986643332222233445667888764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-28  Score=223.26  Aligned_cols=172  Identities=30%  Similarity=0.380  Sum_probs=146.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+++|++.+.||+|.|+.||++.++.+|+.+|+|.++..  .....+.+.+|++|.+.|+|||||+|.+.. ..++..|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-QEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-cccceeEE
Confidence            346888899999999999999999999999999988643  344667889999999999999999999864 45777899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEEEEec
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDF  334 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~KL~DF  334 (372)
                      |+|+|.|++|..-|-.+       ...++..+-.++.||+++|.|+|..+   |||||+||+|+|+...   .-+||+||
T Consensus        88 vFe~m~G~dl~~eIV~R-------~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~F  157 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR-------EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADF  157 (355)
T ss_pred             EEecccchHHHHHHHHH-------HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeeccc
Confidence            99999999998777654       35788888899999999999999988   9999999999999543   45899999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+|..+....   ......|||+||+||+-.
T Consensus       158 GvAi~l~~g~---~~~G~~GtP~fmaPEvvr  185 (355)
T KOG0033|consen  158 GLAIEVNDGE---AWHGFAGTPGYLSPEVLK  185 (355)
T ss_pred             ceEEEeCCcc---ccccccCCCcccCHHHhh
Confidence            9999888332   445678999999988754

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.94  E-value=3.9e-26  Score=218.18  Aligned_cols=168  Identities=24%  Similarity=0.359  Sum_probs=144.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|+..+.||+|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||+++++.+... ...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeecc
Confidence            5899999999999999999998888999999999876555567889999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++..        ..+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~~~~L~~~~~~--------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             cCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            999999999864        34789999999999999999999887   9999999999999999999999999988654


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......|++.|+|||.
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~  187 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEV  187 (296)
T ss_pred             cccc--ccCcccCCccccCHHH
Confidence            3322  1123467888888764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=4.4e-26  Score=215.82  Aligned_cols=173  Identities=25%  Similarity=0.348  Sum_probs=142.0

Q ss_pred             CCeeeceeEcccCceEEEEEEE----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      ..|+..+.||+|+||.||++..    ..++..||+|.++.. .......+.+|++++++++||||+++++++.+. ....
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3578889999999999999975    345788999998754 344556799999999999999999999988764 3457


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~------~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg  154 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  154 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCc
Confidence            89999999999999996542      35899999999999999999999877   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +++.+....... ......|+..|+|||.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~apE~  183 (284)
T cd05079         155 LTKAIETDKEYYTVKDDLDSPVFWYAPEC  183 (284)
T ss_pred             cccccccCccceeecCCCCCCccccCHHH
Confidence            998775443221 1123445666787664

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9.8e-27  Score=248.39  Aligned_cols=181  Identities=29%  Similarity=0.431  Sum_probs=149.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      ..+.+..+.||+|.||.||.|.....     ...||||.+.+. +.+...+|++|..+|++++|||||+++|+|.+.. .
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-~  769 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-P  769 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-C
Confidence            45667789999999999999988542     234999999875 6677889999999999999999999999999854 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++++|||++|+|..+|++.+........+...+.+.++.|||+|+.||++.+   +|||||..+|+||+....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEccc
Confidence            78999999999999999987555444578899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+||.+-..+.......-.--..|||||+-.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~  877 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLK  877 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHh
Confidence            9999654443322111112235799987654

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=5.7e-26  Score=212.43  Aligned_cols=176  Identities=23%  Similarity=0.372  Sum_probs=139.4

Q ss_pred             eeeceeEcccCceEEEEEEECC---CCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-----
Q 017411          184 FSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-----  253 (372)
                      |++.+.||+|+||.||+|....   .+..||+|+++..  .......+.+|+++++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567899999999999998754   3478999998754  33445678999999999999999999998765432     


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++++||+++|+|..++...... .....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLG-GLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhcc-CCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence            368999999999999999664321 11246899999999999999999999877   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++...............++..|+|||.
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  186 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIES  186 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhh
Confidence            999987654432211222234566777664

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.94  E-value=3.3e-26  Score=215.31  Aligned_cols=179  Identities=25%  Similarity=0.344  Sum_probs=143.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .+|.+.+.||+|+||.||+|....     ++..||||.++..... ..+.+.+|++++++++||||+++++++... ...
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCe
Confidence            468888999999999999998743     3578999999765433 567899999999999999999999998775 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKG-------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~-------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ++||||+++++|.+++......       ......+++..+..++.|++.||.|||..+   |+||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            9999999999999999764211       111245889999999999999999999887   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+++...............+++.|+|||.-
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESI  196 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhh
Confidence            999999999865433221122333456778887753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=8.8e-26  Score=210.46  Aligned_cols=173  Identities=24%  Similarity=0.404  Sum_probs=145.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+|....+++.||+|.++..   .....+.+.+|++++++++|+||+++++++.+. ...++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEE
Confidence            5899999999999999999999888999999988642   334456789999999999999999999998774 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|..++.....   ....+++..++.++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||+++
T Consensus        81 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~  154 (267)
T cd08224          81 LELADAGDLSRMIKHFKK---QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EecCCCCCHHHHHHHhcc---cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceee
Confidence            999999999999875322   1246899999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......|+..|+|||.
T Consensus       155 ~~~~~~~--~~~~~~~~~~y~apE~  177 (267)
T cd08224         155 FFSSKTT--AAHSLVGTPYYMSPER  177 (267)
T ss_pred             eccCCCc--ccceecCCccccCHHH
Confidence            7654322  1233467888888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.3e-26  Score=210.42  Aligned_cols=172  Identities=27%  Similarity=0.342  Sum_probs=147.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||+|+||.||++....+++.+++|.+........+.+.+|+.++++++||||+++++++.+ ....+++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEe
Confidence            3689999999999999999999988889999999987665667789999999999999999999998776 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++....      ..+++..+..++.|++.||.|||..+   |+|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  151 (262)
T cd06613          81 YCGGGSLQDIYQVTR------GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQL  151 (262)
T ss_pred             CCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhh
Confidence            999999999987642      46889999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....  ......++..|+|||.-
T Consensus       152 ~~~~~--~~~~~~~~~~y~~Pe~~  173 (262)
T cd06613         152 TATIA--KRKSFIGTPYWMAPEVA  173 (262)
T ss_pred             hhhhh--ccccccCCccccCchhh
Confidence            53321  12335678888887753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.94  E-value=5.3e-26  Score=214.49  Aligned_cols=170  Identities=27%  Similarity=0.424  Sum_probs=141.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||+|....+++.||||.+...  .....+.+.+|+.++++++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEe
Confidence            578889999999999999999888999999998653  223346788999999999999999999998764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++.....    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          80 FLS-MDLKKYLDSLPK----GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             cCC-CCHHHHHhcCCC----CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            997 689888865432    146899999999999999999999887   999999999999999999999999999866


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..+..  ......+++.|+|||.
T Consensus       152 ~~~~~--~~~~~~~~~~y~aPE~  172 (285)
T cd07861         152 GIPVR--VYTHEVVTLWYRAPEV  172 (285)
T ss_pred             CCCcc--cccCCcccccccChHH
Confidence            43322  1223356788888774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=3e-27  Score=206.15  Aligned_cols=168  Identities=26%  Similarity=0.389  Sum_probs=141.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|...++||+|.||+||+|+.+.+.+.||+|++...  +.......++|+.+|+.++|.|||+++++... +..+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHH
Confidence            567778999999999999999999999999998654  44445677899999999999999999998654 566899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      || ..+|..+.....      ..++...+..++.|+++||.|+|+++   ++||||||.|+||+.+|.+|++|||+|+.+
T Consensus        82 ~c-dqdlkkyfdsln------g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglaraf  151 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLN------GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAF  151 (292)
T ss_pred             Hh-hHHHHHHHHhcC------CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhc
Confidence            99 458888877653      57889999999999999999999988   999999999999999999999999999988


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +-+-.-+.  ..+-|..|.||.+
T Consensus       152 gipvrcys--aevvtlwyrppdv  172 (292)
T KOG0662|consen  152 GIPVRCYS--AEVVTLWYRPPDV  172 (292)
T ss_pred             CCceEeee--ceeeeeeccCcce
Confidence            76653221  2345667777654

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=3.8e-26  Score=219.08  Aligned_cols=175  Identities=30%  Similarity=0.389  Sum_probs=142.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~  252 (372)
                      ..++|...+.||+|+||.||++..     ..++..||+|.++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            345799999999999999999975     2345689999987642 34456789999999999 7999999999887644


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                       ..++||||+++|+|.+++.....     ..+++.++..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+
T Consensus       113 -~~~lv~e~~~~~~L~~~i~~~~~-----~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~  183 (302)
T cd05055         113 -PILVITEYCCYGDLLNFLRRKRE-----SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKIC  183 (302)
T ss_pred             -ceEEEEEcCCCCcHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEEC
Confidence             58999999999999999976432     34899999999999999999999877   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+++...............++..|+|||.
T Consensus       184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  214 (302)
T cd05055         184 DFGLARDIMNDSNYVVKGNARLPVKWMAPES  214 (302)
T ss_pred             CCcccccccCCCceeecCCCCcccccCCHhh
Confidence            9999987654432212223345677888774

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.94  E-value=8.5e-26  Score=209.92  Aligned_cols=171  Identities=24%  Similarity=0.333  Sum_probs=144.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +|+..+.||+|+||.||++....++..||+|.++.. .....+.+.+|+.++++++||||+++++.+.+ +...++||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence            578889999999999999999888999999998643 34455678899999999999999999998766 4568999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++.....     ..+++..++.++.|++.||.|||..+   |+|+||||+||+++.++.++|+|||+++...
T Consensus        80 ~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  151 (255)
T cd08219          80 CDGGDLMQKIKLQRG-----KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLT  151 (255)
T ss_pred             CCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeec
Confidence            999999999875432     45789999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  ......|+..|+|||.-
T Consensus       152 ~~~~--~~~~~~~~~~~~aPE~~  172 (255)
T cd08219         152 SPGA--YACTYVGTPYYVPPEIW  172 (255)
T ss_pred             cccc--ccccccCCccccCHHHH
Confidence            4332  22345688889987753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=1.4e-26  Score=215.61  Aligned_cols=171  Identities=28%  Similarity=0.406  Sum_probs=145.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ..+|+..+.||+|+||.||+|.... +..+|+|.+..........+.+|+.+++.++||||+++++++.+.+ ..++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGE-PVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCC-CeEEEEe
Confidence            4578889999999999999999987 7899999998776656678999999999999999999999887654 4899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||..+   |+|+||||+||+++.++.+||+|||++...
T Consensus        83 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~  154 (261)
T cd05148          83 LMEKGSLLAFLRSPEG-----QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI  154 (261)
T ss_pred             ecccCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhc
Confidence            9999999999976432     46899999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......++..|+|||.
T Consensus       155 ~~~~~--~~~~~~~~~~~~~PE~  175 (261)
T cd05148         155 KEDVY--LSSDKKIPYKWTAPEA  175 (261)
T ss_pred             CCccc--cccCCCCceEecCHHH
Confidence            43322  1123345667888664

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=5.6e-26  Score=211.86  Aligned_cols=171  Identities=25%  Similarity=0.343  Sum_probs=140.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.++++++|+||+++++++... ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   81 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIITE   81 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEe
Confidence            3589999999999999999998754 5679999987543 3356889999999999999999999987654 44899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~  153 (261)
T cd05072          82 YMAKGSLLDFLKSDEG-----GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVI  153 (261)
T ss_pred             cCCCCcHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceec
Confidence            9999999999976432     46888999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...... ......++..|+|||.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~aPE~  175 (261)
T cd05072         154 EDNEYT-AREGAKFPIKWTAPEA  175 (261)
T ss_pred             CCCcee-ccCCCccceecCCHHH
Confidence            543321 1122335567777664

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.94  E-value=5.2e-26  Score=217.43  Aligned_cols=169  Identities=24%  Similarity=0.350  Sum_probs=145.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|+..+.||+|+||.||++....+++.||+|.+........+.+.+|+.+++.++||||+++++++... ...++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEeecc
Confidence            5899999999999999999999888999999999876555567789999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~  166 (297)
T cd06656          98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (297)
T ss_pred             cCCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence            999999999864        35789999999999999999999877   9999999999999999999999999998664


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  ......|++.|+|||..
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~  187 (297)
T cd06656         167 PEQS--KRSTMVGTPYWMAPEVV  187 (297)
T ss_pred             CCcc--CcCcccCCccccCHHHH
Confidence            3322  12334678888887643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.94  E-value=5.6e-26  Score=216.04  Aligned_cols=178  Identities=25%  Similarity=0.355  Sum_probs=144.9

Q ss_pred             CCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+|...+.||+|+||.||++...     .++..+++|.+........+.+.+|++++++++||||+++++++...+ ..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD-PLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC-ceE
Confidence            46888899999999999999853     245679999998766666678999999999999999999999987644 489


Q ss_pred             EEEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          257 LIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      +||||+++++|.+++......         ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            999999999999999764311         011135899999999999999999999887   99999999999999999


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+||+|||+++...............++..|+|||.
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  196 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPES  196 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHH
Confidence            999999999987654332222334456777888664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=9e-28  Score=232.84  Aligned_cols=172  Identities=28%  Similarity=0.348  Sum_probs=150.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ...|+..+.||+|.||.||+|.+..+++.||+|+++.. .....+.+++|+.+|.+++++||.++|+.+..+ ..+|++|
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiM   90 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIM   90 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHH
Confidence            34677789999999999999999999999999999865 445567889999999999999999999988774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||.+|++.+.|+..       ..+.+..+..|+++++.||.|||..+   .+|||||+.|||+..+|.+||+|||++..
T Consensus        91 ey~~gGsv~~lL~~~-------~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~q  160 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSG-------NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQ  160 (467)
T ss_pred             HHhcCcchhhhhccC-------CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeee
Confidence            999999999999764       34577777788999999999999988   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +......  ..+.+||+-|||||+-.
T Consensus       161 l~~~~~r--r~tfvGTPfwMAPEVI~  184 (467)
T KOG0201|consen  161 LTNTVKR--RKTFVGTPFWMAPEVIK  184 (467)
T ss_pred             eechhhc--cccccccccccchhhhc
Confidence            7655442  26789999999988754

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=5.2e-26  Score=211.71  Aligned_cols=169  Identities=24%  Similarity=0.432  Sum_probs=137.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||++.... +..+|+|.+.... .....+.+|+.++++++||||+++++++.+. ...++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~   80 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEF   80 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEc
Confidence            468888999999999999998864 5679999886542 2345788999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~  151 (256)
T cd05114          81 MENGCLLNYLRQRQ------GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence            99999999987542      35889999999999999999999877   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..... ......++..|+|||.
T Consensus       152 ~~~~~-~~~~~~~~~~y~aPE~  172 (256)
T cd05114         152 DDEYT-SSSGAKFPVKWSPPEV  172 (256)
T ss_pred             CCcee-ccCCCCCchhhCChhh
Confidence            33221 1112234456777553

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.94  E-value=5.6e-27  Score=219.62  Aligned_cols=179  Identities=26%  Similarity=0.364  Sum_probs=152.0

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEc
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCID  250 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~  250 (372)
                      -++.++...|.     +.||+|+|+.|--+....++.+||||++.+.......++.+|++++.+.+ |+||++|+++|.+
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            45667766664     68999999999999998899999999999998888889999999999996 9999999998776


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC---
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---  327 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~---  327 (372)
                       +.+.|||||-|.||+|.++|+++       ..+++.++.+++.+|+.||.|||..+   |.||||||+|||-....   
T Consensus       148 -d~~FYLVfEKm~GGplLshI~~~-------~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vs  216 (463)
T KOG0607|consen  148 -DTRFYLVFEKMRGGPLLSHIQKR-------KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVS  216 (463)
T ss_pred             -cceEEEEEecccCchHHHHHHHh-------hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcC
Confidence             55689999999999999999887       46899999999999999999999887   99999999999997654   


Q ss_pred             cEEEEecccccccCC-----CCCCccccccccCCCccCcccccc
Q 017411          328 IPKLCDFGLATWTSA-----PSVPFLCKTVKGTFGQNPFCIEEW  366 (372)
Q Consensus       328 ~~KL~DFGla~~~~~-----~~~~~~~~~~~GT~gy~apeaPE~  366 (372)
                      -+||+||.|+.-+.-     +.......+.+|+..|||||+-+.
T Consensus       217 PvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~  260 (463)
T KOG0607|consen  217 PVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDV  260 (463)
T ss_pred             ceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhh
Confidence            479999999865421     112223346789999999887663

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.94  E-value=6.8e-26  Score=240.31  Aligned_cols=169  Identities=25%  Similarity=0.299  Sum_probs=145.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|.+.+.||+|+||.||+|.+..+++.||||+++..   .......+.+|+.++..++||||+++++++.. ....|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence            5899999999999999999999988999999999754   23445678899999999999999999988765 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++...       ..+++..++.|+.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~-------~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-------GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999754       35788999999999999999999877   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......+|+.|++|+.
T Consensus       153 ~~~~~~~--~~~~~~~t~~~~~pe~  175 (669)
T cd05610         153 VTLNREL--NMMDILTTPSMAKPKN  175 (669)
T ss_pred             cccCCcc--cccccccCccccCccc
Confidence            7754433  2234578888888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=4.8e-26  Score=215.36  Aligned_cols=170  Identities=24%  Similarity=0.360  Sum_probs=143.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|++.+.||+|+||.||++....++..||+|.+... .......+.+|+.++++++||||+++++.+.. +...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence            3678889999999999999999888999999988754 34445688999999999999999999998776 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+++++|.+++.....    ...+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||++..
T Consensus        80 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  152 (286)
T cd06622          80 YMDAGSLDKLYAGGVA----TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGN  152 (286)
T ss_pred             ecCCCCHHHHHHhccc----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence            9999999999875321    14689999999999999999999963 5   99999999999999999999999999976


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......    ....|+.+|+|||.
T Consensus       153 ~~~~~~----~~~~~~~~y~aPE~  172 (286)
T cd06622         153 LVASLA----KTNIGCQSYMAPER  172 (286)
T ss_pred             ccCCcc----ccCCCccCccCcch
Confidence            643322    33457888888774

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.94  E-value=7.3e-26  Score=217.61  Aligned_cols=171  Identities=26%  Similarity=0.448  Sum_probs=134.3

Q ss_pred             ceeEcccCceEEEEEEEC--CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEEEEeccC
Q 017411          187 GRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVS  263 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~lV~Ey~~  263 (372)
                      .+.||+|+||.||+|+..  .+++.||+|.+....  ....+.+|++++++++||||+++++++... +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999875  356889999987542  234577899999999999999999987643 345789999985


Q ss_pred             CCCHHHHHHhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE----cCCCcEEEEecccc
Q 017411          264 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA  337 (372)
Q Consensus       264 ~gsL~~~L~~~~~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl----d~~~~~KL~DFGla  337 (372)
                       ++|.+++......  ......+++..+..++.||+.||.|||+.+   |+||||||+|||+    +..+.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5898887643211  111235899999999999999999999887   9999999999999    45678999999999


Q ss_pred             cccCCCCCCc-cccccccCCCccCccc
Q 017411          338 TWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +.......+. ......||+.|+|||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~  186 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPEL  186 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHH
Confidence            8775443221 2234678999999774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=3.8e-26  Score=227.46  Aligned_cols=166  Identities=23%  Similarity=0.269  Sum_probs=139.2

Q ss_pred             CCeeeceeEcccCceEEEEEEEC--CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .+|.+.+.||+|+||.||++...  ..+..||+|.+...     ..+.+|+++|++++||||+++++++.. ....++||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv~  165 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRW-KSTVCMVM  165 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEee-CCEEEEEe
Confidence            57999999999999999999764  34578999988653     235689999999999999999998765 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |++. ++|.+++...       ..+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+||+|||+++.
T Consensus       166 e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-------GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             hhcC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            9995 6898888433       46899999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..............||+.|+|||.-
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~  259 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELL  259 (392)
T ss_pred             cCcccccccccccccccCccCHhHh
Confidence            6654433334456799999997753

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.94  E-value=9.5e-26  Score=214.04  Aligned_cols=171  Identities=26%  Similarity=0.346  Sum_probs=140.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++.+|...+.||+|+||.||+|....++..||+|++.... ......+.+|+.+++.++|+||+++++++.. +...++|
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv   81 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV   81 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence            4578999999999999999999998889999999987543 2233467889999999999999999998876 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      +||+. ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++
T Consensus        82 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~  151 (291)
T cd07870          82 FEYMH-TDLAQYMIQHP------GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR  151 (291)
T ss_pred             Eeccc-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccc
Confidence            99995 68877775432      35788888899999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......+++.|+|||.
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~  174 (291)
T cd07870         152 AKSIPSQ--TYSSEVVTLWYRPPDV  174 (291)
T ss_pred             ccCCCCC--CCCCccccccccCCce
Confidence            6543322  1233457888888774

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=5.2e-26  Score=231.53  Aligned_cols=173  Identities=14%  Similarity=0.209  Sum_probs=139.5

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC------CCeeceeeeE
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH------PNIVPLVGFC  248 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H------pnIv~l~g~~  248 (372)
                      .++...+++|++.+.||+|+||+||+|.+..+++.||||+++... ...+.+..|+.+++.++|      ++++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            344556789999999999999999999998889999999996532 233455667777777654      4588999988


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCC
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~  327 (372)
                      .......++|||++ +++|.+++...       ..+++..+..|+.||+.||.|||+ .+   ||||||||+|||++.++
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~  269 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH-------GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSD  269 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCC
Confidence            76666689999998 77899988754       468999999999999999999997 36   99999999999998765


Q ss_pred             ----------------cEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          328 ----------------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       328 ----------------~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                                      .+||+|||++.....     ......||+.|+|||+-
T Consensus       270 ~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~  317 (467)
T PTZ00284        270 TVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVV  317 (467)
T ss_pred             cccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHh
Confidence                            499999998864322     22456799999998763

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=7.5e-26  Score=210.62  Aligned_cols=166  Identities=27%  Similarity=0.454  Sum_probs=139.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||++...  +..||+|.++...  ..+.+.+|+.++++++|+|++++++++...+...++|+||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888999999999999999875  6789999986543  3457899999999999999999999876666668999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          82 MAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             CCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecc
Confidence            999999999976432     45889999999999999999999877   9999999999999999999999999998654


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...     ....++..|+|||.-
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~  171 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEAL  171 (256)
T ss_pred             ccC-----CCCccceeecCHHHH
Confidence            322     223345678887753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.94  E-value=8.3e-26  Score=216.18  Aligned_cols=181  Identities=20%  Similarity=0.324  Sum_probs=143.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      ..++|.+.+.||+|+||.||+++..       ..+..||+|.+... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3468889999999999999999752       23457999998754 334556789999999999 89999999998876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      . ...++||||+++|+|.+++.......         .....+++..+..++.||+.||.|||+.+   |+||||||+||
T Consensus        93 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni  168 (304)
T cd05101          93 D-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV  168 (304)
T ss_pred             C-CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence            4 45899999999999999998643210         01245889999999999999999999887   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |++.++.+||+|||+++...............++..|+|||.-
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  211 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL  211 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhh
Confidence            9999999999999999877543322222333456778887753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.94  E-value=8.3e-26  Score=214.57  Aligned_cols=177  Identities=25%  Similarity=0.331  Sum_probs=140.0

Q ss_pred             CeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      +|+..+.||+|+||.||+|....     ....+|+|.+.... ......+.+|+.+++.++||||+++++.+...+ ..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDG-PLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC-CcE
Confidence            47778999999999999998642     23579999887543 344567899999999999999999999887644 478


Q ss_pred             EEEeccCCCCHHHHHHhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCC
Q 017411          257 LIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~  319 (372)
                      +|+||+++++|.+++.......                 .....+++..++.++.|++.||.|||+.+   |+||||||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~  156 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAAR  156 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhh
Confidence            9999999999999987542110                 11245889999999999999999999877   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+++++.+||+|||+++...............++..|+|||.
T Consensus       157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~  200 (290)
T cd05045         157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIES  200 (290)
T ss_pred             eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHH
Confidence            99999999999999999986543322112223345677888764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.94  E-value=9.4e-26  Score=215.72  Aligned_cols=168  Identities=26%  Similarity=0.386  Sum_probs=145.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|+..+.||.|+||.||+|....+++.||+|.+........+.+.+|+.+++.++||||+++++++... ...++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEe
Confidence            4799999999999999999999888999999999766555567889999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|..++..        ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          98 LAGGSLTDVVTE--------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             cCCCcHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            999999999864        35899999999999999999999887   9999999999999999999999999988664


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......|+..|+|||.
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~  186 (296)
T cd06655         167 PEQS--KRSTMVGTPYWMAPEV  186 (296)
T ss_pred             cccc--cCCCcCCCccccCcch
Confidence            3322  1233468888999774

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.94  E-value=2.5e-27  Score=221.39  Aligned_cols=176  Identities=27%  Similarity=0.426  Sum_probs=147.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCC----eEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..|+....||+|.||.||+|....+.    +.+|||.++.+  .......-.||+.+++.|+||||+.|..++...+..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            36888899999999999999654332    37899999754  2233456789999999999999999999988777779


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC----CcEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKL  331 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~----~~~KL  331 (372)
                      ++++||.+. +|.+.|+-.+...  ...++...+..|+.||+.|+.|||+.-   |+||||||.|||+..+    |.+||
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~--~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASK--AKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccch--hccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence            999999976 9999998764322  257899999999999999999999988   9999999999999877    89999


Q ss_pred             EecccccccCCCCCCc-cccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +|||+||.+.++-.+. ..-.++-|+-|.|||.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPEL  210 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPEL  210 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHH
Confidence            9999999998887665 3345678888988663

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.94  E-value=5.5e-26  Score=244.58  Aligned_cols=179  Identities=23%  Similarity=0.334  Sum_probs=147.2

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      ...++|.+.+.||+|+||.||++.+..++..||+|.+...  .......|.+|+.+|++|+|||||+++++|.+. ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3446999999999999999999999988999999998753  334556789999999999999999999987653 3458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC----CceEEcCCCCCCEEEcCC-----
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE----RCVVHRDIKPSNILLSSK-----  326 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~----~~IiHrDLKp~NILld~~-----  326 (372)
                      ||||||+++|+|.++|......   ...+++..++.|+.||+.||.|||..+.    .+||||||||+||||+.+     
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~---~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKM---FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            9999999999999999764321   1468999999999999999999998542    349999999999999642     


Q ss_pred             ------------CcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          327 ------------KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       327 ------------~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                                  +.+||+|||+++.+.....   .....||+.|+|||.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEv  212 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPEL  212 (1021)
T ss_pred             cccccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHH
Confidence                        3589999999987654322   234579999999875

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.94  E-value=1.3e-25  Score=208.62  Aligned_cols=170  Identities=26%  Similarity=0.372  Sum_probs=146.3

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||.++...+++.+++|.+...  .....+.+.+|++++++++|+||+++++++.+ ....+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence            588899999999999999999888999999998754  34556678999999999999999999999877 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~  151 (256)
T cd08221          80 YANGGTLYDKIVRQKG-----QLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL  151 (256)
T ss_pred             ecCCCcHHHHHHhccc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEc
Confidence            9999999999976432     46899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|++.|+|||.
T Consensus       152 ~~~~~--~~~~~~~~~~y~ape~  172 (256)
T cd08221         152 GSEYS--MAETVVGTPYYMSPEL  172 (256)
T ss_pred             ccccc--cccccCCCccccCHhh
Confidence            54432  2234568888998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=4e-26  Score=215.55  Aligned_cols=177  Identities=27%  Similarity=0.273  Sum_probs=141.3

Q ss_pred             CeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      +|...+.||+|+||.||+|....     .+..||||+++... ....+.+.+|+.++.+++||||+++++++.... ..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-ceE
Confidence            56777899999999999998743     25789999997543 334567889999999999999999999987654 489


Q ss_pred             EEEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          257 LIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      +++||+++++|.+++......         ......+++..++.++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            999999999999998643110         011235888999999999999999999877   99999999999999999


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+||+|||+++...............+++.|+|||.
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEA  197 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHH
Confidence            999999999987654433222334456778888764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.94  E-value=1.1e-25  Score=213.71  Aligned_cols=183  Identities=25%  Similarity=0.312  Sum_probs=150.5

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      +...++..++++|...+.||+|+||.||++....+++.+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            444566677889999999999999999999998889999999986542 2345678899999999 79999999999875


Q ss_pred             CC----CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          251 PE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       251 ~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      .+    ...++|+||+++++|.+++......   ...+++..++.++.|++.||.|||..+   |+||||||+||+++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~  164 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLIC---GQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE  164 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence            43    3479999999999999998753211   146899999999999999999999877   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.+||+|||+++.......  ......|+..|+|||.
T Consensus       165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  199 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEV  199 (291)
T ss_pred             CCEEEeecccchhcccccc--cccCccCCccccChhh
Confidence            9999999999987653322  1233468888998775

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=1.1e-25  Score=211.00  Aligned_cols=151  Identities=28%  Similarity=0.468  Sum_probs=131.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe---EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+|+..+.||+|+||.||+|....++.   .||||.++.. .....+.|..|+.++++++||||+++++++.+. ...++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceEE
Confidence            357888999999999999999865543   6999998764 455567899999999999999999999987654 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~  153 (269)
T cd05065          83 ITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (269)
T ss_pred             EEecCCCCcHHHHHhhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccc
Confidence            999999999999997642      45899999999999999999999877   999999999999999999999999999


Q ss_pred             cccCC
Q 017411          338 TWTSA  342 (372)
Q Consensus       338 ~~~~~  342 (372)
                      +....
T Consensus       154 ~~~~~  158 (269)
T cd05065         154 RFLED  158 (269)
T ss_pred             ccccc
Confidence            87654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=5.4e-26  Score=212.39  Aligned_cols=174  Identities=25%  Similarity=0.395  Sum_probs=145.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++....++..||||.+...   .......+.+|+.+++.++||||+++++++.+. ...+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-CeEEEE
Confidence            4688889999999999999999888999999988653   333456788999999999999999999988764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++.....   ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~  154 (267)
T cd08229          81 LELADAGDLSRMIKHFKK---QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGR  154 (267)
T ss_pred             EEecCCCCHHHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhh
Confidence            999999999999875321   1146899999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......  ......|+..|+|||.-
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~ape~~  178 (267)
T cd08229         155 FFSSKTT--AAHSLVGTPYYMSPERI  178 (267)
T ss_pred             ccccCCc--ccccccCCcCccCHHHh
Confidence            7654332  12334688888887743

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.94  E-value=1.7e-25  Score=209.65  Aligned_cols=172  Identities=30%  Similarity=0.369  Sum_probs=142.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      .+|+..+.||+|+||.||++....++..||+|.+...     .......+.+|+.++++++||||+++++++.+. ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4788999999999999999999888999999998643     123445788999999999999999999987653 3457


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++++||+++++|.+++...       ..+++...+.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-------GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCC
Confidence            8999999999999999754       35789999999999999999999877   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +++......... ......++.+|+|||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  180 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEV  180 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHH
Confidence            998664322111 1123457888888764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=9.9e-26  Score=210.41  Aligned_cols=172  Identities=25%  Similarity=0.337  Sum_probs=140.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|.... ++.||+|.++... ...+.+.+|+.++++++||||+++++++... +..++||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   80 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVT   80 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeee
Confidence            34579999999999999999998754 5789999987643 2356789999999999999999999987664 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....     ...+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+++.
T Consensus        81 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  152 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-----GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARV  152 (261)
T ss_pred             ecccCCcHHHHHhccC-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEE
Confidence            9999999999997643     146899999999999999999999877   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....... .......+..|+|||.
T Consensus       153 ~~~~~~~-~~~~~~~~~~y~aPE~  175 (261)
T cd05068         153 IKEDIYE-AREGAKFPIKWTAPEA  175 (261)
T ss_pred             ccCCccc-ccCCCcCceeccCccc
Confidence            7533211 1111122346777664

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.94  E-value=1.1e-25  Score=211.06  Aligned_cols=172  Identities=26%  Similarity=0.372  Sum_probs=139.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+|+..+.||+|+||.||+|.+..+   ...+|+|.++... ....+.+.+|+.++++++||||+++++++... ...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEE
Confidence            4788899999999999999987533   3479999987542 34456889999999999999999999987654 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++
T Consensus        83 v~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~  153 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLS  153 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcc
Confidence            999999999999997642      45899999999999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCcc-ccccccCCCccCccc
Q 017411          338 TWTSAPSVPFL-CKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~-~~~~~GT~gy~apea  363 (372)
                      +.......... .....++..|++||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~  180 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEA  180 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhH
Confidence            87754332111 111223456777654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=8.5e-27  Score=232.13  Aligned_cols=174  Identities=25%  Similarity=0.341  Sum_probs=146.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .+.....++||+|.||.|.++.... +..||||.++.... ...++|.+|+++|.+|+|||||+|+|+|...+. +++|+
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-icmI~  614 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-LCMIT  614 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-hHHHH
Confidence            3455677899999999999999864 68999999987644 445899999999999999999999999998554 89999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||++|+|.++|.....     ..+.-....+|+.||+.|++||.+.+   +|||||.+.|+|+|.++++||+|||++|-
T Consensus       615 EYmEnGDLnqFl~ahea-----pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~  686 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHEL-----PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRN  686 (807)
T ss_pred             HHHhcCcHHHHHHhccC-----cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccc
Confidence            99999999999987642     22344556779999999999999988   99999999999999999999999999997


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +-...........+-...|||||+-
T Consensus       687 lysg~yy~vqgr~vlpiRwmawEsi  711 (807)
T KOG1094|consen  687 LYSGDYYRVQGRAVLPIRWMAWESI  711 (807)
T ss_pred             cccCCceeeecceeeeeeehhHHHH
Confidence            7655554444455556789998763

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.94  E-value=1.1e-25  Score=212.23  Aligned_cols=181  Identities=20%  Similarity=0.298  Sum_probs=146.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      ..++|+..+.||+|+||.||+|.+..    .+..|++|.+... .......+.+|+.++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            34689999999999999999999865    3578999998754 344567789999999999999999999998876666


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGV-RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      .++++||+++++|.+++....... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999997643210 11246899999999999999999999877   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++.+.............++..|+|||.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~  190 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALES  190 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHH
Confidence            999987644332212223345667888664

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=1.5e-25  Score=214.66  Aligned_cols=147  Identities=27%  Similarity=0.416  Sum_probs=131.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.+..   ......+.+|+++++.++||||+++++.+.. +...++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence            47889999999999999999999889999999987643   2344578899999999999999999998765 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        80 ~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~  149 (305)
T cd05609          80 MEYVEGGDCATLLKNI-------GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK  149 (305)
T ss_pred             EecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCcc
Confidence            9999999999999764       45899999999999999999999877   9999999999999999999999999987


Q ss_pred             c
Q 017411          339 W  339 (372)
Q Consensus       339 ~  339 (372)
                      .
T Consensus       150 ~  150 (305)
T cd05609         150 I  150 (305)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.94  E-value=1e-25  Score=213.68  Aligned_cols=169  Identities=29%  Similarity=0.410  Sum_probs=140.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|+||.||+|....+++.||||.+..... .....+.+|++++++++||||+++++++.+ +...++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEe
Confidence            589999999999999999999988889999999875422 223456789999999999999999999876 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~~-~~L~~~~~~~~------~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  153 (291)
T cd07844          84 YLD-TDLKQYMDDCG------GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK  153 (291)
T ss_pred             cCC-CCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence            997 49999887643      36789999999999999999999887   999999999999999999999999999765


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..+..  ......++..|+|||.
T Consensus       154 ~~~~~--~~~~~~~~~~~~aPE~  174 (291)
T cd07844         154 SVPSK--TYSNEVVTLWYRPPDV  174 (291)
T ss_pred             CCCCc--cccccccccccCCcHH
Confidence            43322  1122346777888663

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=1.1e-25  Score=210.26  Aligned_cols=170  Identities=24%  Similarity=0.398  Sum_probs=142.1

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      +|+..+.||+|+||.||++....+++.||+|.+....      ....+.+.+|+.++++++||||+++++++.+.+ ..+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC-eEE
Confidence            4778899999999999999998889999999987532      224567899999999999999999999987654 489


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEecc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFG  335 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFG  335 (372)
                      +|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++ .+||+|||
T Consensus        80 ~v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg  149 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKY-------GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFG  149 (268)
T ss_pred             EEEeccCCCcHHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccc
Confidence            999999999999999764       46889999999999999999999887   99999999999998776 59999999


Q ss_pred             cccccCCCCCC--ccccccccCCCccCccc
Q 017411          336 LATWTSAPSVP--FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~--~~~~~~~GT~gy~apea  363 (372)
                      ++.........  .......|+..|+|||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~  179 (268)
T cd06630         150 AAARLAAKGTGAGEFQGQLLGTIAFMAPEV  179 (268)
T ss_pred             cccccccccccCCccccccccccceeCHhH
Confidence            99877543211  11233467888888763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=1.3e-25  Score=210.70  Aligned_cols=170  Identities=25%  Similarity=0.356  Sum_probs=141.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC----------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      +|...+.||+|+||.||+|....+++.||+|.++...          ....+.+.+|+.++++++||||+++++++... 
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence            4777899999999999999988889999999885321          11234678899999999999999999987764 


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~  150 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY-------GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKIS  150 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEe
Confidence            4589999999999999999764       45889999999999999999999877   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+++...............|+..|+|||.
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  181 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEV  181 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHH
Confidence            9999986654332222344568888998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=1.4e-25  Score=211.39  Aligned_cols=170  Identities=26%  Similarity=0.360  Sum_probs=144.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....  ......+.+|+.++++++||||+++++++.. +...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence            4788899999999999999998889999999987643  3445678999999999999999999999876 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+ +++|.+++....      ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~-~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~  149 (286)
T cd07832          80 YM-PSDLSEVLRDEE------RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLF  149 (286)
T ss_pred             cc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccc
Confidence            99 999999987643      46899999999999999999999887   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..... .......|+..|+|||..
T Consensus       150 ~~~~~-~~~~~~~~~~~y~aPE~~  172 (286)
T cd07832         150 SEEEP-RLYSHQVATRWYRAPELL  172 (286)
T ss_pred             cCCCC-CccccccCcccccCceee
Confidence            54432 112334688889987753

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=7.8e-26  Score=209.90  Aligned_cols=158  Identities=25%  Similarity=0.397  Sum_probs=131.7

Q ss_pred             eeEcccCceEEEEEEECCCC----------eEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          188 RVLGRGALSFVFKGKVGLLR----------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~----------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      +.||+|+||.||+|.+..++          ..|++|.+...... ...|.+|+.++++++||||+++++++.. . ..++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-D-ENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-C-CcEE
Confidence            46899999999999987655          35888887654333 6789999999999999999999999877 3 4689


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-------cEE
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-------IPK  330 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-------~~K  330 (372)
                      ||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++       .+|
T Consensus        78 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k  148 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK------NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK  148 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence            999999999999998653      36889999999999999999999877   99999999999999887       799


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+|||+++.....      ....++..|+|||.
T Consensus       149 l~Dfg~a~~~~~~------~~~~~~~~y~aPE~  175 (259)
T cd05037         149 LSDPGIPITVLSR------EERVERIPWIAPEC  175 (259)
T ss_pred             eCCCCcccccccc------cccccCCCccChhh
Confidence            9999999876432      22345666777654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.94  E-value=1.4e-25  Score=210.84  Aligned_cols=169  Identities=19%  Similarity=0.239  Sum_probs=132.9

Q ss_pred             eEcccCceEEEEEEECCC--CeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCC
Q 017411          189 VLGRGALSFVFKGKVGLL--RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~--~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      .||+|+||.||++.....  ...+++|.+.... ....+.+.+|+.+++.++||||+++++.|.+.. ..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAI-PYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCC-ccEEEEecCCCC
Confidence            599999999999975432  3456777776543 345678999999999999999999999987644 489999999999


Q ss_pred             CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 017411          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (372)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~  345 (372)
                      +|.+++......   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        81 ~L~~~l~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          81 DLKSYLSQEQWH---RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             cHHHHHHhhhcc---cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh
Confidence            999999764321   134677778899999999999999877   99999999999999999999999999865332221


Q ss_pred             CccccccccCCCccCcccc
Q 017411          346 PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       346 ~~~~~~~~GT~gy~apeaP  364 (372)
                      ........|+..|+|||..
T Consensus       155 ~~~~~~~~~~~~y~aPE~~  173 (268)
T cd05086         155 IETEDDKCVPLRWLAPELV  173 (268)
T ss_pred             hhcccCCcCcccccCchhc
Confidence            1122334677888887764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.94  E-value=2e-25  Score=210.35  Aligned_cols=171  Identities=26%  Similarity=0.361  Sum_probs=138.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHH-HHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~i-L~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||++.+..+++.||+|+++... ......+..|+.+ ++.++||||+++++++.... ..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-DVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEEh
Confidence            47899999999999999999999889999999987642 2333456667665 56678999999999987644 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||++ |+|.+++......   ...+++..++.++.||+.||.|||+. +   ++||||||+||+++.++.+||+|||+++
T Consensus        80 e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDK---GLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             hhhc-ccHHHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccc
Confidence            9996 6898888764321   15689999999999999999999975 5   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......   .....|+..|+|||.
T Consensus       153 ~~~~~~~---~~~~~~~~~y~aPE~  174 (283)
T cd06617         153 YLVDSVA---KTIDAGCKPYMAPER  174 (283)
T ss_pred             ccccccc---cccccCCccccChhh
Confidence            7643221   123467888888774

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=3.7e-27  Score=248.67  Aligned_cols=178  Identities=28%  Similarity=0.269  Sum_probs=154.1

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      .++....++|.+.++||+|+||.|..++++.+++.||+|++++-   .......|..|-.+|..-+.+.|+.+.-.|.+ 
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-  146 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-  146 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence            44556678999999999999999999999999999999999873   23445678899999999999999999877766 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      +.++|+|||||+||+|-.++.+.       ..+|+..++.++..|..||.-||..+   +|||||||+|||||..|++||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~-------~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF-------DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc-------CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEee
Confidence            56699999999999999999875       46899999999999999999999887   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||.+-.+..... ..+...+|||-|++||+-
T Consensus       217 ADFGsClkm~~dG~-V~s~~aVGTPDYISPEvL  248 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGT-VRSSVAVGTPDYISPEVL  248 (1317)
T ss_pred             ccchhHHhcCCCCc-EEeccccCCCCccCHHHH
Confidence            99998876664443 245667899999998764

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.94  E-value=1.4e-25  Score=211.48  Aligned_cols=169  Identities=26%  Similarity=0.386  Sum_probs=142.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++... ...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEE
Confidence            47888999999999999999998889999999986432  23345678999999999999999999988764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++++.|..++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  149 (286)
T cd07847          80 EYCDHTVLNELEKNP-------RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARI  149 (286)
T ss_pred             eccCccHHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECcccccee
Confidence            999998888876543       35899999999999999999999877   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  ......++..|+|||.
T Consensus       150 ~~~~~~--~~~~~~~~~~~~aPE~  171 (286)
T cd07847         150 LTGPGD--DYTDYVATRWYRAPEL  171 (286)
T ss_pred             cCCCcc--cccCcccccccCCHHH
Confidence            754432  1123456778888775

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=1.2e-25  Score=212.60  Aligned_cols=178  Identities=24%  Similarity=0.331  Sum_probs=144.0

Q ss_pred             CCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+|+..+.||+|+||.||++...     .++..+|+|.+..........+.+|++++++++|+||+++++++.+.. ..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR-PLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC-ceE
Confidence            47788899999999999999742     346689999988777677778999999999999999999999887644 489


Q ss_pred             EEEeccCCCCHHHHHHhhccC--------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          257 LIYKYVSGGSLERHLHEKKKG--------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~--------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ++|||+++++|.+++......        ......+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCC
Confidence            999999999999999764311        011135889999999999999999999877   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+++...............+++.|+|||.
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPES  195 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHH
Confidence            99999999986643322222233345677888663

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=1.3e-25  Score=215.26  Aligned_cols=180  Identities=22%  Similarity=0.311  Sum_probs=141.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      .++|.+.+.||+|+||.||++....       ....+|+|.++.. .......+.+|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4689999999999999999998642       2346999999764 234456788999999999 799999999998764


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NIL  322 (372)
                      + ..++||||+++|+|.+++.......         .....+++..++.++.|++.||.|||..+   ++||||||+||+
T Consensus        97 ~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil  172 (307)
T cd05098          97 G-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  172 (307)
T ss_pred             C-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence            4 5899999999999999997653210         11235899999999999999999999877   999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       323 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.++.+||+|||+++...............++..|+|||.-
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  214 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  214 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHh
Confidence            999999999999999866432211111122344678887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=2e-25  Score=214.13  Aligned_cols=171  Identities=27%  Similarity=0.451  Sum_probs=134.0

Q ss_pred             ceeEcccCceEEEEEEECC--CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc-CCCeEEEEEeccC
Q 017411          187 GRVLGRGALSFVFKGKVGL--LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVS  263 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~~~~lV~Ey~~  263 (372)
                      +..||+|+||.||+|....  ++..||+|.+....  ....+.+|++++++++||||+++++++.. .+...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3689999999999999753  56789999987543  23457899999999999999999998764 3445789999986


Q ss_pred             CCCHHHHHHhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE----cCCCcEEEEecccc
Q 017411          264 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA  337 (372)
Q Consensus       264 ~gsL~~~L~~~~~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl----d~~~~~KL~DFGla  337 (372)
                       ++|.+++......  ......+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             5888887543211  111245889999999999999999999887   9999999999999    56679999999999


Q ss_pred             cccCCCCCCc-cccccccCCCccCccc
Q 017411          338 TWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +......... ......||+.|+|||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~  186 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPEL  186 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHH
Confidence            8775443221 1234568899999774

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.94  E-value=1.9e-25  Score=209.12  Aligned_cols=173  Identities=25%  Similarity=0.354  Sum_probs=139.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCe---EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|....++.   .+|+|.++.. .....+.+.+|++++++++||||+++++++.+.+ ..+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK-PAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC-CcE
Confidence            3578889999999999999999865443   7999998754 3445667899999999999999999999887644 489


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++++|.+++....      ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+
T Consensus        83 lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  153 (268)
T cd05063          83 IITEYMENGALDKYLRDHD------GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGL  153 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcc
Confidence            9999999999999997642      46899999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccc-cccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLC-KTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~-~~~~GT~gy~apea  363 (372)
                      ++........... .....+..|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~  181 (268)
T cd05063         154 SRVLEDDPEGTYTTSGGKIPIRWTAPEA  181 (268)
T ss_pred             ceecccccccceeccCCCcCceecCHHH
Confidence            9876533221111 11122345777653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.94  E-value=1.3e-25  Score=212.04  Aligned_cols=181  Identities=25%  Similarity=0.318  Sum_probs=149.8

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      .++.++..+...|+..+.||+|+||.||+|.+..+++.||+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355566667789999999999999999999998889999999986643 3345688899999998 69999999998853


Q ss_pred             C-----CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC
Q 017411          251 P-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       251 ~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~  325 (372)
                      .     ....+++|||+++|+|.+++.....     ..+++..+..++.||+.||.|||+.+   |+|+||||+||+++.
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~  156 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-----NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTE  156 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECC
Confidence            2     3457999999999999999976432     45788889999999999999999887   999999999999999


Q ss_pred             CCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.++|+|||+++.......  ......|++.|+|||.
T Consensus       157 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  192 (282)
T cd06636         157 NAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEV  192 (282)
T ss_pred             CCCEEEeeCcchhhhhcccc--CCCcccccccccCHhh
Confidence            99999999999886543221  1234568889999774

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=1.6e-25  Score=207.05  Aligned_cols=172  Identities=31%  Similarity=0.433  Sum_probs=141.7

Q ss_pred             eeEcccCceEEEEEEECCC---CeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.....   +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+ ....++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            4699999999999998755   789999999865333 36788999999999999999999998877 555899999999


Q ss_pred             CCCHHHHHHhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          264 GGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       264 ~gsL~~~L~~~~~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|.+++......  ......+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  156 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY  156 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence            99999999875210  000156899999999999999999999877   9999999999999999999999999998876


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ............++..|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~  178 (262)
T cd00192         157 DDDYYRKKTGGKLPIRWMAPES  178 (262)
T ss_pred             cccccccccCCCcCccccCHHH
Confidence            5432222344567778888663

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.94  E-value=2.3e-25  Score=206.54  Aligned_cols=177  Identities=27%  Similarity=0.354  Sum_probs=146.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~lV~  259 (372)
                      +|+..+.||.|+||.||++.+..++..||+|.+...  .....+.+.+|+.++++++||||+++++++... ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999999888999999998753  344556788999999999999999999987643 34578999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||+++++|.+++......   ...+++..++.++.|++.||.|||..+  ..+|+|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKE---RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999764321   257899999999999999999999332  234999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ........  ......|+..|+|||.-
T Consensus       158 ~~~~~~~~--~~~~~~~~~~~~~pE~~  182 (265)
T cd08217         158 KILGHDSS--FAKTYVGTPYYMSPEQL  182 (265)
T ss_pred             ccccCCcc--cccccccCCCccChhhh
Confidence            87754432  12345688899997753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=1.7e-25  Score=215.39  Aligned_cols=180  Identities=21%  Similarity=0.335  Sum_probs=140.5

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      ..++|.+.+.||+|+||.||+++..       .....||+|.+... .......+.+|+++++++ +||||+++++++.+
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3458889999999999999999753       23457999998754 334456788999999999 69999999998876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      . ...++||||+++|+|.+++.......         .....+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus        90 ~-~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          90 E-GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             C-CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            4 45899999999999999997643210         11245899999999999999999999877   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |++.++.+||+|||+++...............++..|+|||.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  207 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEA  207 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHH
Confidence            999999999999999987643222111112233456777664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.8e-26  Score=221.08  Aligned_cols=173  Identities=25%  Similarity=0.350  Sum_probs=144.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeeEEcCCC---e
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPEQ---G  254 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~~~~---~  254 (372)
                      ...+.+..+.||+|.||.||+|.++  |+.||||++...++   +.+.+|.++.+.  |+|+||+.+++.-..+.+   .
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            3457788899999999999999998  78999999976443   567889998876  599999999987543333   2


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----cCCCCceEEcCCCCCCEEEcCCCcE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-----NGTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                      +|||.+|-+.|+|.++|.+        ..++....+++++.+|.||+|||     .+++|.|.|||||+.|||+..++..
T Consensus       284 LwLvTdYHe~GSL~DyL~r--------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C  355 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR--------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  355 (513)
T ss_pred             EEEeeecccCCcHHHHHhh--------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence            7999999999999999987        46899999999999999999999     4678889999999999999999999


Q ss_pred             EEEecccccccCCCCC--CccccccccCCCccCccccc
Q 017411          330 KLCDFGLATWTSAPSV--PFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       330 KL~DFGla~~~~~~~~--~~~~~~~~GT~gy~apeaPE  365 (372)
                      -|+|+|||........  .-.....+||-.|||||+-.
T Consensus       356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLd  393 (513)
T KOG2052|consen  356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLD  393 (513)
T ss_pred             EEeeceeeEEecccCCcccCCCCCccceeeccChHHhh
Confidence            9999999976654321  11234568999999988643

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=9.2e-26  Score=213.28  Aligned_cols=158  Identities=22%  Similarity=0.354  Sum_probs=129.0

Q ss_pred             eEcccCceEEEEEEECC------------------------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeece
Q 017411          189 VLGRGALSFVFKGKVGL------------------------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL  244 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~------------------------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l  244 (372)
                      .||+|+||.||+|....                        ....||+|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            58999999999997531                        123589999876655556778999999999999999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld  324 (372)
                      +++|.+.. ..++||||+++|+|..++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++
T Consensus        82 ~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~  151 (274)
T cd05076          82 HGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK------GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLA  151 (274)
T ss_pred             EEEEEeCC-ceEEEEecCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEe
Confidence            99988754 4789999999999999987532      46889999999999999999999877   99999999999997


Q ss_pred             CCC-------cEEEEecccccccCCCCCCccccccccCCCccCcc
Q 017411          325 SKK-------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       325 ~~~-------~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      ..+       .+|++|||++.......      ...++..|+|||
T Consensus       152 ~~~~~~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe  190 (274)
T cd05076         152 RLGLAEGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPE  190 (274)
T ss_pred             ccCcccCccceeeecCCcccccccccc------ccccCCcccCch
Confidence            654       48999999986543221      234677788866

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.93  E-value=1.8e-25  Score=207.10  Aligned_cols=168  Identities=32%  Similarity=0.454  Sum_probs=143.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      +|+..+.||+|+||.||+|....++..|++|.+....     ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEE
Confidence            3667789999999999999998788999999986532     34556789999999999999999999988764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++
T Consensus        80 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~  149 (258)
T cd06632          80 FLELVPGGSLAKLLKKY-------GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMA  149 (258)
T ss_pred             EEEecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccc
Confidence            99999999999999754       35889999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......   ......|+..|++||..
T Consensus       150 ~~~~~~~---~~~~~~~~~~y~~pe~~  173 (258)
T cd06632         150 KQVVEFS---FAKSFKGSPYWMAPEVI  173 (258)
T ss_pred             eeccccc---cccccCCCcceeCHHHh
Confidence            8765433   12345688889887654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.93  E-value=1.4e-25  Score=213.45  Aligned_cols=168  Identities=27%  Similarity=0.409  Sum_probs=141.3

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-----hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      +|+..+.||+|+||.||+|....+++.||||.+.....     .....+..|++++++++|+||+++++++.+ ....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            47788999999999999999988899999999976432     234567789999999999999999999877 556899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+ +++|.+++....      ..+++..+..++.||++||.|||..+   |+|+||||+||+++.++.+||+|||++
T Consensus        80 v~e~~-~~~L~~~i~~~~------~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~  149 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS------IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA  149 (298)
T ss_pred             EEccc-CCCHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceee
Confidence            99999 899999997542      26899999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +........  .....+++.|+|||.
T Consensus       150 ~~~~~~~~~--~~~~~~~~~y~aPE~  173 (298)
T cd07841         150 RSFGSPNRK--MTHQVVTRWYRAPEL  173 (298)
T ss_pred             eeccCCCcc--ccccccceeeeCHHH
Confidence            877554321  123346677888663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=1.3e-25  Score=212.78  Aligned_cols=178  Identities=26%  Similarity=0.385  Sum_probs=141.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++|+..+.||+|+||.||++....     ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+ .
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~-~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK-P   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC-c
Confidence            4689999999999999999998742     5678999998764 3445567999999999999999999999887644 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCC
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGV---------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~---------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~  319 (372)
                      .++|+||+++|+|.+++.......               .....+++..++.++.|++.||.|||..+   ++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            899999999999999997542110               11135789999999999999999999877   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcc
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      ||+++.++.+||+|||+++...............++..|+|||
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE  202 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHH
Confidence            9999999999999999987654332211112223445577655

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.93  E-value=1.4e-25  Score=217.87  Aligned_cols=180  Identities=21%  Similarity=0.318  Sum_probs=141.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      ..+|++.+.||+|+||.||++....       ....||+|.++.. .....+.+.+|+++++++ +||||++++++|.+.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3478999999999999999997632       1236899988754 334567899999999999 799999999998764


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NIL  322 (372)
                       ...++++||+++|+|.+++......         ......+++..++.++.|++.||.|||..+   |+||||||+|||
T Consensus        91 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  166 (334)
T cd05100          91 -GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL  166 (334)
T ss_pred             -CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence             4589999999999999999764311         011246889999999999999999999877   999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       323 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.++.+||+|||+++...............++..|+|||.-
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  208 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL  208 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHh
Confidence            999999999999999876543221112223345568876643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.93  E-value=1.5e-26  Score=210.30  Aligned_cols=189  Identities=26%  Similarity=0.310  Sum_probs=155.9

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc----CCCe
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID----PEQG  254 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----~~~~  254 (372)
                      ...++|.+.+.||+|||+.||+++...++..||+|++.....+..+..++|++..++++||||+++++++..    ....
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~   97 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE   97 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence            455789999999999999999999888999999999988777888889999999999999999999988753    3345


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .||++.|...|+|.+.+...+..   ...+++.+.+.|+.+|++||++||... ++.+||||||.|||+.+++.++|.||
T Consensus        98 ~yll~Pyy~~Gsl~d~i~~~k~k---g~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   98 AYLLLPYYKRGSLLDEIERLKIK---GNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             EEEEeehhccccHHHHHHHHhhc---CCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEec
Confidence            89999999999999999876432   257999999999999999999999886 57999999999999999999999999


Q ss_pred             ccccccCCC----CCCccccccccCCCccCccccccccccC
Q 017411          335 GLATWTSAP----SVPFLCKTVKGTFGQNPFCIEEWQRLKS  371 (372)
Q Consensus       335 Gla~~~~~~----~~~~~~~~~~GT~gy~apeaPE~~~~~~  371 (372)
                      |.++...-.    ...........-...++|+|||...+++
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~  214 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS  214 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence            998765311    1111111222334567888899877654

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=1.8e-25  Score=208.90  Aligned_cols=169  Identities=27%  Similarity=0.419  Sum_probs=139.9

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      |.....||+|+||.||+|....+++.||+|.+.....         ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~   80 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-DH   80 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-Cc
Confidence            6677899999999999999988889999998865321         2235688999999999999999999988764 45


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++|+||+++++|.+++...       ..+++..+..++.|++.||.|||..+   ++||||+|+||+++.++.+||+||
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-------GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-------cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEeccc
Confidence            89999999999999999764       45888999999999999999999877   999999999999999999999999


Q ss_pred             ccccccCCCCCCc----cccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPF----LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~----~~~~~~GT~gy~apea  363 (372)
                      |+++.........    ......|+..|+|||.
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~  183 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEV  183 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhH
Confidence            9998775322111    1123457788888764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3e-25  Score=207.76  Aligned_cols=172  Identities=30%  Similarity=0.396  Sum_probs=143.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~  255 (372)
                      .+|...+.||+|+||.||+|.+..++..||+|.+...     .......+.+|++++++++||||+++++++.+.. ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4789999999999999999999888999999987532     2344567889999999999999999999876643 347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++|+||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-------GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccc
Confidence            8999999999999998754       35788999999999999999999887   9999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccCCCccCccc
Q 017411          336 LATWTSAPSVP-FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~-~~~~~~~GT~gy~apea  363 (372)
                      +++........ .......|+..|+|||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  180 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEV  180 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhh
Confidence            99876432111 11123568888888764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.93  E-value=1.6e-25  Score=209.80  Aligned_cols=171  Identities=26%  Similarity=0.345  Sum_probs=139.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ..+|.+.+.||+|+||.||+|.+..+ ..||+|.++.... ..+.+.+|+.++++++||||+++++.+.+  ...++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e   80 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE   80 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEE
Confidence            35799999999999999999988654 4699999975432 34578999999999999999999987643  34789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++|+|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~  152 (262)
T cd05071          81 YMSKGSLLDFLKGEMG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  152 (262)
T ss_pred             cCCCCcHHHHHhhccc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeec
Confidence            9999999999976422     45789999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...... ......++..|+|||.-
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~  175 (262)
T cd05071         153 EDNEYT-ARQGAKFPIKWTAPEAA  175 (262)
T ss_pred             cccccc-cccCCcccceecCHhHh
Confidence            544321 11223456678887643

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.93  E-value=2e-25  Score=212.82  Aligned_cols=177  Identities=24%  Similarity=0.341  Sum_probs=140.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECC----------------CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeece
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGL----------------LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPL  244 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~----------------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l  244 (372)
                      ++|++.+.||+|+||.||++....                +...||+|.+... .......+.+|+.++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            579999999999999999986432                2457999999754 34456789999999999999999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCC
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV----RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~----~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~N  320 (372)
                      ++++...+ ..++||||+++++|.+++.......    .....+++..+..++.|++.||.|||+.+   |+||||||+|
T Consensus        85 ~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          85 LAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEecCC-ccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99887644 4899999999999999997643211    11235788899999999999999999887   9999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcc
Q 017411          321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       321 ILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      ||++.++.++|+|||+++...............++..|++||
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence            999999999999999998664332211122233456677765

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=1.4e-25  Score=214.98  Aligned_cols=172  Identities=28%  Similarity=0.434  Sum_probs=140.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe----EEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+|+..+.||+|+||.||+|.+..++.    .||+|.+.... ......+.+|+.++++++||||++++++|....  .+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~--~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT--IQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC--ce
Confidence            578888999999999999999866554    57899887543 333457889999999999999999999886532  57


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +++||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        85 ~v~e~~~~g~l~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~  155 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK------DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGL  155 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccc
Confidence            9999999999999987643      35889999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++...............++..|+|||.-
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~  183 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECI  183 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHh
Confidence            9876544332222233456678886643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.93  E-value=9.4e-26  Score=212.86  Aligned_cols=170  Identities=28%  Similarity=0.392  Sum_probs=143.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++.+..  ....+.+.+|+++++.++||||+++++++.+ +...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            47888999999999999999998889999999986532  2345678899999999999999999999865 45589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|..+....       ..+++..++.++.||+.||.|||+.+   |+|+||+|+||+++.++.++|+|||+++.
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~  149 (286)
T cd07846          80 EFVDHTVLDDLEKYP-------NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFART  149 (286)
T ss_pred             ecCCccHHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeee
Confidence            999999998876543       35899999999999999999999877   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......  ......++..|+|||..
T Consensus       150 ~~~~~~--~~~~~~~~~~y~aPE~~  172 (286)
T cd07846         150 LAAPGE--VYTDYVATRWYRAPELL  172 (286)
T ss_pred             ccCCcc--ccCcccceeeccCcHHh
Confidence            654432  22334678889987753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.93  E-value=2.6e-25  Score=207.98  Aligned_cols=165  Identities=30%  Similarity=0.413  Sum_probs=133.2

Q ss_pred             eEcccCceEEEEEEEC--CCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCC
Q 017411          189 VLGRGALSFVFKGKVG--LLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      .||+|+||.||+|.+.  ..+..||+|++.... ....+.+.+|+.++++++||||+++++++.. + ..++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~-~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-E-ALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-C-CeEEEEEeCCCC
Confidence            4899999999999764  345679999987653 3445679999999999999999999998753 3 478999999999


Q ss_pred             CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 017411          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (372)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~  345 (372)
                      +|.+++....      ..+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          80 PLNKFLSGKK------DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS  150 (257)
T ss_pred             CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCcc
Confidence            9999997543      46899999999999999999999877   99999999999999999999999999986654432


Q ss_pred             Cccc-cccccCCCccCcccc
Q 017411          346 PFLC-KTVKGTFGQNPFCIE  364 (372)
Q Consensus       346 ~~~~-~~~~GT~gy~apeaP  364 (372)
                      .... ....++..|+|||.-
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~  170 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECI  170 (257)
T ss_pred             ceeccCCCCCCcccCCHHHH
Confidence            1111 112235678887643

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.93  E-value=1.8e-25  Score=208.33  Aligned_cols=167  Identities=25%  Similarity=0.392  Sum_probs=134.7

Q ss_pred             eeEcccCceEEEEEEECC---CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|....   ....||+|.+... .....+.+.+|+.+++.++||||+++++++...+...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   3467999998643 345567889999999999999999999988765666889999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++....      ..+++..+..++.|++.||.|||..+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~  151 (262)
T cd05058          81 HGDLRNFIRSET------HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK  151 (262)
T ss_pred             CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence            999999997542      34677888899999999999999877   999999999999999999999999999865432


Q ss_pred             CCC--ccccccccCCCccCccc
Q 017411          344 SVP--FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       344 ~~~--~~~~~~~GT~gy~apea  363 (372)
                      ...  .......++..|+|||.
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~  173 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALES  173 (262)
T ss_pred             cceeecccccCcCCccccChhH
Confidence            210  11123455677888764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.7e-25  Score=213.56  Aligned_cols=151  Identities=31%  Similarity=0.391  Sum_probs=133.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++....+++.||+|.+.+...   ...+.+.+|+++++.++||||+++++.+.+ ....++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence            378899999999999999999988899999999976532   345678899999999999999999998766 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+.+++|.+++.....     ..+++..+..++.|++.||.|||..+   ++|+||||+||+++.++.++|+|||++.
T Consensus        80 ~e~~~~~~L~~~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~  151 (316)
T cd05574          80 MDYCPGGELFRLLQRQPG-----KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSK  151 (316)
T ss_pred             EEecCCCCHHHHHHhCCC-----CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhh
Confidence            999999999999875432     46899999999999999999999877   9999999999999999999999999987


Q ss_pred             ccC
Q 017411          339 WTS  341 (372)
Q Consensus       339 ~~~  341 (372)
                      ...
T Consensus       152 ~~~  154 (316)
T cd05574         152 QSD  154 (316)
T ss_pred             ccc
Confidence            653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.93  E-value=1.2e-25  Score=212.29  Aligned_cols=168  Identities=26%  Similarity=0.379  Sum_probs=140.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|++++++++||||+++++++.+. ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEe
Confidence            4778899999999999999999889999999987532  22335678899999999999999999988764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++....      ..+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        80 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  149 (284)
T cd07839          80 YCD-QDLKKYFDSCN------GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAF  149 (284)
T ss_pred             cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhcc
Confidence            996 58888876532      45899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  .....++..|+|||.
T Consensus       150 ~~~~~~--~~~~~~~~~y~aPE~  170 (284)
T cd07839         150 GIPVRC--YSAEVVTLWYRPPDV  170 (284)
T ss_pred             CCCCCC--cCCCccccCCcChHH
Confidence            543321  223457888888774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.93  E-value=2e-25  Score=208.39  Aligned_cols=169  Identities=25%  Similarity=0.372  Sum_probs=137.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|...+.||+|+||.||++.... +..||+|.+.... .....+.+|+.++++++||||+++++++.+.. ..++||||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~   80 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR-PIYIVTEY   80 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCC-CcEEEEEc
Confidence            468888999999999999998764 4569999987543 23467899999999999999999999886644 47999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~  151 (256)
T cd05113          81 MSNGCLLNYLREHG------KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVL  151 (256)
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecC
Confidence            99999999997642      35899999999999999999999877   9999999999999999999999999998764


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+... ......++..|+|||.
T Consensus       152 ~~~~~-~~~~~~~~~~y~~pe~  172 (256)
T cd05113         152 DDEYT-SSVGSKFPVRWSPPEV  172 (256)
T ss_pred             CCcee-ecCCCccChhhCCHHH
Confidence            43221 1111234556777654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=2.8e-25  Score=208.35  Aligned_cols=170  Identities=25%  Similarity=0.362  Sum_probs=140.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|...+.||+|+||.||+|.+...   ...||||...... ....+.+.+|+.++++++||||+++++++.+ + ..++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~-~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N-PVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C-CcEE
Confidence            4688889999999999999987543   3579999887654 4556789999999999999999999998764 3 3689


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++
T Consensus        84 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~  154 (270)
T cd05056          84 VMELAPLGELRSYLQVNK------YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLS  154 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCcee
Confidence            999999999999997642      35899999999999999999999877   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +........ ......++..|+|||.
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~y~aPE~  179 (270)
T cd05056         155 RYLEDESYY-KASKGKLPIKWMAPES  179 (270)
T ss_pred             eecccccce-ecCCCCccccccChhh
Confidence            876544221 1222334567888764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.1e-25  Score=206.25  Aligned_cols=167  Identities=27%  Similarity=0.459  Sum_probs=141.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||.|+||.||+|...  ++.||+|.+..... ..+.+.+|+.++++++|+||+++++++.+ ....++|||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   80 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTE   80 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEE
Confidence            357888899999999999999875  68899999976544 56789999999999999999999999876 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~  152 (256)
T cd05039          81 YMAKGSLVDYLRSRGR-----AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEA  152 (256)
T ss_pred             ecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccc
Confidence            9999999999976432     36899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....     ...++.+|+|||..
T Consensus       153 ~~~~~-----~~~~~~~~~ape~~  171 (256)
T cd05039         153 SQGQD-----SGKLPVKWTAPEAL  171 (256)
T ss_pred             ccccc-----cCCCcccccCchhh
Confidence            43221     22345678887654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.93  E-value=9.5e-26  Score=215.28  Aligned_cols=167  Identities=25%  Similarity=0.365  Sum_probs=141.8

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      .|.....||+|+||.||++....++..||||.+........+.+.+|+.+++.++||||+++++.+... ...++||||+
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~  101 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFL  101 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCC
Confidence            344446799999999999999888999999999776666667789999999999999999999988764 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       102 ~~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (292)
T cd06658         102 EGGALTDIVTH--------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK  170 (292)
T ss_pred             CCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence            99999998854        35789999999999999999999887   99999999999999999999999999976543


Q ss_pred             CCCCccccccccCCCccCccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...  ......|+..|+|||.
T Consensus       171 ~~~--~~~~~~~~~~y~aPE~  189 (292)
T cd06658         171 EVP--KRKSLVGTPYWMAPEV  189 (292)
T ss_pred             ccc--cCceeecCccccCHHH
Confidence            322  1234568888998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=2.4e-25  Score=208.95  Aligned_cols=160  Identities=26%  Similarity=0.384  Sum_probs=131.3

Q ss_pred             eeEcccCceEEEEEEECC------------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          188 RVLGRGALSFVFKGKVGL------------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~------------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      +.||+|+||.||+|....            ....|++|.+..........|.+|+.+++.++||||+++++++.+.. ..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~-~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV-EN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CC
Confidence            368999999999998532            12368999987665556668899999999999999999999987654 47


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc-------
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-------  328 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~-------  328 (372)
                      ++||||+++|+|..++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.       
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~  150 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS------DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF  150 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence            89999999999999887542      45899999999999999999999877   999999999999987664       


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|++|||++......      ....|+..|+|||.
T Consensus       151 ~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~  179 (262)
T cd05077         151 IKLSDPGIPITVLSR------QECVERIPWIAPEC  179 (262)
T ss_pred             eEeCCCCCCccccCc------ccccccccccChhh
Confidence            899999998765422      22356777888664

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.93  E-value=2e-25  Score=207.94  Aligned_cols=168  Identities=27%  Similarity=0.431  Sum_probs=136.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      +|+..+.||+|+||.||++.+.. +..+|+|.+.+... ....+.+|++++++++||||+++++++... ...++||||+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~   81 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYM   81 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecC
Confidence            57788999999999999998864 56899999865432 335688999999999999999999987654 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++....      ..+++..++.++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~  152 (256)
T cd05059          82 ANGCLLNYLRERK------GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLD  152 (256)
T ss_pred             CCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccc
Confidence            9999999997543      36899999999999999999999887   99999999999999999999999999987653


Q ss_pred             CCCCccccccccCCCccCccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apea  363 (372)
                      .... ......++..|+|||.
T Consensus       153 ~~~~-~~~~~~~~~~y~~Pe~  172 (256)
T cd05059         153 DQYT-SSQGTKFPVKWAPPEV  172 (256)
T ss_pred             cccc-ccCCCCCCccccCHHH
Confidence            3221 1111123346777553

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=2.4e-25  Score=213.38  Aligned_cols=176  Identities=26%  Similarity=0.377  Sum_probs=138.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|.+..++.  .+|+|.++.. .......+.+|++++.++ +||||+++++++... ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~   84 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLY   84 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCce
Confidence            3588889999999999999999876664  4688877643 344556788999999999 899999999988664 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          257 LIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      +||||+++++|.+++.......         .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCC
Confidence            9999999999999997643210         01236889999999999999999999877   99999999999999999


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+||+|||+++.......   .....++..|+|||.
T Consensus       162 ~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  194 (303)
T cd05088         162 VAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIES  194 (303)
T ss_pred             cEEeCccccCcccchhhh---cccCCCcccccCHHH
Confidence            999999999864321111   111223556777664

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.93  E-value=1.8e-25  Score=208.11  Aligned_cols=167  Identities=30%  Similarity=0.401  Sum_probs=143.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +|+..+.||.|+||.||++.+..+++.||+|.+.+..   ....+.+.+|++++++++||||+++++.+.+ +...++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            5888999999999999999998889999999997542   2456788999999999999999999998765 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++...       ..+++..+..++.|+++||.|||..+   |+|+||+|+||+++.++.++|+|||++..
T Consensus        80 e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~  149 (258)
T cd05578          80 DLLLGGDLRYHLSQK-------VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATK  149 (258)
T ss_pred             eCCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccc
Confidence            999999999999764       36889999999999999999999887   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....   ......|+..|+|||.
T Consensus       150 ~~~~~---~~~~~~~~~~y~~PE~  170 (258)
T cd05578         150 VTPDT---LTTSTSGTPGYMAPEV  170 (258)
T ss_pred             cCCCc---cccccCCChhhcCHHH
Confidence            65432   1234567788888664

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.93  E-value=3.1e-25  Score=205.51  Aligned_cols=168  Identities=26%  Similarity=0.326  Sum_probs=146.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||+|....++..|++|.+.....  .+.+.+|++++++++||||+++++++.+. ...++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEec
Confidence            678899999999999999999988889999999976433  67899999999999999999999988765 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~~~L~~~l~~~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~  150 (256)
T cd06612          80 CGAGSVSDIMKITN------KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLT  150 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcc
Confidence            99999999997543      56899999999999999999999887   9999999999999999999999999998775


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......|+..|+|||.
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~  170 (256)
T cd06612         151 DTMA--KRNTVIGTPFWMAPEV  170 (256)
T ss_pred             cCcc--ccccccCCccccCHHH
Confidence            4432  2234458889999775

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.93  E-value=3.9e-25  Score=208.45  Aligned_cols=170  Identities=25%  Similarity=0.385  Sum_probs=142.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +|+..+.||+|++|.||+|++..+++.||||.++... ......+.+|++++++++||||+++++++.+.+ ..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTEN-KLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCC-cEEEEEec
Confidence            5888999999999999999998889999999987653 223456788999999999999999999987754 48999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++ +|.+++.....    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus        80 ~~~-~l~~~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          80 MDK-DLKKYMDTHGV----RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             CCc-cHHHHHHhcCC----CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            975 89888865432    146899999999999999999999887   9999999999999999999999999998664


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......++..|++||.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~  171 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDV  171 (284)
T ss_pred             CCcc--ccccccccccccChHH
Confidence            4322  1123457888888774

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=1.5e-25  Score=212.22  Aligned_cols=167  Identities=29%  Similarity=0.369  Sum_probs=143.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|+||.||++....+++.||+|++... .....+.+.+|+++++.++||||+++++++... ...++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEe
Confidence            4788889999999999999999888999999988654 344567899999999999999999999998775 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+++++|.+++...       ..+++..+..++.+++.||.|||+ .+   |+||||||+||+++.++.++|+|||++..
T Consensus        84 ~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~  153 (284)
T cd06620          84 FMDCGSLDRIYKKG-------GPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGE  153 (284)
T ss_pred             cCCCCCHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccc
Confidence            99999999998764       468999999999999999999996 34   99999999999999999999999999876


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....    .....|+..|+|||.
T Consensus       154 ~~~~~----~~~~~~~~~~~aPE~  173 (284)
T cd06620         154 LINSI----ADTFVGTSTYMSPER  173 (284)
T ss_pred             hhhhc----cCccccCcccCCHHH
Confidence            53322    234568889998775

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.93  E-value=4e-25  Score=208.97  Aligned_cols=170  Identities=30%  Similarity=0.373  Sum_probs=138.1

Q ss_pred             eeeceeEcccCceEEEEEEE----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  257 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~l  257 (372)
                      |+..+.||+|+||+||++..    ..++..||+|.++... ......+.+|++++++++||||+++++++.... ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48889999999999988653    3457789999987643 345567889999999999999999999876543 35789


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        86 v~e~~~~~~l~~~~~~--------~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          86 IMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EecCCCCCCHHHHHHH--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccc
Confidence            9999999999999965        35899999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCcc-ccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFL-CKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~-~~~~~GT~gy~apeaP  364 (372)
                      +.......... .....++..|+|||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~  182 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECL  182 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHh
Confidence            87654332111 1222345568887754

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.93  E-value=2.8e-25  Score=206.42  Aligned_cols=167  Identities=26%  Similarity=0.358  Sum_probs=139.4

Q ss_pred             eeEcccCceEEEEEEECC-CC--eEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGL-LR--TSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-~~--~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.+.. .+  ..||||.+..... ...+.+.+|+.++++++||||+++++++.+  ...++|+||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999998754 22  3699999987655 667789999999999999999999999876  55899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +++|.+++.....     ..+++..++.++.|++.||.|||..+   ++|+||||+||+++.++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          79 LGSLLDRLRKDAL-----GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             CCcHHHHHHhccc-----ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccc
Confidence            9999999976431     36899999999999999999999877   999999999999999999999999999887553


Q ss_pred             CCCc-cccccccCCCccCcccc
Q 017411          344 SVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      .... ......++.+|+|||.-
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~  172 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESL  172 (257)
T ss_pred             ccceecccCCCCCceecCHHHh
Confidence            3221 11234577889987743

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.93  E-value=2.4e-25  Score=211.44  Aligned_cols=170  Identities=26%  Similarity=0.388  Sum_probs=142.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+|....+++.+|+|.++...  ......+.+|+.++++++||||+++++++...+ ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            47888899999999999999998889999999997542  223345778999999999999999999887642 558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+. ++|.+++....      ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++
T Consensus        85 ~e~~~-~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          85 MEYVE-HDLKSLMETMK------QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             ehhcC-cCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            99997 59999987643      35899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....+..  ......+++.|+|||.
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~  177 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPEL  177 (293)
T ss_pred             eccCCcc--ccccccccccccCchh
Confidence            7765432  1233457888998774

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.93  E-value=2.6e-25  Score=208.91  Aligned_cols=177  Identities=26%  Similarity=0.303  Sum_probs=141.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .+|+..+.||+|+||.||+|+...     ..+.|++|.+...... ..+.+.+|++++++++||||+++++++.+. ...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-Ccc
Confidence            578899999999999999998643     3467999998765433 456799999999999999999999987654 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVR--GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ++||||+++|+|.+++........  ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcc
Confidence            999999999999999976532110  0126899999999999999999999887   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++........ ......++..|+|||.
T Consensus       161 ~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~  189 (275)
T cd05046         161 LSLSKDVYNSEYY-KLRNALIPLRWLAPEA  189 (275)
T ss_pred             cccccccCccccc-ccCCceeEEeecChhh
Confidence            9998755332211 1122345667888664

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.93  E-value=5.2e-25  Score=204.90  Aligned_cols=170  Identities=28%  Similarity=0.439  Sum_probs=144.2

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||+|....++..||+|.++....  ...+.+.+|+.++++++|+||+++++++... ...++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEe
Confidence            47788999999999999999988889999999876543  3667899999999999999999999987654 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~  149 (264)
T cd06626          80 YCSGGTLEELLEHG-------RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKL  149 (264)
T ss_pred             cCCCCcHHHHHhhc-------CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccccccccc
Confidence            99999999999754       35788999999999999999999887   999999999999999999999999999877


Q ss_pred             CCCCCCcc--ccccccCCCccCccc
Q 017411          341 SAPSVPFL--CKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~--~~~~~GT~gy~apea  363 (372)
                      ........  .....++..|+|||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~  174 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEV  174 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhh
Confidence            54433211  113467788888775

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.93  E-value=4.2e-25  Score=210.76  Aligned_cols=168  Identities=25%  Similarity=0.372  Sum_probs=144.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.++++++||||+++++++...+ ..++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGD-ELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCC-cEEEEEec
Confidence            58889999999999999999988788999999987655555677899999999999999999999987654 48999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        98 ~~~~~L~~~~~~--------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          98 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             CCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            999999999865        34788999999999999999999887   9999999999999999999999999987665


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......|++.|+|||.
T Consensus       167 ~~~~--~~~~~~~~~~y~~PE~  186 (293)
T cd06647         167 PEQS--KRSTMVGTPYWMAPEV  186 (293)
T ss_pred             cccc--ccccccCChhhcCchh
Confidence            4332  1233467888888765

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.3e-25  Score=206.91  Aligned_cols=176  Identities=28%  Similarity=0.333  Sum_probs=147.0

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC-----
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-----  252 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~-----  252 (372)
                      .++++|+..+.||+|+||.||+|....+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            356899999999999999999999988889999999876543 346789999999999 6999999999986533     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++||||+++++|.+++......   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~  155 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKK---GKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLV  155 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEEC
Confidence            2478999999999999998764311   146899999999999999999999887   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||++........  ......|+..|+|||.
T Consensus       156 d~~~~~~~~~~~~--~~~~~~~~~~y~aPE~  184 (275)
T cd06608         156 DFGVSAQLDSTLG--RRNTFIGTPYWMAPEV  184 (275)
T ss_pred             CCccceecccchh--hhcCccccccccCHhH
Confidence            9999987643322  1233568889999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.93  E-value=7.3e-25  Score=203.99  Aligned_cols=174  Identities=28%  Similarity=0.360  Sum_probs=147.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||.|+||.||+|....++..+|+|++.... ....+.+.+|+++++.++|+||+++++.+... ...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEe
Confidence            47899999999999999999988888999999987542 33567889999999999999999999987764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....    ...+++..+..++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          80 YLSGGSLLDIMKSSYP----RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             ccCCCcHHHHHHHhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            9999999999976432    135899999999999999999999877   999999999999999999999999999877


Q ss_pred             CCCCCCc--cccccccCCCccCccc
Q 017411          341 SAPSVPF--LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~--~~~~~~GT~gy~apea  363 (372)
                      .......  ......|+..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~  177 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEV  177 (267)
T ss_pred             ccCccccccccccccCChhhcChHH
Confidence            6544321  2234568888998764

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.93  E-value=5.7e-25  Score=204.23  Aligned_cols=170  Identities=24%  Similarity=0.344  Sum_probs=143.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||++....+++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+ ....++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence            478889999999999999999888999999998643  33445678999999999999999999998765 456899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~  151 (256)
T cd08218          80 YCEGGDLYKKINAQRG-----VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVL  151 (256)
T ss_pred             cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeec
Confidence            9999999999876432     35789999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|++.|+|||.
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~  172 (256)
T cd08218         152 NSTVE--LARTCIGTPYYLSPEI  172 (256)
T ss_pred             Ccchh--hhhhccCCccccCHHH
Confidence            54322  1233467888888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.93  E-value=3.6e-25  Score=208.94  Aligned_cols=169  Identities=27%  Similarity=0.443  Sum_probs=141.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||+|....+++.||||.+....  ......+.+|++++++++||||+++++++.+. ...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEee
Confidence            5888899999999999999998889999999987542  23345788999999999999999999998764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+. ++|..++.....     ..+++..+..++.|++.||.|||..+   ++|+||+|+||+++.++.+||+|||+++..
T Consensus        80 ~~~-~~l~~~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~  150 (284)
T cd07860          80 FLH-QDLKKFMDASPL-----SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAF  150 (284)
T ss_pred             ccc-cCHHHHHHhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhc
Confidence            995 689998875432     46899999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......++..|+|||.
T Consensus       151 ~~~~~--~~~~~~~~~~y~aPE~  171 (284)
T cd07860         151 GVPVR--TYTHEVVTLWYRAPEI  171 (284)
T ss_pred             ccCcc--ccccccccccccCCeE
Confidence            54322  1223356788888774

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.93  E-value=5.1e-25  Score=210.24  Aligned_cols=175  Identities=24%  Similarity=0.340  Sum_probs=137.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|+..+.||+|+||.||+|....++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++.+. ...++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceE
Confidence            578899999999999999999876554  4788888743 344556789999999999 799999999987664 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          258 IYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      |+||+++++|.+++.......         .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            999999999999997642110         01135889999999999999999999877   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||++........   ......+..|+|||.
T Consensus       158 ~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  189 (297)
T cd05089         158 SKIADFGLSRGEEVYVK---KTMGRLPVRWMAIES  189 (297)
T ss_pred             EEECCcCCCccccceec---cCCCCcCccccCchh
Confidence            99999999864322111   111223456887664

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=5.8e-25  Score=206.77  Aligned_cols=174  Identities=26%  Similarity=0.352  Sum_probs=141.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECC----CCeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      ..|+..+.||+|+||.||++....    ++..||||.+...... ..+.|.+|+.++++++||||+++++++... ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            367777999999999999998643    4789999999865443 567899999999999999999999987652 2347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~------~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  154 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFG  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccc
Confidence            89999999999999997643      35899999999999999999999877   9999999999999999999999999


Q ss_pred             cccccCCCCCCcc-ccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFL-CKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~-~~~~~GT~gy~apeaP  364 (372)
                      ++........... .....++..|++||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  184 (284)
T cd05038         155 LAKVLPEDKDYYYVKEPGESPIFWYAPECL  184 (284)
T ss_pred             cccccccCCcceeccCCCCCcccccCcHHH
Confidence            9988764332211 1122345568887754

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.9e-25  Score=207.84  Aligned_cols=168  Identities=27%  Similarity=0.322  Sum_probs=144.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||.|+||.||+|.+..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEE
Confidence            36788899999999999999998889999999987643 44456788999999999999999999988764 56899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||+++..
T Consensus        80 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~  148 (274)
T cd06609          80 YCGGGSCLDLLKP--------GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQL  148 (274)
T ss_pred             eeCCCcHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceee
Confidence            9999999999865        25899999999999999999999877   999999999999999999999999999887


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|+..|+|||.
T Consensus       149 ~~~~~--~~~~~~~~~~y~~PE~  169 (274)
T cd06609         149 TSTMS--KRNTFVGTPFWMAPEV  169 (274)
T ss_pred             ccccc--ccccccCCccccChhh
Confidence            64422  2234568888998764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.93  E-value=6.5e-25  Score=204.01  Aligned_cols=169  Identities=29%  Similarity=0.429  Sum_probs=146.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|++|.||++.+..+++.|+||++..... .....+.+|+..+.+++|+||+++++++... ...++|+|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEE
Confidence            478889999999999999999998899999999976543 4567899999999999999999999988764 55899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+++++|.+++...       ..+++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~~~~~~L~~~l~~~-------~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~  149 (264)
T cd06623          80 YMDGGSLADLLKKV-------GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKV  149 (264)
T ss_pred             ecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCcccee
Confidence            99999999999764       468999999999999999999998 77   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  .....++..|+|||.
T Consensus       150 ~~~~~~~--~~~~~~~~~y~~pE~  171 (264)
T cd06623         150 LENTLDQ--CNTFVGTVTYMSPER  171 (264)
T ss_pred             cccCCCc--ccceeecccccCHhh
Confidence            7544331  234567888888764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=5.3e-25  Score=203.65  Aligned_cols=171  Identities=31%  Similarity=0.453  Sum_probs=141.9

Q ss_pred             eeeceeEcccCceEEEEEEECCCC----eEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      |++.+.||.|+||.||++.....+    ..||+|.+...... ..+.+..|++++..++|+||+++++++.+. ...+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEE
Confidence            345689999999999999997655    88999999765432 567899999999999999999999988775 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++
T Consensus        80 ~e~~~~~~l~~~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~  151 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRP-----KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSR  151 (258)
T ss_pred             EeccCCCCHHHHHHhhhh-----ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCce
Confidence            999999999999976431     12899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......... ....+++.|+|||.-
T Consensus       152 ~~~~~~~~~~-~~~~~~~~y~~Pe~~  176 (258)
T smart00219      152 DLYDDDYYKK-KGGKLPIRWMAPESL  176 (258)
T ss_pred             eccccccccc-ccCCCcccccChHHh
Confidence            7765432111 122367788887753

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.93  E-value=6.4e-25  Score=205.14  Aligned_cols=169  Identities=33%  Similarity=0.494  Sum_probs=139.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      +|+..+.||+|+||.||+|... +++.+|+|.+....      ......+.+|++++++++|+||+++++++.+. ...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEE
Confidence            4677899999999999999874 57899999886431      22345688999999999999999999998765 5589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+++++|.+++.+.       ..+++..+..++.|++.||.|||..+   |+|+||+|+||+++.++.+||+|||+
T Consensus        79 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          79 IFMEFVPGGSISSILNRF-------GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchh
Confidence            999999999999999754       35789999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCC----CccccccccCCCccCccc
Q 017411          337 ATWTSAPSV----PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~----~~~~~~~~GT~gy~apea  363 (372)
                      +........    ........|+..|+|||.
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~  179 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV  179 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhh
Confidence            986532111    111233568888888775

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.93  E-value=4.1e-25  Score=208.47  Aligned_cols=171  Identities=29%  Similarity=0.388  Sum_probs=143.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++..  .....+.+.+|++++++++|+||+++++++.. +...++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence            3688999999999999999999888999999998753  33345678999999999999999999999876 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++++.+..++...       ..+++..+..++.||+.||.|||..+   |+|+||+|+||+++.++.+||+|||++..
T Consensus        80 e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~  149 (288)
T cd07833          80 EYVERTLLELLEASP-------GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARA  149 (288)
T ss_pred             ecCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccc
Confidence            999987776655432       35889999999999999999999887   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....... ......++..|+|||.-
T Consensus       150 ~~~~~~~-~~~~~~~~~~~~~PE~~  173 (288)
T cd07833         150 LRARPAS-PLTDYVATRWYRAPELL  173 (288)
T ss_pred             cCCCccc-cccCcccccCCcCCchh
Confidence            7654321 22345678889987753

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.93  E-value=2e-25  Score=213.59  Aligned_cols=165  Identities=24%  Similarity=0.334  Sum_probs=139.8

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      .....||+|+||.||++....+++.||+|.+........+.+.+|+.++..++||||+++++++... ...++|+||+++
T Consensus        24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~  102 (297)
T cd06659          24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQG  102 (297)
T ss_pred             HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCCC
Confidence            3345799999999999999888899999999765545566788999999999999999999988764 458999999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      ++|..++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       103 ~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659         103 GALTDIVSQ--------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             CCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999998754        35889999999999999999999887   9999999999999999999999999997654332


Q ss_pred             CCccccccccCCCccCccc
Q 017411          345 VPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apea  363 (372)
                      .  ......|+.+|+|||.
T Consensus       172 ~--~~~~~~~~~~y~aPE~  188 (297)
T cd06659         172 P--KRKSLVGTPYWMAPEV  188 (297)
T ss_pred             c--cccceecCccccCHHH
Confidence            2  1234568888998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.93  E-value=4.4e-25  Score=213.81  Aligned_cols=169  Identities=21%  Similarity=0.232  Sum_probs=135.7

Q ss_pred             eceeEccc--CceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          186 KGRVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       186 ~~~~LG~G--~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ..++||+|  +|++||++....+++.||+|+++..  .....+.+.+|+++++.++||||+++++++... ...++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEec
Confidence            34789999  7889999999999999999999754  234455678899999999999999999998764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++++||+.+....
T Consensus        81 ~~~~~l~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~  152 (327)
T cd08227          81 MAYGSAKDLICTHFM-----DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  152 (327)
T ss_pred             cCCCcHHHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccc
Confidence            999999999975432     35899999999999999999999887   9999999999999999999999998765432


Q ss_pred             CCCCCc-----cccccccCCCccCccc
Q 017411          342 APSVPF-----LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~-----~~~~~~GT~gy~apea  363 (372)
                      ......     ......++..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~  179 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEV  179 (327)
T ss_pred             cccccccccccccccccceecccChHH
Confidence            211100     0112345666777664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=1.1e-25  Score=210.26  Aligned_cols=160  Identities=26%  Similarity=0.360  Sum_probs=133.2

Q ss_pred             eeEcccCceEEEEEEECCCC-------eEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          188 RVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~-------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.||+|+||.||+|.....+       ..||+|.+........+.+.+|+.+++.++||||+++++++.... ..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEEEe
Confidence            36899999999999875433       348999887665566678899999999999999999999987754 4789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc--------EEEE
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--------PKLC  332 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~--------~KL~  332 (372)
                      |+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.        ++++
T Consensus        80 ~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~  150 (258)
T cd05078          80 YVKFGSLDTYLKKNK------NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLS  150 (258)
T ss_pred             cCCCCcHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEec
Confidence            999999999997643      35889999999999999999999877   999999999999987764        6999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||++......      ....++..|+|||.
T Consensus       151 d~g~~~~~~~~------~~~~~~~~y~aPE~  175 (258)
T cd05078         151 DPGISITVLPK------EILLERIPWVPPEC  175 (258)
T ss_pred             ccccccccCCc------hhccccCCccCchh
Confidence            99998765432      23467888888764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.93  E-value=8.1e-25  Score=202.49  Aligned_cols=164  Identities=28%  Similarity=0.439  Sum_probs=133.3

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      +.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.... ..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCc
Confidence            36899999999999875 47889999987653 344457899999999999999999999987654 5899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++....      ..+++..+..++.|++.+|.|||..+   ++||||||+||+++.++.+||+|||++.........
T Consensus        79 L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          79 FLSFLRKKK------DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc
Confidence            999986542      35789999999999999999999877   999999999999999999999999999765432211


Q ss_pred             ccccccccCCCccCccc
Q 017411          347 FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       347 ~~~~~~~GT~gy~apea  363 (372)
                       ......++..|+|||.
T Consensus       150 -~~~~~~~~~~y~aPE~  165 (250)
T cd05085         150 -SSGLKQIPIKWTAPEA  165 (250)
T ss_pred             -cCCCCCCcccccCHHH
Confidence             1112234556777664

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=7.8e-27  Score=233.79  Aligned_cols=171  Identities=23%  Similarity=0.317  Sum_probs=148.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +-|.++..||.|+||+||++..+.++...|.|++........+.++-|++||..++||+||+|++.|+- ++.+|++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEee
Confidence            345666789999999999999998888889999988888888999999999999999999999987765 4459999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |.||-++.++-...      ..|.+.++.-++.|++.||.|||+..   |||||||..|||++.+|.++|+|||++....
T Consensus       111 C~GGAVDaimlEL~------r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~  181 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG------RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNK  181 (1187)
T ss_pred             cCCchHhHHHHHhc------cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccch
Confidence            99999999987654      67999999999999999999999988   9999999999999999999999999986543


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  .--++.|||.|||||+-
T Consensus       182 ~t~q--kRDsFIGTPYWMAPEVv  202 (1187)
T KOG0579|consen  182 STRQ--KRDSFIGTPYWMAPEVV  202 (1187)
T ss_pred             hHHh--hhccccCCcccccchhe
Confidence            2211  22457899999998763

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.8e-25  Score=203.13  Aligned_cols=165  Identities=25%  Similarity=0.413  Sum_probs=135.9

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      +.||+|+||.||++.+.. ++.||+|.+..... .....+.+|+.++++++||||+++++++.+.. ..++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQ-PIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCC-CeEEEEEcCCCCc
Confidence            469999999999999877 89999999876533 35668999999999999999999999887654 5899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++....      ..+++..+..++.+++.||.|||+.+   ++||||||+||+++.++.+||+|||+++........
T Consensus        79 l~~~l~~~~------~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          79 LLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             HHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcce
Confidence            999997642      35789999999999999999999887   999999999999999999999999999866432221


Q ss_pred             ccccccccCCCccCccc
Q 017411          347 FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       347 ~~~~~~~GT~gy~apea  363 (372)
                      .......++..|+|||.
T Consensus       150 ~~~~~~~~~~~y~~PE~  166 (251)
T cd05041         150 VSDGLKQIPIKWTAPEA  166 (251)
T ss_pred             eccccCcceeccCChHh
Confidence            11122233556888664

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=1.2e-24  Score=206.54  Aligned_cols=172  Identities=31%  Similarity=0.384  Sum_probs=143.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~lV~  259 (372)
                      ++|...+.||.|++|.||++.+..+++.||+|.+... .......+.+|++++++++||||+++++++.+. ....++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688899999999999999999888999999998754 234556789999999999999999999988653 33589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++......   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKR---GGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EecCCCCHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccc
Confidence            999999999988653221   146889999999999999999999877   99999999999999999999999999876


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......    ....++..|+|||.
T Consensus       155 ~~~~~~----~~~~~~~~y~~pE~  174 (287)
T cd06621         155 LVNSLA----GTFTGTSFYMAPER  174 (287)
T ss_pred             cccccc----ccccCCccccCHHH
Confidence            543322    23457788888764

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.93  E-value=2.5e-25  Score=209.66  Aligned_cols=167  Identities=29%  Similarity=0.385  Sum_probs=141.1

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .|+..+.||+|+||.||+|.+..++..||+|.++... ....+.+.+|++++++++||||+++++++... ...++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEEc
Confidence            4666788999999999999998888999999987543 34556789999999999999999999988764 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||+++...
T Consensus        84 ~~~~~L~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          84 LGGGSALDLLKP--------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             cCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999998853        35889999999999999999999877   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......|+..|+|||.
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~  172 (277)
T cd06642         153 DTQI--KRNTFVGTPFWMAPEV  172 (277)
T ss_pred             Ccch--hhhcccCcccccCHHH
Confidence            4322  1223457888888764

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=5e-25  Score=205.53  Aligned_cols=170  Identities=27%  Similarity=0.371  Sum_probs=139.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||+|+||.||+|.... ++.||+|.+..... ....+.+|+.++++++||||+++++++.  ....+++||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e   80 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITE   80 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEE
Confidence            4578899999999999999998754 67899999875433 3467899999999999999999998753  334799999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          81 YMENGSLVDFLKTPEG-----IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             cCCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence            9999999999875432     46899999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...... ......++..|+|||.
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~pe~  174 (260)
T cd05067         153 EDNEYT-AREGAKFPIKWTAPEA  174 (260)
T ss_pred             CCCCcc-cccCCcccccccCHHH
Confidence            533221 1122345667887664

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=4.5e-25  Score=217.13  Aligned_cols=166  Identities=19%  Similarity=0.146  Sum_probs=128.2

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECC-CCeEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      ...++|...+.||+|+||+||+|.+.. +++.||||++...     .....+.|.+|+++|++++|+|++..+..+   +
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            345789999999999999999998865 6777899987533     223456789999999999999999633221   2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCC-CCCCEEEcCCCcEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI-KPSNILLSSKKIPKL  331 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDL-Kp~NILld~~~~~KL  331 (372)
                       ..|+||||+++++|... ..          ..   ...++.|++++|.|||+.+   |+|||| ||+|||++.++.+||
T Consensus        92 -~~~LVmE~~~G~~L~~~-~~----------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         92 -KDGLVRGWTEGVPLHLA-RP----------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             -CcEEEEEccCCCCHHHh-Cc----------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence             36899999999999632 10          01   1357889999999999877   999999 999999999999999


Q ss_pred             EecccccccCCCCCCcc------ccccccCCCccCccccc
Q 017411          332 CDFGLATWTSAPSVPFL------CKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~------~~~~~GT~gy~apeaPE  365 (372)
                      +|||+|+.+........      .....+++.|++||++.
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999997754432111      13567788888877654

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.93  E-value=6.5e-25  Score=210.07  Aligned_cols=175  Identities=27%  Similarity=0.411  Sum_probs=141.6

Q ss_pred             CeeeceeEcccCceEEEEEEECC--CCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGL--LRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~  256 (372)
                      .|+..+.||+|+||.||+|....  ++..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.. ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            37788999999999999999987  78999999997632   344467789999999999999999999987652 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC----CCcEEEE
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS----KKIPKLC  332 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~----~~~~KL~  332 (372)
                      +||||+++ +|.+++.......  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.    ++.+||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~  154 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAK--RVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIG  154 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCC--CcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEEC
Confidence            99999964 7777775443211  136889999999999999999999887   999999999999999    8999999


Q ss_pred             ecccccccCCCCC-CccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSV-PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~-~~~~~~~~GT~gy~apea  363 (372)
                      |||+++....... ........+++.|+|||.
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  186 (316)
T cd07842         155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPEL  186 (316)
T ss_pred             CCccccccCCCcccccccCCccccccccCHHH
Confidence            9999987654432 112234567888988773

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.93  E-value=1e-24  Score=202.08  Aligned_cols=171  Identities=28%  Similarity=0.385  Sum_probs=144.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||++....+++.+|||.+...  .....+.+.+|++++++++||||+++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            578889999999999999999888999999998754  33456788999999999999999999998765 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DFGla~~  339 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.+|.|||+.+   |+|+||||+||+++.+ +.+||+|||++..
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (256)
T cd08220          80 YAPGGTLAEYIQKRCN-----SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI  151 (256)
T ss_pred             cCCCCCHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCcee
Confidence            9999999999976432     45899999999999999999999887   9999999999999865 4689999999987


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ......   .....|+..|+|||.-+
T Consensus       152 ~~~~~~---~~~~~~~~~y~aPE~~~  174 (256)
T cd08220         152 LSSKSK---AYTVVGTPCYISPELCE  174 (256)
T ss_pred             cCCCcc---ccccccCCcccCchhcc
Confidence            754432   23356888999987543

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.93  E-value=3.9e-25  Score=206.29  Aligned_cols=169  Identities=25%  Similarity=0.356  Sum_probs=137.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|++.+.||+|+||.||+|.... +..||+|.+..... ..+.+.+|+.++++++||||+++++++..  ...+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEY   81 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEe
Confidence            478888999999999999998764 56799999876433 34578999999999999999999998643  347899999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          82 MSKGSLLDFLKDGEG-----RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             cCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            999999999976422     45899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..... ......++..|+|||.
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~  174 (260)
T cd05070         154 DNEYT-ARQGAKFPIKWTAPEA  174 (260)
T ss_pred             Ccccc-cccCCCCCccccChHH
Confidence            43221 1112234556777664

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.93  E-value=8.5e-25  Score=204.20  Aligned_cols=170  Identities=26%  Similarity=0.367  Sum_probs=138.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|.+.+.||+|+||.||++....+ ..+|+|.+.... ...+.+.+|+.++++++|||++++++++..  ...++||||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEF   81 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEc
Confidence            4688889999999999999988654 469999886543 234678899999999999999999987643  347899999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++.....     ..+++..+..++.|++.||.|||..+   |+|+||||+||++++++.+||+|||+++...
T Consensus        82 ~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~  153 (260)
T cd05069          82 MGKGSLLDFLKEGDG-----KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIE  153 (260)
T ss_pred             CCCCCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEcc
Confidence            999999999976421     45889999999999999999999877   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..... ......++..|+|||..
T Consensus       154 ~~~~~-~~~~~~~~~~y~~Pe~~  175 (260)
T cd05069         154 DNEYT-ARQGAKFPIKWTAPEAA  175 (260)
T ss_pred             CCccc-ccCCCccchhhCCHHHh
Confidence            43221 11223456778887643

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.93  E-value=7.7e-25  Score=204.13  Aligned_cols=162  Identities=24%  Similarity=0.355  Sum_probs=131.9

Q ss_pred             eEcccCceEEEEEEE--CCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          189 VLGRGALSFVFKGKV--GLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~--~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      .||+|+||.||+|.+  ..++..||+|+++..  .....+.+.+|+.++++++||||+++++++..  ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA--ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCcEEEEecCCC
Confidence            589999999999965  345789999998654  34456789999999999999999999998743  347899999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      ++|.+++...       ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          80 GPLNKFLQKN-------KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             CcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            9999999754       35889999999999999999999877   9999999999999999999999999998775443


Q ss_pred             CCccc-cccccCCCccCcc
Q 017411          345 VPFLC-KTVKGTFGQNPFC  362 (372)
Q Consensus       345 ~~~~~-~~~~GT~gy~ape  362 (372)
                      ..... ....++..|+|||
T Consensus       150 ~~~~~~~~~~~~~~y~aPE  168 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPE  168 (257)
T ss_pred             CeeeecCCCCCCccccCHh
Confidence            32111 1122345666655

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.1e-25  Score=207.13  Aligned_cols=167  Identities=28%  Similarity=0.411  Sum_probs=142.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCC---CCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .|+..+.||+|+||.||+|.+..+++.||+|.++.. .......+.+|+.++++++   |||++++++++.+ +...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence            577788999999999999999888999999998754 3344567889999999996   9999999998876 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++..        ..+++..+..++.|++.||.|||..+   |+|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~e~~~~~~L~~~~~~--------~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~  149 (277)
T cd06917          81 MEYAEGGSVRTLMKA--------GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAA  149 (277)
T ss_pred             EecCCCCcHHHHHHc--------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCcee
Confidence            999999999999854        35889999999999999999999877   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......|+..|+|||.
T Consensus       150 ~~~~~~~--~~~~~~~~~~y~aPE~  172 (277)
T cd06917         150 LLNQNSS--KRSTFVGTPYWMAPEV  172 (277)
T ss_pred             ecCCCcc--ccccccCCcceeCHHH
Confidence            7754432  2234468888998774

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=227.31  Aligned_cols=166  Identities=28%  Similarity=0.384  Sum_probs=144.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCH
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL  267 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL  267 (372)
                      -+||+|.||+||-|++..+....|||.+...+.+..+-+..|+.+.++|+|.|||+++|.|.+ ++.+-+.||-++||+|
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcH
Confidence            479999999999999999999999999988777777888999999999999999999998655 5567799999999999


Q ss_pred             HHHHHhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEecccccccCCCC
Q 017411          268 ERHLHEKKKGVRGNSTL--PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       268 ~~~L~~~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~~~~~~  344 (372)
                      .++|+..-      .++  .+...-.+.+||++||.|||...   |||||||-+|||++. .|.+||+|||.++.+..-.
T Consensus       660 SsLLrskW------GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin  730 (1226)
T KOG4279|consen  660 SSLLRSKW------GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN  730 (1226)
T ss_pred             HHHHHhcc------CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC
Confidence            99998754      345  67777789999999999999988   999999999999964 6899999999998775332


Q ss_pred             CCccccccccCCCccCccccc
Q 017411          345 VPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apeaPE  365 (372)
                        ..+.+..||..|||||+-.
T Consensus       731 --P~TETFTGTLQYMAPEvID  749 (1226)
T KOG4279|consen  731 --PCTETFTGTLQYMAPEVID  749 (1226)
T ss_pred             --ccccccccchhhhChHhhc
Confidence              2557789999999988653

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=7e-25  Score=207.78  Aligned_cols=161  Identities=28%  Similarity=0.322  Sum_probs=130.3

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHH---hCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIAS---SLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~---~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      .||+|+||.||++....+++.||+|.+.+..   ......+.+|..++.   ..+||||+.+++++... +..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecC
Confidence            4899999999999998889999999986532   122233445554443   34799999999887664 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~~~L~~~i~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~  149 (279)
T cd05633          80 NGGDLHYHLSQH-------GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (279)
T ss_pred             CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccc
Confidence            999999998754       46899999999999999999999887   99999999999999999999999999976543


Q ss_pred             CCCCccccccccCCCccCcccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...    ....||..|+|||.-
T Consensus       150 ~~~----~~~~~~~~y~aPE~~  167 (279)
T cd05633         150 KKP----HASVGTHGYMAPEVL  167 (279)
T ss_pred             cCc----cCcCCCcCccCHHHh
Confidence            322    234688899997753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=3.7e-25  Score=206.94  Aligned_cols=172  Identities=28%  Similarity=0.377  Sum_probs=135.9

Q ss_pred             eeEcccCceEEEEEEECCCC------eEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          188 RVLGRGALSFVFKGKVGLLR------TSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~------~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.||+|+||.||+|+.....      ..+|||.+.+.. ......+.+|+.+++.++||||+++++++...+ ..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNE-PQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCC-CeEEEEe
Confidence            36899999999999875433      679999886542 344567899999999999999999999987644 5899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-----cEEEEecc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFG  335 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-----~~KL~DFG  335 (372)
                      |+++++|.+++............+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++     .+||+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999999764322112245789999999999999999999877   99999999999999877     89999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++...............++..|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPES  184 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHH
Confidence            9987644332212223345667777663

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.93  E-value=8.1e-25  Score=206.41  Aligned_cols=167  Identities=28%  Similarity=0.373  Sum_probs=142.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++++.+ +...++||||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEY   83 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEec
Confidence            5777789999999999999998889999999987543 4456778999999999999999999998876 4558999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++..        ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~~~~L~~~i~~--------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          84 LGGGSALDLLRA--------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999864        35788899999999999999999877   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ......++..|+|||.
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~  172 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEV  172 (277)
T ss_pred             CCcc--ccccccCcccccCHhH
Confidence            4332  1233467888888664

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=1.2e-24  Score=205.36  Aligned_cols=168  Identities=29%  Similarity=0.387  Sum_probs=142.1

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      -|+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+ +...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEe
Confidence            4667789999999999999988888999999986542 3445678899999999999999999998876 4458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++..        ..+++..+..++.|++.++.|||..+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~~~~~l~~~i~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          84 LGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             CCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999864        35889999999999999999999877   9999999999999999999999999997764


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  ......|+..|+|||.-
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~  173 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVI  173 (277)
T ss_pred             cchh--hhccccCCccccChhhh
Confidence            3321  22334678889997754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-25  Score=221.21  Aligned_cols=169  Identities=29%  Similarity=0.402  Sum_probs=145.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .-|...+.||+|-|+.|-++++.-+|+.||||++++.  +......+.+|++.|+-++|||||+||.+ ++....+|||+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV-iDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV-IDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh-hcccceEEEEE
Confidence            4577789999999999999999999999999999876  33445578899999999999999999997 56677799999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DFGla~  338 (372)
                      |+=.+|+|.++|-++.      ..+.+..+.+++.||+.|+.|+|..+   +|||||||+||++-+. |-+||.|||++-
T Consensus        97 ELGD~GDl~DyImKHe------~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN  167 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE------EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN  167 (864)
T ss_pred             EecCCchHHHHHHhhh------ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence            9999999999998775      46889999999999999999999888   9999999999998654 899999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+.....   ..+.+|+..|-|||+
T Consensus       168 kf~PG~k---L~TsCGSLAYSAPEI  189 (864)
T KOG4717|consen  168 KFQPGKK---LTTSCGSLAYSAPEI  189 (864)
T ss_pred             cCCCcch---hhcccchhhccCchh
Confidence            7765543   355677777776554

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.93  E-value=1.3e-24  Score=206.13  Aligned_cols=174  Identities=24%  Similarity=0.333  Sum_probs=139.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCC----e
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ----G  254 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~----~  254 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|+.++++++ ||||+++++++...+.    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            47889999999999999999999889999999886542  223457888999999995 6999999998765332    2


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEe
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCD  333 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~D  333 (372)
                      .|+||||+++ +|.+++......  ....+++..++.++.||+.||.|||..+   |+||||||+||+++. ++.+||+|
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~d  154 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRG--PGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIAD  154 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhccc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEee
Confidence            7899999975 899988754321  1246899999999999999999999877   999999999999998 88999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++....+...  .....+++.|+|||.
T Consensus       155 fg~~~~~~~~~~~--~~~~~~~~~~~aPE~  182 (295)
T cd07837         155 LGLGRAFSIPVKS--YTHEIVTLWYRAPEV  182 (295)
T ss_pred             cccceecCCCccc--cCCcccccCCCChHH
Confidence            9999866433221  122346778888664

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.93  E-value=1.2e-24  Score=207.40  Aligned_cols=172  Identities=27%  Similarity=0.384  Sum_probs=140.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-------
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-------  252 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-------  252 (372)
                      ++|+..+.||+|+||.||+|....+++.||||.+....  ......+.+|+.++++++||||+++++++...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            57999999999999999999998889999999886432  223345678999999999999999999886543       


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++||||+. ++|.+++....      ..+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~  161 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN------VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLA  161 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEEC
Confidence            23589999996 58888886532      36899999999999999999999887   9999999999999999999999


Q ss_pred             ecccccccCCCCCC--ccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVP--FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~--~~~~~~~GT~gy~apea  363 (372)
                      |||++.........  .......++..|+|||.
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  194 (310)
T cd07865         162 DFGLARAFSLSKNSKPNRYTNRVVTLWYRPPEL  194 (310)
T ss_pred             cCCCcccccCCcccCCCCccCcccCccccCcHH
Confidence            99999876543321  11223456777888664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.93  E-value=8.1e-25  Score=212.75  Aligned_cols=171  Identities=23%  Similarity=0.329  Sum_probs=141.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----CeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~~  255 (372)
                      +++|++.+.||+|+||.||+|.+..+++.||||.+... .......+.+|+.++++++||||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999999888999999998643 2334567889999999999999999998765432    247


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++|+||+. ++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~-~~l~~~~~~--------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg  151 (336)
T cd07849          84 YIVQELME-TDLYKLIKT--------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFG  151 (336)
T ss_pred             EEEehhcc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccc
Confidence            89999996 588887754        35899999999999999999999887   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +++......... ......||..|+|||.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  180 (336)
T cd07849         152 LARIADPEHDHTGFLTEYVATRWYRAPEI  180 (336)
T ss_pred             ceeeccccccccCCcCCcCcCCCccChHH
Confidence            998764432211 2233568888999774

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.8e-24  Score=199.69  Aligned_cols=168  Identities=33%  Similarity=0.464  Sum_probs=145.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh--hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|++|.||++....+++.|++|.+.....  .....+.+|++++++++|||++++++++.+. ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEe
Confidence            47788999999999999999988889999999976543  4567899999999999999999999987764 56899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||+++..
T Consensus        80 ~~~~~~L~~~~~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  149 (254)
T cd06627          80 YAENGSLRQIIKKF-------GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKL  149 (254)
T ss_pred             cCCCCcHHHHHHhc-------cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceec
Confidence            99999999998764       46899999999999999999999877   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|+..|+|||.
T Consensus       150 ~~~~~--~~~~~~~~~~y~~pe~  170 (254)
T cd06627         150 NDVSK--DDASVVGTPYWMAPEV  170 (254)
T ss_pred             CCCcc--cccccccchhhcCHhh
Confidence            65433  1234567888998764

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.93  E-value=1.3e-24  Score=206.12  Aligned_cols=170  Identities=28%  Similarity=0.271  Sum_probs=140.0

Q ss_pred             CeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      +|+..+.||+|+||.||++...   .++..||+|++....    ....+.+.+|+.++.++ +|+||+++++.+.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            4788899999999999999874   367899999987532    23345678899999999 59999999987655 456


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++|+||+++++|.+++...       ..+++..+..++.|++.||.|||..+   ++||||||+|||++.++.+||+||
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df  149 (290)
T cd05613          80 LHLILDYINGGELFTHLSQR-------ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDF  149 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeC
Confidence            89999999999999999764       45888899999999999999999877   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........ ......|+..|+|||..
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~  178 (290)
T cd05613         150 GLSKEFHEDEVE-RAYSFCGTIEYMAPDIV  178 (290)
T ss_pred             ccceeccccccc-ccccccCCcccCChhhc
Confidence            999876443221 12345688888887753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.93  E-value=5.4e-25  Score=222.72  Aligned_cols=165  Identities=25%  Similarity=0.297  Sum_probs=137.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-C-----CCeeceeeeEEcCCCeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-H-----PNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-H-----pnIv~l~g~~~~~~~~~~  256 (372)
                      +|.+.++||+|+||.|.+|.+..+++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|+++++|...+ .+|
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-cee
Confidence            788899999999999999999999999999999764 344556678999999996 4     39999999987754 499


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC--CcEEEEec
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDF  334 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~--~~~KL~DF  334 (372)
                      ||+|.+ ..+|+++|+..+.     ..++...++.++.||+.||.+||..+   |||+||||+||||.+.  ..+||+||
T Consensus       265 iVfELL-~~NLYellK~n~f-----~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDF  335 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNKF-----RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDF  335 (586)
T ss_pred             eeehhh-hhhHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEec
Confidence            999999 5699999988754     56899999999999999999999887   9999999999999654  37999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |.|.+....--     +..-+.-|.|||+
T Consensus       336 GSSc~~~q~vy-----tYiQSRfYRAPEV  359 (586)
T KOG0667|consen  336 GSSCFESQRVY-----TYIQSRFYRAPEV  359 (586)
T ss_pred             ccccccCCcce-----eeeeccccccchh
Confidence            99987654321     3334455666654

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.93  E-value=4.1e-25  Score=205.95  Aligned_cols=168  Identities=30%  Similarity=0.400  Sum_probs=143.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|+..+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|++++++++||||+++++++... ...++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEE
Confidence            36777889999999999999999889999999987653 45566789999999999999999999988775 55899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+++++|.+++....      ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.+||+|||++..
T Consensus        80 ~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~  150 (265)
T cd06605          80 YMDGGSLDKILKEVQ------GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQ  150 (265)
T ss_pred             ecCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchh
Confidence            999999999997643      468889999999999999999998 66   99999999999999999999999999977


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......    ....|+..|+|||.
T Consensus       151 ~~~~~~----~~~~~~~~y~~PE~  170 (265)
T cd06605         151 LVNSLA----KTFVGTSSYMAPER  170 (265)
T ss_pred             hHHHHh----hcccCChhccCHHH
Confidence            643322    12567888888764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.93  E-value=1e-24  Score=209.17  Aligned_cols=171  Identities=26%  Similarity=0.402  Sum_probs=141.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~l  257 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||+|.++...  ......+.+|+.++++++|+||+++++++.+.. ...++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            368999999999999999999999889999999986432  222335678999999999999999999886543 45799


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+. ++|.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        86 v~e~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP------TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             EEecCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcccee
Confidence            999996 58988887543      46899999999999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +........  .....++..|+|||.
T Consensus       156 ~~~~~~~~~--~~~~~~~~~y~aPE~  179 (309)
T cd07845         156 RTYGLPAKP--MTPKVVTLWYRAPEL  179 (309)
T ss_pred             eecCCccCC--CCcccccccccChhh
Confidence            877544321  122345777888774

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.92  E-value=1.8e-24  Score=207.33  Aligned_cols=166  Identities=28%  Similarity=0.376  Sum_probs=140.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ...|+..+.||+|+||.||+|....+++.||+|.+...   .....+.+.+|+++++.++||||++++++|.+.+ ..++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~-~~~l   92 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREH-TAWL   92 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCC-eEEE
Confidence            35688889999999999999999888999999998643   3344567889999999999999999999988744 4899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |+||+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++
T Consensus        93 v~e~~~-g~l~~~~~~~~------~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          93 VMEYCL-GSASDILEVHK------KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             EHHhhC-CCHHHHHHHcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcc
Confidence            999996 67877775432      45899999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......      ....|+..|+|||.
T Consensus       163 ~~~~~~------~~~~~~~~y~aPE~  182 (307)
T cd06607         163 SLVSPA------NSFVGTPYWMAPEV  182 (307)
T ss_pred             eecCCC------CCccCCccccCcee
Confidence            765432      23467888998775

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.92  E-value=2.8e-24  Score=197.04  Aligned_cols=168  Identities=32%  Similarity=0.430  Sum_probs=146.2

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      +|...+.||+|++|.||++....+++.+++|++........+.+.+|++++++++||||+++++.+... ...++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecC
Confidence            477889999999999999999888899999999876555667899999999999999999999987764 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++....      ..+++..+..++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 ~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  150 (253)
T cd05122          80 SGGSLKDLLKSTN------QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSD  150 (253)
T ss_pred             CCCcHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccc
Confidence            9999999987642      46899999999999999999999877   99999999999999999999999999987765


Q ss_pred             CCCCccccccccCCCccCccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...   .....|+..|+|||.
T Consensus       151 ~~~---~~~~~~~~~~~~PE~  168 (253)
T cd05122         151 TKA---RNTMVGTPYWMAPEV  168 (253)
T ss_pred             ccc---ccceecCCcccCHHH
Confidence            432   234567888888664

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.92  E-value=1.5e-24  Score=202.36  Aligned_cols=161  Identities=27%  Similarity=0.299  Sum_probs=138.5

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||.|+||.||++....+++.||+|.+.+..   ....+.+.+|+.++++++||||+++++++.+. ...++|+||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCc
Confidence            689999999999998889999999987542   24456789999999999999999999987764 45899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++......  
T Consensus        80 L~~~l~~~-------~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--  147 (262)
T cd05572          80 LWTILRDR-------GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--  147 (262)
T ss_pred             HHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--
Confidence            99999764       35889999999999999999999877   9999999999999999999999999998775443  


Q ss_pred             ccccccccCCCccCcccc
Q 017411          347 FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       347 ~~~~~~~GT~gy~apeaP  364 (372)
                       ......|+..|++||..
T Consensus       148 -~~~~~~~~~~~~~PE~~  164 (262)
T cd05572         148 -KTWTFCGTPEYVAPEII  164 (262)
T ss_pred             -ccccccCCcCccChhHh
Confidence             12345688899998754

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.92  E-value=1.3e-24  Score=211.31  Aligned_cols=172  Identities=30%  Similarity=0.426  Sum_probs=144.7

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      +++...+++|+..+.||+|+||.||++....+++.||||++.+.  .....+.+.+|++++++++||||+++++++....
T Consensus         3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            44556788999999999999999999999988999999988643  2334567889999999999999999999887656


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++|+||+ +++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~~--------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~  150 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLTS--------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKIC  150 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeC
Confidence            6689999998 5689888764        35788888899999999999999887   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+++......     ....++..|+|||.
T Consensus       151 dfg~~~~~~~~~-----~~~~~~~~y~aPE~  176 (328)
T cd07856         151 DFGLARIQDPQM-----TGYVSTRYYRAPEI  176 (328)
T ss_pred             ccccccccCCCc-----CCCcccccccCcee
Confidence            999997653321     23356788888774

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=1.3e-24  Score=202.50  Aligned_cols=171  Identities=29%  Similarity=0.400  Sum_probs=139.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|.+.+.||+|+||.||++.... +..||||.+.... ...+.+.+|+.++++++||||+++++++.. ....++|||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   81 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTE   81 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEe
Confidence            4689999999999999999999764 5779999987543 334678999999999999999999998765 345899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||..+   |+|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~~~~~L~~~i~~~~~-----~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~  153 (261)
T cd05034          82 YMSKGSLLDFLKSGEG-----KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLI  153 (261)
T ss_pred             ccCCCCHHHHHhcccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceec
Confidence            9999999999976432     46899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...... ......++..|+|||.
T Consensus       154 ~~~~~~-~~~~~~~~~~y~~PE~  175 (261)
T cd05034         154 EDDEYT-AREGAKFPIKWTAPEA  175 (261)
T ss_pred             cchhhh-hhhccCCCccccCHHH
Confidence            532211 1112223456776653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.92  E-value=1.7e-24  Score=202.17  Aligned_cols=170  Identities=24%  Similarity=0.355  Sum_probs=138.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ..+|+..+.||+|+||.||++.... +..+|+|.+.... ...+.+.+|++++++++|+||+++++.+..  ...+++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e   80 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITE   80 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEE
Confidence            4689999999999999999998654 5679999887542 345678999999999999999999998765  44789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        81 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  152 (260)
T cd05073          81 FMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVI  152 (260)
T ss_pred             eCCCCcHHHHHHhCCc-----cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeec
Confidence            9999999999976432     46789999999999999999999877   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...... ......++..|+|||.
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~  174 (260)
T cd05073         153 EDNEYT-AREGAKFPIKWTAPEA  174 (260)
T ss_pred             cCCCcc-cccCCcccccccCHhH
Confidence            543221 1112234556777553

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-25  Score=229.23  Aligned_cols=178  Identities=26%  Similarity=0.414  Sum_probs=149.8

Q ss_pred             CeeeceeEcccCceEEEEEEECCCC---eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ...+.++||.|.||.|++|+++..+   ..||||.++.. .+....+|+.|+.||.+++||||++|.|+... ...+.+|
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~PvMIi  708 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKPVMII  708 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-CceeEEE
Confidence            4467799999999999999997554   47999999875 45566789999999999999999999998544 4558899


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      .|||++|+|+.+|+...      ..+.+.+...+.++||.|+.||-+.+   .|||||...|||++.+..+|++||||+|
T Consensus       709 TEyMENGsLDsFLR~~D------GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSR  779 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQND------GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSR  779 (996)
T ss_pred             hhhhhCCcHHHHHhhcC------CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccccee
Confidence            99999999999998764      46899999999999999999999888   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccC--CCccCccccccccccC
Q 017411          339 WTSAPSVPFLCKTVKGT--FGQNPFCIEEWQRLKS  371 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT--~gy~apeaPE~~~~~~  371 (372)
                      .+.++... ..++.-|.  ..|.||||--+..+.+
T Consensus       780 vledd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTs  813 (996)
T KOG0196|consen  780 VLEDDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTS  813 (996)
T ss_pred             ecccCCCc-cccccCCccceeecChhHhhhcccCc
Confidence            98655422 22222233  5799999988876654

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.92  E-value=9.9e-25  Score=204.52  Aligned_cols=171  Identities=29%  Similarity=0.395  Sum_probs=144.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|...+.||+|+||.||++....+++.||+|++.+.   .....+.+.+|+.++++++ ||||+++++++.+ +...++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence            4788999999999999999999888999999998753   2334467889999999998 9999999998765 445899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++
T Consensus        80 v~e~~~~~~L~~~l~~~-------~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~  149 (280)
T cd05581          80 VLEYAPNGELLQYIRKY-------GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTA  149 (280)
T ss_pred             EEcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccc
Confidence            99999999999999764       36999999999999999999999887   999999999999999999999999999


Q ss_pred             cccCCCCCC------------------ccccccccCCCccCccc
Q 017411          338 TWTSAPSVP------------------FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~------------------~~~~~~~GT~gy~apea  363 (372)
                      .........                  .......|+..|+|||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~  193 (280)
T cd05581         150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPEL  193 (280)
T ss_pred             cccCCccccccCCCCCccccccccccccccccccCCccccCHHH
Confidence            876543321                  11223457788888664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=2.1e-24  Score=202.35  Aligned_cols=176  Identities=23%  Similarity=0.344  Sum_probs=137.4

Q ss_pred             eeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-----
Q 017411          184 FSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-----  253 (372)
                      |...+.||+|+||.||+|...   .++..||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456789999999999999864   35689999998754  34456678999999999999999999998765322     


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++++||+++|+|.+++...... .....+++...+.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~-~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIG-EEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence            247889999999999988643211 11135789999999999999999999877   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++...............+++.|++||.
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~  186 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALES  186 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhH
Confidence            999987654332112223344566777664

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2.6e-24  Score=210.37  Aligned_cols=174  Identities=22%  Similarity=0.289  Sum_probs=144.1

Q ss_pred             cHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       173 s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      ...++...+++|+..+.||+|+||.||++....+++.||+|++.+.  .....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3455667889999999999999999999999888999999999753  23345678899999999999999999998753


Q ss_pred             CC-----CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC
Q 017411          251 PE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       251 ~~-----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~  325 (372)
                      ..     ...+++++++ +++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~  155 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNE  155 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcC
Confidence            22     2367888877 7899888754        35899999999999999999999887   999999999999999


Q ss_pred             CCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.+||+|||+++.....     .....|+..|+|||.
T Consensus       156 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~  188 (345)
T cd07877         156 DCELKILDFGLARHTDDE-----MTGYVATRWYRAPEI  188 (345)
T ss_pred             CCCEEEeccccccccccc-----ccccccCCCccCHHH
Confidence            999999999999865432     123467888888764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.92  E-value=2.4e-24  Score=210.51  Aligned_cols=169  Identities=21%  Similarity=0.298  Sum_probs=141.3

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---  253 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---  253 (372)
                      ...++|+..+.||+|+||.||++....++..||||++...  .......+.+|+.++++++||||+++++++.....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467899999999999999999999888999999998653  23344568899999999999999999998765332   


Q ss_pred             --eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          254 --GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       254 --~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                        ..++||||+ +++|.+++..        ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl  159 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH--------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKI  159 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEE
Confidence              358999999 7799888753        35899999999999999999999877   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++......     ....+++.|++||.-
T Consensus       160 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~  187 (343)
T cd07880         160 LDFGLARQTDSEM-----TGYVVTRWYRAPEVI  187 (343)
T ss_pred             eecccccccccCc-----cccccCCcccCHHHH
Confidence            9999998664332     234568888887753

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.92  E-value=1.2e-25  Score=238.96  Aligned_cols=176  Identities=26%  Similarity=0.334  Sum_probs=141.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-------
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-------  252 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-------  252 (372)
                      ..+|...+.||+||||.||+++.+-+|..||||++... +......+.+|+.+|++|+|||||+++..+.+..       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            35889999999999999999999999999999999764 3444567889999999999999999987553211       


Q ss_pred             --------------------------------------------------------------------------------
Q 017411          253 --------------------------------------------------------------------------------  252 (372)
Q Consensus       253 --------------------------------------------------------------------------------  252 (372)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             -------------------------------CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 017411          253 -------------------------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA  301 (372)
Q Consensus       253 -------------------------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~  301 (372)
                                                     ..+||-||||+.-.|++++++....      -.-...++++++|++||.
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~------~~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN------SQRDEAWRLFREILEGLA  711 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc------hhhHHHHHHHHHHHHHHH
Confidence                                           1268899999998888888765321      135667899999999999


Q ss_pred             HHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC----------------CCCCCccccccccCCCccCccccc
Q 017411          302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS----------------APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       302 yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~----------------~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+|+++   ||||||||.||++|++..+||+|||+|+...                ........+..+||.-|+|||.-+
T Consensus       712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            999988   9999999999999999999999999998711                011111335567999999987654

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.92  E-value=1e-24  Score=211.91  Aligned_cols=171  Identities=28%  Similarity=0.412  Sum_probs=142.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC-CeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE-QGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~-~~~~  256 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...  .......+.+|+.+++++ +||||+++++++...+ ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46788899999999999999999888999999988642  333445678899999999 9999999999876533 3579


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||++ ++|..++..        ..++|..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        86 lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~  153 (337)
T cd07852          86 LVFEYME-TDLHAVIRA--------NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGL  153 (337)
T ss_pred             EEecccc-cCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccc
Confidence            9999996 599988864        25788899999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCC---ccccccccCCCccCccc
Q 017411          337 ATWTSAPSVP---FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~---~~~~~~~GT~gy~apea  363 (372)
                      ++........   .......||..|+|||.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  183 (337)
T cd07852         154 ARSLSELEENPENPVLTDYVATRWYRAPEI  183 (337)
T ss_pred             hhccccccccccCcchhcccccccccCcee
Confidence            9876543321   12234568889999774

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.92  E-value=1.4e-24  Score=201.17  Aligned_cols=170  Identities=24%  Similarity=0.372  Sum_probs=142.2

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||+|+||.||++....++..||+|.+...  .....+.+.+|+.++++++|+||+++++.+.+ ....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence            578889999999999999999988999999998653  22344578899999999999999999998766 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGla~~  339 (372)
                      |+++++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++ .+||+|||++..
T Consensus        80 ~~~~~~L~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~  151 (257)
T cd08225          80 YCDGGDLMKRINRQRG-----VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ  151 (257)
T ss_pred             cCCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchh
Confidence            9999999999976432     35799999999999999999999887   99999999999999885 469999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  ......|++.|+|||.
T Consensus       152 ~~~~~~--~~~~~~~~~~~~ape~  173 (257)
T cd08225         152 LNDSME--LAYTCVGTPYYLSPEI  173 (257)
T ss_pred             ccCCcc--cccccCCCccccCHHH
Confidence            654332  2233468888888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.92  E-value=2.8e-24  Score=204.31  Aligned_cols=170  Identities=25%  Similarity=0.388  Sum_probs=138.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|++++++++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEE
Confidence            47899999999999999999998889999999986542  23345688999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~  338 (372)
                      ||++ ++|.+++.....     ..+++..+..++.||+.||.|||+.+   |+||||+|+||+++. ++.+||+|||++.
T Consensus        81 e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~  151 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-----FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLAR  151 (294)
T ss_pred             eccc-ccHHHHHHhCCC-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEccccccc
Confidence            9995 588888765321     34678888899999999999999877   999999999999985 5679999999997


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......|++.|+|||.
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~~PE~  174 (294)
T PLN00009        152 AFGIPVR--TFTHEVVTLWYRAPEI  174 (294)
T ss_pred             ccCCCcc--ccccCceeecccCHHH
Confidence            6543321  1233456788888764

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.92  E-value=1.3e-24  Score=201.55  Aligned_cols=163  Identities=29%  Similarity=0.348  Sum_probs=136.8

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||+|+||.||++.+..+++.|++|.+.....   ...+.+.+|++++++++||||+++++.+.. +...++|+||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            6899999999999988899999999976533   455678899999999999999999988765 555899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCC-
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV-  345 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~-  345 (372)
                      |.+++.+.       ..+++..+..++.||+.||.|||..+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        80 L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          80 LASLLENV-------GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             HHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            99999764       36899999999999999999999877   99999999999999999999999999876543321 


Q ss_pred             -----CccccccccCCCccCccc
Q 017411          346 -----PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       346 -----~~~~~~~~GT~gy~apea  363 (372)
                           ........++..|++||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~  172 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEV  172 (265)
T ss_pred             ccccccccccCcccCccccCHHH
Confidence                 112233457778888664

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.92  E-value=1.6e-24  Score=204.32  Aligned_cols=162  Identities=26%  Similarity=0.298  Sum_probs=135.3

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||+|+||.||++....+++.||+|.+.+..   ......+.+|++++++++||||+++++++... ...|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCc
Confidence            689999999999998889999999987532   22345678899999999999999999987664 45899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++.....     ..+++..++.++.|++.||.|||..+   |+||||+|+||+++.++.+||+|||++........ 
T Consensus        80 L~~~l~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  150 (277)
T cd05577          80 LKYHIYNVGE-----PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-  150 (277)
T ss_pred             HHHHHHHcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc-
Confidence            9999976532     36899999999999999999999877   99999999999999999999999999987654221 


Q ss_pred             ccccccccCCCccCccc
Q 017411          347 FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       347 ~~~~~~~GT~gy~apea  363 (372)
                        .....++..|+|||.
T Consensus       151 --~~~~~~~~~y~~PE~  165 (277)
T cd05577         151 --IKGRAGTPGYMAPEV  165 (277)
T ss_pred             --cccccCCCCcCCHHH
Confidence              123456777887664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.92  E-value=2.7e-24  Score=204.22  Aligned_cols=167  Identities=25%  Similarity=0.363  Sum_probs=142.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      .|...+.||+|++|.||++....+++.|++|+++.......+.+.+|+.+++.++||||+++++++... ...++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEecc
Confidence            455567999999999999998888899999998766555566789999999999999999999988764 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.....
T Consensus        99 ~~~~L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~  167 (285)
T cd06648          99 EGGALTDIVTH--------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK  167 (285)
T ss_pred             CCCCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence            99999999875        24788999999999999999999887   99999999999999999999999999876543


Q ss_pred             CCCCccccccccCCCccCccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...  ......|++.|+|||.
T Consensus       168 ~~~--~~~~~~~~~~y~aPE~  186 (285)
T cd06648         168 EVP--RRKSLVGTPYWMAPEV  186 (285)
T ss_pred             CCc--ccccccCCccccCHHH
Confidence            321  1233568888998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-25  Score=222.50  Aligned_cols=175  Identities=27%  Similarity=0.434  Sum_probs=149.7

Q ss_pred             eeeceeEcccCceEEEEEEECC----CCeEEEEEEecC-CChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKVGL----LRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~-~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ....+.||+|.||.||+|....    ..-.||||.-+. ..++..+.|+.|.-+|++++|||||+|+|+|.+  ..+|+|
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wiv  468 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWIV  468 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeEE
Confidence            3456789999999999998743    244699999887 467778899999999999999999999999975  348999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||+++-|.|..+|+..+      ..|+......++.||+.||.|||+..   +|||||...|||+....-+||+||||+|
T Consensus       469 mEL~~~GELr~yLq~nk------~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  469 MELAPLGELREYLQQNK------DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             EecccchhHHHHHHhcc------ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence            99999999999998865      56888899999999999999999987   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCcccccccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLK  370 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE~~~~~  370 (372)
                      .+....... .+...-..-|||||.-.++++.
T Consensus       540 ~~ed~~yYk-aS~~kLPIKWmaPESINfRrFT  570 (974)
T KOG4257|consen  540 YLEDDAYYK-ASRGKLPIKWMAPESINFRRFT  570 (974)
T ss_pred             hccccchhh-ccccccceeecCccccchhccc
Confidence            987665432 2344445679999988888765

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.92  E-value=2.4e-24  Score=210.96  Aligned_cols=169  Identities=23%  Similarity=0.315  Sum_probs=140.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----  252 (372)
                      ..++|+..+.||+|+||.||++....+++.||||.+.+.  .......+.+|+.++++++||||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            346899999999999999999999988999999998653  3444567889999999999999999999875432     


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++||||+. ++|.+.+..         .+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~---------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~  160 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM---------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL  160 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh---------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEc
Confidence            24689999995 588888753         2788889999999999999999887   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++.......   .....|+..|+|||.-
T Consensus       161 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~  189 (353)
T cd07850         161 DFGLARTAGTSFM---MTPYVVTRYYRAPEVI  189 (353)
T ss_pred             cCccceeCCCCCC---CCCCcccccccCHHHH
Confidence            9999987654322   2334678888887753

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.92  E-value=1.7e-24  Score=206.06  Aligned_cols=173  Identities=26%  Similarity=0.323  Sum_probs=141.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----  252 (372)
                      ..++|++.+.||+|+||.||+|....+++.||+|+++...  ......+.+|++++++++||||+++++++.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4568999999999999999999998889999999997542  233456788999999999999999999886543     


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          253 ----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       253 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                          ...++|+||+++ +|...+....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~  154 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGL------VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQ  154 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCc
Confidence                258999999975 7777776432      46899999999999999999999887   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+++........ ......++..|+|||.
T Consensus       155 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~  188 (302)
T cd07864         155 IKLADFGLARLYNSEESR-PYTNKVITLWYRPPEL  188 (302)
T ss_pred             EEeCcccccccccCCccc-ccccceeccCccChHH
Confidence            999999999877544321 1122345677888663

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.92  E-value=1.5e-24  Score=201.70  Aligned_cols=163  Identities=28%  Similarity=0.481  Sum_probs=134.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|++.+.||+|+||.||++..  +++.||+|.++...  ....+.+|+.++++++||||+++++++.. + ..++||||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~-~~~~v~e~   79 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-N-GLYIVMEL   79 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-C-CcEEEEEC
Confidence            4688899999999999999875  47789999986542  34578999999999999999999998764 3 36899999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++.....     ..+++..++.++.|++.||.|||..+   ++||||||+||+++.++.+||+|||+++...
T Consensus        80 ~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~  151 (254)
T cd05083          80 MSKGNLVNFLRTRGR-----ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGS  151 (254)
T ss_pred             CCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecc
Confidence            999999999976432     45889999999999999999999877   9999999999999999999999999987643


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...     .....+..|+|||.
T Consensus       152 ~~~-----~~~~~~~~y~~pe~  168 (254)
T cd05083         152 MGV-----DNSKLPVKWTAPEA  168 (254)
T ss_pred             ccC-----CCCCCCceecCHHH
Confidence            221     11223456777653

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.92  E-value=2.5e-24  Score=203.72  Aligned_cols=161  Identities=27%  Similarity=0.311  Sum_probs=130.2

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHH---HHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELM---IASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~---iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      .||+|+||.||++....+++.||+|.+.+...   .....+..|..   +++...||+|+++++++.+. ...++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecC
Confidence            48999999999999988899999999875421   22223344443   44556899999999887664 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        80 ~g~~L~~~l~~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          80 NGGDLHYHLSQH-------GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             CCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            999999988653       46899999999999999999999877   99999999999999999999999999976643


Q ss_pred             CCCCccccccccCCCccCcccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...    ....|+..|+|||.-
T Consensus       150 ~~~----~~~~~~~~y~aPE~~  167 (278)
T cd05606         150 KKP----HASVGTHGYMAPEVL  167 (278)
T ss_pred             cCC----cCcCCCcCCcCcHHh
Confidence            322    234688999997764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.92  E-value=3.3e-24  Score=199.69  Aligned_cols=165  Identities=30%  Similarity=0.418  Sum_probs=133.6

Q ss_pred             eeEcccCceEEEEEEECCCC---eEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|......   ..||+|.+..... ...+.+.+|+.+++++.||||+++++++.. + ..++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-E-PLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-C-ceEEEEEeCC
Confidence            46999999999999875443   7899999876533 355678999999999999999999998653 3 4789999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +++|.+++...       ..+++..+..++.|++.||.|||..+   ++|+||||+|||++.++.+||+|||+++.....
T Consensus        79 ~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~  148 (257)
T cd05060          79 LGPLLKYLKKR-------REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG  148 (257)
T ss_pred             CCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecC
Confidence            99999999764       35899999999999999999999877   999999999999999999999999999877544


Q ss_pred             CCCcc-ccccccCCCccCcccc
Q 017411          344 SVPFL-CKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~-~~~~~GT~gy~apeaP  364 (372)
                      ..... .....++..|+|||..
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~  170 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECI  170 (257)
T ss_pred             CcccccccCccccccccCHHHh
Confidence            32211 1112234567776643

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.92  E-value=2.7e-24  Score=202.29  Aligned_cols=169  Identities=26%  Similarity=0.367  Sum_probs=141.4

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEEEEe
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYK  260 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~lV~E  260 (372)
                      |+..+.||+|+||.||+|....+++.+|+|.+....  ......+.+|++++++++|||++++++++.+. ....++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999998889999999998652  34456788999999999999999999998765 256899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++....      ..+++..++.++.||+.||.|||..+   ++|+||||+||+++.++.+||+|||++...
T Consensus        81 ~~~-~~l~~~~~~~~------~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          81 YMD-HDLTGLLDSPE------VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             ccc-ccHHHHHhccC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            997 48988886532      36899999999999999999999887   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...... ......++..|+|||.
T Consensus       151 ~~~~~~-~~~~~~~~~~y~~PE~  172 (287)
T cd07840         151 TKRNSA-DYTNRVITLWYRPPEL  172 (287)
T ss_pred             cCCCcc-cccccccccccCCcee
Confidence            654321 1223456778888774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.92  E-value=3.9e-24  Score=196.88  Aligned_cols=172  Identities=36%  Similarity=0.447  Sum_probs=146.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~lV~  259 (372)
                      +|+..+.||+|++|.||+|....+++.|++|++....  ....+.+.+|+.++++++||||+++++.+.+.. ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999998889999999987654  345678899999999999999999999887641 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+..
T Consensus        81 e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          81 EYVSGGSLSSLLKKF-------GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             EecCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            999999999999764       36899999999999999999999877   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..............++..|+|||..
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~  175 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVI  175 (260)
T ss_pred             cccccccccccCCCCCccccCHhhh
Confidence            7655431112345678888887643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.92  E-value=3e-24  Score=201.77  Aligned_cols=169  Identities=27%  Similarity=0.398  Sum_probs=132.5

Q ss_pred             eeEcccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|....++.  .+|+|.+... .....+.+.+|++++.++ +||||+++++++... ...++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-CCceEEEEeCC
Confidence            368999999999999877664  5688888753 345556789999999999 799999999988764 45899999999


Q ss_pred             CCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          264 GGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      +|+|.+++.......         .....+++..+..++.|++.||+|||+.+   ++||||||+|||++.++.+||+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            999999997643110         11135889999999999999999999877   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+++......   .......+..|+|||.
T Consensus       157 gl~~~~~~~~---~~~~~~~~~~y~apE~  182 (270)
T cd05047         157 GLSRGQEVYV---KKTMGRLPVRWMAIES  182 (270)
T ss_pred             CCccccchhh---hccCCCCccccCChHH
Confidence            9986332111   1111223556787664

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.92  E-value=4.4e-24  Score=196.94  Aligned_cols=172  Identities=26%  Similarity=0.399  Sum_probs=146.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|+..+.||.|+||.||++.+..++..||+|++....  ....+.+.+|++++++++|||++++++.+... ...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence            5788899999999999999998889999999997643  35667789999999999999999999987765 56899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....   ....+++..+..++.+++.||.|||..+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~  153 (258)
T cd08215          80 YADGGDLSQKIKKQKK---EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL  153 (258)
T ss_pred             ecCCCcHHHHHHHhhc---cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeec
Confidence            9999999999987531   1156899999999999999999999887   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  ......|++.|+|||.
T Consensus       154 ~~~~~--~~~~~~~~~~y~~pe~  174 (258)
T cd08215         154 SSTVD--LAKTVVGTPYYLSPEL  174 (258)
T ss_pred             ccCcc--eecceeeeecccChhH
Confidence            55431  2334567888888764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.92  E-value=4.3e-24  Score=235.09  Aligned_cols=169  Identities=27%  Similarity=0.453  Sum_probs=137.5

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      +++.++.   ..|...+.||+|+||.||+|....++..||||+++.....    ..+|++++++++|||||+++++|.+.
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence            4455544   3567778999999999999999888999999998754321    23568899999999999999999875


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      + ..++||||+++|+|.++++          .++|..+..++.|+++||+|||+.+.++|+||||||+||+++.++.+++
T Consensus       756 ~-~~~lv~Ey~~~g~L~~~l~----------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        756 K-GAYLIHEYIEGKNLSEVLR----------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             C-CCEEEEeCCCCCcHHHHHh----------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            5 4799999999999999994          3789999999999999999999776667999999999999999998887


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      . ||.+......      ....||++|+|||.-.
T Consensus       825 ~-~~~~~~~~~~------~~~~~t~~y~aPE~~~  851 (968)
T PLN00113        825 R-LSLPGLLCTD------TKCFISSAYVAPETRE  851 (968)
T ss_pred             E-eccccccccC------CCccccccccCccccc
Confidence            6 7766543222      2236889999987543

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=3e-24  Score=202.53  Aligned_cols=168  Identities=26%  Similarity=0.406  Sum_probs=139.9

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      |+..+.||.|++|.||+|.+..++..||+|++....  ......+.+|++++++++||||+++++++.+. ...+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEec
Confidence            566789999999999999998889999999987542  23345688999999999999999999998764 558999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      ++ ++|.+++.....     ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++...
T Consensus        80 ~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~  150 (283)
T cd07835          80 LD-LDLKKYMDSSPL-----TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG  150 (283)
T ss_pred             cC-cCHHHHHhhCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence            95 689999876432     36899999999999999999999877   9999999999999999999999999997664


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  .....++..|+|||.
T Consensus       151 ~~~~~--~~~~~~~~~~~aPE~  170 (283)
T cd07835         151 VPVRT--YTHEVVTLWYRAPEI  170 (283)
T ss_pred             CCccc--cCccccccCCCCCce
Confidence            33221  122356788998774

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2.4e-24  Score=223.01  Aligned_cols=180  Identities=26%  Similarity=0.337  Sum_probs=152.9

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc--
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCID--  250 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~--  250 (372)
                      +..+...++-|.+.++||.|.+|.||+++.+.+++.+|+|++.... ...+++..|.++|+.. .|||++.++|++.-  
T Consensus        11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            3444456788999999999999999999999999999999987643 2335667788888887 69999999999863  


Q ss_pred             --CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          251 --PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       251 --~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                        .++.+|||||||.+|+.-++++....     ..+.|..+..|++.++.||.+||...   +||||||-.|||++.++.
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~g-----~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTKG-----NRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhcc-----cchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCc
Confidence              23349999999999999999988752     68999999999999999999999888   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||.|||+++.++....  ...+..||+.|||||+-
T Consensus       162 VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEVi  195 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVI  195 (953)
T ss_pred             EEEeeeeeeeeeecccc--cccCcCCCcccccceee
Confidence            99999999988764433  33567899999998864

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.92  E-value=1.5e-24  Score=210.73  Aligned_cols=172  Identities=22%  Similarity=0.308  Sum_probs=142.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC---CCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~~~  255 (372)
                      .++|+..+.||+|+||.||+|....+++.||+|++...  .....+.+.+|+.++++++||||+++++++...   ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            36899999999999999999999988999999998754  223456778899999999999999999876532   2347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+. ++|.+++...       ..+++..+..++.||+.||.|||..+   |+||||||+||+++.++.+||+|||
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg  152 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD-------QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFG  152 (334)
T ss_pred             EEEEehhh-hhHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccc
Confidence            99999995 6899988653       45899999999999999999999877   9999999999999999999999999


Q ss_pred             cccccCCCCCC--ccccccccCCCccCccc
Q 017411          336 LATWTSAPSVP--FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~--~~~~~~~GT~gy~apea  363 (372)
                      +++........  .......|+..|+|||.
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~  182 (334)
T cd07855         153 MARGLSSSPTEHKYFMTEYVATRWYRAPEL  182 (334)
T ss_pred             cceeecccCcCCCcccccccccccccChHH
Confidence            99876443221  12234578888998775

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.92  E-value=3.7e-24  Score=202.61  Aligned_cols=171  Identities=27%  Similarity=0.362  Sum_probs=146.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++.|+..+.||+|+||.||++.+..++..|++|++..... ..+.+.+|++++++++|+||+++++++... ...++|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEE
Confidence            45678888999999999999999987889999999986544 556788999999999999999999988775 5589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....      ..+++..+..++.|++.||.|||..+   |+|+||+|+||+++.++.++|+|||++..
T Consensus        95 e~~~~~~L~~~l~~~~------~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          95 EYMDGGSLTDIITQNF------VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             eccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999998752      36899999999999999999999877   99999999999999999999999999876


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  ......++.+|++||.
T Consensus       166 ~~~~~~--~~~~~~~~~~y~~PE~  187 (286)
T cd06614         166 LTKEKS--KRNSVVGTPYWMAPEV  187 (286)
T ss_pred             hccchh--hhccccCCcccCCHhH
Confidence            654322  1233457888998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.92  E-value=4.2e-24  Score=200.07  Aligned_cols=171  Identities=25%  Similarity=0.403  Sum_probs=139.0

Q ss_pred             CeeeceeEcccCceEEEEEEECC-CCeEEEEEEecCC----------ChhhHHHHHHHHHHHHh-CCCCCeeceeeeEEc
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE----------DKESSKAFCRELMIASS-LHHPNIVPLVGFCID  250 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~----------~~~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~  250 (372)
                      +|+..+.||+|+||.||++.+.. .++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999876 6789999987532          22344567788888865 799999999998876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                       +...++||||+++++|.+++......   ...+++..++.++.|++.||.|||+ .+   |+|+||||+||+++.++.+
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEK---KQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcE
Confidence             45589999999999999998653221   1468999999999999999999996 44   9999999999999999999


Q ss_pred             EEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|||++.......   ......|+..|+|||.
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~  184 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEI  184 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhh
Confidence            999999998765433   2234567888888664

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.92  E-value=2.9e-24  Score=204.88  Aligned_cols=173  Identities=27%  Similarity=0.388  Sum_probs=140.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-----
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-----  253 (372)
                      .++|+..+.||+|+||.||+|....+++.||||++....  ......+.+|++++++++||||+++++++.+...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            469999999999999999999998889999999986432  2223457789999999999999999998765433     


Q ss_pred             --eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          254 --GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       254 --~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                        .+++|+||+.+ +|...+....      ..+++..+..++.|+++||.|||+.+   |+|+||||+||+++.++.+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~------~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPS------VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence              36899999964 7777775432      46899999999999999999999887   999999999999999999999


Q ss_pred             EecccccccCCCCCC---------ccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVP---------FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~---------~~~~~~~GT~gy~apea  363 (372)
                      +|||+++........         .......|++.|+|||.
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  197 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL  197 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHH
Confidence            999999876433211         11233467788888774

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=2.8e-24  Score=209.21  Aligned_cols=170  Identities=25%  Similarity=0.395  Sum_probs=141.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----Ce
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~  254 (372)
                      .++|...+.||+|+||.||++.+..+++.||||.+...  .......+.+|+.+++.++||||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999999888999999998753  2334456788999999999999999999876432    23


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++|+||+. ++|.+++...       ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Df  152 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-------QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDF  152 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcC
Confidence            799999995 6898888653       46899999999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+++.......  ......++..|+|||.
T Consensus       153 g~~~~~~~~~~--~~~~~~~~~~y~aPE~  179 (337)
T cd07858         153 GLARTTSEKGD--FMTEYVVTRWYRAPEL  179 (337)
T ss_pred             ccccccCCCcc--cccccccccCccChHH
Confidence            99987654321  2234467888888774

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.92  E-value=2.8e-24  Score=205.34  Aligned_cols=164  Identities=24%  Similarity=0.329  Sum_probs=139.8

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ...||+|+||.||++....+++.||||.+..........+.+|+.+++.++|+||+++++++... ...++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCCc
Confidence            36799999999999999888999999998765555667789999999999999999999988764 45899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++..        ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++........ 
T Consensus       104 L~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         104 LTDIVTH--------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             HHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            9998753        35789999999999999999999887   99999999999999999999999999876644322 


Q ss_pred             ccccccccCCCccCcccc
Q 017411          347 FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       347 ~~~~~~~GT~gy~apeaP  364 (372)
                       ......|+++|+|||.-
T Consensus       172 -~~~~~~~~~~y~~pE~~  188 (292)
T cd06657         172 -RRKSLVGTPYWMAPELI  188 (292)
T ss_pred             -cccccccCccccCHHHh
Confidence             12345688889987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.92  E-value=8e-24  Score=204.14  Aligned_cols=164  Identities=27%  Similarity=0.381  Sum_probs=138.3

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .|...+.||+|+||.||++....++..||+|.+...   .......+.+|++++++++|||++++++++.+.. ..++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH-TAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC-eEEEEE
Confidence            467778999999999999999888999999998743   2344567889999999999999999999987644 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++ |+|.+.+....      ..+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++..
T Consensus       105 e~~~-g~l~~~~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635         105 EYCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             eCCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccc
Confidence            9996 58888776432      46899999999999999999999887   99999999999999999999999999876


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....      ....|++.|+|||.
T Consensus       175 ~~~~------~~~~~~~~y~aPE~  192 (317)
T cd06635         175 ASPA------NSFVGTPYWMAPEV  192 (317)
T ss_pred             cCCc------ccccCCccccChhh
Confidence            5432      23467888888664

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.92  E-value=5e-25  Score=219.39  Aligned_cols=170  Identities=25%  Similarity=0.276  Sum_probs=144.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHHhCC---CCCeeceeeeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLH---HPNIVPLVGFCI  249 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~  249 (372)
                      ..+|+..+.+|+|+||.|+.|.++....+|+||.+.++..        ...-.+-.|+.||..++   |+||++++++|.
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            3478999999999999999999998889999999987521        11112446999999997   999999999877


Q ss_pred             cCCCeEEEEEecc-CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          250 DPEQGLFLIYKYV-SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       250 ~~~~~~~lV~Ey~-~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      + ++++||+||-- ++.+|.++|..+       ..+++..+..|++||+-|+++||+++   |||||||-+||.++.+|-
T Consensus       640 d-dd~yyl~te~hg~gIDLFd~IE~k-------p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  640 D-DDYYYLETEVHGEGIDLFDFIEFK-------PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             c-CCeeEEEecCCCCCcchhhhhhcc-------CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence            6 55689999976 567999999876       56899999999999999999999988   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +||+|||.|.....+.-    -..+||.+|.|||.-.
T Consensus       709 ~klidfgsaa~~ksgpf----d~f~gtv~~aapevl~  741 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKSGPF----DVFVGTVDYAAPEVLG  741 (772)
T ss_pred             EEEeeccchhhhcCCCc----ceeeeeccccchhhhC
Confidence            99999999987764432    4578999999987643

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=8e-26  Score=241.30  Aligned_cols=175  Identities=27%  Similarity=0.383  Sum_probs=147.3

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..+-+++....||.|.||.||-|....+|+..|+|.+..++  ....+.+.+|..++..|+|||+|+++|+-...+ .++
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRe-kv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHRE-KVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHH-HHH
Confidence            34457788899999999999999999999999999887553  333456789999999999999999999876644 488


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      |.||||++|+|.+.+...       ...++.....+..|++.|+.|||.++   ||||||||+||+|+.+|.+|++|||.
T Consensus      1311 IFMEyC~~GsLa~ll~~g-------ri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHG-------RIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred             HHHHHhccCcHHHHHHhc-------chhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccc
Confidence            999999999999999764       35677777788999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCC--CccccccccCCCccCcccc
Q 017411          337 ATWTSAPSV--PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~--~~~~~~~~GT~gy~apeaP  364 (372)
                      |..+.++..  +......+||+.|||||+-
T Consensus      1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvi 1410 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVI 1410 (1509)
T ss_pred             eeEecCchhcCCHHHHhhcCCchhcCchhh
Confidence            998866532  2223456899999998753

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=1.6e-24  Score=222.71  Aligned_cols=177  Identities=19%  Similarity=0.187  Sum_probs=131.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC-eEEEEEE--------------ec---CCChhhHHHHHHHHHHHHhCCCCCee
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKR--------------LD---KEDKESSKAFCRELMIASSLHHPNIV  242 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~--------------l~---~~~~~~~~~~~~Ev~iL~~l~HpnIv  242 (372)
                      .++|++.+.||+|+||.||++..+... ..+++|.              +.   .........+.+|+++|++++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            468999999999999999998764322 1222221              11   11223445688999999999999999


Q ss_pred             ceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEE
Q 017411          243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (372)
Q Consensus       243 ~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NIL  322 (372)
                      ++++++...+ ..|+|+|++. ++|..++.......  ........+..|+.||+.||.|||+.+   ||||||||+|||
T Consensus       227 ~l~~~~~~~~-~~~lv~e~~~-~~l~~~l~~~~~~~--~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        227 KIEEILRSEA-NTYMITQKYD-FDLYSFMYDEAFDW--KDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             cEeEEEEECC-eeEEEEeccc-cCHHHHHhhccccc--cccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            9999987654 4889999984 67887775432110  122345667789999999999999887   999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       323 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ++.++.+||+|||+++.+...... ......||..|+|||.-.
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~  341 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILA  341 (501)
T ss_pred             ECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhc
Confidence            999999999999999877544322 223457899999877643

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.92  E-value=6.6e-24  Score=199.63  Aligned_cols=166  Identities=25%  Similarity=0.289  Sum_probs=135.5

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCC-CeEEEEEe
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE-QGLFLIYK  260 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~-~~~~lV~E  260 (372)
                      |+..+.||+|+||.||+|....+++.||+|.++... ........+|+.++.++. ||||+++++++.+.. ...++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566789999999999999998889999999987542 222234567899999885 999999999987641 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ ++|.+++....      ..+++..+..++.|++.||.|||..+   |+||||||+||+++. +.+||+|||+++..
T Consensus        81 ~~~-~~l~~~l~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          81 LMD-MNLYELIKGRK------RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             cCC-ccHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            996 58888886542      46899999999999999999999887   999999999999999 99999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....   .....++..|+|||.
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~  169 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPEC  169 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhH
Confidence            54322   123457788888763

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.92  E-value=4.8e-24  Score=197.26  Aligned_cols=170  Identities=25%  Similarity=0.378  Sum_probs=143.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|++.+.||+|+||.||++....+++.+|+|.+...  .......+.+|++++++++||||+++++++.+. ...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEeh
Confidence            478889999999999999999888999999998754  234456788999999999999999999988764 55899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++......   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++...
T Consensus        80 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~  153 (256)
T cd08530          80 YAPFGDLSKAISKRKKK---RKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL  153 (256)
T ss_pred             hcCCCCHHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhh
Confidence            99999999998764221   146899999999999999999999887   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....    .....|+..|+|||.
T Consensus       154 ~~~~----~~~~~~~~~~~~Pe~  172 (256)
T cd08530         154 KKNM----AKTQIGTPHYMAPEV  172 (256)
T ss_pred             ccCC----cccccCCccccCHHH
Confidence            6542    223457888888653

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2e-25  Score=214.89  Aligned_cols=175  Identities=26%  Similarity=0.314  Sum_probs=147.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+|....+||+|+||+|.++..+.+.+.+|||++++.   ..+..+.-+.|-++|.-. +-|.++++... ++.-+++|+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHSc-FQTmDRLyF  427 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSC-FQTMDRLYF  427 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHH-hhhhhheee
Confidence            4888899999999999999999999999999999875   223334445677777766 56788888875 455667999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+.||+|..+++..       ..+.+..+..++.+||-||-+||+.+   ||.||||.+|||||.+|++||+|||++
T Consensus       428 VMEyvnGGDLMyhiQQ~-------GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc  497 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV-------GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC  497 (683)
T ss_pred             EEEEecCchhhhHHHHh-------cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence            99999999999999876       45778888899999999999999888   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccccccccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRL  369 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaPE~~~~  369 (372)
                      +.---+..  .+.+.+||+.|+|||+--|++.
T Consensus       498 KEni~~~~--TTkTFCGTPdYiAPEIi~YqPY  527 (683)
T KOG0696|consen  498 KENIFDGV--TTKTFCGTPDYIAPEIIAYQPY  527 (683)
T ss_pred             cccccCCc--ceeeecCCCcccccceEEeccc
Confidence            86544333  5678999999999998877664

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7.8e-25  Score=219.66  Aligned_cols=148  Identities=26%  Similarity=0.302  Sum_probs=131.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh---hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE---SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~---~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      -.-|.+++.||-|+||.|.+++..++...||+|.+.+.+.-   ....+..|-.||..-+.+.||+||-.|.+.+ .+|+
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYF  706 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYF  706 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEE
Confidence            35689999999999999999999889999999999876432   3345678999999999999999998776644 5999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||++||++..+|-+.       ..+.+..++.++.++..|+++.|..+   +|||||||+|||||.+|++||.||||+
T Consensus       707 VMdYIPGGDmMSLLIrm-------gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLC  776 (1034)
T KOG0608|consen  707 VMDYIPGGDMMSLLIRM-------GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLC  776 (1034)
T ss_pred             EEeccCCccHHHHHHHh-------ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccc
Confidence            99999999999999876       57899999999999999999999777   999999999999999999999999998


Q ss_pred             cc
Q 017411          338 TW  339 (372)
Q Consensus       338 ~~  339 (372)
                      +-
T Consensus       777 TG  778 (1034)
T KOG0608|consen  777 TG  778 (1034)
T ss_pred             cc
Confidence            53

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.91  E-value=8.8e-24  Score=196.23  Aligned_cols=169  Identities=22%  Similarity=0.418  Sum_probs=137.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      .+|+..+.||+|+||.||++.+.. +..+|+|.+..... ....|.+|++++++++||||+++++++... ...++|+||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   80 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEF   80 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEc
Confidence            478888999999999999998753 56899999875432 345788999999999999999999987654 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++++|.+++....      ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++...
T Consensus        81 ~~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  151 (256)
T cd05112          81 MEHGCLSDYLRAQR------GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVL  151 (256)
T ss_pred             CCCCcHHHHHHhCc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecc
Confidence            99999999987543      35789999999999999999999887   9999999999999999999999999998664


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..... ......++.+|+|||.
T Consensus       152 ~~~~~-~~~~~~~~~~~~aPe~  172 (256)
T cd05112         152 DDQYT-SSTGTKFPVKWSSPEV  172 (256)
T ss_pred             cCccc-ccCCCccchhhcCHhH
Confidence            33211 1111224456777653

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=9.6e-24  Score=196.65  Aligned_cols=161  Identities=25%  Similarity=0.283  Sum_probs=132.0

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHH-HhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIA-SSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL-~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|....+++.||||.+.+...   .....+..|..++ ...+||||+++++++.. +...++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            579999999999999988899999999976432   2223345555544 45589999999998876 445899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +++|.+++...       ..+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||+++.... 
T Consensus        81 ~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-  149 (260)
T cd05611          81 GGDCASLIKTL-------GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-  149 (260)
T ss_pred             CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-
Confidence            99999999764       45889999999999999999999887   99999999999999999999999999876543 


Q ss_pred             CCCccccccccCCCccCccccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaPE  365 (372)
                           .....|++.|++||..+
T Consensus       150 -----~~~~~~~~~y~~pe~~~  166 (260)
T cd05611         150 -----NKKFVGTPDYLAPETIL  166 (260)
T ss_pred             -----cccCCCCcCccChhhhc
Confidence                 23346788898877543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.91  E-value=4.4e-24  Score=202.14  Aligned_cols=171  Identities=24%  Similarity=0.288  Sum_probs=136.1

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +|...+.||+|+||.||++.+..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++.... ..+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~-~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG-DCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC-cEEEEEe
Confidence            5666788999999999999999889999999987542 344567889999999996 999999999887644 4789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+. ++|.++......  .....+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~-~~l~~l~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  157 (288)
T cd06616          84 LMD-ISLDKFYKYVYE--VLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQ  157 (288)
T ss_pred             ccc-CCHHHHHHHHHH--hhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHH
Confidence            985 466554432110  0014689999999999999999999974 5   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......   .....|+..|+|||.
T Consensus       158 ~~~~~~---~~~~~~~~~y~aPE~  178 (288)
T cd06616         158 LVDSIA---KTRDAGCRPYMAPER  178 (288)
T ss_pred             hccCCc---cccccCccCccCHHH
Confidence            654332   233467888888764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=8.4e-24  Score=199.24  Aligned_cols=168  Identities=26%  Similarity=0.356  Sum_probs=139.8

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEec
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      |++.+.||+|+||.||+|....+++.|+||++..... .......+|+..+++++ ||||+++++++.+ +...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            5677899999999999999988889999999875422 22234567999999999 9999999999877 4458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      + +|+|.+++.....     ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||+++...
T Consensus        80 ~-~~~l~~~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~  150 (283)
T cd07830          80 M-EGNLYQLMKDRKG-----KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR  150 (283)
T ss_pred             C-CCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceecc
Confidence            9 8899999876531     46899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....   .....|+..|+|||..
T Consensus       151 ~~~~---~~~~~~~~~~~aPE~~  170 (283)
T cd07830         151 SRPP---YTDYVSTRWYRAPEIL  170 (283)
T ss_pred             CCCC---cCCCCCcccccCceee
Confidence            4322   1234578888887754

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.91  E-value=5.1e-24  Score=205.96  Aligned_cols=170  Identities=25%  Similarity=0.317  Sum_probs=142.8

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----CeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~~~  256 (372)
                      +|++.+.||+|+||.||+|....+++.||||.+....  ....+.+.+|+.+++.++||||+++++++....    ...|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999998889999999987643  445567899999999999999999999887654    3579


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||++ ++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||+
T Consensus        81 lv~e~~~-~~l~~~l~~~-------~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-------QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             EEecchh-hhHHHHHhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCc
Confidence            9999997 5898888653       46899999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccCCCccCccc
Q 017411          337 ATWTSAPSVP-FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~-~~~~~~~GT~gy~apea  363 (372)
                      +......... .......++..|+|||.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  177 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPEL  177 (330)
T ss_pred             eEeecccccccccccccccccCcCCcee
Confidence            9887654311 11233457788888764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.91  E-value=1.8e-23  Score=196.95  Aligned_cols=165  Identities=24%  Similarity=0.268  Sum_probs=132.8

Q ss_pred             HhhCCeeeceeE--cccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeE
Q 017411          179 AATHNFSKGRVL--GRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       179 ~~t~~f~~~~~L--G~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~  255 (372)
                      ...++|...+.+  |+|+||.||++....++..+|+|.+.......     .|+.....+ +||||+++++++...+ ..
T Consensus        11 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~-~~   84 (267)
T PHA03390         11 QFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLK-GH   84 (267)
T ss_pred             HHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCC-ee
Confidence            334566666665  99999999999998889999999987542211     122222222 7999999999887754 58


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEec
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDF  334 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DF  334 (372)
                      ++||||+++++|.+++...       ..+++..+..++.|+++||.|||+.+   |+||||||+||+++.++ .++|+||
T Consensus        85 ~iv~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKE-------GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999764       36899999999999999999999887   99999999999999998 9999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+++......      ...|+..|+|||.-+
T Consensus       155 g~~~~~~~~~------~~~~~~~y~aPE~~~  179 (267)
T PHA03390        155 GLCKIIGTPS------CYDGTLDYFSPEKIK  179 (267)
T ss_pred             ccceecCCCc------cCCCCCcccChhhhc
Confidence            9998765332      246888999987654

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.2e-23  Score=205.35  Aligned_cols=165  Identities=22%  Similarity=0.323  Sum_probs=136.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----C
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~  253 (372)
                      .++|...+.||+|+||.||+|....+++.||||++.+.  .......+.+|+.++++++||||+++++++....     .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37899999999999999999999888999999998753  2233456889999999999999999999876432     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++|+||+. .+|..++.         ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~d  160 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG---------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILD  160 (342)
T ss_pred             eEEEEecccc-cCHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence            3689999996 47766542         35889999999999999999999887   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++......     ....++..|+|||.
T Consensus       161 fg~~~~~~~~~-----~~~~~~~~y~aPE~  185 (342)
T cd07879         161 FGLARHADAEM-----TGYVVTRWYRAPEV  185 (342)
T ss_pred             CCCCcCCCCCC-----CCceeeecccChhh
Confidence            99997654322     23457788888774

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.91  E-value=1.3e-23  Score=199.14  Aligned_cols=170  Identities=29%  Similarity=0.266  Sum_probs=139.2

Q ss_pred             CeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      +|+..+.||+|+||.||++...   .+++.||||.+++..    ....+.+.+|+.++.++ +||||+++++.+.. +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            4778899999999999999863   356789999987532    23345688999999999 59999999987655 455


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+++++|.+++...       ..+++..+..++.|+++||.|||..+   ++||||||+||+++.++.++|+||
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df  149 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQR-------EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDF  149 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhc-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEEC
Confidence            89999999999999998753       45889999999999999999999877   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........ ......|+..|++||..
T Consensus       150 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~  178 (288)
T cd05583         150 GLSKEFLAEEEE-RAYSFCGTIEYMAPEVI  178 (288)
T ss_pred             cccccccccccc-ccccccCCccccCHHHh
Confidence            999876543321 12234678888887753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.91  E-value=1.4e-23  Score=203.76  Aligned_cols=170  Identities=26%  Similarity=0.296  Sum_probs=137.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCC--CeEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC---CCe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLL--RTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP---EQG  254 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~--~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~---~~~  254 (372)
                      +|...+.||+|+||.||++....+  +..||+|.+...  .....+.+.+|+++++++ +||||+++++.+...   ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999877  889999998753  233456788999999999 599999999875432   234


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++++||+. ++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Df  149 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-------QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDF  149 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcC
Confidence            688899985 6899988643       46899999999999999999999887   999999999999999999999999


Q ss_pred             ccccccCCCCCC--ccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVP--FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~--~~~~~~~GT~gy~apea  363 (372)
                      |+++.+......  .......||..|+|||.
T Consensus       150 g~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~  180 (332)
T cd07857         150 GLARGFSENPGENAGFMTEYVATRWYRAPEI  180 (332)
T ss_pred             CCceecccccccccccccCcccCccccCcHH
Confidence            999876533221  11233568888888774

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.4e-23  Score=214.73  Aligned_cols=180  Identities=22%  Similarity=0.270  Sum_probs=132.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC----------------CCCeEEEEEEecCCChhhHHHH--------------HHH
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG----------------LLRTSVAIKRLDKEDKESSKAF--------------CRE  229 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~----------------~~~~~vAvK~l~~~~~~~~~~~--------------~~E  229 (372)
                      ..++|++.++||+|+||.||+|...                ..++.||||++........+.|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999999752                2346799999875443333333              346


Q ss_pred             HHHHHhCCCCCe-----eceeeeEEcC-------CCeEEEEEeccCCCCHHHHHHhhccCC-----------------CC
Q 017411          230 LMIASSLHHPNI-----VPLVGFCIDP-------EQGLFLIYKYVSGGSLERHLHEKKKGV-----------------RG  280 (372)
Q Consensus       230 v~iL~~l~HpnI-----v~l~g~~~~~-------~~~~~lV~Ey~~~gsL~~~L~~~~~~~-----------------~~  280 (372)
                      +..+.+++|.++     ++++++|...       ....+|||||+++++|.++++......                 ..
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777776654     6777776431       234799999999999999997532110                 01


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccC
Q 017411          281 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNP  360 (372)
Q Consensus       281 ~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~a  360 (372)
                      ...++|..+..++.|++.+|.|||..+   |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence            124578889999999999999999877   99999999999999999999999999976543321 11122345788999


Q ss_pred             ccc
Q 017411          361 FCI  363 (372)
Q Consensus       361 pea  363 (372)
                      ||.
T Consensus       379 PE~  381 (507)
T PLN03224        379 PEE  381 (507)
T ss_pred             hhh
Confidence            874

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.91  E-value=4.4e-23  Score=198.80  Aligned_cols=163  Identities=27%  Similarity=0.381  Sum_probs=136.5

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      |...+.||+|+||.||+|....+++.|++|.+...   .....+.+.+|++++++++|||++++++++.+. ...++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-HTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEEe
Confidence            55567899999999999999888999999998743   233445788999999999999999999998774 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||++...
T Consensus       102 ~~~-~~l~~~l~~~~------~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633         102 YCL-GSASDLLEVHK------KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             cCC-CCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            995 57888776532      46899999999999999999999887   999999999999999999999999998643


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..      .....|+..|+|||.
T Consensus       172 ~~------~~~~~~~~~y~aPE~  188 (313)
T cd06633         172 SP------ANSFVGTPYWMAPEV  188 (313)
T ss_pred             CC------CCCccccccccChhh
Confidence            22      123568888888664

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.91  E-value=1.5e-23  Score=204.57  Aligned_cols=169  Identities=24%  Similarity=0.306  Sum_probs=138.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC---------
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE---------  252 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~---------  252 (372)
                      .+|...+.||.|+||.||+|....+++.||+|.+........+.+.+|++++++++||||+++++++....         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            68999999999999999999999889999999997766566677899999999999999999998765432         


Q ss_pred             ----CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CC
Q 017411          253 ----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KK  327 (372)
Q Consensus       253 ----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~  327 (372)
                          ...++|+||++ ++|.+++..        ..+++..+..++.||+.||.|||..+   |+||||||+||+++. ++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~  152 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ--------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCc
Confidence                23689999996 589888753        35889999999999999999999887   999999999999974 56


Q ss_pred             cEEEEecccccccCCCCCCc-cccccccCCCccCcc
Q 017411          328 IPKLCDFGLATWTSAPSVPF-LCKTVKGTFGQNPFC  362 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~-~~~~~~GT~gy~ape  362 (372)
                      .+||+|||+++......... ......|+..|+|||
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  188 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPR  188 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHH
Confidence            78999999998664322111 112235677788866

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.91  E-value=4.3e-23  Score=194.31  Aligned_cols=168  Identities=29%  Similarity=0.399  Sum_probs=135.8

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhC---CCCCeeceeeeEEcCCC----e
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQ----G  254 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~~~~----~  254 (372)
                      |++.+.||+|+||.||+|....+++.||+|.+...  .......+.+|+.+++++   +||||+++++++...+.    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            56778999999999999999888899999999743  222334566788777666   59999999999876443    3


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .+++|||+. ++|.+++.....     ..+++..+..++.|++.||.|||..+   ++|+||+|+||+++.++.+||+||
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPK-----PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEecc
Confidence            789999996 589998876432     35899999999999999999999877   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |++........   .....++..|+|||.
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~  177 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEV  177 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHH
Confidence            99987754432   123346777888664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.91  E-value=3.1e-23  Score=197.65  Aligned_cols=169  Identities=25%  Similarity=0.399  Sum_probs=137.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      -++|+..+.||+|+||.||+|.+..+++.||||.+++.. ......+.+|+.++.+.. ||||+++++++.+. ...++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v   92 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFIC   92 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEE
Confidence            357888999999999999999998889999999997643 334456777887777775 99999999998774 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |||++ ++|.+++....      ..+++..+..++.|++.||.|||+ .+   |+||||+|+||+++.++.+||+|||++
T Consensus        93 ~e~~~-~~l~~l~~~~~------~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          93 MELMS-TCLDKLLKRIQ------GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             eeccC-cCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccc
Confidence            99985 57877776532      468999999999999999999997 35   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..+.....   .....++..|+|||.
T Consensus       163 ~~~~~~~~---~~~~~~~~~y~aPE~  185 (296)
T cd06618         163 GRLVDSKA---KTRSAGCAAYMAPER  185 (296)
T ss_pred             hhccCCCc---ccCCCCCccccCHhh
Confidence            77643322   122356778888663

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.6e-24  Score=210.14  Aligned_cols=176  Identities=26%  Similarity=0.339  Sum_probs=146.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-------ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-------DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      ..++|-.+..||+|||+.||++.+....+-||||+-...       .....+...+|.+|.+.|+||.||++|+|+.-..
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            345777889999999999999998877888999986432       1122345678999999999999999999987666


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc---CCCcE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIP  329 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld---~~~~~  329 (372)
                      +.+|-|+|||+|.+|+-+|+..       ..+++..+..|+.||+.||.||.... +||||-||||.||||.   ..|.+
T Consensus       541 dsFCTVLEYceGNDLDFYLKQh-------klmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQH-------KLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhh-------hhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence            6789999999999999999876       46899999999999999999999875 7799999999999995   44789


Q ss_pred             EEEecccccccCCCCCCc-----cccccccCCCccCccc
Q 017411          330 KLCDFGLATWTSAPSVPF-----LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~-----~~~~~~GT~gy~apea  363 (372)
                      ||.||||++.....+...     .+....||..|+|||.
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEc  651 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPEC  651 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcce
Confidence            999999999886554332     3445689999999763

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.91  E-value=2.1e-23  Score=202.41  Aligned_cols=148  Identities=30%  Similarity=0.393  Sum_probs=126.4

Q ss_pred             CCee-eceeEcccCceEEEEEEECCCCeEEEEEEecCCChhh--------------HHHHHHHHHHHHhCCCCCeeceee
Q 017411          182 HNFS-KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES--------------SKAFCRELMIASSLHHPNIVPLVG  246 (372)
Q Consensus       182 ~~f~-~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~--------------~~~~~~Ev~iL~~l~HpnIv~l~g  246 (372)
                      ++|. +.+.||+|+||.||+|.+..+++.||||.+.......              ...+.+|++++++++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4554 4577999999999999998889999999986532211              124778999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       247 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      ++... ...++||||+. |+|.+++...       ..+++.....++.|++.||.|||..+   |+|+||||+||+++.+
T Consensus        88 ~~~~~-~~~~lv~e~~~-~~l~~~l~~~-------~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~  155 (335)
T PTZ00024         88 VYVEG-DFINLVMDIMA-SDLKKVVDRK-------IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSK  155 (335)
T ss_pred             EEecC-CcEEEEEeccc-cCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCC
Confidence            98764 45899999996 6999998653       45889999999999999999999877   9999999999999999


Q ss_pred             CcEEEEecccccccC
Q 017411          327 KIPKLCDFGLATWTS  341 (372)
Q Consensus       327 ~~~KL~DFGla~~~~  341 (372)
                      +.+||+|||+++...
T Consensus       156 ~~~kl~dfg~~~~~~  170 (335)
T PTZ00024        156 GICKIADFGLARRYG  170 (335)
T ss_pred             CCEEECCccceeecc
Confidence            999999999998765

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.91  E-value=2.5e-23  Score=195.59  Aligned_cols=168  Identities=26%  Similarity=0.409  Sum_probs=140.3

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      |+..+.||+|++|.||++....+++.+++|.++...  ......+.+|+.++++++|+||+++++++... ...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEec
Confidence            456689999999999999998889999999987542  23456788999999999999999999988765 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++ +|.+++....      ..+++..+..++.|++.||.|||..+   |+|+||||+||+++.++.+||+|||.+....
T Consensus        80 ~~~-~l~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~  149 (283)
T cd05118          80 MDT-DLYKLIKDRQ------RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFG  149 (283)
T ss_pred             cCC-CHHHHHHhhc------ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecC
Confidence            975 8988887642      46899999999999999999999887   9999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  ......++..|+|||.-
T Consensus       150 ~~~~--~~~~~~~~~~~~~PE~~  170 (283)
T cd05118         150 SPVR--PYTHYVVTRWYRAPELL  170 (283)
T ss_pred             CCcc--cccCccCcccccCcHHH
Confidence            5431  12234577778887653

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.90  E-value=2.3e-23  Score=200.12  Aligned_cols=165  Identities=28%  Similarity=0.373  Sum_probs=138.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ..|+..+.||+|+||.||+|....++..||+|.+...   .....+.+.+|+++++.++|+|++++++++... ...++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEE
Confidence            3477778999999999999999888899999998642   334456788999999999999999999998775 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        94 ~e~~~-~~l~~~~~~~~------~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  163 (308)
T cd06634          94 MEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS  163 (308)
T ss_pred             EEccC-CCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccce
Confidence            99996 68888776432      45889999999999999999999877   9999999999999999999999999987


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....      ....|+..|+|||.
T Consensus       164 ~~~~~------~~~~~~~~y~aPE~  182 (308)
T cd06634         164 IMAPA------NXFVGTPYWMAPEV  182 (308)
T ss_pred             eecCc------ccccCCccccCHHH
Confidence            65432      23457888998775

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.90  E-value=3.8e-23  Score=190.86  Aligned_cols=162  Identities=30%  Similarity=0.342  Sum_probs=138.0

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      ||+|+||.||++....+++.||+|.+.+..   ......+.+|+.++++++||||+++++.+.. +...++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            689999999999998888999999987642   2345678899999999999999999998765 455899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP  346 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~  346 (372)
                      |.+++...       ..+++..+..++.|++.||.|||..+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 L~~~l~~~-------~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-  148 (250)
T cd05123          80 LFSHLSKE-------GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-  148 (250)
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC-
Confidence            99999764       35899999999999999999999877   99999999999999999999999999987654321 


Q ss_pred             ccccccccCCCccCcccc
Q 017411          347 FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       347 ~~~~~~~GT~gy~apeaP  364 (372)
                       ......|+.+|++||.-
T Consensus       149 -~~~~~~~~~~~~~Pe~~  165 (250)
T cd05123         149 -RTNTFCGTPEYLAPEVL  165 (250)
T ss_pred             -cccCCcCCccccChHHh
Confidence             23445688889987753

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.90  E-value=3.8e-23  Score=197.50  Aligned_cols=172  Identities=13%  Similarity=0.153  Sum_probs=125.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCCChhhH-----------HHHHHHHHHHHhCCCCCeeceee
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESS-----------KAFCRELMIASSLHHPNIVPLVG  246 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~~~-----------~~~~~Ev~iL~~l~HpnIv~l~g  246 (372)
                      ...|++.+.||+|+||.||+|....+   +..+|+|..........           .....+...+..++|+||+++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            36899999999999999999998766   56777776543221110           11223344556778999999998


Q ss_pred             eEEcCCC---eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          247 FCIDPEQ---GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       247 ~~~~~~~---~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      ++.....   ..++++|++. .++.+.+...       ...++..+..++.|++.||.|||+.+   |+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill  159 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-------KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMV  159 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh-------ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence            7654332   2367788774 4676666543       23578888999999999999999877   9999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCCC-----ccccccccCCCccCccc
Q 017411          324 SSKKIPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       324 d~~~~~KL~DFGla~~~~~~~~~-----~~~~~~~GT~gy~apea  363 (372)
                      +.++.++|+|||+|+.+......     .......||+.|+|||+
T Consensus       160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~  204 (294)
T PHA02882        160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDA  204 (294)
T ss_pred             cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHH
Confidence            99999999999999876432211     11123469999999764

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.90  E-value=2.1e-23  Score=195.95  Aligned_cols=167  Identities=27%  Similarity=0.424  Sum_probs=139.7

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      |+..+.||+|+||.||+|....+++.||+|.+....  ....+.+.+|+.++++++|+||+++++++.+. ...++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence            456688999999999999999889999999998652  33456788999999999999999999988765 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      ++ ++|.+++....      ..+++..++.++.|++.||.|||..+   |+||||+|+||+++.++.+||+|||+++...
T Consensus        80 ~~-~~l~~~i~~~~------~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~  149 (282)
T cd07829          80 CD-MDLKKYLDKRP------GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFG  149 (282)
T ss_pred             cC-cCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccC
Confidence            97 59999998652      35899999999999999999999887   9999999999999999999999999998765


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....  .....++..|+|||.
T Consensus       150 ~~~~~--~~~~~~~~~~~aPE~  169 (282)
T cd07829         150 IPLRT--YTHEVVTLWYRAPEI  169 (282)
T ss_pred             CCccc--cCccccCcCcCChHH
Confidence            44321  122345667888664

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.6e-24  Score=214.45  Aligned_cols=180  Identities=24%  Similarity=0.401  Sum_probs=151.0

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      +++|+....+....++||-|.||.||.|.++.-.-.||||.++. +.-..++|+.|+.+|+.|+|||+|+|+|+|.... 
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep-  336 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP-  336 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC-
Confidence            46777777788888999999999999999987778899999975 4455689999999999999999999999997644 


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      .+|||.|||..|+|.++|++...     ..++....+.++.||..|++||...+   +|||||...|+|+.++..+||+|
T Consensus       337 PFYIiTEfM~yGNLLdYLRecnr-----~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  337 PFYIITEFMCYGNLLDYLRECNR-----SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             CeEEEEecccCccHHHHHHHhch-----hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeec
Confidence            48999999999999999998754     55777778889999999999999887   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccC---CCccCccccccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGT---FGQNPFCIEEWQ  367 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT---~gy~apeaPE~~  367 (372)
                      |||+|+...+...    ...|.   +-|.|||.--|.
T Consensus       409 FGLsRlMtgDTYT----AHAGAKFPIKWTAPEsLAyN  441 (1157)
T KOG4278|consen  409 FGLSRLMTGDTYT----AHAGAKFPIKWTAPESLAYN  441 (1157)
T ss_pred             cchhhhhcCCcee----cccCccCcccccCccccccc
Confidence            9999998755431    12233   346665554443

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=3.7e-23  Score=200.46  Aligned_cols=143  Identities=24%  Similarity=0.338  Sum_probs=123.7

Q ss_pred             eeEccc--CceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G--~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      ..||+|  +||+||++.+..+++.||+|++...  .....+.+.+|+.+++.++||||+++++++...+ ..++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~-~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGS-WLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCC-ceEEEEeccc
Confidence            356666  9999999999888999999998753  3344577889999999999999999999987644 5899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      +++|.+++.....     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++||+.+..
T Consensus        83 ~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          83 YGSANSLLKTYFP-----EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             CCCHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            9999999876532     35889999999999999999999877   99999999999999999999999986543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.90  E-value=2.6e-23  Score=193.78  Aligned_cols=172  Identities=24%  Similarity=0.323  Sum_probs=138.1

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      +|.+.+.||+|+||.||++.+...+..+++|.++..     .......+.+|+.++++++||||+++++++.+.. ..++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERD-AFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCC-ceEE
Confidence            477889999999999999998776666777766532     2233445778999999999999999999887654 4899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |+||+++++|.+++......   ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++. +.+||+|||++
T Consensus        80 v~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~  152 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHT---GKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVS  152 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhc---ccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCce
Confidence            99999999999998753221   156899999999999999999999877   999999999999975 56999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......  ......|+..|+|||.-
T Consensus       153 ~~~~~~~~--~~~~~~~~~~~~~pe~~  177 (260)
T cd08222         153 RLLMGSCD--LATTFTGTPYYMSPEAL  177 (260)
T ss_pred             eecCCCcc--cccCCCCCcCccCHHHH
Confidence            87654332  22345688889987753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.90  E-value=4.3e-23  Score=197.90  Aligned_cols=165  Identities=22%  Similarity=0.255  Sum_probs=129.9

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      +.+|.|+  .||.++...+++.||||++...  .....+.+.+|++++++++||||+++++++.+. ...+++|||++++
T Consensus         8 ~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~   84 (314)
T cd08216           8 KCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYG   84 (314)
T ss_pred             HhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCC
Confidence            3444444  4555555557899999998754  445567899999999999999999999988764 4589999999999


Q ss_pred             CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 017411          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (372)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~  345 (372)
                      +|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||.+........
T Consensus        85 ~l~~~l~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~  156 (314)
T cd08216          85 SCEDLLKTHFP-----EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK  156 (314)
T ss_pred             CHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccc
Confidence            99999986532     35888999999999999999999887   99999999999999999999999999876532221


Q ss_pred             C-----ccccccccCCCccCccc
Q 017411          346 P-----FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       346 ~-----~~~~~~~GT~gy~apea  363 (372)
                      .     .......++..|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~  179 (314)
T cd08216         157 RQRVVHDFPKSSVKNLPWLSPEV  179 (314)
T ss_pred             cccccccccccccccccccCHHH
Confidence            1     01123456777888664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.2e-24  Score=201.45  Aligned_cols=172  Identities=27%  Similarity=0.351  Sum_probs=149.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~  256 (372)
                      -++|...++||+|+|++|..+++..+.+.+|+|+++++   +.+.....+.|-.+..+. +||.+|-+..+ ++.+.+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc-fqtesrlf  327 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC-FQTESRLF  327 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh-hcccceEE
Confidence            36899999999999999999999999999999999874   445556677888887776 69999999875 56677899


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|.||++||+|.-+++++       ..|++..+..+...|+.||.|||+.+   ||.||||.+|||+|..|.+||.|+|+
T Consensus       328 fvieyv~ggdlmfhmqrq-------rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygm  397 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGM  397 (593)
T ss_pred             EEEEEecCcceeeehhhh-------hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccch
Confidence            999999999999998876       46999999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .+.--.+..  .+.+.+||+.|+|||+-.
T Consensus       398 cke~l~~gd--~tstfcgtpnyiapeilr  424 (593)
T KOG0695|consen  398 CKEGLGPGD--TTSTFCGTPNYIAPEILR  424 (593)
T ss_pred             hhcCCCCCc--ccccccCCCcccchhhhc
Confidence            987544433  467889999999987653

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.90  E-value=3.5e-23  Score=202.11  Aligned_cols=167  Identities=24%  Similarity=0.313  Sum_probs=140.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC----
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~----  253 (372)
                      ..++|+..+.||+|+||.||+|....+++.||||++...  .....+.+.+|+.++++++||||+++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999888999999998653  23345667889999999999999999987654332    


Q ss_pred             -eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          254 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       254 -~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                       ..++|+||+ +++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~  160 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC--------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKIL  160 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEc
Confidence             378999998 6799998864        35899999999999999999999877   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||++.......     ....++..|+|||.
T Consensus       161 dfg~~~~~~~~~-----~~~~~~~~y~aPE~  186 (343)
T cd07851         161 DFGLARHTDDEM-----TGYVATRWYRAPEI  186 (343)
T ss_pred             cccccccccccc-----cCCcccccccCHHH
Confidence            999998764332     23457778888764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.90  E-value=4.5e-24  Score=198.72  Aligned_cols=168  Identities=25%  Similarity=0.312  Sum_probs=139.7

Q ss_pred             hhCCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC---CCe
Q 017411          180 ATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP---EQG  254 (372)
Q Consensus       180 ~t~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~---~~~  254 (372)
                      .+++|++. ++||-|-.|.|..+.++.+++.+|+|++...     ..-++|+++.-.. .|||||.+++++.+.   ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45677553 6899999999999999999999999998532     3456899887666 699999999987542   334


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKL  331 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL  331 (372)
                      +.+|||.|+||.|.+.++++..     ..+++.++-.|+.||+.|+.|||+.+   |.||||||+|+|...   +..+||
T Consensus       134 LLiVmE~meGGeLfsriq~~g~-----~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKL  205 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGD-----QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKL  205 (400)
T ss_pred             eEeeeecccchHHHHHHHHccc-----ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEe
Confidence            7799999999999999998754     67999999999999999999999988   999999999999964   457899


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|||+|+....+.   ...+.+-|+.|.|||+
T Consensus       206 tDfGFAK~t~~~~---~L~TPc~TPyYvaPev  234 (400)
T KOG0604|consen  206 TDFGFAKETQEPG---DLMTPCFTPYYVAPEV  234 (400)
T ss_pred             cccccccccCCCc---cccCCcccccccCHHH
Confidence            9999998765433   3456677888888875

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.7e-23  Score=207.89  Aligned_cols=173  Identities=23%  Similarity=0.281  Sum_probs=145.5

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEec--CCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~--~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~  255 (372)
                      .....|++.+.||.||.+.||++...+ ...||+|++.  ..+.+....|+.|+.+|.+|+ |.+||+|++|-.. ++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceE
Confidence            345678999999999999999998764 4577877664  346777889999999999995 9999999998654 7789


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      |+||||= ..+|.++|.....      .++...++.+..|++.++.++|.++   |||.||||.|+|+ -.|.+||+|||
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~------~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLl-VkG~LKLIDFG  504 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKS------IDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLL-VKGRLKLIDFG  504 (677)
T ss_pred             EEEeecc-cccHHHHHHhccC------CCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEE-EeeeEEeeeec
Confidence            9999975 6799999987642      3342367789999999999999888   9999999999999 56799999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|..+......-...+-+||+.||+|||-
T Consensus       505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl  533 (677)
T KOG0596|consen  505 IANAIQPDTTSIVKDSQVGTVNYMSPEAL  533 (677)
T ss_pred             hhcccCccccceeeccccCcccccCHHHH
Confidence            99998877776666778999999999874

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=193.59  Aligned_cols=168  Identities=27%  Similarity=0.402  Sum_probs=137.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.+....||.|+.|.|++++++.++...|||.+.+. .....++++..+.++.+.. .|.||+.+|||..... +++.||
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-V~IcMe  171 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-VFICME  171 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-HHHHHH
Confidence            344456799999999999999999999999999875 4556677888888777664 8999999999987444 789999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      .|. ..++.++.+-.      .++++..+=.+...+..||.||...+  +|||||+||+|||+|+.|++||||||++-.+
T Consensus       172 lMs-~C~ekLlkrik------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIK------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             HHH-HHHHHHHHHhc------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence            994 46777776654      56888888888999999999998744  5999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....   .+...|.+.|||||-
T Consensus       243 vdSkA---htrsAGC~~YMaPER  262 (391)
T KOG0983|consen  243 VDSKA---HTRSAGCAAYMAPER  262 (391)
T ss_pred             ecccc---cccccCCccccCccc
Confidence            54432   244578888888763

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=3.7e-25  Score=201.79  Aligned_cols=171  Identities=27%  Similarity=0.401  Sum_probs=137.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecC--CChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC---CC---
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQ---  253 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~---  253 (372)
                      ..|.....||+|.||.||+|+.+.+++.||+|++-.  +.......-++|+.+|..++|+|++.++..|...   ..   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            356677899999999999999999999999986532  2333345668999999999999999999888532   22   


Q ss_pred             -eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          254 -GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       254 -~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                       .+|+|+++|+. +|.-+|....      ..++..++..++.++..||.|+|...   |+|||+|++|+||+.+|.+||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~------vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRK------VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCcc------ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEee
Confidence             38999999965 8999987654      57899999999999999999999888   9999999999999999999999


Q ss_pred             ecccccccCCCCCCc--cccccccCCCccCcc
Q 017411          333 DFGLATWTSAPSVPF--LCKTVKGTFGQNPFC  362 (372)
Q Consensus       333 DFGla~~~~~~~~~~--~~~~~~GT~gy~ape  362 (372)
                      |||+||.++.+....  .-+..+-|..|.+||
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppE  198 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPE  198 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHH
Confidence            999998876443211  111223466777755

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.89  E-value=2e-23  Score=185.79  Aligned_cols=178  Identities=24%  Similarity=0.320  Sum_probs=143.2

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      +....++...+..||+|++|.|-+-++..+|+..|+|++... ..+..++.++|+.+..+. ..|.+|+++|..+... .
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-d  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-D  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-c
Confidence            334445666678899999999999999999999999999754 345566788999877665 7999999999877644 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      +|+.||.| ..+|..+-.+-..   ....+++...=+|+..+..||.|||++  ..|||||+||+|||++.+|++|+|||
T Consensus       120 vwIcME~M-~tSldkfy~~v~~---~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDF  193 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLK---KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDF  193 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHh---cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccc
Confidence            99999999 4588887665332   126789999999999999999999984  45999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |++-.+.+.-.   .+...|.-.|||||.-
T Consensus       194 GIsG~L~dSiA---kt~daGCkpYmaPEri  220 (282)
T KOG0984|consen  194 GISGYLVDSIA---KTMDAGCKPYMAPERI  220 (282)
T ss_pred             ccceeehhhhH---HHHhcCCCccCChhhc
Confidence            99987765432   2225678888887753

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=2.8e-23  Score=213.50  Aligned_cols=171  Identities=27%  Similarity=0.357  Sum_probs=140.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCC----eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .....++||+|+||+||+|.+-..+    .+||||++... ..+...++++|+-+|.+++||||++|+|+|..+.  +.|
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~ql  774 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQL  774 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHH
Confidence            3455689999999999999884434    47899988654 4556788999999999999999999999997643  679


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |++||+.|+|.++++..+      ..+.-...+.|..|||+|+.|||.+.   ++||||-..|||+.+...+||.|||+|
T Consensus       775 vtq~mP~G~LlDyvr~hr------~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR------DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             HHHhcccchHHHHHHHhh------ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchh
Confidence            999999999999999876      45777888899999999999999777   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.+.............-.+-|||-|+.
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i  872 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESI  872 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHh
Confidence            998766554433333333445554443

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.89  E-value=1.7e-22  Score=186.87  Aligned_cols=151  Identities=21%  Similarity=0.242  Sum_probs=125.2

Q ss_pred             cCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHH
Q 017411          193 GALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  272 (372)
Q Consensus       193 G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~  272 (372)
                      |.||.||++++..+++.||+|.+.+..     .+.+|...+....||||+++++++.+. ...++||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHH
Confidence            889999999999999999999997643     234455566667899999999988764 45899999999999999997


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCcccccc
Q 017411          273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  352 (372)
Q Consensus       273 ~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~  352 (372)
                      ..       ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.++++|||++.......     ...
T Consensus        78 ~~-------~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~  142 (237)
T cd05576          78 KF-------LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGE  142 (237)
T ss_pred             Hh-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccC
Confidence            64       35899999999999999999999877   9999999999999999999999999886654321     223


Q ss_pred             ccCCCccCcccc
Q 017411          353 KGTFGQNPFCIE  364 (372)
Q Consensus       353 ~GT~gy~apeaP  364 (372)
                      .++..|+|||..
T Consensus       143 ~~~~~y~aPE~~  154 (237)
T cd05576         143 AVENMYCAPEVG  154 (237)
T ss_pred             CcCccccCCccc
Confidence            456678887653

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.89  E-value=1.1e-22  Score=211.61  Aligned_cols=175  Identities=19%  Similarity=0.210  Sum_probs=121.5

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCC----CeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEE-----c
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI-----D  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~----~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~-----~  250 (372)
                      ..++|+..+.||+|+||.||+|.+..+    +..||||++......  +.+..|  .+....+.+++.++..+.     .
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            457999999999999999999999888    889999998653221  111111  112222223322221111     2


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV-------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~-------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK  317 (372)
                      .+...++||||+++++|.+++.......             .......+..+..++.||+.||.|||+.+   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            3445899999999999999987542100             00011123345678999999999999877   9999999


Q ss_pred             CCCEEEcC-CCcEEEEecccccccCCCCCCccccccccCCCccCcc
Q 017411          318 PSNILLSS-KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC  362 (372)
Q Consensus       318 p~NILld~-~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~ape  362 (372)
                      |+|||++. ++.+||+|||+|+.+..... .......||++|+|||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE  327 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPE  327 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChH
Confidence            99999986 57999999999987643322 1234567899999988

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3.9e-24  Score=210.40  Aligned_cols=168  Identities=25%  Similarity=0.279  Sum_probs=146.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .+++....||-|+||.|-++........+|+|.+++.   +....+.+..|-.+|..++.|.||++|--|.+ +.++|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhh
Confidence            3556667899999999999988765556899998765   44455678899999999999999999988766 5568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||-|-||.|...|+++       ..++...+..++..+++|++|||..+   ||+|||||+|++||.+|.+||.|||+|+
T Consensus       499 mEaClGGElWTiLrdR-------g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAK  568 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-------GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAK  568 (732)
T ss_pred             HHhhcCchhhhhhhhc-------CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHH
Confidence            9999999999999876       56888888889999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+.....   +-+.+||+.|.|||+
T Consensus       569 ki~~g~K---TwTFcGTpEYVAPEI  590 (732)
T KOG0614|consen  569 KIGSGRK---TWTFCGTPEYVAPEI  590 (732)
T ss_pred             HhccCCc---eeeecCCcccccchh
Confidence            9987764   467899999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.7e-22  Score=182.27  Aligned_cols=142  Identities=14%  Similarity=0.118  Sum_probs=109.1

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChh--h-------HH-----------------HHHHHHHHHHhCCCCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--S-------SK-----------------AFCRELMIASSLHHPN  240 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~-------~~-----------------~~~~Ev~iL~~l~Hpn  240 (372)
                      ...||+|+||.||+|... +|+.||||+++.....  .       ..                 ...+|++++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            367999999999999987 7999999999754210  0       11                 2234999999998877


Q ss_pred             eeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCceEEcCCCCC
Q 017411          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCVVHRDIKPS  319 (372)
Q Consensus       241 Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~IiHrDLKp~  319 (372)
                      +.....+..  .. .++||||++++++...+...       ..+++.....++.|++.+|.|+ |..+   |+||||||+
T Consensus        81 v~~p~~~~~--~~-~~iVmE~i~g~~l~~~~~~~-------~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~  147 (190)
T cd05147          81 IPCPEPILL--KS-HVLVMEFIGDDGWAAPRLKD-------APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEY  147 (190)
T ss_pred             CCCCcEEEe--cC-CEEEEEEeCCCCCcchhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHH
Confidence            644433221  22 37999999988776553222       3578899999999999999999 6767   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCC
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      |||++ ++.++|+|||+|.....+
T Consensus       148 NIli~-~~~v~LiDFG~a~~~~~~  170 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEHDHP  170 (190)
T ss_pred             HEEEE-CCcEEEEEccccccCCCc
Confidence            99998 478999999999865444

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.88  E-value=6e-24  Score=195.16  Aligned_cols=172  Identities=23%  Similarity=0.261  Sum_probs=134.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.+....||.|.||+|++..++.+|+..|||++... .....++++.|.+...+- +.||||+++|.++..+. .|+.||
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-cWiCME  143 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-CWICME  143 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc-eeeeHH
Confidence            445567899999999999999999999999999865 335567889999866555 68999999999987554 799999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      +| ..+|+.+...-...  ....+++...-.|+.-...||.||-..  ..|||||+||+|||++..|.+||||||++-.+
T Consensus       144 LM-d~SlDklYk~vy~v--q~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqL  218 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSV--QKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQL  218 (361)
T ss_pred             HH-hhhHHHHHHHHHHH--HhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhH
Confidence            99 45776655432110  115688888888888889999999763  34999999999999999999999999999766


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...-   ..+...|...|||||-
T Consensus       219 v~Si---AkT~daGCrpYmAPER  238 (361)
T KOG1006|consen  219 VDSI---AKTVDAGCRPYMAPER  238 (361)
T ss_pred             HHHH---HhhhccCCccccChhc
Confidence            5332   2344568888888764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.88  E-value=9.8e-24  Score=213.06  Aligned_cols=171  Identities=26%  Similarity=0.327  Sum_probs=150.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|...+.+|.|+||.|||+++..+++..|+|+++.........+..|+-+++..+|||||.++|.+.- ....|+.|
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicM   91 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICM   91 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEE
Confidence            34689999999999999999999999999999999998877777788899999999999999999998765 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||.+|+|++.-+..       .++++.++-.+.+..++||.|||+.+   =+|||||-.|||+++.|.+|++|||.+..
T Consensus        92 EycgggslQdiy~~T-------gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaq  161 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHVT-------GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQ  161 (829)
T ss_pred             EecCCCcccceeeec-------ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhh
Confidence            999999999887654       67889999899999999999999988   78999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.+.-.  ......||+.|||||+
T Consensus       162 itati~--KrksfiGtpywmapEv  183 (829)
T KOG0576|consen  162 ITATIA--KRKSFIGTPYWMAPEV  183 (829)
T ss_pred             hhhhhh--hhhcccCCccccchhH
Confidence            764432  2245689999999775

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=1.1e-21  Score=176.72  Aligned_cols=142  Identities=15%  Similarity=0.143  Sum_probs=111.7

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChh--------------------------hHHHHHHHHHHHHhCCCCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--------------------------SSKAFCRELMIASSLHHPN  240 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--------------------------~~~~~~~Ev~iL~~l~Hpn  240 (372)
                      ...||+|+||.||+|.+. +|+.||||+++.....                          ....+.+|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 7999999998764210                          0122457899999999998


Q ss_pred             eeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCC
Q 017411          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPS  319 (372)
Q Consensus       241 Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~  319 (372)
                      +.....+... .  .+|||||++++++.......       ..++......++.|++.+|.++|+ .+   |+||||||+
T Consensus        81 i~~p~~~~~~-~--~~lVmE~~~g~~~~~~~l~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~  147 (190)
T cd05145          81 VPVPEPILLK-K--NVLVMEFIGDDGSPAPRLKD-------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEY  147 (190)
T ss_pred             CCCceEEEec-C--CEEEEEEecCCCchhhhhhh-------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChh
Confidence            8655444332 2  37999999887554432221       346778888999999999999998 77   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCC
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      |||++ ++.++|+|||+|+....+
T Consensus       148 NIll~-~~~~~liDFG~a~~~~~~  170 (190)
T cd05145         148 NILYH-DGKPYIIDVSQAVELDHP  170 (190)
T ss_pred             hEEEE-CCCEEEEEcccceecCCC
Confidence            99999 889999999999877654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.87  E-value=3e-21  Score=174.39  Aligned_cols=169  Identities=38%  Similarity=0.519  Sum_probs=142.4

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      |...+.||+|++|.||++....+++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++... ...++++||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEecc
Confidence            45678999999999999999887899999999876544 667899999999999999999999987664 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++++|.+++....      ..+++..+..++.+++.++.|||..+   ++|+||+|.||+++.++.++|+|||++.....
T Consensus        80 ~~~~L~~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~  150 (225)
T smart00221       80 EGGDLFDYLRKKG------GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHR  150 (225)
T ss_pred             CCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence            9999999998642      11789999999999999999999887   99999999999999999999999999988765


Q ss_pred             CCCCccccccccCCCccCccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apea  363 (372)
                      .... ......++..|++||.
T Consensus       151 ~~~~-~~~~~~~~~~~~~pe~  170 (225)
T smart00221      151 DLAA-LLKTVKGTPFYLAPEV  170 (225)
T ss_pred             cccc-cccceeccCCcCCHhH
Confidence            4311 1233456777888765

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.87  E-value=1.1e-22  Score=206.36  Aligned_cols=155  Identities=30%  Similarity=0.458  Sum_probs=133.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      +....+.||+|.||.|++|.+...   -..||||.+...... ....|++|+.+|.+|+|||+|+|||+..+  ..+.+|
T Consensus       111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV  188 (1039)
T KOG0199|consen  111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMV  188 (1039)
T ss_pred             HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHH
Confidence            445568999999999999988532   346999999765433 66789999999999999999999999775  347799


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      +|+++.|+|.+.|++...     ..|.......++.|||.|+.||.+++   +|||||-..|+||.....+||+||||.|
T Consensus       189 ~ELaplGSLldrLrka~~-----~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmR  260 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKK-----AILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMR  260 (1039)
T ss_pred             hhhcccchHHHHHhhccc-----cceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeeccccee
Confidence            999999999999987332     56777888899999999999999887   9999999999999999999999999999


Q ss_pred             ccCCCCCCc
Q 017411          339 WTSAPSVPF  347 (372)
Q Consensus       339 ~~~~~~~~~  347 (372)
                      .+...+..+
T Consensus       261 aLg~ned~Y  269 (1039)
T KOG0199|consen  261 ALGENEDMY  269 (1039)
T ss_pred             ccCCCCcce
Confidence            998776644

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.86  E-value=1.9e-23  Score=192.56  Aligned_cols=169  Identities=25%  Similarity=0.347  Sum_probs=137.9

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC----eEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ----GLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~----~~~  256 (372)
                      +.+..+.||-|+||.||...+..+++.||+|++..-  .....+.+.+|+.+|.-++|.|++..++....+.-    .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            455568999999999999999999999999998642  44556788999999999999999999987543321    257


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ++.|.|. .+|...|-..       ..++-..+.-+..||++||.|||+.+   |+||||||.|+|++.+..+||+||||
T Consensus       134 V~TELmQ-SDLHKIIVSP-------Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGL  202 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIVSP-------QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGL  202 (449)
T ss_pred             HHHHHHH-hhhhheeccC-------CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccc
Confidence            7888884 4787777543       67888888889999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||.-...+...++ ..+-|..|.|||.
T Consensus       203 ARvee~d~~~hMT-qEVVTQYYRAPEi  228 (449)
T KOG0664|consen  203 ARTWDQRDRLNMT-HEVVTQYYRAPEL  228 (449)
T ss_pred             ccccchhhhhhhH-HHHHHHHhccHHH
Confidence            9987665554433 3345777888664

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.86  E-value=2.2e-20  Score=164.93  Aligned_cols=163  Identities=37%  Similarity=0.541  Sum_probs=137.2

Q ss_pred             EcccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCHH
Q 017411          190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE  268 (372)
Q Consensus       190 LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~  268 (372)
                      ||+|.+|.||++....+++.+++|++...... ..+.+.+|++.++.++|++|+++++++... ...++++||+.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHH
Confidence            68999999999999877899999999865432 456789999999999999999999988764 4589999999999999


Q ss_pred             HHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEecccccccCCCCCCc
Q 017411          269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTSAPSVPF  347 (372)
Q Consensus       269 ~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~~~~~~~~~  347 (372)
                      +++....      ..+++..+..++.+++++|.+||..+   ++|+||+|.||+++. ++.++|+|||.+........  
T Consensus        80 ~~~~~~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--  148 (215)
T cd00180          80 DLLKENE------GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--  148 (215)
T ss_pred             HHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--
Confidence            9997642      35889999999999999999999887   999999999999999 89999999999987765432  


Q ss_pred             cccccccCCCccCcccc
Q 017411          348 LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       348 ~~~~~~GT~gy~apeaP  364 (372)
                      ......+...|++||..
T Consensus       149 ~~~~~~~~~~~~~pe~~  165 (215)
T cd00180         149 LLKTIVGTPAYMAPEVL  165 (215)
T ss_pred             hhhcccCCCCccChhHh
Confidence            12334567778887643

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.85  E-value=1.1e-20  Score=171.69  Aligned_cols=156  Identities=33%  Similarity=0.432  Sum_probs=133.5

Q ss_pred             CceEEEEEEECCCCeEEEEEEecCCChhh-HHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHH
Q 017411          194 ALSFVFKGKVGLLRTSVAIKRLDKEDKES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH  272 (372)
Q Consensus       194 ~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~-~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~  272 (372)
                      +||.||+|....+++.+|+|++....... .+.+.+|++.+++++|+||+++++++... ...++++||+++++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHH
Confidence            58999999998888999999997654433 67899999999999999999999988764 45899999999999999997


Q ss_pred             hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCcccccc
Q 017411          273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV  352 (372)
Q Consensus       273 ~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~  352 (372)
                      ..       ..+++..++.++.+++.++.|||..+   |+|+||+|+||+++.++.++|+|||++.......   .....
T Consensus        80 ~~-------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~  146 (244)
T smart00220       80 KR-------GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTF  146 (244)
T ss_pred             hc-------cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccc
Confidence            64       23889999999999999999999887   9999999999999999999999999998776542   22345


Q ss_pred             ccCCCccCccc
Q 017411          353 KGTFGQNPFCI  363 (372)
Q Consensus       353 ~GT~gy~apea  363 (372)
                      .++..|++||.
T Consensus       147 ~~~~~~~~pE~  157 (244)
T smart00220      147 VGTPEYMAPEV  157 (244)
T ss_pred             cCCcCCCCHHH
Confidence            67788888663

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.85  E-value=9.8e-22  Score=181.12  Aligned_cols=148  Identities=21%  Similarity=0.392  Sum_probs=127.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.|.+.+.||+|.||.+-+++++.+.+.+++|.+++. ....++|.+|..---.| .|.||+.-|++-++..+...+++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            5788889999999999999999999999999999764 34457899998765555 599999999887777777889999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc--CCCcEEEEeccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLAT  338 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld--~~~~~KL~DFGla~  338 (372)
                      |++.|+|.+-+..        ..+.+.-...++.|++.|+.|+|+.+   +||||||.+||||-  +..++||+|||+.+
T Consensus       103 ~aP~gdL~snv~~--------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA--------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             cCccchhhhhcCc--------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999987754        34777888899999999999999988   99999999999993  34689999999987


Q ss_pred             ccC
Q 017411          339 WTS  341 (372)
Q Consensus       339 ~~~  341 (372)
                      ..+
T Consensus       172 k~g  174 (378)
T KOG1345|consen  172 KVG  174 (378)
T ss_pred             ccC
Confidence            654

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.85  E-value=8.4e-21  Score=199.30  Aligned_cols=186  Identities=30%  Similarity=0.402  Sum_probs=145.7

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceee
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVG  246 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g  246 (372)
                      .++...++..+.+.||+|.||.|++|....       ....||||.++.. .....+.+..|+++|..+ +||||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            345555666777799999999999997531       1467999999764 345667899999999998 6999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhhc--cCCCC-----C--CCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC
Q 017411          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKK--KGVRG-----N--STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (372)
Q Consensus       247 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~--~~~~~-----~--~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK  317 (372)
                      +|.. .+..++|+||+..|+|..+|+..+  .....     .  ..++..+.+.++.|||.|++||++..   +|||||-
T Consensus       370 ~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLA  445 (609)
T KOG0200|consen  370 ACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLA  445 (609)
T ss_pred             eecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhh
Confidence            9987 556899999999999999999876  01111     1  24889999999999999999999877   9999999


Q ss_pred             CCCEEEcCCCcEEEEecccccccCCCCCCccccccccC--CCccCcccccc
Q 017411          318 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT--FGQNPFCIEEW  366 (372)
Q Consensus       318 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT--~gy~apeaPE~  366 (372)
                      ..|||+..+..+||+|||+||......... ...-.||  ..|||||+-+.
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~  495 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFD  495 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhcc
Confidence            999999999999999999999765444321 1111222  34888776653

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=1.4e-20  Score=172.26  Aligned_cols=139  Identities=21%  Similarity=0.263  Sum_probs=108.4

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-----CCCCeeceeeeEEcCC--CeEE-
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-----HHPNIVPLVGFCIDPE--QGLF-  256 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-----~HpnIv~l~g~~~~~~--~~~~-  256 (372)
                      ...+.||+|+||.||.  ++.++.. +||++........+.+.+|+.+++.+     .||||++++|++.+..  +.++ 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            3457899999999995  6555555 69988765445567899999999999     5799999999987653  2333 


Q ss_pred             EEEec--cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCceEEcCCCCCCEEEcC----CCcE
Q 017411          257 LIYKY--VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV-AYLHNGTERCVVHRDIKPSNILLSS----KKIP  329 (372)
Q Consensus       257 lV~Ey--~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~~~~IiHrDLKp~NILld~----~~~~  329 (372)
                      +|+||  +++|+|.+++.+.        .+++.  ..++.+++.++ +|||+.+   |+||||||+|||++.    +..+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~--------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~  148 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC--------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIP  148 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc--------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcE
Confidence            78999  5579999999652        24444  35678888888 9999988   999999999999974    3489


Q ss_pred             EEEe-cccccc
Q 017411          330 KLCD-FGLATW  339 (372)
Q Consensus       330 KL~D-FGla~~  339 (372)
                      +|+| ||...+
T Consensus       149 ~LiDg~G~~~~  159 (210)
T PRK10345        149 VVCDNIGESTF  159 (210)
T ss_pred             EEEECCCCcce
Confidence            9999 555444

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.85  E-value=2.4e-21  Score=200.07  Aligned_cols=169  Identities=29%  Similarity=0.325  Sum_probs=129.8

Q ss_pred             eeeceeEcccCce-EEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEec
Q 017411          184 FSKGRVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       184 f~~~~~LG~G~fG-~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      |...+++|.|+-| .||+|...  +++||||++-...   ..-..+|+.+|+.- +|||||++++. ....+..|+..|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~-E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCS-EQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEee-ccCCceEEEEehH
Confidence            4455788999887 67999987  6899999985432   23456899999988 59999999875 3446678999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---C--CcEEEEeccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---K--KIPKLCDFGL  336 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~--~~~KL~DFGl  336 (372)
                      | ..+|++++.......   ....-...+.+..|++.||++||+.+   ||||||||.||||+.   +  .+++|+|||+
T Consensus       585 C-~~sL~dlie~~~~d~---~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfgl  657 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDV---EMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGL  657 (903)
T ss_pred             h-hhhHHHHHhccccch---hhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccc
Confidence            9 569999998741111   11111345678899999999999988   999999999999976   3  4789999999


Q ss_pred             ccccCCCCCCc-cccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPF-LCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~-~~~~~~GT~gy~apeaPE  365 (372)
                      ++.+.....+. ......||-||+|||.-+
T Consensus       658 sKkl~~~~sS~~r~s~~sGt~GW~APE~L~  687 (903)
T KOG1027|consen  658 SKKLAGGKSSFSRLSGGSGTSGWQAPEQLR  687 (903)
T ss_pred             ccccCCCcchhhcccCCCCcccccCHHHHh
Confidence            99887655433 245678999999987654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.84  E-value=1.4e-21  Score=176.29  Aligned_cols=150  Identities=28%  Similarity=0.419  Sum_probs=130.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCe-EEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG-LFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~-~~l  257 (372)
                      ..++|++.+.+|+|.|+.||.|....+.+.++||++++   ...+.+.+|+.+|..|. ||||++|++...++... ..|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            34689999999999999999999888889999999975   34567899999999997 99999999988776543 569


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEeccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGL  336 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DFGl  336 (372)
                      |+||+.+.+...+.          ..|+...+..++.+++.||.|+|+.+   |+|||+||.|++||.. ..++|+|+||
T Consensus       113 iFE~v~n~Dfk~ly----------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGL  179 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY----------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGL  179 (338)
T ss_pred             HhhhhccccHHHHh----------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecch
Confidence            99999998887765          45777788889999999999999988   9999999999999966 5699999999


Q ss_pred             ccccCCCCC
Q 017411          337 ATWTSAPSV  345 (372)
Q Consensus       337 a~~~~~~~~  345 (372)
                      |.++.....
T Consensus       180 AEFYHp~~e  188 (338)
T KOG0668|consen  180 AEFYHPGKE  188 (338)
T ss_pred             HhhcCCCce
Confidence            999876543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.81  E-value=6.2e-20  Score=175.91  Aligned_cols=175  Identities=25%  Similarity=0.338  Sum_probs=140.2

Q ss_pred             cccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC--C----Ceece
Q 017411          171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--P----NIVPL  244 (372)
Q Consensus       171 ~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--p----nIv~l  244 (372)
                      .+..+++.  ++.|.+...+|+|.||.|-.+.+..++..||||+++.- ..-.++-+-|+++|.+|.+  |    -+|.+
T Consensus        80 v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   80 VYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            34445544  67999999999999999999999888899999998643 2333455679999999942  2    36777


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld  324 (372)
                      .+|| +-.+.+|+|+|.+ |-++.++|.....     .+++...+..++.|++++++|||+..   ++|-||||+|||+.
T Consensus       157 ~~wF-dyrghiCivfell-G~S~~dFlk~N~y-----~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfv  226 (415)
T KOG0671|consen  157 RDWF-DYRGHICIVFELL-GLSTFDFLKENNY-----IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFV  226 (415)
T ss_pred             ehhh-hccCceEEEEecc-ChhHHHHhccCCc-----cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEe
Confidence            7764 4456699999998 6699999987532     67899999999999999999999988   99999999999994


Q ss_pred             C--------------------CCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          325 S--------------------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       325 ~--------------------~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +                    +-.+||+|||-|++-....     .+++.|..|.|||+
T Consensus       227 ss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEV  280 (415)
T KOG0671|consen  227 SSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEV  280 (415)
T ss_pred             ccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchh
Confidence            2                    1258999999998765443     56778999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.81  E-value=4.4e-20  Score=186.68  Aligned_cols=163  Identities=29%  Similarity=0.347  Sum_probs=133.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++.|.....+|.|+|+.|-++.+..+++..++|++.+...    .-.+|+.++... +||||+++.+.+.+.. ..|+||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~-~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK-EIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCc-eeeeee
Confidence            5678888889999999999999999999999999987522    234677666655 7999999999987644 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE-cCCCcEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl-d~~~~~KL~DFGla~  338 (372)
                      |++.++-|.+.+...+        .....+..|+.+|+.|+.|||.++   ||||||||+|||+ +..++++|+|||.++
T Consensus       396 e~l~g~ell~ri~~~~--------~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKP--------EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             hhccccHHHHHHHhcc--------hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhh
Confidence            9999998888876542        222677789999999999999988   9999999999999 588999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...+.     +.+.+-|..|.|||+-
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl  485 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVL  485 (612)
T ss_pred             hCchh-----hcccchhhcccChhhh
Confidence            77654     3344567778887654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=8e-19  Score=159.69  Aligned_cols=168  Identities=21%  Similarity=0.229  Sum_probs=132.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC-CCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ...|.+.+.||.|+||.+|.|.....|+.||||.-....  ...++..|..+.+.|++ ..|..+..+..+ ..+-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTE-KDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccc-cccceeee
Confidence            358999999999999999999999899999999865432  22457789999999975 566666655444 44457999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~KL~DFGl  336 (372)
                      |.+ |.+|+++..-+.      ..++..+++.++-|++.-++|+|..+   .|||||||+|.|+.-+   ..+.++||||
T Consensus        91 dLL-GPsLEdLfnfC~------R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS------RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ecc-CccHHHHHHHHh------hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccc
Confidence            998 889999987654      56889999999999999999999888   9999999999999644   5789999999


Q ss_pred             ccccCCCCCCc-----cccccccCCCccCc
Q 017411          337 ATWTSAPSVPF-----LCKTVKGTFGQNPF  361 (372)
Q Consensus       337 a~~~~~~~~~~-----~~~~~~GT~gy~ap  361 (372)
                      |+.+.+..+..     ......||..|..-
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASi  190 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASI  190 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhh
Confidence            98765443211     22345788887653

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=1.2e-18  Score=169.34  Aligned_cols=177  Identities=21%  Similarity=0.257  Sum_probs=136.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCC-eEEEEEEecCCChhhHHHHHHHHHHHHhCCC----CCeeceeeeEEcCCCeEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHH----PNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H----pnIv~l~g~~~~~~~~~~l  257 (372)
                      +|.+.+.||+|+||.||.+.....+ ..+|+|............+..|+.++..+..    +++..+++.....+..-|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999987653 6789998776433322367789999988873    5788888765334555789


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-----CcEEEE
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLC  332 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-----~~~KL~  332 (372)
                      ||+.+ |.+|.++.....     ...++..+++.|+.|++.+|++||+.+   ++||||||+|+++...     ..+.|.
T Consensus        99 VM~l~-G~sL~dl~~~~~-----~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ll  169 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-----PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLL  169 (322)
T ss_pred             EEecc-CccHHHHHHhCC-----CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEE
Confidence            99988 889999876543     257899999999999999999999888   9999999999999865     468999


Q ss_pred             eccccc--ccCCCCC----Cc-c-ccccccCCCccCcccccccc
Q 017411          333 DFGLAT--WTSAPSV----PF-L-CKTVKGTFGQNPFCIEEWQR  368 (372)
Q Consensus       333 DFGla~--~~~~~~~----~~-~-~~~~~GT~gy~apeaPE~~~  368 (372)
                      |||+|+  .+.....    +. . ....+||..|.++.+.....
T Consensus       170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e  213 (322)
T KOG1164|consen  170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE  213 (322)
T ss_pred             ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc
Confidence            999998  3221111    11 1 23456999999877665443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=1.7e-18  Score=157.22  Aligned_cols=136  Identities=24%  Similarity=0.387  Sum_probs=111.6

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +.||+|++|.||+|..  .+..|++|+......        .....+.+|++++..++|++|.....++..... .++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-FIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-CEEEE
Confidence            5799999999999987  467899997653211        122457889999999999998877776665444 68999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++|++|.+++...          .+ .+..++.+++.+|.++|..+   ++|+|++|.|||++ ++.++|+|||+++.
T Consensus        79 e~~~G~~L~~~~~~~----------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSN----------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhc----------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999998642          12 77789999999999999887   99999999999999 78999999999986


Q ss_pred             cC
Q 017411          340 TS  341 (372)
Q Consensus       340 ~~  341 (372)
                      ..
T Consensus       144 ~~  145 (211)
T PRK14879        144 SK  145 (211)
T ss_pred             CC
Confidence            43

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=1.1e-18  Score=162.89  Aligned_cols=149  Identities=15%  Similarity=0.117  Sum_probs=113.3

Q ss_pred             hCCeeeceeEcccCceEEEEEE-ECCCCeEEEEEEecCCChh------------------------hHHHHHHHHHHHHh
Q 017411          181 THNFSKGRVLGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKE------------------------SSKAFCRELMIASS  235 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~-~~~~~~~vAvK~l~~~~~~------------------------~~~~~~~Ev~iL~~  235 (372)
                      ...|++.+.||+|+||.||+|. +..+++.||||+++.....                        ....+.+|++++.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457788999999999999998 6567899999998753210                        11235689999999


Q ss_pred             CCCCC--eeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEE
Q 017411          236 LHHPN--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  313 (372)
Q Consensus       236 l~Hpn--Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiH  313 (372)
                      +.+..  +.+++++    .. .++||||+++.+|.......       ..+.......++.|++.+|.+||..+  .|+|
T Consensus       107 L~~~~i~~p~~~~~----~~-~~lV~E~~~g~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH  172 (237)
T smart00090      107 LYEAGVPVPKPIAW----RR-NVLVMEFIGGDGLPAPRLKD-------VEPEEEEEFELYDDILEEMRKLYKEG--ELVH  172 (237)
T ss_pred             HHhcCCCCCeeeEe----cC-ceEEEEEecCCccccccccc-------CCcchHHHHHHHHHHHHHHHHHHhcC--CEEe
Confidence            97533  3444432    22 47999999998887654221       23455566789999999999999654  2999


Q ss_pred             cCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       314 rDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |||||+||+++ ++.++|+|||++.....+.
T Consensus       173 ~Dikp~NIli~-~~~i~LiDFg~a~~~~~~~  202 (237)
T smart00090      173 GDLSEYNILVH-DGKVVIIDVSQSVELDHPM  202 (237)
T ss_pred             CCCChhhEEEE-CCCEEEEEChhhhccCCcc
Confidence            99999999999 8899999999998776554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=1.3e-18  Score=164.53  Aligned_cols=166  Identities=22%  Similarity=0.300  Sum_probs=134.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      -+|.++++||+|.||..+.|+.--+++.||||.-...+  ...++..|.+..+.|. .+.|..++-+..++.. -.||+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~-NiLVid  104 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY-NILVID  104 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccch-hhhhhh
Confidence            48999999999999999999998889999999865432  2245667888777774 6888888755433332 469999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-----cEEEEecc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFG  335 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-----~~KL~DFG  335 (372)
                      ++ |.+|+++..-+.      ..++..++..+|.|++.-++|+|++.   +|.|||||+|.||...+     .+.|+|||
T Consensus       105 LL-GPSLEDLFD~Cg------R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG  174 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCG------RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFG  174 (449)
T ss_pred             hh-CcCHHHHHHHhc------CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEecc
Confidence            98 889999987654      67999999999999999999999988   99999999999997543     58999999


Q ss_pred             cccccCCCCCCc-----cccccccCCCccC
Q 017411          336 LATWTSAPSVPF-----LCKTVKGTFGQNP  360 (372)
Q Consensus       336 la~~~~~~~~~~-----~~~~~~GT~gy~a  360 (372)
                      +|+.+.++.+..     ......||..||.
T Consensus       175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMS  204 (449)
T KOG1165|consen  175 MAKEYRDPKTKQHIPYREHKSLSGTARYMS  204 (449)
T ss_pred             chhhhcCccccccCccccccccccceeeeE
Confidence            999987765432     2235679999986

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.78  E-value=1.7e-18  Score=159.97  Aligned_cols=141  Identities=16%  Similarity=0.168  Sum_probs=113.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHH------HHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKA------FCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~------~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      ...+|...+.||.|+||.||+...  ++..+|||.+.....   .....      +.+|+..+.+++||+|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999755  366899999975422   22222      5789999999999999999988654


Q ss_pred             CC-------CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          251 PE-------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       251 ~~-------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      ..       ...++||||++|.+|.++..           ++.    ....+++.+|..+|..+   ++|||+||+||++
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili  168 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-----------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV  168 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh-----------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence            32       34789999999999988732           222    24568999999999888   9999999999999


Q ss_pred             cCCCcEEEEecccccccC
Q 017411          324 SSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       324 d~~~~~KL~DFGla~~~~  341 (372)
                      +.++ ++|+|||..+...
T Consensus       169 ~~~g-i~liDfg~~~~~~  185 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTA  185 (232)
T ss_pred             eCCC-EEEEECCCccccc
Confidence            9988 9999999987653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.78  E-value=4.8e-19  Score=171.62  Aligned_cols=145  Identities=26%  Similarity=0.356  Sum_probs=124.1

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECC---CCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCC
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~  253 (372)
                      ....+.|...++||+|.|++||++.+..   .+..||+|.+....  ....+.+|+++|..+. +.||+++.+++.. ++
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-nd  108 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-ND  108 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc-CC
Confidence            3455688899999999999999998865   67899999987542  3356889999999995 8999999997655 44


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEE
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLC  332 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~  332 (372)
                      ...+|+||++.....+++.          .++...+..+++.++.||.++|..+   ||||||||+|+|.+.. ++-.|.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~----------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR----------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             eeEEEecccCccCHHHHHh----------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEE
Confidence            5899999999999988884          3678888899999999999999988   9999999999999865 678899


Q ss_pred             eccccc
Q 017411          333 DFGLAT  338 (372)
Q Consensus       333 DFGla~  338 (372)
                      |||||.
T Consensus       176 DFgLA~  181 (418)
T KOG1167|consen  176 DFGLAQ  181 (418)
T ss_pred             echhHH
Confidence            999997

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.78  E-value=2.5e-19  Score=168.48  Aligned_cols=167  Identities=25%  Similarity=0.352  Sum_probs=136.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----C
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~  253 (372)
                      ..+|...+.+|.|.- .|--+.+.-.+++||+|.+...  .....++-.+|..++..++|+||++++.++....     .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            357788889999988 6777777777899999987543  3445567789999999999999999999864321     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..|+||||| ..+|.+.+.-         .++-.....|..|++.|+.|||+.+   |+||||||+||++..+..+||.|
T Consensus        95 e~y~v~e~m-~~nl~~vi~~---------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~d  161 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM---------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILD  161 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH---------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeecc
Confidence            378999999 5699998873         3677888899999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|+.....   ...+..+.|.-|.|||+-
T Consensus       162 fg~ar~e~~~---~~mtpyVvtRyyrapevi  189 (369)
T KOG0665|consen  162 FGLARTEDTD---FMMTPYVVTRYYRAPEVI  189 (369)
T ss_pred             chhhcccCcc---cccCchhheeeccCchhe
Confidence            9999866543   234556778888888763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.77  E-value=1.1e-17  Score=155.23  Aligned_cols=171  Identities=37%  Similarity=0.515  Sum_probs=139.5

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCC-CeeceeeeEEcCCCeEEEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHP-NIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~Hp-nIv~l~g~~~~~~~~~~lV~  259 (372)
                      |...+.||.|+||.||++.+.   ..+++|.+.....   .....+.+|+.++..+.|+ +|+++++.+.. ....++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEE
Confidence            667789999999999999987   6899999876532   2467899999999999988 79999998744 44478999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGla~  338 (372)
                      +++.++++.+++......    ..+.......++.|++.++.|+|..+   ++|||+||+||+++..+ .++++|||+++
T Consensus        78 ~~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRK----GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             ecCCCCcHHHHHHhcccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            999999999777653210    25888899999999999999999888   99999999999999988 79999999998


Q ss_pred             ccCCCCCCc----cccccccCCCccCccccc
Q 017411          339 WTSAPSVPF----LCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~----~~~~~~GT~gy~apeaPE  365 (372)
                      .........    ......||..|++||.-.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~  181 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLL  181 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhc
Confidence            665443221    235678999999977543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.8e-18  Score=154.26  Aligned_cols=146  Identities=19%  Similarity=0.145  Sum_probs=111.2

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh----------------------hhHHHHHHHHHHH
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----------------------ESSKAFCRELMIA  233 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~----------------------~~~~~~~~Ev~iL  233 (372)
                      ++......|...+.||+|+||.||++... +++.||||+++....                      .....+.+|..++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            34444445777899999999999999875 689999998764320                      0112366788999


Q ss_pred             HhCCCCC--eeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCce
Q 017411          234 SSLHHPN--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV  311 (372)
Q Consensus       234 ~~l~Hpn--Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~I  311 (372)
                      .++.|++  ++..++.     ...++||||+++++|......             .....++.+++.++.++|..+   |
T Consensus        88 ~~l~~~~i~v~~~~~~-----~~~~lv~e~~~g~~L~~~~~~-------------~~~~~~~~~i~~~l~~lh~~g---i  146 (198)
T cd05144          88 KALYEEGFPVPKPIDW-----NRHAVVMEYIDGVELYRVRVL-------------EDPEEVLDEILEEIVKAYKHG---I  146 (198)
T ss_pred             HHHHHcCCCCCceeec-----CCceEEEEEeCCcchhhcccc-------------ccHHHHHHHHHHHHHHHHHCC---C
Confidence            9998774  4444432     235899999999998765421             123468889999999999877   9


Q ss_pred             EEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       312 iHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +||||||+||+++.++.++|+|||++.....+
T Consensus       147 ~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~~  178 (198)
T cd05144         147 IHGDLSEFNILVDDDEKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             CcCCCCcccEEEcCCCcEEEEECCccccCCCc
Confidence            99999999999999999999999999766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.76  E-value=6.4e-18  Score=175.22  Aligned_cols=139  Identities=24%  Similarity=0.341  Sum_probs=110.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEe-cCC-------ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRL-DKE-------DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l-~~~-------~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      ...|...+.||+|+||.||+|.+...  .+++|+. .+.       .....+.+.+|++++..++|++++....++.+..
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            34456678999999999999987643  3444432 111       1122356889999999999999988777766644


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      . .++||||+++++|.+++.               ....++.+++++|.|||..+   |+||||||+|||+ .++.++|+
T Consensus       410 ~-~~lv~E~~~g~~L~~~l~---------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        410 E-KTIVMEYIGGKDLKDVLE---------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             C-CEEEEEecCCCcHHHHHH---------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEE
Confidence            4 689999999999998874               23468999999999999887   9999999999999 67799999


Q ss_pred             ecccccccC
Q 017411          333 DFGLATWTS  341 (372)
Q Consensus       333 DFGla~~~~  341 (372)
                      |||+++...
T Consensus       470 DFGla~~~~  478 (535)
T PRK09605        470 DFGLGKYSD  478 (535)
T ss_pred             eCcccccCC
Confidence            999998754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.75  E-value=7e-18  Score=151.95  Aligned_cols=132  Identities=22%  Similarity=0.380  Sum_probs=104.9

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .||+|+||.||+|...  +..|++|......        ......+.+|++++..++|+++.....++..... .++|||
T Consensus         1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-KTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-CEEEEE
Confidence            3899999999999854  6789999864321        1123567789999999998876555444444333 689999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++|++|.+++....       .       .++.+++.+|.+||..+   ++|+|++|.||+++ ++.++++|||+++..
T Consensus        78 ~~~g~~l~~~~~~~~-------~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        78 YIEGKPLKDVIEEGN-------D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             EECCccHHHHHhhcH-------H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999999998875421       0       68899999999999887   99999999999999 889999999999875


Q ss_pred             C
Q 017411          341 S  341 (372)
Q Consensus       341 ~  341 (372)
                      .
T Consensus       140 ~  140 (199)
T TIGR03724       140 D  140 (199)
T ss_pred             C
Confidence            4

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.4e-17  Score=151.47  Aligned_cols=133  Identities=18%  Similarity=0.198  Sum_probs=104.7

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh----hhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEE
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK----ESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~----~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .....|++|+||+||.+..  .+..++.+.+.....    -....+.+|+++|++|+ |+++++++++    . ..+++|
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~-~~~lvm   77 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----D-GRHLDR   77 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----c-CEEEEE
Confidence            3457899999999997765  467788777765422    11225789999999995 5889999885    2 268999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCC-CCCCEEEcCCCcEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI-KPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDL-Kp~NILld~~~~~KL~DFGla~  338 (372)
                      ||+.|.+|.+.+..        .      ...++.|++.+|.++|..+   |+|||| ||+|||++.++.++|+|||+|.
T Consensus        78 eyI~G~~L~~~~~~--------~------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~  140 (218)
T PRK12274         78 SYLAGAAMYQRPPR--------G------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAV  140 (218)
T ss_pred             eeecCccHHhhhhh--------h------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCce
Confidence            99999998754321        0      1246789999999999888   999999 7999999999999999999998


Q ss_pred             ccC
Q 017411          339 WTS  341 (372)
Q Consensus       339 ~~~  341 (372)
                      ...
T Consensus       141 ~~~  143 (218)
T PRK12274        141 RGN  143 (218)
T ss_pred             ecC
Confidence            554

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.74  E-value=4.8e-18  Score=168.10  Aligned_cols=163  Identities=26%  Similarity=0.364  Sum_probs=134.4

Q ss_pred             cccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC------CCCeece
Q 017411          171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH------HPNIVPL  244 (372)
Q Consensus       171 ~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~------HpnIv~l  244 (372)
                      ++.++|+.  ...|.+....|+|-|+.|.+|.+...+..||||++... ....+.=++|+++|++|+      --|+++|
T Consensus       423 rv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl  499 (752)
T KOG0670|consen  423 RVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRL  499 (752)
T ss_pred             EEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence            34555544  45888889999999999999999888889999999764 334455678999999995      3478898


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld  324 (372)
                      +-.|... +.+|||+|-+ ..+|.++|......    ..|....+..++.|+..||..|-..+   |+|.||||+|||++
T Consensus       500 ~r~F~hk-nHLClVFE~L-slNLRevLKKyG~n----vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  500 FRHFKHK-NHLCLVFEPL-SLNLREVLKKYGRN----VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN  570 (752)
T ss_pred             HHHhhhc-ceeEEEehhh-hchHHHHHHHhCcc----cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence            8877654 4599999988 56999999887543    56788889999999999999999877   99999999999998


Q ss_pred             CC-CcEEEEecccccccCCCCC
Q 017411          325 SK-KIPKLCDFGLATWTSAPSV  345 (372)
Q Consensus       325 ~~-~~~KL~DFGla~~~~~~~~  345 (372)
                      +. ..+||||||.|.++...+.
T Consensus       571 E~k~iLKLCDfGSA~~~~enei  592 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEI  592 (752)
T ss_pred             cCcceeeeccCccccccccccc
Confidence            76 4689999999988875543

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.73  E-value=3.7e-17  Score=160.97  Aligned_cols=137  Identities=22%  Similarity=0.350  Sum_probs=115.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-----C---CCeeceeeeEEcC-
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----H---PNIVPLVGFCIDP-  251 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----H---pnIv~l~g~~~~~-  251 (372)
                      ..+|.+.++||.|-|++||++.+....+.||+|+.+. ...-.+.-+.||++|++++     |   ..||+|++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            3589999999999999999999999899999999864 3455567789999999984     3   3799999988532 


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          252 --EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       252 --~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                        +..+|+|+|++ |-+|..+|....-     +.++...+.+|++||+.||.|||..+  +|||-||||+|||+...
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~Y-----rGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNY-----RGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCC-----CCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence              33589999999 6789999987543     67999999999999999999999865  69999999999999644

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.69  E-value=2.5e-16  Score=132.94  Aligned_cols=137  Identities=20%  Similarity=0.229  Sum_probs=111.6

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC--CCeeceeeeEEcCCCeEEEEEeccC
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.+.||+|.++.||++....  ..+++|.......  ...+.+|+.++..++|  .++++++.+.... +..++++||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecC
Confidence            34789999999999999853  6899999866433  4578899999999976  5888888876543 45799999998


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      ++.+..+              +......++.+++++|.+||.....+++|+|++|+||+++..+.++++|||+++...
T Consensus        77 g~~~~~~--------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~~  140 (155)
T cd05120          77 GETLDEV--------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP  140 (155)
T ss_pred             CeecccC--------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCCC
Confidence            8766432              345566788999999999998765679999999999999998999999999987543

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.4e-16  Score=141.96  Aligned_cols=138  Identities=20%  Similarity=0.215  Sum_probs=97.8

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChh--hHHH----------------------HHHHHHHHHhCCCCC--
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE--SSKA----------------------FCRELMIASSLHHPN--  240 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~--~~~~----------------------~~~Ev~iL~~l~Hpn--  240 (372)
                      .+.||+|+||.||+|.+. +++.||||++......  ....                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 6889999998653211  1111                      134666666664433  


Q ss_pred             eeceeeeEEcCCCeEEEEEeccCCCCHHH-HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCC
Q 017411          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKP  318 (372)
Q Consensus       241 Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp  318 (372)
                      +.+.++.    . ..++||||++++.+.. .+...        ... .....++.+++.++.++|. .+   |+|+||||
T Consensus        81 ~~~~~~~----~-~~~lv~e~~~g~~~~~~~l~~~--------~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p  143 (187)
T cd05119          81 VPKPIDL----N-RHVLVMEFIGGDGIPAPRLKDV--------RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSE  143 (187)
T ss_pred             CCceEec----C-CCEEEEEEeCCCCccChhhhhh--------hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCCh
Confidence            3444432    1 2589999999855432 12111        011 4567889999999999998 66   99999999


Q ss_pred             CCEEEcCCCcEEEEecccccccCCC
Q 017411          319 SNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       319 ~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +||+++ ++.++|+|||.++....+
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~~~  167 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEIDHP  167 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccccCc
Confidence            999999 899999999999766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=6.8e-16  Score=144.18  Aligned_cols=137  Identities=17%  Similarity=0.173  Sum_probs=105.7

Q ss_pred             eeEc-ccCceEEEEEEECCCCeEEEEEEecCCC-------------hhhHHHHHHHHHHHHhCCCCCe--eceeeeEEcC
Q 017411          188 RVLG-RGALSFVFKGKVGLLRTSVAIKRLDKED-------------KESSKAFCRELMIASSLHHPNI--VPLVGFCIDP  251 (372)
Q Consensus       188 ~~LG-~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-------------~~~~~~~~~Ev~iL~~l~HpnI--v~l~g~~~~~  251 (372)
                      ..|| .|+.|+||++...  +..++||.+....             ......+.+|++++.+|+|++|  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            5687 7889999998875  5689999875321             1223467889999999998875  6666664432


Q ss_pred             CCe---EEEEEeccCC-CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          252 EQG---LFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       252 ~~~---~~lV~Ey~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      ...   .++|+|++++ .+|.+++...        .++..    .+.+|+.+|.+||..+   |+||||||.|||++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~  179 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA--------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDG  179 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC--------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCC
Confidence            222   3599999997 6999888542        34433    3568999999999888   99999999999999989


Q ss_pred             cEEEEecccccccC
Q 017411          328 IPKLCDFGLATWTS  341 (372)
Q Consensus       328 ~~KL~DFGla~~~~  341 (372)
                      .++|+|||.++...
T Consensus       180 ~v~LIDfg~~~~~~  193 (239)
T PRK01723        180 KFWLIDFDRGELRT  193 (239)
T ss_pred             CEEEEECCCcccCC
Confidence            99999999998765

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.65  E-value=2.7e-16  Score=151.48  Aligned_cols=190  Identities=18%  Similarity=0.203  Sum_probs=147.6

Q ss_pred             cHHHHHHhhCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceee
Q 017411          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVG  246 (372)
Q Consensus       173 s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g  246 (372)
                      ...++.....+++....+-+|.||.||+|.++..     .+.|-+|.++.. ++-....++.|..++..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3455666667788888999999999999977542     245667776543 4555677899999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC
Q 017411          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       247 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~-~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~  325 (372)
                      ++.+.....+++|.++.-|+|..+|.-.+.. ....+.+...+...++.|++.|++|||..+   |||.||...|++||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence            9988777789999999999999999854422 223466778888899999999999999887   999999999999999


Q ss_pred             CCcEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .-++||+|=.|+|.+-........-..-....||++||-.
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~  471 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ  471 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence            9999999999998764333211111112234688877654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.60  E-value=1e-15  Score=159.96  Aligned_cols=167  Identities=25%  Similarity=0.263  Sum_probs=127.8

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEec----C-CChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD----K-EDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~----~-~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ...+++|.|++|.|+........+.++.|...    . .... ....+..|+.+-..+.|||++..+..+.+... ..-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence            35578999999988877765555555555432    1 1111 11226678888889999999988877666544 4455


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||||++ +|..++...       ..+....+..++.|++.||.|||..+   |.|||||++|++++.+|.+||+|||.+.
T Consensus       400 mE~~~~-Dlf~~~~~~-------~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSN-------GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAAS  468 (601)
T ss_pred             hhcccH-HHHHHHhcc-------cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcce
Confidence            999999 999999764       35777888899999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccCCCccCccc
Q 017411          339 WTSAPSVP--FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~--~~~~~~~GT~gy~apea  363 (372)
                      .+..+...  .....+.|+-.|+|||.
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~  495 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEV  495 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCccc
Confidence            87665544  44556677778888553

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.55  E-value=2.5e-15  Score=162.70  Aligned_cols=95  Identities=21%  Similarity=0.263  Sum_probs=72.8

Q ss_pred             hCCC-CCeeceeeeEEc------CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 017411          235 SLHH-PNIVPLVGFCID------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT  307 (372)
Q Consensus       235 ~l~H-pnIv~l~g~~~~------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~  307 (372)
                      .++| +||..++++|..      ....+++++||+ +++|.++|....      ..+++..++.++.||++||.|||+.+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD------RSVDAFECFHVFRQIVEIVNAAHSQG  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc------ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence            3455 577778887611      112367788887 669999997532      46899999999999999999999887


Q ss_pred             CCceEEcCCCCCCEEEcC-------------------CCcEEEEecccccc
Q 017411          308 ERCVVHRDIKPSNILLSS-------------------KKIPKLCDFGLATW  339 (372)
Q Consensus       308 ~~~IiHrDLKp~NILld~-------------------~~~~KL~DFGla~~  339 (372)
                         |+||||||+||||+.                   ++.+||+|||+++.
T Consensus       101 ---IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~  148 (793)
T PLN00181        101 ---IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRR  148 (793)
T ss_pred             ---eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccc
Confidence               999999999999954                   44566667776654

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=1.3e-14  Score=155.92  Aligned_cols=149  Identities=21%  Similarity=0.254  Sum_probs=111.7

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeeEEcCCC
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~  253 (372)
                      +......|.+.+.||+|+||+||+|.... ++.||+|+=+....   =+|.--.+++.+|+   -+-|.++.....-.+.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34455689999999999999999999987 99999998765422   11222223334443   1223333332222233


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-------C
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-------K  326 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-------~  326 (372)
                       -+||+||.+.|+|.+++...       ..++|.....++.|++.-++.||..+   |||+||||+|.||..       .
T Consensus       769 -S~lv~ey~~~Gtlld~~N~~-------~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~  837 (974)
T KOG1166|consen  769 -SVLVSEYSPYGTLLDLINTN-------KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDS  837 (974)
T ss_pred             -ceeeeeccccccHHHhhccC-------CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcc
Confidence             57999999999999999733       67999999999999999999999988   999999999999942       2


Q ss_pred             CcEEEEeccccccc
Q 017411          327 KIPKLCDFGLATWT  340 (372)
Q Consensus       327 ~~~KL~DFGla~~~  340 (372)
                      .-++|+|||.+-.+
T Consensus       838 ~~l~lIDfG~siDm  851 (974)
T KOG1166|consen  838 KGLYLIDFGRSIDM  851 (974)
T ss_pred             cceEEEecccceee
Confidence            46899999998543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.51  E-value=1.3e-13  Score=139.53  Aligned_cols=146  Identities=21%  Similarity=0.221  Sum_probs=100.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhH---------------------------------------
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---------------------------------------  223 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~---------------------------------------  223 (372)
                      .|.. +.||.|++|.||+|+.. +|+.||||+.++.-....                                       
T Consensus       119 ~fd~-~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~  196 (437)
T TIGR01982       119 EFEE-KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR  196 (437)
T ss_pred             hCCC-cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence            4443 68999999999999986 588999999865411100                                       


Q ss_pred             -HHHHHHHHHHHhC----CCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH
Q 017411          224 -KAFCRELMIASSL----HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE  298 (372)
Q Consensus       224 -~~~~~Ev~iL~~l----~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~  298 (372)
                       -.|.+|++.+.++    +|.+-+.+-.++.+.....+|||||++|++|.++......      ..+   +..++..++.
T Consensus       197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~------~~~---~~~ia~~~~~  267 (437)
T TIGR01982       197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA------GLD---RKALAENLAR  267 (437)
T ss_pred             HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc------CCC---HHHHHHHHHH
Confidence             0244566555554    2332233322332222335899999999999988754321      122   3346666655


Q ss_pred             -HHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          299 -SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       299 -gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                       .+..+|..+   ++|+|+||.||+++.+++++++|||++..++.
T Consensus       268 ~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       268 SFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             HHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             467888777   99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=9.8e-13  Score=114.89  Aligned_cols=132  Identities=19%  Similarity=0.123  Sum_probs=96.8

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeeEEcCCCeEEEEEeccCCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv-~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      .+.|+.|.++.||+++..  +..|++|....... ....+.+|+.++..+.+.+++ +++.+ .. .. .++||||+++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~-~~-~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DP-ET-GVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eC-CC-CeEEEEecCCC
Confidence            367899999999999875  67899998765421 223467899999988655544 44443 22 22 47999999998


Q ss_pred             CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      ++....           ..    ...++.+++++|..||...  ...++|+|++|.||+++ ++.++++|||.+..-
T Consensus        77 ~l~~~~-----------~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~  137 (170)
T cd05151          77 ELLTED-----------FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN  137 (170)
T ss_pred             cccccc-----------cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence            775430           00    1235678999999999876  23469999999999999 678999999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.42  E-value=1.3e-14  Score=147.20  Aligned_cols=160  Identities=26%  Similarity=0.262  Sum_probs=126.9

Q ss_pred             eEcccCceEEEEEEE---CCCCeEEEEEEecCCChhh--HHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEecc
Q 017411          189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKES--SKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~---~~~~~~vAvK~l~~~~~~~--~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      .+|+|.||.|++++-   ...+..+|+|++.+.....  ......|..++..++ ||.+|++.-.+ +.+...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-qt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-QTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-ccccchhHhhhhc
Confidence            379999999997543   3457789999987652211  113456778888887 99999997654 4566689999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      .+|+|...+...       ..+.......+...++-+++++|..+   |+|||+|++||+++.+|.+|+.|||+++....
T Consensus        80 rgg~lft~l~~~-------~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~  149 (612)
T KOG0603|consen   80 RGGDLFTRLSKE-------VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK  149 (612)
T ss_pred             ccchhhhccccC-------CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence            999999888664       45666667777888999999999877   99999999999999999999999999998765


Q ss_pred             CCCCccccccccCCCccCccccc
Q 017411          343 PSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       343 ~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ....      +||..|||||+--
T Consensus       150 ~~~~------cgt~eymApEI~~  166 (612)
T KOG0603|consen  150 EKIA------CGTYEYRAPEIIN  166 (612)
T ss_pred             hhhc------ccchhhhhhHhhh
Confidence            5431      7999999987643

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=1.7e-12  Score=133.81  Aligned_cols=150  Identities=17%  Similarity=0.143  Sum_probs=95.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh----------------------------------hHH--
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE----------------------------------SSK--  224 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~----------------------------------~~~--  224 (372)
                      ..+|+. +.||+|++|.||+|+++.+|+.||||+.++.-..                                  ..+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            446776 7999999999999999887999999999754110                                  011  


Q ss_pred             ----HHHHHHHHHHhCC----CCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 017411          225 ----AFCRELMIASSLH----HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI  296 (372)
Q Consensus       225 ----~~~~Ev~iL~~l~----HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qi  296 (372)
                          .|.+|+..+.+++    +.+.+.+-.++.+-....+|||||+.|+.+.++-.-...+. ....+....+..++.|+
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHHH
Confidence                1344554444442    33333333333222233579999999999987532111100 00112222233333343


Q ss_pred             HHHHHHHHcCCCCceEEcCCCCCCEEEcCCC----cEEEEecccccccCC
Q 017411          297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKLCDFGLATWTSA  342 (372)
Q Consensus       297 a~gL~yLH~~~~~~IiHrDLKp~NILld~~~----~~KL~DFGla~~~~~  342 (372)
                             ...+   ++|+|+||.||+++.++    +++++|||++..++.
T Consensus       277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                   3345   99999999999999888    999999999987654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.37  E-value=4.4e-12  Score=120.87  Aligned_cols=174  Identities=23%  Similarity=0.289  Sum_probs=106.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCC-----------CCeeceeee
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHH-----------PNIVPLVGF  247 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~H-----------pnIv~l~g~  247 (372)
                      ..+..++.||.|+|+.||.+++..+++.+|+|++...   .....+.+.+|.-....+.+           .-++.+--.
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3566789999999999999999999999999987532   23345667776654444322           122222111


Q ss_pred             EEcC-------C---C-----eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceE
Q 017411          248 CIDP-------E---Q-----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  312 (372)
Q Consensus       248 ~~~~-------~---~-----~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~Ii  312 (372)
                      -...       .   .     +.+++|+-+ .++|.+++..-.........+....++.+..|+++.+++||+.+   |+
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1110       0   0     135677777 56898887642211111122344555677799999999999988   99


Q ss_pred             EcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          313 HRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       313 HrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+||||+|++++.+|.++|+||+.....+...   .+  ...+.+|.|||..
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~--~~~~~~~~PPe~~  214 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC--SEFPVAFTPPELE  214 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG--GGS-TTTS-HHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCcee---ec--cCCCcccCChhhh
Confidence            99999999999999999999998776554321   11  2344667776643

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.33  E-value=2.4e-12  Score=124.79  Aligned_cols=90  Identities=31%  Similarity=0.459  Sum_probs=72.1

Q ss_pred             CCCCeeceeeeEEcC--------------------------CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHH
Q 017411          237 HHPNIVPLVGFCIDP--------------------------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY  290 (372)
Q Consensus       237 ~HpnIv~l~g~~~~~--------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~  290 (372)
                      +|||||++.++|.+.                          ...+|+||.-.+ .+|.+++...        ..+.....
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~--------~~s~r~~~  344 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR--------HRSYRTGR  344 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC--------CCchHHHH
Confidence            599999999887532                          123789998774 5899999764        34555666


Q ss_pred             HHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc--CC--CcEEEEeccccc
Q 017411          291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SK--KIPKLCDFGLAT  338 (372)
Q Consensus       291 ~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld--~~--~~~KL~DFGla~  338 (372)
                      .++.|+++|+.|||.++   |.|||+|++|||+.  +|  ..+.|+|||++-
T Consensus       345 ~~laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL  393 (598)
T KOG4158|consen  345 VILAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL  393 (598)
T ss_pred             HHHHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence            78999999999999888   99999999999994  33  367899999874

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.32  E-value=3.7e-13  Score=124.78  Aligned_cols=137  Identities=23%  Similarity=0.393  Sum_probs=114.9

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      ..+|.+...|..|+|++.  |..+++|++...  .....+.|..|.-.|+.+.||||+.++|.|..+.+ +.++..||+.
T Consensus       195 ~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn-lv~isq~mp~  271 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN-LVIISQYMPF  271 (448)
T ss_pred             hhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-ceEeeeeccc
Confidence            356788889999999997  456677877643  44556789999999999999999999999988765 7899999999


Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      |+|+..|++...     ...+..++.++++++++|++|||+.. +-|.---|.+..+++|++.+++|+
T Consensus       272 gslynvlhe~t~-----vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris  333 (448)
T KOG0195|consen  272 GSLYNVLHEQTS-----VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS  333 (448)
T ss_pred             hHHHHHHhcCcc-----EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence            999999987643     56788899999999999999999986 335556789999999999988875

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.25  E-value=1.2e-10  Score=105.52  Aligned_cols=139  Identities=17%  Similarity=0.210  Sum_probs=98.1

Q ss_pred             eeEcccCceEEEEEEECC------CCeEEEEEEecCC-------------Ch---------hhHHHHH----HHHHHHHh
Q 017411          188 RVLGRGALSFVFKGKVGL------LRTSVAIKRLDKE-------------DK---------ESSKAFC----RELMIASS  235 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~------~~~~vAvK~l~~~-------------~~---------~~~~~~~----~Ev~iL~~  235 (372)
                      ..||.|--+.||.|....      .+..+|||+.+..             +.         ...+.+.    +|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999997643      2478999976421             10         1122333    79999999


Q ss_pred             CCC--CCeeceeeeEEcCCCeEEEEEeccCCCCHHH-HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCce
Q 017411          236 LHH--PNIVPLVGFCIDPEQGLFLIYKYVSGGSLER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL-HNGTERCV  311 (372)
Q Consensus       236 l~H--pnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~-~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL-H~~~~~~I  311 (372)
                      +.-  -++.+.+++   ..  -+|||||+.+..+.. .+.+        ..++......+..+++.+|..| |..+   |
T Consensus        83 l~~~Gv~vP~pi~~---~~--~~lvME~Ig~~~~~~~~Lkd--------~~~~~~~~~~i~~~i~~~l~~l~H~~g---l  146 (197)
T cd05146          83 MQKAGIPCPEVVVL---KK--HVLVMSFIGDDQVPAPKLKD--------AKLNDEEMKNAYYQVLSMMKQLYKECN---L  146 (197)
T ss_pred             HHHcCCCCCeEEEe---cC--CEEEEEEcCCCCccchhhhc--------cccCHHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            853  456666653   12  479999997654422 2221        2344455667788999999998 7777   9


Q ss_pred             EEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       312 iHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      ||+||++.|||++ ++.+.|+|||.+.....+
T Consensus       147 VHGDLs~~NIL~~-~~~v~iIDF~qav~~~hp  177 (197)
T cd05146         147 VHADLSEYNMLWH-DGKVWFIDVSQSVEPTHP  177 (197)
T ss_pred             ecCCCCHHHEEEE-CCcEEEEECCCceeCCCC
Confidence            9999999999997 467999999998766543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.24  E-value=7.1e-11  Score=107.14  Aligned_cols=143  Identities=23%  Similarity=0.342  Sum_probs=105.4

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCC--CCeeceeeeEEcCC--CeEEEEEecc
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHH--PNIVPLVGFCIDPE--QGLFLIYKYV  262 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~--~~~~lV~Ey~  262 (372)
                      +.|+.|.++.||++.... +..+++|....... .....+.+|+++++.+.+  ..+.+++.+.....  +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            678999999999998754 57899998765322 234578899999999975  34566776654321  2458999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----------------------------------
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----------------------------------  307 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----------------------------------  307 (372)
                      ++.++.+.+..        ..++......++.++++.|..||+..                                   
T Consensus        83 ~G~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (223)
T cd05154          83 DGRVLRDRLLR--------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP  154 (223)
T ss_pred             CCEecCCCCCC--------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence            99887665421        13566666677777777777777421                                   


Q ss_pred             ------------------CCceEEcCCCCCCEEEcC--CCcEEEEecccccc
Q 017411          308 ------------------ERCVVHRDIKPSNILLSS--KKIPKLCDFGLATW  339 (372)
Q Consensus       308 ------------------~~~IiHrDLKp~NILld~--~~~~KL~DFGla~~  339 (372)
                                        ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                              245899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=7e-10  Score=98.49  Aligned_cols=134  Identities=23%  Similarity=0.382  Sum_probs=97.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEec-CC--Chh-----hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KE--DKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~-~~--~~~-----~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..+++|+-+.+|.+.+.  +..+.+|.-. +.  .+.     ....-.+|++++.+++--.|....-+.++++. ..++|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-GLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CEEEE
Confidence            35789999999999764  4457777533 22  121     12345679999998865444443334456555 57999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++|..|.+.+...              ...++..+-.-+.-||..+   |+|+||.++||++..++ +.++||||+.+
T Consensus        79 e~I~G~~lkd~l~~~--------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA--------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc--------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999998888653              1356777788888999888   99999999999997765 99999999986


Q ss_pred             cCC
Q 017411          340 TSA  342 (372)
Q Consensus       340 ~~~  342 (372)
                      -..
T Consensus       141 s~~  143 (204)
T COG3642         141 SDE  143 (204)
T ss_pred             ccc
Confidence            543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.13  E-value=1.1e-11  Score=132.41  Aligned_cols=143  Identities=24%  Similarity=0.271  Sum_probs=112.6

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHH---HHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAF---CRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~---~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++...+.||++.|=+|.+|+++. | .|+||++-+.+ .-..+.|   ++|++ ...++|||++.+.-+- ..+...|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-VTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-HhhHHHHHH
Confidence            66777899999999999999874 4 49999986654 2233334   44444 5556899999987653 334556788


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      -+|+.+ +|++.|..+       ..+...+.+-|+.|++.||.-+|..+   |+|+|||.+||||+.=.-+.|+||.--+
T Consensus       100 Rqyvkh-nLyDRlSTR-------PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFK  168 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTR-------PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFK  168 (1431)
T ss_pred             HHHHhh-hhhhhhccc-------hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccC
Confidence            888854 899998765       45777778889999999999999888   9999999999999998889999998766


Q ss_pred             cc
Q 017411          339 WT  340 (372)
Q Consensus       339 ~~  340 (372)
                      ..
T Consensus       169 Pt  170 (1431)
T KOG1240|consen  169 PT  170 (1431)
T ss_pred             Cc
Confidence            53

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=9.4e-12  Score=130.37  Aligned_cols=174  Identities=26%  Similarity=0.297  Sum_probs=132.7

Q ss_pred             CCeeeceeEcccCceEEEEEEEC-CCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKED--KESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..|...+.||+|+|+.|-..... .....+|+|.+....  .........|..+-..+. |+|++++++...+++ ..++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~-~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR-SYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc-cccc
Confidence            46777788999999999877653 334567777776542  333344556777777776 999999999766544 4789


Q ss_pred             EEeccCCCCHHHHHH-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceEEcCCCCCCEEEcCCC-cEEEEec
Q 017411          258 IYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTERCVVHRDIKPSNILLSSKK-IPKLCDF  334 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~-~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~IiHrDLKp~NILld~~~-~~KL~DF  334 (372)
                      +.+|..++++...+. ...      ...+......+..|+..++.|+| ..+   +.|||+||+|.+++..+ .+|++||
T Consensus        99 ~~~~s~g~~~f~~i~~~~~------~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df  169 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS------TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADF  169 (601)
T ss_pred             ccCcccccccccccccCCc------cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCc
Confidence            999999999998883 221      13455566778999999999999 666   99999999999999999 9999999


Q ss_pred             ccccccCC-CCCCcccccccc-CCCccCccccc
Q 017411          335 GLATWTSA-PSVPFLCKTVKG-TFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~-~~~~~~~~~~~G-T~gy~apeaPE  365 (372)
                      |+|..+.. ...........| ++.|+|||.+.
T Consensus       170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~  202 (601)
T KOG0590|consen  170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLS  202 (601)
T ss_pred             hhhccccccCCcceeeecccCCCCCCCCccccc
Confidence            99998876 444444555677 78888866554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.11  E-value=1.7e-09  Score=95.88  Aligned_cols=146  Identities=23%  Similarity=0.270  Sum_probs=104.5

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEec-CC-------ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KE-------DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~-~~-------~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ....|-+|+-+.|+++.+.  |+.+.||.-. +.       ..-..++..+|+++|.+++--.|.--.-++.+... -.|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeE
Confidence            4578899999999999876  6777787532 22       11234456789999998864444433334555444 469


Q ss_pred             EEeccCC-CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC---cEEEEe
Q 017411          258 IYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCD  333 (372)
Q Consensus       258 V~Ey~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~---~~KL~D  333 (372)
                      +|||+++ -++.+++......    ...+ .....++..|-+.+.-||..+   |||+||.++||+|..++   .+.++|
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~----~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lId  159 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMED----ESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILID  159 (229)
T ss_pred             EEEeccchhHHHHHHHHHccC----cccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEe
Confidence            9999976 4888988876432    1222 222578888999999999988   99999999999997664   458999


Q ss_pred             cccccccCC
Q 017411          334 FGLATWTSA  342 (372)
Q Consensus       334 FGla~~~~~  342 (372)
                      ||++..-..
T Consensus       160 fgls~~s~~  168 (229)
T KOG3087|consen  160 FGLSSVSRL  168 (229)
T ss_pred             ecchhcccC
Confidence            999865433

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.09  E-value=5.5e-11  Score=126.85  Aligned_cols=138  Identities=30%  Similarity=0.422  Sum_probs=95.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ...+|..++.|..|+||.||..+++.+.+.+|+| ++++..           +++     ||..+-+      + .+.| 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----------ilR-----nilt~a~------n-pfvv-  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----------ILR-----NILTFAG------N-PFVV-  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----------hhh-----ccccccC------C-ccee-
Confidence            3468999999999999999999999999999994 444321           111     1222211      1 2333 


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                           |+-...++..       ..++-.        ++.+++|||+-+   |+|||+||+|.||+.-|++|+.|||+.+.
T Consensus       136 -----gDc~tllk~~-------g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~  192 (1205)
T KOG0606|consen  136 -----GDCATLLKNI-------GPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKK  192 (1205)
T ss_pred             -----chhhhhcccC-------CCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhh
Confidence                 5555555432       233322        267899999876   99999999999999999999999999875


Q ss_pred             cCCC-------------CCCccccccccCCCccCccccc
Q 017411          340 TSAP-------------SVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~-------------~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ....             ...+....++||+.|+|||+--
T Consensus       193 GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil  231 (1205)
T KOG0606|consen  193 GLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL  231 (1205)
T ss_pred             hhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence            3211             1112334578999999987643

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.07  E-value=3.4e-10  Score=99.34  Aligned_cols=76  Identities=21%  Similarity=0.125  Sum_probs=63.9

Q ss_pred             CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          265 GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       265 gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      |+|.+++....      ..++|..++.|+.|++.||.|||+.+         ||+|||++.++.+|+  ||+++......
T Consensus         1 GsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~   63 (176)
T smart00750        1 VSLADILEVRG------RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ   63 (176)
T ss_pred             CcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc
Confidence            68999997643      46999999999999999999999754         999999999999999  99998765432


Q ss_pred             CCccccccccCCCccCcccc
Q 017411          345 VPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       345 ~~~~~~~~~GT~gy~apeaP  364 (372)
                             ..||+.|+|||.-
T Consensus        64 -------~~g~~~y~aPE~~   76 (176)
T smart00750       64 -------SRVDPYFMAPEVI   76 (176)
T ss_pred             -------CCCcccccChHHh
Confidence                   2588999997753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.07  E-value=1.7e-10  Score=116.88  Aligned_cols=100  Identities=31%  Similarity=0.477  Sum_probs=89.2

Q ss_pred             HHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceE
Q 017411          233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVV  312 (372)
Q Consensus       233 L~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~Ii  312 (372)
                      |+.+.|.|+.+++|.+.++. ..+.|.+||..|+|.+.+....      ..++|.-...++++|+.||.|||+..  -..
T Consensus         1 l~~l~h~n~~~f~g~~~~~~-~~~~i~~~c~rGsl~D~i~~~~------~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGP-EMIVIWEYCSRGSLLDILSNED------IKLDYFFILSFIRDISKGLAYLHNSP--IGY   71 (484)
T ss_pred             CcccchhhhhhheeeEecCC-ceEEEEeeecCccHHhHHhccc------cCccHHHHHHHHHHHHHHHHHHhcCc--cee
Confidence            45789999999999999974 4889999999999999998742      67999999999999999999999754  229


Q ss_pred             EcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          313 HRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       313 HrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |+.|++.|+++|..+.+||+|||+.....
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~  100 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLE  100 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhccccc
Confidence            99999999999999999999999998774

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.97  E-value=2e-08  Score=95.40  Aligned_cols=141  Identities=17%  Similarity=0.064  Sum_probs=97.3

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCCChh-hH----------HHHHHHHHHHHhCCCCC--eeceeeeEEcC----
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SS----------KAFCRELMIASSLHHPN--IVPLVGFCIDP----  251 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~----------~~~~~Ev~iL~~l~Hpn--Iv~l~g~~~~~----  251 (372)
                      .+-+-....|++....  |+.|.||+.....-. ..          ..+.+|.+.+.++...+  .+.++++....    
T Consensus        29 ~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         29 VFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             EEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3333333456676654  678999977433211 11          13778998888874333  33444444321    


Q ss_pred             CCeEEEEEeccCCC-CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-----
Q 017411          252 EQGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----  325 (372)
Q Consensus       252 ~~~~~lV~Ey~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-----  325 (372)
                      ....+||+|++++. +|.+++.....     ...+...+..++.+++..+.-||..+   |+|+|+++.|||++.     
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~-----~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~  178 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWAT-----NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGR  178 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCC
Confidence            22368999999876 89999864321     23455667789999999999999988   999999999999975     


Q ss_pred             --CCcEEEEecccccc
Q 017411          326 --KKIPKLCDFGLATW  339 (372)
Q Consensus       326 --~~~~KL~DFGla~~  339 (372)
                        +..+.|+||+.++.
T Consensus       179 ~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        179 EEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCCceEEEEECCcccc
Confidence              46899999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=3.1e-08  Score=89.24  Aligned_cols=128  Identities=22%  Similarity=0.231  Sum_probs=81.6

Q ss_pred             EEEEEEECCCCeEEEEEEecCC-------------C-------------hhhHHHHHHHHHHHHhCCCC--CeeceeeeE
Q 017411          197 FVFKGKVGLLRTSVAIKRLDKE-------------D-------------KESSKAFCRELMIASSLHHP--NIVPLVGFC  248 (372)
Q Consensus       197 ~Vy~~~~~~~~~~vAvK~l~~~-------------~-------------~~~~~~~~~Ev~iL~~l~Hp--nIv~l~g~~  248 (372)
                      .||.|.... +..+|||+....             .             ........+|.+.|.++..-  ++.+++.+ 
T Consensus         1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            388888753 779999987531             0             01123456899999999755  56667654 


Q ss_pred             EcCCCeEEEEEeccC--CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HHcCCCCceEEcCCCCCCEEEcC
Q 017411          249 IDPEQGLFLIYKYVS--GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY-LHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~--~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~~~~IiHrDLKp~NILld~  325 (372)
                       . .+  .|||||++  |..+..+....         +.......++.+++..+.. +|..+   |+|+||.+.|||+++
T Consensus        79 -~-~~--~ivME~I~~~G~~~~~l~~~~---------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~  142 (188)
T PF01163_consen   79 -N-RN--VIVMEYIGEDGVPLPRLKDVD---------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDD  142 (188)
T ss_dssp             -E-TT--EEEEE--EETTEEGGCHHHCG---------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEET
T ss_pred             -e-CC--EEEEEecCCCccchhhHHhcc---------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeec
Confidence             2 22  69999998  65555543321         1123344567777775555 57777   999999999999988


Q ss_pred             CCcEEEEecccccccCCC
Q 017411          326 KKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~  343 (372)
                      + .+.|+|||.+.....+
T Consensus       143 ~-~~~iIDf~qav~~~~p  159 (188)
T PF01163_consen  143 G-KVYIIDFGQAVDSSHP  159 (188)
T ss_dssp             T-CEEE--GTTEEETTST
T ss_pred             c-eEEEEecCcceecCCc
Confidence            7 8999999998766543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=98.82  E-value=7.6e-10  Score=110.94  Aligned_cols=100  Identities=27%  Similarity=0.344  Sum_probs=81.6

Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ++|+.|++|...+|.+||.+.+..    ...++...+.++.|++.|++|   .+   .+|||+||.||+...+..+||.|
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~----e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD  399 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG----EERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD  399 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc----cccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence            378999999999999999765432    457888899999999999999   44   89999999999999999999999


Q ss_pred             cccccccCCCCC----CccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSV----PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~----~~~~~~~~GT~gy~apea  363 (372)
                      ||+........+    ....+...||..||+||-
T Consensus       400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQ  433 (516)
T KOG1033|consen  400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQ  433 (516)
T ss_pred             hhheeecccCCcccchhhhhhhcccccccCCHHH
Confidence            999877654441    112245679999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.79  E-value=5.7e-08  Score=97.74  Aligned_cols=146  Identities=16%  Similarity=0.220  Sum_probs=114.5

Q ss_pred             ceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc---CCCeEEEEEeccCC-CCHHHH
Q 017411          195 LSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGLFLIYKYVSG-GSLERH  270 (372)
Q Consensus       195 fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~~~~lV~Ey~~~-gsL~~~  270 (372)
                      -.+.|++....+|..|++|+++....+.......-++.++++.|+|||++..++..   .+..+++||+|.++ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            34789999988999999999965433333344456788999999999999988752   24458999999985 678777


Q ss_pred             HHhhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          271 LHEKKKGV--------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       271 L~~~~~~~--------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      -.......        ..+...++...|.++.|+..||.++|+.+   +.-+-|.|.+||++.+.+++|+.-|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            65433222        22356788999999999999999999988   88899999999999999999988887766544


Q ss_pred             C
Q 017411          343 P  343 (372)
Q Consensus       343 ~  343 (372)
                      +
T Consensus       446 d  446 (655)
T KOG3741|consen  446 D  446 (655)
T ss_pred             C
Confidence            3

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.78  E-value=3.9e-09  Score=107.33  Aligned_cols=172  Identities=24%  Similarity=0.264  Sum_probs=131.6

Q ss_pred             CeeeceeEcc--cCceEEEEEEE--CCCCeEEEEEEec--CCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeE
Q 017411          183 NFSKGRVLGR--GALSFVFKGKV--GLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       183 ~f~~~~~LG~--G~fG~Vy~~~~--~~~~~~vAvK~l~--~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~  255 (372)
                      .|.....+|.  |.+|.||.+..  ..++..+|+|.-+  ...+.....-.+|+.-.++++ |+|.++....+.. .+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCcc
Confidence            4556678999  99999999988  7778899999733  333444445567888778884 9999998777655 4447


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE----SVAYLHNGTERCVVHRDIKPSNILLSSK-KIPK  330 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~K  330 (372)
                      ++-.|++ +.+|..+.....      ..++....+.+..+...    ||.++|+..   |+|-|+||.||++..+ ...+
T Consensus       194 fiqtE~~-~~sl~~~~~~~~------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~  263 (524)
T KOG0601|consen  194 FIQTELC-GESLQSYCHTPC------NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCK  263 (524)
T ss_pred             eeeeccc-cchhHHhhhccc------ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceee
Confidence            8888888 578888877643      34666777777888888    999999888   9999999999999999 8899


Q ss_pred             EEecccccccCCCCCCcc---ccccccCCCccCccccc
Q 017411          331 LCDFGLATWTSAPSVPFL---CKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~---~~~~~GT~gy~apeaPE  365 (372)
                      +.|||+...+....-...   .....|..-|++||+-+
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~  301 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN  301 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc
Confidence            999999998876653221   12235777898887665

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.75  E-value=1e-08  Score=104.41  Aligned_cols=149  Identities=25%  Similarity=0.237  Sum_probs=116.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC-CCCeEEEEEEecCCChhhHHH--HHHHHHHHHhC-CCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKEDKESSKA--FCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~~~~~vAvK~l~~~~~~~~~~--~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~  255 (372)
                      ...+|..+..||.|.|+.|+....+ .++..|++|.+.+.-.....+  -+.|+-+...+ .|.+++..+..+.+-.+ .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence            3458899999999999999988765 567789999886643222222  24566666665 58888887766665444 6


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEec
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDF  334 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DF  334 (372)
                      |+-.|||+++++...+.-.       ..+....++++..|++.++.++|+..   ++|+|+||+||++..+ +..++.||
T Consensus       342 ~ip~e~~~~~s~~l~~~~~-------~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~  411 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTS-------QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDF  411 (524)
T ss_pred             cCchhhhcCcchhhhhHHH-------HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccc
Confidence            7999999999988777332       56788888999999999999999766   9999999999999886 77899999


Q ss_pred             ccccc
Q 017411          335 GLATW  339 (372)
Q Consensus       335 Gla~~  339 (372)
                      |+++.
T Consensus       412 ~~~t~  416 (524)
T KOG0601|consen  412 GCWTR  416 (524)
T ss_pred             ccccc
Confidence            99864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.64  E-value=2e-07  Score=96.29  Aligned_cols=127  Identities=20%  Similarity=0.236  Sum_probs=101.1

Q ss_pred             EEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCC
Q 017411          200 KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR  279 (372)
Q Consensus       200 ~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~  279 (372)
                      .|..+.++.+|.|...+...........+-+..|+.++||||++++..... +..+|||+|-+  -.|..++...     
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV--~Pl~~~lk~l-----  101 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERV--RPLETVLKEL-----  101 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeecc--ccHHHHHHHh-----
Confidence            355666788999998877655444556778889999999999999997655 55699999988  3677777653     


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       280 ~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                           ......-.+.||+.||.|||+.+  .++|++|.-+.|+++..|..||.+|-++....
T Consensus       102 -----~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~  156 (690)
T KOG1243|consen  102 -----GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS  156 (690)
T ss_pred             -----HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence                 23344456789999999999655  39999999999999999999999999886544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.59  E-value=8.1e-07  Score=81.04  Aligned_cols=108  Identities=23%  Similarity=0.255  Sum_probs=82.4

Q ss_pred             HHHHHHHHHHHhCCC--CCeeceeeeEEcCC---CeEEEEEeccCCC-CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 017411          224 KAFCRELMIASSLHH--PNIVPLVGFCIDPE---QGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  297 (372)
Q Consensus       224 ~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~---~~~~lV~Ey~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia  297 (372)
                      ....+|...+..|..  -.+.+.+++.....   ...+||+|++++. +|.+++....       .++......++.+++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-------~~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-------QLDPSQRRELLRALA  128 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-------ccchhhHHHHHHHHH
Confidence            456788887777743  23445555544322   2358999999874 8999987642       245556778999999


Q ss_pred             HHHHHHHcCCCCceEEcCCCCCCEEEcCCC---cEEEEecccccccC
Q 017411          298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTS  341 (372)
Q Consensus       298 ~gL~yLH~~~~~~IiHrDLKp~NILld~~~---~~KL~DFGla~~~~  341 (372)
                      ..+.-||..+   |+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       129 ~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  129 RLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             HHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            9999999988   99999999999999887   89999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=2.2e-06  Score=78.35  Aligned_cols=139  Identities=16%  Similarity=0.119  Sum_probs=101.3

Q ss_pred             cccCceEEEEEEECCCCeEEEEEEecCC------ChhhHHHHHHHHHHHHhCCC--CCeeceeeeEE-c---CCCeEEEE
Q 017411          191 GRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLHH--PNIVPLVGFCI-D---PEQGLFLI  258 (372)
Q Consensus       191 G~G~fG~Vy~~~~~~~~~~vAvK~l~~~------~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~-~---~~~~~~lV  258 (372)
                      |.||-+.|++-...  |+.+=+|+-...      -+.....|.+|...|.++..  -.+.+.. ++. .   .....+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            56888889987765  346788876421      14466789999999998853  2244444 222 1   11236799


Q ss_pred             EeccCC-CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc--EEEEecc
Q 017411          259 YKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFG  335 (372)
Q Consensus       259 ~Ey~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~--~KL~DFG  335 (372)
                      +|-+++ -+|.+++.....     ...+...+..+..+++..+.-||..+   +.|+|+-+.||+++.++.  ++++||.
T Consensus       104 Te~L~g~~~L~~~l~~~~~-----~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAV-----SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             EEeCCCCccHHHHHhcCCc-----CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            997753 689998865321     34566777889999999999999988   999999999999986666  9999998


Q ss_pred             ccccc
Q 017411          336 LATWT  340 (372)
Q Consensus       336 la~~~  340 (372)
                      -++..
T Consensus       176 k~r~~  180 (216)
T PRK09902        176 KSRRR  180 (216)
T ss_pred             ccchh
Confidence            77643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.45  E-value=2.4e-06  Score=80.45  Aligned_cols=139  Identities=22%  Similarity=0.152  Sum_probs=94.0

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC----------------------hhhHHHHHHHHHHHHhCCCC--
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----------------------KESSKAFCRELMIASSLHHP--  239 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----------------------~~~~~~~~~Ev~iL~~l~Hp--  239 (372)
                      ..++..||.|--+.||.|... .+.++|||.-+...                      ........+|.++|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            455689999999999999986 47899999643210                      11223456899999999754  


Q ss_pred             CeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCC
Q 017411          240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (372)
Q Consensus       240 nIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~  319 (372)
                      .+.+.+++    + +..+||||++|-.|...-            ++....-.++..|++-+.-+-..+   |||+|+.+=
T Consensus       172 ~VP~P~~~----n-RHaVvMe~ieG~eL~~~r------------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSef  231 (304)
T COG0478         172 KVPKPIAW----N-RHAVVMEYIEGVELYRLR------------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEF  231 (304)
T ss_pred             CCCCcccc----c-cceeeeehcccceeeccc------------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchh
Confidence            67777664    2 357999999886665432            111112223333333333333344   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCC
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      ||+++++|.+.++||--+...+.+
T Consensus       232 NIlV~~dg~~~vIDwPQ~v~~~hp  255 (304)
T COG0478         232 NILVTEDGDIVVIDWPQAVPISHP  255 (304)
T ss_pred             eEEEecCCCEEEEeCcccccCCCC
Confidence            999999999999999666544433

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.37  E-value=4e-07  Score=87.18  Aligned_cols=97  Identities=24%  Similarity=0.360  Sum_probs=80.4

Q ss_pred             HHHhCCCCCeeceeeeEEcCC----CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 017411          232 IASSLHHPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT  307 (372)
Q Consensus       232 iL~~l~HpnIv~l~g~~~~~~----~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~  307 (372)
                      -|-++-|.|||++..|+.+..    .+..++.|||+.|+|.++|++.+...   ..+......+++-||+.||.|||+..
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~---~a~~~~~wkkw~tqIlsal~yLhs~~  196 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ---KALFQKAWKKWCTQILSALSYLHSCD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh---hhhhHHHHHHHHHHHHhhhhhhhccC
Confidence            345567999999998875432    24689999999999999999876433   56777777889999999999999876


Q ss_pred             CCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          308 ERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                       |+|+|+++..+.|++..+|-+||.
T Consensus       197 -PpiihgnlTc~tifiq~ngLIkig  220 (458)
T KOG1266|consen  197 -PPIIHGNLTCDTIFIQHNGLIKIG  220 (458)
T ss_pred             -CccccCCcchhheeecCCceEEec
Confidence             779999999999999999888864

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=1e-05  Score=75.06  Aligned_cols=143  Identities=18%  Similarity=0.184  Sum_probs=81.7

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeeEEcCCCeEEEEEeccCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      ..||+|..+.||+..    +..+++|......  ......+|.++++.+..-.  +.+.+++..+ .....+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCc
Confidence            578999999999842    3467788876533  2345688999998875333  3556665544 34467899999886


Q ss_pred             C-HHHHH--------------Hh----hccCCCCCCCCCHHHHHHHHH----------HHHH-HHHHHHcC-CCCceEEc
Q 017411          266 S-LERHL--------------HE----KKKGVRGNSTLPWSVRYKVAL----------GIAE-SVAYLHNG-TERCVVHR  314 (372)
Q Consensus       266 s-L~~~L--------------~~----~~~~~~~~~~l~~~~~~~i~~----------qia~-gL~yLH~~-~~~~IiHr  314 (372)
                      + +...+              ..    -.........++... ..+..          .+.. ...+|... ..+.++|+
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            3 21111              11    110000001111000 00000          0111 12222211 12347899


Q ss_pred             CCCCCCEEEcCCCcEEEEecccccc
Q 017411          315 DIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       315 DLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |+.|.||+++.++ +.|+||+.+..
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999888 99999998864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.32  E-value=4.5e-06  Score=86.04  Aligned_cols=147  Identities=18%  Similarity=0.226  Sum_probs=91.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------------------------------hhHH-------
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------------------------------ESSK-------  224 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------------------------------~~~~-------  224 (372)
                      ..|.. +.|+.++-|.||+|++.. |+.||||+.++.-.                              ...+       
T Consensus       126 ~eF~~-~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         126 SEFEP-EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             HHcCC-CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            44543 689999999999999986 89999998765310                              0001       


Q ss_pred             ---HHHHHHHHHHhCC-----CCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHH
Q 017411          225 ---AFCRELMIASSLH-----HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI  296 (372)
Q Consensus       225 ---~~~~Ev~iL~~l~-----HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qi  296 (372)
                         .+.+|...+.+++     .+++. +=.++.+-...-.|+|||+.|..+.+...-..      ...+-.   .++..+
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~------~g~d~k---~ia~~~  273 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKS------AGIDRK---ELAELL  273 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHh------cCCCHH---HHHHHH
Confidence               1334555555442     33332 11222221223479999999999988854332      223322   233333


Q ss_pred             HHHH-HHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          297 AESV-AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       297 a~gL-~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +++. ..+-..+   ++|.|..|.||+++.+|++-+.|||+...++..
T Consensus       274 ~~~f~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         274 VRAFLRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             HHHHHHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            2222 1222234   999999999999999999999999998766533

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=6.6e-06  Score=74.14  Aligned_cols=105  Identities=25%  Similarity=0.313  Sum_probs=81.6

Q ss_pred             HHHHHHHHhCCC-CCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 017411          227 CRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN  305 (372)
Q Consensus       227 ~~Ev~iL~~l~H-pnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~  305 (372)
                      ..|..+++.+++ +++++++|+|-     .++|.||...+++...-..    .......+|..+.+|+.++++.+.+|++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~----l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRP----LSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccc----cccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            458888999976 69999999983     2689999987765422000    0001346899999999999999999998


Q ss_pred             CCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       306 ~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      .....+.-.|++++|+-+++++++|++|...+...
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            65555788999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.18  E-value=2.1e-05  Score=72.34  Aligned_cols=139  Identities=17%  Similarity=0.205  Sum_probs=88.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHH---------HHHHHHHHhCCCC---Ceeceeee
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---------CRELMIASSLHHP---NIVPLVGF  247 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~---------~~Ev~iL~~l~Hp---nIv~l~g~  247 (372)
                      ...+|...+.+-......|.+-...  +..+.+|..........+.|         .+++..+.+++..   .++.++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            3467888888888777777766654  67899998765433222222         2333333333222   22222221


Q ss_pred             EEc----CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          248 CID----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       248 ~~~----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      ..-    -....+++|||++|..|.+...           ++.    .++..+.+++.-||..+   +.|+|..|.|+++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv  168 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-----------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLV  168 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh-----------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEE
Confidence            110    0122468999999988766532           222    24456777899999888   9999999999999


Q ss_pred             cCCCcEEEEecccccc
Q 017411          324 SSKKIPKLCDFGLATW  339 (372)
Q Consensus       324 d~~~~~KL~DFGla~~  339 (372)
                      +.++ ++++||+..+.
T Consensus       169 ~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  169 SNNG-IRIIDTQGKRM  183 (229)
T ss_pred             ECCc-EEEEECccccc
Confidence            8654 99999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.17  E-value=2.7e-05  Score=70.60  Aligned_cols=150  Identities=19%  Similarity=0.216  Sum_probs=85.9

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCC--CeeceeeeEEcC--CCeEEEEEecc
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP--NIVPLVGFCIDP--EQGLFLIYKYV  262 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIv~l~g~~~~~--~~~~~lV~Ey~  262 (372)
                      .+.|+.|..+.||+.....  ..+++|.....  .....+.+|..+++.+...  .+.+++.++...  ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4689999999999998865  48999997654  4556778898888887432  345566543221  22368999999


Q ss_pred             CCCCHHH----------------HHHhhccCCCCCCCCCHHHH---------HHH------------HHHHHH-HHHHHH
Q 017411          263 SGGSLER----------------HLHEKKKGVRGNSTLPWSVR---------YKV------------ALGIAE-SVAYLH  304 (372)
Q Consensus       263 ~~gsL~~----------------~L~~~~~~~~~~~~l~~~~~---------~~i------------~~qia~-gL~yLH  304 (372)
                      ++..+..                .+..-...........+...         ...            ...+.. .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988777                22211111000111111110         000            011222 233333


Q ss_pred             c----CCCCceEEcCCCCCCEEEc-CCCcEEEEeccccccc
Q 017411          305 N----GTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWT  340 (372)
Q Consensus       305 ~----~~~~~IiHrDLKp~NILld-~~~~~KL~DFGla~~~  340 (372)
                      .    .....++|+|+.|.|||++ .++.+-|+||+.+...
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~  198 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG  198 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence            2    2345699999999999999 6666689999988643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.13  E-value=3.8e-05  Score=71.33  Aligned_cols=145  Identities=16%  Similarity=0.114  Sum_probs=83.3

Q ss_pred             eEcccCc-eEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          189 VLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       189 ~LG~G~f-G~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      .|-.|.. ..||+....  +..+.||+.....   ...+.+|+++++.+. +--+.+++++.... +..++|||+++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCcc
Confidence            4555555 689998754  3578888876543   335678888888774 33455667655443 34689999999877


Q ss_pred             HHHHHH----------------hhccCCCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHc---
Q 017411          267 LERHLH----------------EKKKGVRGNSTLPW--SVRYKVAL--------------------GIAESVAYLHN---  305 (372)
Q Consensus       267 L~~~L~----------------~~~~~~~~~~~l~~--~~~~~i~~--------------------qia~gL~yLH~---  305 (372)
                      |.....                .-.........+..  ........                    .+...+..|-.   
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            764421                00000000011110  00000000                    01111222211   


Q ss_pred             -CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          306 -GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       306 -~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                       ...+.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence             1235589999999999999987788999998864

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.11  E-value=4.4e-05  Score=83.55  Aligned_cols=80  Identities=21%  Similarity=0.319  Sum_probs=56.5

Q ss_pred             ceeEcccCceEEEEEEECCCC--eEEEEEEecCCC-hhhHHHHHHHHHHHHhCC-CCCe--eceeeeEEcCC--CeEEEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKED-KESSKAFCRELMIASSLH-HPNI--VPLVGFCIDPE--QGLFLI  258 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~--~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~-HpnI--v~l~g~~~~~~--~~~~lV  258 (372)
                      .+.|+.|.+..+|+......+  ..+++|+..... ......+.+|+++|+.+. |+++  .+++.+|.+..  +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            467899999999998765422  467788765432 223456889999999995 6655  77777775532  347899


Q ss_pred             EeccCCCC
Q 017411          259 YKYVSGGS  266 (372)
Q Consensus       259 ~Ey~~~gs  266 (372)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.07  E-value=2.9e-05  Score=68.94  Aligned_cols=135  Identities=21%  Similarity=0.283  Sum_probs=90.1

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeec-eeeeEEcCCCeEEEEEeccC
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP-LVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~-l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      ...+.|++|.+|.||+|.+.  +..+|+|+-..++  ....+..|+++|..++-.++.+ ++.|.   .  .++.|||+.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---~--~~i~me~i~   95 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---E--DFIRMEYID   95 (201)
T ss_pred             hhhhhhhcccccEEEEeecc--CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---h--hhhhhhhhc
Confidence            34578999999999999987  5689999876543  3467889999999988666644 44442   2  246699998


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC-CCCEEEcCCCcEEEEecccccccCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK-PSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK-p~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      |-.|.++-...          +-.+    ...+++.---|-..+   |-|..|. |...+|..++.+-|+||.-|++...
T Consensus        96 G~~L~~~~~~~----------~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~  158 (201)
T COG2112          96 GRPLGKLEIGG----------DRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK  158 (201)
T ss_pred             Ccchhhhhhcc----------cHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence            87887765421          1112    223334322233333   7777775 4455555566999999999987655


Q ss_pred             CCC
Q 017411          343 PSV  345 (372)
Q Consensus       343 ~~~  345 (372)
                      +..
T Consensus       159 p~N  161 (201)
T COG2112         159 PRN  161 (201)
T ss_pred             Cch
Confidence            543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.01  E-value=0.00011  Score=68.60  Aligned_cols=155  Identities=15%  Similarity=0.146  Sum_probs=97.9

Q ss_pred             ccHHHHHHhhCCeeece---eEcccCceEEEEEEECCCCeEEEEEEecCCChh-------------------hH-----H
Q 017411          172 LSYGEILAATHNFSKGR---VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-------------------SS-----K  224 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~---~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-------------------~~-----~  224 (372)
                      .++..|....+...+..   .|..|--+.||+|... .+..+|||+.......                   ..     .
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            44445544444444444   4556777799998763 4789999988643110                   11     1


Q ss_pred             HHHHHHHHHHhCC--CCCeeceeeeEEcCCCeEEEEEeccCCC-CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH
Q 017411          225 AFCRELMIASSLH--HPNIVPLVGFCIDPEQGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA  301 (372)
Q Consensus       225 ~~~~Ev~iL~~l~--HpnIv~l~g~~~~~~~~~~lV~Ey~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~  301 (372)
                      ...+|..-|.++.  +-.+.+-+++.   +  -.|||||+... .-.-.|.+        ..+.......+..++++.+.
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~---~--nVLvMEfIg~~g~pAP~LkD--------v~~e~~e~~~~~~~~v~~~~  180 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR---N--NVLVMEFIGDDGLPAPRLKD--------VPLELEEAEGLYEDVVEYMR  180 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec---C--CeEEEEeccCCCCCCCCccc--------CCcCchhHHHHHHHHHHHHH
Confidence            2345777777763  44555555542   2  25999999543 11111111        22233356666777778887


Q ss_pred             HHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          302 YLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       302 yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      -|-. .+   +||+||+.=|||+. ++.+.|+|||-|.....|.
T Consensus       181 ~l~~~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp~  220 (268)
T COG1718         181 RLYKEAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHPN  220 (268)
T ss_pred             HHHHhcC---cccccchhhheEEE-CCeEEEEECccccccCCCc
Confidence            7765 55   99999999999999 8899999999987665443

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.97  E-value=5.6e-05  Score=78.00  Aligned_cols=139  Identities=19%  Similarity=0.172  Sum_probs=87.0

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCCh-------------------------------hhHH------HHHHHH
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------------------------------ESSK------AFCREL  230 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------------------------------~~~~------~~~~Ev  230 (372)
                      +.||.-+.|.||+|+.+. |+.||||+-++.-.                               +..+      .|.+|.
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            689999999999999987 89999998654310                               0001      244455


Q ss_pred             HHHHh----CCCCC------eeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 017411          231 MIASS----LHHPN------IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV  300 (372)
Q Consensus       231 ~iL~~----l~Hpn------Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL  300 (372)
                      +-..+    +.|-+      |.+++-.+   ...-.|+||||+|..+.+.-.-..      ..++...   ++..+.++.
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~---st~RVLtME~~~G~~i~Dl~~i~~------~gi~~~~---i~~~l~~~~  313 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL---STKRVLTMEYVDGIKINDLDAIDK------RGISPHD---ILNKLVEAY  313 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc---CcceEEEEEecCCccCCCHHHHHH------cCCCHHH---HHHHHHHHH
Confidence            43333    34555      44443322   223579999999987766643322      2233333   333333322


Q ss_pred             HH-HHcCCCCceEEcCCCCCCEEEcC----CCcEEEEecccccccCC
Q 017411          301 AY-LHNGTERCVVHRDIKPSNILLSS----KKIPKLCDFGLATWTSA  342 (372)
Q Consensus       301 ~y-LH~~~~~~IiHrDLKp~NILld~----~~~~KL~DFGla~~~~~  342 (372)
                      .. |-..+   ++|+|-.|.||+++.    ++.+.+-|||+.+.++.
T Consensus       314 ~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            21 11223   899999999999984    57899999999876653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.96  E-value=9.2e-05  Score=68.58  Aligned_cols=74  Identities=11%  Similarity=0.134  Sum_probs=44.6

Q ss_pred             eeEcccCce-EEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCC---CeeceeeeEEcCC--CeEEEEEec
Q 017411          188 RVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPE--QGLFLIYKY  261 (372)
Q Consensus       188 ~~LG~G~fG-~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIv~l~g~~~~~~--~~~~lV~Ey  261 (372)
                      +.|+.|+.. .||+..     ..+.+|..+..  .....+.+|.+++..+...   -+.++++.....+  ...+++|++
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            567777766 588752     35677865542  2234788999998877521   2334443322211  134789999


Q ss_pred             cCCCCHH
Q 017411          262 VSGGSLE  268 (372)
Q Consensus       262 ~~~gsL~  268 (372)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9886653

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.85  E-value=2.6e-06  Score=91.83  Aligned_cols=148  Identities=21%  Similarity=0.225  Sum_probs=105.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..+.|.+.+.+-+|.++.++.+.-..++...++|...+..   ....+...++-.++-..+||.++...--+. .....+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~-~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFP-CRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCC-CCCCcc
Confidence            4567888888899999999988877777666666554331   112223334444444445677776544322 233478


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||++|+.+++|...|+...       ..+..........+.++++|||...   ++|||++|.|+|...++..+++|||+
T Consensus       881 L~~~~~~~~~~~Skl~~~~-------~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t  950 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNSG-------CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGT  950 (1205)
T ss_pred             hhhHHhccCCchhhhhcCC-------CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccc
Confidence            9999999999999998642       3444444456667888999999876   89999999999999999999999985


Q ss_pred             cc
Q 017411          337 AT  338 (372)
Q Consensus       337 a~  338 (372)
                      ..
T Consensus       951 ~~  952 (1205)
T KOG0606|consen  951 LS  952 (1205)
T ss_pred             cc
Confidence            43

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.79  E-value=0.00053  Score=62.37  Aligned_cols=128  Identities=23%  Similarity=0.285  Sum_probs=86.3

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCC----------------hhhHHHHHHHHHHHHhCC------CCCeece
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----------------KESSKAFCRELMIASSLH------HPNIVPL  244 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----------------~~~~~~~~~Ev~iL~~l~------HpnIv~l  244 (372)
                      ...||+|+.=.||.-  +. .....||++....                ....++..+|+.-...+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~H--P~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEEC--CC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            467999999999853  22 3456788887654                223456777776655555      8899999


Q ss_pred             eeeEEcCCCeEEEEEeccCC------CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCC
Q 017411          245 VGFCIDPEQGLFLIYKYVSG------GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~------gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp  318 (372)
                      +|+... +....+|+|.+.+      -+|.+++...        .++. ...+.+.   +-..||-...   |+.+|++|
T Consensus        83 ~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--------~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~  146 (199)
T PF10707_consen   83 YGFVET-NLGLGLVVELIRDADGNISPTLEDYLKEG--------GLTE-ELRQALD---EFKRYLLDHH---IVIRDLNP  146 (199)
T ss_pred             eEEEec-CCceEEEEEEEECCCCCcCccHHHHHHcC--------CccH-HHHHHHH---HHHHHHHHcC---CeecCCCc
Confidence            998654 5558899988642      4678887542        3444 3333333   3345666555   99999999


Q ss_pred             CCEEEcCC---C-cEEEEe
Q 017411          319 SNILLSSK---K-IPKLCD  333 (372)
Q Consensus       319 ~NILld~~---~-~~KL~D  333 (372)
                      .||++...   . .+.|+|
T Consensus       147 ~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             ccEEEEecCCCceEEEEEe
Confidence            99999643   2 578888

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.00033  Score=64.47  Aligned_cols=147  Identities=18%  Similarity=0.207  Sum_probs=81.2

Q ss_pred             eeEcccCceEEEEEEECC-CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeeEEcCCCeEEEEEeccCCC
Q 017411          188 RVLGRGALSFVFKGKVGL-LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      +.|..|-...+|+..... .+..|++|+....... .-...+|+.++..+....+ .++++.+ +  .  .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~-~--~--~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATF-Q--N--GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEe-C--C--cEEEEeeCCC
Confidence            567788888999987543 2467889976543221 1223478888888853333 3444332 2  2  3799999886


Q ss_pred             CHHH--------------HHHhhccCCCCC--------CCCCHHHHHHHHH----------------------HHH---H
Q 017411          266 SLER--------------HLHEKKKGVRGN--------STLPWSVRYKVAL----------------------GIA---E  298 (372)
Q Consensus       266 sL~~--------------~L~~~~~~~~~~--------~~l~~~~~~~i~~----------------------qia---~  298 (372)
                      ++..              .+.+-.......        ..-.|.....+..                      .+.   .
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            6521              111111111100        1111222111111                      111   1


Q ss_pred             HHH-HHHcC-CCCceEEcCCCCCCEEEcC-CCcEEEEeccccccc
Q 017411          299 SVA-YLHNG-TERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWT  340 (372)
Q Consensus       299 gL~-yLH~~-~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~~  340 (372)
                      .|. .+-.. ....++|+|+.+.|||++. ++.+.|+||..|..-
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~~  202 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGYN  202 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCcC
Confidence            111 12211 2345899999999999998 578999999988643

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.68  E-value=0.00078  Score=61.29  Aligned_cols=126  Identities=22%  Similarity=0.293  Sum_probs=89.0

Q ss_pred             CCeeeceeEcccCc-eEEEEEEECCCCeEEEEEEecC---C------------Ch------hhHHHHHHHHHHHHhCC--
Q 017411          182 HNFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDK---E------------DK------ESSKAFCRELMIASSLH--  237 (372)
Q Consensus       182 ~~f~~~~~LG~G~f-G~Vy~~~~~~~~~~vAvK~l~~---~------------~~------~~~~~~~~Ev~iL~~l~--  237 (372)
                      .+++..+.||.|.- |.||+++..  |+.+|+|.+..   .            ..      .....|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 999999987  67999999321   0            00      12235788998877774  


Q ss_pred             -CCCe--eceeeeEEcCC-----------------CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 017411          238 -HPNI--VPLVGFCIDPE-----------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA  297 (372)
Q Consensus       238 -HpnI--v~l~g~~~~~~-----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia  297 (372)
                       +.++  |+.+||..-..                 ....||.||++...                .+..    .-+.+|.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------------~~~~----~~~~~~~  174 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------------PLQI----RDIPQML  174 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------ccch----hHHHHHH
Confidence             4466  88888864221                 11357777775432                1111    2345567


Q ss_pred             HHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       298 ~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      +-|.-+|..+   |+-+|+|+.|..     .-||+|||.+
T Consensus       175 ~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  175 RDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            7788899877   999999999987     3589999864

>PRK10593 hypothetical protein; Provisional

Probab=97.56  E-value=0.0017  Score=62.58  Aligned_cols=79  Identities=10%  Similarity=-0.008  Sum_probs=55.1

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC---CCeeceeeeEEcC--CCeEEEEE
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH---PNIVPLVGFCIDP--EQGLFLIY  259 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H---pnIv~l~g~~~~~--~~~~~lV~  259 (372)
                      ...+.||.|..+.||+....+ + .+.+|..+..  .....|.+|.+.|+.|.-   ..+.+++++|...  .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            345789999999999986543 2 4666775331  122478899999988842   3677788776532  34479999


Q ss_pred             eccCCCCH
Q 017411          260 KYVSGGSL  267 (372)
Q Consensus       260 Ey~~~gsL  267 (372)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99988754

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.53  E-value=0.0016  Score=61.01  Aligned_cols=143  Identities=17%  Similarity=0.143  Sum_probs=77.6

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeeEEcCCCeEEEEEeccCCCCH
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYVSGGSL  267 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~~~~lV~Ey~~~gsL  267 (372)
                      .+..|-...+|+...  .+..+++|..........-...+|.++++.+....+ .+++..+   .+  ++||||++|..+
T Consensus         3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---~~--~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---EH--WLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---CC--EEEEEeccCccc
Confidence            345677778998873  356788887654322211134678888888854333 3344332   22  589999988664


Q ss_pred             HH--------------HHHhhccCCCCCCCCCHHHH-HHHHHH---------HHHHHHHHHcC-----CCCceEEcCCCC
Q 017411          268 ER--------------HLHEKKKGVRGNSTLPWSVR-YKVALG---------IAESVAYLHNG-----TERCVVHRDIKP  318 (372)
Q Consensus       268 ~~--------------~L~~~~~~~~~~~~l~~~~~-~~i~~q---------ia~gL~yLH~~-----~~~~IiHrDLKp  318 (372)
                      ..              .+.+-.........++.... ..+..+         +...+..+-..     ....++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            32              11211111111112222211 111111         11112222111     123489999999


Q ss_pred             CCEEEcCCCcEEEEecccccc
Q 017411          319 SNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       319 ~NILld~~~~~KL~DFGla~~  339 (372)
                      .||+++.++ +.|+||..|..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.43  E-value=0.0058  Score=61.39  Aligned_cols=77  Identities=17%  Similarity=0.087  Sum_probs=53.5

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCC------C-hhhHHHHHHHHHHHHhCC---CCCeeceeeeEEcCCCeEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------D-KESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~------~-~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+.||.|.+..||+......++.|.||.-...      . +.....+..|.+.|..+.   -..+.+++.+  +.+. .+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~-~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL-AV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC-CE
Confidence            36899999999999998654468999985421      1 223456778888888762   3456777765  3333 57


Q ss_pred             EEEeccCCCC
Q 017411          257 LIYKYVSGGS  266 (372)
Q Consensus       257 lV~Ey~~~gs  266 (372)
                      +||||+++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999997643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.38  E-value=3.9e-05  Score=79.48  Aligned_cols=160  Identities=20%  Similarity=0.092  Sum_probs=104.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC-eeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~~~~~~~~~lV~E  260 (372)
                      ..+...+-+++|++++++|.+...+...+ .+.+...     ....-++++|.+++||| .+..++-+ +.+...+++++
T Consensus       242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~-~~E~~~~i~~~  314 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDY-DGEDYLWIPMR  314 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccC-Ccccccchhhh
Confidence            33444456789999999998865544333 6665433     34456889999999999 55555543 44556889999


Q ss_pred             ccCCC-CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          261 YVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       261 y~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ++.++ +-......      ....+...+...+.+.-+++++|||+..   =+|||    ||+..+ +..|..||+.+..
T Consensus       315 i~s~~rs~~~~~~~------se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~  380 (829)
T KOG0576|consen  315 ICSTGRSSALEMTV------SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ  380 (829)
T ss_pred             hhcCCccccccCCh------hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence            99776 11111100      0012333334445666778999999754   47888    787765 6789999999887


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +....   ...+..+|+.++|||+..
T Consensus       381 L~~~~---~~~t~~~~~~~~~pev~~  403 (829)
T KOG0576|consen  381 LTRTM---KPRTAIGTPEPLAPEVIQ  403 (829)
T ss_pred             cCccc---ccccCCCCCCCCCchhhc
Confidence            76543   234567888888888543

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.36  E-value=0.0019  Score=61.99  Aligned_cols=147  Identities=20%  Similarity=0.228  Sum_probs=82.1

Q ss_pred             eeEcccCceEEEEEEECC------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeeEEcCCCeEEEEEe
Q 017411          188 RVLGRGALSFVFKGKVGL------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~~~~lV~E  260 (372)
                      +.|..|-...||+.....      .++.+++|+..... .......+|.+++..+....+ .++++++ . +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~-~-~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIF-P-N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEe-C-C---Cchhh
Confidence            456666667899887643      24688899875532 222345678888887753333 3455443 2 2   36899


Q ss_pred             ccCCCCHHHH--------------HHhhccCCCCC-----CCC--CHHHHHHH--------------------------H
Q 017411          261 YVSGGSLERH--------------LHEKKKGVRGN-----STL--PWSVRYKV--------------------------A  293 (372)
Q Consensus       261 y~~~gsL~~~--------------L~~~~~~~~~~-----~~l--~~~~~~~i--------------------------~  293 (372)
                      |++|..+...              +.+-.......     ...  -|.....+                          .
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            9988665431              11111100000     011  11111110                          1


Q ss_pred             HHHHHHHHHHHc------CCCCceEEcCCCCCCEEEcCC----CcEEEEeccccccc
Q 017411          294 LGIAESVAYLHN------GTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWT  340 (372)
Q Consensus       294 ~qia~gL~yLH~------~~~~~IiHrDLKp~NILld~~----~~~KL~DFGla~~~  340 (372)
                      ..+..-+.+|-.      .....++|+|+.+.|||++.+    +.+.++||..|..-
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            112222334432      234568999999999999985    88999999998643

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.30  E-value=0.01  Score=57.31  Aligned_cols=30  Identities=30%  Similarity=0.553  Sum_probs=26.1

Q ss_pred             CceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      .++||+|+.|.|||++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            469999999999999876666899999885

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.26  E-value=0.0091  Score=56.92  Aligned_cols=148  Identities=16%  Similarity=0.166  Sum_probs=84.0

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeee-----EEcCCCeEEEEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGF-----CIDPEQGLFLIY  259 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~-----~~~~~~~~~lV~  259 (372)
                      .+.|..|....+|+....  +..+++|+....   ....+..|++++..+.+..  +.+++..     ....++..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            467777877899987654  346888987642   2345667887777774322  4444331     111123468999


Q ss_pred             eccCCCCHHH-----------HH---HhhccCCC----CCCCCCHHHHHH----------HHHHHHHHHHHHHc----CC
Q 017411          260 KYVSGGSLER-----------HL---HEKKKGVR----GNSTLPWSVRYK----------VALGIAESVAYLHN----GT  307 (372)
Q Consensus       260 Ey~~~gsL~~-----------~L---~~~~~~~~----~~~~l~~~~~~~----------i~~qia~gL~yLH~----~~  307 (372)
                      +|++|..+..           .+   +.......    ......|.....          ....+...+.++..    .-
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9998866421           11   11100000    001123322210          11112334444443    12


Q ss_pred             CCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ...++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            24589999999999999987788999988753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.15  E-value=0.0045  Score=61.83  Aligned_cols=169  Identities=19%  Similarity=0.159  Sum_probs=102.8

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeec--------eeeeEEcCCCeEE
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVP--------LVGFCIDPEQGLF  256 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~--------l~g~~~~~~~~~~  256 (372)
                      .++.||+|+-+.+|-.-.-  +.. +.|+.....+....+.   ++.|.+. .||-+..        |+|-  +....+-
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~-VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iG   86 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQ-VAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGG--RRGKVIG   86 (637)
T ss_pred             CCccccCCccceeeecchh--hch-hheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCC--CccceeE
Confidence            4578999999999954221  222 4477765543332222   2223333 4554332        2221  1122256


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +.|..+++..--..+.+............|.-.++.++.++.+.+-||..+   .+-+|+.++|+|+++++.+.|.|=.-
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDs  163 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDS  163 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccc
Confidence            777777664322222222222233467899999999999999999999988   77899999999999999999998433


Q ss_pred             ccccCCCCCCccccccccCCCccCccccccccccC
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQRLKS  371 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE~~~~~~  371 (372)
                      -..-.+ ...+  .-.+|...|.+   ||.+++++
T Consensus       164 fqi~~n-g~~~--~cpVg~~eftP---PElQ~~~s  192 (637)
T COG4248         164 FQINAN-GTLH--LCPVGVSEFTP---PELQTLPS  192 (637)
T ss_pred             eeeccC-CceE--ecccCccccCC---HHHhcccc
Confidence            222211 1111  22467777888   67776654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.05  E-value=0.0084  Score=58.41  Aligned_cols=133  Identities=20%  Similarity=0.318  Sum_probs=75.1

Q ss_pred             CeEEEEEEecC--CChhhHHHHHHHHHHHHhCCC--CCeeceeeeEEcCC-CeEEEEEeccCCCCH--------------
Q 017411          207 RTSVAIKRLDK--EDKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPE-QGLFLIYKYVSGGSL--------------  267 (372)
Q Consensus       207 ~~~vAvK~l~~--~~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~-~~~~lV~Ey~~~gsL--------------  267 (372)
                      ++.+++. .+.  ..........+|.++++.+.-  .-+...+++|.+.. ...|.||+|++|..+              
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~  126 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFA  126 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHH
Confidence            6677777 432  233444566788888887742  23444567776554 457999999987322              


Q ss_pred             ----HHHHHhhccCC-------------CCCCCCCHHHHHHHH--------HHHHHHHHHHHcCC-----CCceEEcCCC
Q 017411          268 ----ERHLHEKKKGV-------------RGNSTLPWSVRYKVA--------LGIAESVAYLHNGT-----ERCVVHRDIK  317 (372)
Q Consensus       268 ----~~~L~~~~~~~-------------~~~~~l~~~~~~~i~--------~qia~gL~yLH~~~-----~~~IiHrDLK  317 (372)
                          .+.|..-..-.             ...+.-.|...+..+        -....-..||+...     .++++|+|+.
T Consensus       127 ~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~  206 (321)
T COG3173         127 LDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYR  206 (321)
T ss_pred             HHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcc
Confidence                12222111100             000011122222110        01222334554332     3469999999


Q ss_pred             CCCEEEcCCCcEEEEeccccccc
Q 017411          318 PSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       318 p~NILld~~~~~KL~DFGla~~~  340 (372)
                      +.||+++.++-+-|.||+++..-
T Consensus       207 ~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         207 PGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             cCCEEEeCCCeeEEEeccccccC
Confidence            99999999988999999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.99  E-value=0.019  Score=55.30  Aligned_cols=148  Identities=16%  Similarity=0.191  Sum_probs=80.8

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCC--CeeceeeeE-----EcCCCeEEEEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP--NIVPLVGFC-----IDPEQGLFLIY  259 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp--nIv~l~g~~-----~~~~~~~~lV~  259 (372)
                      .+.++.|....+|+....  +..+.+|+.....  ....+..|++++..|...  .+.+++...     ....+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            466777777889987653  3357788775431  123445666776666322  233443321     11234468999


Q ss_pred             eccCCCCHH-----------HHH---HhhccCCCCC-----CCCCHHHHHH------------HHHHHHHHHHHHHc---
Q 017411          260 KYVSGGSLE-----------RHL---HEKKKGVRGN-----STLPWSVRYK------------VALGIAESVAYLHN---  305 (372)
Q Consensus       260 Ey~~~gsL~-----------~~L---~~~~~~~~~~-----~~l~~~~~~~------------i~~qia~gL~yLH~---  305 (372)
                      ||++|..+.           ..+   +.........     ..-.|.....            ....+...++++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            999875431           111   1111110000     0112221110            01123334555532   


Q ss_pred             -CCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          306 -GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       306 -~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                       .-..+++|+|+.+.||+++.++...|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             223569999999999999988877899999884

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=96.82  E-value=0.014  Score=57.49  Aligned_cols=147  Identities=16%  Similarity=0.162  Sum_probs=80.0

Q ss_pred             eeEcccCceEEEEEEECC----CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeeEEcCCCeEEEEEecc
Q 017411          188 RVLGRGALSFVFKGKVGL----LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv-~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      +.|-.|-.-.+|+.....    .++.|.+|+.......... -.+|..++..+...++. ++++.+ . +.   .|+||+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~-~-~g---~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRF-P-NG---RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEE-C-Cc---eEEEee
Confidence            455456677889886532    2367889987654322222 25688888877543343 445543 2 22   578998


Q ss_pred             CCCCHHHH--------------HHhhccCC-CCC-CCCCHHHHHHHHHHH-----------------HHHHHHH----Hc
Q 017411          263 SGGSLERH--------------LHEKKKGV-RGN-STLPWSVRYKVALGI-----------------AESVAYL----HN  305 (372)
Q Consensus       263 ~~gsL~~~--------------L~~~~~~~-~~~-~~l~~~~~~~i~~qi-----------------a~gL~yL----H~  305 (372)
                      ++.+|...              +.+-.... ... ....|.....+..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665321              11111100 000 112233332332111                 1112222    21


Q ss_pred             -CCCCceEEcCCCCCCEEEcC-CCcEEEEeccccccc
Q 017411          306 -GTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWT  340 (372)
Q Consensus       306 -~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~~  340 (372)
                       .....++|+|+++.|||+++ ++.+.++||..|..-
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence             22345899999999999986 468999999988653

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.79  E-value=0.014  Score=55.76  Aligned_cols=32  Identities=28%  Similarity=0.434  Sum_probs=26.3

Q ss_pred             CceEEcCCCCCCEEEcCCCc-EEEEeccccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKI-PKLCDFGLATWT  340 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~-~KL~DFGla~~~  340 (372)
                      +.++|+|+.|.|||++.++. .-|+||+.+..-
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            45899999999999997555 569999988643

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.65  E-value=0.026  Score=55.94  Aligned_cols=73  Identities=16%  Similarity=0.063  Sum_probs=47.2

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecC-------CChhhHHHHHHHHHHHHhCC--CC-CeeceeeeEEcCCCeEEEE
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK-------EDKESSKAFCRELMIASSLH--HP-NIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~-------~~~~~~~~~~~Ev~iL~~l~--Hp-nIv~l~g~~~~~~~~~~lV  258 (372)
                      .||.|....||++.....++.|+||.-..       .-+-...+...|.+.|+...  -| .+.+++.+  +++. ..+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~-~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEM-AVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--cccc-ceeh
Confidence            57999999999999764346899997532       11223344556777776653  24 45556553  4444 4699


Q ss_pred             EeccCC
Q 017411          259 YKYVSG  264 (372)
Q Consensus       259 ~Ey~~~  264 (372)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999964

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.38  E-value=0.0059  Score=59.39  Aligned_cols=136  Identities=18%  Similarity=0.139  Sum_probs=89.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----------------Ch-----hhHHHHHHHHHHHHhCC-CC
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----------------DK-----ESSKAFCRELMIASSLH-HP  239 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----------------~~-----~~~~~~~~Ev~iL~~l~-Hp  239 (372)
                      -++.++.||-|--+-||.+-+.. |++.++|.-...                 ..     -..-...+|...|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            46778999999999999998753 778888843211                 00     01123457888898884 33


Q ss_pred             -CeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCC
Q 017411          240 -NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP  318 (372)
Q Consensus       240 -nIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp  318 (372)
                       -+.+.+++     .+.++|||++.+..|.+.-+-          .+...++.-+.   .-+--|-.++   +||+|..-
T Consensus       172 fpVPkpiD~-----~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm---~~Iv~la~~G---lIHgDFNE  230 (465)
T KOG2268|consen  172 FPVPKPIDH-----NRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLM---GLIVRLANHG---LIHGDFNE  230 (465)
T ss_pred             CCCCCcccc-----cceeeHHHhhcccceeeeeec----------CChHHHHHHHH---HHHHHHHHcC---ceecccch
Confidence             23444443     236899999998888765422          22233332222   2233344445   99999999


Q ss_pred             CCEEEcCCCcEEEEeccccccc
Q 017411          319 SNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       319 ~NILld~~~~~KL~DFGla~~~  340 (372)
                      =||++++++.++++||--....
T Consensus       231 FNimv~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  231 FNIMVKDDDKIVVIDFPQMVST  252 (465)
T ss_pred             heeEEecCCCEEEeechHhhcc
Confidence            9999999999999999644333

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.12  E-value=0.14  Score=48.95  Aligned_cols=29  Identities=34%  Similarity=0.423  Sum_probs=25.4

Q ss_pred             CceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            56899999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.90  E-value=0.099  Score=51.16  Aligned_cols=147  Identities=16%  Similarity=0.235  Sum_probs=78.3

Q ss_pred             eeEcccCceEEEEEEECCC---CeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv-~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.|-.|---.+|+......   +..|.+|+........ -.-.+|..+++.+..-++. ++++++  ..+   +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~--~~G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVF--GNG---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEe--CCc---Eeehhhc
Confidence            4554566678888865432   2378888876543211 1234688888887544443 455543  232   5889987


Q ss_pred             CCCHHH--------------HHHhhccCC-CCCC-CCCHHHHHHHHHHH----------------------HHHHH----
Q 017411          264 GGSLER--------------HLHEKKKGV-RGNS-TLPWSVRYKVALGI----------------------AESVA----  301 (372)
Q Consensus       264 ~gsL~~--------------~L~~~~~~~-~~~~-~l~~~~~~~i~~qi----------------------a~gL~----  301 (372)
                      +..|..              .+.+-.... .... .-.|.....+..++                      ..-+.    
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765421              111111110 1001 11233332222211                      11111    


Q ss_pred             HHHc-CCCCceEEcCCCCCCEEEcC-CCcEEEEeccccccc
Q 017411          302 YLHN-GTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWT  340 (372)
Q Consensus       302 yLH~-~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~~  340 (372)
                      ++.. ..+....|.|+.+.|||+++ ++.++++||..|..-
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            1211 11234799999999999975 578999999988643

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.77  E-value=0.087  Score=50.68  Aligned_cols=76  Identities=12%  Similarity=0.135  Sum_probs=44.9

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeeEEcCCCeEEEEEe
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .+..+.|+.|....+|+..  .+++.+-||.-..   .....|..|.+-|+.|.   --.+.+++++....+. .+||+|
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEEE
Confidence            3445789999999999877  4577899998763   23346778888777773   3456677776554333 589999


Q ss_pred             ccCCC
Q 017411          261 YVSGG  265 (372)
Q Consensus       261 y~~~g  265 (372)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.70  E-value=0.14  Score=49.43  Aligned_cols=32  Identities=19%  Similarity=0.313  Sum_probs=28.4

Q ss_pred             CCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ..+++|+|+.+.|||++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34699999999999999999999999988864

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.63  E-value=0.068  Score=53.67  Aligned_cols=75  Identities=21%  Similarity=0.183  Sum_probs=49.5

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecC------CChhhHHHHHHHHHHHHhCC--CC-CeeceeeeEEcCCCeEEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLH--HP-NIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~------~~~~~~~~~~~Ev~iL~~l~--Hp-nIv~l~g~~~~~~~~~~l  257 (372)
                      .+.||.|.-..||++.+...++.|+||.-..      .-+-...+..-|.+.|+...  -| .+.+++.+  +++. ..+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~-~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVM-NCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHH-hhH
Confidence            4789999999999999753356799996432      11233455566777777653  34 45556653  4443 469


Q ss_pred             EEeccCC
Q 017411          258 IYKYVSG  264 (372)
Q Consensus       258 V~Ey~~~  264 (372)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999964

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.60  E-value=0.037  Score=54.74  Aligned_cols=76  Identities=20%  Similarity=0.223  Sum_probs=55.1

Q ss_pred             cCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcE
Q 017411          250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       250 ~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                      +...+.|++|++- |+++.. +          ..-.|.+...++.+.+.-+.-+..  ..+.=|||+...||||+ +|++
T Consensus       296 de~~y~yl~~kdh-gt~is~-i----------k~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~Gnv  360 (488)
T COG5072         296 DETLYLYLHFKDH-GTPISI-I----------KADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNV  360 (488)
T ss_pred             CCceEEEEEEecC-Cceeee-e----------ecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCce
Confidence            3344467777775 444432 2          234678888888887766665554  34578999999999999 9999


Q ss_pred             EEEeccccccc
Q 017411          330 KLCDFGLATWT  340 (372)
Q Consensus       330 KL~DFGla~~~  340 (372)
                      .|+||-++|.-
T Consensus       361 tLIDfklsRl~  371 (488)
T COG5072         361 TLIDFKLSRLS  371 (488)
T ss_pred             EEEEeeeeecc
Confidence            99999999953

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.50  E-value=0.34  Score=48.92  Aligned_cols=73  Identities=15%  Similarity=0.122  Sum_probs=48.6

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCC----Ch---hhHHHHHHHHHHHHhCC---CCCeeceeeeEEcCCCeEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DK---ESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~----~~---~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+.||.|....||+....  +..|+||+-...    ..   ....+-..|.+.|+.+.   ...+.+++.++.  +. .+
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~-~v  111 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TM-AL  111 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CC-CE
Confidence            478999999999998864  456899986521    11   12334445666666553   347778888764  22 47


Q ss_pred             EEEeccCC
Q 017411          257 LIYKYVSG  264 (372)
Q Consensus       257 lV~Ey~~~  264 (372)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            89999976

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.11  E-value=0.08  Score=53.17  Aligned_cols=59  Identities=29%  Similarity=0.352  Sum_probs=41.6

Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCceEEcCCCCCCEEEc
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NGTERCVVHRDIKPSNILLS  324 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~~~~IiHrDLKp~NILld  324 (372)
                      ..++-+|+.|.++..++...        ..++....+++.--+.|+.-+- -.+   .+|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~--------~~pe~l~kkva~lg~~AllkMl~vDN---FvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWK--------SQPEALVKKVAKLGVNALLKMLIVDN---FVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcc--------cChHHHHHHHHHHHHHHHHHHHHhhc---ceecccCCCcEEEE
Confidence            45777899999999998764        3455556666655555554332 233   89999999999995

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.84  E-value=0.27  Score=48.99  Aligned_cols=140  Identities=14%  Similarity=0.126  Sum_probs=89.9

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCC------------------------Chh-hHH-HHHHHHHHHHhCCCCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------------------------DKE-SSK-AFCRELMIASSLHHPN  240 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~------------------------~~~-~~~-~~~~Ev~iL~~l~Hpn  240 (372)
                      .-+|..|--+-||.+... .|..+|||+.+..                        .+. ..+ ....|++-|.+|....
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            357888999999998765 4778999987531                        011 111 1235788888876555


Q ss_pred             eeceeeeEEcCCCeEEEEEeccCCCC-HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCC
Q 017411          241 IVPLVGFCIDPEQGLFLIYKYVSGGS-LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (372)
Q Consensus       241 Iv~l~g~~~~~~~~~~lV~Ey~~~gs-L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~  319 (372)
                      |...--...  .+ ..|||+|+..-. ..-.|+.        ..++...+..+-.|++.-+.-|-..+  .+||.||.-=
T Consensus       228 IP~PePIlL--k~-hVLVM~FlGrdgw~aPkLKd--------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEf  294 (520)
T KOG2270|consen  228 IPCPEPILL--KN-HVLVMEFLGRDGWAAPKLKD--------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEF  294 (520)
T ss_pred             CCCCCceee--ec-ceEeeeeccCCCCcCccccc--------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhh
Confidence            433222211  11 369999995321 1222221        45666667777777777777776554  3999999999


Q ss_pred             CEEEcCCCcEEEEecccccccC
Q 017411          320 NILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~  341 (372)
                      |+|+ .+|.+.|+|.+-+....
T Consensus       295 N~Ly-hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  295 NLLY-HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hheE-ECCEEEEEEccccccCC
Confidence            9999 56789999987765443

>PRK06148 hypothetical protein; Provisional

Probab=94.40  E-value=0.94  Score=51.10  Aligned_cols=31  Identities=35%  Similarity=0.453  Sum_probs=25.9

Q ss_pred             CceEEcCCCCCCEEEcCCC--cEE-EEecccccc
Q 017411          309 RCVVHRDIKPSNILLSSKK--IPK-LCDFGLATW  339 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~--~~K-L~DFGla~~  339 (372)
                      ..+||.|+.+.|||++.++  ++. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4599999999999999875  554 999998753

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.21  E-value=0.77  Score=45.09  Aligned_cols=145  Identities=19%  Similarity=0.256  Sum_probs=78.0

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCC---eeceeeeEE-cCC--CeEEEEE
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPN---IVPLVGFCI-DPE--QGLFLIY  259 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---Hpn---Iv~l~g~~~-~~~--~~~~lV~  259 (372)
                      .|.+ .-..||+.....  ..+++|+....  ....++..|...|..|.   .+=   |..+-|-.. .-.  .+.+-++
T Consensus        33 ~l~s-~eN~~f~~~~~~--g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          33 GLNS-EENSNFRVQTED--GRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             cccc-ccCceEEEEecC--CCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            3444 445688887653  34488888765  33345566676666652   111   222212111 012  2577899


Q ss_pred             eccCCCCHHH------------H---HHhhccCC----CC-CCCCCHHH-------------HHHHHHHHHHHHHHHHcC
Q 017411          260 KYVSGGSLER------------H---LHEKKKGV----RG-NSTLPWSV-------------RYKVALGIAESVAYLHNG  306 (372)
Q Consensus       260 Ey~~~gsL~~------------~---L~~~~~~~----~~-~~~l~~~~-------------~~~i~~qia~gL~yLH~~  306 (372)
                      +|++|..+..            .   ++......    .. .....|..             ......++...+..+...
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999877772            1   11111111    11 11334431             011223344444444422


Q ss_pred             C----CCc---eEEcCCCCCCEEEcCCCc-EEEEeccccc
Q 017411          307 T----ERC---VVHRDIKPSNILLSSKKI-PKLCDFGLAT  338 (372)
Q Consensus       307 ~----~~~---IiHrDLKp~NILld~~~~-~KL~DFGla~  338 (372)
                      -    ...   |||.|+.|.||+++.+.. +.++||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            1    112   899999999999998874 8999999875

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=94.18  E-value=0.25  Score=45.98  Aligned_cols=102  Identities=15%  Similarity=0.119  Sum_probs=65.8

Q ss_pred             EEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHH
Q 017411          209 SVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS  287 (372)
Q Consensus       209 ~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~  287 (372)
                      +..+|++..-... ...-|..+.++++++.  .|+++..   +.....-++.|+|-...                .++- 
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~----------------i~~~-  144 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIK----------------INFS-  144 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCcc----------------cchh-
Confidence            3445555443333 3445678888988876  4777763   33344668999883210                1110 


Q ss_pred             HHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       288 ~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                         .++.-=+.+|.-.|+.. ...+|+|..|+||+-|..|.+||.|=+.
T Consensus       145 ---N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  145 ---NFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             ---HHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence               11111246778888654 4489999999999999999999999663

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=94.16  E-value=0.68  Score=46.37  Aligned_cols=75  Identities=21%  Similarity=0.268  Sum_probs=42.9

Q ss_pred             eeEcccCceEEEEEEECCCC-e-----EEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeec-eeeeEEcCCCeEEEEEe
Q 017411          188 RVLGRGALSFVFKGKVGLLR-T-----SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP-LVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~-~-----~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~-l~g~~~~~~~~~~lV~E  260 (372)
                      +.|..|-...+|++...... .     .|.++...... ...-.-.+|+++++.+...++.+ +++.+ .  +  ++++|
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-~--~--g~l~e  129 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRF-G--D--FTIQE  129 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEec-C--C--EEEEE
Confidence            45656778889998754321 1     24444322211 11112246888998886555544 44443 2  2  58999


Q ss_pred             ccCCCCHH
Q 017411          261 YVSGGSLE  268 (372)
Q Consensus       261 y~~~gsL~  268 (372)
                      |++|-+|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99886654

>PRK11768 serine/threonine protein kinase; Provisional

Probab=93.98  E-value=1.7  Score=42.25  Aligned_cols=29  Identities=31%  Similarity=0.397  Sum_probs=24.4

Q ss_pred             CceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      .++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4589999999999995 4 578999998763

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=93.41  E-value=0.021  Score=58.23  Aligned_cols=72  Identities=25%  Similarity=0.412  Sum_probs=60.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      ..++|..+..+|.|+||+|+.+....++..+|||++... ......+.++|+.-+.++.|++++.+...+...
T Consensus        47 ~a~~~e~~~~~~~~g~~~~~~~~n~~d~~~~avkritlkn~e~s~~rvl~~~~s~a~feh~g~~~~~ha~~~~  119 (516)
T KOG1033|consen   47 EANDFEPGQCLGRGGFGVVFSAQNKADENKYAVKRITLKNREESRSRVLREVSSLAEFEHPGIKRYFHAWYER  119 (516)
T ss_pred             hhccccccccccccCccccCCccccccchhhHHHHhcccchhhhhhhhhccccchhhhcccchhhheeceecC
Confidence            456899999999999999999998877778999998754 344556788999999999999999987766543

>PTZ00296 choline kinase; Provisional

Probab=92.75  E-value=1.4  Score=45.04  Aligned_cols=75  Identities=16%  Similarity=0.147  Sum_probs=43.7

Q ss_pred             ceeEcccCceEEEEEEECC--------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCee-ceeeeEEcCCCeEEE
Q 017411          187 GRVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV-PLVGFCIDPEQGLFL  257 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv-~l~g~~~~~~~~~~l  257 (372)
                      .+.|..|---.+|+.....        .++.|.+++.-....... .-.+|..+++.+....|- ++++.+ . +   +.
T Consensus       110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f-~-g---g~  183 (442)
T PTZ00296        110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTF-S-G---GR  183 (442)
T ss_pred             EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEe-C-C---CE
Confidence            4566666666888876542        145788887755432222 234577777776544443 344543 2 2   36


Q ss_pred             EEeccCCCCH
Q 017411          258 IYKYVSGGSL  267 (372)
Q Consensus       258 V~Ey~~~gsL  267 (372)
                      |.||++|-+|
T Consensus       184 I~efi~g~~l  193 (442)
T PTZ00296        184 IEEWLYGDPL  193 (442)
T ss_pred             EEEeeCCccC
Confidence            7999987644

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=91.78  E-value=0.17  Score=53.52  Aligned_cols=46  Identities=28%  Similarity=0.502  Sum_probs=38.9

Q ss_pred             HHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       295 qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      +++.|+.|+|..  ..+||++|.|++|.++..+..||+.|+.+.....
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~  152 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG  152 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCC
Confidence            345899999974  3599999999999999999999999998765543

>PRK10271 thiK thiamine kinase; Provisional

Probab=90.50  E-value=0.24  Score=44.67  Aligned_cols=29  Identities=24%  Similarity=0.342  Sum_probs=25.5

Q ss_pred             ceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          310 CVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       310 ~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ..+|+|+.|.||++++++ ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            369999999999998877 89999999864

>PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli []

Probab=89.96  E-value=0.16  Score=42.17  Aligned_cols=44  Identities=16%  Similarity=0.167  Sum_probs=34.0

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHh
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS  235 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~  235 (372)
                      +.||.|+.|.||+|++.. |+.||||+.++.   ..+.+...+.+|+.
T Consensus        17 ~PlasASiaQVh~a~l~~-g~~VaVKV~rP~---i~~~i~~Dl~~l~~   60 (119)
T PF03109_consen   17 EPLASASIAQVHRARLKD-GEEVAVKVQRPG---IEEQIEADLRILRR   60 (119)
T ss_pred             chhhheehhhheeeeecc-cchhhhhhcchH---HHHHHHHHHHHHHH
Confidence            789999999999999875 899999998653   33455556666554

These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins.

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=89.55  E-value=8.6  Score=36.16  Aligned_cols=75  Identities=15%  Similarity=0.251  Sum_probs=44.1

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC---CCCCeeceeeeEEcCCCeEEEEEeccCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL---HHPNIVPLVGFCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~~~~~~~lV~Ey~~~  264 (372)
                      +.+.-|.--..|+..+.  ..++-||+-.   ......|..|+.-|..+   +--.+.+++.+-.+ ....|+|+||++-
T Consensus        22 ~~v~gG~inea~~v~dg--~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~-~~~sylVle~L~~   95 (286)
T COG3001          22 EEVSGGDINEAWRLRDG--TDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGAS-RDHSYLVLEYLPT   95 (286)
T ss_pred             cccCCccccceeEeecC--CcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCC-CCeeEEEEeeccC
Confidence            34444444444554443  4567777643   33445677887665555   33456666655444 3447999999987


Q ss_pred             CCHH
Q 017411          265 GSLE  268 (372)
Q Consensus       265 gsL~  268 (372)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	372
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-23
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-22
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-22
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-22
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		9e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-17
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-17
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-14
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-13
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-12
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-12
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-12
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-12
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-12
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-12
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		5e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		6e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-11
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-11
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-11
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-11
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-10
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-10
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-10
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-10
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-10
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-10
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-10
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-10
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-10
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-10
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-10
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		4e-10
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-10
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-10
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		4e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-10
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-10
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		5e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-10
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-10
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-10
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-10
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		7e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		8e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		8e-10
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		9e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-10
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		9e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		9e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		9e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		9e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		9e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		9e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-09
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-09
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-09
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-09
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-09
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-09
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-09
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-09
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-09
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-09
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-09
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-09
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-09
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-09
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		6e-09
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-09
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		7e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		7e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-09
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-09
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		8e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-09
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-08
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-08
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-08
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-08
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-08
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-08
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-08
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-08
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-08
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		3e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-08
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		3e-08
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-08
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-08
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		5e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		5e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		6e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		7e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-08
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		8e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		9e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-07
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-07
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-07
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		3e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		4e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-07
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		4e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		4e-07
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-07
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		4e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-07
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-07
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-07
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-07
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-07
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-07
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-07
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		6e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-07
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-07
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-07
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-07
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-07
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-07
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-07
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-07
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		8e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-07
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		8e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-07
3soa_A	444	Full-Length Human Camkii Length = 444		9e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-07
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-07
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-07
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		9e-07
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		9e-07
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-07
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		9e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-07
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-07
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-06
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-06
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		1e-06
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-06
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-06
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-06
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-06
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-06
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-06
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-06
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-06
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-06
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-06
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-06
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-06
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-06
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-06
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		5e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		5e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-06
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		7e-06
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		7e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		7e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		7e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		7e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		7e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		7e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-06
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		8e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		9e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		9e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-05
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-05
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-05
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-05
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-05
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-05
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-05
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-05
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-05
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-05
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-05
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-05
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		4e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-05
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		4e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-05
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-05
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-05
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-05
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		5e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-05
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-05
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-05
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-05
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		6e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-05
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-05
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		9e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-04
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-04
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-04
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-04
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-04
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		4e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-04
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		5e-04
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		5e-04
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-04
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-04
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-04
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-04
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-04
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-04
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 68/191 (35%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 168 SLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AF 226
            L R S  E+  A+ NFS   +LGRG    V+KG++    T VA+KRL +E  +  +  F
Sbjct: 24  QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEERXQGGELQF 82
Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
             E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L W
Sbjct: 83  QTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPLDW 138
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
             R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA         
Sbjct: 139 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX- 197
Query: 347 FLCKTVKGTFG 357
            +   V+GT G
Sbjct: 198 HVXXAVRGTIG 208

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCR 228
           R+   ++  AT+NF    ++G G    V+KG   +LR    VA+KR   E  +  + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG---VLRDGAKVALKRRTPESSQGIEEFET 84
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--- 285
           E+   S   HP++V L+GFC D    + LIYKY+  G+L+RHL+         S LP   
Sbjct: 85  EIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 286 --WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             W  R ++ +G A  + YLH    R ++HRD+K  NILL    +PK+ DFG++   +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 344 SVPFLCKTVKGTFG 357
               L   VKGT G
Sbjct: 193 DQTHLXXVVKGTLG 206

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 22/194 (11%)
Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCR 228
           R+   ++  AT+NF    ++G G    V+KG   +LR    VA+KR   E  +  + F  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKG---VLRDGAKVALKRRTPESSQGIEEFET 84
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--- 285
           E+   S   HP++V L+GFC D    + LIYKY+  G+L+RHL+         S LP   
Sbjct: 85  EIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLY--------GSDLPTMS 135
Query: 286 --WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             W  R ++ +G A  + YLH    R ++HRD+K  NILL    +PK+ DFG++   +  
Sbjct: 136 MSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 344 SVPFLCKTVKGTFG 357
               L   VKGT G
Sbjct: 193 GQTHLXXVVKGTLG 206

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/174 (36%), Positives = 97/174 (55%), Gaps = 10/174 (5%)
Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKEDKESSK 224
             L R S  E+  A+ NF    +LGRG    V+KG++  G L   VA+KRL +E  +  +
Sbjct: 15  GQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL---VAVKRLKEERTQGGE 71
Query: 225 -AFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             F  E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       
Sbjct: 72  LQFQTEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPP 127
Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           L W  R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA
Sbjct: 128 LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 127
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 342 APSVPFLCKTVKGT 355
             +   +   + GT
Sbjct: 185 KFAQTVMXXRIVGT 198

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 72
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 127
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 342 APSVPFLCKTVKGT 355
             +   +   + GT
Sbjct: 185 KFAQTVMXSRIVGT 198

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 20/194 (10%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G  +G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 66
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y+  GSL   L      + G 
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYMPNGSLLDRL----SCLDGT 121
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             L W +R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA  + 
Sbjct: 122 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 178
Query: 342 APSVPFLCKTVKGT 355
             +   +   + GT
Sbjct: 179 KFAQXVMXXRIVGT 192

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 59/153 (38%), Positives = 83/153 (54%), Gaps = 18/153 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G C
Sbjct: 16  VVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---ALGIAESVAYLHN 305
           ++P   + L+ +Y  GGSL   LH       G   LP+          L  ++ VAYLH+
Sbjct: 72  LNP---VCLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 121
Query: 306 GTERCVVHRDIKPSNILL-SSKKIPKLCDFGLA 337
              + ++HRD+KP N+LL +   + K+CDFG A
Sbjct: 122 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 154

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/153 (38%), Positives = 83/153 (54%), Gaps = 18/153 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G C
Sbjct: 15  VVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---ALGIAESVAYLHN 305
           ++P   + L+ +Y  GGSL   LH       G   LP+          L  ++ VAYLH+
Sbjct: 71  LNP---VCLVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 306 GTERCVVHRDIKPSNILL-SSKKIPKLCDFGLA 337
              + ++HRD+KP N+LL +   + K+CDFG A
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/176 (35%), Positives = 87/176 (49%), Gaps = 20/176 (11%)
Query: 172 LSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKE 221
            S+ E+   T+NF +      G   G G    V+KG V    T+VA+K+L    D   +E
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEE 63
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F +E+ + +   H N+V L+GF  D +  L L+Y Y   GSL   L      + G 
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDD-LCLVYVYXPNGSLLDRL----SCLDGT 118
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             L W  R K+A G A  + +LH   E   +HRDIK +NILL      K+ DFGLA
Sbjct: 119 PPLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLA 171

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/147 (38%), Positives = 77/147 (52%), Gaps = 8/147 (5%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID 250
           GA SF    +     + VA+K L ++D   E    F RE+ I   L HPNIV  +G    
Sbjct: 46  GAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 310
           P   L ++ +Y+S GSL R LH  K G R    L    R  +A  +A+ + YLHN     
Sbjct: 106 PPN-LSIVTEYLSRGSLYRLLH--KSGAR--EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 311 VVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +VHRD+K  N+L+  K   K+CDFGL+
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 84/160 (52%), Gaps = 22/160 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESSKAFCRELMIASSLHHPNIV 242
           +G+G    V KG++   ++ VAIK L       + E  E  + F RE+ I S+L+HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++ L IA  + Y
Sbjct: 87  KLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRLMLDIALGIEY 137
Query: 303 LHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLA 337
           + N     +VHRD++  NI L S  +  P   K+ DFGL+
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 16/159 (10%)
Query: 184 FSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHH 238
             + +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ H
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++V L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA+
Sbjct: 77  PHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAK 128
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + YL    ER +VHRD+   N+L+ S    K+ DFGLA
Sbjct: 129 GMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 164

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/147 (37%), Positives = 77/147 (52%), Gaps = 8/147 (5%)
Query: 193 GALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCID 250
           GA SF    +     + VA+K L ++D   E    F RE+ I   L HPNIV  +G    
Sbjct: 46  GAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC 310
           P   L ++ +Y+S GSL R LH  K G R    L    R  +A  +A+ + YLHN     
Sbjct: 106 PPN-LSIVTEYLSRGSLYRLLH--KSGAR--EQLDERRRLSMAYDVAKGMNYLHNRNP-P 159
Query: 311 VVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +VHR++K  N+L+  K   K+CDFGL+
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLS 186

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 85/160 (53%), Gaps = 16/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH 237
              + +VLG GA   V+KG    +   ++  VAIK L++    +++  F  E +I +S+ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP++V L+G C+ P   + L+ + +  G L  ++HE K  +     L W V+      IA
Sbjct: 99  HPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IA 150
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + + YL    ER +VHRD+   N+L+ S    K+ DFGLA
Sbjct: 151 KGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA 187

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 82/158 (51%), Gaps = 22/158 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESSKAFCRELMIASSLHHPNIV 242
           +G+G    V KG++   ++ VAIK L       + E  E  + F RE+ I S+L+HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++ L IA  + Y
Sbjct: 87  KLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRLMLDIALGIEY 137
Query: 303 LHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFG 335
           + N     +VHRD++  NI L S  +  P   K+ DFG
Sbjct: 138 MQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 83/160 (51%), Gaps = 22/160 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL-------DKEDKESSKAFCRELMIASSLHHPNIV 242
           +G+G    V KG++   ++ VAIK L       + E  E  + F RE+ I S+L+HPNIV
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G   +P +   ++ ++V  G L   L +K   ++      WSV+ ++ L IA  + Y
Sbjct: 87  KLYGLMHNPPR---MVMEFVPCGDLYHRLLDKAHPIK------WSVKLRLMLDIALGIEY 137
Query: 303 LHNGTERCVVHRDIKPSNILLSS--KKIP---KLCDFGLA 337
           + N     +VHRD++  NI L S  +  P   K+ DF L+
Sbjct: 138 MQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS 176

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/165 (34%), Positives = 83/165 (50%), Gaps = 19/165 (11%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+   YK  L +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKDLYKDFLTLEHL 146
Query: 300 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 147 ICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLA 191

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 83/162 (51%), Gaps = 20/162 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G +S V+  +  +L   VAIK +    +E +E+ K F RE+  +S L H NIV ++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 247 FCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESVAYL 303
             +D E    +L+ +Y+ G +L  ++          S  P SV   +     I + + + 
Sbjct: 79  --VDEEDDCYYLVMEYIEGPTLSEYIE---------SHGPLSVDTAINFTNQILDGIKHA 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           H+     +VHRDIKP NIL+ S K  K+ DFG+A   S  S+
Sbjct: 128 HD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 3   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 292
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 63  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 160

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 292
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 111
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 112 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 159

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 10/151 (6%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           G VLG+G      K         + +K L + D+E+ + F +E+ +   L HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             +  ++ L  I +Y+ GG+L   +         +S  PWS R   A  IA  +AYLH+ 
Sbjct: 75  -VLYKDKRLNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               ++HRD+   N L+   K   + DFGLA
Sbjct: 128 N---IIHRDLNSHNCLVRENKNVVVADFGLA 155

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L+++         H+H+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFE---------HVHQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 18/171 (10%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L    NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKV 292
           L+HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +    
Sbjct: 63  LNHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSY 112
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
              + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 LFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 160

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 16/163 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   +G G    V+K K    R  VA+KR  LD ED+       RE+ +   LHHPNI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESV 300
           V L+   I  E+ L L+++++    L++ L E K G++ +         K+ L  +   V
Sbjct: 82  VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQI-------KIYLYQLLRGV 132
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           A+ H   +  ++HRD+KP N+L++S    KL DFGLA     P
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 16/163 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNI 241
           + K   +G G    V+K K    R  VA+KR  LD ED+       RE+ +   LHHPNI
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAESV 300
           V L+   I  E+ L L+++++    L++ L E K G++ +       + K+ L  +   V
Sbjct: 82  VSLID-VIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDS-------QIKIYLYQLLRGV 132
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           A+ H   +  ++HRD+KP N+L++S    KL DFGLA     P
Sbjct: 133 AHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLH 237
           +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVAL 294
           HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +      
Sbjct: 61  HPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLF 110
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 111 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP 156

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 82/168 (48%), Gaps = 12/168 (7%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L+HPNIV L+   I  E  L+L+++++S         +K       + +P  +       
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEFLSMDL------KKFMDASALTGIPLPLIKSYLFQ 114
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 115 LLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP 159

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 157

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKTFMDASALTGIPLPLIKSYL 112
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 159

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 157

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 111 FQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP 157

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 71  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 121 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 163

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 65  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 115 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 157

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 158

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 112
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 159

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 158

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 18/170 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 2   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 61
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVA 293
           +HPNIV L+   I  E  L+L++++         LH+  K     S L   P  +     
Sbjct: 62  NHPNIVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYL 111
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
             + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 112 FQLLQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP 158

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 71  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 121 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 163

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 146
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 147 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 183
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 184 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 232

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 27  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 137
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
               VHRD+   N+L+S   + K+ DFGL    S+
Sbjct: 138 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/169 (34%), Positives = 84/169 (49%), Gaps = 23/169 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR----YKVALG 295
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+ V     YK  L 
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKR-----NEFVPYKVAPEDLYKDFLT 137
Query: 296 IAESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +   + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 138 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 186

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 12/149 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 199 QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 309
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
               VHRD+   N+L+S   + K+ DFGL
Sbjct: 310 ---FVHRDLAARNVLVSEDNVAKVSDFGL 335

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 12  QTIGKGEFGDVMLGDYR--GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 122
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
               VHRD+   N+L+S   + K+ DFGL    S+
Sbjct: 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 78/149 (52%), Gaps = 12/149 (8%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           + +G+G    V  G        VA+K +  ++  +++AF  E  + + L H N+V L+G 
Sbjct: 18  QTIGKGEFGDVMLGD--YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            ++ + GL+++ +Y++ GSL  +L  + + V G   L      K +L + E++ YL    
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-----LKFSLDVCEAMEYLEGNN 128
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
               VHRD+   N+L+S   + K+ DFGL
Sbjct: 129 ---FVHRDLAARNVLVSEDNVAKVSDFGL 154

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 1   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 60
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L+HPNIV L+   I  E  L+L+++++S   ++         + G   +P  +       
Sbjct: 61  LNHPNIVKLLD-VIHTENKLYLVFEFLS---MDLKDFMDASALTG---IPLPLIKSYLFQ 113
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 158

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 23  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 83  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 134
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 135 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 187

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 1   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 60
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           +HPNIV L+   I  E  L+L+++++S         +K       + +P  +       +
Sbjct: 61  NHPNIVKLLD-VIHTENKLYLVFEFLSMDL------KKFMDASALTGIPLPLIKSYLFQL 113
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 LQGLAFCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP 157

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 12/168 (7%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           L +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   
Sbjct: 2   LGSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 61
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L+HPNIV L+   I  E  L+L+++++S   ++         + G   +P  +       
Sbjct: 62  LNHPNIVKLLD-VIHTENKLYLVFEFLS---MDLKDFMDASALTG---IPLPLIKSYLFQ 114
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 115 LLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 159

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +++ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLSFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 119
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 172

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 83/167 (49%), Gaps = 21/167 (12%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKVALGIA 297
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+     YK  L + 
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKPEDLYKDFLTLE 148
Query: 298 ESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 149 HLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/168 (33%), Positives = 83/168 (49%), Gaps = 22/168 (13%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---YKVALGI 296
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+      YK  L +
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKTPEDLYKDFLTL 147
Query: 297 AESVAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 173

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 63  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 114
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 115 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 167

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 170

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 82/165 (49%), Gaps = 19/165 (11%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N+V L+G C  P   L +I ++   G+L  +L  K+     N  +P+   YK  L +   
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKR-----NEFVPYKDLYKDFLTLEHL 146
Query: 300 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + Y   +  G E    R  +HRD+   NILLS K + K+ DFGLA
Sbjct: 147 IXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLA 191

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTL 171

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 143
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 196

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSL 236
            +  NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L
Sbjct: 3   GSMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 62
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST--LPWSVRYKVAL 294
           +HPNIV L+   I  E  L+L++++V          + KK +  ++   +P  +      
Sbjct: 63  NHPNIVKLLD-VIHTENKLYLVFEHVD--------QDLKKFMDASALTGIPLPLIKSYLF 113
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            + + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 159

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 173

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 81/165 (49%), Gaps = 15/165 (9%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N+V L+G C  P   L +I ++   G+L  +L  K+         P  + YK  L +   
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDL-YKDFLTLEHL 152
Query: 300 VAY---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + Y   +  G E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 153 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 197

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTL 170

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 65  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 116
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 117 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 169

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTL 170

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+   RLD E +       RE+ +   L+HPN
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 64  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 114 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 156

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+   RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL---PWSVRYKVALGIA 297
           IV L+   I  E  L+L++++         LH+  K     S L   P  +       + 
Sbjct: 63  IVKLLD-VIHTENKLYLVFEF---------LHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + +A+ H+     V+HRD+KP N+L++++   KL DFGLA     P
Sbjct: 113 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 170

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 171

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 70  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 121
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 122 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 174

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 170

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 170

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTL 175

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 92  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 143
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 144 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL 196

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL 173

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 66  RHPNILRLYGYFHDSTR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 118 ANALSYCHS---KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G + + L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNI 241
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 242 VPL-VGFCIDPEQGLFLIYKYVSGGS---LERHL---HEKKKGVRGNSTLPWSVRYKVAL 294
           V     F +  E  L+L+ K +SGGS   + +H+    E K GV   ST+   +R     
Sbjct: 76  VSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 129
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            + E + YLH   +   +HRD+K  NILL      ++ DFG++ + +
Sbjct: 130 -VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLA 172

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 245
           G  +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG-IAESVAYLH 304
           G C   +Q ++++ + V GG     L  + +G R        +R K  L  + ++ A + 
Sbjct: 179 GVCTQ-KQPIYIVMELVQGGDFLTFL--RTEGAR--------LRVKTLLQMVGDAAAGME 227
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               +C +HRD+   N L++ K + K+ DFG++
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 68  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 119
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ +FG +    +     LC T+
Sbjct: 120 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 172

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 13/153 (8%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVPLV 245
           G  +GRG    VF G++    T VA+K   +      KA F +E  I     HPNIV L+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG-IAESVAYLH 304
           G C   +Q ++++ + V GG     L  + +G R        +R K  L  + ++ A + 
Sbjct: 179 GVCTQ-KQPIYIVMELVQGGDFLTFL--RTEGAR--------LRVKTLLQMVGDAAAGME 227
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               +C +HRD+   N L++ K + K+ DFG++
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 83/169 (49%), Gaps = 18/169 (10%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 67  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 118
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPS 344
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG   W+  APS
Sbjct: 119 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFG---WSCHAPS 161

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNI 241
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 70
Query: 242 VPL-VGFCIDPEQGLFLIYKYVSGGS---LERHL---HEKKKGVRGNSTLPWSVRYKVAL 294
           V     F +  E  L+L+ K +SGGS   + +H+    E K GV   ST+   +R     
Sbjct: 71  VSYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE---- 124
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            + E + YLH   +   +HRD+K  NILL      ++ DFG++ + +
Sbjct: 125 -VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLA 167

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L HP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L G+  D  + ++LI +Y   G++ R L +  +     +             +A +
Sbjct: 73  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           ++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL 174

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 14/176 (7%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G++ R L +  K     +             +
Sbjct: 69  RHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITEL 120
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A +++Y H+   + V+HRDIKP N+LL S    K+ +FG +    +     LC T+
Sbjct: 121 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 173

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L HP
Sbjct: 13  DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L G+  D  + ++LI +Y   G++ R L +  +     +             +A +
Sbjct: 73  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRTA-------TYITELANA 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           ++Y H+   + V+HRDIKP N+LL S    K+ DFG +    +     LC T+
Sbjct: 125 LSYCHS---KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTL 174

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 83/163 (50%), Gaps = 10/163 (6%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 239
           NF   + +GRG  S V++    L    VA+K++   D   +KA     +E+ +   L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++      I+ +  L ++ +    G L R +   KK  R    +P    +K  + +  +
Sbjct: 93  NVIKYYASFIE-DNELNIVLELADAGDLSRMIKHFKKQKR---LIPERTVWKYFVQLCSA 148
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + ++H+   R V+HRDIKP+N+ +++  + KL D GL  + S+
Sbjct: 149 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL 236
           A  +F  GR LG+G    V+  +    +  +A+K L K   E +       RE+ I S L
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L G+  D  + ++LI +Y   G + + L +  K     +             +
Sbjct: 71  RHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRTA-------TYITEL 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPS 344
           A +++Y H+   + V+HRDIKP N+LL S    K+ DFG   W+  APS
Sbjct: 123 ANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFG---WSVHAPS 165

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 73  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           E + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 125 EGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 166

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 86  MGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 137
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADXNIKIADFGFS 160

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 81/161 (50%), Gaps = 21/161 (13%)
Query: 187 GRVLGRGALSFVFK---GKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           G V+    L+FV +   G+ GL+       +  VAIK + +E   S + F  E  +   L
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +V L G C++ +  + L+++++  G L  +L   ++G+    TL       + L +
Sbjct: 60  SHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDV 112
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            E +AYL    E CV+HRD+   N L+   ++ K+ DFG+ 
Sbjct: 113 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMT 150

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 17  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 73
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 74  MGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 125
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 126 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 156

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 23/161 (14%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKESSKAFCRELMIASSLHHPNIVPL 244
           ++G G    V++     +   VA+K      D++  ++ +   +E  + + L HPNI+ L
Sbjct: 14  IIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G C+  E  L L+ ++  GG L R L  K+        +P  +    A+ IA  + YLH
Sbjct: 72  RGVCLK-EPNLCLVMEFARGGPLNRVLSGKR--------IPPDILVNWAVQIARGMNYLH 122
Query: 305 NGTERCVVHRDIKPSNILLSSK--------KIPKLCDFGLA 337
           +     ++HRD+K SNIL+  K        KI K+ DFGLA
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           ++G G+   V K +       VAIK+     +DK   K   RE+ +   L H N+V L+ 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C   ++  +L++++V    L+  L     G      L + V  K    I   + + H+ 
Sbjct: 92  VC-KKKKRWYLVFEFVDHTILD-DLELFPNG------LDYQVVQKYLFQIINGIGFCHSH 143
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
               ++HRDIKP NIL+S   + KLCDFG A   +AP 
Sbjct: 144 N---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A  + YLH
Sbjct: 86  MGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLI------DIARQTARGMDYLH 137
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 138 ---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 77  NPHVCRLLGICLT--STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 129 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 170

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
              K +VLG G    V KG    +   ++  V IK + DK  ++S +A    ++   SL 
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W V+      IA
Sbjct: 74  HAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + + YL    E  +VHR++   N+LL S    ++ DFG+A
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVA 162

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR-LDKEDKESSKAFC-RELMIASSLHHPNIVPLVGF 247
           +G G+   VFK +       VAIK+ L+ ED    K    RE+ +   L HPN+V L+  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE- 69
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
               ++ L L+++Y     L    HE  +  RG   +P  +   +     ++V + H   
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL----HELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN 122
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
               +HRD+KP NIL++   + KLCDFG A   + PS
Sbjct: 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
              K +VLG G    V KG    +   ++  V IK + DK  ++S +A    ++   SL 
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 91
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W V+      IA
Sbjct: 92  HAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ------IA 143
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + + YL    E  +VHR++   N+LL S    ++ DFG+A
Sbjct: 144 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVA 180

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VAIK +DK   +  S +   RE+ I   L+HPN
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 298
           IV L    I+ E+ L+LI +Y SGG +  +L  H + K     S             I  
Sbjct: 76  IVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---------IVS 125
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 126 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 161

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 76  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 77  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 128
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 129 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 170

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 78/159 (49%), Gaps = 17/159 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VAIK +DK   +  S +   RE+ I   L+HPN
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 298
           IV L    I+ E+ L+LI +Y SGG +  +L  H + K     S             I  
Sbjct: 73  IVKLFE-VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ---------IVS 122
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS 158

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + KE   S   F  E  +   L HP +V L G C+
Sbjct: 35  IGSGQFGLVHLG-YWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 93  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 142
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
           CV+HRD+   N L+   ++ K+ DFG+  + 
Sbjct: 143 CVIHRDLAARNCLVGENQVIKVSDFGMTRFV 173

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 80  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 132 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 173

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 101 NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 152
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 153 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 194

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 79  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 76  NPHVCRLLGICLT--STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 78  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 171

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA++ +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA++ +DK    SS  +   RE+ I   L+HPN
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 75  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 122
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 123 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 160

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 13  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 71  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 120
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           CV+HRD+   N L+   ++ K+ DFG+ 
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMT 148

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 82  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 133
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 134 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 175

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 79  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK    SS  +   RE+ I   L+HPN
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 68  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-----------QI 115
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL +    K+ DFG +
Sbjct: 116 VSAVQYCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS 153

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 86  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 137
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 138 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 179

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 18  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+++++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 76  E-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 125
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           CV+HRD+   N L+   ++ K+ DFG+ 
Sbjct: 126 CVIHRDLAARNCLVGENQVIKVSDFGMT 153

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 79  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 78  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 171

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 83  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 76  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 79  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 130
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 131 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 172

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 70  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 121
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 122 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 76  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 82/152 (53%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--FCRELMIASSLH-HPNIVPLVG 246
           LG+GA   V+K         VA+K++    + S+ A    RE+MI + L  H NIV L+ 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 247 FC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D ++ ++L++ Y     +E  LH     +R N   P   +Y V   + + + YLH+
Sbjct: 77  VLRADNDRDVYLVFDY-----METDLH---AVIRANILEPVHKQY-VVYQLIKVIKYLHS 127
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           G    ++HRD+KPSNILL+++   K+ DFGL+
Sbjct: 128 GG---LLHRDMKPSNILLNAECHVKVADFGLS 156

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           N+   + +G+G  + V   +  L    VA+K +DK   +  S +   RE+ I   L+HPN
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS----LERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           IV L    I+ E+ L+L+ +Y SGG     L  H   K+K  R                I
Sbjct: 76  IVKLFE-VIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-----------QI 123
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +V Y H   ++ +VHRD+K  N+LL      K+ DFG +
Sbjct: 124 VSAVQYCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFS 161

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/165 (33%), Positives = 80/165 (48%), Gaps = 20/165 (12%)
Query: 188 RVLGRGALSFVFKGK-VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLV 245
           RVL  G  +FV++ + VG  R   A+KRL   ++E ++A  +E+     L  HPNIV   
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGR-EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ-- 90
Query: 246 GFCI---------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            FC          D  Q  FL+   +  G L   L  KK   RG   L      K+    
Sbjct: 91  -FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL--KKMESRG--PLSCDTVLKIFYQT 145
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             +V ++H   +  ++HRD+K  N+LLS++   KLCDFG AT  S
Sbjct: 146 CRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVP 243
           RV+G+G    V+ G+       R   AIK L +  + +  +AF RE ++   L+HPN++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+G  + PE    ++  Y+  G L + +   ++    N T+   + +   L +A  + YL
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR----NPTVKDLISF--GLQVARGMEYL 140
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               E+  VHRD+   N +L      K+ DFGLA
Sbjct: 141 ---AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 18/167 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 75
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ +  +  D  + ++L+ ++   G L + L +  +     S          A  + E 
Sbjct: 76  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRS----------ATFMEEL 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSV 345
              LH   ER V+HRDIKP N+L+  K   K+ DFG   W+  APS+
Sbjct: 125 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSL 168

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 363 I 363
           I
Sbjct: 193 I 193

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 81  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 131
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 363 I 363
           I
Sbjct: 192 I 192

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 12/156 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGFC 248
           LG G  + V+KGK  L    VA+K +  E +E +     RE+ +   L H NIV L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI- 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           I  E+ L L+++Y+    L+++L +      GN     +V+      +   +AY H    
Sbjct: 69  IHTEKSLTLVFEYLDK-DLKQYLDDC-----GNIINMHNVKL-FLFQLLRGLAYCHR--- 118
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + V+HRD+KP N+L++ +   KL DFGLA   S P+
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 93  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 143
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 363 I 363
           I
Sbjct: 204 I 204

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 27/171 (15%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  ++G G    VFK K  +   +  IKR+    K +++   RE+   + L H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNIV 67
Query: 243 PL----VGFCIDPEQG-----------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
                  GF  DPE             LF+  ++   G+LE+ + EK++G + +  L   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALE 126
Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           +  ++  G    V Y+H+   + +++RD+KPSNI L   K  K+ DFGL T
Sbjct: 127 LFEQITKG----VDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 363 IE 364
           I+
Sbjct: 196 IK 197

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 86/188 (45%), Gaps = 27/188 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--ESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G G+   V+KGK       VA+K L   D   E  +AF  E+ +     H NI+  +G+
Sbjct: 44  IGSGSFGTVYKGK---WHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
               +  L ++ ++  G SL +HLH ++   +    +       +A   A+ + YLH   
Sbjct: 101 MT--KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLI------DIARQTAQGMDYLH--- 149
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLAT----WTSAP-------SVPFLCKTVKGTF 356
            + ++HRD+K +NI L      K+ DFGLAT    W+ +        SV ++   V    
Sbjct: 150 AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ 209
Query: 357 GQNPFCIE 364
             NPF  +
Sbjct: 210 DNNPFSFQ 217

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 363 I 363
           I
Sbjct: 191 I 191

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 363 I 363
           I
Sbjct: 193 I 193

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 82  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 132
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 363 I 363
           I
Sbjct: 193 I 193

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 363 IE 364
           I+
Sbjct: 196 IK 197

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 363 I 363
           I
Sbjct: 191 I 191

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 363 I 363
           I
Sbjct: 196 I 196

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 363 IE 364
           I+
Sbjct: 191 IK 192

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 84  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 134
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 363 IE 364
           I+
Sbjct: 195 IK 196

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 363 I 363
           I
Sbjct: 191 I 191

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +V L G C+
Sbjct: 16  IGSGQFGLVHLG-YWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + L+ +++  G L  +L   ++G+    TL       + L + E +AYL    E 
Sbjct: 74  E-QAPICLVTEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDVCEGMAYLE---EA 123
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           CV+HRD+   N L+   ++ K+ DFG+ 
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMT 151

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 363 I 363
           I
Sbjct: 191 I 191

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 363 I 363
           I
Sbjct: 196 I 196

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 80  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 363 IE 364
           I+
Sbjct: 191 IK 192

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 15  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 71
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 72  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 123
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 124 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 154

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 18  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 75  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 126
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 157

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 18  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 75  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 126
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 127 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 157

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 81/156 (51%), Gaps = 18/156 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EILEDS-SSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMH- 138
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
             +  +VHRD+KP NILL SK+     K+ DFGL+T
Sbjct: 139 --KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 33  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 89
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 90  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 141
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 142 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 172

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 41  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 98  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 149
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 180

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/183 (34%), Positives = 89/183 (48%), Gaps = 24/183 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           LGRGA S V++ K    +   A+K L K  DK+  +    E+ +   L HPNI+ L    
Sbjct: 61  LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIF 117
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             P + + L+ + V+GG L   + EK  G         +V+      I E+VAYLH   E
Sbjct: 118 ETPTE-ISLVLELVTGGELFDRIVEK--GYYSERDAADAVK-----QILEAVAYLH---E 166
Query: 309 RCVVHRDIKPSNILLSS--KKIP-KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE 365
             +VHRD+KP N+L ++     P K+ DFGL+          L KTV GT G   +C  E
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPG---YCAPE 220
Query: 366 WQR 368
             R
Sbjct: 221 ILR 223

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 41  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 98  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 149
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 150 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 180

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 40  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 96
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 97  MGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 148
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 149 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 179

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 78  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 171

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 16/154 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H NI+  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +        +       +A   A+ + YLH
Sbjct: 70  MGYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLI------DIARQTAQGMDYLH 121
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++HRD+K +NI L      K+ DFGLAT
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 80  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 131
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A
Sbjct: 132 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 173

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 78  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 171

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 83  NPHVCRLLGICLT--STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 13/164 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR---ELMIASSLHHP 239
           +F  G +LG+G+ + V++ +       VAIK +DK+    +    R   E+ I   L HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           +I+ L  +  D    ++L+ +    G + R+L  + K    N    +  +      I   
Sbjct: 72  SILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ------IITG 124
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + YLH+     ++HRD+  SN+LL+     K+ DFGLAT    P
Sbjct: 125 MLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 142
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSA 342
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAI  L +    +++K    E  + +S+ 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVD 109
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 110 NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 161
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 162 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 203

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 84/181 (46%), Gaps = 17/181 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL     +
Sbjct: 78  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLEK---K 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 363 I 363
           I
Sbjct: 189 I 189

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 76  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 169

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 170
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 171 VKIGDFGLT 179

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 132
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 133 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 183
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 184 VKIGDFGLT 192

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 78  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 129
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A
Sbjct: 130 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 171

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 82/179 (45%), Gaps = 27/179 (15%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSKA-FCRELMIASS 235
           +N    R +G GA   VF+ +  GLL     T VA+K L +E     +A F RE  + + 
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH-----------------EKKKGV 278
             +PNIV L+G C    + + L+++Y++ G L   L                    +   
Sbjct: 107 FDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            G   L  + +  +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 221

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 105 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 155
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 156 VKIGDFGLT 164

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 83  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 176

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 106
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 107 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 157
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 158 VKIGDFGLT 166

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VL  GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 76  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 127
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A
Sbjct: 128 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 16/165 (9%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
            F K +VLG GA   V+KG    +   ++  VAIK L +    +++K    E  + +S+ 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +P++  L+G C+     + LI + +  G L  ++ E K  +     L W V+      IA
Sbjct: 83  NPHVCRLLGICLT--STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IA 134
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
           + + YL +   R +VHRD+   N+L+ + +  K+ DFG A    A
Sbjct: 135 KGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGA 176

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 119
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 120 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 170
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 171 VKIGDFGLT 179

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 99
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 100 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 150
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 151 VKIGDFGLT 159

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 153 VKIGDFGLT 161

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 153 VKIGDFGLT 161

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 108
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 109 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 159
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 160 VKIGDFGLT 168

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 100
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 101 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 151
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 152 VKIGDFGLT 160

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+A
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 102 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 152
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 153 VKIGDFGLT 161

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+A
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 107
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 108 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 158
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 159 VKIGDFGLT 167

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 105
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 106 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 156
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 157 VKIGDFGLT 165

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 78/155 (50%), Gaps = 14/155 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTS----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           R LG+G    V   +   L+ +    VA+K+L    +E  + F RE+ I  SL H NIV 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 244 LVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             G C     + L LI +++  GSL  +L + K+ +     L ++ +      I + + Y
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQ------ICKGMEY 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           L  GT+R  +HRD+   NIL+ ++   K+ DFGL 
Sbjct: 133 L--GTKR-YIHRDLATRNILVENENRVKIGDFGLT 164

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL     +
Sbjct: 78  R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLEK---K 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD+   N L+    + K+ DFGL+
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLS 156

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 163
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 55  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 115 YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 165
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSA 342
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A
Sbjct: 166 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 204

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 31  YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 90
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 91  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 140
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+A
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 180

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 80/160 (50%), Gaps = 21/160 (13%)
Query: 187 GRVLGRGALSFVFK---GKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           G V+    L+FV +   G+ GL+       +  VAIK + +E   S + F  E  +   L
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKL 59
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +V L G C++ +  + L+++++  G L  +L   ++G+    TL       + L +
Sbjct: 60  SHPKLVQLYGVCLE-QAPICLVFEFMEHGCLSDYLR-TQRGLFAAETL-----LGMCLDV 112
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            E +AYL    E  V+HRD+   N L+   ++ K+ DFG+
Sbjct: 113 CEGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGM 149

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 86/182 (47%), Gaps = 20/182 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +       VA+K L K   E         RE+ I + LHHP
Sbjct: 24  DFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHP 83
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L  +  D  + ++LI +Y   G L + L +       + T        +   +A++
Sbjct: 84  NILRLYNYFYD-RRRIYLILEYAPRGELYKELQK-------SCTFDEQRTATIMEELADA 135
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSVPFLCKTVKGTFGQ 358
           + Y H    + V+HRDIKP N+LL  K   K+ DFG   W+  APS+    KT+ GT   
Sbjct: 136 LMYCHG---KKVIHRDIKPENLLLGLKGELKIADFG---WSVHAPSL--RRKTMCGTLDY 187
Query: 359 NP 360
            P
Sbjct: 188 LP 189

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/165 (30%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 38  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  FC   ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 98  FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 149
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 150 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 191

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 79
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 80  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 131
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+
Sbjct: 132 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 167

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 56  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 116 YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 166
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSA 342
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A
Sbjct: 167 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 81  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 131
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD+   N L+    + K+ DFGL+
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLS 159

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 85  R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 135
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD+   N L+    + K+ DFGL+
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLS 163

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 287 R-EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 337
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HR++   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 363 IE 364
           I+
Sbjct: 398 IK 399

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 19/162 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI+ L
Sbjct: 38  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y+
Sbjct: 98  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYM 148
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSA 342
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A
Sbjct: 149 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 187

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 29/182 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K    S +AF  E  +  +L H  +V L    +
Sbjct: 21  LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VV 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ +++I +Y++ GSL   L   K    G   LP  + +     IAE +AY+     +
Sbjct: 78  TREEPIYIITEYMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIER---K 129
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------------------TWTSAPSVPFLCKT 351
             +HRD++ +N+L+S   + K+ DFGLA                   WT+  ++ F C T
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 352 VK 353
           +K
Sbjct: 190 IK 191

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 74/148 (50%), Gaps = 10/148 (6%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 78  R-EPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLY-----MATQISSAMEYLE---KK 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD+   N L+    + K+ DFGL+
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLS 156

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 81/156 (51%), Gaps = 18/156 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              ++     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
                +VHRD+KP NILL SK+     K+ DFGL+T
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 64
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 65  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 116
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+
Sbjct: 117 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 152

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 27/179 (15%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIK---RLDKEDKESSK--AFCRELMIASS 235
            N   G+VLG GA   V      G+ +T V+I+   ++ KE  +SS+  A   EL + + 
Sbjct: 45  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN------------- 281
           L  H NIV L+G C      ++LI++Y   G L  +L  K++    +             
Sbjct: 105 LGSHENIVNLLGACT-LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 282 ---STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + L +      A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 81/156 (51%), Gaps = 18/156 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           +LG+G+   V K K  + +   A+K ++K   ++K++S    RE+ +   L HPNI+ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS-TILREVELLKKLDHPNIMKLF 87
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              ++     +++ +  +GG L   + ++K+    ++        ++   +   + Y+H 
Sbjct: 88  EI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
                +VHRD+KP NILL SK+     K+ DFGL+T
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 86/182 (47%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   ++I ++++ G+L  +L E  +       L +     +A  I+ ++ YL    ++
Sbjct: 326 R-EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY-----MATQISSAMEYLE---KK 376
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HR++   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 363 IE 364
           I+
Sbjct: 437 IK 438

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 86/177 (48%), Gaps = 9/177 (5%)
Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           ++++  F +   LG G  + V+KG        VA+K  +LD E+   S A  RE+ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA-IREISLMKE 59
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H NIV L    I  E  L L+++++    L++++  +  G          V+Y     
Sbjct: 60  LKHENIVRLYD-VIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY-FQWQ 116
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           + + +A+ H   E  ++HRD+KP N+L++ +   KL DFGLA     P   F  + V
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV 170

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+     ++HRD+K  NIL +     KL DFG++
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+     ++HRD+K  NIL +     KL DFG++
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 74/155 (47%), Gaps = 24/155 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV L+    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD-AF 103
Query: 250 DPEQGLFLIYKYVSGGS-------LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             E  L+++ ++ +GG+       LER L E +  V    TL             +++ Y
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL-------------DALNY 150
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+     ++HRD+K  NIL +     KL DFG++
Sbjct: 151 LHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS 182

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 15/159 (9%)
Query: 182 HNFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +F   RV+GRG+ + V     K    +    V  K L  +D++       + +   + +
Sbjct: 9   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP +V L   C   E  LF + +YV+GG L  H+  ++K       LP       +  I+
Sbjct: 69  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRK-------LPEEHARFYSAEIS 120
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            ++ YLH   ER +++RD+K  N+LL S+   KL D+G+
Sbjct: 121 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G       +VA+K L KED    + F +E  +   + HPN+V L+G C 
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E   +++ +Y+  G+L  +L E  +       +   V   +A  I+ ++ YL    ++
Sbjct: 99  -LEPPFYIVTEYMPYGNLLDYLRECNR-----EEVTAVVLLYMATQISSAMEYLE---KK 149
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK-TVKGTFGQNPFC 362
             +HRD+   N L+    + K+ DFGL+      T+T+     F  K T   +   N F 
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 363 IE 364
           I+
Sbjct: 210 IK 211

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 64/113 (56%), Gaps = 12/113 (10%)
Query: 226 FCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL 284
             REL +    + P IV   G F  D E  + +  +++ GGSL++ L E K+       +
Sbjct: 61  IIRELQVLHECNSPYIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKEAKR-------I 111
Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           P  +  KV++ +   +AYL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 112 PEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS 162

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 40/184 (21%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  ++G G    VFK K  +   +  I+R+    K +++   RE+   + L H NIV
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRV----KYNNEKAEREVKALAKLDHVNIV 68
Query: 243 PL----VGFCIDPEQG------------------------LFLIYKYVSGGSLERHLHEK 274
                  GF  DPE                          LF+  ++   G+LE+ + EK
Sbjct: 69  HYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EK 127
Query: 275 KKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF 334
           ++G + +  L   +  ++  G    V Y+H+   + ++HRD+KPSNI L   K  K+ DF
Sbjct: 128 RRGEKLDKVLALELFEQITKG----VDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 335 GLAT 338
           GL T
Sbjct: 181 GLVT 184

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 75/162 (46%), Gaps = 17/162 (10%)
Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 82  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+
Sbjct: 141 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 179

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F   + LGRG    VF+ K  +   + AIKR+   ++E + +   RE+   + L HP I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 242 VPLVGFCIDPEQGLFL------IYKYVSGGSLERHLHEKKKGVRGNSTLP---WSVRYKV 292
           V      ++      L      +Y Y+      +     K  + G  T+     SV   +
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKE--NLKDWMNGRCTIEERERSVCLHI 123
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            L IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFGL T
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 29/182 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K    S +AF  E  +  +L H  +V L    +
Sbjct: 20  LGAGQFGEVWMGYYNN-STKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYA-VV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ +++I ++++ GSL   L   K    G   LP  + +     IAE +AY+     +
Sbjct: 77  TKEEPIYIITEFMAKGSLLDFL---KSDEGGKVLLPKLIDFSAQ--IAEGMAYIER---K 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA------------------TWTSAPSVPFLCKT 351
             +HRD++ +N+L+S   + K+ DFGLA                   WT+  ++ F C T
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 352 VK 353
           +K
Sbjct: 189 IK 190

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 92  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+              VK T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 199
Query: 356 FGQNPFCIEEWQRLKS 371
            G+ P     W  ++S
Sbjct: 200 MGRLPV---RWMAIES 212

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 77/167 (46%), Gaps = 18/167 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHP 239
           +F   R LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ +  +  D  + ++L+ ++   G L + L +  +     S          A  + E 
Sbjct: 75  NILRMYNYFHD-RKRIYLMLEFAPRGELYKELQKHGRFDEQRS----------ATFMEEL 123
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT-SAPSV 345
              LH   ER V+HRDIKP N+L+  K   K+ DFG   W+  APS+
Sbjct: 124 ADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG---WSVHAPSL 167

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSL 236
           HN    R LG GA   VF  +   L     +  VA+K L      + K F RE  + ++L
Sbjct: 13  HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 72
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG----VRGN--STLPWSVRY 290
            H +IV   G C++ +  L ++++Y+  G L + L            GN  + L  S   
Sbjct: 73  QHEHIVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML 131
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +A  IA  + YL     +  VHRD+   N L+    + K+ DFG++
Sbjct: 132 HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 27/179 (15%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCR---ELMIA 233
            +F   R LG G+      G+V L+R+       A+K L KE     K       E ++ 
Sbjct: 6   QDFQILRTLGTGSF-----GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           S + HP I+ + G   D +Q +F+I  Y+ GG L   L       R +   P  V    A
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLL-------RKSQRFPNPVAKFYA 112
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF-LCKT 351
             +  ++ YLH+   + +++RD+KP NILL      K+ DFG A +   P V + LC T
Sbjct: 113 AEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYXLCGT 166

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 102
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L + K+ +     L ++ +      I + + YL  GT+R  +HR++   NIL+ ++  
Sbjct: 103 DYLQKHKERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRNLATRNILVENENR 153
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 154 VKIGDFGLT 162

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 55  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 115 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 165
Query: 329 PKLCDFGLA 337
            K+ DFGLA
Sbjct: 166 VKIADFGLA 174

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/158 (31%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPNIVP 243
           G  LG G    V  GK  L    VA+K L+++   S        RE+       HP+I+ 
Sbjct: 21  GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK 80
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L      P   +F++ +YVSGG L  ++ +       N  L      ++   I   V Y 
Sbjct: 81  LYQVISTPSD-IFMVMEYVSGGELFDYICK-------NGRLDEKESRRLFQQILSGVDYC 132
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
           H      VVHRD+KP N+LL +    K+ DFGL+   S
Sbjct: 133 HR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 79/163 (48%), Gaps = 25/163 (15%)
Query: 185 SKGRVLGRGALSFVFKGKVGLLRTS-------VAIKRLDKEDKESSKA-FCRELMIASSL 236
           ++ +V+G G    V+KG   +L+TS       VAIK L     E  +  F  E  I    
Sbjct: 47  TRQKVIGAGEFGEVYKG---MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-- 294
            H NI+ L G  I   + + +I +Y+  G+L++ L EK           +SV   V +  
Sbjct: 104 SHHNIIRLEG-VISKYKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLR 154
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           GIA  + YL N      VHRD+   NIL++S  + K+ DFGL+
Sbjct: 155 GIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLS 194

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 19/162 (11%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPL 244
           RVLG+G+   V   K  +     A+K + K   + K   ++  RE+ +   L HPNI  L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 245 VGFCIDPEQGLF-LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F  D  +G F L+ +  +GG L   +  +K+    ++        ++   +   + Y 
Sbjct: 92  YEFFED--KGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYX 142
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSA 342
           H      +VHRD+KP N+LL SK      ++ DFGL+T   A
Sbjct: 143 HKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 42  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 101
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 102 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 152
Query: 329 PKLCDFGLA 337
            K+ DFGLA
Sbjct: 153 VKIADFGLA 161

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 116
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   L+   +  ++HRD+KP+NIL+S+    K+ DFG+A
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIA 163

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 64/129 (49%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P  Q L L+ +Y+  G L 
Sbjct: 43  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 102
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 103 DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 153
Query: 329 PKLCDFGLA 337
            K+ DFGLA
Sbjct: 154 VKIADFGLA 162

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 139
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA
Sbjct: 140 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLA 178

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 63
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 64  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 115
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA
Sbjct: 116 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLA 154

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 249 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 306
              E G   I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH+ 
Sbjct: 89  --SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN 141
Query: 307 TERCVVHRDIKPSNILLSS-KKIPKLCDFG 335
               +VHRDIK  N+L+++   + K+ DFG
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFG 168

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           + N+     LG+GA S V +   K   L  +  I    K      +   RE  I   L H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILE 116
Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           S+AY H NG    +VHR++KP N+LL+SK      KL DFGLA
Sbjct: 117 SIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLA 155

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASS 235
           A  +    R+LG G    V++G        + +VA+K   K+   ++ + F  E +I  +
Sbjct: 6   AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 65
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 66  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 117
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +
Sbjct: 118 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 158

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLA 327

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE-DKESSKAFCRELMIASS 235
           A  +    R+LG G    V++G        + +VA+K   K+   ++ + F  E +I  +
Sbjct: 10  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 69
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 70  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 121
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLA 327

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/129 (33%), Positives = 66/129 (51%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE 268
           VA+K+L    +E  + F RE+ I  SL H NIV   G C     + L LI +Y+  GSL 
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR 104
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
            +L    + +     L ++ +      I + + YL  GT+R  +HRD+   NIL+ ++  
Sbjct: 105 DYLQAHAERIDHIKLLQYTSQ------ICKGMEYL--GTKR-YIHRDLATRNILVENENR 155
Query: 329 PKLCDFGLA 337
            K+ DFGL 
Sbjct: 156 VKIGDFGLT 164

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 249 IDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGN-STLPWSVRYKVALGIAESVAYLHNG 306
              E G   I+ + V GGSL   L  K   ++ N  T+ +  +      I E + YLH+ 
Sbjct: 75  --SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ-----ILEGLKYLHDN 127
Query: 307 TERCVVHRDIKPSNILLSS-KKIPKLCDFG 335
               +VHRDIK  N+L+++   + K+ DFG
Sbjct: 128 Q---IVHRDIKGDNVLINTYSGVLKISDFG 154

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S L
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 91
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/164 (29%), Positives = 83/164 (50%), Gaps = 15/164 (9%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE-DKESSKAFCRELMIASS 235
           A  +    R+LG G    V++G        + +VA+K   K+   ++ + F  E +I  +
Sbjct: 22  AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKN 81
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L HP+IV L+G  I  E+  ++I +    G L  +L   K  ++  + + +S      L 
Sbjct: 82  LDHPHIVKLIG--IIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQ 133
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           I +++AYL +      VHRDI   NIL++S +  KL DFGL+ +
Sbjct: 134 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 174

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+A
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 79/160 (49%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP 
Sbjct: 14  YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 241 IVPL--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +   G    P   L +++ +YV G +L   +H +          P + +  + + IA
Sbjct: 74  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEV-IA 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   L+   +  ++HRD+KP+NI++S+    K+ DFG+A
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 26  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 85
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 86  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 136
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 137 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 171

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S L
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKL 105
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/150 (35%), Positives = 78/150 (52%), Gaps = 16/150 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 330
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+    E
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYV----E 380
Query: 309 RC-VVHRDIKPSNILLSSKKIPKLCDFGLA 337
           R   VHRD++ +NIL+    + K+ DFGLA
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLA 410

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 141
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+M+ +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 243 --------------PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
                         P+    +  +  LF+  +Y   G+L   +H +    + +       
Sbjct: 66  RYYAAWLERRNFVKPMT--AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY----- 118
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +++   I E+++Y+H+   + ++HRD+KP NI +   +  K+ DFGLA
Sbjct: 119 -WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLA 163

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 30  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 90  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 141
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 142 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 183

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 76/149 (51%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 247
Query: 250 DPEQGLFLIYKYVSGGSLERHLH-EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L  E  K +R    LP  V   +A  IA  +AY+     
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYLR----LPQLV--DMAAQIASGMAYVERMN- 300
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLA 327

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 69  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 128
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 129 VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 179
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 180 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 214

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 70  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 120
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 155

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 189 VLGRGALSFVFKGKVGL--LRTSVAIKRL-DKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           V+G G    V K ++    LR   AIKR+ +   K+  + F  EL +   L HHPNI+ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNST---LPWSVRYKVALG 295
           +G C +    L+L  +Y   G+L       R L         NST   L        A  
Sbjct: 89  LGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           +A  + YL   +++  +HR++   NIL+    + K+ DFGL+              VK T
Sbjct: 148 VARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV--------YVKKT 196
Query: 356 FGQNPFCIEEWQRLKS 371
            G+ P     W  ++S
Sbjct: 197 MGRLPV---RWMAIES 209

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPL 244
           G ++G+G    V+ G+       VAI+ +D  +++++  KAF RE+M      H N+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G C+ P   L +I     G +L   + + K  +  N T       ++A  I + + YLH
Sbjct: 95  MGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKT------RQIAQEIVKGMGYLH 147
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
               + ++H+D+K  N+   + K+  + DFGL
Sbjct: 148 ---AKGILHKDLKSKNVFYDNGKV-VITDFGL 175

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 34  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 94  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 145 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 15  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 75  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 126
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 127 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 168

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVIEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 70/160 (43%), Gaps = 13/160 (8%)
Query: 187 GRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           G++LG G    V +G +       L+ +V   +LD   +   + F  E        HPN+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 242 VPLVGFCID-PEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           + L+G CI+   QG+    +I  ++  G L  +L   +    G   +P     K  + IA
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET-GPKHIPLQTLLKFMVDIA 157
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             + YL N   R  +HRD+   N +L       + DFGL+
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLS 194

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGF 247
           VLG GA S V   +    +  VAIK + KE  E  + +   E+ +   + HPNIV L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 248 CIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               E G  L+LI + VSGG L   + EK      +++       ++   + ++V YLH+
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHD 134
Query: 306 GTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSV 345
                +VHRD+KP N+L   L       + DFGL+      SV
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 81/185 (43%), Gaps = 31/185 (16%)
Query: 161 SISPV--ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE 218
           S+ PV   N  +   + EIL         R +G+G+   V   +    +   A+K ++K+
Sbjct: 1   SMPPVFDENEDVNFDHFEIL---------RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 219 ---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
              ++   +   +EL I   L HP +V L  +    E+ +F++   + GG L  HL +  
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNL-WYSFQDEEDMFMVVDLLLGGDLRYHLQQ-- 108
Query: 276 KGVRGNSTLPWSVRYK---VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
                      +V +K   V L I E V  L     + ++HRD+KP NILL       + 
Sbjct: 109 -----------NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHIT 157
Query: 333 DFGLA 337
           DF +A
Sbjct: 158 DFNIA 162

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 80/193 (41%), Gaps = 27/193 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 13  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 72
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 73  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 124
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 352
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A          
Sbjct: 125 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA------GNEF 175
Query: 353 KGTFGQNPFCIEE 365
           K  FG   F   E
Sbjct: 176 KNIFGTPEFVAPE 188

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 70
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 123
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 124 --YVHRDLRAANILVGENLVCKVADFGLA 150

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 74
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFL----KGETGKYLRLPQLV--DMAAQIASGMAYVERMN- 127
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 128 --YVHRDLRAANILVGENLVCKVADFGLA 154

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           V   G F  D E  + +  +++ GGSL++ L  KK G      +P  +  KV++ + + +
Sbjct: 67  VGFYGAFYSDGE--ISICMEHMDGGSLDQVL--KKAG-----RIPEQILGKVSIAVIKGL 117
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL    +  ++HRD+KPSNIL++S+   KLCDFG++
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGF 247
           VLG GA S V   +    +  VAIK + KE  E  + +   E+ +   + HPNIV L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 248 CIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               E G  L+LI + VSGG L   + EK      +++       ++   + ++V YLH+
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHD 134
Query: 306 GTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSV 345
                +VHRD+KP N+L   L       + DFGL+      SV
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 69  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 120
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 121 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 81/193 (41%), Gaps = 27/193 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 66  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 117
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 352
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +        
Sbjct: 118 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN------EF 168
Query: 353 KGTFGQNPFCIEE 365
           K  FG   F   E
Sbjct: 169 KNIFGTPEFVAPE 181

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 81/193 (41%), Gaps = 27/193 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSL 236
           ++  G  LG G  + V K +        A K + K    SS+         RE+ I   +
Sbjct: 27  HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREI 86
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L     + +  + LI + VSGG L   L EK+      +T       +    I
Sbjct: 87  RHPNIITLHD-IFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQI 138
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTV 352
            + V YLH+   + + H D+KP NI+L  K +P    KL DFG+A    A +        
Sbjct: 139 LDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN------EF 189
Query: 353 KGTFGQNPFCIEE 365
           K  FG   F   E
Sbjct: 190 KNIFGTPEFVAPE 202

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 145
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 8   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 68  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 119
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 120 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 161

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 125
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 126 --YVHRDLRAANILVGENLVCKVADFGLA 152

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPLVGF 247
           VLG GA S V   +    +  VAIK + KE  E  + +   E+ +   + HPNIV L   
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDI 84
Query: 248 CIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               E G  L+LI + VSGG L   + EK      +++       ++   + ++V YLH+
Sbjct: 85  Y---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYLHD 134
Query: 306 GTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSV 345
                +VHRD+KP N+L   L       + DFGL+      SV
Sbjct: 135 ---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 10  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 70  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 121
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 122 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 163

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 149 ELKWRKIQSLERSISPVANSLIRLSYGEILAATHN-FSKGRVLGRGALSFVFKGKV-GLL 206
           E++W+ ++ +  + + V     +L Y        N  S G+ LG GA   V +    GL+
Sbjct: 6   EVQWKVVEEINGN-NXVXIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLI 64
Query: 207 RTSVAIKRLDKEDKESS-----KAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK 260
           ++  A+    K  K S+     +A   EL + S L +H NIV L+G C      L +I +
Sbjct: 65  KSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTL-VITE 123
Query: 261 YVSGGSLERHLHEKKKGVRGNSTLP---------------WSVRYKVALGIAESVAYLHN 305
           Y   G L   L  K+     + T P                S  Y+VA G+A    +L  
Sbjct: 124 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA----FL-- 177
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            ++ C+ HRD+   NILL+  +I K+CDFGLA
Sbjct: 178 ASKNCI-HRDLAARNILLTHGRITKICDFGLA 208

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 34  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 94  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 145
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 146 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 187

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 36  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 96  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 147
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 148 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 189

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVCEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 11  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 71  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 122
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 123 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 164

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 131
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 132 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGLA
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLA 194

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 107
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 108 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 164
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 165 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 207

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 205

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 91
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 92  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 149 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 191

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 117
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 118 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 174
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 175 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 217

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 105
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 106 NHQNIVRCIGVSL---QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 163 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 205

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 108
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 109 NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 165
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 166 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 208

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 97
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 98  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 154
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 155 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 197

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQL--YAV 248
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 301
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGL 
Sbjct: 302 --YVHRDLRAANILVGENLVCKVADFGLG 328

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 91  NHQNIVRCIGVSL---QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 33  DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 93  FFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDET----CTRFYTA-EIVSA 144
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 145 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 257 LIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           +I +Y   G L   L  K + +         NSTL        +  +A+ +A+L   ++ 
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL--ASKN 184
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           C+ HRD+   N+LL++  + K+ DFGLA
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLA 211

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 90
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 91  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   + H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 15/162 (9%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIAS 234
           A   +F   +V+G+G+   V   +        A+K L K+     KE         ++  
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLK 94
Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           ++ HP +V L  F       L+ +  Y++GG L  HL       R    L    R+  A 
Sbjct: 95  NVKHPFLVGL-HFSFQTADKLYFVLDYINGGELFYHLQ------RERCFLEPRARFYAA- 146
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            IA ++ YLH+     +V+RD+KP NILL S+    L DFGL
Sbjct: 147 EIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL 185

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL---HHPN 240
           F   R+ G+G    V  GK      SVAIK++ ++ +  +    REL I   L   HHPN
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----RELQIMQDLAVLHHPN 80
Query: 241 IVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL-GIAE 298
           IV L   F    E+    IY  V    +   LH   +        P  +  KV L  +  
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSA--PSVPFLC 349
           S+  LH  +   V HRDIKP N+L++ +    KLCDFG A   S   P+V ++C
Sbjct: 141 SIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC 193

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 184 FSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASSL- 236
            S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP----------- 285
           +H NIV L+G C      L +I +Y   G L   L  K+     + T P           
Sbjct: 85  NHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 286 ----WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA
Sbjct: 144 LEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLA 192

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 75/166 (45%), Gaps = 25/166 (15%)
Query: 184 FSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKEDKESSKAFCRE-----LMIASS 235
           +  G  LG G  + V K +    GL   +  IK+  ++ + S +  CRE     + I   
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKK--RQSRASRRGVCREEIEREVSILRQ 71
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HPNI+ L     +    + LI + VSGG L   L +K+      +T            
Sbjct: 72  VLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQ 123
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
           I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKA-FCRELMIASSL 236
           N +  R LG GA   V++G+V  +        VA+K L +   E  +  F  E +I S  
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF 82
Query: 237 HHPNIVPLVGFCIDPEQGL--FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +H NIV  +G  +   Q L  F++ + ++GG L+  L E +      S+L       VA 
Sbjct: 83  NHQNIVRCIGVSL---QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 139
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            IA    YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 140 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 182

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 83/178 (46%), Gaps = 30/178 (16%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 235
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 285
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 101 LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 159
Query: 286 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA
Sbjct: 160 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLA 210

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
           A S   L YG       + +  + LG G    V  GK    +  VAIK + KE   S   
Sbjct: 8   APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDE 65
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           F  E  +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQLL- 123
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
                ++   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 124 -----EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA 225
           A S   L YG       + +  + LG G    V  GK    +  VAIK + KE   S   
Sbjct: 8   APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDE 65
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
           F  E  +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L 
Sbjct: 66  FIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYMANGCLLNYLREMRHRFQTQQLL- 123
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
                ++   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 124 -----EMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/178 (32%), Positives = 83/178 (46%), Gaps = 30/178 (16%)
Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASS 235
           +  S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S 
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--------- 285
           L +H NIV L+G C      L +I +Y   G L   L  K+     + T P         
Sbjct: 106 LGNHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 286 ------WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                  S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA
Sbjct: 165 LDLEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLA 215

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGSLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD+  +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLAAANILVGENLVCKVADFGLA 161

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/176 (32%), Positives = 82/176 (46%), Gaps = 30/176 (17%)
Query: 184 FSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESS-----KAFCRELMIASSL- 236
            S G+ LG GA   V +    GL+++  A+    K  K S+     +A   EL + S L 
Sbjct: 48  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 107
Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP----------- 285
           +H NIV L+G C      L +I +Y   G L   L  K+     + T P           
Sbjct: 108 NHMNIVNLLGACTIGGPTL-VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 166
Query: 286 ----WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                S  Y+VA G+A    +L   ++ C+ HRD+   NILL+  +I K+CDFGLA
Sbjct: 167 LEDLLSFSYQVAKGMA----FL--ASKNCI-HRDLAARNILLTHGRITKICDFGLA 215

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 14/134 (10%)
Query: 209 SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSL 267
            VA+K++D   ++  +    E++I    HH N+V +   + +  E  L+++ +++ GG+L
Sbjct: 72  QVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDE--LWVVMEFLEGGAL 129
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              +   +      +T        V L +  +++YLHN   + V+HRDIK  +ILL+S  
Sbjct: 130 TDIVTHTRMNEEQIAT--------VCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDG 178
Query: 328 IPKLCDFGLATWTS 341
             KL DFG     S
Sbjct: 179 RIKLSDFGFCAQVS 192

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 77  TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+
Sbjct: 126 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV 172

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLXGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 169 DFGLA------------RTAGTSFMMTPYVVTRYYR 192

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 134
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLA 162

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 188 RVLGRGALSFVFKGKVGLLR---------TSVAIKRLDKEDKESSKA-FCRELMIASSLH 237
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 15  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 238 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C  D   G+ LI +++  GSL+ +L + K  +     L ++V+      I
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ------I 123
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL 
Sbjct: 124 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 161

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 16  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 71
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 72  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 123
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 124 NYIHRDLRAANILVSDTLSCKIADFGLA 151

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 26  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 82  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 133
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 134 NYIHRDLRAANILVSDTLSCKIADFGLA 161

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 25/161 (15%)
Query: 188 RVLGRGALSFVFKGKVGLLR---------TSVAIKRLDKEDKESSKA-FCRELMIASSLH 237
           R LG G       GKV L R           VA+K L  E   +  A   +E+ I  +L+
Sbjct: 27  RDLGEGHF-----GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 238 HPNIVPLVGFCI-DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C  D   G+ LI +++  GSL+ +L + K  +     L ++V+      I
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQ------I 135
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + YL +   R  VHRD+   N+L+ S+   K+ DFGL 
Sbjct: 136 CKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT 173

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLA 156

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 22  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 77
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 78  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 129
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 130 NYIHRDLRAANILVSDTLSCKIADFGLA 157

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 27  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 82
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 134
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 135 NYIHRDLRAANILVSDTLSCKIADFGLA 162

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLA 156

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 89
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 145
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 146 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 31  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 86
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 87  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 138
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 139 NYIHRDLRAANILVSDTLSCKIADFGLA 166

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 29  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 84
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 85  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 136
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 137 NYIHRDLRAANILVSDTLSCKIADFGLA 164

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 169 DFGLA------------RTAGTSFMMTPYVVTRYYR 192

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 33/181 (18%)
Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 233
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 280
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 281 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 337 A 337
           +
Sbjct: 197 S 197

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 21  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 76
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLA 156

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLXQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLXGIK----HLHSA---GIIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 169 DFGLA------------RTAGTSFMMTPYVVTRYYR 192

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 68  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 118
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 119 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 165

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 307
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H+  
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCHD-- 118
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            R V+HRD+KP N+L++ +   K+ DFGLA     P
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 307
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H+  
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCHD-- 118
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            R V+HRD+KP N+L++ +   K+ DFGLA     P
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 81
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 137
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 138 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 14/156 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIK-RLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
           +G G    V+K +     T    K RL+KED+       RE+ I   L H NIV L    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD-V 68
Query: 249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK-VALGIAESVAYLHNGT 307
           I  ++ L L+++++    L++ L   + G+        SV  K   L +   +AY H+  
Sbjct: 69  IHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE-------SVTAKSFLLQLLNGIAYCHD-- 118
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            R V+HRD+KP N+L++ +   K+ DFGLA     P
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 70/130 (53%), Gaps = 16/130 (12%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           + I R+  +++E S+   RE+ + +++ HPNIV       +    L+++  Y  GG L +
Sbjct: 57  INISRMSSKEREESR---REVAVLANMKHPNIVQYRE-SFEENGSLYIVMDYCEGGDLFK 112
Query: 270 HLHEKKKGV--RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
            ++ +K GV  + +  L W V+  +AL       ++H+   R ++HRDIK  NI L+   
Sbjct: 113 RINAQK-GVLFQEDQILDWFVQICLAL------KHVHD---RKILHRDIKSQNIFLTKDG 162
Query: 328 IPKLCDFGLA 337
             +L DFG+A
Sbjct: 163 TVQLGDFGIA 172

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S G L   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVMEYMSKGCLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 104
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 160
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 161 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFC-RELMIASSLHHP 239
           +F  G++LG G+ S     +        AIK L+K    KE+   +  RE  + S L HP
Sbjct: 31  DFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L  F    ++ L+    Y   G L +++  +K G    +      R+  A  I  +
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDET----CTRFYTA-EIVSA 142
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 30  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 85
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 86  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 137
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 138 NYIHRDLRAANILVSDTLSCKIADFGLA 165

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 23  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 79  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 130
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRD++ +NIL+S     K+ DFGLA
Sbjct: 131 NYIHRDLRAANILVSDTLSCKIADFGLA 158

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 12/169 (7%)
Query: 172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM 231
           L YG       + +  + LG G    V  GK    +  VAIK + KE   S   F  E  
Sbjct: 5   LGYGSWEIDPKDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAK 62
Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           +  +L H  +V L G C   ++ +F+I +Y++ G L  +L E +   +    L      +
Sbjct: 63  VMMNLSHEKLVQLYGVCT-KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------E 115
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
           +   + E++ YL +   +  +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 116 MCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 161

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/129 (32%), Positives = 64/129 (49%), Gaps = 10/129 (7%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG-LFLIYKYVSGGSLE 268
           VA+K+L     +  + F RE+ I  +LH   IV   G    P +  L L+ +Y+  G L 
Sbjct: 39  VAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLR 98
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L   +  +  +  L +S +      I + + YL  G+ RCV HRD+   NIL+ S+  
Sbjct: 99  DFLQRHRARLDASRLLLYSSQ------ICKGMEYL--GSRRCV-HRDLAARNILVESEAH 149
Query: 329 PKLCDFGLA 337
            K+ DFGLA
Sbjct: 150 VKIADFGLA 158

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 26  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 84
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 85  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 135
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 136 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 182

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 166
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 167 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 20/174 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           ++  +V+G G+   VF+ K+ +    VAIK++ ++ +  +    REL I   + HPN+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKL-VESDEVAIKKVLQDKRFKN----RELQIMRIVKHPNVVD 96
Query: 244 LVGFCI---DPEQGLFL--IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           L  F     D +  +FL  + +YV         H  K       T+P  +       +  
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKL----KQTMPMLLIKLYMYQLLR 152
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSA--PSVPFLC 349
           S+AY+H+     + HRDIKP N+LL     + KL DFG A    A  P+V  +C
Sbjct: 153 SLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 26  LGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 81
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y+S G L   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 82  VSEEPIYIVTEYMSKGCLLDFL----KGEMGKYLRLPQLV--DMAAQIASGMAYVERMN- 134
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 135 --YVHRDLRAANILVGENLVCKVADFGLA 161

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 36  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 94
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 95  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 145
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 146 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 192

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 19/154 (12%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 207 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 263
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 264 LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 315
Query: 328 IPKLCDFGLA--------TWTSAPSVPFLCKTVK 353
           + K+ DFGLA         WT+  ++ F   T+K
Sbjct: 316 VCKIADFGLARVGAKFPIKWTAPEAINFGSFTIK 349

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 155
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 211
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 212 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+S++ +    +E+     L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGS---LERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            +   G C   E   +L+ +Y  G +   LE H    KK ++            V  G  
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVH----KKPLQEVEIA------AVTHGAL 164
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
           + +AYLH+     ++HRD+K  NILLS   + KL DFG A+   AP+  F+
Sbjct: 165 QGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFV 211

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEYMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL 
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLG 194

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 71
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ + ++ +Y+S GSL   L    KG  G    LP  V   +A  IA  +AY+     
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFL----KGETGKYLRLPQLV--DMAAQIASGMAYVERMN- 124
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 125 --YVHRDLRAANILVGENLVCKVADFGLA 151

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 241
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 242 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 114
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV     E      +   R   TLP          + 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 170
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 171 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 79/176 (44%), Gaps = 21/176 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 241
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 242 VPLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++ +GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLVGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 79/175 (45%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 112
Query: 243 PLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 168
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V ++C
Sbjct: 169 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHPNIVPLV 245
           VLG GA S V   +    +  VAIK + K   E KE S     E+ +   + HPNIV L 
Sbjct: 25  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHKIKHPNIVALD 82
Query: 246 GFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                 E G  L+LI + VSGG L   + EK      +++       ++   + ++V YL
Sbjct: 83  DIY---ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS-------RLIFQVLDAVKYL 132
Query: 304 HNGTERCVVHRDIKPSNIL---LSSKKIPKLCDFGLATWTSAPSV 345
           H+     +VHRD+KP N+L   L       + DFGL+      SV
Sbjct: 133 HD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 174

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 80/168 (47%), Gaps = 20/168 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-LPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y++ GSL   L    KG  G    LP  V   ++  IA  +AY+     
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL----KGETGKYLRLPQLV--DMSAQIASGMAYVERMN- 131
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLCK 350
              VHRD++ +NIL+    + K+ DFGLA       WT+     F  K
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIK 177

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 239
           ++  G  LG G    V  G+  L    VA+K L+++   S        RE+       HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIA 297
           +I+ L      P    F++ +YVSGG L  ++  H + + +            ++   I 
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEAR---------RLFQQIL 121
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S
Sbjct: 122 SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 73/164 (44%), Gaps = 18/164 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC---RELMIASSLHHP 239
           ++  G  LG G    V  G+  L    VA+K L+++   S        RE+       HP
Sbjct: 12  HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIA 297
           +I+ L      P    F++ +YVSGG L  ++  H + + +            ++   I 
Sbjct: 72  HIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEAR---------RLFQQIL 121
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            +V Y H      VVHRD+KP N+LL +    K+ DFGL+   S
Sbjct: 122 SAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 134 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 193 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 238

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 33/181 (18%)
Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 233
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 280
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 281 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 337 A 337
           +
Sbjct: 197 S 197

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 79/181 (43%), Gaps = 33/181 (18%)
Query: 183 NFSKGRVLGRG-------ALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIA 233
           N   G+ LG G       A +F  KG+ G   T+VA+K L KE+   S  +    E  + 
Sbjct: 24  NLVLGKTLGEGEFGKVVKATAFHLKGRAGY--TTVAVKML-KENASPSELRDLLSEFNVL 80
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRG------------- 280
             ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G             
Sbjct: 81  KQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 281 ----NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                  L        A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 337 A 337
           +
Sbjct: 197 S 197

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 69/132 (52%), Gaps = 12/132 (9%)
Query: 207 RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG 265
           +  VAIK L +  +K  ++   RE  I   L +P IV L+G C    + L L+ +   GG
Sbjct: 37  QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALMLVMEMAGGG 94
Query: 266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 325
            L + L  K++ +  ++     + ++V++G+     YL    E+  VHRD+   N+LL +
Sbjct: 95  PLHKFLVGKREEIPVSNVA--ELLHQVSMGMK----YLE---EKNFVHRDLAARNVLLVN 145
Query: 326 KKIPKLCDFGLA 337
           +   K+ DFGL+
Sbjct: 146 RHYAKISDFGLS 157

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 75/160 (46%), Gaps = 16/160 (10%)
Query: 184 FSKGRVLGRGALSFVF--KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           + + + LG GA   V   + KV  +  ++ I R       S+     E+ +   L HPNI
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L  F  D ++  +L+ +   GG L   +  + K    ++ +       +   +   V 
Sbjct: 99  MKLYDFFED-KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV-------IIKQVLSGVT 150
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
           YLH   +  +VHRD+KP N+LL SK+   + K+ DFGL+ 
Sbjct: 151 YLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 69/130 (53%), Gaps = 11/130 (8%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K L K+   S  AF  E  +   L H  +V L  + +  ++ +++I +Y+  GSL
Sbjct: 38  TKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAVVTQEPIYIITEYMENGSL 94
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L +   G++    L  +    +A  IAE +A++    ER  +HRD++ +NIL+S   
Sbjct: 95  VDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTL 146
Query: 328 IPKLCDFGLA 337
             K+ DFGLA
Sbjct: 147 SCKIADFGLA 156

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 151
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 197

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 82  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 140
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 141 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 186

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/149 (32%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  + +
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNS-TLPWSVRYKVALGIAESVAYLHNGTE 308
             E+ ++++ +Y++ GSL   L    KG  G    LP  V   ++  IA  +AY+     
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFL----KGETGKYLRLPQLV--DMSAQIASGMAYVERMN- 131
Query: 309 RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              VHRD++ +NIL+    + K+ DFGLA
Sbjct: 132 --YVHRDLRAANILVGENLVCKVADFGLA 158

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI     +
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLXQVIQMELDHERMSYLL-----YQMLXGIK----H 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLA------------RTAGTSFMMTPYV 179
Query: 363 IEEWQR 368
           +  + R
Sbjct: 180 VTRYYR 185

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 86  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 144
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 145 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 190

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 36  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 145
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 179

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 75  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
             +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 16  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 74  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 123
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
             +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 124 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 154

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 169 DFGLA------------RTAGTSFMMTPYVVTRYYR 192

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 85  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 143
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 144 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 189

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 15/158 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           NF   RVLG+G+   V   +V       A+K L K+    D +       + +++ + +H
Sbjct: 24  NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      LF + ++V+GG L  H+ + ++     +          A  I  
Sbjct: 84  PFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-------YAAEIIS 135
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           ++ +LH+   + +++RD+K  N+LL  +   KL DFG+
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGM 170

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 55  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 164
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 165 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 198

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 26/169 (15%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+M+ +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVV 65
Query: 243 --------------PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
                         P+    +  +  LF+  +Y    +L   +H +    + +       
Sbjct: 66  RYYAAWLERRNFVKPMT--AVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEY----- 118
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +++   I E+++Y+H+   + ++HRD+KP NI +   +  K+ DFGLA
Sbjct: 119 -WRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLA 163

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 36  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 145
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 146 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 179

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 70  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 119
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
             +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 150

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +V L G C 
Sbjct: 17  LGTGQFGVVKYGK-WRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +F+I +Y++ G L  +L E +   +    L      ++   + E++ YL +   +
Sbjct: 75  -KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLL------EMCKDVCEAMEYLES---K 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
             +HRD+   N L++ + + K+ DFGL+ + 
Sbjct: 125 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 155

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 147 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 17/164 (10%)
Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH 237
           +  + + + LG GA   V   K  L     AIK + K       +S A   E+ +   L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPNI+ L  F  D ++  +L+ +   GG L   +  ++K     S +  +V  K  L   
Sbjct: 63  HPNIMKLYEFFED-KRNYYLVMEVYRGGELFDEIILRQK----FSEVDAAVIMKQVLS-- 115
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
               YLH      +VHRD+KP N+LL SK    + K+ DFGL+ 
Sbjct: 116 -GTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSA 155

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNI 241
           +++  +V+G G+   V++ K+      VAIK++ +      KAF  REL I   L H NI
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----GKAFKNRELQIMRKLDHCNI 75
Query: 242 VPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V L  F         E  L L+  YV         H      R   TLP          +
Sbjct: 76  VRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYS----RAKQTLPVIYVKLYMYQL 131
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA 337
             S+AY+H+     + HRDIKP N+LL     + KLCDFG A
Sbjct: 132 FRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 181 THNFSKGRVLGRGALSFVFK--GKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           T ++     LG+GA S V +   K      +  I    K      +   RE  I   L H
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKH 89
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 90  PNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIHQILE 141
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           SV ++H   +  +VHRD+KP N+LL+SK      KL DFGLA
Sbjct: 142 SVNHIH---QHDIVHRDLKPENLLLASKCKGAAVKLADFGLA 180

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 29  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 138
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 139 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 172

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 32  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 141
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 142 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 35  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 145 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 178

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKD 151
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 197

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 34  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 143
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 144 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 56  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 165
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 166 KYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 199

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 28/208 (13%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 257 LIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           +I +Y   G L   L  K + +         NST         +  +A+ +A+L   ++ 
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL--ASKN 184
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           C+ HRD+   N+LL++  + K+ DFGLA
Sbjct: 185 CI-HRDVAARNVLLTNGHVAKIGDFGLA 211

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 28/161 (17%)
Query: 188 RVLGRGALSFVFK---------GKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           RVLG+G    VF+         GK+    +L+ ++ ++  + +D   +KA   E  I   
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKA---ERNILEE 77
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP IV L+ +       L+LI +Y+SGG L   L  +++G+    T  + +       
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE----- 129
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           I+ ++ +LH   ++ +++RD+KP NI+L+ +   KL DFGL
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 28/161 (17%)
Query: 188 RVLGRGALSFVFK---------GKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           RVLG+G    VF+         GK+    +L+ ++ ++  + +D   +KA   E  I   
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR--NAKDTAHTKA---ERNILEE 77
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP IV L+ +       L+LI +Y+SGG L   L  +++G+    T  + +       
Sbjct: 78  VKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL--EREGIFMEDTACFYLAE----- 129
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           I+ ++ +LH   ++ +++RD+KP NI+L+ +   KL DFGL
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL 167

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP------------ 285
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P            
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKD 151
Query: 286 -WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             S  Y+VA G+     YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 152 LVSCAYQVARGME----YL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 197

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  + +
Sbjct: 17  LGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL--YAV 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             ++ +++I +Y+  GSL   L +   G++    L  +    +A  IAE +A++    ER
Sbjct: 73  VTQEPIYIITEYMENGSLVDFL-KTPSGIK----LTINKLLDMAAQIAEGMAFIE---ER 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HR+++ +NIL+S     K+ DFGLA
Sbjct: 125 NYIHRNLRAANILVSDTLSCKIADFGLA 152

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 95
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 151
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 152 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 88
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 144
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 77
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 133
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 134 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 84
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 140
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 141 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 88
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 144
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 145 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 78/175 (44%), Gaps = 19/175 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 80
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F         E  L L+  YV         H      R   TLP          + 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 136
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWT--SAPSVPFLC 349
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 137 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLH 237
           +  + + + LG GA   V   K  L     AIK + K       +S A   E+ +   L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPNI+ L  F  D ++  +L+ +   GG L   +  ++K    ++ +       +   + 
Sbjct: 80  HPNIMKLYEFFED-KRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-------IMKQVL 131
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLAT 338
               YLH      +VHRD+KP N+LL SK    + K+ DFGL+ 
Sbjct: 132 SGTTYLHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSA 172

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 23/177 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 110
Query: 243 PLVGFCID-----PEQGLFLIYKYVSGG--SLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            L  F         E  L L+  YV      + RH        R   TLP          
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS------RAKQTLPVIYVKLYMYQ 164
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATW--TSAPSVPFLC 349
           +  S+AY+H+     + HRDIKP N+LL     + KLCDFG A       P+V  +C
Sbjct: 165 LFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 27/174 (15%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAFCRELM--- 231
           + K R LG GA   V   K     +  AIK + K         +D ++ + F  E+    
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97
Query: 232 -IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  SL HPNI+ L     + ++  +L+ ++  GG L   +  + K    ++        
Sbjct: 98  SLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA------- 149
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFGLATWTS 341
            +   I   + YLH   +  +VHRDIKP NILL +K      K+ DFGL+++ S
Sbjct: 150 NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 173 SYGEILAATHNFSKG---------RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK 220
           +Y +   A H F+K          RV+G G    V  G++   G     VAIK L     
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 221 ESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           E  +  F  E  I     HPNI+ L G  +   + + ++ +Y+  GSL+  L +K  G  
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEG-VVTKSKPVMIVTEYMENGSLDTFL-KKNDGQF 121
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               L   +R     GI+  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 122 TVIQLVGMLR-----GISAGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 171

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/153 (32%), Positives = 70/153 (45%), Gaps = 16/153 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFC 248
            +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L    
Sbjct: 33  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-T 91
Query: 249 IDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            +    ++L+ +  +GG L ER +H  K+  R +         ++   +  +VAY H   
Sbjct: 92  FEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAA------RIMKDVLSAVAYCHKLN 143
Query: 308 ERCVVHRDIKPSNILL--SSKKIP-KLCDFGLA 337
              V HRD+KP N L    S   P KL DFGLA
Sbjct: 144 ---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 100 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 158
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 159 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 207 DFGLA------------RTAGTSFMMTPYVVTRYYR 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 38  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 147
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 181

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 38  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 147
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 148 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 181

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 288
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+             L    
Sbjct: 93  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 151
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 152 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 197

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 32/192 (16%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 137
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T    F
Sbjct: 138 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTASTNF 178
Query: 357 GQNPFCIEEWQR 368
              P+ +  + R
Sbjct: 179 MMTPYVVTRYYR 190

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 5   QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 59
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 60  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 118
Query: 257 LIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALG--IAESVAYLHNGTERCVVH 313
           +I +Y   G L   L  K +  +      P  +R  +     +A+ +A+L   ++ C+ H
Sbjct: 119 VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCI-H 175
Query: 314 RDIKPSNILLSSKKIPKLCDFGLA 337
           RD+   N+LL++  + K+ DFGLA
Sbjct: 176 RDVAARNVLLTNGHVAKIGDFGLA 199

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
            VLG GA S VF  K  L     A+K + K       +   E+ +   + H NIV L   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
             +     +L+ + VSGG L   + E+      +++L       V   +  +V YLH   
Sbjct: 75  -YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKYLH--- 123
Query: 308 ERCVVHRDIKPSNIL-LSSKKIPK--LCDFGLA 337
           E  +VHRD+KP N+L L+ ++  K  + DFGL+
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VL 126
Query: 257 LIYKYVSGGSLERHLHEKKKG-VRGNSTLPWSVRYKVALG--IAESVAYLHNGTERCVVH 313
           +I +Y   G L   L  K +  +      P  +R  +     +A+ +A+L   ++ C+ H
Sbjct: 127 VITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL--ASKNCI-H 183
Query: 314 RDIKPSNILLSSKKIPKLCDFGLA 337
           RD+   N+LL++  + K+ DFGLA
Sbjct: 184 RDVAARNVLLTNGHVAKIGDFGLA 207

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 42  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 151
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 152 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 185

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 81/178 (45%), Gaps = 24/178 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-----AFCRELMIASSLHH 238
           + K   LG G  + V+K +       VAIK++    +  +K        RE+ +   L H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--RGNSTL--PWSVRYKVAL 294
           PNI+           GL   + + S  SL     E    V  + NS +  P  ++  + +
Sbjct: 72  PNII-----------GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
            + + + YLH   +  ++HRD+KP+N+LL    + KL DFGLA    +P+  +  + V
Sbjct: 121 TL-QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV 174

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE-TF 75
Query: 250 DPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTE 308
           +    ++L+ +  +GG L ER +H  K+  R +         ++   +  +VAY H    
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVH--KRVFRESDAA------RIMKDVLSAVAYCHKLN- 126
Query: 309 RCVVHRDIKPSNILL--SSKKIP-KLCDFGLA 337
             V HRD+KP N L    S   P KL DFGLA
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    +GL +      T VA+K L  D  +K+ S       M+     
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 288
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+             L    
Sbjct: 78  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKD 136
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               A  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 137 LVSCAYQVARGMEYL--ASKKCI-HRDLAARNVLVTEDNVMKIADFGLA 182

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 21/158 (13%)
Query: 188 RVLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNI 241
            V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN+
Sbjct: 95  EVIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAES 299
           + L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKG 204
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 205 MKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 35  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 144
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 145 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 178

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 72  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V+ G      T VAIK L K    S ++F  E  I   L H  +V L  + +
Sbjct: 17  LGNGQFGEVWMGTWNG-NTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E+ ++++ +Y++ GSL   L   K G      LP  V   +A  +A  +AY+    ER
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFL---KDGEGRALKLPNLV--DMAAQVAAGMAYI----ER 123
Query: 310 C-VVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +HRD++ +NIL+ +  I K+ DFGLA
Sbjct: 124 MNYIHRDLRSANILVGNGLICKIADFGLA 152

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 21/157 (13%)
Query: 189 VLGRGALSFVFKGKVGLL-----RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIV 242
           V+GRG    V+ G   LL     +   A+K L++  D      F  E +I     HPN++
Sbjct: 37  VIGRGHFGCVYHGT--LLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG--IAESV 300
            L+G C+  E    ++  Y+  G L   +         N T   +V+  +  G  +A+ +
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR--------NETHNPTVKDLIGFGLQVAKGM 146
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 147 KFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 180

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 72  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 123
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 124 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 27/182 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV L+G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             +  L+++ ++  GG+++  + E  +G+             V   + E++ +LH+   +
Sbjct: 87  H-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI------QVVCRQMLEALNFLHS---K 136
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLAT----------------WTSAPSVPFLCKTVK 353
            ++HRD+K  N+L++ +   +L DFG++                 +  AP V  +C+T+K
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV-VMCETMK 195
Query: 354 GT 355
            T
Sbjct: 196 DT 197

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 71/153 (46%), Gaps = 16/153 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLD--KEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG+GA S V +    L     A K ++  K      +   RE  I   L HPNIV L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I  E   +LI+  V+GG L   +  ++     +++            I E+V + H   
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH--- 138
Query: 308 ERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           +  VVHRD+KP N+LL+SK      KL DFGLA
Sbjct: 139 QMGVVHRDLKPENLLLASKLKGAAVKLADFGLA 171

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 76/160 (47%), Gaps = 16/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLH 237
              K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + + + 
Sbjct: 18  ELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG 77
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            P +  L+G C+     + L+ + +  G L  H+ E +  +     L W ++      IA
Sbjct: 78  SPYVSRLLGICL--TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IA 129
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + ++YL +     +VHRD+   N+L+ S    K+ DFGLA
Sbjct: 130 KGMSYLEDVR---LVHRDLAARNVLVKSPNHVKITDFGLA 166

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 87/182 (47%), Gaps = 27/182 (14%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV L+G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             +  L+++ ++  GG+++  + E  +G+             V   + E++ +LH+   +
Sbjct: 79  H-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI------QVVCRQMLEALNFLHS---K 128
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLAT----------------WTSAPSVPFLCKTVK 353
            ++HRD+K  N+L++ +   +L DFG++                 +  AP V  +C+T+K
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV-VMCETMK 187
Query: 354 GT 355
            T
Sbjct: 188 DT 189

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 17/161 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +  +    REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN----RELQIMRKLDHCNIV 76
Query: 243 PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F     +      L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYS----RAKQTLPVIYVKLYMYQLF 132
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA 337
            S+AY+H+     + HRDIKP N+LL     + KLCDFG A
Sbjct: 133 RSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 72  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 129
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 130 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 157

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 100 QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 158
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 159 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 206
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 207 DFGLA------------RTAGTSFMMTPYVVTRYYR 230

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 62
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 121
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 122 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 170 DFGLA------------RTAGTSFMMTPYVVTRYYR 193

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 169 DFGLA------------RTAGTSFMMTPYVVTRYYR 192

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 78  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 135
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 136 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 163

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 61
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 62  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 120
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 121 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 169 DFGLA------------RTAGTSFMMTPYVVTRYYR 192

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 160

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 60
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 61  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 119
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 120 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 167
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 168 DFGLA------------RTAGTSFMMTPYVVTRYYR 191

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/216 (24%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 161 SISPVANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-- 217
           S S V N    +  G+        +   + +G GA   V      +L  +VAIK+L +  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 62
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLH 272
           +++  +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + + 
Sbjct: 63  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ 121
Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
            +    R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ 
Sbjct: 122 MELDHERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
           DFGLA            +T   +F   P+ +  + R
Sbjct: 170 DFGLA------------RTAGTSFMMTPYVVTRYYR 193

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 103 KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 160
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 161 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 188

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 160

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 213 TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 269
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 270 LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 321
Query: 328 IPKLCDFGLA 337
           + K+ DFGLA
Sbjct: 322 VCKIADFGLA 331

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 92/192 (47%), Gaps = 32/192 (16%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNI 241
           + + + +G GA   V      +L  +VA+K+L +  +++  +K   REL++   ++H NI
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           + L+        ++  Q ++L+ + +   +L + +H +    R +  L     Y++  GI
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLL-----YQMLCGI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
                +LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T    F
Sbjct: 140 K----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTACTNF 180
Query: 357 GQNPFCIEEWQR 368
              P+ +  + R
Sbjct: 181 MMTPYVVTRYYR 192

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 77  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 135 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 162

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA------FCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 96/211 (45%), Gaps = 33/211 (15%)
Query: 166 ANSLIRLSYGE-ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKES 222
           AN    +  G+        +   + +G GA   V      +L  +VAIK+L +  +++  
Sbjct: 1   ANQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTH 60
Query: 223 SKAFCRELMIASSLHHPNIVPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
           +K   REL++   ++H NI+ L+        ++  Q ++L+ + +   +L + +  +   
Sbjct: 61  AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDH 119
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            R +  L     Y++  GI     +LH+     ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 120 ERMSYLL-----YQMLCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 167
Query: 338 TWTSAPSVPFLCKTVKGTFGQNPFCIEEWQR 368
                       +T   +F   P+ +  + R
Sbjct: 168 ------------RTAGTSFMMTPYVVTRYYR 186

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 80  KLIG--VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 138 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 165

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 239
             + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L    +  ++ L L++++            KK     N  L   +       + + 
Sbjct: 62  NIVRLHD-VLHSDKKLTLVFEFCDQDL-------KKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + + H+   R V+HRD+KP N+L++     KL DFGLA     P
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 9   FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 67
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 68  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 118
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 119 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 165

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 31/202 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW  A +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAGT 201
Query: 345 VPFLCKTVKGTFGQNPFCIEEW 366
             +L   +  + G N   ++ W
Sbjct: 202 PEYLAPEIILSKGYNK-AVDWW 222

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 6/112 (5%)
Query: 229 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL--P 285
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +R    L +A    +  +     V+HRD+KP+N+ L  K+  KL DFGLA
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 63/214 (29%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 63/214 (29%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 153
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 154 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 213
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 214 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 247

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 63/214 (29%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 151
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 152 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 211
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 212 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 245

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 54/112 (48%), Gaps = 6/112 (5%)
Query: 229 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 288 VRYKVALGIAESVAYLHNGTE--RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +V   +  ++   H  ++    V+HRD+KP+N+ L  K+  KL DFGLA
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 74/157 (47%), Gaps = 24/157 (15%)
Query: 190 LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG+GA S V    K   G    +  I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 68
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
               I  E   +L++  V+GG L   +  ++     +++            I ESV + H
Sbjct: 69  HD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCH 120
Query: 305 -NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            NG    +VHRD+KP N+LL+SK      KL DFGLA
Sbjct: 121 LNG----IVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 19/170 (11%)
Query: 174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKEDKESSK-AFCRE 229
           + + L AT N S  +V+G G    V  G++ L      SVAIK L     E  +  F  E
Sbjct: 38  FAKELDAT-NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGE 96
Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
             I     HPNI+ L G  +   + + ++ + +  GSL+  L +            ++V 
Sbjct: 97  ASIMGQFDHPNIIRLEG-VVTKSKPVMIVTEXMENGSLDSFLRKHDA--------QFTVI 147
Query: 290 YKVAL--GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V +  GIA  + YL   ++   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 148 QLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLS 194

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLA 175

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/112 (32%), Positives = 54/112 (48%), Gaps = 6/112 (5%)
Query: 229 ELMIASSLHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL--P 285
           E+ +   L HPNIV      ID     L+++ +Y  GG L   +    KG +    L   
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEE 111
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +R    L +A    +  +     V+HRD+KP+N+ L  K+  KL DFGLA
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 86/214 (40%), Gaps = 63/214 (29%)
Query: 187 GRVLGRGALSFVFKGKV-GLLRT----SVAIKRLDKEDKESS-KAFCRELMIASSL-HHP 239
           G+ LGRGA   V +    G+ +T    +VA+K L +    S  +A   EL I   + HH 
Sbjct: 25  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 84
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK--------KGVRGNS------TLP 285
           N+V L+G C  P   L +I ++   G+L  +L  K+        KG R          +P
Sbjct: 85  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 144
Query: 286 WSVR-----------------------------------YKVALGIAESVAY---LHNGT 307
             ++                                   YK  L +   + Y   +  G 
Sbjct: 145 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 204
Query: 308 E----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           E    R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 205 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 238

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 133 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 160

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 26  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 84
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 85  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 139
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 140 G---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRY 184
Query: 367 QR 368
            R
Sbjct: 185 YR 186

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS+         RE+ I   + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     + +  + LI + V+GG L   L EK+      +T       +    I 
Sbjct: 73  HPNVITLHE-VYENKTDVILIGELVAGGELFDFLAEKESLTEEEAT-------EFLKQIL 124
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH+     + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 125 NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 455 KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+SS    KL DFGL+ +
Sbjct: 513 ---------VHRDIAARNVLVSSNDCVKLGDFGLSRY 540

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 37  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 95
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 96  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 150
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 151 G---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRY 195
Query: 367 QR 368
            R
Sbjct: 196 YR 197

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/151 (27%), Positives = 67/151 (44%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G    V  GK    +  VA+K + KE   S   F +E      L HP +V   G C 
Sbjct: 16  LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC- 72
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
             E  ++++ +Y+S G L  +L    KG+  +  L      ++   + E +A+L +    
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLL------EMCYDVCEGMAFLESHQ-- 124
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLATWT 340
             +HRD+   N L+      K+ DFG+  + 
Sbjct: 125 -FIHRDLAARNCLVDRDLCVKVSDFGMTRYV 154

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLA 175

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 85/165 (51%), Gaps = 14/165 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 34  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 92
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 93  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 147
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA--TWTSAPSVPFLC 349
               ++HRD+KPSNI++ S    K+ DFGLA    TS   VPF+ 
Sbjct: 148 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVV 189

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV-----P 243
           LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+V     P
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 301
                + P     L  +Y  GG L ++L++ +   G++        +R  ++  I+ ++ 
Sbjct: 83  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRTLLS-DISSALR 136
Query: 302 YLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLA 337
           YLH   E  ++HRD+KP NI+L     + I K+ D G A
Sbjct: 137 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 172

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 11/130 (8%)
Query: 208 TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           T VA+K + K    S +AF  E  +  +L H  +V L    +  ++ +++I ++++ GSL
Sbjct: 40  TKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 96
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
              L   +      S  P       +  IAE +A++    +R  +HRD++ +NIL+S+  
Sbjct: 97  LDFLKSDE-----GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASL 148
Query: 328 IPKLCDFGLA 337
           + K+ DFGLA
Sbjct: 149 VCKIADFGLA 158

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 9/152 (5%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVGF 247
           LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 119 LF--REGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 171
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           +  V+HRD+KPSN+L+++    K+CDFG++ +
Sbjct: 172 KLSVIHRDVKPSNVLINALGQVKMCDFGISGY 203

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV-----P 243
           LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+V     P
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK--GVRGNSTLPWSVRYKVALGIAESVA 301
                + P     L  +Y  GG L ++L++ +   G++        +R  ++  I+ ++ 
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGP-----IRTLLS-DISSALR 135
Query: 302 YLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGLA 337
           YLH   E  ++HRD+KP NI+L     + I K+ D G A
Sbjct: 136 YLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 25  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI     +
Sbjct: 85  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGIK----H 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYV 179
Query: 363 IEEWQR 368
           +  + R
Sbjct: 180 VTRYYR 185

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/157 (34%), Positives = 74/157 (47%), Gaps = 24/157 (15%)
Query: 190 LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG+GA S V    K   G    +  I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 68
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
               I  E   +L++  V+GG L   +  ++     +++            I ESV + H
Sbjct: 69  HD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILESVNHCH 120
Query: 305 -NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
            NG    +VHRD+KP N+LL+SK      KL DFGLA
Sbjct: 121 LNG----IVHRDLKPENLLLASKSKGAAVKLADFGLA 153

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 26  IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 85
Query: 248 -----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
                 ++  Q ++L+ + +   +L + +  +    R +  L     Y++  GI     +
Sbjct: 86  FTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCGIK----H 135
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC 362
           LH+     ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYV 180
Query: 363 IEEWQR 368
           +  + R
Sbjct: 181 VTRYYR 186

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRG----NSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+      N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ + L HPN+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTL-----PWSVRYKVA 293
           L+G  +  +Q L +I+ Y S G L   L     H        + T+     P    + VA
Sbjct: 94  LLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             IA  + YL   +   VVH+D+   N+L+  K   K+ D GL
Sbjct: 153 -QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL 191

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 33  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 91
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 92  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 146
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 147 G---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRY 191
Query: 367 QR 368
            R
Sbjct: 192 YR 193

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 78/152 (51%), Gaps = 9/152 (5%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVGF 247
           LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 75  LF--REGDVWICMELMDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 127
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           +  V+HRD+KPSN+L+++    K+CDFG++ +
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGY 159

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           R LG GA   VF  +   L  +     VA+K L      + K F RE  + ++L H +IV
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVA 293
              G C D +  L ++++Y+  G L + L                +    L  S    +A
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             IA  + YL     +  VHRD+   N L+ +  + K+ DFG++
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 88/182 (48%), Gaps = 24/182 (13%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEEW 366
               ++HRD+KPSNI++ S    K+ DFGLA            +T   +F   P+ +  +
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLA------------RTAGTSFMMTPYVVTRY 190
Query: 367 QR 368
            R
Sbjct: 191 YR 192

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 25/161 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAF--CRELMIASSLH---HPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +   L    HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + +LH+     VVHRD+KP NIL++S    KL DFGLA
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 69/132 (52%), Gaps = 12/132 (9%)
Query: 207 RTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGG 265
           +  VAIK L +  +K  ++   RE  I   L +P IV L+G C    + L L+ +   GG
Sbjct: 363 QIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALMLVMEMAGGG 420
Query: 266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS 325
            L + L  K++ +  ++     + ++V++G+     YL    E+  VHR++   N+LL +
Sbjct: 421 PLHKFLVGKREEIPVSNVA--ELLHQVSMGMK----YLE---EKNFVHRNLAARNVLLVN 471
Query: 326 KKIPKLCDFGLA 337
           +   K+ DFGL+
Sbjct: 472 RHYAKISDFGLS 483

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 59  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 114 RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 167
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL------ATWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG       ATWT   +
Sbjct: 168 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGT 222
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 223 PEYLAPEIILSKGYN 237

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELM 231
           +I     +F   ++LG+G+   VF  +        AIK L K+    D +       + +
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 71
Query: 232 IASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ +  HP +  +  FC    ++ LF + +Y++GG L  H+    K     +T       
Sbjct: 72  LSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF------ 123
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             A  I   + +LH+   + +V+RD+K  NILL      K+ DFG+
Sbjct: 124 -YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 165

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIITLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 81/166 (48%), Gaps = 30/166 (18%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 28  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 79
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P   RY +
Sbjct: 80  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEP-EARYFM 132
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT
Sbjct: 133 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT 174

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
            +  H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTSDLKICDFGLA 173

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 30/166 (18%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P + RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEPEA-RYFM 148
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT 190

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 22/161 (13%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGF- 247
           +  RG    V+K +  L+   VA+K    +DK+S ++  RE+     + H N++  +   
Sbjct: 22  IKARGRFGCVWKAQ--LMNDFVAVKIFPLQDKQSWQSE-REIFSTPGMKHENLLQFIAAE 78
Query: 248 --CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               + E  L+LI  +   GSL  +L       +GN  + W+    VA  ++  ++YLH 
Sbjct: 79  KRGSNLEVELWLITAFHDKGSLTDYL-------KGN-IITWNELCHVAETMSRGLSYLHE 130
Query: 306 GTERC--------VVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               C        + HRD K  N+LL S     L DFGLA 
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV 171

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 190 LGRGALSFVFKGKV-----GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVP 243
           LG      V+KG +     G    +VAIK L DK +    + F  E M+ + L HPN+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHL-----HEKKKGVRGNSTL-----PWSVRYKVA 293
           L+G  +  +Q L +I+ Y S G L   L     H        + T+     P    + VA
Sbjct: 77  LLG-VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             IA  + YL   +   VVH+D+   N+L+  K   K+ D GL
Sbjct: 136 -QIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGL 174

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 30/166 (18%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P + RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEPEA-RYFM 148
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT 190

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I + L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 82/166 (49%), Gaps = 30/166 (18%)
Query: 184 FSKGRVLGRGALSF-----------VFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI 232
           + +GR LG+G  +            VF GKV  +  S+ +K   KE   +      E+ I
Sbjct: 44  YMRGRFLGKGGFAKCYEITDMDTKEVFAGKV--VPKSMLLKPHQKEKMST------EIAI 95
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             SL +P++V   GF  D +  ++++ +     SL   LH+++K V    T P + RY +
Sbjct: 96  HKSLDNPHVVGFHGFFED-DDFVYVVLEICRRRSL-LELHKRRKAV----TEPEA-RYFM 148
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              I + V YLHN     V+HRD+K  N+ L+     K+ DFGLAT
Sbjct: 149 RQTI-QGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT 190

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 237
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 238 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 237
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 238 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 12/150 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH-PNIVPLVGF 247
           +G G    V+K +       +A+K++ +  +KE +K    +L +    H  P IV   G 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I     +F+  + +  G+    L ++ +G      +P  +  K+ + I +++ YL    
Sbjct: 93  FIT-NTDVFIAMELM--GTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKE-- 142
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  V+HRD+KPSNILL  +   KLCDFG++
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 18/167 (10%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF--CRELMIASSLH 237
           AT  +     +G GA   V+K +       VA+K +   + E        RE+ +   L 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 238 ---HPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
              HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 115
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA
Sbjct: 116 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 159

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 25/161 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAF--CRELMIASSLH---HPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +   L    HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + +LH+     VVHRD+KP NIL++S    KL DFGLA
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 75/161 (46%), Gaps = 25/161 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTS---VAIKRLDKEDKESSKAF--CRELMIASSLH---HPNI 241
           +G GA   VFK +   L+     VA+KR+  +  E        RE+ +   L    HPN+
Sbjct: 19  IGEGAYGKVFKARD--LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 242 VPLVGFCI----DPEQGLFLIYKYVSGGSLERHLHE-KKKGVRGNSTLPWSVRYKVALGI 296
           V L   C     D E  L L++++V    L  +L +  + GV      P      +   +
Sbjct: 77  VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGV------PTETIKDMMFQL 129
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + +LH+     VVHRD+KP NIL++S    KL DFGLA
Sbjct: 130 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 167

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 75  KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+S+    KL DFGL+ +
Sbjct: 133 ---------VHRDIAARNVLVSATDCVKLGDFGLSRY 160

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 21  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 80
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 138 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 176

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 22  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 81
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 82  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 138
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 139 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 177

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 13  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 72
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 73  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 129
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 130 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 168

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TWT   +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 14  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 73
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 131 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 169

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 74/156 (47%), Gaps = 22/156 (14%)
Query: 190 LGRGALSFV---FKGKVGLLRTSVAI--KRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG+GA S V    K   G    ++ I  K+L   D +  +   RE  I   L HPNIV L
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVRL 75
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
               I  E   +LI+  V+GG L   +  ++     +++            I E+V + H
Sbjct: 76  HD-SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHCH 127
Query: 305 NGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
              +  VVHR++KP N+LL+SK      KL DFGLA
Sbjct: 128 ---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 14  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 73
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 74  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 130
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 131 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 169

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 21  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 80
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 81  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 137
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 138 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 176

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 187 GRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           GR +G G    V +G          +VAIK       +S +  F +E +      HP+IV
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  +  E  +++I +  + G L   L  +K  +   S + ++ +   AL   ES  +
Sbjct: 455 KLIG--VITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                    VHRDI   N+L+S+    KL DFGL+ +
Sbjct: 513 ---------VHRDIAARNVLVSATDCVKLGDFGLSRY 540

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 76/152 (50%), Gaps = 9/152 (5%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIAS-SLHHPNIVPLVGF 247
           LGRGA   V K +        A+KR+    + +  K    +L I+  ++  P  V   G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
                +G   I   +   SL++     K+ +    T+P  +  K+A+ I +++ +LH  +
Sbjct: 102 LF--REGDVWICXELXDTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLH--S 154
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
           +  V+HRD+KPSN+L+++    K CDFG++ +
Sbjct: 155 KLSVIHRDVKPSNVLINALGQVKXCDFGISGY 186

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 65  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 116
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + E +  LH      +VHRD+KP NILL      KL DFG +
Sbjct: 117 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 158

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 80  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 131
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 132 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 161

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIIHLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 24  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 83
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 84  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 135
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TWT   +  +L 
Sbjct: 136 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEYLA 192
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 193 PEIILSKGYN 202

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLA 171

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 78  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 129
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + E +  LH      +VHRD+KP NILL      KL DFG +
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 71/165 (43%), Gaps = 21/165 (12%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---------KEDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D         +E +E  +A  +E+ I 
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L     +     FL++  +  G L  +L EK        TL      K+
Sbjct: 78  RKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKI 129
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + E +  LH      +VHRD+KP NILL      KL DFG +
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 17/161 (10%)
Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR----GNSTLPWSVRYKVALGIAESV 300
            G C +  + L ++++Y+  G L R L       +    G    P  +     L +A  V
Sbjct: 109 FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 301 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A    YL        VHRD+   N L+    + K+ DFG++
Sbjct: 168 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 71  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 122 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 151

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 243
           V+G+GA S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 91  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 304 HNGTERCVVHRDIKPSNILLSSKK--IP-KLCDFGLA 337
           H+     ++HRD+KP N+LL+SK+   P KL DFG+A
Sbjct: 147 HDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVA 180

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 17/166 (10%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELM 231
           +I     +F   ++LG+G+   VF  +        AIK L K+    D +       + +
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV 70
Query: 232 IASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ +  HP +  +  FC    ++ LF + +Y++GG L  H+    K     +T       
Sbjct: 71  LSLAWEHPFLTHM--FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF------ 122
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             A  I   + +LH+   + +V+RD+K  NILL      K+ DFG+
Sbjct: 123 -YAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGM 164

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAIK++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 67/130 (51%), Gaps = 13/130 (10%)
Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 267
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D  E+ L L+ +YV  GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
             +L     G+        +     A  I E +AYLH+   +  +HR++   N+LL + +
Sbjct: 106 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHS---QHYIHRNLAARNVLLDNDR 154
Query: 328 IPKLCDFGLA 337
           + K+ DFGLA
Sbjct: 155 LVKIGDFGLA 164

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 73  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 124 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 153

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLA 171

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I  Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLH----EKKKGVRGNSTLPWSVRYKVALGIAESV 300
            G C +  + L ++++Y+  G L R L     + K    G    P  +     L +A  V
Sbjct: 80  FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 301 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A    YL        VHRD+   N L+    + K+ DFG++
Sbjct: 139 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMS 176

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
            +  H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LAFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 173

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 79/155 (50%), Gaps = 17/155 (10%)
Query: 189 VLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVG 246
           +LG GA + V +G V L      A+K ++K+   S     RE+  +     + NI+ L+ 
Sbjct: 20  LLGEGAYAKV-QGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
           F  D +   +L+++ + GGS+  H+ ++K      ++       +V   +A ++ +LH  
Sbjct: 79  FFED-DTRFYLVFEKLQGGSILAHIQKQKHFNEREAS-------RVVRDVAAALDFLHT- 129
Query: 307 TERCVVHRDIKPSNILLSS--KKIP-KLCDFGLAT 338
             + + HRD+KP NIL  S  K  P K+CDF L +
Sbjct: 130 --KGIAHRDLKPENILCESPEKVSPVKICDFDLGS 162

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 17/161 (10%)
Query: 190 LGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           LG GA   VF  +   L     +  VA+K L +  + + + F RE  + + L H +IV  
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLH----EKKKGVRGNSTLPWSVRYKVALGIAESV 300
            G C +  + L ++++Y+  G L R L     + K    G    P  +     L +A  V
Sbjct: 86  FGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 301 A----YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A    YL        VHRD+   N L+    + K+ DFG++
Sbjct: 145 AAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMS 182

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 86  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 137
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 167

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           + LG GA   V      +   +VA+K +D K   +  +   +E+ I   L+H N+V   G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 247 FCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +   Q LFL  +Y SGG L          +  +  +P     +    +   V YLH 
Sbjct: 72  HRREGNIQYLFL--EYCSGGELFDR-------IEPDIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                + HRDIKP N+LL  +   K+ DFGLAT
Sbjct: 123 IG---ITHRDIKPENLLLDERDNLKISDFGLAT 152

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 86  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 137
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 138 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 167

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 239
             + K   +G G    VFK K       VA+KR  LD +D+    +  RE+ +   L H 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L    +  ++ L L++++            KK     N  L   +       + + 
Sbjct: 62  NIVRLHD-VLHSDKKLTLVFEFCDQDL-------KKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           + + H+   R V+HRD+KP N+L++     KL +FGLA     P
Sbjct: 114 LGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 31/202 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXGT 201
Query: 345 VPFLCKTVKGTFGQNPFCIEEW 366
             +L   +  + G N   ++ W
Sbjct: 202 PEYLAPEIILSKGYNK-AVDWW 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 80  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 131
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 132 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 161

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKE 221
           N  +R    EI A+     K  V+G G    V  G++   G     VAIK L     DK+
Sbjct: 16  NQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 73
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F  E  I     HPNI+ L G  +   + + +I +Y+  GSL+  L +      G 
Sbjct: 74  R-RDFLSEASIMGQFDHPNIIHLEG-VVTKCKPVMIITEYMENGSLDAFLRKND----GR 127
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            T+   V   +  GI   + YL   ++   VHRD+   NIL++S  + K+ DFG++
Sbjct: 128 FTVIQLV--GMLRGIGSGMKYL---SDMSAVHRDLAARNILVNSNLVCKVSDFGMS 178

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + ++ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMRIADFGLA 204

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + R LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           LG G+   V +G+         SVA+K L  +     E+   F RE+    SL H N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  + P   + ++ +    GSL   L + +    G+  L    RY  A+ +AE + YL
Sbjct: 76  LYGVVLTPP--MKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQVAEGMGYL 127
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            +   +  +HRD+   N+LL+++ + K+ DFGL
Sbjct: 128 ES---KRFIHRDLAARNLLLATRDLVKIGDFGL 157

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 31/202 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQNPFCIEEW 366
             +L   +  + G N   ++ W
Sbjct: 202 PEYLAPAIILSKGYNK-AVDWW 222

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 37/214 (17%)
Query: 152 WRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV-GL 205
           W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +    GL
Sbjct: 1   WKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 55
Query: 206 LRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY 259
            +      VA+K L        K A   EL I S L  H NIV L+G C      + +I 
Sbjct: 56  GKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVIT 114
Query: 260 KYVSGGSLERHLHEKKKGVRGNSTLP--------------WSVRYKVALG--IAESVAYL 303
           +Y   G L   L  K + + G S  P                +R  +     +A+ +A+L
Sbjct: 115 EYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL 174
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              ++ C+ HRD+   N+LL++  + K+ DFGLA
Sbjct: 175 --ASKNCI-HRDVAARNVLLTNGHVAKIGDFGLA 205

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 173 SYGEILAATHNFSKG---------RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDK 220
           +Y +   A H F+K          RV+G G    V  G++   G    +VAIK L     
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 221 ESSKA-FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           E  +  F  E  I     HPN+V L G  +   + + ++ +++  G+L+  L +      
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEG-VVTRGKPVMIVIEFMENGALDAFLRKHD---- 139
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           G  T+   V   +  GIA  + YL    +   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 140 GQFTVIQLV--GMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLS 192

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPL 244
           V+G G    V +G++   G   + VAIK L     E  +  F  E  I     HPNI+ L
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 82
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G   +    + ++ +++  G+L+  L        G  T+   V   +  GIA  + YL 
Sbjct: 83  EGVVTN-SMPVMILTEFMENGALDSFLRLND----GQFTVIQLV--GMLRGIASGMRYL- 134
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              E   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 135 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLS 165

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I  Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      L +  VAI+++   E +   +   RE+ I 
Sbjct: 20  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKIL 79
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 80  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 136
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 137 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVPL 244
           V+G G    V +G++   G   + VAIK L     E  +  F  E  I     HPNI+ L
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRL 80
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            G   +    + ++ +++  G+L+  L        G  T+   V   +  GIA  + YL 
Sbjct: 81  EGVVTN-SMPVMILTEFMENGALDSFLRLND----GQFTVIQLV--GMLRGIASGMRYL- 132
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              E   VHRD+   NIL++S  + K+ DFGL+
Sbjct: 133 --AEMSYVHRDLAARNILVNSNLVCKVSDFGLS 163

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 240
           N+    ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 299
           I+ L    I PE  L     Y+     +  L +  K  +        ++ Y + LG    
Sbjct: 89  IIRLHDLII-PEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLG---- 143
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++H   E  ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 144 EKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLA 178

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 25  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 79
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 80  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFY 133
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 134 --AAQIVLTFEYLHSLD---LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGT 188
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 189 PEYLAPEIILSKGYN 203

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 69  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 119
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC 362
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +       + TF   PF 
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK------RNTFVGTPFW 170
Query: 363 I 363
           +
Sbjct: 171 M 171

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 66/130 (50%), Gaps = 13/130 (10%)
Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 267
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D  E+ L L+ +YV  GSL
Sbjct: 46  VAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSL 105
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
             +L     G+        +     A  I E +AYLH    +  +HR++   N+LL + +
Sbjct: 106 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHA---QHYIHRNLAARNVLLDNDR 154
Query: 328 IPKLCDFGLA 337
           + K+ DFGLA
Sbjct: 155 LVKIGDFGLA 164

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 13/155 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 84  KYYGSYLK-DTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILR-----EILKGLDY 134
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+  +   +HRDIK +N+LLS     KL DFG+A
Sbjct: 135 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 166

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 85/179 (47%), Gaps = 19/179 (10%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 89  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 139
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPF 361
           LH+  +   +HRDIK +N+LLS     KL DFG+A   +   +       + TF   PF
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK------RNTFVGTPF 189

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 31/202 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQNPFCIEEW 366
             +L   +  + G N   ++ W
Sbjct: 202 PEYLAPEIILSKGYNK-AVDWW 222

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 39  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 94  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 147
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 148 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 202
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 203 PEYLAPEIILSKGYN 217

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKE 221
           N  +R    EI A+     K  V+G G    V  G++   G     VAIK L     DK+
Sbjct: 1   NQAVREFAKEIDASCIKIEK--VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ 58
Query: 222 SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGN 281
             + F  E  I     HPNI+ L G  +   + + +I +Y+  GSL+  L +      G 
Sbjct: 59  R-RDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMIITEYMENGSLDAFLRKND----GR 112
Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            T+   V   +  GI   + YL   ++   VHRD+   NIL++S  + K+ DFG++
Sbjct: 113 FTVIQLV--GMLRGIGSGMKYL---SDMSYVHRDLAARNILVNSNLVCKVSDFGMS 163

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 80/168 (47%), Gaps = 17/168 (10%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 36  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 234 SSLHHPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
               H NI+ +        I+  + ++L+  ++ G  L + L   K     N  + + + 
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLL---KTQHLSNDHICYFL- 150
Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           Y++  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 151 YQILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLA 191

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 70/155 (45%), Gaps = 19/155 (12%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           LG G    V+K    +   +VAIKR  L+ E++       RE+ +   L H NI+ L   
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS- 100
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
            I     L LI++Y          ++ KK +  N  +   V       +   V + H  +
Sbjct: 101 VIHHNHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH--S 150
Query: 308 ERCVVHRDIKPSNILL-----SSKKIPKLCDFGLA 337
            RC+ HRD+KP N+LL     S   + K+ DFGLA
Sbjct: 151 RRCL-HRDLKPQNLLLSVSDASETPVLKIGDFGLA 184

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 171

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 78/155 (50%), Gaps = 13/155 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S    P + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +  +  L++I +Y+ GGS    L   + G    + +   +R      I + + Y
Sbjct: 69  KYYGSYLK-DTKLWIIMEYLGGGS---ALDLLEPGPLDETQIATILR-----EILKGLDY 119
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+  +   +HRDIK +N+LLS     KL DFG+A
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVA 151

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 79/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG GA    V    VG+ +       +VA+K L  D  +++ S       M+     
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 100 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 159 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 204

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 18  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 77
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 78  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 134
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 135 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 173

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 24  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 83
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 84  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 140
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 141 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 179

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 171

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 80/183 (43%), Gaps = 14/183 (7%)
Query: 161 SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK 220
           S SP A SL  +    +      F    ++G G    V+KG+        AIK +D    
Sbjct: 4   SDSP-ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD 62
Query: 221 ESSKAFCRELMIASSLHHPNIVPLVGFCI--DP---EQGLFLIYKYVSGGSLERHLHEKK 275
           E  +      M+    HH NI    G  I  +P   +  L+L+ ++   GS+   +    
Sbjct: 63  EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---- 118
Query: 276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           K  +GN+     + Y +   I   +++LH   +  V+HRDIK  N+LL+     KL DFG
Sbjct: 119 KNTKGNTLKEEWIAY-ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG 174
Query: 336 LAT 338
           ++ 
Sbjct: 175 VSA 177

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 33  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 87
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 88  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 141
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 142 --AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 196
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 197 PEYLAPEIILSKGYN 211

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 83/180 (46%), Gaps = 19/180 (10%)
Query: 163 SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFK---GKVGLLRTSVAIKRLDKED 219
           +P  + ++    G +  + +  SK  +LG G    V K      GL   +  IK    +D
Sbjct: 71  APFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129
Query: 220 KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           KE  K    E+ + + L H N++ L     + +  + L+ +YV GG L   + ++   + 
Sbjct: 130 KEEVK---NEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLA 337
              T+ +  +      I E + ++H   +  ++H D+KP NIL  ++  K  K+ DFGLA
Sbjct: 186 ELDTILFMKQ------ICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFAEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 80/155 (51%), Gaps = 13/155 (8%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   V+KG     +  VAIK +D +E ++  +   +E+ + S    P I 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G  +   + L++I +Y+ GGS    L   K G    + +   +R      I + + Y
Sbjct: 81  RYFGSYLKSTK-LWIIMEYLGGGSA---LDLLKPGPLEETYIATILR-----EILKGLDY 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH  +ER + HRDIK +N+LLS +   KL DFG+A
Sbjct: 132 LH--SERKI-HRDIKAANVLLSEQGDVKLADFGVA 163

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 189 VLGRGALSFVFK-------GKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLH-HP 239
           V+GRG  S V +        +  +    V  +RL  E  +E  +A  RE  I   +  HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           +I+ L+    +    +FL++  +  G L  +L EK         L       +   + E+
Sbjct: 161 HIITLID-SYESSSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEA 212
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           V++LH      +VHRD+KP NILL      +L DFG +
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS 247

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 47  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 104
Query: 213 KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 161
Query: 270 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 162 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 210
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
             KL DFG     +   +   C T  GT
Sbjct: 211 HLKLADFGTCMKMNKEGM-VRCDTAVGT 237

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 81/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRI-----GRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 57/111 (51%), Gaps = 12/111 (10%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           RE+ I  +L+H +IV   G C D  E+ + L+ +YV  GSL  +L     G+        
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-------- 111
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +     A  I E +AYLH    +  +HR +   N+LL + ++ K+ DFGLA
Sbjct: 112 AQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLA 159

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 76/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 36  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 95
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 96  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 152
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 153 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 191

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 12/151 (7%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGF 247
           +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+  
Sbjct: 32  IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLN- 90
Query: 248 CIDPEQGLFLIYK-YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
              P++ L      Y+    ++ +L +  +    +  + + + Y++  GI     +LH+ 
Sbjct: 91  VFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-LLYQMLCGIK----HLHSA 145
Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLA 173

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 73/161 (45%), Gaps = 25/161 (15%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG-- 246
           V  RG    V+K +  LL   VA+K    +DK+S +    E+     + H NI+  +G  
Sbjct: 31  VKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQSWQNE-YEVYSLPGMKHENILQFIGAE 87
Query: 247 ---FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                +D +  L+LI  +   GSL   L          + + W+    +A  +A  +AYL
Sbjct: 88  KRGTSVDVD--LWLITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYL 137
Query: 304 H-------NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           H       +G +  + HRDIK  N+LL +     + DFGLA
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 243
           +V+G G    V  G +   G     VAIK L     E  +  F  E  I     HPN++ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +     + +I +++  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 99  LEG-VVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL 151
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW----TSAPS 344
               +   VHRD+   NIL++S  + K+ DFGL+ +    TS P+
Sbjct: 152 ---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 64/130 (49%), Gaps = 13/130 (10%)
Query: 210 VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL 267
           VA+K L  +   +    + +E+ I  +L+H +I+   G C D     L L+ +YV  GSL
Sbjct: 63  VAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSL 122
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
             +L     G+        +     A  I E +AYLH    +  +HRD+   N+LL + +
Sbjct: 123 RDYLPRHSIGL--------AQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDR 171
Query: 328 IPKLCDFGLA 337
           + K+ DFGLA
Sbjct: 172 LVKIGDFGLA 181

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 84/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIILSKGYN 216

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/111 (33%), Positives = 57/111 (51%), Gaps = 12/111 (10%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           RE+ I  +L+H +IV   G C D  E+ + L+ +YV  GSL  +L     G+        
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGL-------- 110
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +     A  I E +AYLH    +  +HR +   N+LL + ++ K+ DFGLA
Sbjct: 111 AQLLLFAQQICEGMAYLHA---QHYIHRALAARNVLLDNDRLVKIGDFGLA 158

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 77/167 (46%), Gaps = 22/167 (13%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  VLG+GA   V K +  L     AIK++ +  +E       E+ + +SL+H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVV 65
Query: 243 PLVG------------FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                             +  +  LF+  +Y    +L   +H +    + +        +
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY------W 119
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++   I E+++Y+H+   + ++HR++KP NI +   +  K+ DFGLA
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLA 163

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 142
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 199
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 200 PEIILSKGYN 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 22/208 (10%)
Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 42  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 99
Query: 213 KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 156
Query: 270 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 157 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 205
Query: 328 IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
             KL DFG     +   +   C T  GT
Sbjct: 206 HLKLADFGTCMKMNKEGM-VRCDTAVGT 232

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIV 242
           +V+G G    V  G++   G     VAIK L     DK+  + F  E  I     HPNI+
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQR-RDFLSEASIMGQFDHPNII 72
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G  +   + + +I +Y+  GSL+  L +      G  T+   V   +  GI   + Y
Sbjct: 73  HLEGV-VTKCKPVMIITEYMENGSLDAFLRKND----GRFTVIQLV--GMLRGIGSGMKY 125
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           L   ++   VHRD+   NIL++S  + K+ DFG++
Sbjct: 126 L---SDMSYVHRDLAARNILVNSNLVCKVSDFGMS 157

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 288
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+             + +  
Sbjct: 87  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 145
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 146 LVSCTYQLARGMEYL--ASQKCI-HRDLTARNVLVTENNVMKIADFGLA 191

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 30/195 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 38  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G  + P +  Y
Sbjct: 93  RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFSEPHARFY 146
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+++  +   ++ DFG A      TW    +
Sbjct: 147 --AAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGT 201
Query: 345 VPFLCKTVKGTFGQN 359
             +L   +  + G N
Sbjct: 202 PEYLAPEIIISKGYN 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 21/188 (11%)
Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           RK ++++  +S   +++ ++   ++     ++   +V+GRGA   V   +    R   A+
Sbjct: 47  RKNKNIDNFLSRYKDTINKIR--DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAM 104
Query: 213 KRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           K L K +   +  S  F  E  I +  + P +V L  +    ++ L+++ +Y+ GG L  
Sbjct: 105 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL-- 161
Query: 270 HLHEKKKGVRGNSTLP--WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                   +  N  +P  W+  Y      AE V  L        +HRD+KP N+LL    
Sbjct: 162 ------VNLMSNYDVPEKWARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG 210
Query: 328 IPKLCDFG 335
             KL DFG
Sbjct: 211 HLKLADFG 218

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 75/153 (49%), Gaps = 17/153 (11%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRL---DKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           LG G  S+V   +        A+KR+   +++D+E ++   RE  +    +HPNI+ LV 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ---READMHRLFNHPNILRLVA 93
Query: 247 FCIDPEQGL----FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           +C+  E+G     +L+  +   G+L   +   K   +GN      + + + LGI   +  
Sbjct: 94  YCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKD--KGNFLTEDQILW-LLLGICRGLEA 149
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           +H    +   HRD+KP+NILL  +  P L D G
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLG 179

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 146 HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 205 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 250

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----GVRGNSTLPWSVRYKV 292
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++          N      + +K 
Sbjct: 92  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 150
Query: 293 ALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +     +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 151 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 196

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HRDIK  NILL      KL DFG 
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 83  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HRDIK  NILL      KL DFG 
Sbjct: 133 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 163

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 69/143 (48%), Gaps = 13/143 (9%)
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST-- 283
           F  EL I + + +   +   G   + ++ +++IY+Y+   S+ +   E    +  N T  
Sbjct: 90  FKNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILK-FDEYFFVLDKNYTCF 147
Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           +P  V   +   +  S +Y+HN  E+ + HRD+KPSNIL+      KL DFG + +    
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--- 202
Query: 344 SVPFLCKTVKGTFGQNPFCIEEW 366
               + K +KG+ G   F   E+
Sbjct: 203 ----VDKKIKGSRGTYEFMPPEF 221

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 20/132 (15%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ S+    E+++     HPNI+ L     D  + ++L+ + + GG L ++
Sbjct: 56  AVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKD-VYDDGKHVYLVTELMRGGELLDK 111
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH+   + VVHRD+KPSNIL      +
Sbjct: 112 ILRQKFFSEREASF--------VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 326 KKIPKLCDFGLA 337
            +  ++CDFG A
Sbjct: 161 PECLRICDFGFA 172

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HRDIK  NILL      KL DFG 
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 131
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HRDIK  NILL      KL DFG 
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGF 162

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 149 ELKWRKIQSLERS----ISPVANSLIRLSYGEILA-ATHNFSKGRVLGRGALSFVFKGKV 203
           +++W+ I+S E +    I P      +L Y E      +N   G+ LG GA   V +   
Sbjct: 13  QVRWKIIESYEGNSYTFIDPT-----QLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATA 67
Query: 204 -GLLRTS----VAIKRLDKEDKESSK-AFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF 256
            GL +      VA+K L        K A   EL I S L  H NIV L+G C      + 
Sbjct: 68  FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-GGPVL 126
Query: 257 LIYKYVSGGSLERHLHEKKKGVRGNSTLP-------WSVRYKVALG--IAESVAYLHNGT 307
           +I +Y   G L   L  K+      S  P        S R  +     +A+ +A+L   +
Sbjct: 127 VITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFL--AS 184
Query: 308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + C+ HRD+   N+LL++  + K+ DFGLA
Sbjct: 185 KNCI-HRDVAARNVLLTNGHVAKIGDFGLA 213

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 31/202 (15%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CREL 230
           A    F + + LG G+      G+V L++        A+K LDK+     K       E 
Sbjct: 59  AQLDQFDRIKTLGTGSF-----GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            I  +++ P +V L  F       L+++ +YV+GG +  HL        G    P +  Y
Sbjct: 114 RILQAVNFPFLVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRR-----IGRFXEPHARFY 167
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +
Sbjct: 168 --AAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGT 222
Query: 345 VPFLCKTVKGTFGQNPFCIEEW 366
             +L   +  + G N   ++ W
Sbjct: 223 PEYLAPEIILSKGYNK-AVDWW 243

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 187 GRVLGRGAL-SFVFKGKVGLLR------TSVAIKRL--DKEDKESSKAFCRELMIASSLH 237
           G+ LG G     V    VG+ +       +VA+K L  D  +K+ S       M+     
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVR--------GNSTLPWSV 288
           H NI+ L+G C   +  L++I +Y S G+L  +L  ++  G+             + +  
Sbjct: 89  HKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 147
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                  +A  + YL   +++C+ HRD+   N+L++   + K+ DFGLA
Sbjct: 148 LVSCTYQLARGMEYL--ASQKCI-HRDLAARNVLVTENNVMKIADFGLA 193

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFGLA      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 31  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 91  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFXEPHARFY--AAQ 142
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 143 IVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 199
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 200 PEIILSKGYN 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 18/114 (15%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           +E+ I   L HPN+V LV    DP E  L+++++ V+ G +          +   +  P 
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----------MEVPTLKPL 134
Query: 287 S---VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           S    R+     + + + YLH    + ++HRDIKPSN+L+      K+ DFG++
Sbjct: 135 SEDQARFYFQ-DLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVS 184

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 74/141 (52%), Gaps = 17/141 (12%)
Query: 190 LGRGALSFVFKG---KVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           LG+G  + +FKG   +VG    L  T V +K LDK  +  S++F     + S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G C+  ++ + L+ ++V  GSL+ +L + K  +     + W  + +VA  +A ++ +
Sbjct: 76  LNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKNCI----NILW--KLEVAKQLAAAMHF 128
Query: 303 LHNGTERCVVHRDIKPSNILL 323
           L   T   ++H ++   NILL
Sbjct: 129 LEENT---LIHGNVCAKNILL 146

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 69/132 (52%), Gaps = 20/132 (15%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ S+    E+++     HPNI+ L     D  + ++L+ + + GG L ++
Sbjct: 56  AVKVIDKSKRDPSEEI--EILLRYG-QHPNIITLKD-VYDDGKHVYLVTELMRGGELLDK 111
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH+   + VVHRD+KPSNIL      +
Sbjct: 112 ILRQKFFSEREASF--------VLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGN 160
Query: 326 KKIPKLCDFGLA 337
            +  ++CDFG A
Sbjct: 161 PECLRICDFGFA 172

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 59  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 119 VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 170
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 171 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 227
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 228 PEIILSKGYN 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 243 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 295
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA
Sbjct: 296 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 338

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 32/185 (17%)
Query: 159 ERSISP--VANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
           +R I P  +  +L   S+G++  ATH  ++ +V    AL F+ +    LL+ S    R++
Sbjct: 5   KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKV----ALKFISRQ---LLKKSDMHMRVE 57
Query: 217 KEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
                      RE+     L HP+I+ L      P   + ++ +Y +GG L  ++ EKK+
Sbjct: 58  -----------REISYLKLLRHPHIIKLYDVITTP-TDIVMVIEY-AGGELFDYIVEKKR 104
Query: 277 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                         +    I  ++ Y H      +VHRD+KP N+LL      K+ DFGL
Sbjct: 105 MTEDEGR-------RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154
Query: 337 ATWTS 341
           +   +
Sbjct: 155 SNIMT 159

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 11/158 (6%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 240
           N+    ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK-KKGVRGNSTLPWSVRYKVALGIAES 299
           I+ L    I P+  L     Y+     +  L +  K  +        ++ Y + LG    
Sbjct: 87  IIRLYDLII-PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG---- 141
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++H   E  ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 142 ENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 13/157 (8%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F+   VLG+G+   V            AIK L K+     +  +    E  + + L  P
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             +  +  C      L+ + +YV+GG L  H+ +      G    P +V Y   + I   
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISIG-- 132
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + +LH   +R +++RD+K  N++L S+   K+ DFG+
Sbjct: 133 LFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGM 166

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 77/167 (46%), Gaps = 17/167 (10%)
Query: 177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMI 232
           I    ++FS  R++GRG    V+  +        A+K LDK+     +  + A    +M+
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 233 A--SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  S+   P IV  + +       L  I   ++GG L  H H  + GV   + + +    
Sbjct: 244 SLVSTGDCPFIV-CMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGVFSEADMRF---- 296
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             A  I   + ++HN   R VV+RD+KP+NILL      ++ D GLA
Sbjct: 297 -YAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLA 339

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFXEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +YV GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRI-----GRFXEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y+ GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 20/132 (15%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ ++    E+++     HPNI+ L     D  + ++++ + + GG L ++
Sbjct: 51  AVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKD-VYDDGKYVYVVTELMKGGELLDK 106
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH    + VVHRD+KPSNIL      +
Sbjct: 107 ILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 326 KKIPKLCDFGLA 337
            +  ++CDFG A
Sbjct: 156 PESIRICDFGFA 167

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/181 (23%), Positives = 83/181 (45%), Gaps = 17/181 (9%)
Query: 162 ISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDK 220
           + P     + +  G+       +++ + +G GA   V      + +T VAIK++   E +
Sbjct: 23  VGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQ 82
Query: 221 ESSKAFCRELMIASSLHHPNIVP----LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK 276
              +   RE+ I     H N++     L    ++  + +     Y+    +E  L++  K
Sbjct: 83  TYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDV-----YIVQDLMETDLYKLLK 137
Query: 277 GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             + ++       Y++  G+     Y+H+     V+HRD+KPSN+L+++    K+CDFGL
Sbjct: 138 SQQLSNDHICYFLYQILRGLK----YIHSAN---VLHRDLKPSNLLINTTCDLKICDFGL 190
Query: 337 A 337
           A
Sbjct: 191 A 191

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + +G G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y+ GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   K+ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 74/166 (44%), Gaps = 31/166 (18%)
Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKED---KESSKAFCRELMI 232
             ++   +V+GRGA      G+V L+R        A+K L K +   +  S  F  E  I
Sbjct: 74  AEDYDVVKVIGRGAF-----GEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDI 128
Query: 233 ASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP--WSVR 289
            +  + P +V L  FC    ++ L+++ +Y+ GG L          +  N  +P  W+  
Sbjct: 129 MAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDL--------VNLMSNYDVPEKWAKF 178
Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
           Y      AE V  L       ++HRD+KP N+LL      KL DFG
Sbjct: 179 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 219

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 69/164 (42%), Gaps = 21/164 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK------AFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K    +S+         RE+ I   + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           H N++ L     +    + LI + VSGG L   L +K+      +T            I 
Sbjct: 74  HHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQIL 125
Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
           + V YLH    + + H D+KP NI+L  K IP    KL DFGLA
Sbjct: 126 DGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  +       L+++ +YV GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+L+  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 14/123 (11%)
Query: 224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVR 279
           K   RE+ + +  HHPNI+ L    +  E+     L+L+ + +    L + +H+++  + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                 +   Y + LG       LH   E  VVHRD+ P NILL+      +CDF LA  
Sbjct: 133 PQHIQYFM--YHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 340 TSA 342
            +A
Sbjct: 184 DTA 186

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/123 (29%), Positives = 58/123 (47%), Gaps = 14/123 (11%)
Query: 224 KAFCRELMIASSLHHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVR 279
           K   RE+ + +  HHPNI+ L    +  E+     L+L+ + +    L + +H+++  + 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVIS 132
Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                 +   Y + LG       LH   E  VVHRD+ P NILL+      +CDF LA  
Sbjct: 133 PQHIQYFM--YHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLARE 183
Query: 340 TSA 342
            +A
Sbjct: 184 DTA 186

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/172 (22%), Positives = 70/172 (40%), Gaps = 14/172 (8%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKAFCREL 230
           ++L     F+ GR+LG+G    V + ++       ++ +V + + D       + F RE 
Sbjct: 17  DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREA 76
Query: 231 MIASSLHHPNIVPLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
                  HP++  LVG  +            +I  ++  G L   L   + G      LP
Sbjct: 77  ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIG-ENPFNLP 135
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                +  + IA  + YL   + R  +HRD+   N +L+      + DFGL+
Sbjct: 136 LQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 51/107 (47%), Gaps = 13/107 (12%)
Query: 235 SLHHPNIVPLVGFC----IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +  HPN+V L+  C     D E  + L++++V    L  +L +          LP     
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-----PGLPAETIK 123
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +       + +LH     C+VHRD+KP NIL++S    KL DFGLA
Sbjct: 124 DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLA 167

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGK------VGLLRTSVAIKRLDKEDKESSKAFCR-ELMIASS 235
           NF   +VLG GA   VF  +       G L     +K+     K  +    R E  +   
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +     +  + +    E  L LI  Y++GG L  HL ++++             ++V + 
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER----------FTEHEVQIY 164
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + E V  L +  +  +++RDIK  NILL S     L DFGL+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 81/154 (52%), Gaps = 15/154 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVGF 247
           VLG GA + V      +     A+K ++K+         RE+ M+     H N++ L+ F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
             + ++  +L+++ + GGS+  H+H++    R  + L  SV   V   +A ++ +LHN  
Sbjct: 80  FEEEDR-FYLVFEKMRGGSILSHIHKR----RHFNELEASV---VVQDVASALDFLHN-- 129
Query: 308 ERCVVHRDIKPSNILLS--SKKIP-KLCDFGLAT 338
            + + HRD+KP NIL    ++  P K+CDFGL +
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFGLGS 162

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 80/190 (42%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   ++ DFGLA      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 71/168 (42%), Gaps = 9/168 (5%)
Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           +G  +GRG    V+K K    +          E    S + CRE+ +   L HPN++ L 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ 84
Query: 246 G-FCIDPEQGLFLIYKYVSGGSLE-RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
             F    ++ ++L++ Y           H   K  +    LP  +   +   I + + YL
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 304 HNGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLATWTSAPSVPF 347
           H      V+HRD+KP+NIL+      +   K+ D G A   ++P  P 
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 67/132 (50%), Gaps = 20/132 (15%)
Query: 211 AIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER 269
           A+K +DK  ++ ++    E+++     HPNI+ L     D  + ++++ +   GG L ++
Sbjct: 51  AVKIIDKSKRDPTEEI--EILLRYG-QHPNIITLKD-VYDDGKYVYVVTELXKGGELLDK 106
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SS 325
            L +K    R  S         V   I ++V YLH    + VVHRD+KPSNIL      +
Sbjct: 107 ILRQKFFSEREASA--------VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGN 155
Query: 326 KKIPKLCDFGLA 337
            +  ++CDFG A
Sbjct: 156 PESIRICDFGFA 167

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 72/142 (50%), Gaps = 19/142 (13%)
Query: 190 LGRGALSFVFKG---KVG----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           LG+G  + +FKG   +VG    L  T V +K LDK  +  S++F     + S L H ++V
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G C   ++ + L+ ++V  GSL+ +L + K  +     + W       L +A+ +A+
Sbjct: 76  LNYGVCFCGDENI-LVQEFVKFGSLDTYLKKNKNCI----NILWK------LEVAKQLAW 124
Query: 303 -LHNGTERCVVHRDIKPSNILL 323
            +H   E  ++H ++   NILL
Sbjct: 125 AMHFLEENTLIHGNVCAKNILL 146

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 72/161 (44%), Gaps = 21/161 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           F     LG GA S V   +        A+K + K+    KESS     E+ +   + H N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L      P   L+L+ + VSGG L   + EK  G          +R      + ++V
Sbjct: 82  IVALEDIYESPNH-LYLVMQLVSGGELFDRIVEK--GFYTEKDASTLIR-----QVLDAV 133
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLA 337
            YLH      +VHRD+KP N+L  S+    KI  + DFGL+
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKI-MISDFGLS 170

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           E+  ATH       LGRG+   V + +        A+K++  E   +      ELM  + 
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAG 122
Query: 236 LHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L  P IVPL G   + P   +F+  + + GGSL + + E+         LP   R    L
Sbjct: 123 LTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQ-------GCLP-EDRALYYL 172
Query: 295 GIA-ESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLAT 338
           G A E + YLH+   R ++H D+K  N+LLSS      LCDFG A 
Sbjct: 173 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAV 215

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G    P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/154 (24%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 244 -LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L  + +  E  L+++ +Y++GGSL   + E        + +       V     +++ +
Sbjct: 83  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEF 132
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           LH+     V+HR+IK  NILL      KL DFG 
Sbjct: 133 LHSNQ---VIHRNIKSDNILLGMDGSVKLTDFGF 163

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 12/133 (9%)
Query: 209 SVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
            VA+K +D   ++  +    E++I     H N+V +    +  E+ L+++ +++ GG+L 
Sbjct: 72  QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLMEFLQGGALT 130
Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             + + +      +T        V   + +++AYLH    + V+HRDIK  +ILL+    
Sbjct: 131 DIVSQVRLNEEQIAT--------VCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGR 179
Query: 329 PKLCDFGLATWTS 341
            KL DFG     S
Sbjct: 180 VKLSDFGFCAQIS 192

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 87/223 (39%), Gaps = 66/223 (29%)
Query: 180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS--KAFCRELMI 232
           A      G+ LGRGA   V +     ++ S     VA+K L KE   +S  KA   EL I
Sbjct: 25  ARERLKLGKSLGRGAFGKVVQASAFGIKKSPTCRTVAVKML-KEGATASEYKALMTELKI 83
Query: 233 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER-----------------HLHEK 274
            + + HH N+V L+G C      L +I +Y   G+L                   H+  K
Sbjct: 84  LTHIGHHLNVVNLLGACTKQGGPLMVIVEYCKYGNLSNYLKSKRDLFFLNKDAALHMEPK 143
Query: 275 KKGV-----RGNSTLPWSVR----------------------------YKVALGIAESVA 301
           K+ +     +G      SV                             YK  + + + ++
Sbjct: 144 KEKMEPGLEQGKKPRLDSVTSSESFASSGFQEDKSLSDVEEEEDSDGFYKEPITMEDLIS 203
Query: 302 Y---LHNGTE----RCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           Y   +  G E    R  +HRD+   NILLS   + K+CDFGLA
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLA 246

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/166 (32%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           E+  ATH       LGRG+   V + +        A+K++  E   +      ELM  + 
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE-----ELMACAG 141
Query: 236 LHHPNIVPLVGFCID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L  P IVPL G   + P   +F+  + + GGSL + + E+         LP   R    L
Sbjct: 142 LTSPRIVPLYGAVREGPWVNIFM--ELLEGGSLGQLVKEQ-------GCLP-EDRALYYL 191
Query: 295 GIA-ESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLAT 338
           G A E + YLH+   R ++H D+K  N+LLSS      LCDFG A 
Sbjct: 192 GQALEGLEYLHS---RRILHGDVKADNVLLSSDGSHAALCDFGHAV 234

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 74/165 (44%), Gaps = 18/165 (10%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSK-AFCRELMIASSLHHPNIVP 243
           +V+G G    V  G +   G     VAIK L     E  +  F  E  I     HPN++ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G  +     + +I +++  GSL+  L +      G  T+   V   +  GIA  + YL
Sbjct: 73  LEG-VVTKSTPVMIITEFMENGSLDSFLRQND----GQFTVIQLV--GMLRGIAAGMKYL 125
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW----TSAPS 344
               +   VHR +   NIL++S  + K+ DFGL+ +    TS P+
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 121 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 175
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 176 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 222

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 17/161 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVG 246
           ++G G+   V +    L +  VAIK++ +  ED    K   RE+ I + L+H ++V ++ 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW----SVRYKVALGIAESVAY 302
             I  +   F     V    LE    + KK  R    L      ++ Y + +G    V Y
Sbjct: 120 IVIPKDVEKFDELYVV----LEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG----VKY 171
Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           +H+     ++HRD+KP+N L++     K+CDFGLA     P
Sbjct: 172 VHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 16  GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 75
Query: 234 SSLHHPNIVPLVGFCIDP--EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
               H NI+ +      P  EQ   +   Y+    +E  L++  K    ++       Y+
Sbjct: 76  LRFRHENIIGINDIIRAPTIEQ---MKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ 132
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  G+     Y+H+     V+HRD+KPSN+LL++    K+ DFGLA
Sbjct: 133 ILRGLK----YIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLA 171

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 169
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V +        + A K +    +   +   +E+   S L HP +V L     
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AF 117
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + +IY+++SGG L   + ++   +  +  + +  +      + + + ++H   E 
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH---EN 168
Query: 310 CVVHRDIKPSNILLSSKKIP--KLCDFGLA 337
             VH D+KP NI+ ++K+    KL DFGL 
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLT 198

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 79/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 38  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +V L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 98  VNFPFLVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 149
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   ++ DFG A      TW    +  +L 
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLA 206
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 207 PEIILSKGYN 216

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 69/150 (46%), Gaps = 12/150 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG GA   V +        + A K +    +   +   +E+   S L HP +V L     
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AF 223
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
           + +  + +IY+++SGG L   + ++   +  +  + +  +      + + + ++H   E 
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCHMH---EN 274
Query: 310 CVVHRDIKPSNILLSSKKIP--KLCDFGLA 337
             VH D+KP NI+ ++K+    KL DFGL 
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT 304

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 172

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 172

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 54/110 (49%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 71  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 125
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T+ 
Sbjct: 126 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG 172

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQD-----RGDQAFTEREASEIXKS 169
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 170 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 76/158 (48%), Gaps = 19/158 (12%)
Query: 188 RVLGRGALS---FVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVP 243
           R LG GA      V +   GL R    IK ++K+  +   +    E+ +  SL HPNI+ 
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERV---IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           +     D    ++++ +   GG L ER +  + +G      L      ++   +  ++AY
Sbjct: 85  IFEVFED-YHNMYIVMETCEGGELLERIVSAQARG----KALSEGYVAELMKQMMNALAY 139
Query: 303 LHNGTERCVVHRDIKPSNILL--SSKKIP-KLCDFGLA 337
            H+   + VVH+D+KP NIL   +S   P K+ DFGLA
Sbjct: 140 FHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 56/112 (50%), Gaps = 12/112 (10%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I + LHHP ++ L     + +  + LI +++SGG L   +  +   +     + +  
Sbjct: 98  EISIMNQLHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR 156
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLAT 338
           +        E + ++H   E  +VH DIKP NI+  +KK    K+ DFGLAT
Sbjct: 157 Q------ACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 123
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 124 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 170

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 70  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 124
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 125 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 171

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 76  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 130
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 131 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 177

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 85  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 139
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 140 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 186

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 77  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 131
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 132 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 178

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 75  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 129
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 130 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 176

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 14/110 (12%)
Query: 239 PNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           P+IV +V    +   G   L ++ + + GG L   + +     RG+         ++   
Sbjct: 69  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKS 123
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSA 342
           I E++ YLH+     + HRD+KP N+L +SK+   I KL DFG A  T++
Sbjct: 124 IGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 170

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +  L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 78/190 (41%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +  L  F       L+++ +Y  GG +  HL        G  + P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFSEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 259
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 260 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 301

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD-KEDKESSKAFCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D +E ++  +   +E+ + S      + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---S 299
              G  +   + L++I +Y+ GGS    L             P+   +++A  + E    
Sbjct: 85  KYYGSYLKGSK-LWIIMEYLGGGSALDLLRAG----------PFD-EFQIATMLKEILKG 132
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + YLH+  +   +HRDIK +N+LLS +   KL DFG+A
Sbjct: 133 LDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVA 167

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 32/172 (18%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-----EDKESSKA 225
           A   +F   +VLG+G+      GKV L+R           A+K L K      D+  +K 
Sbjct: 25  ADPSHFELLKVLGQGSF-----GKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM 79
Query: 226 FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP 285
              E  I + ++HP +V L  +    E  L+LI  ++ GG L   L ++      +    
Sbjct: 80  ---ERDILADVNHPFVVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEED---- 131
Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             V++ +A  +A  + +LH+     +++RD+KP NILL  +   KL DFGL+
Sbjct: 132 --VKFYLA-ELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 177

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 130
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA
Sbjct: 131 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 82  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 140
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+
Sbjct: 141 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 184

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 72/162 (44%), Gaps = 34/162 (20%)
Query: 190 LGRGALSFV-----------FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +G+GA S V           +  K+      +  K+L   D +  +   RE  I   L H
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKI------INTKKLSARDHQKLE---REARICRLLKH 62
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            NIV L    I  E   +L++  V+GG L   +  ++     +++            I E
Sbjct: 63  SNIVRLHD-SISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILE 114
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
           +V + H   +  VVHRD+KP N+LL+SK      KL DFGLA
Sbjct: 115 AVLHCH---QMGVVHRDLKPENLLLASKCKGAAVKLADFGLA 153

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 34/180 (18%)
Query: 178 LAATHNFSKG------------RVLGRGALSFVF---KGKVGLLRTSVAIKRLDK----- 217
           +A TH+  +G            +VLG+G+   VF   K      R   A+K L K     
Sbjct: 8   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
            D+  +K    E  I   ++HP IV L  +    E  L+LI  ++ GG L   L ++   
Sbjct: 68  RDRVRTKM---ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +      V++ +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL+
Sbjct: 124 TEED------VKFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/167 (24%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 12  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 71
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 72  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+
Sbjct: 131 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGM 174

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 245
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 246 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 287

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 34/180 (18%)
Query: 178 LAATHNFSKG------------RVLGRGALSFVF---KGKVGLLRTSVAIKRLDK----- 217
           +A TH+  +G            +VLG+G+   VF   K      R   A+K L K     
Sbjct: 8   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 67
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
            D+  +K    E  I   ++HP IV L  +    E  L+LI  ++ GG L   L ++   
Sbjct: 68  RDRVRTKM---ERDILVEVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +      V++ +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL+
Sbjct: 124 TEED------VKFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 65  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 120
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 121 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 91/214 (42%), Gaps = 57/214 (26%)
Query: 179 AATHNFSKGRVLGRGALSFV---FKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
            ++  +S G+ LG G+   V   F  + G      A+K++ ++ +  +    REL I   
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESG---KRFALKKVLQDPRYKN----RELDIMKV 56
Query: 236 LHHPNIVPLVGF-----------------------------------CIDPEQGLFL--I 258
           L H NI+ LV +                                    ++P Q  +L  I
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKP 318
            +YV   +L + L   K  +R   ++P ++       +  +V ++H+     + HRDIKP
Sbjct: 117 MEYVPD-TLHKVL---KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKP 169
Query: 319 SNILLSSK-KIPKLCDFGLAT--WTSAPSVPFLC 349
            N+L++SK    KLCDFG A     S PSV  +C
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXIC 203

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 34/180 (18%)
Query: 178 LAATHNFSKG------------RVLGRGALSFVF---KGKVGLLRTSVAIKRLDK----- 217
           +A TH+  +G            +VLG+G+   VF   K      R   A+K L K     
Sbjct: 9   IAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV 68
Query: 218 EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG 277
            D+  +K   R++++   ++HP IV L  +    E  L+LI  ++ GG L   L ++   
Sbjct: 69  RDRVRTK-MERDILV--EVNHPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 124
Query: 278 VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +      V++ +A  +A ++ +LH+     +++RD+KP NILL  +   KL DFGL+
Sbjct: 125 TEED------VKFYLA-ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 174

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 64  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 119
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 120 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 161

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 69/298 (23%), Positives = 115/298 (38%), Gaps = 57/298 (19%)
Query: 72  DDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQSVHSSFRFSLCSQVELESMNIGASASA 131
           DD  K+ G NL  N         G +L    P+ + ++     C+Q              
Sbjct: 95  DDKRKACGRNLTQN----FLSHTGPDLIPEVPRQLVTN-----CTQ-------------- 131
Query: 132 TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL---------AATH 182
                 LE G C    QEL     + L  S++P A+ L  + +   L            +
Sbjct: 132 -----RLEQGPCKDLFQELTRLTHEYL--SVAPFADYLDSIYFNRFLQWKWLERQPVTKN 184
Query: 183 NFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
            F + RVLG+G    V   +V   G +     +++   + ++       E  I   ++  
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V L  +  + +  L L+   ++GG L+ H++       G +  P +     A  I   
Sbjct: 245 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCG 298
Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           +  LH   ER +V+RD+KP NILL      ++ D GLA            +T+KG  G
Sbjct: 299 LEDLHR--ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPE------GQTIKGRVG 347

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--YKV 292
           V L+  C     P    +  ++L++ +      E  L     G+  N  + +++    +V
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDL----AGLLSNVLVKFTLSEIKRV 129
Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +   + Y+H      ++HRD+K +N+L++   + KL DFGLA
Sbjct: 130 MQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            +LH   +R +++RD+KP N+LL      ++ D GLA 
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 13  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 72
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 73  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 132 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 176

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 82  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 140
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 141 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 185

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 57/232 (24%), Positives = 96/232 (41%), Gaps = 29/232 (12%)
Query: 138 LENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEIL---------AATHNFSKGR 188
           LE G C    QEL     + L  S++P A+ L  + +   L            + F + R
Sbjct: 133 LEQGPCKDLFQELTRLTHEYL--SVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYR 190
Query: 189 VLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           VLG+G    V   +V   G +     +++   + ++       E  I   ++   +V L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
            +  + +  L L+   ++GG L+ H++       G +  P +     A  I   +  LH 
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHM-----GQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
             ER +V+RD+KP NILL      ++ D GLA            +T+KG  G
Sbjct: 305 --ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPE------GQTIKGRVG 347

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 76  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 135 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 179

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 75  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 134 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 178

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            +LH   +R +++RD+KP N+LL      ++ D GLA 
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 20/190 (10%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF---CRELMIASS 235
           A    F + + LG G+   V   K        A+K LDK+     K       E  I  +
Sbjct: 39  AHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           ++ P +  L  F       L+++ +Y  GG +  HL        G    P +  Y  A  
Sbjct: 99  VNFPFLTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRR-----IGRFXEPHARFY--AAQ 150
Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPFLC 349
           I  +  YLH+     +++RD+KP N+++  +   K+ DFG A      TW    +  +L 
Sbjct: 151 IVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLA 207
Query: 350 KTVKGTFGQN 359
             +  + G N
Sbjct: 208 PEIILSKGYN 217

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 16  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 75
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 76  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 135 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 179

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 19/163 (11%)
Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC--RELMIASSLHHPNI 241
           + K   +G+G    VFK +       VA+K++  E+++        RE+ I   L H N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 242 VPLVGFC---IDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           V L+  C     P    +  ++L++ +      E  L      V    TL  S   +V  
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFC-----EHDLAGLLSNVLVKFTL--SEIKRVMQ 132
Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +   + Y+H      ++HRD+K +N+L++   + KL DFGLA
Sbjct: 133 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 172

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 28  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 84
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L          +  ++ +       V L + ++++
Sbjct: 85  EMYNSYLVGDE--LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCLAVLQALS 134
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            LH    + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 135 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 171

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 15  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 74
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 75  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 133
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 134 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 178

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 58/110 (52%), Gaps = 15/110 (13%)
Query: 229 ELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           E+ I   L+HP I+ +  F  D E   +++ + + GG L   +   K+       L +  
Sbjct: 71  EIEILKKLNHPCIIKIKNF-FDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYF-- 126
Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFG 335
            Y++ L    +V YLH   E  ++HRD+KP N+LLSS++   + K+ DFG
Sbjct: 127 -YQMLL----AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG 168

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            +LH   +R +++RD+KP N+LL      ++ D GLA 
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 69  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 128 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 172

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 10/158 (6%)
Query: 184 FSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           F   RVLGRG    VF  ++   G L     + +   + ++  +    E  I + +H   
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y     I   +
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE-PRAIFYTAQ--IVSGL 302
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            +LH   +R +++RD+KP N+LL      ++ D GLA 
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 24  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L   +   +      +         V L + ++++
Sbjct: 81  EMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALS 130
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            LH    + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 131 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 167

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 15/154 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCREL-MIASSLHHPNIVPLVGF 247
           VLG GA + V      +     A+K ++K+         RE+ M+     H N++ L+ F
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT 307
             + ++  +L+++ + GGS+  H+H++    R  + L  SV   V   +A ++ +LHN  
Sbjct: 80  FEEEDR-FYLVFEKMRGGSILSHIHKR----RHFNELEASV---VVQDVASALDFLHN-- 129
Query: 308 ERCVVHRDIKPSNILLS--SKKIP-KLCDFGLAT 338
            + + HRD+KP NIL    ++  P K+CDF L +
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 7   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 66
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 67  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 126 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 170

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 35  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 91
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L   +   +      +         V L + ++++
Sbjct: 92  EMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALS 141
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            LH    + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 142 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 178

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 44  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 103
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 104 MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 162
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 163 IQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT 207

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 17/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 33  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 89
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L   +   +      +         V L + ++++
Sbjct: 90  EMYNSYLVGDE--LWVVMEFLEGGALTDIVTHTRMNEEQIAA--------VCLAVLQALS 139
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            LH    + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 140 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 176

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 20/47 (42%), Positives = 32/47 (68%), Gaps = 3/47 (6%)
Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           + + IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFGL T
Sbjct: 169 IFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 212

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L +I + + GG L   + E     RG+         ++   I  ++ +LH+     + HR
Sbjct: 82  LLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHR 133
Query: 315 DIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKT 351
           D+KP N+L +SK+   + KL DFG A  T+  ++   C T
Sbjct: 134 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 173

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/100 (29%), Positives = 49/100 (49%), Gaps = 11/100 (11%)
Query: 255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR 314
           L +I + + GG L   + E     RG+         ++   I  ++ +LH+     + HR
Sbjct: 101 LLIIMECMEGGELFSRIQE-----RGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHR 152
Query: 315 DIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKT 351
           D+KP N+L +SK+   + KL DFG A  T+  ++   C T
Sbjct: 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 61/134 (45%), Gaps = 13/134 (9%)
Query: 228 RELMIASSLHHPNIVPLVGFC-IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
           RE   A  L  P++VP+  F  ID +  L++  + ++G  L   L  +     G    P 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQ--LYVDXRLINGVDLAAXLRRQ-----GPLAPPR 135
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP 346
           +V     +G A   A+    T     HRD+KP NIL+S+     L DFG+A+ T+   + 
Sbjct: 136 AVAIVRQIGSALDAAHAAGAT-----HRDVKPENILVSADDFAYLVDFGIASATTDEKLT 190
Query: 347 FLCKTVKGTFGQNP 360
            L  TV   +   P
Sbjct: 191 QLGNTVGTLYYXAP 204

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGF 247
           +LG+GA + VF+G+        AIK  +            RE  +   L+H NIV L  F
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 248 CIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            I+ E       LI ++   GSL   L E          LP S   +  + + + V  ++
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY----GLPES---EFLIVLRDVVGGMN 126
Query: 305 NGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA 337
           +  E  +VHR+IKP NI+       + + KL DFG A
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 70/157 (44%), Gaps = 17/157 (10%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGF 247
           +LG+GA + VF+G+        AIK  +            RE  +   L+H NIV L  F
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL--F 73
Query: 248 CIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
            I+ E       LI ++   GSL   L E          LP S   +  + + + V  ++
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAY----GLPES---EFLIVLRDVVGGMN 126
Query: 305 NGTERCVVHRDIKPSNILL----SSKKIPKLCDFGLA 337
           +  E  +VHR+IKP NI+       + + KL DFG A
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 14/154 (9%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +++G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G        + ++ +Y+  GSL+  L        G  T+   V   +  G+   + YL
Sbjct: 115 LEGVVTRGRLAM-IVTEYMENGSLDTFLRTHD----GQFTIMQLV--GMLRGVGAGMRYL 167
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              ++   VHRD+   N+L+ S  + K+ DFGL+
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 68/154 (44%), Gaps = 14/154 (9%)
Query: 188 RVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIVP 243
           +++G G    V  G++   G     VAIK L     E  +  F  E  I     HPNI+ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L G        + ++ +Y+  GSL+  L        G  T+   V   +  G+   + YL
Sbjct: 115 LEGVVTRGRLAM-IVTEYMENGSLDTFLRTHD----GQFTIMQLV--GMLRGVGAGMRYL 167
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              ++   VHRD+   N+L+ S  + K+ DFGL+
Sbjct: 168 ---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/160 (25%), Positives = 74/160 (46%), Gaps = 17/160 (10%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF K   +G G+   V    V      VA+K++D   ++  +    E++I     H N+V
Sbjct: 78  NFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV 134
Query: 243 PLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
            +   + +  E  L+++ +++ GG+L          +  ++ +       V L + ++++
Sbjct: 135 EMYNSYLVGDE--LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVCLAVLQALS 184
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
            LH    + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 185 VLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 221

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 21/57 (36%), Positives = 34/57 (59%), Gaps = 2/57 (3%)
Query: 281 NSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  +P  +  K+ L   +++ +L    +  ++HRDIKPSNILL      KLCDFG++
Sbjct: 119 DDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGIS 173

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 77/168 (45%), Gaps = 17/168 (10%)
Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS 234
           G+  +   NF K   +G G+   V    V      VA+K++D   ++  +    E++I  
Sbjct: 147 GDPRSYLDNFIK---IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMR 203
Query: 235 SLHHPNIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
              H N+V +   + +  E  L+++ +++ GG+L          +  ++ +       V 
Sbjct: 204 DYQHENVVEMYNSYLVGDE--LWVVMEFLEGGAL--------TDIVTHTRMNEEQIAAVC 253
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
           L + ++++ LH    + V+HRDIK  +ILL+     KL DFG     S
Sbjct: 254 LAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAE 298
           + +      P+        Y+    ++  LH      R  ST   S   ++Y +   +  
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH------RVISTQMLSDDHIQYFIYQTL-R 123
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +V  LH      V+HRD+KPSN+L++S    K+CDFGLA
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAE 298
           + +      P+        Y+    ++  LH      R  ST   S   ++Y +   +  
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH------RVISTQMLSDDHIQYFIYQTL-R 123
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +V  LH      V+HRD+KPSN+L++S    K+CDFGLA
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 71/159 (44%), Gaps = 15/159 (9%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNI 241
           +F    +LG GA   V           VAIK+++  DK   +    RE+ I     H NI
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS---VRYKVALGIAE 298
           + +      P+        Y+    ++  LH      R  ST   S   ++Y +   +  
Sbjct: 72  ITIFNIQ-RPDSFENFNEVYIIQELMQTDLH------RVISTQMLSDDHIQYFIYQTL-R 123
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +V  LH      V+HRD+KPSN+L++S    K+CDFGLA
Sbjct: 124 AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 69/163 (42%), Gaps = 24/163 (14%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCRELMIA 233
           ++F   ++LG+G       GKV L+R        A+K L KE    K+       E  + 
Sbjct: 8   NDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 62
Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            +  HP +  L  +       L  + +Y +GG L  HL  ++      +           
Sbjct: 63  QNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-------YG 114
Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
             I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 115 AEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 154

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 7   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 61
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 62  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 114
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 115 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 156

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 72/158 (45%), Gaps = 15/158 (9%)
Query: 183 NFSKGRVLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH 238
           +F+   VLG+G+   V     KG   L    +  K +  +D +       + ++A     
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  L   C      L+ + +YV+GG L  H+ +      G    P +V Y  A  IA 
Sbjct: 81  PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQ-----VGRFKEPHAVFY--AAEIAI 132
Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
            + +L +   + +++RD+K  N++L S+   K+ DFG+
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGM 167

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 78/168 (46%), Gaps = 13/168 (7%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSK-AFCRELMI 232
            A    +  R LG+G+   V++G   G+++    T VAIK +++      +  F  E  +
Sbjct: 9   VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 68
Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYK 291
               +  ++V L+G  +   Q   +I + ++ G L+ +L   +  +  N  L P S+   
Sbjct: 69  MKEFNCHHVVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 292 VALG--IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + +   IA+ +AYL+       VHRD+   N  ++     K+ DFG+ 
Sbjct: 128 IQMAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMT 172

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 66/148 (44%), Gaps = 17/148 (11%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +++ +K ++    RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 47  VAVKYIERGEKIAANV-KREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 104
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 105 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 154
Query: 330 --KLCDFGLATWTSAPSVPFLCKTVKGT 355
             K+CDFG +  +   S P   K+  GT
Sbjct: 155 RLKICDFGYSKSSVLHSQP---KSTVGT 179

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE---DKESSKAFCREL 230
              ++F   ++LG+G       GKV L+R        A+K L KE    K+       E 
Sbjct: 2   VTMNDFDYLKLLGKGTF-----GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTES 56
Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
            +  +  HP +  L  +       L  + +Y +GG L  HL  ++      +        
Sbjct: 57  RVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF------ 109
Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
                I  ++ YLH+   R VV+RDIK  N++L      K+ DFGL
Sbjct: 110 -YGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGL 151

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 16/165 (9%)
Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
           K + LG G+ S   K        + A+K + K  + +++     L +     HPNIV L 
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLH 72
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
               D +   FL+ + ++GG L   + +KK      ++        +   +  +V+++H+
Sbjct: 73  EVFHD-QLHTFLVMELLNGGELFERIKKKKHFSETEASY-------IMRKLVSAVSHMHD 124
Query: 306 GTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPF 347
                VVHRD+KP N+L + +      K+ DFG A      + P 
Sbjct: 125 VG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL 166

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 189 VLGRGALSFVF----KGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL 244
           VLG+G+   V     KG   L    +  K +  +D +       + ++A     P +  L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
              C      L+ + +YV+GG L  H+ +      G    P +V Y  A  IA  + +L 
Sbjct: 408 HS-CFQTMDRLYFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFY--AAEIAIGLFFLQ 459
Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           +   + +++RD+K  N++L S+   K+ DFG+
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGM 488

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 17/148 (11%)
Query: 210 VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           VA+K +++ +K   +   RE++   SL HPNIV      + P   L ++ +Y SGG L  
Sbjct: 46  VAVKYIERGEK-IDENVKREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGELFE 103
Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
            +    +     +   +         +   V+Y H      V HRD+K  N LL     P
Sbjct: 104 RICNAGRFSEDEARFFFQ-------QLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAP 153
Query: 330 --KLCDFGLATWTSAPSVPFLCKTVKGT 355
             K+CDFG +  +   S P   K+  GT
Sbjct: 154 RLKICDFGYSKSSVLHSQP---KSTVGT 178

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 95  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 144
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 145 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 174

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 95  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 144
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 145 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 174

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 75  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 124
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 125 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 154

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 73  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 122
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 123 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 152

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 248
           LGRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 133
Query: 249 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 306
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 134 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 182
Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLA 337
             R ++H D+K  N+LLSS      LCDFG A
Sbjct: 183 --RRILHGDVKADNVLLSSDGSRAALCDFGHA 212

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 74/176 (42%), Gaps = 19/176 (10%)
Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
           ++F K   +G G        +  L +  VA+K +++      +   RE++   SL HPNI
Sbjct: 22  YDFVKD--IGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNI 78
Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V      + P   L +I +Y SGG L   +    +     +   +         +   V+
Sbjct: 79  VRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQ-------QLLSGVS 130
Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVKGT 355
           Y H+     + HRD+K  N LL     P  K+CDFG +  +   S P   K+  GT
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT 180

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 79  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 128
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 129 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 158

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 85  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 134
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 79  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 128
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 129 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 158

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 93  GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 142
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 143 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 172

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 75  DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    +  L+L+  Y  GG L   L + +  +       +     +A+   +SV
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI---DSV 191
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             LH       VHRDIKP NIL+      +L DFG
Sbjct: 192 HQLH------YVHRDIKPDNILMDMNGHIRLADFG 220

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 243
           V+G+G  S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 91  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 304 HNGTERCVVHRDIKPSNILLSSKK--IP-KLCDFGLA 337
           H+     ++HRD+KP  +LL+SK+   P KL  FG+A
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+ 
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 65/148 (43%), Gaps = 12/148 (8%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCI 249
           LG G+   V+K         VAIK++  E     +   +E+ I      P++V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 250 DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTER 309
                L+++ +Y   GS+   +  +      N TL       +     + + YLH   + 
Sbjct: 95  K-NTDLWIVMEYCGAGSVSDIIRLR------NKTLTEDEIATILQSTLKGLEYLHFMRK- 146
Query: 310 CVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +HRDIK  NILL+++   KL DFG+A
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGVA 172

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 169 LIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAF 226
           ++RL   E+     +F   +V+GRGA S V   K+       A+K ++K D  K    + 
Sbjct: 50  VVRLK--EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW 286
            RE            +  + F    E  L+L+ +Y  GG L   L   K G R  + +  
Sbjct: 108 FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL--SKFGERIPAEM-- 163
Query: 287 SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             R+     +AE V  + +      VHRDIKP NILL      +L DFG
Sbjct: 164 -ARFY----LAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 85/213 (39%), Gaps = 25/213 (11%)
Query: 132 TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANS-----LIRLSYGEILAATHNFSK 186
           T  +  + +GL    A E+ +R       S SP  NS      + L+  +     + F  
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFR-------SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 152
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
            ++LG+G    V   K        A+K L KE    K+       E  +  +  HP +  
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +       L  + +Y +GG L  HL  ++      +             I  ++ YL
Sbjct: 213 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYL 264
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H  +E+ VV+RD+K  N++L      K+ DFGL
Sbjct: 265 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGL 295

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/157 (28%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-----RELMIASSLHHPNIVP 243
           V+G+G  S V +          A+K +D     SS         RE  I   L HP+IV 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L+      +  L+++++++ G  L     E  K          +V       I E++ Y 
Sbjct: 93  LLE-TYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 148
Query: 304 HNGTERCVVHRDIKPSNILLSSKK--IP-KLCDFGLA 337
           H+     ++HRD+KP  +LL+SK+   P KL  FG+A
Sbjct: 149 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 182

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 20  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 78
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 79  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 136
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+ 
Sbjct: 137 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT 174

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+ 
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 85/213 (39%), Gaps = 25/213 (11%)
Query: 132 TVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANS-----LIRLSYGEILAATHNFSK 186
           T  +  + +GL     +E+ +R       S SP  NS      + L+  +     + F  
Sbjct: 103 TTAIQTVADGLKKQEEEEMDFR-------SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEY 155
Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
            ++LG+G    V   K        A+K L KE    K+       E  +  +  HP +  
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           L  +       L  + +Y +GG L  HL  ++      +             I  ++ YL
Sbjct: 216 L-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-------YGAEIVSALDYL 267
Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL 336
           H  +E+ VV+RD+K  N++L      K+ DFGL
Sbjct: 268 H--SEKNVVYRDLKLENLMLDKDGHIKITDFGL 298

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+ 
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 11/155 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 91  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 150
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       I E V
Sbjct: 151 WITALHYAFQDENHLYLVMDYYVGGDLLTLLS------KFEDKLPEDM---ARFYIGEMV 201
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             + +  +   VHRDIKP N+LL      +L DFG
Sbjct: 202 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG 236

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 23  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 81
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 82  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 139
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+ 
Sbjct: 140 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT 177

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 74/161 (45%), Gaps = 17/161 (10%)
Query: 188 RVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSK-AFCRE--LMIASSLHHP 239
           R LG+G+   V++G       G   T VA+K +++      +  F  E  +M   + HH 
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH- 80
Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV---RYKVALGI 296
            +V L+G  +   Q   ++ + ++ G L+ +L   +     N   P        ++A  I
Sbjct: 81  -VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 138
Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+    +  VHRD+   N +++     K+ DFG+ 
Sbjct: 139 ADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMT 176

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 10/135 (7%)
Query: 210 VAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL 267
           VAIK+L +  + +  +K   REL++   + H N++ L+     P   L   Y +      
Sbjct: 52  VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLD-VFTPASSLRNFYDFYLVMPF 110
Query: 268 ERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
            +   +K  G++ +      + Y++  G+     Y+H+     VVHRD+KP N+ ++   
Sbjct: 111 MQTDLQKIMGLKFSEEKIQYLVYQMLKGLK----YIHSA---GVVHRDLKPGNLAVNEDC 163
Query: 328 IPKLCDFGLATWTSA 342
             K+ DFGLA    A
Sbjct: 164 ELKILDFGLARHADA 178

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 63/155 (40%), Gaps = 11/155 (7%)
Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +F   +V+GRGA   V   K+       A+K L+K +  K +  A  RE           
Sbjct: 75  DFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVNGDCQ 134
Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +  + +    E  L+L+  Y  GG L   L       +    LP  +       I E V
Sbjct: 135 WITALHYAFQDENHLYLVMDYYVGGDLLTLLS------KFEDKLPEDM---ARFYIGEMV 185
Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
             + +  +   VHRDIKP N+LL      +L DFG
Sbjct: 186 LAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG 220

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 437 GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 486
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 487 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 516

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 16/152 (10%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELM----IASSLHHPNIVPLV 245
           LG G    V KG   + +    +     +++ +  A   EL+    +   L +P IV ++
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    +   L+ +    G L ++L + +  V+  + +   + ++V++G+     YL  
Sbjct: 438 GIC--EAESWMLVMEMAELGPLNKYLQQNRH-VKDKNII--ELVHQVSMGMK----YLE- 487
Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 488 --ESNFVHRDLAARNVLLVTQHYAKISDFGLS 517

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 248
           +GRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 119
Query: 249 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 306
            + P   +F+  + + GGSL + + +          LP   R    LG A E + YLH  
Sbjct: 120 REGPWVNIFM--ELLEGGSLGQLIKQM-------GCLP-EDRALYYLGQALEGLEYLHT- 168
Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLA 337
             R ++H D+K  N+LLSS      LCDFG A
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHA 198

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 33/136 (24%), Positives = 63/136 (46%), Gaps = 14/136 (10%)
Query: 228 RELMIASSLHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLER--HLHEKKKGVRGNSTL 284
           +E+ +   L H N++ LV    + E Q ++++ +Y   G  E    + EK+         
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR--------F 106
Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           P    +     + + + YLH+   + +VH+DIKP N+LL++    K+   G+A      +
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 345 VPFLCKTVKGTFGQNP 360
               C+T +G+    P
Sbjct: 164 ADDTCRTSQGSPAFQP 179

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 70/152 (46%), Gaps = 23/152 (15%)
Query: 190 LGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF-CRELMIASSLHHPNIVPLVGFC 248
           +GRG+   V + K        A+K++  E       F   EL+  + L  P IVPL G  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVRLE------VFRVEELVACAGLSSPRIVPLYGAV 135
Query: 249 ID-PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA-ESVAYLHNG 306
            + P   +F+  + + GGSL +        ++    LP   R    LG A E + YLH  
Sbjct: 136 REGPWVNIFM--ELLEGGSLGQL-------IKQMGCLP-EDRALYYLGQALEGLEYLHT- 184
Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLA 337
             R ++H D+K  N+LLSS      LCDFG A
Sbjct: 185 --RRILHGDVKADNVLLSSDGSRAALCDFGHA 214

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 42/161 (26%)
Query: 212 IKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL 271
           I++++ +D E  K    E+ +   LHHPNI  L     D EQ + L+ +   GG L   L
Sbjct: 64  IRQINPKDVERIKT---EVRLMKKLHHPNIARLYEVYED-EQYICLVMELCHGGHLLDKL 119
Query: 272 HE------------------------KKKGVRGN-----STLPWSVRYKVALGIAESV-- 300
           +                          ++ + G+      +L +  R K+   I   +  
Sbjct: 120 NVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179
Query: 301 --AYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFGLA 337
              YLHN   + + HRDIKP N L S+ K    KL DFGL+
Sbjct: 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLS 217

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	372
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-56
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-56
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-56
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-44
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-40
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-40
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-39
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-39
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-38
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	4e-38
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-38
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-37
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-33
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-31
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	5e-29
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	8e-29
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-29
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-28
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-28
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-27
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-27
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	6e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-26
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-26
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-26
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-26
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	7e-26
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-25
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-25
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-25
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-25
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-24
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-24
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-24
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-24
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-24
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	7e-24
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-23
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-23
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-23
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-23
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	6e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-23
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-22
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-22
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-22
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-22
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-22
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-22
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-22
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-22
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-22
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	7e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-21
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-21
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-21
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-21
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-21
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-21
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-21
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-21
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	5e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	8e-21
3uqc_A	286	Probable conserved transmembrane protein; structur	8e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-21
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-20
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-20
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-20
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-20
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-20
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-20
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-20
3o0g_A	292	Cell division protein kinase 5; kinase activator c	8e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-19
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-19
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-19
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-19
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-19
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-19
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-18
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-18
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-18
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-18
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	7e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-18
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	9e-18
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	8e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-16
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-16
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-16
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-16
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-15
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-15
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	8e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-14
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-14
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	4e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-14
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-06
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-05
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  187 bits (476), Expect = 1e-56
 Identities = 69/195 (35%), Positives = 102/195 (52%), Gaps = 21/195 (10%)

Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKA-FC 227
           R S  E+  A+ NFS   +LGRG    V+KG+   L   T VA+KRL +E  +  +  F 
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGR---LADGTLVAVKRLKEERTQGGELQFQ 75

Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
            E+ + S   H N++ L GFC+ P + L L+Y Y++ GS+   L E+ +       L W 
Sbjct: 76  TEVEMISMAVHRNLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPES---QPPLDWP 131

Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
            R ++ALG A  +AYLH+  +  ++HRD+K +NILL  +    + DFGLA          
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY----- 186

Query: 348 LCKT-----VKGTFG 357
              T     V+GT G
Sbjct: 187 -KDTHVTTAVRGTIG 200

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  185 bits (472), Expect = 3e-56
 Identities = 63/214 (29%), Positives = 96/214 (44%), Gaps = 30/214 (14%)

Query: 159 ERSISPVANSLIRLSYGEILAATHNFSK------GRVLGRGALSFVFKGKVGLLRTSVAI 212
            +S+          S+ E+   T+NF +      G  +G G    V+KG V    T+VA+
Sbjct: 2   NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAV 59

Query: 213 KRLDKEDKESS----KAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLE 268
           K+L      ++    + F +E+ + +   H N+V L+GF  D +    L+Y Y+  GSL 
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC-LVYVYMPNGSLL 118

Query: 269 RHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI 328
             L      + G   L W +R K+A G A  + +LH   E   +HRDIK +NILL     
Sbjct: 119 DRLS----CLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFT 171

Query: 329 PKLCDFGLATWTSAPSVPFLCKT-----VKGTFG 357
            K+ DFGLA            +T     + GT  
Sbjct: 172 AKISDFGLARA-----SEKFAQTVMTSRIVGTTA 200

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  185 bits (472), Expect = 3e-56
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 22/204 (10%)

Query: 161 SISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKE 218
           S   V     R+   ++  AT+NF    ++G G    V+KG +  G     VA+KR   E
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG---AKVALKRRTPE 74

Query: 219 DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV 278
             +  + F  E+   S   HP++V L+GFC +  + + LIYKY+  G+L+RHL+      
Sbjct: 75  SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MILIYKYMENGNLKRHLYGSDLPT 133

Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               ++ W  R ++ +G A  + YLH      ++HRD+K  NILL    +PK+ DFG++ 
Sbjct: 134 ---MSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187

Query: 339 WTSAPSVPFLCKT-----VKGTFG 357
                    L +T     VKGT G
Sbjct: 188 -----KGTELDQTHLSTVVKGTLG 206

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  153 bits (388), Expect = 8e-44
 Identities = 47/201 (23%), Positives = 73/201 (36%), Gaps = 21/201 (10%)

Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAF 226
           +S + L    +   +       V  RG    V+K ++      VA+K    +D + S   
Sbjct: 9   SSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQN 65

Query: 227 CRELMIASSLHHPNIVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             E+     + H NI+  +G           L+LI  +   GSL   L          + 
Sbjct: 66  EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--------ANV 117

Query: 284 LPWSVRYKVALGIAESVAYLHNGTER-------CVVHRDIKPSNILLSSKKIPKLCDFGL 336
           + W+    +A  +A  +AYLH             + HRDIK  N+LL +     + DFGL
Sbjct: 118 VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177

Query: 337 ATWTSAPSVPFLCKTVKGTFG 357
           A    A           GT  
Sbjct: 178 ALKFEAGKSAGDTHGQVGTRR 198

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (384), Expect = 2e-43
 Identities = 56/152 (36%), Positives = 81/152 (53%), Gaps = 12/152 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
             V+GRGA   V K K       VAIK+++ E +   KAF  EL   S ++HPNIV L G
Sbjct: 13  EEVVGRGAFGVVCKAK--WRAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYG 68

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C++P   + L+ +Y  GGSL   LH  +           +      L  ++ VAYLH+ 
Sbjct: 69  ACLNP---VCLVMEYAEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 307 TERCVVHRDIKPSNILLSSK-KIPKLCDFGLA 337
             + ++HRD+KP N+LL +   + K+CDFG A
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  146 bits (370), Expect = 1e-41
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 22/163 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-------KAFCRELMIASSLHHP 239
            + +G+G    V KG++   ++ VAIK L   D E         + F RE+ I S+L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV L G   +P     ++ ++V  G L   L +K         + WSV+ ++ L IA  
Sbjct: 84  NIVKLYGLMHNP---PRMVMEFVPCGDLYHRLLDKAH------PIKWSVKLRLMLDIALG 134

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSK-----KIPKLCDFGLA 337
           + Y+ N     +VHRD++  NI L S         K+ DFGL+
Sbjct: 135 IEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  144 bits (365), Expect = 1e-40
 Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 10/154 (6%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
              +G G+   V + +     + VA+K L ++D   E    F RE+ I   L HPNIV  
Sbjct: 42  KEKIGAGSFGTVHRAE--WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G    P   L ++ +Y+S GSL R LH+          L    R  +A  +A+ + YLH
Sbjct: 100 MGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLH 154

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           N     +VHR++K  N+L+  K   K+CDFGL+ 
Sbjct: 155 NRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  143 bits (362), Expect = 2e-40
 Identities = 34/155 (21%), Positives = 59/155 (38%), Gaps = 11/155 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
              L       ++KG+       + +K L   D     S+ F  E        HPN++P+
Sbjct: 15  LTKLNENHSGELWKGR--WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 245 VGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           +G C  P      LI  ++  GSL   LHE       N  +  S   K AL +A  +A+L
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-----NFVVDQSQAVKFALDMARGMAFL 127

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           H   E  +    +   ++++      ++    +  
Sbjct: 128 HT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  141 bits (358), Expect = 1e-39
 Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 10/151 (6%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
           G VLG+G      K         + +K L + D+E+ + F +E+ +   L HPN++  +G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ L  I +Y+ GG+L   +         +S  PWS R   A  IA  +AYLH  
Sbjct: 75  VLYKDKR-LNFITEYIKGGTLRGIIKSM------DSQYPWSQRVSFAKDIASGMAYLH-- 125

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               ++HRD+   N L+   K   + DFGLA
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLA 155

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  140 bits (354), Expect = 2e-39
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 23/163 (14%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRL----DKEDKESSKAFCRELMIASSLHHPNIV 242
             ++G G    V++     +   VA+K      D++  ++ +   +E  + + L HPNI+
Sbjct: 12  EEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G C+     L L+ ++  GG L R L  K+        +P  +    A+ IA  + Y
Sbjct: 70  ALRGVCLKEPN-LCLVMEFARGGPLNRVLSGKR--------IPPDILVNWAVQIARGMNY 120

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP--------KLCDFGLA 337
           LH+     ++HRD+K SNIL+  K           K+ DFGLA
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  138 bits (349), Expect = 4e-38
 Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 16/154 (10%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
           G ++G+G    V+ G+       VAI+ +D E   ++  KAF RE+M      H N+V  
Sbjct: 38  GELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G C+ P   L +I     G +L   + + K        L  +   ++A  I + + YLH
Sbjct: 95  MGACMSPPH-LAIITSLCKGRTLYSVVRDAKI------VLDVNKTRQIAQEIVKGMGYLH 147

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               + ++H+D+K  N+   + K+  + DFGL +
Sbjct: 148 A---KGILHKDLKSKNVFYDNGKV-VITDFGLFS 177

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  137 bits (346), Expect = 5e-38
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 16/171 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNIVPL 244
           G+ +G G+   V+KGK       VA+K L       +  +AF  E+ +     H NI+  
Sbjct: 29  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 85

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G+   P+  L ++ ++  G SL  HLH  +                +A   A  + YLH
Sbjct: 86  MGYSTAPQ--LAIVTQWCEGSSLYHHLHASET------KFEMKKLIDIARQTARGMDYLH 137

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
               + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+
Sbjct: 138 A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  136 bits (344), Expect = 3e-37
 Identities = 42/206 (20%), Positives = 71/206 (34%), Gaps = 31/206 (15%)

Query: 170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
           +  +  E      N     ++GRG    V+KG   L    VA+K     ++++   F  E
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQN---FINE 55

Query: 230 LMIA--SSLHHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNST 283
             I     + H NI   +               L+ +Y   GSL ++L           T
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--------T 107

Query: 284 LPWSVRYKVALGIAESVAYLHN------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             W    ++A  +   +AYLH         +  + HRD+   N+L+ +     + DFGL+
Sbjct: 108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

Query: 338 ------TWTSAPSVPFLCKTVKGTFG 357
                              +  GT  
Sbjct: 168 MRLTGNRLVRPGEEDNAAISEVGTIR 193

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  127 bits (320), Expect = 8e-34
 Identities = 44/182 (24%), Positives = 70/182 (38%), Gaps = 25/182 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA--SSLHHPNIVPL 244
            + +G+G    V+ GK       VA+K     ++ S   + RE  I     + H NI+  
Sbjct: 42  VKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEAS---WFRETEIYQTVLMRHENILGF 96

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +   I        L+LI  Y   GSL  +L         ++TL      K+A      + 
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYLK--------STTLDAKSMLKLAYSSVSGLC 148

Query: 302 YLHNGTER-----CVVHRDIKPSNILLSSKKIPKLCDFGLA-TWTSAPSVPFLCKTVK-G 354
           +LH           + HRD+K  NIL+       + D GLA  + S  +   +    + G
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVG 208

Query: 355 TF 356
           T 
Sbjct: 209 TK 210

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  125 bits (317), Expect = 1e-33
 Identities = 46/182 (25%), Positives = 69/182 (37%), Gaps = 25/182 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE--LMIASSLHHPNIVPL 244
              +G+G    V++G       +VA+K     D++S   + RE  L     L H NI+  
Sbjct: 13  LECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEKS---WFRETELYNTVMLRHENILGF 67

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +   +        L+LI  Y   GSL  +L           TL      ++ L IA  +A
Sbjct: 68  IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT--------TLDTVSCLRIVLSIASGLA 119

Query: 302 YLHNGTERC-----VVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 354
           +LH           + HRD+K  NIL+       + D GLA     S   +        G
Sbjct: 120 HLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG 179

Query: 355 TF 356
           T 
Sbjct: 180 TK 181

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  124 bits (314), Expect = 4e-33
 Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 9/160 (5%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            ++   + LG G  S+V   +        A+KR+   +++  +   RE  +    +HPNI
Sbjct: 29  KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNI 88

Query: 242 VPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           + LV +C+         +L+  +   G+L   +   ++     + L       + LGI  
Sbjct: 89  LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---ERLKDKGNFLTEDQILWLLLGICR 145

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            +  +H    +   HRD+KP+NILL  +  P L D G   
Sbjct: 146 GLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN 182

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  120 bits (302), Expect = 3e-31
 Identities = 44/182 (24%), Positives = 70/182 (38%), Gaps = 25/182 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA--SSLHHPNIVPL 244
              +G+G    V++GK       VA+K     ++ S   + RE  I     L H NI+  
Sbjct: 47  QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS---WFREAEIYQTVMLRHENILGF 101

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +            L+L+  Y   GSL  +L+          T+      K+AL  A  +A
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--------TVTVEGMIKLALSTASGLA 153

Query: 302 YLHNGTERC-----VVHRDIKPSNILLSSKKIPKLCDFGLATW--TSAPSVPFLCKTVKG 354
           +LH           + HRD+K  NIL+       + D GLA    ++  ++        G
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 213

Query: 355 TF 356
           T 
Sbjct: 214 TK 215

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (289), Expect = 1e-29
 Identities = 39/178 (21%), Positives = 76/178 (42%), Gaps = 18/178 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 28  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 240 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 87  SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 137

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 138 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 191

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  114 bits (286), Expect = 5e-29
 Identities = 46/164 (28%), Positives = 72/164 (43%), Gaps = 12/164 (7%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPN 240
                 RVL  G  +FV++ +        A+KRL   ++E ++A  +E+     L  HPN
Sbjct: 28  LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPN 87

Query: 241 IVPLVGFCI------DPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           IV             D  Q  FL+   +  G L   L + +        L      K+  
Sbjct: 88  IVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP----LSCDTVLKIFY 143

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
               +V ++H   +  ++HRD+K  N+LLS++   KLCDFG AT
Sbjct: 144 QTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  112 bits (283), Expect = 8e-29
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 22/170 (12%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
             +F +  VLG+GA   V K +  L     AIK++   +++ S     E+M+ +SL+H  
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTIL-SEVMLLASLNHQY 63

Query: 241 IVPLVGFCIDPEQG------------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV 288
           +V      ++                LF+  +Y   G+L   +H +    + +       
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           +      I E+++Y+H    + ++HRD+KP NI +   +  K+ DFGLA 
Sbjct: 124 Q------ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (285), Expect = 8e-29
 Identities = 39/178 (21%), Positives = 76/178 (42%), Gaps = 18/178 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 9   RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 240 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 68  SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 118

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  GT
Sbjct: 119 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGT 172

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  111 bits (279), Expect = 3e-28
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 12/176 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHP 239
           NF   + +GRG  S V++    L    VA+K++   D   +KA     +E+ +   L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++      I+  + L ++ +    G L R +   KK       +P    +K  + +  +
Sbjct: 93  NVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSA 148

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + ++H    R V+HRDIKP+N+ +++  + KL D GL  + S+ +      ++ GT
Sbjct: 149 LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGT 199

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  112 bits (282), Expect = 4e-28
 Identities = 38/178 (21%), Positives = 75/178 (42%), Gaps = 18/178 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +S  + +G G  S VF+      +   AIK ++ E  D ++  ++  E+   + L   
Sbjct: 56  RIYSILKQIGSGGSSKVFQVL-NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 240 N--IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +  I+ L  + I  +  ++++ +      L   L +KK        +    R      + 
Sbjct: 115 SDKIIRLYDYEITDQY-IYMVMEC-GNIDLNSWLKKKKS-------IDPWERKSYWKNML 165

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           E+V  +H   +  +VH D+KP+N L+    + KL DFG+A      +   +  +  G 
Sbjct: 166 EAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGA 219

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (275), Expect = 6e-28
 Identities = 50/181 (27%), Positives = 77/181 (42%), Gaps = 25/181 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA---FCRELMIAS 234
           +F  G +LG+G  SF     V           VAIK +DK+    +        E+ I  
Sbjct: 12  DFKVGNLLGKG--SF---AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HP+I+ L  +  D    ++L+ +    G + R+L  + K            R+ +  
Sbjct: 67  QLKHPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFS-----ENEARHFMH- 119

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            I   + YLH      ++HRD+  SN+LL+     K+ DFGLAT    P       T+ G
Sbjct: 120 QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCG 174

Query: 355 T 355
           T
Sbjct: 175 T 175

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  108 bits (272), Expect = 2e-27
 Identities = 46/168 (27%), Positives = 79/168 (47%), Gaps = 19/168 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNI 241
           +F   + LGRG    VF+ K  +   + AIKR+   ++E ++    RE+   + L HP I
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65

Query: 242 VPLVGFCID-----------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           V      ++           P+  L++  +     +L+  ++ +            SV  
Sbjct: 66  VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC----TIEERERSVCL 121

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            + L IAE+V +LH    + ++HRD+KPSNI  +   + K+ DFGL T
Sbjct: 122 HIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT 166

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (271), Expect = 2e-27
 Identities = 46/179 (25%), Positives = 73/179 (40%), Gaps = 12/179 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           ++     +G G+     K +       +  K LD     + E       E+ +   L HP
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLV-SEVNLLRELKHP 65

Query: 240 NIVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           NIV      ID     L+++ +Y  GG L   +    KG +    L      +V   +  
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI---TKGTKERQYLDEEFVLRVMTQLTL 122

Query: 299 SVAYLH--NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           ++   H  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  +     KT  GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGT 179

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  109 bits (273), Expect = 5e-27
 Identities = 39/176 (22%), Positives = 75/176 (42%), Gaps = 15/176 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
            + + + +G G+       K         IK ++      KE  ++  RE+ + +++ HP
Sbjct: 25  KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR-REVAVLANMKHP 83

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV       +    L+++  Y  GG L + ++ +K                  + I  +
Sbjct: 84  NIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGV-----LFQEDQILDWFVQICLA 137

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           + ++H   +R ++HRDIK  NI L+     +L DFG+A   ++     L +   GT
Sbjct: 138 LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGT 188

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (270), Expect = 6e-27
 Identities = 48/180 (26%), Positives = 70/180 (38%), Gaps = 16/180 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPN 240
           H +    +LG+GA + VF+G+        AIK  +            RE  +   L+H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 241 IVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV L     +   +   LI ++   GSL   L E          LP S    V   +   
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGG 124

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 355
           + +L    E  +VHR+IKP NI+    +      KL DFG A             ++ GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGT 178

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  108 bits (271), Expect = 8e-27
 Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 29/180 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKEDKESSKAFC------------ 227
           ++   R L +G   F    K+ L        A+K+ +K   E  + F             
Sbjct: 32  DYRIIRTLNQG--KF---NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSK 86

Query: 228 -----RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-GVRGN 281
                 EL I + + +   +   G   + ++ +++IY+Y+   S+ +             
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYT 145

Query: 282 STLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
             +P  V   +   +  S +Y+HN  E+ + HRD+KPSNIL+      KL DFG + +  
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  107 bits (270), Expect = 8e-27
 Identities = 44/178 (24%), Positives = 67/178 (37%), Gaps = 18/178 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHH 238
             + +GR LG+G  +  F+      +   A K + K              E+ I  SL H
Sbjct: 41  RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIA 297
            ++V   G   +    +F++ +     SL      +K        L     RY +   I 
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKA-------LTEPEARYYLR-QIV 151

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
               YLH      V+HRD+K  N+ L+     K+ DFGLAT           K + GT
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGT 204

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  106 bits (268), Expect = 1e-26
 Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 18/177 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHP 239
            + +GR LG+G  +  F+      +   A K + K              E+ I  SL H 
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIAE 298
           ++V   G   +    +F++ +     SL      +K        L     RY +   I  
Sbjct: 76  HVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKA-------LTEPEARYYLR-QIVL 126

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
              YLH      V+HRD+K  N+ L+     K+ DFGLAT           K + GT
Sbjct: 127 GCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGT 178

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  106 bits (266), Expect = 1e-26
 Identities = 53/164 (32%), Positives = 77/164 (46%), Gaps = 24/164 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRT-----SVAIKRLDKEDKESSKA---FCRELMIAS 234
           +F  GR LG+G   F   G V L R       +A+K L K   E +       RE+ I S
Sbjct: 10  DFEIGRPLGKG--KF---GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HPNI+ L G+  D  + ++LI +Y   G++ R L +  K                  
Sbjct: 65  HLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK-------FDEQRTATYIT 116

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            +A +++Y H    + V+HRDIKP N+LL S    K+ DFG + 
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV 157

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  110 bits (276), Expect = 1e-26
 Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 19/158 (12%)

Query: 187 GRVLGRGALSFVFKGK-VGLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIVPL 244
              +  G L +++      +    V +K L    D E+      E    + + HP+IV +
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 245 VGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
             F    ++      +++ +YV G SL+R   +K         LP +      L I  ++
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---------LPVAEAIAYLLEILPAL 195

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           +YLH      +V+ D+KP NI+L+ +++ KL D G  +
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS 229

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  106 bits (267), Expect = 1e-26
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 11/171 (6%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLV 245
              VLG+G    V+ G+    +  +AIK + + D   S+    E+ +   L H NIV  +
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G   +    + +  + V GGSL   L  K   ++ N      +       I E + YLH 
Sbjct: 86  GSFSENGF-IKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLH- 139

Query: 306 GTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
             +  +VHRDIK  N+L+++   + K+ DFG +   +  +     +T  GT
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGT 186

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  105 bits (265), Expect = 2e-26
 Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 30/188 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +F +  ++G G    VFK K  +   +  IKR+   ++++     RE+   + L H NIV
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIV 67

Query: 243 PLVGFCIDPEQG---------------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWS 287
              G     +                 LF+  ++   G+LE+ + +++        L   
Sbjct: 68  HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-----GEKLDKV 122

Query: 288 VRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
           +  ++   I + V Y+H    + +++RD+KPSNI L   K  K+ DFGL T         
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG--- 176

Query: 348 LCKTVKGT 355
                KGT
Sbjct: 177 KRTRSKGT 184

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  104 bits (263), Expect = 4e-26
 Identities = 49/164 (29%), Positives = 77/164 (46%), Gaps = 26/164 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA---FCRELMIAS 234
           +F  GR LG+G   F   G V L R       +A+K L K   E         RE+ I S
Sbjct: 15  DFDIGRPLGKG--KF---GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS 69

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVA 293
            L HPNI+ +  +  D ++ ++L+ ++   G L + L +  +                + 
Sbjct: 70  HLRHPNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGR-------FDEQRSATFME 121

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +A+++ Y H   ER V+HRDIKP N+L+  K   K+ DFG +
Sbjct: 122 E-LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWS 161

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (264), Expect = 7e-26
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 18/162 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 235
             F K +VLG GA   V+KG    +   ++  VAIK L +E    +++K    E  + +S
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMAS 73

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + +P++  L+G C      + LI + +  G L  ++ E K  +     L W       + 
Sbjct: 74  VDNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQ 125

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           IA+ + YL    +R +VHRD+   N+L+ + +  K+ DFGLA
Sbjct: 126 IAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  106 bits (266), Expect = 7e-26
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 13/157 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPN 240
           +   G  +GRG    VF G++    T VA+K   +E    +    F +E  I     HPN
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPN 173

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+G C   +Q ++++ + V GG     L  +         L      ++    A  +
Sbjct: 174 IVRLIGVCTQ-KQPIYIVMELVQGGDFLTFLRTEGA------RLRVKTLLQMVGDAAAGM 226

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            YL     +C +HRD+   N L++ K + K+ DFG++
Sbjct: 227 EYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  108 bits (270), Expect = 7e-26
 Identities = 47/182 (25%), Positives = 75/182 (41%), Gaps = 19/182 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNI 241
            +     LG G   +V +         VAIK+  +E   ++ + +C E+ I   L+HPN+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 242 VPLVGF-----CIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           V           + P     L  +Y  GG L ++L++ +        L       +   I
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDI 130

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVK 353
           + ++ YLH   E  ++HRD+KP NI+L       I K+ D G A          LC    
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFV 184

Query: 354 GT 355
           GT
Sbjct: 185 GT 186

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (262), Expect = 1e-25
 Identities = 50/207 (24%), Positives = 77/207 (37%), Gaps = 20/207 (9%)

Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           R     E +   +    ++    E     H  +    +GRG+   V + K        A+
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 213 KRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH 272
           K++  E          EL+  + L  P IVPL G   +    + +  + + GGSL + + 
Sbjct: 89  KKVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPW-VNIFMELLEGGSLGQLI- 141

Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KL 331
            K+ G      LP            E + YLH    R ++H D+K  N+LLSS      L
Sbjct: 142 -KQMG-----CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAAL 192

Query: 332 CDFGLA---TWTSAPSVPFLCKTVKGT 355
           CDFG A                 + GT
Sbjct: 193 CDFGHALCLQPDGLGKSLLTGDYIPGT 219

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  106 bits (265), Expect = 1e-25
 Identities = 48/180 (26%), Positives = 70/180 (38%), Gaps = 16/180 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPN 240
           H +    +LG+GA + VF+G+        AIK  +            RE  +   L+H N
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 241 IVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV L     +   +   LI ++   GSL   L E          LP S    V   +   
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN----AYGLPESEFLIVLRDVVGG 124

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 355
           + +L    E  +VHR+IKP NI+    +      KL DFG A             ++ GT
Sbjct: 125 MNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGT 178

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 1e-25
 Identities = 46/206 (22%), Positives = 78/206 (37%), Gaps = 22/206 (10%)

Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
            + ++ E   SP  +     S+ +      +F +   LG G+   VFK +        A+
Sbjct: 33  FRGEASETLQSPGYDPSRPESFFQ-----QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87

Query: 213 KRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLER 269
           KR        K+ ++             HP  V L     +    L+L  +   G SL++
Sbjct: 88  KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQTEL-CGPSLQQ 145

Query: 270 HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP 329
           H   +  G      LP +  +        ++A+LH    + +VH D+KP+NI L  +   
Sbjct: 146 HC--EAWGAS----LPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRC 196

Query: 330 KLCDFGLATWTSAPSVPFLCKTVKGT 355
           KL DFGL             +  +G 
Sbjct: 197 KLGDFGLLVELGTAG---AGEVQEGD 219

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  104 bits (261), Expect = 1e-25
 Identities = 42/166 (25%), Positives = 72/166 (43%), Gaps = 22/166 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
            R++GRG +  V++ +  +    VA+K + +    D        RE   A  L  P++VP
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 244 L--VGFCIDPEQG--LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           +   G     E    L++  + ++G  L   L       +G    P +V   +   I  +
Sbjct: 99  IHDFG-----EIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVA--IVRQIGSA 146

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
           +   H        HRD+KP NIL+S+     L DFG+A+ T+   +
Sbjct: 147 LDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  103 bits (259), Expect = 2e-25
 Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 22/158 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
              LG G +S V+  +  +L   VAIK +       +E+ K F RE+  +S L H NIV 
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 244 L--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +  V      E    +L+ +Y+ G +L  ++            L           I + +
Sbjct: 76  MIDVDE----EDDCYYLVMEYIEGPTLSEYIESHGP-------LSVDTAINFTNQILDGI 124

Query: 301 AYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + H       +VHRDIKP NIL+ S K  K+ DFG+A
Sbjct: 125 KHAHDMR----IVHRDIKPQNILIDSNKTLKIFDFGIA 158

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  103 bits (258), Expect = 2e-25
 Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 18/176 (10%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPNIVP 243
               +GRG+   V+KG        VA    +  K  K   + F  E  +   L HPNIV 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 244 LVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                    +G   + L+ + ++ G+L+ +L   K        +   V       I + +
Sbjct: 90  FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGL 142

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
            +LH      ++HRD+K  NI ++      K+ D GLAT   A       K V GT
Sbjct: 143 QFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 193

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  102 bits (256), Expect = 3e-25
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 12/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + +G+G    V  G        VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 26  LQTIGKGEFGDVMLGD--YRGNKVAVKCI-KND-ATAQAFLAEASVMTQLRHSNLVQLLG 81

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ YL   
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYL--- 133

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                VHRD+   N+L+S   + K+ DFGL 
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  101 bits (253), Expect = 1e-24
 Identities = 45/158 (28%), Positives = 76/158 (48%), Gaps = 18/158 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVP 243
           G +LG G +S V   +       VA+K L  +   D      F RE   A++L+HP IV 
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 244 L--VGFCIDPEQGL-FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +   G    P   L +++ +YV G +L   +H +         +      +V     +++
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADACQAL 129

Query: 301 AYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + H NG    ++HRD+KP+NI++S+    K+ DFG+A
Sbjct: 130 NFSHQNG----IIHRDVKPANIMISATNAVKVMDFGIA 163

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =   99 bits (250), Expect = 2e-24
 Identities = 43/156 (27%), Positives = 72/156 (46%), Gaps = 12/156 (7%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
              +  + +G G    V  G   L +  VAIK + +E   S + F  E  +   L HP +
Sbjct: 8   SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKL 65

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L G C++ +  + L+ +++  G L  +L  +    RG       +     L + E +A
Sbjct: 66  VQLYGVCLE-QAPICLVTEFMEHGCLSDYLRTQ----RGLFAAETLLGM--CLDVCEGMA 118

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL    E CV+HRD+   N L+   ++ K+ DFG+ 
Sbjct: 119 YL---EEACVIHRDLAARNCLVGENQVIKVSDFGMT 151

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  100 bits (250), Expect = 3e-24
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 14/161 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +    + LG+G    V   +   L+      VA+K+L    +E  + F RE+ I  SL 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C     + L LI +Y+  GSL  +L + K+ +     L +         I
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQI 123

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + YL     +  +HRD+   NIL+ ++   K+ DFGL 
Sbjct: 124 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 161

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  102 bits (257), Expect = 3e-24
 Identities = 47/190 (24%), Positives = 84/190 (44%), Gaps = 24/190 (12%)

Query: 157 SLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD 216
           S+   +       ++ S       +  +   RVLG+G+   V   K  +     A+K + 
Sbjct: 4   SMMDHLHATPGMFVQHSTAIF---SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVIS 60

Query: 217 K---EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE 273
           K   + K   ++  RE+ +   L HPNI+ L  F  D     +L+ +  +GG L   +  
Sbjct: 61  KRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIIS 119

Query: 274 KKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---I 328
           +K+         +S     ++   +   + Y+H   +  +VHRD+KP N+LL SK     
Sbjct: 120 RKR---------FSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN 167

Query: 329 PKLCDFGLAT 338
            ++ DFGL+T
Sbjct: 168 IRIIDFGLST 177

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  100 bits (251), Expect = 3e-24
 Identities = 48/161 (29%), Positives = 81/161 (50%), Gaps = 18/161 (11%)

Query: 183 NFSKGRVLGRGALSFVFKG----KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
            F K +VLG GA   V+KG    +   ++  VAIK L +E    +++K    E  + +S+
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASV 74

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            +P++  L+G C      + LI + +  G L  ++ E K  +     L W       + I
Sbjct: 75  DNPHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQI 126

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ + YL    +R +VHRD+   N+L+ + +  K+ DFGLA
Sbjct: 127 AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA 164

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  100 bits (251), Expect = 3e-24
 Identities = 46/161 (28%), Positives = 73/161 (45%), Gaps = 14/161 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +    + LG+G    V   +   L+      VA+K+L    +E  + F RE+ I  SL 
Sbjct: 41  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           H NIV   G C     + L LI +Y+  GSL  +L + K+ +     L +         I
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY------TSQI 154

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + YL     +  +HRD+   NIL+ ++   K+ DFGL 
Sbjct: 155 CKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT 192

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  101 bits (252), Expect = 4e-24
 Identities = 28/237 (11%), Positives = 51/237 (21%), Gaps = 34/237 (14%)

Query: 139 ENGLCDSRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFV 198
             G C   A +     ++++  ++ P        S   +            L  G  S V
Sbjct: 21  LIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVV 78

Query: 199 FKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPNIV------------- 242
           F  +        A+K      + S    +        A+ L   +               
Sbjct: 79  FLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD 138

Query: 243 -------PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
                  P        +         L+    S   LE                     +
Sbjct: 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASV-DLELLFSTLDFVYVFRGDEGILALH 197

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
            +   +    A L     + +VH    P N+ +       L D              
Sbjct: 198 ILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPAS 251

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  100 bits (250), Expect = 4e-24
 Identities = 45/161 (27%), Positives = 68/161 (42%), Gaps = 14/161 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKEDKESSKAFCRELMIASSLH 237
            +      LG+G    V   +   L       VA+K+L     +  + F RE+ I  +LH
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
              IV   G    P  Q L L+ +Y+  G L   L   +  +  +  L +      +  I
Sbjct: 83  SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQI 136

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + YL     R  VHRD+   NIL+ S+   K+ DFGLA
Sbjct: 137 CKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLA 174

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 99.3 bits (248), Expect = 6e-24
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 17/163 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKED--KESSKAFCRELMIASS 235
               + R LG G    V   +           VA+K L K +          +E+ I  +
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIADLKKEIEILRN 79

Query: 236 LHHPNIVPLVGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L+H NIV   G C +    G+ LI +++  GSL+ +L + K  +     L +      A+
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY------AV 133

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            I + + YL     R  VHRD+   N+L+ S+   K+ DFGL 
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT 173

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  101 bits (254), Expect = 7e-24
 Identities = 47/193 (24%), Positives = 81/193 (41%), Gaps = 23/193 (11%)

Query: 153 RKIQSLERSISPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAI 212
           R+    +  +       I    G +   +  + + + LG GA   V   +  +     AI
Sbjct: 11  RENLYFQGDLQATPGMFITSKKGHL---SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAI 67

Query: 213 KRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERH 270
           K + K      S+     E+ +   L HPNI+ L  F  D ++  +L+ +   GG L   
Sbjct: 68  KIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVMECYKGGELFDE 126

Query: 271 LHEKKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK- 327
           +  + K         ++      +   +   V YLH   +  +VHRD+KP N+LL SK+ 
Sbjct: 127 IIHRMK---------FNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEK 174

Query: 328 --IPKLCDFGLAT 338
             + K+ DFGL+ 
Sbjct: 175 DALIKIVDFGLSA 187

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.9 bits (247), Expect = 7e-24
 Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 10/156 (6%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +    LG G    V++G       +VA+K L KED    + F +E  +   + HPN+
Sbjct: 13  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+G C   E   ++I ++++ G+L  +L E          +   V   +A  I+ ++ 
Sbjct: 72  VQLLGVCTR-EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAME 125

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL    ++  +HRD+   N L+    + K+ DFGL+
Sbjct: 126 YL---EKKNFIHRDLAARNCLVGENHLVKVADFGLS 158

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  101 bits (254), Expect = 7e-24
 Identities = 41/151 (27%), Positives = 73/151 (48%), Gaps = 10/151 (6%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG G    V++G       +VA+K L KED    + F +E  +   + HPN+V L+G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
            C   E   ++I ++++ G+L  +L E          +   V   +A  I+ ++ YL   
Sbjct: 284 VCTR-EPPFYIITEFMTYGNLLDYLRE-----CNRQEVSAVVLLYMATQISSAMEYLE-- 335

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            ++  +HR++   N L+    + K+ DFGL+
Sbjct: 336 -KKNFIHRNLAARNCLVGENHLVKVADFGLS 365

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 7e-24
 Identities = 46/161 (28%), Positives = 65/161 (40%), Gaps = 26/161 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              +GRG+   V        R   A K++ K   E    F +E+ I  SL HPNI+ L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 247 FCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
              D    ++L+ +  +GG L ER        E                 ++   +  +V
Sbjct: 74  TFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAA-------------RIMKDVLSAV 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
           AY H   +  V HRD+KP N L  +       KL DFGLA 
Sbjct: 120 AYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  100 bits (252), Expect = 9e-24
 Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 12/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + +G+G    V  G        VA+K + K D  +++AF  E  + + L H N+V L+G
Sbjct: 198 LQTIGKGEFGDVMLGD--YRGNKVAVKCI-KND-ATAQAFLAEASVMTQLRHSNLVQLLG 253

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
             ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ YL   
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEYLE-- 306

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                VHRD+   N+L+S   + K+ DFGL 
Sbjct: 307 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 18/162 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 235
               K +VLG G    V KG        ++  V IK + ++   ++S +A    ++   S
Sbjct: 13  TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGS 71

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H +IV L+G C  P   L L+ +Y+  GSL  H+ + +  +     L W       + 
Sbjct: 72  LDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQ 123

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           IA+ + YL    E  +VHR++   N+LL S    ++ DFG+A
Sbjct: 124 IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVA 162

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 98.1 bits (245), Expect = 1e-23
 Identities = 46/162 (28%), Positives = 74/162 (45%), Gaps = 19/162 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKEDKESS----KAFCRELMIASS 235
           +      LG G+   V +G+         SVA+K L K D  S       F RE+    S
Sbjct: 19  DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHS 77

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H N++ L G  +     + ++ +    GSL   L + +    G+  L    RY  A+ 
Sbjct: 78  LDHRNLIRLYGVVL--TPPMKMVTELAPLGSLLDRLRKHQ----GHFLLGTLSRY--AVQ 129

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +AE + YL     +  +HRD+   N+LL+++ + K+ DFGL 
Sbjct: 130 VAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLM 168

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.4 bits (243), Expect = 2e-23
 Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 25/170 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGK-------VGLLRTSVAIKRLDKEDKESSKAFCRELMIASS 235
           +      LG+G  + +FKG          L  T V +K LDK  +  S++F     + S 
Sbjct: 9   DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSK 68

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H ++V   G C+       L+ ++V  GSL+ +L +     +    + W +    A  
Sbjct: 69  LSHKHLVLNYGVCVC-GDENILVQEFVKFGSLDTYLKKN----KNCINILWKLEV--AKQ 121

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--------KLCDFGLA 337
           +A ++ +L    E  ++H ++   NILL  ++          KL D G++
Sbjct: 122 LAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 15/156 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 241
            RV+G+G    V+ G+           AIK L       +  +AF RE ++   L+HPN+
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L+G  + PE    ++  Y+  G L + +       + N T+   + +   L +A  + 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP----QRNPTVKDLISF--GLQVARGME 138

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL    E+  VHRD+   N +L      K+ DFGLA
Sbjct: 139 YL---AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 26/200 (13%), Positives = 52/200 (26%), Gaps = 32/200 (16%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS---KAFCRELMIASSL---- 236
             +G VLG+       +        S  +      ++  S   K    E++    L    
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 237 ---------------------HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
                                    ++ +     D               +L+       
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
                + +L    R ++ L +   +A LH      +VH  ++P +I+L  +    L  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 336 LATWTSAPSVPFLCKTVKGT 355
                 A +V          
Sbjct: 257 HLVRDGASAVS-PIGRGFAP 275

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 97.3 bits (243), Expect = 4e-23
 Identities = 49/161 (30%), Positives = 66/161 (40%), Gaps = 28/161 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
             VLG GA S VF  K  L     A+K + K       +   E+ +   + H NIV L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 247 FCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                    +L+ + VSGG L     ER    EK                 V   +  +V
Sbjct: 74  IYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDAS-------------LVIQQVLSAV 119

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLA 337
            YLH   E  +VHRD+KP N+L  +     KI  + DFGL+
Sbjct: 120 KYLH---ENGIVHRDLKPENLLYLTPEENSKI-MITDFGLS 156

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 96.9 bits (242), Expect = 4e-23
 Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 13/155 (8%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIV 242
             V+GRG    V+ G +      +   A+K L    D      F  E +I     HPN++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+  E    ++  Y+  G L   +  +      N T+   + +   L +A+ + Y
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGF--GLQVAKGMKY 143

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 144 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 96.1 bits (240), Expect = 6e-23
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 12/156 (7%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +  + LG G    V  GK    +  VAIK + KE   S   F  E  +  +L H  +
Sbjct: 24  KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKL 81

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L G C   ++ +F+I +Y++ G L  +L E     R        +       + E++ 
Sbjct: 82  VQLYGVCTK-QRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEM--CKDVCEAME 134

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL     +  +HRD+   N L++ + + K+ DFGL+
Sbjct: 135 YL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 95.7 bits (239), Expect = 6e-23
 Identities = 40/158 (25%), Positives = 64/158 (40%), Gaps = 16/158 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR--TSVAIKRLDKEDKESSKAFCRELMIASSLHHP 239
              +  + LG G    V  GK    +    VA+K + KE   S   F +E      L HP
Sbjct: 8   EEITLLKELGSGQFGVVKLGK---WKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHP 63

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V   G C   E  ++++ +Y+S G L  +L    KG+         +       + E 
Sbjct: 64  KLVKFYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGL----EPSQLLEM--CYDVCEG 116

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +A+L        +HRD+   N L+      K+ DFG+ 
Sbjct: 117 MAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 43/180 (23%), Positives = 75/180 (41%), Gaps = 23/180 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-----EDKESSKAFCRELMIASSLHHPNI 241
             V+G+G  S V +          A+K +D          S++   RE  I   L HP+I
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRY--KVALGIAE 298
           V L+      +  L+++++++ G  L    +       R ++   +S          I E
Sbjct: 89  VELLETYSS-DGMLYMVFEFMDGADLCFEIVK------RADAGFVYSEAVASHYMRQILE 141

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGT 355
           ++ Y H   +  ++HRD+KP  +LL+SK+     KL  FG+A       +        GT
Sbjct: 142 ALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGT 196

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 98.2 bits (245), Expect = 9e-23
 Identities = 42/169 (24%), Positives = 74/169 (43%), Gaps = 28/169 (16%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHH 238
              ++   +LG+G+   V K K  + +   A+K ++K     + +    RE+ +   L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 292
           PNI+ L     D     +++ +  +GG L +         E                 ++
Sbjct: 81  PNIMKLFEILED-SSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------------RI 126

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
              +   + Y+H   +  +VHRD+KP NILL SK+     K+ DFGL+T
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 33/181 (18%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LGRGA S V++ K    +   A+K L K   +  K    E+ +   L HPNI+ L  
Sbjct: 58  ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKE 115

Query: 247 FCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
               P + + L+ + V+GG L     E+ +  E+                     I E+V
Sbjct: 116 IFETPTE-ISLVLELVTGGELFDRIVEKGYYSERDAA-------------DAVKQILEAV 161

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
           AYLH   E  +VHRD+KP N+L ++      + K+ DFGL+       +    KTV GT 
Sbjct: 162 AYLH---ENGIVHRDLKPENLLYATPAPDAPL-KIADFGLSKIVEHQVL---MKTVCGTP 214

Query: 357 G 357
           G
Sbjct: 215 G 215

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 97.5 bits (243), Expect = 1e-22
 Identities = 47/184 (25%), Positives = 74/184 (40%), Gaps = 26/184 (14%)

Query: 183 NFSKGRVLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE--LMIASSLHHP 239
           +F    VLG GA  + V++G        VA+KR+  E    +    RE  L+  S   HP
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD--NRDVAVKRILPECFSFAD---REVQLLRESD-EHP 78

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           N++       D  Q  ++  +     +L+ ++ +K     G   +       +       
Sbjct: 79  NVIRYFCTEKD-RQFQYIAIELC-AATLQEYVEQKDFAHLGLEPI------TLLQQTTSG 130

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKK-----IPKLCDFGLATWTSAPSVPFLC-KTVK 353
           +A+LH      +VHRD+KP NIL+S           + DFGL    +     F     V 
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187

Query: 354 GTFG 357
           GT G
Sbjct: 188 GTEG 191

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.4 bits (240), Expect = 1e-22
 Identities = 46/217 (21%), Positives = 70/217 (32%), Gaps = 46/217 (21%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASS 235
              +     +G+G+   V        R   AIK ++K      + +  +    E+ +   
Sbjct: 25  QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           LHHPNI  L     D +  + L+ +   GG L   L+       G   +           
Sbjct: 85  LHHPNIARLYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 296 ---------------------------------IAESVAYLHNGTERCVVHRDIKPSNIL 322
                                            I  ++ YLH    + + HRDIKP N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFL 200

Query: 323 LSSKK--IPKLCDFGLATWTSA--PSVPFLCKTVKGT 355
            S+ K    KL DFGL+           +   T  GT
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 95.4 bits (238), Expect = 1e-22
 Identities = 38/156 (24%), Positives = 68/156 (43%), Gaps = 16/156 (10%)

Query: 186 KGRVLGRGALSFVFKG--KVGLLRTSVAIKRL--DKEDKESSKAFCRELMIASSLHHPNI 241
           + + LG G    V KG  ++  +  +VA+K L  +  D         E  +   L +P I
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V ++G C    +   L+ +    G L ++L       + N  +      ++   ++  + 
Sbjct: 81  VRMIGICE--AESWMLVMEMAELGPLNKYL-------QQNRHVKDKNIIELVHQVSMGMK 131

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL    E   VHRD+   N+LL ++   K+ DFGL+
Sbjct: 132 YL---EESNFVHRDLAARNVLLVTQHYAKISDFGLS 164

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.9 bits (237), Expect = 1e-22
 Identities = 50/173 (28%), Positives = 68/173 (39%), Gaps = 32/173 (18%)

Query: 181 THNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIAS 234
           +  FS        LG+GA S V +          A K ++ +       +   RE  I  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSV 288
            L HPNIV L     +     +L++  V+GG L      R    E               
Sbjct: 61  KLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADAS----------- 108

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
                  I ES+AY H      +VHR++KP N+LL+SK      KL DFGLA 
Sbjct: 109 --HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 13/155 (8%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRL-DKEDKESSKAFCRELMIASSLHHPNIV 242
             V+GRG    V+ G +      +   A+K L    D      F  E +I     HPN++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+  E    ++  Y+  G L   +  +      N T+   + +   L +A+ + +
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGF--GLQVAKGMKF 207

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           L     +  VHRD+   N +L  K   K+ DFGLA
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 42/162 (25%), Positives = 68/162 (41%), Gaps = 16/162 (9%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESS---KAFCRELMIASSLHHPN 240
           GR+LG+G    V + ++         VA+K L K D  +S   + F RE        HP+
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPH 86

Query: 241 IVPLVGFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +  LVG  +            +I  ++  G L   L   + G    + LP     +  + 
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN-LPLQTLVRFMVD 145

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           IA  + YL   + R  +HRD+   N +L+      + DFGL+
Sbjct: 146 IACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.0 bits (237), Expect = 2e-22
 Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 28/163 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 244
             +LG+G+   V K K  + +   A+K ++K     + +    RE+ +   L HPNI+ L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 245 VGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
                D     +++ +  +GG L       +   E                 ++   +  
Sbjct: 87  FEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAA-------------RIIKQVFS 132

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
            + Y+H   +  +VHRD+KP NILL SK+     K+ DFGL+T
Sbjct: 133 GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 97.1 bits (242), Expect = 2e-22
 Identities = 42/151 (27%), Positives = 72/151 (47%), Gaps = 12/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
            + LG G    V+        T VA+K + K    S +AF  E  +  +L H  +V L  
Sbjct: 193 EKKLGAGQFGEVWMAT-YNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 250

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ +++I ++++ GSL   L          S  P       +  IAE +A++   
Sbjct: 251 VVT--KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEGMAFI--- 300

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +R  +HRD++ +NIL+S+  + K+ DFGLA
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLA 331

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 51/182 (28%), Positives = 70/182 (38%), Gaps = 30/182 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 244
              LG+GA S V +    L     A   ++ +       +   RE  I   L HPNIV L
Sbjct: 16  FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL 75

Query: 245 VGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
                +     +LI+  V+GG L E      +  E                      I E
Sbjct: 76  HDSISEEGH-HYLIFDLVTGGELFEDIVAREYYSEADAS-------------HCIQQILE 121

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLCKTVKGT 355
           +V + H   +  VVHR++KP N+LL+SK      KL DFGLA         +      GT
Sbjct: 122 AVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGT 176

Query: 356 FG 357
            G
Sbjct: 177 PG 178

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 94.6 bits (236), Expect = 2e-22
 Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 12/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG G    V+ G      T VA+K L K+   S  AF  E  +   L H  +V L  
Sbjct: 18  VERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA 75

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                ++ +++I +Y+  GSL   L            L  +    +A  IAE +A++   
Sbjct: 76  VVT--QEPIYIITEYMENGSLVDFLKT-----PSGIKLTINKLLDMAAQIAEGMAFI--- 125

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            ER  +HRD++ +NIL+S     K+ DFGLA
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA 156

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 51/162 (31%), Positives = 76/162 (46%), Gaps = 27/162 (16%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
            + +G+G  +F    KV L R       VAIK +DK   +  S +   RE+ I   L+HP
Sbjct: 20  LKTIGKG--NF---AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 240 NIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           NIV L  V   I+ E+ L+LI +Y SGG +  +L    +       +           I 
Sbjct: 75  NIVKLFEV---IETEKTLYLIMEYASGGEVFDYLVAHGR-------MKEKEARSKFRQIV 124

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
            +V Y H    + +VHRD+K  N+LL +    K+ DFG +  
Sbjct: 125 SAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNE 163

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 48/172 (27%), Positives = 82/172 (47%), Gaps = 9/172 (5%)

Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASS 235
           ++++  F +   LG G  + V+KG        VA+K  +LD E+   S A  RE+ +   
Sbjct: 1   MSSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAI-REISLMKE 59

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           L H NIV L       E  L L+++++    L++++  +  G          V+      
Sbjct: 60  LKHENIVRLYDVIHT-ENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK-YFQWQ 116

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
           + + +A+ H   E  ++HRD+KP N+L++ +   KL DFGLA     P   F
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF 165

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 94.7 bits (236), Expect = 4e-22
 Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 32/181 (17%)

Query: 185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVP 243
            K + LG G+ S   K        + A+K + K  + +++   +E+        HPNIV 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVK 70

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIA 297
           L     D     FL+ + ++GG L   + +KK              +       +   + 
Sbjct: 71  LHEVFHDQLH-TFLVMELLNGGELFERIKKKKH-------------FSETEASYIMRKLV 116

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKG 354
            +V+++H   +  VVHRD+KP N+L + +      K+ DFG A      + P   KT   
Sbjct: 117 SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCF 171

Query: 355 T 355
           T
Sbjct: 172 T 172

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 50/167 (29%), Positives = 79/167 (47%), Gaps = 14/167 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            + K   LG G  + V+KGK  L    VA+K  RL+ E+     A  RE+ +   L H N
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHAN 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L       E+ L L+++Y+    L+++L +          +           +   +
Sbjct: 62  IVTLHDIIHT-EKSLTLVFEYLDK-DLKQYLDDCGNI------INMHNVKLFLFQLLRGL 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
           AY H    + V+HRD+KP N+L++ +   KL DFGLA   S P+  +
Sbjct: 114 AYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 93.8 bits (234), Expect = 4e-22
 Identities = 48/161 (29%), Positives = 79/161 (49%), Gaps = 17/161 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
            +    R+LG G    V++G        + +VA+K   K+D   ++ + F  E +I  +L
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNL 70

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP+IV L+G     E+  ++I +    G L  +L       + +  +   V Y  +L I
Sbjct: 71  DHPHIVKLIGIIE--EEPTWIIMELYPYGELGHYLERN----KNSLKVLTLVLY--SLQI 122

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +++AYL        VHRDI   NIL++S +  KL DFGL+
Sbjct: 123 CKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLS 160

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 51/194 (26%), Positives = 78/194 (40%), Gaps = 42/194 (21%)

Query: 167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------- 217
              +R   G+I     ++ K R LG GA   V   K     +  AIK + K         
Sbjct: 24  GMYVRKKEGKI---GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYS 80

Query: 218 ----EDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER--- 269
                 ++  +    E+ +  SL HPNI+ L     D ++  +L+ ++  GG L E+   
Sbjct: 81  DDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFED-KKYFYLVTEFYEGGELFEQIIN 139

Query: 270 --HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
                E                  +   I   + YLH   +  +VHRDIKP NILL +K 
Sbjct: 140 RHKFDECDAA-------------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKN 183

Query: 328 ---IPKLCDFGLAT 338
                K+ DFGL++
Sbjct: 184 SLLNIKIVDFGLSS 197

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 12/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  
Sbjct: 189 EVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 246

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                E+ ++++ +Y+S GSL   L            L       +A  IA  +AY+   
Sbjct: 247 VV--SEEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVE-- 297

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                VHRD++ +NIL+    + K+ DFGLA
Sbjct: 298 -RMNYVHRDLRAANILVGENLVCKVADFGLA 327

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 95.6 bits (238), Expect = 5e-22
 Identities = 41/191 (21%), Positives = 69/191 (36%), Gaps = 27/191 (14%)

Query: 184 FSKGRVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNI 241
               ++LG G+    VF+G        VA+KR+  +  + +     E+ +   S  HPN+
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +            L++  +     +L+  +  K                 +   IA  VA
Sbjct: 72  IRYYCSETTDRF-LYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIP-------------KLCDFGLAT--WTSAPSVP 346
           +LH      ++HRD+KP NIL+S+                  + DFGL     +   S  
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 347 FLCKTVKGTFG 357
                  GT G
Sbjct: 187 TNLNNPSGTSG 197

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 93.5 bits (233), Expect = 6e-22
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 17/165 (10%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHP 239
              F   R LG GA   V   +         IK ++K+  +   +    E+ +  SL HP
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGNSTLPWSVRY--KVALGI 296
           NI+ +     D    ++++ +   GG L ER +  + +G         S  Y  ++   +
Sbjct: 81  NIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKA------LSEGYVAELMKQM 133

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
             ++AY H    + VVH+D+KP NIL          K+ DFGLA 
Sbjct: 134 MNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 93.9 bits (234), Expect = 7e-22
 Identities = 41/161 (25%), Positives = 66/161 (40%), Gaps = 15/161 (9%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA---FCRELMIASSLHHPN 240
           G++LG G    V +G +         VA+K + K D  S +    F  E        HPN
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 241 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           ++ L+G CI+          +I  ++  G L  +L   +        +P     K  + I
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH-IPLQTLLKFMVDI 156

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A  + YL   + R  +HRD+   N +L       + DFGL+
Sbjct: 157 ALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 94.7 bits (235), Expect = 7e-22
 Identities = 23/185 (12%), Positives = 48/185 (25%), Gaps = 31/185 (16%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA--------------- 225
                +G VLG+       +        S  +      ++  S A               
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 226 -------------FCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLH 272
                        F     +        ++ +     D               +L+    
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 273 EKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC 332
                   + +L    R ++ L +   +A LH+     +VH  ++P +I+L  +    L 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 333 DFGLA 337
            F   
Sbjct: 249 GFEHL 253

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 95.7 bits (238), Expect = 8e-22
 Identities = 46/151 (30%), Positives = 68/151 (45%), Gaps = 12/151 (7%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              LG+G    V+ G      T VAIK L K    S +AF +E  +   L H  +V L  
Sbjct: 272 EVKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA 329

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                E+ ++++ +Y+S GSL   L            L       +A  IA  +AY+   
Sbjct: 330 VV--SEEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASGMAYVE-- 380

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                VHRD++ +NIL+    + K+ DFGLA
Sbjct: 381 -RMNYVHRDLRAANILVGENLVCKVADFGLA 410

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 48/173 (27%), Positives = 80/173 (46%), Gaps = 15/173 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIASSLHHPNIV 242
           F K   LG G    VFK         +A K +  E K +      REL +    + P IV
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
              G     +  + +  +++ GGSL++ L +          +P  +  KV++ + + + Y
Sbjct: 95  GFYG-AFYSDGEISICMEHMDGGSLDQVLKKAG-------RIPEQILGKVSIAVIKGLTY 146

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           L    +  ++HRD+KPSNIL++S+   KLCDFG+    S   +  +  +  GT
Sbjct: 147 LR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGV----SGQLIDSMANSFVGT 193

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 46/152 (30%), Positives = 74/152 (48%), Gaps = 16/152 (10%)

Query: 190 LGRGALSFVFKG--KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLV 245
           LG G    V +G  ++   +  VAIK L K+   K  ++   RE  I   L +P IV L+
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
           G C    + L L+ +   GG L + L  K++       +P S   ++   ++  + YL  
Sbjct: 77  GVCQ--AEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYL-- 126

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             E+  VHRD+   N+LL ++   K+ DFGL+
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 48/195 (24%), Positives = 73/195 (37%), Gaps = 35/195 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--KAFCRELMIASSL-HHP 239
            F +   +G G    VFK    L     AIKR  K    S   +   RE+   + L  H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           ++V       + +  + +  +Y +GGSL   + E     R  S    +    + L +   
Sbjct: 72  HVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENY---RIMSYFKEAELKDLLLQVGRG 127

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP-------------------KLCDFGLATWT 340
           + Y+H      +VH DIKPSNI +S   IP                   K+ D G  T  
Sbjct: 128 LRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 341 SAPSVPFLCKTVKGT 355
           S+P      +  +G 
Sbjct: 185 SSP------QVEEGD 193

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 46/166 (27%), Positives = 72/166 (43%), Gaps = 20/166 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+ LG GA   V +     L        VA+K L K    +   +A   EL I S L  H
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQH 109

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-------K 291
            NIV L+G C      + +I +Y   G L   L  K + +  +     +           
Sbjct: 110 ENIVNLLGACTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  +A+ +A+L     +  +HRD+   N+LL++  + K+ DFGLA
Sbjct: 169 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 92.8 bits (231), Expect = 1e-21
 Identities = 47/163 (28%), Positives = 70/163 (42%), Gaps = 19/163 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKED--KESSKAFCRELMIASS 235
               K R LG G    V               VA+K L K D   +    + +E+ I  +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRT 89

Query: 236 LHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           L+H +I+   G C D     L L+ +YV  GSL  +L            +  +     A 
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--------IGLAQLLLFAQ 141

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            I E +AYLH    +  +HRD+   N+LL + ++ K+ DFGLA
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 51/173 (29%), Positives = 75/173 (43%), Gaps = 21/173 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIAS 234
                G+ LGRGA   V +             +VA+K L KE       +A   EL I  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILI 85

Query: 235 SL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV- 292
            + HH N+V L+G C  P   L +I ++   G+L  +L  K+         P  +     
Sbjct: 86  HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 293 --------ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                   +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 146 TLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 195

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 47/168 (27%), Positives = 67/168 (39%), Gaps = 33/168 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 240
           G  LG G  + V K +        A K + K          S +   RE+ I   + HPN
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKVAL 294
           I+ L     +    + LI + VSGG L +       L E +               +   
Sbjct: 70  IITLHDIFENKTD-VVLILELVSGGELFDFLAEKESLTEDEAT-------------QFLK 115

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLAT 338
            I + V YLH    + + H D+KP NI+L  K +P    KL DFG+A 
Sbjct: 116 QILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 17/161 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
                GR +G G    V +G          +VAIK   K        + F +E +     
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 73

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP+IV L+G     E  +++I +  + G L   L  +    + +  L   + Y  A  +
Sbjct: 74  DHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR----KYSLDLASLILY--AYQL 125

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + ++AYL     +  VHRDI   N+L+SS    KL DFGL+
Sbjct: 126 STALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 3e-21
 Identities = 51/177 (28%), Positives = 71/177 (40%), Gaps = 32/177 (18%)

Query: 177 ILAATHNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCREL 230
           ++ A+  FS        LG+GA S V +          A K ++ +       +   RE 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTL 284
            I   L HPNIV L     +     +L++  V+GG L      R    E           
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADAS------- 131

Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
                      I ES+AY H      +VHR++KP N+LL+SK      KL DFGLA 
Sbjct: 132 ------HCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 92.0 bits (229), Expect = 3e-21
 Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 27/163 (16%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPL 244
           +  VLG GA + V      +     A+K ++K+         RE+ +      H N++ L
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAE 298
           + F  + ++  +L+++ + GGS+  H+H+++              +       V   +A 
Sbjct: 77  IEFFEEEDR-FYLVFEKMRGGSILSHIHKRRH-------------FNELEASVVVQDVAS 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
           ++ +LHN   + + HRD+KP NIL          K+CDF L +
Sbjct: 123 ALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 44/185 (23%), Positives = 79/185 (42%), Gaps = 36/185 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE----DKESSKAFCRELMIASSLH 237
           G +LG G  S+   GKV  +         A+K L K+             +E+ +   L 
Sbjct: 10  GDLLGEG--SY---GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64

Query: 238 HPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLE--RHLHEKKKGVRGNSTLPWSVRYKVAL 294
           H N++ LV    +  +Q ++++ +Y   G  E    + EK+                 A 
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR------------FPVCQAH 112

Query: 295 G----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCK 350
           G    + + + YLH+   + +VH+DIKP N+LL++    K+   G+A      +    C+
Sbjct: 113 GYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169

Query: 351 TVKGT 355
           T +G+
Sbjct: 170 TSQGS 174

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 49/179 (27%), Positives = 73/179 (40%), Gaps = 37/179 (20%)

Query: 180 ATHNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAF 226
           +TH F +      +LGRG  S V +          A+K +D          E +E  +A 
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 227 CRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-----ER-HLHEKKKGVR 279
            +E+ I   +  HPNI+ L           FL++  +  G L     E+  L EK+    
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNT-FFFLVFDLMKKGELFDYLTEKVTLSEKETR-- 127

Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                      K+   + E +  LH   +  +VHRD+KP NILL      KL DFG + 
Sbjct: 128 -----------KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 91.1 bits (227), Expect = 5e-21
 Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 13/167 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            + K   +G G+   VFK +       VAIK     ++D    K   RE+ +   L HPN
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN 63

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L+      ++ L L+++Y    ++   L   ++G      +P  +   +     ++V
Sbjct: 64  LVNLLE-VFRRKRRLHLVFEYCDH-TVLHELDRYQRG------VPEHLVKSITWQTLQAV 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
            + H   +   +HRD+KP NIL++   + KLCDFG A   + PS  +
Sbjct: 116 NFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY 159

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 92.3 bits (229), Expect = 5e-21
 Identities = 37/165 (22%), Positives = 61/165 (36%), Gaps = 17/165 (10%)

Query: 184 FSKGRVLGRGALSF--VFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHHP 239
           +    V+G+G      V   +       V ++R  L+    E       EL ++   +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 240 NIVPLVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           NIVP    F  D E  L+++  +++ GS  + L         N      +   V   +  
Sbjct: 87  NIVPYRATFIADNE--LWVVTSFMAYGSA-KDLICTHFMDGMNELAIAYILQGVLKALD- 142

Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
              Y+H  G     VHR +K S+IL+S      L          +
Sbjct: 143 ---YIHHMG----YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 93.4 bits (232), Expect = 5e-21
 Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 26/164 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +     LG GA   V +        + A K +    +   +   +E+   S L HP +V 
Sbjct: 159 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 218

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSL-ER------HLHEKKKGVRGNSTLPWSVRYKVALGI 296
           L     D  + + +IY+++SGG L E+       + E +           +V Y     +
Sbjct: 219 LHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDE-----------AVEY--MRQV 264

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLAT 338
            + + ++H   E   VH D+KP NI+ ++K+    KL DFGL  
Sbjct: 265 CKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.2 bits (229), Expect = 6e-21
 Identities = 40/171 (23%), Positives = 73/171 (42%), Gaps = 15/171 (8%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +G  +GRG    V+K K    +     A+K+++      S   CRE+ +   L HPN++ 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA--CREIALLRELKHPNVIS 82

Query: 244 LVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KVALGIAESV 300
           L    +   ++ ++L++ Y     L   +   +        +         +   I + +
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPF 347
            YLH      V+HRD+KP+NIL+  +       K+ D G A   ++P  P 
Sbjct: 142 HYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.4 bits (230), Expect = 6e-21
 Identities = 44/186 (23%), Positives = 74/186 (39%), Gaps = 38/186 (20%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLHH 238
            + LG GA   V           VAI+ + K         + + +     E+ I   L+H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKV 292
           P I+ +  F    +   +++ + + GG L       + L E                   
Sbjct: 200 PCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------------LY 244

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLATWTSAPSVPFLC 349
              +  +V YLH   E  ++HRD+KP N+LLSS++     K+ DFG +      S+    
Sbjct: 245 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM--- 298

Query: 350 KTVKGT 355
           +T+ GT
Sbjct: 299 RTLCGT 304

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 91.2 bits (227), Expect = 7e-21
 Identities = 45/180 (25%), Positives = 70/180 (38%), Gaps = 34/180 (18%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 245
              +G G+ S   +          A+K +DK  K        E+ I      HPNI+ L 
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPT---EEIEILLRYGQHPNIITLK 82

Query: 246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAES 299
               D  + ++++ + + GG L   +  +K              +       V   I ++
Sbjct: 83  DVYDD-GKYVYVVTELMKGGELLDKILRQKF-------------FSEREASAVLFTITKT 128

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLATWTSAPSVPFLCKTVKGT 355
           V YLH    + VVHRD+KPSNIL   +       ++CDFG A    A +      T   T
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL--MTPCYT 183

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 91.7 bits (228), Expect = 7e-21
 Identities = 49/213 (23%), Positives = 82/213 (38%), Gaps = 36/213 (16%)

Query: 145 SRAQELKWRKIQSLERSISPVANSLIRLSYGEILAATHNFSK----GRVLGRGALSFVFK 200
           +   E K       + + +    S+         AA   F +      V+GRG  S V +
Sbjct: 53  NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112

Query: 201 GKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP 251
                     A+K ++         + +E  +A  RE  I   +  HP+I+ L+      
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172

Query: 252 EQGLFLIYKYVSGGSL-----ER-HLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN 305
              +FL++  +  G L     E+  L EK+                +   + E+V++LH 
Sbjct: 173 SF-MFLVFDLMRKGELFDYLTEKVALSEKETR-------------SIMRSLLEAVSFLH- 217

Query: 306 GTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
                +VHRD+KP NILL      +L DFG + 
Sbjct: 218 --ANNIVHRDLKPENILLDDNMQIRLSDFGFSC 248

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 7e-21
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 16/153 (10%)

Query: 189 VLGRGALSFVFKG--KVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPL 244
            LG G    V +G  ++   +  VAIK L K+   K  ++   RE  I   L +P IV L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRL 401

Query: 245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH 304
           +G C    + L L+ +   GG L + L  K++       +P S   ++   ++  + YL 
Sbjct: 402 IGVCQ--AEALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAELLHQVSMGMKYL- 452

Query: 305 NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              E+  VHR++   N+LL ++   K+ DFGL+
Sbjct: 453 --EEKNFVHRNLAARNVLLVNRHYAKISDFGLS 483

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 90.8 bits (226), Expect = 8e-21
 Identities = 34/163 (20%), Positives = 65/163 (39%), Gaps = 31/163 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPL 244
              LGRG    V +      + +   K +     D+   K   +E+ I +   H NI+ L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHL 66

Query: 245 VGFCIDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
                  E+ L +I++++SG  +          L+E++                    + 
Sbjct: 67  HESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIV-------------SYVHQVC 112

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLAT 338
           E++ +LH      + H DI+P NI+  +++    K+ +FG A 
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 89.9 bits (224), Expect = 8e-21
 Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 22/175 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
            + LG G  ++   G+V L        +VA+K +D +          +E+ I   L+H N
Sbjct: 12  VQTLGEG--AY---GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V   G         +L  +Y SGG L   +            +P     +    +   V
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGV 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
            YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 90.2 bits (224), Expect = 8e-21
 Identities = 22/164 (13%), Positives = 47/164 (28%), Gaps = 22/164 (13%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPNIVP 243
               G       ++     L   VA+  +D       +  +      +  S +  P +  
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 244 L--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           +  V        G  ++ +++ GGSL+            + +   ++R      +A +  
Sbjct: 96  VLDVV---HTRAGGLVVAEWIRGGSLQEVA-------DTSPSPVGAIR--AMQSLAAAAD 143

Query: 302 YLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
             H  G    V      PS + +S      L         +   
Sbjct: 144 AAHRAG----VALSIDHPSRVRVSIDGDVVLAYPATMPDANPQD 183

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 17/162 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKED--KESSKAFCRELMIASS 235
              ++ +V+G G    V+KG      G     VAIK L K    ++    F  E  I   
Sbjct: 44  SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQ 102

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
             H NI+ L G      + + +I +Y+  G+L++ L EK     G  ++   V      G
Sbjct: 103 FSHHNIIRLEGVISK-YKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGM--LRG 155

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           IA  + YL        VHRD+   NIL++S  + K+ DFGL+
Sbjct: 156 IAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 91.3 bits (227), Expect = 9e-21
 Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 15/161 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R LG GA   V++G+V  +        VA+K L  E   ++    F  E +I S  +H 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQ 134

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV  +G  +      F++ + ++GG L+  L E +      S+L       VA  IA  
Sbjct: 135 NIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
             YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 194 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 15/161 (9%)

Query: 187 GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R LG GA   V++G+V           VA+K L  E   ++    F  E +I S  +H 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQ 93

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NIV  +G  +      F++ + ++GG L+  L E +      S+L       VA  IA  
Sbjct: 94  NIVRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGLA 337
             YL    E   +HRDI   N LL+     ++ K+ DFG+A
Sbjct: 153 CQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 43/156 (27%), Positives = 67/156 (42%), Gaps = 16/156 (10%)

Query: 187 GRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 241
            +++G G    V  G+    G     VAIK L K    +   + F  E  I     HPNI
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNI 112

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L G      +   ++ +Y+  GSL+  L        G  T+   V      G+   + 
Sbjct: 113 IRLEGVVTR-GRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGM--LRGVGAGMR 165

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL   ++   VHRD+   N+L+ S  + K+ DFGL+
Sbjct: 166 YL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLS 198

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 39/182 (21%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +G G  +F   G   L+R       VA+K +++          RE++   SL HPNI
Sbjct: 25  VKDIGSG--NF---GVARLMRDKLTKELVAVKYIERGAAIDENVQ-REIINHRSLRHPNI 78

Query: 242 VPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG---- 295
           V    V   I     L +I +Y SGG L   +    +                A      
Sbjct: 79  VRFKEV---ILTPTHLAIIMEYASGGELYERICNAGR-----------FSEDEARFFFQQ 124

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTSAPSVPFLCKTVK 353
           +   V+Y H+     + HRD+K  N LL     P  K+CDFG +  +   S P   K+  
Sbjct: 125 LLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTV 178

Query: 354 GT 355
           GT
Sbjct: 179 GT 180

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 45/178 (25%), Positives = 67/178 (37%), Gaps = 37/178 (20%)

Query: 181 THNFSK----GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCREL 230
             N       G  LG G  + V K +        A K + K          S +   RE+
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTL 284
            I   + HPN++ L     +    + LI + V+GG L      +  L E++         
Sbjct: 66  SILKEIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEAT------- 117

Query: 285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLAT 338
                 +    I   V YLH      + H D+KP NI+L  + +P    K+ DFGLA 
Sbjct: 118 ------EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 1e-20
 Identities = 47/167 (28%), Positives = 75/167 (44%), Gaps = 13/167 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            +    ++G G+   V K +       VAIK      +DK   K   RE+ +   L H N
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L+  C   ++  +L++++V   ++   L     G      L + V  K    I   +
Sbjct: 86  LVNLLEVCKK-KKRWYLVFEFVDH-TILDDLELFPNG------LDYQVVQKYLFQIINGI 137

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
            + H      ++HRDIKP NIL+S   + KLCDFG A   +AP   +
Sbjct: 138 GFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY 181

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 39/161 (24%), Positives = 69/161 (42%), Gaps = 15/161 (9%)

Query: 187 GRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R LG+G+   V++G    +      T VAIK +  E         F  E  +    +  
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCH 88

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY---KVALGI 296
           ++V L+G      Q   +I + ++ G L+ +L   +  +  N  L         ++A  I
Sbjct: 89  HVVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A+ +AYL+       VHRD+   N +++     K+ DFG+ 
Sbjct: 148 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 48/168 (28%), Positives = 66/168 (39%), Gaps = 33/168 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 240
           G  LG G  + V K +        A K + K            +   RE+ I   + HPN
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           I+ L     +    + LI + VSGG L      +  L E++                   
Sbjct: 77  IITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEAT-------------SFIK 122

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLAT 338
            I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA 
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 47/175 (26%), Positives = 71/175 (40%), Gaps = 22/175 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
            + LG G  ++   G+V L        +VA+K +D +          +E+ I   L+H N
Sbjct: 12  VQTLGEG--AY---GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V   G         +L  +Y SGG L   +            +P     +    +   V
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGV 118

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGT 355
            YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 41/164 (25%), Positives = 68/164 (41%), Gaps = 32/164 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 245
            +VLG G    V +      +   A+K L    K       RE+ +   +   P+IV +V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIV 77

Query: 246 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGI 296
               +   G   L ++ + + GG L   + ++               +      ++   I
Sbjct: 78  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-----------AFTEREASEIMKSI 126

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLA 337
            E++ YLH      + HRD+KP N+L +SK+   I KL DFG A
Sbjct: 127 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 89.2 bits (222), Expect = 2e-20
 Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 20/166 (12%)

Query: 187 GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
            R LG GA   VF  +         +  VA+K L K+   +++  F RE  + ++L H +
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL-KDPTLAARKDFQREAELLTNLQHEH 78

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--------- 291
           IV   G C D    L ++++Y+  G L + L                             
Sbjct: 79  IVKFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 137

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +A  IA  + YL     +  VHRD+   N L+ +  + K+ DFG++
Sbjct: 138 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.5 bits (225), Expect = 2e-20
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNI 241
            +V+G G    V  G++        SVAIK L K    ++  + F  E  I     HPNI
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNI 108

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           + L G      + + ++ +Y+  GSL+  L +         T+   V      GIA  + 
Sbjct: 109 IRLEGVVTK-SKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGM--LRGIASGMK 161

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           YL   ++   VHRD+   NIL++S  + K+ DFGL 
Sbjct: 162 YL---SDMGYVHRDLAARNILINSNLVCKVSDFGLG 194

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 41/169 (24%), Positives = 68/169 (40%), Gaps = 35/169 (20%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--------EDKESSKAFCRELMIASSLHH 238
            + LG GA   V           VAIK + K         + + +     E+ I   L+H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ER-----HLHEKKKGVRGNSTLPWSVRYKV 292
           P I+ +  F    +   +++ + + GG L ++      L E                   
Sbjct: 75  PCIIKIKNFFDAED--YYIVLELMEGGELFDKVVGNKRLKEATCK-------------LY 119

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
              +  +V YLH   E  ++HRD+KP N+LLSS++     K+ DFG + 
Sbjct: 120 FYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 55/184 (29%), Positives = 85/184 (46%), Gaps = 13/184 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 241
           ++    V+G GA + V        +  VAIKR++ E  ++S     +E+   S  HHPNI
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75

Query: 242 VPLVG-FCIDPEQGLFLIYKYVSGGSLERHL--HEKKKGVRGNSTLPWSVRYKVALGIAE 298
           V     F +  E  L+L+ K +SGGS+   +  H   KG   +  L  S    +   + E
Sbjct: 76  VSYYTSFVVKDE--LWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 299 SVAYLH-NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            + YLH NG     +HRD+K  NILL      ++ DFG++ + +          V+ TF 
Sbjct: 133 GLEYLHKNG----QIHRDVKAGNILLGEDGSVQIADFGVSAFLAT-GGDITRNKVRKTFV 187

Query: 358 QNPF 361
             P 
Sbjct: 188 GTPC 191

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.8 bits (221), Expect = 3e-20
 Identities = 47/167 (28%), Positives = 68/167 (40%), Gaps = 21/167 (12%)

Query: 187 GRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
              LG      V+KG +     G    +VAIK L K+       + F  E M+ + L HP
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHP 72

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---------Y 290
           N+V L+G     +Q L +I+ Y S G L   L  +       ST                
Sbjct: 73  NVVCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV 131

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +   IA  + YL   +   VVH+D+   N+L+  K   K+ D GL 
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 33/168 (19%)

Query: 186 KGRVLGRGALSFVFKGKVGLLRTSVAIK-----RLDKEDKESSKAFCRELMIASSL-HHP 239
             + LGRG  + V +          A K     R  ++ +        E+ +       P
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL---HEIAVLELAKSCP 89

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--KVALG-- 295
            ++ L     +  + + LI +Y +GG +      +                     +   
Sbjct: 90  RVINLHEVYENTSE-IILILEYAAGGEIFSLCLPELAE-----------MVSENDVIRLI 137

Query: 296 --IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP---KLCDFGLAT 338
             I E V YLH   +  +VH D+KP NILLSS       K+ DFG++ 
Sbjct: 138 KQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 47/168 (27%), Positives = 66/168 (39%), Gaps = 33/168 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSLHHPN 240
           G  LG G  + V K +        A K + K          S +   RE+ I   + H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           ++ L     +    + LI + VSGG L      +  L E++                   
Sbjct: 77  VITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEAT-------------SFIK 122

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLAT 338
            I + V YLH    + + H D+KP NI+L  K IP    KL DFGLA 
Sbjct: 123 QILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 53/169 (31%), Positives = 75/169 (44%), Gaps = 29/169 (17%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMIASSLHH 238
             +++  +V+G G+   V++ K+      VAIK+   DK  K       REL I   L H
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN------RELQIMRKLDH 106

Query: 239 PNIVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV----R 289
            NIV L  F         E  L L+  YV   ++ R     +   R   TLP        
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVA---RHYSRAKQTLPVIYVKLYM 162

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA 337
           Y++   +A    Y+H+     + HRDIKP N+LL     + KLCDFG A
Sbjct: 163 YQLFRSLA----YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 42/167 (25%), Positives = 65/167 (38%), Gaps = 26/167 (15%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
              +     LG GA   V +            K ++            E+ I + LHHP 
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL-ER------HLHEKKKGVRGNSTLPWSVRYKVA 293
           ++ L     D  + + LI +++SGG L +R       + E +                  
Sbjct: 110 LINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVI-------------NYM 155

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLAT 338
               E + ++H   E  +VH DIKP NI+  +KK    K+ DFGLAT
Sbjct: 156 RQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 40/185 (21%), Positives = 74/185 (40%), Gaps = 27/185 (14%)

Query: 163 SPVANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKES 222
           +P  + ++    G +  + +  SK  +LG G    V K +       +A K +     + 
Sbjct: 71  APFDHRIVTAKQGAV-NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 223 SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSL-ERHLHEKKKGVRGN 281
            +    E+ + + L H N++ L          + L+ +YV GG L +R + E        
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYVDGGELFDRIIDES------- 181

Query: 282 STLPWSVRY--KVALG----IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCD 333
                         +     I E + ++H   +  ++H D+KP NIL  ++     K+ D
Sbjct: 182 ------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIID 232

Query: 334 FGLAT 338
           FGLA 
Sbjct: 233 FGLAR 237

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.8 bits (221), Expect = 4e-20
 Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 24/175 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKED--KESSKAFCRELMIAS 234
           +  S G+ LG GA   V +    GL++     +VA+K L K        +A   EL + S
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLS 81

Query: 235 SL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR---- 289
            L +H NIV L+G C        +I +Y   G L   L  K+     + T P  +     
Sbjct: 82  YLGNHMNIVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 290 -------YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                     +  +A+ +A+L     +  +HRD+   NILL+  +I K+CDFGLA
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 192

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 46/165 (27%), Positives = 70/165 (42%), Gaps = 19/165 (11%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESSKA-FCRELMIASSLHHPN 240
              LG GA   VF  +   LL       VA+K L KE  ES++  F RE  + + L H +
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQH 104

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR--------YKV 292
           IV   G C +  + L ++++Y+  G L R L       +  +                 V
Sbjct: 105 IVRFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A  +A  + YL        VHRD+   N L+    + K+ DFG++
Sbjct: 164 ASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 89.6 bits (222), Expect = 4e-20
 Identities = 31/200 (15%), Positives = 63/200 (31%), Gaps = 24/200 (12%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESSKAFCRELMIASS 235
           +       +LG GA + V++   G L  +       +K     +        + +     
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
                 +      +    G  L+ +  S G+L   ++  K        +P  +    A+ 
Sbjct: 124 SMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLNAINLYKN--TPEKVMPQGLVISFAMR 180

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-----------KLCDFGLATWTSAPS 344
           +   +  +H   +  ++H DIKP N +L +  +             L D G +       
Sbjct: 181 MLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 345 VPFLCKTVKGTFGQNPFCIE 364
              +      T G    C+E
Sbjct: 238 KGTIFTAKCETSGFQ--CVE 255

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 50/165 (30%), Positives = 75/165 (45%), Gaps = 19/165 (11%)

Query: 187 GRVLGRGALSFVFKGKV--GLLRTSVAIKRLDKED--KESSKAFCRELMIASSL-HHPNI 241
             V+G G    V K ++    LR   AIKR+ KE   K+  + F  EL +   L HHPNI
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNI 88

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------GNSTLPWSVRYKV 292
           + L+G C      L+L  +Y   G+L   L + +               STL        
Sbjct: 89  INLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A  +A  + YL   +++  +HRD+   NIL+    + K+ DFGL+
Sbjct: 148 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS 189

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 90.7 bits (225), Expect = 5e-20
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 17/161 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGK---VGLLRTSVAIKRLDKED--KESSKAFCRELMIASSL 236
                GR +G G    V +G          +VAIK   K        + F +E +     
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQF 448

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP+IV L+G     E  +++I +  + G L   L  +    + +  L   + Y  A  +
Sbjct: 449 DHPHIVKLIGVIT--ENPVWIIMELCTLGELRSFLQVR----KFSLDLASLILY--AYQL 500

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + ++AYL     +  VHRDI   N+L+SS    KL DFGL+
Sbjct: 501 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.9 bits (221), Expect = 5e-20
 Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 36/180 (20%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLVGF 247
           VLG G    V +          A+K L       S    +E+     +   P+IV ++  
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90

Query: 248 CIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGIAE 298
             +   G   L +I + + GG L   + E+               +      ++   I  
Sbjct: 91  YENMHHGKRCLLIIMECMEGGELFSRIQERG-----------DQAFTEREAAEIMRDIGT 139

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGT 355
           ++ +LH      + HRD+KP N+L +SK+   + KL DFG A  T+  ++    +T   T
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYT 192

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 20/166 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--------DKESSKAFCRELMIA 233
             +S    LG GA  FV+          V +K + KE        +         E+ I 
Sbjct: 24  QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIY-KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           S + H NI+ ++    + +    L+  K+ SG  L   +    +       L   +   +
Sbjct: 84  SRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPR-------LDEPLASYI 135

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
              +  +V YL     + ++HRDIK  NI+++     KL DFG A 
Sbjct: 136 FRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAA 178

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 41/165 (24%), Positives = 67/165 (40%), Gaps = 32/165 (19%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLV 245
            +VLG G    V +      +   A+K L    K       RE+ +       P+IV +V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-----REVELHWRASQCPHIVRIV 121

Query: 246 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY------KVALGI 296
               +   G   L ++ + + GG L   + ++               +      ++   I
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG-----------DQAFTEREASEIMKSI 170

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLAT 338
            E++ YLH      + HRD+KP N+L +SK+   I KL DFG A 
Sbjct: 171 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 88.0 bits (219), Expect = 6e-20
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 16/159 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 238
           NF K   +G G    V+K +  L    VA+K  RLD E  E   S A  RE+ +   L+H
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAI-REISLLKELNH 61

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           PNIV L+      E  L+L+++++    L++ +            +P  +       + +
Sbjct: 62  PNIVKLLDVIHT-ENKLYLVFEFLHQ-DLKKFMDASALT-----GIPLPLIKSYLFQLLQ 114

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +A+ H      V+HRD+KP N+L++++   KL DFGLA
Sbjct: 115 GLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 87.6 bits (218), Expect = 8e-20
 Identities = 44/159 (27%), Positives = 70/159 (44%), Gaps = 17/159 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 238
            + K   +G G    VFK K       VA+K  RLD +  E   S A  RE+ +   L H
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSAL-REICLLKELKH 60

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            NIV L       ++ L L++++     L+++             L   +       + +
Sbjct: 61  KNIVRLHDVLHS-DKKLTLVFEFCDQ-DLKKYFDSCNGD------LDPEIVKSFLFQLLK 112

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + + H    R V+HRD+KP N+L++     KL +FGLA
Sbjct: 113 GLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLA 148

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 9/151 (5%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIA-SSLHHPNIVPLVG 246
            LGRGA   V K +       +A+KR+    + +  K    +L I+  ++  P  V   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                   +++  + +   SL++     K+ +    T+P  +  K+A+ I +++ +LH+ 
Sbjct: 74  ALFREGD-VWICMELM-DTSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS- 127

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  V+HRD+KPSN+L+++    K+CDFG++
Sbjct: 128 -KLSVIHRDVKPSNVLINALGQVKMCDFGIS 157

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 52/167 (31%), Positives = 76/167 (45%), Gaps = 32/167 (19%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRT-SVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           ++  +V+G G+   VF+ K  L+ +  VAIK    DK  K       REL I   + HPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAK--LVESDEVAIKKVLQDKRFKN------RELQIMRIVKHPN 93

Query: 241 IVPLVGFCIDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSV----RYK 291
           +V L  F         E  L L+ +YV   ++ R      K      T+P  +     Y+
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKL---KQTMPMLLIKLYMYQ 149

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA 337
           +   +A    Y+H+     + HRDIKP N+LL     + KL DFG A
Sbjct: 150 LLRSLA----YIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA 189

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.0 bits (214), Expect = 2e-19
 Identities = 47/161 (29%), Positives = 74/161 (45%), Gaps = 22/161 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRELMIASSL 236
            +     +G G    V+K +          A+K  RL+KED E   S    RE+ I   L
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN---NYGETFALKKIRLEKED-EGIPSTTI-REISILKEL 57

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H NIV L       ++ L L+++++    L++ L   + G      L         L +
Sbjct: 58  KHSNIVKLYDVIHT-KKRLVLVFEHLDQ-DLKKLLDVCEGG------LESVTAKSFLLQL 109

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +AY H   +R V+HRD+KP N+L++ +   K+ DFGLA
Sbjct: 110 LNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLA 147

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 40/149 (26%), Positives = 62/149 (41%), Gaps = 8/149 (5%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS-KAFCRELMIA-SSLHHPNIVPLVG 246
            +GRGA   V K         +A+KR+     E   K    +L +   S   P IV   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                E   ++  + +   S ++        +     +P  +  K+ L   +++ +L   
Sbjct: 89  ALFR-EGDCWICMELM-STSFDKFYKYVYSVLDD--VIPEEILGKITLATVKALNHLKE- 143

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFG 335
               ++HRDIKPSNILL      KLCDFG
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFG 171

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 85.7 bits (213), Expect = 3e-19
 Identities = 47/163 (28%), Positives = 72/163 (44%), Gaps = 28/163 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 238
           G  LG G  +F   GKV +         VA+K L+++   S        RE+       H
Sbjct: 16  GDTLGVG--TF---GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70

Query: 239 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           P+I+ L  V   I      F++ +YVSGG L  ++ +  +       +      ++   I
Sbjct: 71  PHIIKLYQV---ISTPTDFFMVMEYVSGGELFDYICKHGR-------VEEMEARRLFQQI 120

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
             +V Y H      VVHRD+KP N+LL +    K+ DFGL+  
Sbjct: 121 LSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM 160

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 51/180 (28%), Positives = 76/180 (42%), Gaps = 29/180 (16%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESS--KAFCRELMIAS 234
            N   G+ LG G    V K     L+     T+VA+K L KE+   S  +    E  +  
Sbjct: 23  KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLK 81

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY---- 290
            ++HP+++ L G C   +  L LI +Y   GSL   L E +K   G      S       
Sbjct: 82  QVNHPHVIKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 291 -------------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                          A  I++ + YL    E  +VHRD+   NIL++  +  K+ DFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLS 197

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.1 bits (214), Expect = 3e-19
 Identities = 55/171 (32%), Positives = 80/171 (46%), Gaps = 22/171 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRELMIASSL 236
            + K   +G G    V+K K         VA+K  RLD E  E   S A  RE+ +   L
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKD---SQGRIVALKRIRLDAE-DEGIPSTAI-REISLLKEL 76

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           HHPNIV L+      E+ L L+++++    L++ L E K G      L  S        +
Sbjct: 77  HHPNIVSLIDVIHS-ERCLTLVFEFMEK-DLKKVLDENKTG------LQDSQIKIYLYQL 128

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
              VA+ H   +  ++HRD+KP N+L++S    KL DFGLA     P   +
Sbjct: 129 LRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 86.2 bits (214), Expect = 4e-19
 Identities = 40/175 (22%), Positives = 73/175 (41%), Gaps = 24/175 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED--KESSKAFCRELMI 232
              + G+ LG GA   V   +   +         +VA+K L K+D  ++       E+ +
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEM 93

Query: 233 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL---------HEKKKGVRGNS 282
              +  H NI+ L+G C   +  L++I +Y S G+L  +L         +          
Sbjct: 94  MKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152

Query: 283 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + +         +A  + YL     +  +HRD+   N+L++   + K+ DFGLA
Sbjct: 153 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 204

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 85.7 bits (213), Expect = 5e-19
 Identities = 45/168 (26%), Positives = 68/168 (40%), Gaps = 23/168 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAF----CRELMIASSL 236
            +     +G GA   V+K +       VA+K  R+                RE+ +   L
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNG-GGGGGGLPISTVREVALLRRL 68

Query: 237 H---HPNIVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
               HPN+V L         D E  + L++++V    L  +L +          LP    
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-----APPPGLPAETI 122

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +       + +LH     C+VHRD+KP NIL++S    KL DFGLA
Sbjct: 123 KDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLA 167

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 29/175 (16%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKED--KESSKAFCRELMIASSLHHP 239
            R +G GA   VF+ +  GLL     T VA+K L KE+   +    F RE  + +   +P
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNP 110

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY--------- 290
           NIV L+G C    + + L+++Y++ G L   L         + +                
Sbjct: 111 NIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169

Query: 291 --------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                    +A  +A  +AYL   +ER  VHRD+   N L+    + K+ DFGL+
Sbjct: 170 PLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLS 221

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 85.7 bits (213), Expect = 7e-19
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 18/171 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKES----SKAFCRELMIASSL 236
            + K   LG G  + V+K +       VAIK  +L    +        A  RE+ +   L
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTAL-REIKLLQEL 69

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HPNI+ L+      +  + L++ ++    LE  + +          L  S      L  
Sbjct: 70  SHPNIIGLLD-AFGHKSNISLVFDFME-TDLEVIIKDNSLV------LTPSHIKAYMLMT 121

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF 347
            + + YLH   +  ++HRD+KP+N+LL    + KL DFGLA    +P+  +
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 51/175 (29%), Positives = 81/175 (46%), Gaps = 29/175 (16%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR----TSVAIKRLDKEDKESS--KAFCRELMIASSL-HH 238
           G+VLG GA   V      G+ +      VA+K L KE  +SS  +A   EL + + L  H
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSH 108

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-------- 290
            NIV L+G C      ++LI++Y   G L  +L  K++    +     + +         
Sbjct: 109 ENIVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 291 --------KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                     A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 84.7 bits (210), Expect = 9e-19
 Identities = 38/156 (24%), Positives = 81/156 (51%), Gaps = 12/156 (7%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +     LG GA   V+K K        A K ++ + +E  + +  E+ I ++  HP IV 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           L+G +  D +  L+++ ++  GG+++  + E  +G+         ++  V   + E++ +
Sbjct: 81  LLGAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEP-----QIQV-VCRQMLEALNF 132

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
           LH+   + ++HRD+K  N+L++ +   +L DFG++ 
Sbjct: 133 LHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSA 165

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 27/174 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKES--SKAFCRELMIASSLHH 238
            + K   +G+G    VFK +       VA+K   ++ E KE     A  RE+ I   L H
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITAL-REIKILQLLKH 75

Query: 239 PNIVPLVGFCIDPEQG-------LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY- 290
            N+V L+  C             ++L++ +      E  L     G+  N  + +++   
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDL----AGLLSNVLVKFTLSEI 126

Query: 291 -KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
            +V   +   + Y+H      ++HRD+K +N+L++   + KL DFGLA   S  
Sbjct: 127 KRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 39/175 (22%), Positives = 72/175 (41%), Gaps = 24/175 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKED--KESSKAFCRELMI 232
              + G+ LG G    V   +   +         +VA+K L K+D  ++       E+ +
Sbjct: 81  DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEM 139

Query: 233 ASSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHL---------HEKKKGVRGNS 282
              +  H NI+ L+G C   +  L++I +Y S G+L  +L         +          
Sbjct: 140 MKMIGKHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198

Query: 283 TLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + +         +A  + YL     +  +HRD+   N+L++   + K+ DFGLA
Sbjct: 199 QMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 250

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 84.3 bits (209), Expect = 1e-18
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            +  + +  E  L+++ +Y++GGSL   + E        +         V     +++ +
Sbjct: 82  YLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAA--------VCRECLQALEF 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           LH+     V+HRDIK  NILL      KL DFG  
Sbjct: 132 LHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 49/174 (28%), Positives = 71/174 (40%), Gaps = 23/174 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKE--SSKAFCRELMIASSLHH 238
            + +   LG G    V+K    +   +VAIK  RL+ E +E     A  RE+ +   L H
Sbjct: 35  RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAI-REVSLLKELQH 92

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
            NI+ L          L LI++Y          ++ KK +  N  +   V       +  
Sbjct: 93  RNIIELKSVIHH-NHRLHLIFEYAE--------NDLKKYMDKNPDVSMRVIKSFLYQLIN 143

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIP-----KLCDFGLATWTSAPSVPF 347
            V + H    R  +HRD+KP N+LLS          K+ DFGLA     P   F
Sbjct: 144 GVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF 194

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 83.5 bits (207), Expect = 3e-18
 Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 23/165 (13%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           F+K   +G+G+   VFKG     +  VAIK +D E+ E       +E+ + S    P + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
              G     +  L++I +Y+ GGS         L E +            +  ++  G+ 
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIAT---------ILREILKGLD 133

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA 342
               YLH+      +HRDIK +N+LLS     KL DFG+A   + 
Sbjct: 134 ----YLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 83.9 bits (208), Expect = 3e-18
 Identities = 52/173 (30%), Positives = 72/173 (41%), Gaps = 31/173 (17%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKR--LDKEDKESSKAFCRELMI---ASS 235
              F   R+ G+G    V  GK      SVAIK+   D   +       REL I    + 
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN------RELQIMQDLAV 75

Query: 236 LHHPNIVPL------VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW--- 286
           LHHPNIV L      +G     +  L ++ +YV   +L R     +   R     P    
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCC---RNYYRRQVAPPPILI 131

Query: 287 -SVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLA 337
               ++    +  S+  LH  +   V HRDIKP N+L++      KLCDFG A
Sbjct: 132 KVFLFQ----LIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSA 179

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 83.0 bits (206), Expect = 4e-18
 Identities = 56/181 (30%), Positives = 80/181 (44%), Gaps = 24/181 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 234
           +F  G++LG G  SF     V L R   TS   AIK L+K     +       RE  + S
Sbjct: 31  DFKFGKILGEG--SF---STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 85

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            L HP  V L     D E+ L+    Y   G L +++  +K G    +      R+  A 
Sbjct: 86  RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYI--RKIGSFDETC----TRFYTA- 137

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
            I  ++ YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  G
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194

Query: 355 T 355
           T
Sbjct: 195 T 195

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 82.4 bits (204), Expect = 6e-18
 Identities = 36/169 (21%), Positives = 63/169 (37%), Gaps = 21/169 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASS 235
             +  G +LG G    V+ G        VAIK ++K+      +  +      E+++   
Sbjct: 43  SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102

Query: 236 LHH--PNIVPLVGFCIDPEQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKV 292
           +      ++ L+ +  +      LI +       L   + E+         L   +    
Sbjct: 103 VSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGA-------LQEELARSF 154

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWT 340
              + E+V + HN     V+HRDIK  NIL+   +   KL DFG     
Sbjct: 155 FWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 40/169 (23%), Positives = 68/169 (40%), Gaps = 23/169 (13%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASS 235
             +  G +LG+G    VF G     R  VAIK + +           S     E+ +   
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90

Query: 236 LH----HPNIVPLVGFCIDPEQGLFLIYKY-VSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           +     HP ++ L+ +  + ++G  L+ +  +    L  ++ EK         L      
Sbjct: 91  VGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGP-------LGEGPSR 142

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLAT 338
                +  ++ + H+   R VVHRDIK  NIL+  ++   KL DFG   
Sbjct: 143 CFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGA 188

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 82.4 bits (204), Expect = 7e-18
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 24/160 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
                 +G G+   V   +       VA+K +D   ++  +    E++I     H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 244 LVG-FCIDPEQGLFLIYKYVSGGSL-----ERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           +   + +  E  L+++ +++ GG+L     +  L+E++                V   + 
Sbjct: 107 MYKSYLVGEE--LWVLMEFLQGGALTDIVSQVRLNEEQIAT-------------VCEAVL 151

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +++AYLH    + V+HRDIK  +ILL+     KL DFG  
Sbjct: 152 QALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFC 188

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 25/168 (14%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIK--RLDKEDKE--SSKAFCRE---LMIA 233
            +     +G GA   VFK +  L      VA+K  R+    +E        RE   L   
Sbjct: 12  QYECVAEIGEGAYGKVFKAR-DLKNGGRFVALKRVRVQTG-EEGMPLSTI-REVAVLRHL 68

Query: 234 SSLHHPNIVPL----VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
            +  HPN+V L         D E  L L++++V    L  +L +  +       +P    
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-----VPTETI 122

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +   +   + +LH      VVHRD+KP NIL++S    KL DFGLA
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA 167

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 48/167 (28%), Positives = 73/167 (43%), Gaps = 36/167 (21%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 238
           G  LG G  +F   GKV + +       VA+K L+++   S        RE+       H
Sbjct: 21  GDTLGVG--TF---GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75

Query: 239 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG- 295
           P+I+ L  V   I     +F++ +YVSGG L  ++ +  +           +  K +   
Sbjct: 76  PHIIKLYQV---ISTPSDIFMVMEYVSGGELFDYICKNGR-----------LDEKESRRL 121

Query: 296 ---IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
              I   V Y H      VVHRD+KP N+LL +    K+ DFGL+  
Sbjct: 122 FQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNM 165

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 82.8 bits (205), Expect = 1e-17
 Identities = 46/170 (27%), Positives = 74/170 (43%), Gaps = 24/170 (14%)

Query: 187 GRVLGRGALSFVFKGKV-GLLR------TSVAIKRLDKEDKESS--KAFCRELMIASSL- 236
           G+ LG GA   V   +  GL +      T VA+K L K D           E+ +   + 
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIG 132

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV---- 292
            H NI+ L+G C   +  L++I +Y S G+L  +L  ++      S  P     +     
Sbjct: 133 KHKNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 293 -----ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                A  +A  + YL     +  +HRD+   N+L++   + K+ DFGLA
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 38/151 (25%), Positives = 70/151 (46%), Gaps = 12/151 (7%)

Query: 189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMI-ASSLHHPNIVPLVG 246
            +G G    V+K +       +A+K++ +  +KE +K    +L +   S   P IV   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG 306
                   +F+  + +   + +     +         +P  +  K+ + I +++ YL   
Sbjct: 92  -TFITNTDVFIAMELMGTCAEKLKKRMQG-------PIPERILGKMTVAIVKALYYLKE- 142

Query: 307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +  V+HRD+KPSNILL  +   KLCDFG++
Sbjct: 143 -KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 51/184 (27%), Positives = 81/184 (44%), Gaps = 37/184 (20%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAF---CRELMIA 233
             F + + LG G  SF   G+V L++        A+K LDK+     K       E  I 
Sbjct: 41  DQFDRIKTLGTG--SF---GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRIL 95

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            +++ P +V L     D    L+++ +YV+GG +  HL  ++ G           R+  A
Sbjct: 96  QAVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHL--RRIGRFSEPH----ARFYAA 148

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPSVPF 347
             I  +  YLH      +++RD+KP N+L+  +   ++ DFG A      TWT       
Sbjct: 149 -QIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT------- 197

Query: 348 LCKT 351
           LC T
Sbjct: 198 LCGT 201

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 79.3 bits (196), Expect = 7e-17
 Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 26/162 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            F     LG G+   V+K         VAIK++  E         +E+ I      P++V
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVV 87

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSL-------ERHLHEKKKGVRGNSTLPWSVRYKVALG 295
              G        L+++ +Y   GS+        + L E +                +   
Sbjct: 88  KYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-------------ILQS 133

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             + + YLH       +HRDIK  NILL+++   KL DFG+A
Sbjct: 134 TLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 29/163 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC---RELMIASSLHH 238
              LG G  SF   GKV L         VA+K + ++  + S       RE+     L H
Sbjct: 14  RETLGEG--SF---GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68

Query: 239 PNIVPL--VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           P+I+ L  V   I     + ++ +Y  GG L  ++ EKK+       +      +    I
Sbjct: 69  PHIIKLYDV---ITTPTDIVMVIEYA-GGELFDYIVEKKR-------MTEDEGRRFFQQI 117

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
             ++ Y H      +VHRD+KP N+LL      K+ DFGL+  
Sbjct: 118 ICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNI 157

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 78.7 bits (195), Expect = 1e-16
 Identities = 56/187 (29%), Positives = 83/187 (44%), Gaps = 43/187 (22%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE------DKESSKAFCREL 230
            +F   R LG G  SF   G+V L+R        A+K L KE        E +     E 
Sbjct: 6   QDFQILRTLGTG--SF---GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND---ER 57

Query: 231 MIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
           ++ S + HP I+ + G   D +Q +F+I  Y+ GG L   L  +K     N       ++
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLL--RKSQRFPNPV----AKF 110

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA------TWTSAPS 344
             A  +  ++ YLH    + +++RD+KP NILL      K+ DFG A      T+T    
Sbjct: 111 YAA-EVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT---- 162

Query: 345 VPFLCKT 351
              LC T
Sbjct: 163 ---LCGT 166

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 80.2 bits (198), Expect = 1e-16
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 26/167 (15%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMI 232
             F   RVLGRG   F   G+V   +        A K+L+K+     K    A   E  I
Sbjct: 185 DWFLDFRVLGRG--GF---GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-EKKI 238

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY-- 290
            + +H   IV L  +  + +  L L+   ++GG +  H++   +   G    P ++ Y  
Sbjct: 239 LAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTA 296

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           ++  G+     +LH   +R +++RD+KP N+LL      ++ D GLA
Sbjct: 297 QIVSGLE----HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA 336

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 46/163 (28%), Positives = 71/163 (43%), Gaps = 26/163 (15%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLD---KEDKESSKAFCRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++    K+  E  +   +E+     L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSL------ERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            +   G C   E   +L+ +Y  G +       ++ L E +                V  
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA-------------VTH 161

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           G  + +AYLH+     ++HRD+K  NILLS   + KL DFG A
Sbjct: 162 GALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 77.7 bits (192), Expect = 2e-16
 Identities = 47/190 (24%), Positives = 75/190 (39%), Gaps = 62/190 (32%)

Query: 187 GRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKAFC-------------- 227
              +G+G  S+   G V L       T  A+K L K+       F               
Sbjct: 18  KDEIGKG--SY---GVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72

Query: 228 ------------RELMIASSLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSL-----ER 269
                       +E+ I   L HPN+V LV    DP E  L+++++ V+ G +      +
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132

Query: 270 HLHEKKKGVRGNSTLPWSVRY--KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK 327
            L E +           +  Y   +  G    + YLH    + ++HRDIKPSN+L+    
Sbjct: 133 PLSEDQ-----------ARFYFQDLIKG----IEYLHY---QKIIHRDIKPSNLLVGEDG 174

Query: 328 IPKLCDFGLA 337
             K+ DFG++
Sbjct: 175 HIKIADFGVS 184

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 77.8 bits (192), Expect = 3e-16
 Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 15/160 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIV 242
           F    ++G G    V+KG+        AIK +D    E  +   +E+ +     HH NI 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIA 84

Query: 243 P-----LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
                 +       +  L+L+ ++   GS+   +   K       TL       +   I 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-----TLKEEWIAYICREIL 139

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             +++LH   +  V+HRDIK  N+LL+     KL DFG++
Sbjct: 140 RGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 24/165 (14%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMI 232
           + F + RVLG+G   F   G+V   +        A K+L+K+     K  + A   E  I
Sbjct: 184 NTFRQYRVLGKG--GF---GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQI 237

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
              ++   +V L  +  + +  L L+   ++GG L+ H++   +          +V Y  
Sbjct: 238 LEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG---FPEARAVFY-- 291

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A  I   +  LH      +V+RD+KP NILL      ++ D GLA
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLA 333

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 21/159 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNI 241
           ++   R LGRG  S VF+         V +K L    K+  K   RE+ I  +L   PNI
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK---REIKILENLRGGPNI 93

Query: 242 VPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLP-WSVRYKVALGIAES 299
           + L     DP      L++++V+    ++             TL  + +R+ +   I ++
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYM-YEILKA 142

Query: 300 VAYLHNGTERCVVHRDIKPSNILL-SSKKIPKLCDFGLA 337
           + Y H      ++HRD+KP N+++    +  +L D+GLA
Sbjct: 143 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 26/160 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           R +G+G  SF   GKV +++   T    A+K ++K+   ++   +   +EL I   L HP
Sbjct: 21  RAIGKG--SF---GKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHP 75

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA-LGIAE 298
            +V L     D E  +F++   + GG L  HL  ++       T    V+  +  L +A 
Sbjct: 76  FLVNLWYSFQDEED-MFMVVDLLLGGDLRYHL--QQNVHFKEET----VKLFICELVMA- 127

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            + YL     + ++HRD+KP NILL       + DF +A 
Sbjct: 128 -LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAA 163

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 29/161 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           ++LG+G  SF   GKV L          AIK L K+    D +       + +++ +  H
Sbjct: 23  KMLGKG--SF---GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK--VALGI 296
           P +  +       ++ LF + +Y++GG L  H+    K       L  +  Y   + LG+
Sbjct: 78  PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGL 131

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                +LH    + +V+RD+K  NILL      K+ DFG+ 
Sbjct: 132 Q----FLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMC 165

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 48/166 (28%), Positives = 69/166 (41%), Gaps = 29/166 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 234
           +F   +V+GRG  +F    +V +++   T    A+K ++K D   +     F  E  +  
Sbjct: 62  DFEILKVIGRG--AF---SEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +     I  L  F    E  L+L+ +Y  GG L   L   K G R       +  Y    
Sbjct: 117 NGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL--SKFGER--IPAEMARFY---- 167

Query: 295 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +AE V     +H       VHRDIKP NILL      +L DFG  
Sbjct: 168 -LAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSC 209

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 75.7 bits (187), Expect = 1e-15
 Identities = 50/168 (29%), Positives = 76/168 (45%), Gaps = 40/168 (23%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDKE-------DKESSKAFCRELMI 232
           RVLG+G   +   GKV  +R           A+K L K        D   +KA   E  I
Sbjct: 23  RVLGKG--GY---GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA---ERNI 74

Query: 233 ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
              + HP IV L+ +       L+LI +Y+SGG L   L  +            +  Y  
Sbjct: 75  LEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGI-----FMEDTACFY-- 126

Query: 293 ALGIAE---SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              +AE   ++ +LH   ++ +++RD+KP NI+L+ +   KL DFGL 
Sbjct: 127 ---LAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 46/161 (28%), Positives = 70/161 (43%), Gaps = 30/161 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKE------DKESSKAFCRELMIASSL 236
           ++LG+G  +F   GKV L+R   T    A+K L KE      +   +     E  +  + 
Sbjct: 11  KLLGKG--TF---GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---ESRVLQNT 62

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +  L  +       L  + +Y +GG L  HL  ++       T   +  Y     I
Sbjct: 63  RHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFY--GAEI 114

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++ YLH    R VV+RDIK  N++L      K+ DFGL 
Sbjct: 115 VSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 25/165 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPN 240
            +    ++G G+   V +    L +  VAIK++ +  ED    K   RE+ I + L+H +
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113

Query: 241 IVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPW----SVRYKV 292
           +V ++   I  +      L+++ +       +       K  R    L      ++ Y +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFK---KLFRTPVYLTELHIKTLLYNL 165

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +G+     Y+H+     ++HRD+KP+N L++     K+CDFGLA
Sbjct: 166 LVGVK----YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 40/192 (20%), Positives = 66/192 (34%), Gaps = 47/192 (24%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFC-RELMIASSLHHPNI 241
            +S G+ LG G+   V +          A+K++ ++ +     +  REL I   L H NI
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNI 62

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR------------ 289
           + L         G              +   +       + ++  +              
Sbjct: 63  IKL--VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 290 ----YKVALGIAES-------------------VAYLHNGTERCVVHRDIKPSNILLSSK 326
               +KV      S                   V ++H+     + HRDIKP N+L++SK
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSK 177

Query: 327 K-IPKLCDFGLA 337
               KLCDFG A
Sbjct: 178 DNTLKLCDFGSA 189

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 31/165 (18%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIASS 235
           +   +V+GRG  +F   G+V L+R   T    A+K L K +   +  S  F  E  I + 
Sbjct: 71  YEVVKVIGRG--AF---GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
            + P +V L     D    L+++ +Y+ GG L   +              W+  Y     
Sbjct: 126 ANSPWVVQLFYAFQDDRY-LYMVMEYMPGGDLVNLMSNYD------VPEKWARFY----- 173

Query: 296 IAESVA---YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            AE V     +H       +HRD+KP N+LL      KL DFG  
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 43/161 (26%), Positives = 70/161 (43%), Gaps = 29/161 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE------DKESSKAFCRELMIASSL 236
            VLG+G  SF   GKV L          A+K L K+      D E +    R L +    
Sbjct: 26  MVLGKG--SF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-- 78

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
             P +  L   C      L+ + +YV+GG L  H+ +  +        P +V Y   + I
Sbjct: 79  KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAEIAI 132

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              + +L     + +++RD+K  N++L S+   K+ DFG+ 
Sbjct: 133 G--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 25/164 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFCRELMIA 233
           +F+   VLG+G  SF   GKV L          A+K L K+    D +       + ++A
Sbjct: 342 DFNFLMVLGKG--SF---GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLA 396

Query: 234 SSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
                P +  L   C      L+ + +YV+GG L  H+ +  +        P +V Y   
Sbjct: 397 LPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-----FKEPHAVFYAAE 450

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           + I   + +L     + +++RD+K  N++L S+   K+ DFG+ 
Sbjct: 451 IAIG--LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 76.5 bits (188), Expect = 2e-15
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 27/166 (16%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE----DKESSKAFC--RELM 231
           +FS  R++GRG   F   G+V   R +      A+K LDK+     +  + A      L 
Sbjct: 190 DFSVHRIIGRG--GF---GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           + S+   P IV +  +       L  I   ++GG L  HL +      G  +      Y 
Sbjct: 245 LVSTGDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFY- 297

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            A  I   + ++H    R VV+RD+KP+NILL      ++ D GLA
Sbjct: 298 -AAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA 339

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 75.3 bits (186), Expect = 3e-15
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 29/161 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE------DKESSKAFCRELMIASSL 236
           RVLG+G  SF   GKV L R        A+K L K+      D E +    R L +A + 
Sbjct: 29  RVLGKG--SF---GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN- 82

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +  L   C      LF + ++V+GG L  H+ + ++          +  Y   +  
Sbjct: 83  -HPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEIIS 135

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           A  + +LH   ++ +++RD+K  N+LL  +   KL DFG+ 
Sbjct: 136 A--LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 29/161 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV-----AIKRLDKE------DKESSKAFCRELMIASSL 236
           ++LG+G  +F   GKV L++        A+K L KE      +   +     E  +  + 
Sbjct: 154 KLLGKG--TF---GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---ENRVLQNS 205

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            HP +  L  +       L  + +Y +GG L  HL  ++       +   +  Y     I
Sbjct: 206 RHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERV-----FSEDRARFY--GAEI 257

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
             ++ YLH+  E+ VV+RD+K  N++L      K+ DFGL 
Sbjct: 258 VSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 49/159 (30%), Positives = 79/159 (49%), Gaps = 25/159 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE----DKESSKAFCRELMIASSLHH 238
           RV+GRG  S+    KV L+R   T    A+K + KE    D++       + +   + +H
Sbjct: 15  RVIGRG--SY---AKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +V L   C   E  LF + +YV+GG L  H+  ++K          +  Y   + +A 
Sbjct: 70  PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLA- 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + YLH   ER +++RD+K  N+LL S+   KL D+G+ 
Sbjct: 123 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.6 bits (184), Expect = 3e-15
 Identities = 40/164 (24%), Positives = 68/164 (41%), Gaps = 26/164 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPL--- 244
           + LG G    VF          VAIK++   D +S K   RE+ I   L H NIV +   
Sbjct: 17  KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76

Query: 245 ----------VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
                         +     ++++ +Y     +E  L      +     L    R     
Sbjct: 77  LGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLA---NVLEQGPLLEEHARL-FMY 127

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLA 337
            +   + Y+H+     V+HRD+KP+N+ ++++ +  K+ DFGLA
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLA 168

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.5 bits (184), Expect = 4e-15
 Identities = 51/166 (30%), Positives = 74/166 (44%), Gaps = 38/166 (22%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDKE-----DKESSKAFCRELMIAS 234
           +VLG+G  SF   GKV L++           A+K L K      D+  +K    E  I  
Sbjct: 30  KVLGQG--SF---GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM---ERDILV 81

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
            ++HP IV L  +    E  L+LI  ++ GG L   L ++        T      Y    
Sbjct: 82  EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVM-----FTEEDVKFY---- 131

Query: 295 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +AE      +LH      +++RD+KP NILL  +   KL DFGL+
Sbjct: 132 -LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 74.7 bits (184), Expect = 5e-15
 Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 25/159 (15%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           RV+GRG  S+    KV L+R        A++ + KE    D++       + +   + +H
Sbjct: 58  RVIGRG--SY---AKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +V L   C   E  LF + +YV+GG L  H+  ++K          +  Y   + +A 
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRK-----LPEEHARFYSAEISLA- 165

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            + YLH   ER +++RD+K  N+LL S+   KL D+G+ 
Sbjct: 166 -LNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.2 bits (183), Expect = 6e-15
 Identities = 39/160 (24%), Positives = 66/160 (41%), Gaps = 27/160 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 246
            +LG GA   V           VAIK+++  +    +    RE+ I     H NI+ +  
Sbjct: 17  SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFN 76

Query: 247 FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIA 297
                       +++I +      ++  LH   + +         ++Y +     A+   
Sbjct: 77  IQRPDSFENFNEVYIIQEL-----MQTDLH---RVISTQMLSDDHIQYFIYQTLRAV--- 125

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                LH      V+HRD+KPSN+L++S    K+CDFGLA
Sbjct: 126 ---KVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 26/123 (21%), Positives = 51/123 (41%), Gaps = 8/123 (6%)

Query: 216 DKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKK 275
                    A   ++         N V  +     P+  L++  +     +L+  ++ + 
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQL-QPSSPKVYLYIQMQLCRKENLKDWMNRRC 156

Query: 276 KGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG 335
                   +       + + IAE+V +LH+   + ++HRD+KPSNI  +   + K+ DFG
Sbjct: 157 SLEDREHGVCL----HIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFG 209

Query: 336 LAT 338
           L T
Sbjct: 210 LVT 212

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 31/162 (19%)

Query: 188 RVLGRGALSFVFKGKVGLLR---TSV--AIKRLDKE------DKESSKAFCRELMI-ASS 235
           +V+G+G  SF   GKV L R     V  A+K L K+      +++   +   E  +   +
Sbjct: 44  KVIGKG--SF---GKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMS---ERNVLLKN 95

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           + HP +V L  F       L+ +  Y++GG L  HL  ++         P +  Y  A  
Sbjct: 96  VKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC-----FLEPRARFY--AAE 147

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           IA ++ YLH      +V+RD+KP NILL S+    L DFGL 
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 73.5 bits (181), Expect = 9e-15
 Identities = 37/157 (23%), Positives = 67/157 (42%), Gaps = 20/157 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VAIK+L +  + +  +K   REL++   + H N++ L+
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89

Query: 246 GFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                          +L+  +     ++  L +          + + V Y++  G+    
Sbjct: 90  DVFTPASSLRNFYDFYLVMPF-----MQTDLQKIMGLKFSEEKIQYLV-YQMLKGLK--- 140

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            Y+H+     VVHRD+KP N+ ++     K+ DFGLA
Sbjct: 141 -YIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 27/160 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIASSLHHPNIVPLVG 246
             +G GA   V      L +  VAIK++   E +   +   RE+ I     H NI+ +  
Sbjct: 33  SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 92

Query: 247 FCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIA 297
               P     + ++++        +E  L+   K ++        + Y +      L   
Sbjct: 93  IIRAPTIEQMKDVYIVQDL-----METDLY---KLLKTQHLSNDHICYFLYQILRGL--- 141

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               Y+H+     V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 142 ---KYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 38/162 (23%), Positives = 69/162 (42%), Gaps = 29/162 (17%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
            ++GRG+  +V+         +VAIK++++  ED    K   RE+ I + L    I+ L 
Sbjct: 32  HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91

Query: 246 GFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTL-PWSVRYKV-----ALG 295
              I  +      L+++ +       +  L    K  +    L    ++  +        
Sbjct: 92  DLIIPDDLLKFDELYIVLEI-----ADSDLK---KLFKTPIFLTEEHIKTILYNLLLGE- 142

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                 ++H      ++HRD+KP+N LL+     K+CDFGLA
Sbjct: 143 -----NFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 41/157 (26%), Positives = 82/157 (52%), Gaps = 20/157 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H NI+ L+
Sbjct: 68  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127

Query: 246 -----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   ++  Q ++L+ +      ++ +L +  +    +  + + + Y++  GI    
Sbjct: 128 NVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLL-YQMLCGIK--- 178

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +LH+     ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 179 -HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 211

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 19/157 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
           + +G GA   V     G     VAIK+L +  + +  +K   REL +   + H N++ L+
Sbjct: 31  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90

Query: 246 -----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                   +D     +L+  +     +   L    K ++        +++ V   + + +
Sbjct: 91  DVFTPDETLDDFTDFYLVMPF-----MGTDLG---KLMKHEKLGEDRIQFLV-YQMLKGL 141

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            Y+H      ++HRD+KP N+ ++     K+ DFGLA
Sbjct: 142 RYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 29/166 (17%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLR---TS--VAIKRLDKED---KESSKAFCRELMIAS 234
           +F   +V+GRG  +F   G+V +++        A+K L+K +   +  +  F  E  +  
Sbjct: 75  DFEILKVIGRG--AF---GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           +     I  L  +    +  L+L+  Y  GG L   L +             +  Y    
Sbjct: 130 NGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSK----FEDRLPEEMARFY---- 180

Query: 295 GIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            +AE V     +H       VHRDIKP NIL+      +L DFG  
Sbjct: 181 -LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC 222

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 48/169 (28%), Positives = 72/169 (42%), Gaps = 41/169 (24%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSV--------AIKRLDK-------EDKESSKAFCRELMI 232
           +VLG G  ++   GKV L+R           A+K L K       +  E ++    E  +
Sbjct: 60  KVLGTG--AY---GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRT---ERQV 111

Query: 233 -ASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
                  P +V L  +    E  L LI  Y++GG L  HL ++++      T      Y 
Sbjct: 112 LEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIY- 164

Query: 292 VALGIAESV---AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
               + E V    +LH   +  +++RDIK  NILL S     L DFGL+
Sbjct: 165 ----VGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.0 bits (177), Expect = 4e-14
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 26/159 (16%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLH-HPNIVPL 244
           + LG+GA   V+K         VA+K++    ++   ++   RE+MI + L  H NIV L
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74

Query: 245 VGFCIDPE-QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV-----ALGIAE 298
           +        + ++L++ Y     +E  LH     +R N   P   +Y V      +    
Sbjct: 75  LNVLRADNDRDVYLVFDY-----METDLH---AVIRANILEPVHKQYVVYQLIKVI---- 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
              YLH+G    ++HRD+KPSNILL+++   K+ DFGL+
Sbjct: 123 --KYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLS 156

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 71.6 bits (176), Expect = 4e-14
 Identities = 42/164 (25%), Positives = 82/164 (50%), Gaps = 20/164 (12%)

Query: 181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHH 238
              +   + +G GA   V      +L  +VAIK+L +  +++  +K   REL++   ++H
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83

Query: 239 PNIVPLV-----GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
            NI+ L+        ++  Q ++++ + +   +L + +  +    R +  L     Y++ 
Sbjct: 84  KNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLL-----YQML 137

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            GI     +LH+     ++HRD+KPSNI++ S    K+ DFGLA
Sbjct: 138 CGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 35/157 (22%), Positives = 65/157 (41%), Gaps = 19/157 (12%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDK--EDKESSKAFCRELMIASSLHHPNIVPLV 245
             +G GA   V           VA+K+L +  +    +K   REL +   + H N++ L+
Sbjct: 35  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94

Query: 246 GFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
                         ++L+        +   L+     V+        V++ +   I   +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHL-----MGADLN---NIVKCQKLTDDHVQFLI-YQILRGL 145

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
            Y+H+     ++HRD+KPSN+ ++     K+ DFGLA
Sbjct: 146 KYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.4 bits (160), Expect = 5e-12
 Identities = 42/168 (25%), Positives = 64/168 (38%), Gaps = 32/168 (19%)

Query: 188 RVLGRGALSFVFKG--KVGLLRTSVAIKRLDKEDKE-------SSKAFC----RELMIAS 234
           R +  G+   V  G    G     VAIKR+     +       S    C    RE+ + +
Sbjct: 28  RFISSGSYGAVCAGVDSEG---IPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN 84

Query: 235 SLHHPNIVPLVGFCIDPE----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
             HHPNI+ L    +  E      L+L+ +      +   L    + +     +      
Sbjct: 85  HFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLA---QVIHDQRIVISPQHI 136

Query: 291 KVAL-GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  +  I   +  LH      VVHRD+ P NILL+      +CDF LA
Sbjct: 137 QYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLA 181

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 38/167 (22%), Positives = 62/167 (37%), Gaps = 21/167 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV-GLLR----TSVAIKRL-DKEDKESSKAFCRELMIASS 235
                G+ LGRGA   V +    G+ +     +VA+K L +       +A   EL I   
Sbjct: 22  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81

Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           + HH N+V L+G C  P   L +I ++   G+L  +L  K+       T     R     
Sbjct: 82  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFR----- 136

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
              +   Y+        +  D+K     ++S +      F      S
Sbjct: 137 ---QGKDYVGA------IPVDLKRRLDSITSSQSSASSGFVEEKSLS 174

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 19/45 (42%), Positives = 28/45 (62%), Gaps = 3/45 (6%)

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
           +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA
Sbjct: 199 SFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 51.0 bits (121), Expect = 2e-07
 Identities = 30/213 (14%), Positives = 52/213 (24%), Gaps = 58/213 (27%)

Query: 178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAF--------- 226
              T    +   +G G    VF+       T VAIK   ++  D  +             
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPE 73

Query: 227 ------CRELMIASSLHHPNIVPLVGFCI-----------------------------DP 251
                    L           + L                                    
Sbjct: 74  IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133

Query: 252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCV 311
           +  LF++ ++  GG     +  K            +    +   +  S+A          
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSS--------LATAKSILHQLTASLAVAEASLR--F 183

Query: 312 VHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            HRD+   N+LL    + KL        ++ PS
Sbjct: 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.0 bits (117), Expect = 1e-06
 Identities = 35/193 (18%), Positives = 64/193 (33%), Gaps = 31/193 (16%)

Query: 167 NSLIRLSYGEILAAT--HNFSKGRVLGRGALSFVFKG--------KVGLLRTSVAIK--- 213
            SL  L  G +L       +       R     +++           G  +   ++K   
Sbjct: 25  TSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA 84

Query: 214 ---RLDKEDK----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGS 266
              RL  E       +      +     S     I   +GF +  ++  FL+   + G S
Sbjct: 85  KDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRS 143

Query: 267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK 326
           L+  L    K       L      +VA  + +++ +LH   E   VH ++   NI +  +
Sbjct: 144 LQSALDVSPKH-----VLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPE 195

Query: 327 KIPK--LCDFGLA 337
              +  L  +G A
Sbjct: 196 DQSQVTLAGYGFA 208

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 31/170 (18%), Positives = 63/170 (37%), Gaps = 30/170 (17%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS--------------KAFCRELMI 232
           G+ +G G    ++           A   +  E +E+               K   ++ + 
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIE 101

Query: 233 ASSLHHPNIVPLVGFCIDPEQGL---FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
              L +  I    G  +   +G    F++ + + G  L++   +             S  
Sbjct: 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGT-------FKKSTV 153

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK--LCDFGLA 337
            ++ + + + + Y+H   E   VH DIK +N+LL  K   +  L D+GL+
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLS 200

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 18/38 (47%), Positives = 23/38 (60%), Gaps = 5/38 (13%)

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPK--LCDFGLA 337
           Y+H   E   VH DIK SN+LL+ K   +  L D+GLA
Sbjct: 167 YIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA 201

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 47.4 bits (113), Expect = 4e-06
 Identities = 33/175 (18%), Positives = 63/175 (36%), Gaps = 49/175 (28%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIK--------------------RLDKEDKESSKAFC 227
            ++G+G+   V K    + +  VAIK                     ++K D E      
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 228 RELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHE--KKKGVRGNSTLP 285
              +    +   ++      C+  E              L  +L++  +    RG   + 
Sbjct: 120 H--LKRHFMFRNHL------CLVFE-------------MLSYNLYDLLRNTNFRG---VS 155

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLAT 338
            ++  K A  +  ++ +L       ++H D+KP NILL + K    K+ DFG + 
Sbjct: 156 LNLTRKFAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFGSSC 209

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 46.2 bits (110), Expect = 8e-06
 Identities = 37/165 (22%), Positives = 63/165 (38%), Gaps = 25/165 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           NF  G+ +G G    +  GK       VAIK    + +        E      L   + +
Sbjct: 10  NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQ--LHLEYRFYKQLGSGDGI 67

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA----E 298
           P V +     +   ++ + + G SLE  L +            +S+  K  L IA     
Sbjct: 68  PQVYYFGPCGKYNAMVLELL-GPSLE-DLFDLCDRT-------FSL--KTVLMIAIQLIS 116

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPK-----LCDFGLAT 338
            + Y+H+   + +++RD+KP N L+            + DF LA 
Sbjct: 117 RMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 41/176 (23%), Positives = 73/176 (41%), Gaps = 33/176 (18%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---------- 237
           R LG G  S V+  K  +  T VA+K + + DK  ++A   E+ +   ++          
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 238 -HPNIVPLVG-FCIDPEQG--LFLIYKYVSGGSLERHLHE--KKKGVRGNSTLPWSVRYK 291
              +I+ L+  F      G  + ++++      L  +L    KK   RG   +P     +
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRG---IPLIYVKQ 135

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP------KLCDFGLATWTS 341
           ++  +   + Y+H      ++H DIKP N+L+     P      K+ D G A W  
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 17/50 (34%), Positives = 26/50 (52%), Gaps = 5/50 (10%)

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLAT 338
           K A  I + +  LH   +  ++H D+KP NILL  +     K+ DFG + 
Sbjct: 204 KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 39/165 (23%), Positives = 59/165 (35%), Gaps = 25/165 (15%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           ++  GR +G G+   +F+G   L    VAIK   +           E      L     +
Sbjct: 11  HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGI 68

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE---- 298
           P V +         L+   + G SLE  L +     R  S        K     A+    
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL-GPSLE-DLLDLCG--RKFSV-------KTVAMAAKQMLA 117

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPK-----LCDFGLAT 338
            V  +H   E+ +V+RDIKP N L+            + DFG+  
Sbjct: 118 RVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 40.6 bits (94), Expect = 7e-04
 Identities = 46/357 (12%), Positives = 110/357 (30%), Gaps = 106/357 (29%)

Query: 9   SKSSQHNELYASSIVSDNYCEYKVYNKHYNELKIKTLLRKMIWDFGLSCFLPSLSNNHNN 68
           SK  +  + +   ++  NY ++ + +    E +  +++ +M                 + 
Sbjct: 73  SKQEEMVQKFVEEVLRINY-KF-LMSPIKTEQRQPSMMTRM------------YIEQRDR 118

Query: 69  RINDDDEKSKGSNLEHNKAWLLAESGGAELTSTDPQS---VH-------SSFRFSLCSQV 118
             ND+   +K +         L ++    L    P     +        +     +C   
Sbjct: 119 LYNDNQVFAKYNVSRLQPYLKLRQA----LLELRPAKNVLIDGVLGSGKTWVALDVCLSY 174

Query: 119 ELES--------MNIGASASATVLMVNLENGLCDSRAQELKWRKIQSLERSISPVANSLI 170
           +++         +N+    S   ++  L+  L                + S +      I
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQK-LLYQIDPNWT----SRSDHSSN------I 223

Query: 171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAF--- 226
           +L    I              +  L  + K K       + +  L   ++ ++  AF   
Sbjct: 224 KLRIHSI--------------QAELRRLLKSKP--YENCLLV--LLNVQNAKAWNAFNLS 265

Query: 227 CRELMI-----------ASSLHHPNIVPLV-GFCIDPEQGLFLIYKYVSGGSLERHLHEK 274
           C+ L+            A++  H ++          P++   L+ KY+     +    E 
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TPDEVKSLLLKYL-DCRPQDLPREV 322

Query: 275 KKGVRGNSTLPWSVRYKVALGIAESVA--------YLHNGTERCVVHRDIKPS-NIL 322
                     P     ++++ IAES+         + H   ++  +   I+ S N+L
Sbjct: 323 LTT------NP----RRLSI-IAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVL 366

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	372
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.98
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.98
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.98
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.98
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.98
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.97
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.97
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.97
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.97
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.97
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.97
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.97
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.97
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.97
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.97
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.96
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.96
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.96
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.96
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.96
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.96
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.96
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.96
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.96
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.96
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.96
3bhy_A	283	Death-associated protein kinase 3; death associate	99.96
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.96
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.96
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.96
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.96
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.96
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.96
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.96
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.95
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.95
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.95
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.95
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.95
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.95
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.95
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.95
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.94
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.94
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.94
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.94
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.94
3uqc_A	286	Probable conserved transmembrane protein; structur	99.94
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.93
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.86
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.7
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.38
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.22
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.13
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.52
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.24
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.12
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.77
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.68
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.49
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.17
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.14
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.06
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.02
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.97
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.9
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.62
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.11
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.94
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.74
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	89.46

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.8e-40  Score=319.48  Aligned_cols=172  Identities=27%  Similarity=0.349  Sum_probs=153.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||++++.   .....+.+.+|+++|++++|||||++++++.+ +..+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            5799999999999999999999999999999999764   23345678999999999999999999999876 5569999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||||++|+|.++|...       ..+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+
T Consensus       111 mEy~~gG~L~~~i~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~  180 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  180 (311)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCce
Confidence            9999999999999875       46999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .+..........+.+||+.|||||+-
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl  206 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELL  206 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHH
T ss_pred             ecCCCCCcccccCcccCcccCCHHHH
Confidence            88655443445678999999998764

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-40  Score=316.33  Aligned_cols=180  Identities=26%  Similarity=0.365  Sum_probs=151.2

Q ss_pred             CCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|.+.+.||+|+||.||+|++.     .++..||||+++.......+.|.+|+++|++++|||||+++|+|.+.+ .++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD-PLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEE
Confidence            58899999999999999999875     357889999998877777889999999999999999999999998754 489


Q ss_pred             EEEeccCCCCHHHHHHhhcc------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          257 LIYKYVSGGSLERHLHEKKK------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                      ||||||++|+|.++|+....      .......++|.+++.|+.||+.||.|||+.+   ||||||||+||||+.++.+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence            99999999999999986421      0112257999999999999999999999987   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+|||+|+...............||+.|||||.-.
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~  203 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIM  203 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHH
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHc
Confidence            99999999876544433445567999999987643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.9e-40  Score=321.97  Aligned_cols=173  Identities=22%  Similarity=0.314  Sum_probs=146.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++++.  .....+.+.+|+.+|++|+|||||++++++.+ ++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            6899999999999999999999999999999999764  44556789999999999999999999999877 45599999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||++|+|.++|.....     ..+++..++.|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.
T Consensus       103 Ey~~gg~L~~~i~~~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~  174 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKG-----VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARV  174 (350)
T ss_dssp             ECCTTCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESC
T ss_pred             eCCCCCcHHHHHHHcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEccccccee
Confidence            99999999999976532     46799999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ......  ...+.+||+.|||||.-.
T Consensus       175 ~~~~~~--~~~~~~GT~~YmAPE~l~  198 (350)
T 4b9d_A          175 LNSTVE--LARACIGTPYYLSPEICE  198 (350)
T ss_dssp             CCHHHH--HHHHHHSCCTTCCHHHHT
T ss_pred             ecCCcc--cccccCCCccccCHHHHC
Confidence            753321  234578999999987643

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=316.83  Aligned_cols=180  Identities=23%  Similarity=0.318  Sum_probs=143.6

Q ss_pred             CCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|...+.||+|+||.||+|++.     .+++.||||+++.......+.|.+|+++|++++|||||+++|+|.+.+ .++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~-~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGR-PLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC-EEE
Confidence            57888899999999999999875     357899999998877777889999999999999999999999998754 489


Q ss_pred             EEEeccCCCCHHHHHHhhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGV--------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~--------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ||||||++|+|.++|+......        .....++|.+++.|+.||+.||.|||+.+   ||||||||+||||+.++.
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence            9999999999999998643211        11246999999999999999999999887   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +||+|||+|+...............||+.|||||+-.
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~  233 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESIL  233 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHT
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhc
Confidence            9999999999876554433445678999999987643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.1e-40  Score=320.12  Aligned_cols=170  Identities=23%  Similarity=0.323  Sum_probs=151.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ..|+..+.||+|+||+||+|++..+++.||||+++.......+.+.+|+.+|++++|||||++++++.+. +.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeC
Confidence            4799999999999999999999999999999999866555556789999999999999999999998874 459999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |++|+|.+++..        ..+++..+..|+.||+.||.|||+.+   ||||||||+||||+.++.+||+|||+|+.+.
T Consensus       153 ~~gg~L~~~l~~--------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  221 (346)
T 4fih_A          153 LEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  221 (346)
T ss_dssp             CTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecC
Confidence            999999999975        35899999999999999999999988   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCCccCccccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ....  ...+.+||+.|||||+-.
T Consensus       222 ~~~~--~~~~~~GTp~YmAPEvl~  243 (346)
T 4fih_A          222 KEVP--RRKSLVGTPYWMAPELIS  243 (346)
T ss_dssp             SSSC--CBCCCCSCGGGCCHHHHT
T ss_pred             CCCC--cccccccCcCcCCHHHHC
Confidence            5433  345678999999988643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-39  Score=307.30  Aligned_cols=169  Identities=26%  Similarity=0.338  Sum_probs=146.1

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC---CCeEEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLFLI  258 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~~~~lV  258 (372)
                      |...+.||+|+||.||+|.+..++..||||++...  .....+.|.+|+++|++++|||||+++++|.+.   +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36667899999999999999999999999999753  445567899999999999999999999988642   3458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEecccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLA  337 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla  337 (372)
                      ||||++|+|.+++.+.       ..+++..+..|+.||+.||.|||+++ ++||||||||+||||+. ++.+||+|||+|
T Consensus       108 mEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            9999999999999875       46999999999999999999999865 45999999999999984 799999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.....    ...+.+||+.|||||.-
T Consensus       180 ~~~~~~----~~~~~~GTp~YmAPE~~  202 (290)
T 3fpq_A          180 TLKRAS----FAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGG
T ss_pred             EeCCCC----ccCCcccCccccCHHHc
Confidence            865433    33567899999998864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=313.25  Aligned_cols=172  Identities=27%  Similarity=0.373  Sum_probs=142.3

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ...+++...+.||+|+||+||+|++..   .||||+++..  .....+.|.+|+.+|++++|||||+++|+|.+ + .++
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~-~~~  107 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D-NLA  107 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S-SCE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C-eEE
Confidence            345688889999999999999998753   5999998753  45567789999999999999999999998754 3 479


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||||||++|+|.++|....      ..++|..++.|+.||+.||.|||+.+   ||||||||+||||++++.+||+|||+
T Consensus       108 iVmEy~~gGsL~~~l~~~~------~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGl  178 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQE------TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGL  178 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSS
T ss_pred             EEEEcCCCCCHHHHHhhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccC
Confidence            9999999999999997643      46999999999999999999999887   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+............+..||+.|||||+-
T Consensus       179 a~~~~~~~~~~~~~~~~GT~~ymAPE~l  206 (307)
T 3omv_A          179 ATVKSRWSGSQQVEQPTGSVLWMAPEVI  206 (307)
T ss_dssp             CBC------------CCCCTTSCCHHHH
T ss_pred             ceecccCCcceeecccccCCCccCHHHh
Confidence            9987654433345667899999998754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.4e-39  Score=321.63  Aligned_cols=170  Identities=23%  Similarity=0.323  Sum_probs=152.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ..|+..+.||+|+||.||+|++..+++.||||+++.......+.+.+|+.+|++++|||||++++++.+. +.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeC
Confidence            5799999999999999999999999999999999876555566789999999999999999999998874 459999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |++|+|.+++..        ..+++..+..|+.||+.||.|||+.+   ||||||||+||||+.+|.+||+|||+|+.+.
T Consensus       230 ~~gG~L~~~i~~--------~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~  298 (423)
T 4fie_A          230 LEGGALTDIVTH--------TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVS  298 (423)
T ss_dssp             CTTEEHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECC
Confidence            999999999965        35899999999999999999999988   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCCccCccccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ....  ...+.+||+.|||||+-.
T Consensus       299 ~~~~--~~~~~~GTp~YmAPEvl~  320 (423)
T 4fie_A          299 KEVP--RRKSLVGTPYWMAPELIS  320 (423)
T ss_dssp             SSCC--CBCCCEECTTTCCHHHHT
T ss_pred             CCCc--cccccccCcCcCCHHHHC
Confidence            5433  345678999999987643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.6e-39  Score=309.07  Aligned_cols=180  Identities=26%  Similarity=0.275  Sum_probs=148.1

Q ss_pred             CCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .+++..+.||+|+||.||+|.+.     .+++.||||+++.. .....+.|.+|+.+|++++|||||+++|+|.+.+ .+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~-~~  104 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ-PL  104 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC-EE
Confidence            35677799999999999999874     35689999999754 3345678999999999999999999999997754 48


Q ss_pred             EEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      +||||||++|+|.++|.......         .....++|..++.|+.|||.||.|||+.+   ||||||||+||||+++
T Consensus       105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~  181 (308)
T 4gt4_A          105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDK  181 (308)
T ss_dssp             EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGG
T ss_pred             EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCC
Confidence            99999999999999997643211         01246899999999999999999999987   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +.+||+|||+|+...............||+.|||||+-.
T Consensus       182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~  220 (308)
T 4gt4_A          182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM  220 (308)
T ss_dssp             GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHH
T ss_pred             CCEEECCcccceeccCCCceeEecccccCCcccCHHHHh
Confidence            999999999999875544333455678999999987543

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-38  Score=301.36  Aligned_cols=168  Identities=24%  Similarity=0.350  Sum_probs=134.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++++.   .....+.+.+|+++|++++|||||++++++.+ ++.+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            5899999999999999999999999999999999764   23345679999999999999999999999876 5569999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+ +|+|.+++...       ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+
T Consensus        92 mEy~-~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~  160 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQR-------DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSN  160 (275)
T ss_dssp             EECC-CEEHHHHHHHS-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-
T ss_pred             EeCC-CCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCe
Confidence            9999 68999999764       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   ...+..||+.|||||.-
T Consensus       161 ~~~~~~---~~~~~~GT~~Y~APE~~  183 (275)
T 3hyh_A          161 IMTDGN---FLKTSCGSPNYAAPEVI  183 (275)
T ss_dssp             -----------------CTTSCHHHH
T ss_pred             ecCCCC---ccCCeeECcccCChhhh
Confidence            765443   23457899999998864

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.4e-38  Score=304.99  Aligned_cols=176  Identities=26%  Similarity=0.334  Sum_probs=138.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC--------
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ--------  253 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~--------  253 (372)
                      +|++.+.||+|+||.||+|++..+++.||||+++.. .....+.+.+|+.+|++++|||||++++++.+.+.        
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            699999999999999999999999999999999754 34455789999999999999999999999865332        


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          254 ---GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       254 ---~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                         .+|+|||||++|+|.+++......    ...++..++.|+.||+.||.|||+.+   ||||||||+|||++.++.+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vK  158 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRCTI----EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVK  158 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCCSG----GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcCCC----ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEE
Confidence               368999999999999999764321    23567778899999999999999988   99999999999999999999


Q ss_pred             EEecccccccCCCCCCc----------cccccccCCCccCccccc
Q 017411          331 LCDFGLATWTSAPSVPF----------LCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~----------~~~~~~GT~gy~apeaPE  365 (372)
                      |+|||+|+.........          ...+.+||+.|||||.-.
T Consensus       159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  203 (299)
T 4g31_A          159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH  203 (299)
T ss_dssp             ECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred             EccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence            99999999875433211          123457999999988643

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.4e-38  Score=307.83  Aligned_cols=170  Identities=26%  Similarity=0.334  Sum_probs=143.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..+.|...+.||+|+||.||+|++..+++.||||+++....     +.+|+.+|++++|||||++++++.+. ..+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivm  129 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFM  129 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEE
Confidence            34678999999999999999999999999999999976432     24799999999999999999998774 5589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGla~  338 (372)
                      |||++|+|.++|...       ..+++..+..|+.||+.||.|||+.+   ||||||||+||||+.++ .+||+|||+|+
T Consensus       130 Ey~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~  199 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQM-------GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHAL  199 (336)
T ss_dssp             CCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCE
T ss_pred             eccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCe
Confidence            999999999999875       46999999999999999999999887   99999999999999987 69999999999


Q ss_pred             ccCCCCCC---ccccccccCCCccCccccc
Q 017411          339 WTSAPSVP---FLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~---~~~~~~~GT~gy~apeaPE  365 (372)
                      .+......   .....++||+.|||||.-.
T Consensus       200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  229 (336)
T 4g3f_A          200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVM  229 (336)
T ss_dssp             EC------------CCCCCCGGGCCHHHHT
T ss_pred             EccCCCcccceecCCccccCccccCHHHHC
Confidence            87543321   1233468999999987643

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.4e-38  Score=308.25  Aligned_cols=190  Identities=25%  Similarity=0.322  Sum_probs=158.6

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCC-CCeece
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHH-PNIVPL  244 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~H-pnIv~l  244 (372)
                      +...+++...++|++.+.||+|+||.||+|.+..+     ++.||||+++.. .....+.|.+|+++|++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            34456667778999999999999999999987543     368999999765 34456789999999999965 999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcC
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  315 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrD  315 (372)
                      +|+|.+.+..+++|||||++|+|.++|+......         .....++|..++.++.|||.||.|||+.+   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999876666899999999999999998653211         11246899999999999999999999988   99999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       316 LKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+|||++.++.+||+|||+|+.+..........+..||+.|||||+-
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l  259 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  259 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHH
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHH
Confidence            9999999999999999999999987655444445567899999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-39  Score=308.00  Aligned_cols=171  Identities=27%  Similarity=0.265  Sum_probs=140.3

Q ss_pred             CCeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|++.+.||+|+||+||+|+..   .+++.||||++++..  ......+.+|+++|++++|||||++++++.+ ++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence            57999999999999999999873   467899999997642  2223468899999999999999999999877 45599


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|||||++|+|.++|.+.       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       103 ivmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGl  172 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE-------VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL  172 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEE
T ss_pred             EEEEcCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEeccccc
Confidence            999999999999999875       46999999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+.......  ...+.+||+.|||||.-.
T Consensus       173 a~~~~~~~~--~~~~~~GT~~YmAPE~~~  199 (304)
T 3ubd_A          173 SKESIDHEK--KAYSFCGTVEYMAPEVVN  199 (304)
T ss_dssp             EEC-----C--CCCSCCCCGGGCCHHHHH
T ss_pred             ceeccCCCc--cccccccCcccCCHHHhc
Confidence            987654432  335678999999987643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.2e-37  Score=297.06  Aligned_cols=172  Identities=24%  Similarity=0.276  Sum_probs=138.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---eEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---~~~lV  258 (372)
                      ++|.+.+.||+|+||.||+|++.  ++.||||+++..... ...+.+|+..+.+++|||||+++++|.+.+.   .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            46888899999999999999985  789999999754322 1223345666678999999999999976442   47999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-----TERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ||||++|+|.++|+.        ..++|..+..++.|++.||.|||+.     ..++||||||||+||||+.++.+||+|
T Consensus        80 ~Ey~~~gsL~~~l~~--------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             EECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             ecCCCCCcHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            999999999999975        3589999999999999999999976     234599999999999999999999999


Q ss_pred             cccccccCCCCCCc--cccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPF--LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~--~~~~~~GT~gy~apeaP  364 (372)
                      ||+|+.........  ......||+.|||||.-
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l  184 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL  184 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHH
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHh
Confidence            99999875443321  22346799999998753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-36  Score=297.43  Aligned_cols=171  Identities=22%  Similarity=0.330  Sum_probs=146.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-----CCe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQG  254 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-----~~~  254 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||++++.  .....+.+++|+++|++++|||||++++++...     ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5899999999999999999999999999999999754  345567789999999999999999999986532     245


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      +|||||||+ |+|.+++...       ..+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+||
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-------~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DF  202 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-------QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDF  202 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeCCC-CCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeec
Confidence            899999995 7899999754       57999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCC--CCccccccccCCCccCccc
Q 017411          335 GLATWTSAPS--VPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~--~~~~~~~~~GT~gy~apea  363 (372)
                      |+|+.+....  ......+.+||+.|+|||+
T Consensus       203 Gla~~~~~~~~~~~~~~~~~~GT~~Y~APEv  233 (398)
T 4b99_A          203 GMARGLCTSPAEHQYFMTEYVATRWYRAPEL  233 (398)
T ss_dssp             TTCBCC-------CCCCCSSCCCCTTCCHHH
T ss_pred             ceeeecccCccccccccccceeChHhcCHHH
Confidence            9998764332  1123456789999999886

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.6e-35  Score=308.03  Aligned_cols=168  Identities=27%  Similarity=0.286  Sum_probs=145.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++++..      ........+++.+++.++|||||++++++.+ ...+
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~l  267 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL  267 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCEE
Confidence            58999999999999999999999999999999997531      1222233445677788899999999998876 4569


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      |||||||+||+|.++|...       ..+++..+..++.||+.||.|||+.+   ||||||||+||||+.+|.+||+|||
T Consensus       268 ylVmEy~~GGdL~~~l~~~-------~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFG  337 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  337 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccc
Confidence            9999999999999999875       46999999999999999999999888   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|+.+....    ..+.+||+.|||||+-
T Consensus       338 lA~~~~~~~----~~t~~GTp~YmAPEvl  362 (689)
T 3v5w_A          338 LACDFSKKK----PHASVGTHGYMAPEVL  362 (689)
T ss_dssp             TCEECSSCC----CCSCCSCGGGCCHHHH
T ss_pred             eeeecCCCC----CCCccCCcCccCHHHH
Confidence            999876443    3457899999998864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-34  Score=284.58  Aligned_cols=170  Identities=22%  Similarity=0.266  Sum_probs=140.9

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      ...+.|++.+.||+|+||+||+|+++   .+++.||||.+.+..  ....+.+|+++|+.+ +|||||++++++.+ .+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCE
Confidence            34578999999999999999999874   457899999987643  235678999999998 69999999998876 456


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEe
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCD  333 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~D  333 (372)
                      +|+||||+++|+|.+++.          .+++..+..++.||+.||.|||+.+   |+||||||+|||++.+ +.+||+|
T Consensus        95 ~~lvmE~~~g~~L~~~~~----------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~D  161 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN----------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVD  161 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT----------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECC
T ss_pred             EEEEEeCCCcccHHHHHc----------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECc
Confidence            999999999999999983          4889999999999999999999988   9999999999999877 7999999


Q ss_pred             cccccccCCCCCC--------------------------ccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVP--------------------------FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~--------------------------~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|+........                          ....+.+||++|+|||+-
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l  218 (361)
T 4f9c_A          162 FGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVL  218 (361)
T ss_dssp             CTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHH
T ss_pred             CCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            9999865432210                          112345799999998853

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.7e-34  Score=299.63  Aligned_cols=171  Identities=23%  Similarity=0.367  Sum_probs=152.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|++.+.||+|+||.||+|.++.+++.||||++........+.+.+|+.+|+.++|||||++++++.+ +..+||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E~  235 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEF  235 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEee
Confidence            589999999999999999999999999999999988777777889999999999999999999999876 5569999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC--CcEEEEecccccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLATW  339 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~--~~~KL~DFGla~~  339 (372)
                      |++|+|.++|....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+  +.+||+|||+|+.
T Consensus       236 ~~gg~L~~~i~~~~------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          236 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             CCCCBHHHHHTCTT------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             cCCCcHHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999999996542      46899999999999999999999988   9999999999999854  8999999999998


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +....   ...+.+||+.|||||+-+
T Consensus       307 ~~~~~---~~~~~~GT~~y~APEv~~  329 (573)
T 3uto_A          307 LDPKQ---SVKVTTGTAEFAAPEVAE  329 (573)
T ss_dssp             CCTTS---EEEEECSSGGGCCHHHHT
T ss_pred             ccCCC---ceeeeEECccccCHHHhC
Confidence            86543   235568999999987644

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.98  E-value=6.7e-32  Score=256.94  Aligned_cols=174  Identities=28%  Similarity=0.433  Sum_probs=150.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|...+.||+|+||.||+|.+..+++.||+|.+........+.+.+|++++++++||||+++++++.+. ...++|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEE
Confidence            35899999999999999999999989999999999877777888999999999999999999999998874 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        88 ~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  158 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD------SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLM  158 (310)
T ss_dssp             CCTTCBHHHHHHHCC------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceec
Confidence            999999999998743      46899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCCc------------cccccccCCCccCcccc
Q 017411          341 SAPSVPF------------LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~------------~~~~~~GT~gy~apeaP  364 (372)
                      .......            ......||+.|+|||.-
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  194 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI  194 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHH
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHh
Confidence            5433211            11245799999997753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.98  E-value=1.5e-32  Score=276.14  Aligned_cols=182  Identities=24%  Similarity=0.242  Sum_probs=154.8

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh---hhHHHHHHHHHHHHhCCCCCeeceeeeE
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK---ESSKAFCRELMIASSLHHPNIVPLVGFC  248 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~---~~~~~~~~Ev~iL~~l~HpnIv~l~g~~  248 (372)
                      +.+.++...+++|+..+.||+|+||.||+|++..+++.||||++++...   .....+.+|+.++..++||||++++++|
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3455666778899999999999999999999999999999999975321   1223488999999999999999999988


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      .+ ...+|+||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       144 ~~-~~~~~lV~Ey~~gg~L~~~l~~~~------~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          144 QD-DNNLYLVMDYYVGGDLLTLLSKFE------DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             EC-SSEEEEEECCCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             ee-CCEEEEEEecCCCCcHHHHHHHcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCC
Confidence            76 455899999999999999997642      46999999999999999999999988   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+|+....... .......||++|+|||.-
T Consensus       214 vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l  248 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEIL  248 (437)
T ss_dssp             EEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHH
T ss_pred             EEEcchhhhhhcccCCC-cccccccCCcCeeChHHH
Confidence            99999999987654432 123446899999998753

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.98  E-value=7.4e-32  Score=260.78  Aligned_cols=171  Identities=28%  Similarity=0.350  Sum_probs=151.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ...+|+..+.||+|+||.||+|.+..+++.||||++.+.  .....+.+.+|+++++.++||||+++++++.. ....++
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEE
Confidence            346899999999999999999999889999999999754  44556788999999999999999999999876 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        92 v~e~~~~~~L~~~l~~~-------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  161 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAH-------GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFS  161 (328)
T ss_dssp             EECCCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCC
T ss_pred             EEECCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCc
Confidence            99999999999999775       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +......   ......||+.|+|||.-
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~  185 (328)
T 3fe3_A          162 NEFTVGG---KLDAFCGAPPYAAPELF  185 (328)
T ss_dssp             GGGSSSC---GGGTTSSSGGGCCHHHH
T ss_pred             eecCCCC---ccccccCCcceeCcccc
Confidence            8775443   23456799999998753

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.98  E-value=7.2e-32  Score=256.37  Aligned_cols=170  Identities=24%  Similarity=0.355  Sum_probs=149.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+ ..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECC-EEEEEEE
Confidence            358999999999999999999998899999999997665555678899999999999999999999987744 5899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++|+|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 ~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           98 YLAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             CCTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCCCCCHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            9999999999975        35899999999999999999999987   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....  ......||+.|+|||.-
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~  188 (297)
T 3fxz_A          167 TPEQS--KRSTMVGTPYWMAPEVV  188 (297)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHH
T ss_pred             CCccc--ccCCccCCcCccChhhh
Confidence            65433  23456799999997753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.98  E-value=7e-32  Score=262.16  Aligned_cols=171  Identities=26%  Similarity=0.289  Sum_probs=148.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+++...+++.||||++++.   .......+.+|+.+|+.++||||+++++++.+ ....++|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEEE
Confidence            5899999999999999999999999999999999754   22345678899999999999999999998876 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        84 ~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  153 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchh
Confidence            9999999999999865       46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .......  ...+..||+.|+|||.-.
T Consensus       154 ~~~~~~~--~~~~~~gt~~y~aPE~~~  178 (337)
T 1o6l_A          154 EGISDGA--TMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGS
T ss_pred             hcccCCC--cccccccChhhCChhhhc
Confidence            6543322  235568999999988643

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=3.6e-32  Score=271.44  Aligned_cols=182  Identities=27%  Similarity=0.250  Sum_probs=155.0

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeE
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFC  248 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~  248 (372)
                      +++.++....++|+..+.||+|+||.||++++..+++.||||++++..   ....+.+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            445566667789999999999999999999999899999999997532   12234578999999999999999999988


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      .+ ....|+||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       131 ~~-~~~~~lVmE~~~gg~L~~~l~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          131 QD-ENYLYLVMEYYVGGDLLTLLSKFG------ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             EC-SSEEEEEECCCCSCBHHHHHHHHS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSC
T ss_pred             ee-CCEEEEEEcCCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCC
Confidence            76 456899999999999999998653      36899999999999999999999988   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+++....... .......||+.|+|||+-
T Consensus       201 vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l  235 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEIL  235 (412)
T ss_dssp             EEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHH
T ss_pred             EEEeechhheeccCCCc-cccceeccccCcCCHHHH
Confidence            99999999987754432 123346899999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=7.5e-32  Score=263.55  Aligned_cols=171  Identities=27%  Similarity=0.335  Sum_probs=144.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|++..+++.||||++++.   .....+.+.+|..+++.+ +||||+++++++.+ ....|
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~  100 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRLF  100 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEEE
Confidence            46899999999999999999999999999999999764   233456688999999988 69999999998876 45589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       101 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~  170 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS-------RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGM  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccc
Confidence            999999999999999875       46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+.......  ...+.+||+.|+|||.-
T Consensus       171 a~~~~~~~~--~~~~~~gt~~y~aPE~~  196 (353)
T 3txo_A          171 CKEGICNGV--TTATFCGTPDYIAPEIL  196 (353)
T ss_dssp             CBCSCC-----------CCGGGCCHHHH
T ss_pred             eeecccCCc--cccccCCCcCeEChhhc
Confidence            986543322  34566899999998753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=1.7e-31  Score=256.65  Aligned_cols=180  Identities=24%  Similarity=0.300  Sum_probs=154.6

Q ss_pred             cccHHHHHHhhCC----------eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC
Q 017411          171 RLSYGEILAATHN----------FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN  240 (372)
Q Consensus       171 ~~s~~ei~~~t~~----------f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn  240 (372)
                      .+++.++..+++.          |...+.||+|+||.||+|++..+++.||||++........+.+.+|+.++++++|||
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  103 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN  103 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC
Confidence            4666666666543          778889999999999999998889999999998766666778999999999999999


Q ss_pred             eeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCC
Q 017411          241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (372)
Q Consensus       241 Iv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~N  320 (372)
                      |+++++++...+ ..++||||+++++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|
T Consensus       104 iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~N  171 (321)
T 2c30_A          104 VVEMYKSYLVGE-ELWVLMEFLQGGALTDIVSQ--------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDS  171 (321)
T ss_dssp             BCCEEEEEEETT-EEEEEECCCCSCBHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGG
T ss_pred             cceEEEEEEECC-EEEEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHH
Confidence            999999988754 58999999999999999864        35899999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       321 ILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||++.++.+||+|||+++.......  ......||+.|+|||.-
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~  213 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVI  213 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHH
T ss_pred             EEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhh
Confidence            9999999999999999987754332  22456799999997754

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=2.9e-32  Score=271.98  Aligned_cols=178  Identities=24%  Similarity=0.320  Sum_probs=151.9

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      +.++....++|...+.||+|+||.||+|++..+++.||||++++..   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3455566789999999999999999999999999999999997531   1122357899999999999999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                       +..+|+||||+++|+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       141 -~~~~~lV~E~~~gg~L~~~l~~--------~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          141 -DRYLYMVMEYMPGGDLVNLMSN--------YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             -SSEEEEEECCCTTEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEE
T ss_pred             -CCEEEEEEeCCCCCcHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEE
Confidence             4568999999999999999975        35899999999999999999999988   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+|+....... ....+..||+.|+|||+-
T Consensus       209 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l  241 (410)
T 3v8s_A          209 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVL  241 (410)
T ss_dssp             ECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHH
T ss_pred             EeccceeEeeccCCc-ccccCCcCCccccCHHHh
Confidence            999999987754432 123467899999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.97  E-value=1.9e-31  Score=254.42  Aligned_cols=176  Identities=24%  Similarity=0.330  Sum_probs=145.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-------
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-------  253 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-------  253 (372)
                      ++|+..+.||+|+||.||+|++..+++.||||++... .....+.+.+|+.++++++||||+++++++.+...       
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            4799999999999999999999988999999999754 33456789999999999999999999998865432       


Q ss_pred             -------------------------------------------------eEEEEEeccCCCCHHHHHHhhccCCCCCCCC
Q 017411          254 -------------------------------------------------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTL  284 (372)
Q Consensus       254 -------------------------------------------------~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l  284 (372)
                                                                       ..++||||+++++|.+++......    ...
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~----~~~  161 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL----EDR  161 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG----GGS
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc----cch
Confidence                                                             378999999999999999865321    345


Q ss_pred             CHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCC----------cccccccc
Q 017411          285 PWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVP----------FLCKTVKG  354 (372)
Q Consensus       285 ~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~----------~~~~~~~G  354 (372)
                      ++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........          .......|
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g  238 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG  238 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence            77788999999999999999987   999999999999999999999999999887654321          12234578


Q ss_pred             CCCccCcccc
Q 017411          355 TFGQNPFCIE  364 (372)
Q Consensus       355 T~gy~apeaP  364 (372)
                      |+.|+|||.-
T Consensus       239 t~~y~aPE~~  248 (332)
T 3qd2_B          239 TKLYMSPEQI  248 (332)
T ss_dssp             CGGGSCHHHH
T ss_pred             CcCccChHHh
Confidence            9999997753

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=2.8e-31  Score=258.41  Aligned_cols=170  Identities=29%  Similarity=0.363  Sum_probs=148.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|+..+.||+|+||.||++++..+++.||||++.+.   .....+.+.+|..++.++ +||||+++++++.+ ....|+
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEE
Confidence            5899999999999999999999999999999999764   344566788999999988 89999999998876 456899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        88 v~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a  157 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMC  157 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGC
T ss_pred             EEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccc
Confidence            99999999999999865       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......  ......||+.|+|||.-
T Consensus       158 ~~~~~~~~--~~~~~~gt~~y~aPE~~  182 (345)
T 3a8x_A          158 KEGLRPGD--TTSTFCGTPNYIAPEIL  182 (345)
T ss_dssp             BCSCCTTC--CBCCCCSCGGGCCHHHH
T ss_pred             ccccCCCC--cccccCCCccccCcccc
Confidence            86543322  23556899999997753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=7e-32  Score=261.41  Aligned_cols=190  Identities=25%  Similarity=0.338  Sum_probs=156.5

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEE-----ECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeece
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPL  244 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~-----~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l  244 (372)
                      +...++....++|++.+.||+|+||.||+|+     ...+++.||||+++.. .....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            4556666778899999999999999999998     4456689999999764 344557799999999999 79999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCC---------------------------------------------
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------------------------------------------  279 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~---------------------------------------------  279 (372)
                      ++++.+.+...++||||+++|+|.+++........                                             
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988766668999999999999999986532100                                             


Q ss_pred             --------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCC
Q 017411          280 --------------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV  345 (372)
Q Consensus       280 --------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~  345 (372)
                                    ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                          0122899999999999999999999987   99999999999999999999999999987755444


Q ss_pred             CccccccccCCCccCcccc
Q 017411          346 PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       346 ~~~~~~~~GT~gy~apeaP  364 (372)
                      ........||+.|+|||.-
T Consensus       249 ~~~~~~~~~t~~y~aPE~~  267 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETI  267 (359)
T ss_dssp             CEEC--CEECGGGCCHHHH
T ss_pred             chhccccCCCceeEChhhh
Confidence            3344566789999997743

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=1.3e-31  Score=266.03  Aligned_cols=171  Identities=28%  Similarity=0.357  Sum_probs=146.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|++..+++.||||++++.   .....+.+.+|..++.++ +||||+++++++.+ ...++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence            35899999999999999999999999999999999764   223334678899999887 89999999998876 45689


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       130 lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGl  199 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ-------RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGM  199 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecce
Confidence            999999999999999875       46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+.......  ...+..||+.|+|||+-
T Consensus       200 a~~~~~~~~--~~~~~~gt~~Y~aPE~l  225 (396)
T 4dc2_A          200 CKEGLRPGD--TTSTFCGTPNYIAPEIL  225 (396)
T ss_dssp             CBCCCCTTC--CBCCCCBCGGGCCHHHH
T ss_pred             eeecccCCC--ccccccCCcccCCchhh
Confidence            986433322  34567899999998764

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=2e-31  Score=259.79  Aligned_cols=173  Identities=25%  Similarity=0.311  Sum_probs=148.1

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCe
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~  254 (372)
                      ...++|...+.||+|+||.||+|++..+++.||||++++..   ....+.+.+|..++..+ +||||+++++++.+ ...
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KEN   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCE
Confidence            34579999999999999999999999999999999997642   23345678899999876 89999999998876 455


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .|+||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEEeCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEC
Confidence            89999999999999999875       46899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++.......  ......||+.|+|||+-
T Consensus       163 G~a~~~~~~~~--~~~~~~gt~~y~aPE~~  190 (345)
T 1xjd_A          163 GMCKENMLGDA--KTNTFCGTPDYIAPEIL  190 (345)
T ss_dssp             TTCBCCCCTTC--CBCCCCSCGGGCCHHHH
T ss_pred             hhhhhcccCCC--cccCCCCCcccCChhhh
Confidence            99986543322  23567899999997753

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=263.32  Aligned_cols=169  Identities=24%  Similarity=0.360  Sum_probs=149.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||++.+..+++.||||++.+..   ....+.+.+|+.+|+.++||||+++++++.+. ...|+|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEE
Confidence            58999999999999999999999999999999997532   23456788999999999999999999988764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        94 ~e~~~gg~L~~~l~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~  163 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN-------VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAA  163 (384)
T ss_dssp             ECCCTTEEHHHHHHTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceee
Confidence            9999999999999764       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   ......||+.|+|||.-
T Consensus       164 ~~~~~~---~~~~~~gt~~Y~aPE~~  186 (384)
T 4fr4_A          164 MLPRET---QITTMAGTKPYMAPEMF  186 (384)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCGGGT
T ss_pred             eccCCC---ceeccCCCccccCCeee
Confidence            775443   23556899999998764

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=5.7e-32  Score=258.89  Aligned_cols=185  Identities=33%  Similarity=0.588  Sum_probs=156.3

Q ss_pred             cccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          171 RLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       171 ~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      ++++.++...+++|+..+.||+|+||.||+|.+. +++.||||++........+.+.+|+.++++++||||+++++++.+
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence            4455566678899999999999999999999975 588999999987766677889999999999999999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                      .+ ..++||||+++|+|.+++.....   ....++|..++.++.|++.||.|||+.+   |+||||||+|||++.++.+|
T Consensus       107 ~~-~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          107 RN-EMILIYKYMENGNLKRHLYGSDL---PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             TT-CCEEEEECCTTCBTGGGSSSSCC---CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEE
T ss_pred             CC-eEEEEEEcCCCCcHHHHHhccCC---CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEE
Confidence            44 48999999999999999865421   1246899999999999999999999987   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+|||+++...............||+.|+|||.
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~  212 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEY  212 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHH
Confidence            999999987654433333455678999999775

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.97  E-value=5.5e-31  Score=249.73  Aligned_cols=172  Identities=29%  Similarity=0.408  Sum_probs=143.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++++.+ +...++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence            36899999999999999999999988999999998543   34556789999999999999999999999876 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        89 v~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH-------GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             EEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             EEeCCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            99999999999999865       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +........ ......||+.|+|||.-
T Consensus       159 ~~~~~~~~~-~~~~~~gt~~y~aPE~~  184 (294)
T 4eqm_A          159 KALSETSLT-QTNHVLGTVQYFSPEQA  184 (294)
T ss_dssp             TTC--------------CCSSCCHHHH
T ss_pred             ccccccccc-ccCccccCccccCHhHh
Confidence            877543321 23446799999997753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.97  E-value=3.1e-31  Score=255.33  Aligned_cols=167  Identities=29%  Similarity=0.377  Sum_probs=146.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+++...+++.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEE
Confidence            58999999999999999999999899999999997642   2335678899999999999999999998876 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        85 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~  154 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK  154 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EeCCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcce
Confidence            9999999999999864       46899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....     ..+..||+.|+|||.-
T Consensus       155 ~~~~~-----~~~~~gt~~y~aPE~~  175 (318)
T 1fot_A          155 YVPDV-----TYTLCGTPDYIAPEVV  175 (318)
T ss_dssp             ECSSC-----BCCCCSCTTTCCHHHH
T ss_pred             ecCCc-----cccccCCccccCHhHh
Confidence            76532     2456799999998753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=9e-31  Score=248.25  Aligned_cols=186  Identities=32%  Similarity=0.525  Sum_probs=159.5

Q ss_pred             ccccccHHHHHHhhCCeeec------eeEcccCceEEEEEEECCCCeEEEEEEecCC----ChhhHHHHHHHHHHHHhCC
Q 017411          168 SLIRLSYGEILAATHNFSKG------RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLH  237 (372)
Q Consensus       168 ~~~~~s~~ei~~~t~~f~~~------~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~----~~~~~~~~~~Ev~iL~~l~  237 (372)
                      ....|++.++..++++|...      +.||+|+||.||+|..  .++.||||++...    .....+.+.+|+.++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            45679999999999999887      8999999999999986  4789999998653    2345678999999999999


Q ss_pred             CCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC
Q 017411          238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (372)
Q Consensus       238 HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK  317 (372)
                      ||||+++++++.+.+ ..++||||+++++|.+++.....    ...+++..++.++.|++.||.|||+.+   |+|||||
T Consensus        89 h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlk  160 (307)
T 2nru_A           89 HENLVELLGFSSDGD-DLCLVYVYMPNGSLLDRLSCLDG----TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIK  160 (307)
T ss_dssp             CTTBCCEEEEECSSS-SCEEEEECCTTCBHHHHHHTGGG----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCC
T ss_pred             CCCeEEEEEEEecCC-ceEEEEEecCCCcHHHHHHhccC----CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCC
Confidence            999999999987644 48999999999999999975432    146899999999999999999999987   9999999


Q ss_pred             CCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          318 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       318 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+||+++.++.+||+|||+++...............||+.|+|||.
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~  206 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA  206 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHH
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHH
Confidence            9999999999999999999987765443333445678999999775

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=1.8e-31  Score=255.41  Aligned_cols=193  Identities=35%  Similarity=0.584  Sum_probs=159.8

Q ss_pred             ccccccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-hhHHHHHHHHHHHHhCCCCCeece
Q 017411          166 ANSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-ESSKAFCRELMIASSLHHPNIVPL  244 (372)
Q Consensus       166 ~~~~~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~Ev~iL~~l~HpnIv~l  244 (372)
                      ...+..+++.++...+++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++
T Consensus        14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            345678999999999999999999999999999999864 588999999976432 223368999999999999999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS  324 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld  324 (372)
                      ++++.+... .++||||+++|+|.+++......   ...+++..+..++.|++.||.|||+...++|+||||||+|||++
T Consensus        93 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           93 RGFCMTPTE-RLLVYPYMANGSVASCLRERPES---QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             CEEECCSSC-CEEEEECCTTCBHHHHHHCCSTT---CCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEEC
T ss_pred             EEEEecCCc-eEEEEEeccCCCHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEEC
Confidence            999876544 78999999999999999865321   24699999999999999999999998333499999999999999


Q ss_pred             CCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          325 SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       325 ~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .++.+||+|||+++........ ......||++|+|||.-
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~  207 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYL  207 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHH
T ss_pred             CCCCEEeccCccccccCccccc-ccccccCCcCccCHHHh
Confidence            9999999999999877544332 33445699999997753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=1.5e-31  Score=257.47  Aligned_cols=173  Identities=27%  Similarity=0.355  Sum_probs=146.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+ +...++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence            368999999999999999999999899999999997543 2334668899999999999999999999876 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        85 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  154 (323)
T 3tki_A           85 EYCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATV  154 (323)
T ss_dssp             ECCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccce
Confidence            999999999988643       46899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..............||+.|+|||.-
T Consensus       155 ~~~~~~~~~~~~~~gt~~y~aPE~~  179 (323)
T 3tki_A          155 FRYNNRERLLNKMCGTLPYVAPELL  179 (323)
T ss_dssp             CEETTEECCBCSCCSCGGGSCHHHH
T ss_pred             eccCCcccccCCCccCcCccCcHHh
Confidence            6544332334456899999997754

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=3.6e-31  Score=250.51  Aligned_cols=171  Identities=25%  Similarity=0.335  Sum_probs=142.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh--------------------------hhHHHHHHHHHHHH
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------------------------ESSKAFCRELMIAS  234 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------------------------~~~~~~~~Ev~iL~  234 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            3689999999999999999999998999999999975421                          12356889999999


Q ss_pred             hCCCCCeeceeeeEEcC-CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEE
Q 017411          235 SLHHPNIVPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  313 (372)
Q Consensus       235 ~l~HpnIv~l~g~~~~~-~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiH  313 (372)
                      +++||||+++++++.+. ....++||||+++++|.+++..        ..+++..++.++.||+.||.|||+.+   |+|
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH  160 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL--------KPLSEDQARFYFQDLIKGIEYLHYQK---IIH  160 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence            99999999999998763 4568999999999999875432        46899999999999999999999988   999


Q ss_pred             cCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       314 rDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||||+|||++.++.+||+|||+++.......  ......||+.|+|||.-
T Consensus       161 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~  209 (298)
T 2zv2_A          161 RDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESL  209 (298)
T ss_dssp             CCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGC
T ss_pred             cCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhh
Confidence            99999999999999999999999987764432  23445799999998754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=7.9e-31  Score=257.34  Aligned_cols=180  Identities=21%  Similarity=0.325  Sum_probs=148.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      .++|.+.+.||+|+||.||+|++.       .++..||||+++.. .....+.+.+|+.+++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            468999999999999999999863       24567999999765 345567899999999999 899999999998764


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NIL  322 (372)
                      + ..|+||||+++|+|.+++......         ......+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus       160 ~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl  235 (370)
T 2psq_A          160 G-PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL  235 (370)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred             C-CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence            4 589999999999999999875321         011245899999999999999999999988   999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       323 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.++.+||+|||+++...............||+.|+|||.-
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~  277 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL  277 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHH
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHh
Confidence            999999999999999977654432233445678889997743

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=7.7e-31  Score=257.21  Aligned_cols=171  Identities=30%  Similarity=0.353  Sum_probs=148.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .+.|.+.+.||+|+||.||+|.+..+++.||||++++...      ...+.+.+|+.+|++++||||+++++++.+ ...
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~   89 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RTD   89 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CCE
Confidence            4689999999999999999999999999999999976432      135678999999999999999999999876 455


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC----cEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPK  330 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~----~~K  330 (372)
                      .++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC-------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEE
Confidence            89999999999999999653       46899999999999999999999988   99999999999998877    799


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+|||+++.......   .....||+.|+|||.-.
T Consensus       160 l~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~  191 (361)
T 2yab_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVN  191 (361)
T ss_dssp             ECCCSSCEECCTTCC---CCCCCSCGGGCCHHHHT
T ss_pred             EEecCCceEcCCCCc---cccCCCCccEECchHHc
Confidence            999999988765432   24567999999987643

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.97  E-value=4.5e-31  Score=258.15  Aligned_cols=171  Identities=23%  Similarity=0.258  Sum_probs=148.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|++..+++.||||++++..   ....+.+.+|..++..+ +||||+++++++.+ ....|
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~   97 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLY   97 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEEE
Confidence            468999999999999999999999889999999997642   23456788999999988 79999999998766 45689


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        98 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            999999999999999865       46899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......  ......||+.|+|||+-
T Consensus       168 a~~~~~~~~--~~~~~~gt~~y~aPE~~  193 (353)
T 2i0e_A          168 CKENIWDGV--TTKTFCGTPDYIAPEII  193 (353)
T ss_dssp             CBCCCCTTC--CBCCCCSCGGGCCHHHH
T ss_pred             ccccccCCc--ccccccCCccccChhhh
Confidence            986543322  23556899999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.97  E-value=5.1e-31  Score=257.26  Aligned_cols=167  Identities=26%  Similarity=0.320  Sum_probs=147.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||.||++++..+++.||||++.+..   ....+.+.+|+.+++.++||||+++++++.+ ....|+|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEE
Confidence            58999999999999999999999899999999997542   2345678899999999999999999998876 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       120 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~  189 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EcCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccce
Confidence            9999999999999875       46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....     ..+..||+.|+|||.-
T Consensus       190 ~~~~~-----~~~~~gt~~y~aPE~~  210 (350)
T 1rdq_E          190 RVKGR-----TWTLCGTPEALAPEII  210 (350)
T ss_dssp             ECSSC-----BCCCEECGGGCCHHHH
T ss_pred             eccCC-----cccccCCccccCHHHh
Confidence            76543     2346799999998753

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.97  E-value=1.1e-30  Score=246.52  Aligned_cols=170  Identities=25%  Similarity=0.361  Sum_probs=145.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEE
Confidence            5799999999999999999999989999999999754  334457789999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++ +|.+.+....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 e~~~~-~l~~~~~~~~------~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~  150 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ECCSE-EHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ecCCC-CHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            99975 6666665432      46899999999999999999999988   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...+..  ......||+.|+|||.-
T Consensus       151 ~~~~~~--~~~~~~~t~~y~aPE~~  173 (292)
T 3o0g_A          151 FGIPVR--CYSAEVVTLWYRPPDVL  173 (292)
T ss_dssp             CCSCCS--CCCSCCSCGGGCCHHHH
T ss_pred             cCCccc--cccCCccccCCcChHHH
Confidence            754433  22445789999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=5.7e-31  Score=256.79  Aligned_cols=180  Identities=16%  Similarity=0.161  Sum_probs=147.4

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEE-----ECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeeE
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFC  248 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~-----~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~  248 (372)
                      +....++|.+.+.||+|+||.||+|.     ...+++.||||+++...   ...+.+|++++.+++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            33456789999999999999999994     55678899999997654   346778888888887   99999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---  325 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---  325 (372)
                      ...+. .++||||+++|+|.+++......  ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.   
T Consensus       137 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          137 LFQNG-SVLVGELYSYGTLLNAINLYKNT--PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             ECSSC-EEEEECCCCSCBHHHHHHHHHTS--TTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGT
T ss_pred             ecCCC-cEEEEeccCCCcHHHHHHHhhcc--cccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEeccccc
Confidence            77554 89999999999999999864321  1256999999999999999999999887   999999999999998   


Q ss_pred             --------CCcEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          326 --------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       326 --------~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                              ++.+||+|||+|+...............||++|+|||.-.
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  258 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLS  258 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHT
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhc
Confidence                    8999999999998664333223445678999999987543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.7e-30  Score=250.15  Aligned_cols=170  Identities=18%  Similarity=0.223  Sum_probs=148.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEE
Confidence            468999999999999999999999999999999997543 3456788999999999999999999998764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC--CCcEEEEeccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLAT  338 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~--~~~~KL~DFGla~  338 (372)
                      |+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  ++.+||+|||+++
T Consensus        82 ~~~g~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           82 FISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             eCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            999999999996532      46899999999999999999999987   999999999999987  7899999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   ......||+.|+|||.-
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~  175 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVH  175 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHH
T ss_pred             ECCCCC---ccccccCChhhcCcHHh
Confidence            876443   23456799999997753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=6.5e-31  Score=252.32  Aligned_cols=174  Identities=26%  Similarity=0.323  Sum_probs=145.7

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---eE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GL  255 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---~~  255 (372)
                      ...++|+..+.||+|+||.||+|++.  ++.||||++..... ....+.+|+.++++++||||+++++++.+...   .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   97 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDL   97 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceE
Confidence            34568999999999999999999886  78999999976433 33456679999999999999999999876432   37


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCceEEcCCCCCCEEEcCCCc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-------TERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ++||||+++|+|.+++..        ..+++..++.++.|++.||.|||+.       ..++|+||||||+|||++.++.
T Consensus        98 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~  169 (322)
T 3soc_A           98 WLITAFHEKGSLSDFLKA--------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT  169 (322)
T ss_dssp             EEEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred             EEEEecCCCCCHHHHHHh--------cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe
Confidence            899999999999999975        3589999999999999999999987       0113999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+++...............||+.|+|||.
T Consensus       170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  204 (322)
T 3soc_A          170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV  204 (322)
T ss_dssp             EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHH
T ss_pred             EEEccCCcccccccccCccccccCccCccccCHhh
Confidence            99999999988765544333445679999999775

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=4e-31  Score=259.77  Aligned_cols=178  Identities=22%  Similarity=0.357  Sum_probs=148.7

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      +....++|...+.||+|+||.||+|.+..+++.||||.++.. .....+.|.+|+++|++++||||+++++++.+.+ ..
T Consensus       109 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~~  187 (377)
T 3cbl_A          109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ-PI  187 (377)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS-SC
T ss_pred             cEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC-Cc
Confidence            334556899999999999999999999888999999998754 3444567899999999999999999999987644 48


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG  258 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG------ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG  258 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEcCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCC
Confidence            99999999999999998653      35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++...............+++.|+|||+-
T Consensus       259 ~s~~~~~~~~~~~~~~~~~~~~y~aPE~~  287 (377)
T 3cbl_A          259 MSREEADGVYAASGGLRQVPVKWTAPEAL  287 (377)
T ss_dssp             GCEECTTSEEECCSSCCEEEGGGSCHHHH
T ss_pred             CceecCCCceeecCCCCCCCcCcCCHhHh
Confidence            99875433221111223456778887753

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=1.3e-30  Score=253.65  Aligned_cols=174  Identities=24%  Similarity=0.341  Sum_probs=147.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      +.|++.+.||+|+||.||+|.+..+++.||||+++...     ....+.+.+|+.+++.++||||+++++++.+ +...|
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGMLY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEE
Confidence            47999999999999999999999999999999986431     1235678999999999999999999999876 45589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc---EEEEe
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCD  333 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~---~KL~D  333 (372)
                      +||||+++++|.+++......   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~D  176 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADA---GFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGG  176 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred             EEEeCCCCCCHHHHHHHhccc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEec
Confidence            999999999999888764321   145899999999999999999999988   999999999999987654   99999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++.......  ......||+.|+|||.-
T Consensus       177 fg~a~~~~~~~~--~~~~~~gt~~y~aPE~~  205 (351)
T 3c0i_A          177 FGVAIQLGESGL--VAGGRVGTPHFMAPEVV  205 (351)
T ss_dssp             CTTCEECCTTSC--BCCCCCSCGGGCCHHHH
T ss_pred             CcceeEecCCCe--eecCCcCCcCccCHHHH
Confidence            999988765432  23456799999997754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=3.6e-31  Score=259.34  Aligned_cols=179  Identities=27%  Similarity=0.344  Sum_probs=147.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++|++.+.||+|+||.||+|..     ..+++.||||+++.. .......+.+|+.++++++||||+++++++.+.. .
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCC-C
Confidence            35899999999999999999994     345778999999754 4555667999999999999999999999987644 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC---cEEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKL  331 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~---~~KL  331 (372)
                      .++||||+++|+|.+++............+++..++.++.||+.||.|||+.+   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            79999999999999999876543333356999999999999999999999988   99999999999999555   5999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|||+++...............||+.|+|||.
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  257 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA  257 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHH
Confidence            99999986543322223345678899999774

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.97  E-value=5.9e-31  Score=251.44  Aligned_cols=169  Identities=24%  Similarity=0.239  Sum_probs=140.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|+..+.||+|+||+||+|.+..+++.||||++...  .......+.+|+..+.++ +||||++++++|.+. ...++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEEE
Confidence            5799999999999999999999988999999998653  334444566666666555 899999999998764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+ +++|.+++....      ..++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       136 ~e~~-~~~L~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~  205 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG------ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLV  205 (311)
T ss_dssp             EECC-CCBHHHHHHHHC------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCE
T ss_pred             Eecc-CCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeee
Confidence            9999 779999987753      46999999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......   .....||++|+|||.-
T Consensus       206 ~~~~~~~---~~~~~gt~~y~aPE~~  228 (311)
T 3p1a_A          206 ELGTAGA---GEVQEGDPRYMAPELL  228 (311)
T ss_dssp             ECC---------CCCCCGGGCCGGGG
T ss_pred             ecccCCC---CcccCCCccccCHhHh
Confidence            7754432   2445699999997753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=1.2e-30  Score=251.45  Aligned_cols=171  Identities=28%  Similarity=0.315  Sum_probs=136.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .++|+..+.||+|+||.||+++..   .+++.||||++++..    ......+.+|+.++++++||||+++++++... .
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-G   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-S
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-C
Confidence            358999999999999999999984   578999999997642    23445678999999999999999999998764 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..|+||||+++++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~D  164 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE-------GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTD  164 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECC
T ss_pred             EEEEEEeCCCCCcHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEe
Confidence            589999999999999999865       46899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++.......  ......||+.|+|||.-
T Consensus       165 fg~~~~~~~~~~--~~~~~~gt~~y~aPE~~  193 (327)
T 3a62_A          165 FGLCKESIHDGT--VTHTFCGTIEYMAPEIL  193 (327)
T ss_dssp             CSCC------------CTTSSCCTTSCHHHH
T ss_pred             CCcccccccCCc--cccccCCCcCccCHhhC
Confidence            999986543322  23456799999997753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=1.7e-30  Score=248.40  Aligned_cols=173  Identities=27%  Similarity=0.313  Sum_probs=148.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-eEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-~~~lV~  259 (372)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++..... ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57999999999999999999999899999999997543 3345678899999999999999999999876543 579999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE----cCCCcEEEEecc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDFG  335 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl----d~~~~~KL~DFG  335 (372)
                      ||+++++|.+++......    ..+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||
T Consensus        89 e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSNA----YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             ECCTTCBHHHHHHSGGGT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             eCCCCCCHHHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999875421    34899999999999999999999988   9999999999999    778889999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++.......   .....||+.|+|||.-
T Consensus       162 ~a~~~~~~~~---~~~~~gt~~y~aPE~~  187 (319)
T 4euu_A          162 AARELEDDEQ---FVSLYGTEEYLHPDMY  187 (319)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred             CceecCCCCc---eeecccCCCccCHHHh
Confidence            9988765442   2345799999998753

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=7.7e-31  Score=263.79  Aligned_cols=172  Identities=22%  Similarity=0.326  Sum_probs=135.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----Ce
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~  254 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.+.  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999989999999999753  4555678999999999999999999999885432    45


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      +|+||||+ +++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DF  200 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP-------VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDF  200 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecc-ccchhhhcccC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeeccc
Confidence            89999998 57999998753       46999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCC-------------------------ccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVP-------------------------FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~-------------------------~~~~~~~GT~gy~apea  363 (372)
                      |+|+........                         ......+||+.|+|||+
T Consensus       201 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  254 (458)
T 3rp9_A          201 GLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL  254 (458)
T ss_dssp             TTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred             ccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence            999876533211                         12234578999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=1.9e-30  Score=254.09  Aligned_cols=170  Identities=30%  Similarity=0.394  Sum_probs=147.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ +...++|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            45899999999999999999999989999999999754  34456778999999999999999999999876 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEEEEecc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFG  335 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~KL~DFG  335 (372)
                      |||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+   +.+||+|||
T Consensus       107 ~e~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence            9999999999998754       46899999999999999999999988   9999999999999865   459999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++.......   .....||++|+|||.-
T Consensus       177 ~a~~~~~~~~---~~~~~gt~~y~aPE~~  202 (362)
T 2bdw_A          177 LAIEVNDSEA---WHGFAGTPGYLSPEVL  202 (362)
T ss_dssp             TCBCCTTCCS---CCCSCSCTTTCCHHHH
T ss_pred             cceEecCCcc---cccCCCCccccCHHHH
Confidence            9987764432   2446799999997754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=248.73  Aligned_cols=169  Identities=29%  Similarity=0.358  Sum_probs=147.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      +.|...+.||+|+||.||+|.+..+++.||||++.....      ...+.+.+|+.+|++++||||+++++++.+ ....
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDV   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence            479999999999999999999998999999999975422      235679999999999999999999999876 4558


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC----cEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  331 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~----~~KL  331 (372)
                      ++||||+++++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++    .+||
T Consensus        90 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl  159 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI  159 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS-------SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEcCCCCCHHHHHHhc-------CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEE
Confidence            9999999999999999653       46899999999999999999999988   99999999999999887    8999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++.......   .....||+.|+|||.-
T Consensus       160 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~  189 (326)
T 2y0a_A          160 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIV  189 (326)
T ss_dssp             CCCTTCEECCTTSC---CCCCCSCTTTCCHHHH
T ss_pred             EECCCCeECCCCCc---cccccCCcCcCCceee
Confidence            99999988754332   2345799999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=3.1e-31  Score=266.15  Aligned_cols=172  Identities=25%  Similarity=0.265  Sum_probs=138.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++.+.   .......+.+|+.+++.++||||+++++++.+. ...+
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEE
Confidence            346899999999999999999999999999999999753   334456788999999999999999999998774 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      +||||+++|+|.+++...       ..+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||
T Consensus       225 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG  294 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRE-------RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFG  294 (446)
T ss_dssp             EEECCCSSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCC
T ss_pred             EEEeeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCC
Confidence            999999999999999765       468999999999999999999997 77   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|+.......  ......||++|+|||.-
T Consensus       295 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~  321 (446)
T 4ejn_A          295 LCKEGIKDGA--TMKTFCGTPEYLAPEVL  321 (446)
T ss_dssp             CCCTTCC-------CCSSSCGGGCCHHHH
T ss_pred             CceeccCCCc--ccccccCCccccCHhhc
Confidence            9986543332  23457899999998754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=6.3e-31  Score=248.21  Aligned_cols=174  Identities=25%  Similarity=0.318  Sum_probs=143.5

Q ss_pred             hCCeeeceeEcccCceEEEEEE----ECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      .++|+..+.||+|+||.||+|+    ...+++.||||++........+.+.+|++++++++||||+++++++... ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            3689999999999999999998    4567899999999887777778899999999999999999999988543 2347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  159 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  159 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcc------cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCc
Confidence            89999999999999998753      35899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccCCCccCccc
Q 017411          336 LATWTSAPSVP-FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~-~~~~~~~GT~gy~apea  363 (372)
                      +++........ .......|+..|+|||.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  188 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPES  188 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHH
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHH
Confidence            99877544321 12233456777888764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=1.6e-30  Score=250.31  Aligned_cols=174  Identities=22%  Similarity=0.331  Sum_probs=143.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC---eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|.+.+.||+|+||.||+|.+..++   ..||||+++.. .....+.|.+|+.++++++||||+++++++.+. ...+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-GCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CccE
Confidence            357999999999999999999997544   45999999765 455567899999999999999999999998664 4479


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       127 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~  197 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTHD------GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGL  197 (325)
T ss_dssp             EEEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSS
T ss_pred             EEeeCCCCCcHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCc
Confidence            9999999999999997543      46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      ++........ .......+|+.|+|||.-
T Consensus       198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~  226 (325)
T 3kul_A          198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAI  226 (325)
T ss_dssp             CEECC----CCEECC---CCGGGSCHHHH
T ss_pred             ccccccCccceeeccCCCCcccccCHhHh
Confidence            9987544321 122334567788887753

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=1e-30  Score=250.18  Aligned_cols=178  Identities=30%  Similarity=0.445  Sum_probs=138.8

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      +....++|++.+.||+|+||.||+|+..  ++.||||++...  .....+.+.+|++++++++||||+++++++.+.. .
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~  108 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP-N  108 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT-C
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC-c
Confidence            3345568999999999999999999874  789999999764  3455678999999999999999999999987654 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+++|+|.+++......    ..+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Df  183 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAR----EQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDF  183 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHH----HHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEecCCCCcHHHHHhhcCCC----CCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCC
Confidence            89999999999999999764210    24899999999999999999999765 34999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++.......  ......||+.|+|||.-
T Consensus       184 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~  211 (309)
T 3p86_A          184 GLSRLKASTFL--SSKSAAGTPEWMAPEVL  211 (309)
T ss_dssp             C-------------------CCTTSCHHHH
T ss_pred             CCCcccccccc--ccccCCCCccccChhhh
Confidence            99986554322  23456799999997753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.97  E-value=1.7e-30  Score=261.71  Aligned_cols=173  Identities=28%  Similarity=0.314  Sum_probs=148.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||+|++....  ....+.+.+|+.++++++||||+++++++.+ +...++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~l   87 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHYL   87 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEEE
Confidence            3468999999999999999999999999999999997643  3445678999999999999999999999876 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc---CCCcEEEEec
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDF  334 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld---~~~~~KL~DF  334 (372)
                      ||||+++|+|.+.+...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+||
T Consensus        88 v~E~~~gg~L~~~i~~~-------~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DF  157 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR-------EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADF  157 (444)
T ss_dssp             EECCCBCCBHHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred             EEEeCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccC
Confidence            99999999999999865       46899999999999999999999988   99999999999998   4578999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+++.......  ......||++|+|||.-.
T Consensus       158 G~a~~~~~~~~--~~~~~~gt~~Y~APE~l~  186 (444)
T 3soa_A          158 GLAIEVEGEQQ--AWFGFAGTPGYLSPEVLR  186 (444)
T ss_dssp             SSCBCCCTTCC--BCCCSCSCGGGCCHHHHT
T ss_pred             ceeEEecCCCc--eeecccCCcccCCHHHhc
Confidence            99987765433  234567999999987643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=2.2e-30  Score=259.22  Aligned_cols=172  Identities=22%  Similarity=0.333  Sum_probs=145.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC----Ce
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE----QG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~----~~  254 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+|++++||||+++++++....    ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46999999999999999999999999999999999763  4455678999999999999999999999886543    45


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .|+||||+. ++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-------~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DF  173 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-------IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDF  173 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEecCC-cCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccC
Confidence            899999996 6999999753       46999999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCC--------------------ccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVP--------------------FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~--------------------~~~~~~~GT~gy~apea  363 (372)
                      |+|+........                    .......||+.|+|||.
T Consensus       174 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~  222 (432)
T 3n9x_A          174 GLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL  222 (432)
T ss_dssp             TTCEEC-------------------------------CCCCCTTCCHHH
T ss_pred             CCcccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence            999987543221                    12355689999999875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.97  E-value=1.3e-30  Score=253.22  Aligned_cols=168  Identities=24%  Similarity=0.344  Sum_probs=146.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.+..   ......+.+|+.+++.++||||+++++++... ...++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEE
Confidence            58999999999999999999999899999999997532   12235788999999999999999999998764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+ +|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        88 ~E~~-~g~l~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~  156 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-------KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSN  156 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTB
T ss_pred             EECC-CCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccce
Confidence            9999 78999998765       46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   ......||+.|+|||.-
T Consensus       157 ~~~~~~---~~~~~~gt~~y~aPE~~  179 (336)
T 3h4j_B          157 IMTDGN---FLKTSCGSPNYAAPEVI  179 (336)
T ss_dssp             TTTTSB---TTCCCTTSTTTSCGGGS
T ss_pred             eccCCc---ccccccCCcCcCCHHHH
Confidence            765443   23456799999998764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.97  E-value=8.5e-31  Score=258.07  Aligned_cols=171  Identities=27%  Similarity=0.331  Sum_probs=139.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHH-HHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMI-ASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~i-L~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|++..+++.||||++++..   ......+.+|..+ ++.++||||+++++++.+ ....|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEE
Confidence            358999999999999999999999999999999997642   2334456777776 577899999999998876 45689


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 lv~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~  185 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE-------RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGL  185 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCB
T ss_pred             EEEeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcc
Confidence            999999999999999875       46889999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......  ...+..||+.|+|||.-
T Consensus       186 a~~~~~~~~--~~~~~~gt~~y~aPE~~  211 (373)
T 2r5t_A          186 CKENIEHNS--TTSTFCGTPEYLAPEVL  211 (373)
T ss_dssp             CGGGBCCCC--CCCSBSCCCCCCCHHHH
T ss_pred             ccccccCCC--ccccccCCccccCHHHh
Confidence            987543322  33567899999998764

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=8.8e-31  Score=249.77  Aligned_cols=174  Identities=25%  Similarity=0.338  Sum_probs=140.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---e
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---G  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---~  254 (372)
                      .++|++.+.||+|+||.||+|++..+++.||||++...   .......+.+|+.++++++||||+++++++.....   .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46899999999999999999999889999999999764   34455678999999999999999999998765332   2


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .|+||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df  160 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDF  160 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCC
T ss_pred             cEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeec
Confidence            48999999999999999865       46899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCCC-ccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........ .......||+.|+|||.-
T Consensus       161 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  191 (311)
T 3ork_A          161 GIARAIADSGNSVTQTAAVIGTAQYLSPEQA  191 (311)
T ss_dssp             SCC------------------CCTTCCHHHH
T ss_pred             cCcccccccccccccccccCcCcccCCHHHh
Confidence            999876543321 123345789999997753

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=1.6e-30  Score=246.79  Aligned_cols=181  Identities=25%  Similarity=0.326  Sum_probs=148.8

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      ...++|.+.+.||+|+||.||+|.+.     .++..||||++... .....+.+.+|++++++++||||+++++++.+..
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG   99 (314)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence            34568999999999999999999873     34589999999764 4455678999999999999999999999987644


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcC
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  315 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrD  315 (372)
                       ..++||||+++++|.+++.......                 .....+++..++.++.||+.||.|||+.+   |+|||
T Consensus       100 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~d  175 (314)
T 2ivs_A          100 -PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRD  175 (314)
T ss_dssp             -SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred             -ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccc
Confidence             4899999999999999998753210                 01134899999999999999999999988   99999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       316 LKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||.
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  223 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIES  223 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHH
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhh
Confidence            999999999999999999999987765443323344567788998774

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=2.8e-30  Score=253.92  Aligned_cols=168  Identities=24%  Similarity=0.291  Sum_probs=141.4

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +...+.||+|+||.||+|.+..+++.||+|+++.......+.+.+|++++++++||||+++++++.+. ...++||||++
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~  169 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVD  169 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCT
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCC
Confidence            44467899999999999999988999999999887767778899999999999999999999998764 45899999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE--cCCCcEEEEecccccccC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL--SSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl--d~~~~~KL~DFGla~~~~  341 (372)
                      +++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||+  +.++.+||+|||+++...
T Consensus       170 ~~~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~  240 (373)
T 2x4f_A          170 GGELFDRIIDES------YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK  240 (373)
T ss_dssp             TCEEHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECC
T ss_pred             CCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecC
Confidence            999999987643      35899999999999999999999988   9999999999999  567899999999999876


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....   .....||++|+|||.-
T Consensus       241 ~~~~---~~~~~gt~~y~aPE~~  260 (373)
T 2x4f_A          241 PREK---LKVNFGTPEFLAPEVV  260 (373)
T ss_dssp             TTCB---CCCCCSSCTTCCHHHH
T ss_pred             Cccc---cccccCCCcEeChhhc
Confidence            4432   2345699999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=3.5e-30  Score=254.92  Aligned_cols=171  Identities=23%  Similarity=0.292  Sum_probs=149.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+|++++||||+++++++.+ ....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEE
Confidence            3589999999999999999999998999999999987766666789999999999999999999999876 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC--CCcEEEEeccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLAT  338 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~--~~~~KL~DFGla~  338 (372)
                      |+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.  .+.+||+|||+++
T Consensus       129 ~~~gg~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          129 FLSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             CCCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccce
Confidence            999999999986532      46899999999999999999999988   999999999999974  4789999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......   .....||+.|+|||.-
T Consensus       200 ~~~~~~~---~~~~~gt~~y~aPE~~  222 (387)
T 1kob_A          200 KLNPDEI---VKVTTATAEFAAPEIV  222 (387)
T ss_dssp             ECCTTSC---EEEECSSGGGCCHHHH
T ss_pred             ecCCCcc---eeeeccCCCccCchhc
Confidence            8764432   2345799999997754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=6.8e-30  Score=238.71  Aligned_cols=169  Identities=29%  Similarity=0.357  Sum_probs=149.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|++.+.||+|+||.||+|.+..++..||+|.+........+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEEe
Confidence            3579999999999999999999999899999999987655556789999999999999999999999876 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEecccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DFGla  337 (372)
                      |+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus        87 ~~~~~~L~~~~~~~-------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~  156 (277)
T 3f3z_A           87 LCTGGELFERVVHK-------RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA  156 (277)
T ss_dssp             CCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             ccCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence            99999999999765       46899999999999999999999988   9999999999999   78899999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.......   .....||+.|+|||.
T Consensus       157 ~~~~~~~~---~~~~~~t~~y~aPE~  179 (277)
T 3f3z_A          157 ARFKPGKM---MRTKVGTPYYVSPQV  179 (277)
T ss_dssp             EECCTTSC---BCCCCSCTTTCCHHH
T ss_pred             eeccCccc---hhccCCCCCccChHH
Confidence            87764432   244579999999775

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=3.1e-30  Score=247.03  Aligned_cols=176  Identities=24%  Similarity=0.366  Sum_probs=134.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||+++... ....+.+.+|+.++++++||||+++++++.+ +...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence            458999999999999999999999899999999997543 2334678899999999999999999998766 45689999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||++ |+|.+++...... .....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        83 e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  157 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVG-NTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA  157 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSS-SCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEE
T ss_pred             EecC-CCHHHHHHhcccc-ccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCcccee
Confidence            9997 6999999765321 11245899999999999999999999987   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...+..  ......||+.|+|||.-
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~  180 (317)
T 2pmi_A          158 FGIPVN--TFSSEVVTLWYRAPDVL  180 (317)
T ss_dssp             TTSCCC--CCCCCCSCCTTCCHHHH
T ss_pred             cCCCcc--cCCCCcccccccCchHh
Confidence            754432  22345789999998753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=5.2e-30  Score=245.07  Aligned_cols=169  Identities=30%  Similarity=0.406  Sum_probs=141.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .++|+..+.||+|+||.||+|++.. ++.||+|++...  .....+.+.+|++++++++||||+++++++.+ +...++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEE
Confidence            4689999999999999999999864 889999999754  23345678899999999999999999999866 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||++ ++|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        98 ~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~  167 (311)
T 3niz_A           98 FEFME-KDLKKVLDENK------TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR  167 (311)
T ss_dssp             EECCS-EEHHHHHHTCT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EcCCC-CCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCce
Confidence            99997 58888887543      45899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....+..  ......||+.|+|||.
T Consensus       168 ~~~~~~~--~~~~~~~t~~y~aPE~  190 (311)
T 3niz_A          168 AFGIPVR--SYTHEVVTLWYRAPDV  190 (311)
T ss_dssp             ETTSCCC-----CCCCCCTTCCHHH
T ss_pred             ecCCCcc--cccCCcccCCcCCHHH
Confidence            8754433  2234578999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.97  E-value=1.6e-30  Score=250.21  Aligned_cols=171  Identities=27%  Similarity=0.395  Sum_probs=137.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeE----EEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~----vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ++|+..+.||+|+||.||+|.+..+++.    ||+|.+... .....+.+.+|+.++++++||||++++++|.+. . .+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~-~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T-VQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S-EE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C-eE
Confidence            5899999999999999999998766654    588877543 334567899999999999999999999998764 3 78


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|+||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        93 ~v~e~~~~g~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~  163 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  163 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST------TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred             EEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcc
Confidence            9999999999999998753      46899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++...............||++|+|||.
T Consensus       164 a~~~~~~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3poz_A          164 AKLLGAEEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             HHHHTTTCC-------CCCGGGSCHHH
T ss_pred             eeEccCCcccccccCCCccccccChHH
Confidence            998766554434445567888998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=1.4e-30  Score=250.40  Aligned_cols=183  Identities=26%  Similarity=0.359  Sum_probs=148.6

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      +....++|...+.||+|+||.||+|++.     .+++.||||+++.. .....+.+.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3345679999999999999999999986     34589999999865 44556789999999999999999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVH  313 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiH  313 (372)
                      . ...++||||+++|+|.+++.......                 .....+++..++.++.||+.||.|||+.+   |+|
T Consensus       122 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          122 G-KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             C-CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            4 44899999999999999998742110                 01146899999999999999999999988   999


Q ss_pred             cCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          314 RDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       314 rDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||.
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  247 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPES  247 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHH
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhh
Confidence            99999999999999999999999987654332223344568888999774

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=7.6e-30  Score=250.91  Aligned_cols=176  Identities=19%  Similarity=0.204  Sum_probs=148.6

Q ss_pred             hhCCeeeceeEccc--CceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRG--ALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G--~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..++|++.+.||+|  +||.||+|++..+++.||||++...  .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~  101 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NEL  101 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEE
Confidence            34689999999999  9999999999989999999999754  345567788999999999999999999998874 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++.....     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg  173 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFM-----DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLR  173 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGG
T ss_pred             EEEEEccCCCCHHHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccc
Confidence            999999999999999987532     45899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCC-----CccccccccCCCccCcccc
Q 017411          336 LATWTSAPSV-----PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~-----~~~~~~~~GT~gy~apeaP  364 (372)
                      ++........     ........||+.|+|||.-
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (389)
T 3gni_B          174 SNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVL  207 (389)
T ss_dssp             GCEECEETTEECSCBCCCCTTCTTTGGGSCHHHH
T ss_pred             cceeeccccccccccccccccccccccccCHHHH
Confidence            9875432211     1112234688888887753

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=2.1e-30  Score=243.31  Aligned_cols=168  Identities=25%  Similarity=0.356  Sum_probs=145.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC-------eEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-------~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .++|...+.||+|+||.||+|.+..++       ..||+|.+........+.+.+|+.++++++||||+++++++.+.+ 
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD-   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT-
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC-
Confidence            358999999999999999999987665       579999998776677788999999999999999999999987654 


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc-----
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----  328 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~-----  328 (372)
                      ..++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~  156 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK------NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGN  156 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG------GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTB
T ss_pred             CCEEEEECCCCCCHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccc
Confidence            4789999999999999998753      34899999999999999999999988   999999999999998887     


Q ss_pred             ---EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 ---PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ---~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                         +||+|||+++.....      ....||+.|+|||.-
T Consensus       157 ~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~  189 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLPK------DILQERIPWVPPECI  189 (289)
T ss_dssp             CCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHH
T ss_pred             cceeeeccCcccccccCc------cccCCcCcccCHHHh
Confidence               999999999765422      335688999997753

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=4.2e-30  Score=251.35  Aligned_cols=170  Identities=25%  Similarity=0.340  Sum_probs=138.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||++++..+++.||||++..... ..+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEE
Confidence            34689999999999999999999999999999999976432 235688999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc--EEEEecccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLCDFGLA  337 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~--~KL~DFGla  337 (372)
                      ||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus        96 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a  165 (361)
T 3uc3_A           96 EYASGGELYERICNA-------GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS  165 (361)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC
T ss_pred             EeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcc
Confidence            999999999999765       46899999999999999999999988   999999999999987765  999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......   .....||+.|+|||.-
T Consensus       166 ~~~~~~~~---~~~~~gt~~y~aPE~~  189 (361)
T 3uc3_A          166 KSSVLHSQ---PKSTVGTPAYIAPEVL  189 (361)
T ss_dssp             ------------------CTTSCHHHH
T ss_pred             ccccccCC---CCCCcCCCCcCChhhh
Confidence            85433322   2345799999997753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.97  E-value=6.1e-30  Score=242.96  Aligned_cols=169  Identities=27%  Similarity=0.396  Sum_probs=141.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|++++++++||||+++++++.+. ...++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEE
Confidence            5899999999999999999999989999999998654  334456788999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        82 e~~~~~~l~~~~~~~-------~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ-------RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             ECCSEEHHHHHHHTS-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeCCCchHHHHHhhh-------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            999999999988654       46899999999999999999999988   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  ......||+.|+|||.
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~  173 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPEL  173 (311)
T ss_dssp             CC--------------GGGCCHHH
T ss_pred             ccCccc--ccCCCcCCccccChHH
Confidence            764433  2234578999999774

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=4.5e-30  Score=264.61  Aligned_cols=175  Identities=25%  Similarity=0.297  Sum_probs=150.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|...+.||+|+||.||+|++..+++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+ ....|+
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l  262 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCL  262 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEE
Confidence            368999999999999999999999899999999997542   2334678899999999999999999998776 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++......   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       263 VmE~~~gg~L~~~l~~~~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDED---NPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTT---SCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEeccCCCHHHHHHHhhcc---cccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeeccee
Confidence            99999999999999764321   146899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......  ......||+.|+|||.-
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l  361 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELL  361 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHH
T ss_pred             eeccCCCc--ccccccCCccccChhhh
Confidence            88754432  23445899999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=3.4e-30  Score=266.88  Aligned_cols=173  Identities=25%  Similarity=0.322  Sum_probs=149.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ..++|...+.||+|+||.||+|++..+++.||||++.+..   ......+.+|+.+|++++||||+++++++.+ ....|
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~  260 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALC  260 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEE
Confidence            3468999999999999999999999999999999997532   2334568899999999999999999998876 45689


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       261 lVmEy~~gg~L~~~l~~~~~-----~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGl  332 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQ-----AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGL  332 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEEEcCCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEeccc
Confidence            99999999999999976432     45899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......   .....||+.|+|||+-
T Consensus       333 a~~~~~~~~---~~~~~GT~~Y~APEvl  357 (576)
T 2acx_A          333 AVHVPEGQT---IKGRVGTVGYMAPEVV  357 (576)
T ss_dssp             CEECCTTCC---EECCCSCGGGCCHHHH
T ss_pred             ceecccCcc---ccccCCCccccCHHHH
Confidence            988754432   2345799999998753

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.97  E-value=6.2e-30  Score=248.32  Aligned_cols=182  Identities=22%  Similarity=0.245  Sum_probs=155.7

Q ss_pred             cccccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-----CCCe
Q 017411          167 NSLIRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----HPNI  241 (372)
Q Consensus       167 ~~~~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----HpnI  241 (372)
                      .....+++.+.....++|.+.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++     ||||
T Consensus        20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i   98 (360)
T 3llt_A           20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI   98 (360)
T ss_dssp             CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred             ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence            3455677777777889999999999999999999999888999999999753 445567788999999997     9999


Q ss_pred             eceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       242 v~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      +++++++... ...++||||+ +++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus        99 v~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  168 (360)
T 3llt_A           99 VKYHGKFMYY-DHMCLIFEPL-GPSLYEIITRNNY-----NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENI  168 (360)
T ss_dssp             CCEEEEEEET-TEEEEEECCC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             ecccceeeEC-CeeEEEEcCC-CCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccE
Confidence            9999998774 4589999999 9999999987532     45899999999999999999999988   99999999999


Q ss_pred             EEcC-------------------------CCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          322 LLSS-------------------------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       322 Lld~-------------------------~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |++.                         ++.+||+|||+++......     ....||+.|+|||.-
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~  231 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVI  231 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHH
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHH
Confidence            9975                         7899999999998765432     345789999997754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.97  E-value=7.3e-30  Score=251.14  Aligned_cols=172  Identities=26%  Similarity=0.375  Sum_probs=137.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCC-CeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPE-QGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~-~~~  255 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++.++. ||||+++++++...+ ..+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            346899999999999999999999999999999998653  4555677889999999997 999999999987543 358


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      |+||||++ ++|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        87 ~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG  154 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRA--------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFG  154 (388)
T ss_dssp             EEEEECCS-EEHHHHHHH--------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEecccC-cCHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCc
Confidence            99999997 699999975        35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCC-------------------CccccccccCCCccCccc
Q 017411          336 LATWTSAPSV-------------------PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~-------------------~~~~~~~~GT~gy~apea  363 (372)
                      +|+.......                   ........||+.|+|||+
T Consensus       155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  201 (388)
T 3oz6_A          155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEI  201 (388)
T ss_dssp             TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHH
T ss_pred             ccccccccccccccccccccccccccccccccccCCcccCCcCCHHH
Confidence            9987643111                   112334579999999775

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.97  E-value=2.3e-30  Score=247.45  Aligned_cols=183  Identities=22%  Similarity=0.337  Sum_probs=132.2

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCe---EEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      +....++|+..+.||+|+||.||+|.+..++.   .||||+++..  .....+.+.+|++++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            33456789999999999999999999876554   8999999764  345567899999999999999999999998764


Q ss_pred             CCe-----EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          252 EQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       252 ~~~-----~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      ...     .++||||+++|+|.+++....... ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGE-NPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED  173 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccc-cccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence            432     389999999999999997653211 1136899999999999999999999988   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.+||+|||+++...............+|+.|+|||.
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES  210 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHH
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchh
Confidence            9999999999987755443223334556778888764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.1e-30  Score=248.70  Aligned_cols=182  Identities=27%  Similarity=0.395  Sum_probs=147.0

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      ....++|...+.||+|+||.||+|.+     ..++..||||++... .....+.+.+|+.++.++ +||||+++++++..
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            34557899999999999999999997     235678999999754 334456789999999999 89999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEc
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVR----------------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHR  314 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~----------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHr  314 (372)
                      .+ ..++||||+++|+|.+++........                ....+++..++.++.||+.||.|||+.+   |+||
T Consensus       121 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          121 SG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             CC-ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            44 48999999999999999986532100                0134899999999999999999999987   9999


Q ss_pred             CCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          315 DIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       315 DLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  245 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES  245 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHH
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHH
Confidence            9999999999999999999999987765444334455678888999774

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.97  E-value=2.2e-30  Score=246.04  Aligned_cols=189  Identities=25%  Similarity=0.348  Sum_probs=155.1

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeece
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPL  244 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l  244 (372)
                      +...++....++|.+.+.||+|+||.||+|.+     ..+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34455566678999999999999999999985     345689999999764 344556799999999999 79999999


Q ss_pred             eeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcC
Q 017411          245 VGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR---------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRD  315 (372)
Q Consensus       245 ~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~---------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrD  315 (372)
                      ++++...+...++||||+++|+|.+++........         ....+++..++.++.|++.||.|||+.+   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99988766668999999999999999986532100         0123889999999999999999999987   99999


Q ss_pred             CCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          316 IKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       316 LKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+||+++.++.+||+|||+++...............||+.|+|||.
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~  221 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPET  221 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHH
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchh
Confidence            999999999999999999999987765444334445678889999774

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=3.8e-30  Score=242.51  Aligned_cols=168  Identities=24%  Similarity=0.346  Sum_probs=139.8

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|++ .+++.||||++....  ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEE
Confidence            5799999999999999999998 568899999997543  22346788999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++ +|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        80 e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  149 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCE------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (288)
T ss_dssp             ECCSE-EHHHHHHTST------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EecCC-CHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccc
Confidence            99975 9999987643      46899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ...+..  ......||+.|+|||.
T Consensus       150 ~~~~~~--~~~~~~~t~~y~aPE~  171 (288)
T 1ob3_A          150 FGIPVR--KYTHEIVTLWYRAPDV  171 (288)
T ss_dssp             HCC-----------CCCTTCCHHH
T ss_pred             cCcccc--ccccccccccccCchh
Confidence            754332  2234568999999775

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=2.8e-30  Score=253.88  Aligned_cols=173  Identities=27%  Similarity=0.387  Sum_probs=134.0

Q ss_pred             CCeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|++.+.||+|+||.||+|++.   ..+..||||+++.. .....+.|.+|+.++++++||||+++++++.+.. ..++
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l  123 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK-PVMI  123 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SCEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC-ceEE
Confidence            57899999999999999999876   45678999999764 4455678999999999999999999999987644 4899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       124 v~e~~~~~sL~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  194 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD------AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLG  194 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccc
Confidence            999999999999997642      46899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCC-ccccccccCCCccCcccc
Q 017411          338 TWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      +........ .......+|+.|+|||.-
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  222 (373)
T 2qol_A          195 RVLEDDPEAAYTTRGGKIPIRWTSPEAI  222 (373)
T ss_dssp             -------------------CTTSCHHHH
T ss_pred             cccccCCccceeccCCCcCCCccChhhh
Confidence            877544321 112223456788887753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=4.4e-30  Score=260.89  Aligned_cols=169  Identities=29%  Similarity=0.424  Sum_probs=148.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++.+..   ......+.+|+.+++.++||||+++++++... ...++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence            58999999999999999999999899999999997542   22356789999999999999999999998764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        95 ~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~  164 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-------GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSN  164 (476)
T ss_dssp             EECCSSEEHHHHTTSS-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EeCCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchh
Confidence            9999999999998653       46899999999999999999999887   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......   ...+..||+.|+|||.-
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~  187 (476)
T 2y94_A          165 MMSDGE---FLRTSCGSPNYAAPEVI  187 (476)
T ss_dssp             ECCTTC---CBCCCCSCSTTCCHHHH
T ss_pred             hccccc---cccccCCCcCeEChhhc
Confidence            876443   23456799999997754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=6.6e-30  Score=257.19  Aligned_cols=170  Identities=26%  Similarity=0.439  Sum_probs=144.9

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ....++|+..+.||+|+||.||+|.+.  ++.||||+++...  ..+.|.+|+.+|++++||||+++++++.+.....++
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            345578999999999999999999986  6799999997653  456799999999999999999999998876656899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       265 v~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a  336 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLT  336 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCT-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCcHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCc
Confidence            9999999999999987532     35799999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +......     ....+++.|+|||+-
T Consensus       337 ~~~~~~~-----~~~~~~~~y~aPE~~  358 (450)
T 1k9a_A          337 KEASSTQ-----DTGKLPVKWTAPEAL  358 (450)
T ss_dssp             EECC-----------CCCTTTSCHHHH
T ss_pred             ccccccc-----cCCCCCcceeCHHHh
Confidence            8654322     223578889997754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.97  E-value=2.1e-29  Score=237.65  Aligned_cols=171  Identities=25%  Similarity=0.299  Sum_probs=148.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEE
Confidence            35899999999999999999999988999999998754   34556788999999999999999999999876 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        93 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  162 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA  162 (294)
T ss_dssp             EEECCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCc
Confidence            99999999999998765       46899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......  ......||+.|+|||.-
T Consensus       163 ~~~~~~~~--~~~~~~~~~~y~aPE~~  187 (294)
T 2rku_A          163 TKVEYDGE--RKKVLCGTPNYIAPEVL  187 (294)
T ss_dssp             EECCSTTC--CBCCCCSCCSSCCHHHH
T ss_pred             eecccCcc--ccccccCCCCcCCcchh
Confidence            87654332  22445789999997753

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.97  E-value=2.2e-29  Score=235.77  Aligned_cols=170  Identities=30%  Similarity=0.391  Sum_probs=147.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEEE
Confidence            47899999999999999999999989999999998654  34556778999999999999999999999876 4458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc---EEEEecc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFG  335 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~---~KL~DFG  335 (372)
                      |||+++++|.+.+...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||
T Consensus        84 ~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR-------EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             ECCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            9999999999998765       46899999999999999999999988   999999999999986655   9999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++........   .....||+.|+|||.-
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~  179 (284)
T 3kk8_A          154 LAIEVNDSEA---WHGFAGTPGYLSPEVL  179 (284)
T ss_dssp             TCEECCSSCB---CCCSCSCGGGCCHHHH
T ss_pred             eeEEcccCcc---ccCCCCCcCCcCchhh
Confidence            9987754432   2345789999997753

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.97  E-value=1.2e-29  Score=243.32  Aligned_cols=174  Identities=25%  Similarity=0.328  Sum_probs=149.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEE----CCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      .++|+..+.||+|+||.||+|++    ..+++.||||++........+.+.+|++++++++||||+++++++... ....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            35899999999999999999994    567899999999887777778899999999999999999999988743 4458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  172 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHR------ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFG  172 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGG
T ss_pred             EEEEeecCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccc
Confidence            89999999999999998753      35899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +++......... ......||+.|+|||.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (327)
T 3lxl_A          173 LAKLLPLDKDYYVVREPGQSPIFWYAPES  201 (327)
T ss_dssp             GCEECCTTCSEEECSSCCCSCGGGSCHHH
T ss_pred             cceecccCCccceeeccCCccccccCHHH
Confidence            999876443321 2233467888998774

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.97  E-value=8.7e-30  Score=236.86  Aligned_cols=171  Identities=22%  Similarity=0.335  Sum_probs=144.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|+.++.+++||||+++++++.+. ...++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   82 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-YPIYIVT   82 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CceEEEE
Confidence            44689999999999999999998874 67899999976432 346789999999999999999999998664 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        83 e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  153 (268)
T 3sxs_A           83 EYISNGCLLNYLRSHG------KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRY  153 (268)
T ss_dssp             ECCTTCBHHHHHHHHG------GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred             EccCCCcHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCcccee
Confidence            9999999999998753      35899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....... ......||+.|+|||.
T Consensus       154 ~~~~~~~-~~~~~~~~~~y~aPE~  176 (268)
T 3sxs_A          154 VLDDQYV-SSVGTKFPVKWSAPEV  176 (268)
T ss_dssp             CCTTCEE-ECCSCCCCGGGCCHHH
T ss_pred             cchhhhh-cccCCCcCcccCCHHH
Confidence            7554321 2233445667888665

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.97  E-value=2.1e-30  Score=248.93  Aligned_cols=173  Identities=27%  Similarity=0.394  Sum_probs=142.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeE----EEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~----vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .++|+..+.||+|+||.||+|.+..+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.+  ...
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   89 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG--SSL   89 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB--SSE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--Ccc
Confidence            35899999999999999999998776665    778877543 22333567889999999999999999998753  348


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg  160 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR------GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFG  160 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG------GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCS
T ss_pred             EEEEEeCCCCCHHHHHHHcc------ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCC
Confidence            99999999999999997643      35888999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++...............||++|+|||.-
T Consensus       161 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (325)
T 3kex_A          161 VADLLPPDDKQLLYSEAKTPIKWMALESI  189 (325)
T ss_dssp             GGGGSCCCTTCCC-----CCTTTSCHHHH
T ss_pred             cccccCcccccccccCCCCcccccChHHh
Confidence            99988665544444556788899997753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.97  E-value=8.1e-30  Score=240.43  Aligned_cols=168  Identities=26%  Similarity=0.340  Sum_probs=139.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeeEEcC---CCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDP---EQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~~---~~~~  255 (372)
                      .++|+..+.||+|+||.||+|++  +++.||||++...   ....+.+|.+++..  ++||||+++++++...   ....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46899999999999999999988  4789999999654   33556677777776  7999999999987542   3347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceEEcCCCCCCEEEcCCC
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--------NGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      ++||||+++|+|.+++..        ..+++..++.++.|++.||.|||        ..+   |+||||||+|||++.++
T Consensus        82 ~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~  150 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL--------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNG  150 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTS
T ss_pred             EEehhhccCCCHHHHHhh--------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCC
Confidence            899999999999999954        46899999999999999999999        655   99999999999999999


Q ss_pred             cEEEEecccccccCCCCCCc--cccccccCCCccCcccc
Q 017411          328 IPKLCDFGLATWTSAPSVPF--LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~--~~~~~~GT~gy~apeaP  364 (372)
                      .+||+|||+++.........  ......||+.|+|||.-
T Consensus       151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  189 (301)
T 3q4u_A          151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL  189 (301)
T ss_dssp             CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHH
T ss_pred             CEEEeeCCCeeecccccccccccccccccccceeChhhh
Confidence            99999999998765443321  12334799999997754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.1e-29  Score=249.83  Aligned_cols=180  Identities=23%  Similarity=0.311  Sum_probs=149.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC-------CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      ..++|.+.+.||+|+||.||+|++..       .+..||||++... .....+.+.+|+++++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            44689999999999999999998743       2357999999764 445567899999999999 89999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      .+ ..++||||+++|+|.+++.......         .....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       147 ~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          147 DG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             CC-ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            44 4899999999999999998754210         11246899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |++.++.+||+|||+++...............||+.|+|||.
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  264 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEA  264 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHH
Confidence            999999999999999987765443333445567888999774

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=7.1e-30  Score=239.08  Aligned_cols=170  Identities=31%  Similarity=0.458  Sum_probs=143.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      +.++|++.+.||+|+||.||+|.+..+++.||||++....   ......+.+|+.++++++||||+++++++.+. ...+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEE
Confidence            3468999999999999999999999999999999986532   22346788999999999999999999998764 4589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++++|.+++...       ..+++..++.++.|++.||.|||..+   |+||||||+|||++.++.+||+|||+
T Consensus        86 lv~e~~~~~~l~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~  155 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGW  155 (279)
T ss_dssp             EEECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCE
T ss_pred             EEEecCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccc
Confidence            999999999999999875       45899999999999999999999877   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......    .....||+.|+|||.-
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~  179 (279)
T 3fdn_A          156 SVHAPSSR----RTDLCGTLDYLPPEMI  179 (279)
T ss_dssp             ESCC------------CCCCTTCCHHHH
T ss_pred             cccCCccc----ccccCCCCCccCHhHh
Confidence            86654332    2345789999997753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.96  E-value=7.5e-30  Score=245.33  Aligned_cols=171  Identities=22%  Similarity=0.240  Sum_probs=145.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||||++.....  .+.+.+|+.+++++ +||||+++++++.. ....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEE
Confidence            4689999999999999999999988999999999875432  23588999999999 99999999998877 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc-----EEEEec
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----PKLCDF  334 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~-----~KL~DF  334 (372)
                      ||+ +++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DF  154 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD------RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDF  154 (330)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred             EeC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence            999 999999998642      46999999999999999999999987   999999999999998887     999999


Q ss_pred             ccccccCCCCCCc-----cccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPF-----LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~-----~~~~~~GT~gy~apeaP  364 (372)
                      |+++.........     ......||+.|+|||.-
T Consensus       155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  189 (330)
T 2izr_A          155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTH  189 (330)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             ccceeeecCCCCccccccccCCcCCCccccChHHH
Confidence            9999765443211     12456799999997753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=4.6e-30  Score=243.44  Aligned_cols=181  Identities=27%  Similarity=0.354  Sum_probs=150.0

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEE-----CCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKV-----GLLRTSVAIKRLDKED-KESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~-----~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      ...++|...+.||+|+||.||+|.+     ..+++.||||+++... ....+.+.+|+.+++++ +||||+++++++.+.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3456899999999999999999985     3457899999997653 34567899999999999 899999999998765


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCC
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGV-----------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~N  320 (372)
                      + ..++||||+++|+|.+++.......           .....+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       100 ~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~N  175 (313)
T 1t46_A          100 G-PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (313)
T ss_dssp             S-SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             C-CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccce
Confidence            4 4799999999999999998753210           01135899999999999999999999987   9999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       321 ILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||++.++.+||+|||+++...............||+.|+|||.
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  218 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPES  218 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHH
Confidence            9999999999999999988765544333445567888999774

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=2.3e-30  Score=263.77  Aligned_cols=179  Identities=21%  Similarity=0.351  Sum_probs=150.4

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++.....+|+..+.||+|+||.||+|.+..++..||||.++... ...+.|.+|+.+|++++||||++++++|.+.. .
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~-~  290 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-P  290 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC-c
Confidence            344455678999999999999999999999889999999997643 34578999999999999999999999987644 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       291 ~~lv~E~~~~g~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DF  362 (495)
T 1opk_A          291 FYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADF  362 (495)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             EEEEEEccCCCCHHHHHHhcCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeec
Confidence            8999999999999999986432     46899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........ ......+++.|+|||+-
T Consensus       363 G~a~~~~~~~~~-~~~~~~~~~~y~aPE~~  391 (495)
T 1opk_A          363 GLSRLMTGDTYT-AHAGAKFPIKWTAPESL  391 (495)
T ss_dssp             TCEECCTTCCEE-CCTTCCCCGGGCCHHHH
T ss_pred             ccceeccCCcee-ecCCCcCCcceeCHhHH
Confidence            999877543221 12233456778887653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.96  E-value=6.8e-30  Score=269.72  Aligned_cols=173  Identities=23%  Similarity=0.262  Sum_probs=148.7

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..++|++.+.||+|+||.||+|++..+++.||||++++.   .....+.+.+|..++..+ +||+|+++++++.+ ...+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~  417 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRL  417 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEE
Confidence            456899999999999999999999999999999999753   223345678899999988 79999999998755 5568


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ||||||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   ||||||||+||||+.++.+||+|||
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFG  487 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-------GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFG  487 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCT
T ss_pred             EEEEeCcCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecc
Confidence            9999999999999999875       46899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +|+.......  ...+..||+.|+|||+-.
T Consensus       488 la~~~~~~~~--~~~~~~GT~~Y~APE~l~  515 (674)
T 3pfq_A          488 MCKENIWDGV--TTKTFCGTPDYIAPEIIA  515 (674)
T ss_dssp             TCEECCCTTC--CBCCCCSCSSSCCHHHHT
T ss_pred             eeeccccCCc--ccccccCCCcccCHhhhc
Confidence            9986543332  345678999999987643

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=4.1e-30  Score=239.44  Aligned_cols=171  Identities=22%  Similarity=0.398  Sum_probs=144.0

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|.+.. +..||+|++..... ..+.+.+|++++++++||||+++++++.+.. ..++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~   84 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVF   84 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ceEEEE
Confidence            34689999999999999999999874 67899999976432 3467899999999999999999999987644 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        85 e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  155 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF  155 (269)
T ss_dssp             ECCTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             EeCCCCcHHHHHHhcC------cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccc
Confidence            9999999999997643      46899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....... ......||+.|+|||.
T Consensus       156 ~~~~~~~-~~~~~~~~~~y~aPE~  178 (269)
T 4hcu_A          156 VLDDQYT-SSTGTKFPVKWASPEV  178 (269)
T ss_dssp             BCCHHHH-STTSTTCCGGGCCHHH
T ss_pred             ccccccc-cccCcccccccCCHHH
Confidence            6543211 1233456777888765

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.96  E-value=5.3e-30  Score=249.42  Aligned_cols=169  Identities=34%  Similarity=0.424  Sum_probs=130.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..+.|.+.+.||+|+||.||+|++..+++.||||+++...  ..+.+.+|++++++++||||+++++++.+. ...++||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~  127 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVL  127 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-SEEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEE
Confidence            4468999999999999999999999889999999997643  345688999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL~DFGl  336 (372)
                      ||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       128 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          128 ELVTGGELFDRIVEK-------GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             CCCCSCBHHHHHTTC-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             EeCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            999999999999754       46899999999999999999999987   999999999999975   88999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++......   ......||+.|+|||.-
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~  222 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEIL  222 (349)
T ss_dssp             ------------------CGGGSCHHHH
T ss_pred             ccccCccc---ccccccCCCCccCHHHh
Confidence            98765432   22456799999997754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=2.5e-30  Score=242.68  Aligned_cols=178  Identities=22%  Similarity=0.358  Sum_probs=151.8

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ++....++|+..+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   84 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPF   84 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCE
Confidence            34456679999999999999999999999889999999997643 3457899999999999999999999998764 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg  156 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFG  156 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCT-----TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCC
T ss_pred             EEEEEcCCCCcHHHHHHhccc-----CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCc
Confidence            999999999999999986432     56899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++........ ......||+.|+|||.-
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~  184 (288)
T 3kfa_A          157 LSRLMTGDTYT-AHAGAKFPIKWTAPESL  184 (288)
T ss_dssp             GGGTSCSSSSE-EETTEEECGGGCCHHHH
T ss_pred             cceeccCCccc-cccCCccccCcCChhhh
Confidence            99877644321 23345677889887753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=2.6e-30  Score=248.14  Aligned_cols=184  Identities=27%  Similarity=0.341  Sum_probs=151.3

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCC-----eEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeE
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFC  248 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~  248 (372)
                      ++....++|...+.||+|+||.||+|.+..++     ..||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34556689999999999999999999986554     37999999764 345567899999999999 899999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVR-------GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~-------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      .+.+ ..++||||+++|+|.+++........       ....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       120 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI  195 (333)
T 2i1m_A          120 THGG-PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV  195 (333)
T ss_dssp             CSSS-SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred             ecCC-ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence            7644 48999999999999999986531100       0146899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |++.++.+||+|||+++...............||+.|+|||.
T Consensus       196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  237 (333)
T 2i1m_A          196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPES  237 (333)
T ss_dssp             EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHH
T ss_pred             EECCCCeEEECccccccccccccceeecCCCCCCccccCHHH
Confidence            999999999999999987654443333445567888999774

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.96  E-value=2.4e-29  Score=242.75  Aligned_cols=171  Identities=25%  Similarity=0.299  Sum_probs=149.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence            35899999999999999999999999999999998754   34556788999999999999999999999876 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       119 v~e~~~~~~L~~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  188 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR-------KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLA  188 (335)
T ss_dssp             EECCCTTCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCc
Confidence            99999999999998765       46899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.......  ......||+.|+|||.-
T Consensus       189 ~~~~~~~~--~~~~~~gt~~y~aPE~~  213 (335)
T 2owb_A          189 TKVEYDGE--RKKVLCGTPNYIAPEVL  213 (335)
T ss_dssp             EECCSTTC--CBCCCCSCCSSCCHHHH
T ss_pred             eecccCcc--cccccCCCccccCHHHh
Confidence            87754332  22445789999997753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=1.1e-29  Score=256.85  Aligned_cols=168  Identities=24%  Similarity=0.349  Sum_probs=138.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----C
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~  253 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.+.  .....+.+.+|+.+|+.++||||+++++++....     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999999999999999999764  4555678899999999999999999999986533     3


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..|+||||+++ +|.+.+.         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       141 ~~~lv~E~~~~-~l~~~~~---------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~D  207 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  207 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECC
T ss_pred             eEEEEEeCCCC-CHHHHHh---------hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEE
Confidence            47999999975 5766663         34899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|+......   ......||+.|+|||.-
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~  235 (464)
T 3ttj_A          208 FGLARTAGTSF---MMTPYVVTRYYRAPEVI  235 (464)
T ss_dssp             CCCC-----CC---CC----CCCTTCCHHHH
T ss_pred             EEeeeecCCCc---ccCCCcccccccCHHHH
Confidence            99998775432   23456899999997754

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.96  E-value=1.5e-29  Score=239.05  Aligned_cols=173  Identities=25%  Similarity=0.324  Sum_probs=144.4

Q ss_pred             CCeeeceeEcccCceEEEEEE----ECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGK----VGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~----~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~  255 (372)
                      +.|+..+.||+|+||.||+|+    ...+++.||||++... .....+.+.+|+.++++++||||+++++++.+.. ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            468999999999999999998    4567899999999754 3334577899999999999999999999987642 447


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg  171 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK------NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG  171 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred             EEEEEeCCCCcHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence            89999999999999997653      46899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccCCCccCccc
Q 017411          336 LATWTSAPSVP-FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~-~~~~~~~GT~gy~apea  363 (372)
                      +++........ .......||..|+|||.
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  200 (302)
T 4e5w_A          172 LTKAIETDKEYYTVKDDRDSPVFWYAPEC  200 (302)
T ss_dssp             TCEECCTTCCEEECCCCTTCCGGGCCHHH
T ss_pred             ccccccCCCcceeccCCCCCCccccCCee
Confidence            99887654332 12334567888998774

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.96  E-value=8.7e-30  Score=238.10  Aligned_cols=172  Identities=27%  Similarity=0.394  Sum_probs=135.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEE
Confidence            358999999999999999999998889999999996532   2234678999999999999999999999876 455899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~  159 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRV------KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLA  159 (278)
T ss_dssp             EEECCTTEEHHHHHHTCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecce
Confidence            999999999999997642      46899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +....+..  ......||+.|+|||.-
T Consensus       160 ~~~~~~~~--~~~~~~~~~~y~aPE~~  184 (278)
T 3cok_A          160 TQLKMPHE--KHYTLCGTPNYISPEIA  184 (278)
T ss_dssp             EECC-----------------------
T ss_pred             eeccCCCC--cceeccCCCCcCCcchh
Confidence            87754432  22345789999998754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.96  E-value=1.6e-29  Score=235.83  Aligned_cols=171  Identities=26%  Similarity=0.336  Sum_probs=145.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...  .......+.+|+..+.++ +||||+++++++.+. ...++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~l   88 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLI   88 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEE
Confidence            35899999999999999999999988999999999764  334556788999999999 999999999998764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-----------
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-----------  326 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-----------  326 (372)
                      ||||+++++|.+++......   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+           
T Consensus        89 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~  162 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRI---MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGD  162 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-------------
T ss_pred             EEEecCCCcHHHHHHhhccc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccc
Confidence            99999999999999865321   146899999999999999999999988   9999999999999844           


Q ss_pred             --------CcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          327 --------KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       327 --------~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                              ..+||+|||+++......      ...||+.|+|||.-
T Consensus       163 ~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~  202 (289)
T 1x8b_A          163 EDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVL  202 (289)
T ss_dssp             -------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHH
T ss_pred             cccccCCceEEEEcccccccccCCcc------ccCCCccccChhHh
Confidence                    479999999998876443      23589999997753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.96  E-value=8.9e-30  Score=251.75  Aligned_cols=174  Identities=27%  Similarity=0.312  Sum_probs=148.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-eEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-GLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-~~~lV  258 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++.+... ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357999999999999999999999999999999997542 3345678899999999999999999999876543 57999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE----cCCCcEEEEec
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLCDF  334 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl----d~~~~~KL~DF  334 (372)
                      |||+++|+|.+++......    ..+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+||
T Consensus        88 ~e~~~~g~L~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DF  160 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNA----YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDF  160 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCG
T ss_pred             EecCCCCCHHHHHHhhhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecC
Confidence            9999999999999765321    34899999999999999999999988   9999999999999    77788999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++.......   .....||+.|+|||.-
T Consensus       161 G~a~~~~~~~~---~~~~~gt~~y~aPE~~  187 (396)
T 4eut_A          161 GAARELEDDEQ---FVSLYGTEEYLHPDMY  187 (396)
T ss_dssp             GGCEECCCGGG---SSCSSSCCTTCCHHHH
T ss_pred             CCceEccCCCc---cccccCCccccCHHHh
Confidence            99987754432   2346799999997753

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.96  E-value=2.7e-31  Score=256.03  Aligned_cols=164  Identities=18%  Similarity=0.218  Sum_probs=133.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHHhCC---------CCCeec
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLH---------HPNIVP  243 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~---------HpnIv~  243 (372)
                      .++|++.+.||+|+||.||+|++  +++.||||++....        ....+.+.+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35788899999999999999998  47999999997642        223467889999998886         666666


Q ss_pred             eeeeEE-----------------c------------CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 017411          244 LVGFCI-----------------D------------PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL  294 (372)
Q Consensus       244 l~g~~~-----------------~------------~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~  294 (372)
                      +.+.+.                 +            .....|+||||+++|++.+.+.+        ..+++..++.++.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--------~~~~~~~~~~i~~  168 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--------KLSSLATAKSILH  168 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--------TCCCHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--------cCCCHHHHHHHHH
Confidence            665432                 2            14568999999999976666533        3589999999999


Q ss_pred             HHHHHHHHHH-cCCCCceEEcCCCCCCEEEcCCC--------------------cEEEEecccccccCCCCCCccccccc
Q 017411          295 GIAESVAYLH-NGTERCVVHRDIKPSNILLSSKK--------------------IPKLCDFGLATWTSAPSVPFLCKTVK  353 (372)
Q Consensus       295 qia~gL~yLH-~~~~~~IiHrDLKp~NILld~~~--------------------~~KL~DFGla~~~~~~~~~~~~~~~~  353 (372)
                      ||+.||.||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....       ...
T Consensus       169 qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          169 QLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            9999999999 888   99999999999999887                    8999999999877532       347


Q ss_pred             cCCCccCcccc
Q 017411          354 GTFGQNPFCIE  364 (372)
Q Consensus       354 GT~gy~apeaP  364 (372)
                      ||+.|+|||.-
T Consensus       239 gt~~y~aPE~~  249 (336)
T 2vuw_A          239 FCDVSMDEDLF  249 (336)
T ss_dssp             CCCCTTCSGGG
T ss_pred             EeecccChhhh
Confidence            99999997753

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.96  E-value=1.1e-29  Score=241.76  Aligned_cols=172  Identities=24%  Similarity=0.331  Sum_probs=141.1

Q ss_pred             CCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +.|.+. +.||+|+||.||+|.+..+++.||||++........+.+.+|++++.++ +||||+++++++.+. ...++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEE
Confidence            578874 7899999999999999888999999999876655667899999999985 799999999998774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc---EEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~---~KL~DFGl  336 (372)
                      ||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.   +||+|||+
T Consensus        91 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~  160 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-------RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDL  160 (316)
T ss_dssp             ECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred             EcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence            999999999999875       46899999999999999999999987   999999999999998775   99999999


Q ss_pred             ccccCCCCC-----CccccccccCCCccCcccc
Q 017411          337 ATWTSAPSV-----PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~-----~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......     ........||+.|+|||.-
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  193 (316)
T 2ac3_A          161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV  193 (316)
T ss_dssp             CC-------------------CCSGGGCCHHHH
T ss_pred             ccccccCCccccccccccccccCCcCccChHHh
Confidence            987642211     1112345689999997753

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.96  E-value=3.9e-29  Score=235.35  Aligned_cols=171  Identities=26%  Similarity=0.320  Sum_probs=146.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC---CCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~~~~  256 (372)
                      ..|...+.||+|+||.||+|.+..++..||+|.+...  .....+.+.+|+.++++++||||+++++++...   ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            4588889999999999999999999999999998753  455567899999999999999999999987642   34579


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-CCCcEEEEecc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFG  335 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-~~~~~KL~DFG  335 (372)
                      +||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+ ++|+||||||+|||++ .++.+||+|||
T Consensus       106 lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             EEEEecCCCCHHHHHHHc-------cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence            999999999999999875       46899999999999999999999765 3499999999999998 78999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++......    .....||+.|+|||.-
T Consensus       178 ~~~~~~~~~----~~~~~~t~~y~aPE~~  202 (290)
T 1t4h_A          178 LATLKRASF----AKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             GGGGCCTTS----BEESCSSCCCCCGGGG
T ss_pred             Ccccccccc----cccccCCcCcCCHHHH
Confidence            997655432    2445799999997753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=240.79  Aligned_cols=173  Identities=27%  Similarity=0.358  Sum_probs=142.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-----hhhHHHHHHHHHHHHhC---CCCCeeceeeeEEcC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-----KESSKAFCRELMIASSL---HHPNIVPLVGFCIDP  251 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~~  251 (372)
                      ..++|++.+.||+|+||.||+|++..+++.||||++....     ......+.+|+.+++++   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3579999999999999999999998889999999986422     11234566777777766   499999999998765


Q ss_pred             CC----eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC
Q 017411          252 EQ----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK  327 (372)
Q Consensus       252 ~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~  327 (372)
                      ..    ..++||||+. ++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~  157 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP-----PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGG  157 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCC
Confidence            43    4789999996 699999976532     34899999999999999999999988   99999999999999999


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .+||+|||+++.......   .....||+.|+|||.-
T Consensus       158 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~  191 (308)
T 3g33_A          158 TVKLADFGLARIYSYQMA---LTPVVVTLWYRAPEVL  191 (308)
T ss_dssp             CEEECSCSCTTTSTTCCC---SGGGGCCCSSCCHHHH
T ss_pred             CEEEeeCccccccCCCcc---cCCccccccccCchHH
Confidence            999999999987754432   3456799999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=1.4e-29  Score=238.98  Aligned_cols=174  Identities=24%  Similarity=0.338  Sum_probs=143.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..|+..+.||+|+||.||+|.+...   ...||+|.+... .....+.+.+|+.++++++||||+++++++.+.+...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4788999999999999999987532   346899998764 445567899999999999999999999998776767899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       105 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a  175 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLA  175 (298)
T ss_dssp             EEECCTTCBHHHHHHCTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGG
T ss_pred             EEeCCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccc
Confidence            999999999999997542      46899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCC--ccccccccCCCccCcccc
Q 017411          338 TWTSAPSVP--FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~--~~~~~~~GT~gy~apeaP  364 (372)
                      +........  .......||+.|+|||.-
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  204 (298)
T 3f66_A          176 RDMYDKEYYSVHNKTGAKLPVKWMALESL  204 (298)
T ss_dssp             CCCSCGGGCBC-----CCBCGGGSCHHHH
T ss_pred             ccccccchhccccccCCCCCccccChHHh
Confidence            876543221  122334577788887643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.96  E-value=1.6e-29  Score=246.26  Aligned_cols=165  Identities=28%  Similarity=0.383  Sum_probs=143.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      +.|+..+.||+|+||.||+|++..+++.||||++...   .....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEE
Confidence            4699999999999999999999888999999999754   234456789999999999999999999998774 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+. |+|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       133 ~e~~~-g~l~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHK------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             EECCS-EEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             EecCC-CCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            99997 68888886543      46899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .....      ....||+.|+|||.
T Consensus       203 ~~~~~------~~~~gt~~y~aPE~  221 (348)
T 1u5q_A          203 IMAPA------NSFVGTPYWMAPEV  221 (348)
T ss_dssp             SSSSB------CCCCSCGGGCCHHH
T ss_pred             ecCCC------CcccCCcceeCHhh
Confidence            76532      23578999999875

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=3e-30  Score=248.58  Aligned_cols=185  Identities=26%  Similarity=0.298  Sum_probs=145.4

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----DKESSKAFCRELMIASSLHHPNIVPLVGFCID  250 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~  250 (372)
                      ++....++|++.+.||+|+||.||+|.+..+++.||+|++.+.     .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3455667999999999999999999999999999999998653     33456789999999999999999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC---------------------------------CCCCCCCHHHHHHHHHHHH
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV---------------------------------RGNSTLPWSVRYKVALGIA  297 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------------------------------~~~~~l~~~~~~~i~~qia  297 (372)
                       ....++||||+++|+|.+++.......                                 .....+++..++.++.||+
T Consensus       100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A          100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence             455899999999999999985321100                                 0011235677888999999


Q ss_pred             HHHHHHHcCCCCceEEcCCCCCCEEEcCCC--cEEEEecccccccCCCCC--CccccccccCCCccCcccc
Q 017411          298 ESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLATWTSAPSV--PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       298 ~gL~yLH~~~~~~IiHrDLKp~NILld~~~--~~KL~DFGla~~~~~~~~--~~~~~~~~GT~gy~apeaP  364 (372)
                      .||.|||+.+   |+||||||+|||++.++  .+||+|||+++.+.....  ........||+.|+|||.-
T Consensus       179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  246 (345)
T 3hko_A          179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVL  246 (345)
T ss_dssp             HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHH
T ss_pred             HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhh
Confidence            9999999987   99999999999998776  899999999987643221  1123456799999997753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.96  E-value=9.5e-30  Score=239.69  Aligned_cols=172  Identities=25%  Similarity=0.341  Sum_probs=142.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|...+.||+|+||.||++....++..||+|++.... ....+.+.+|++++++++||||+++++++.+ ....++|||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e  100 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVME  100 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEEE
Confidence            58999999999999999999999889999999987642 3345788999999999999999999999876 455899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEecccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DFGla  337 (372)
                      |+++|+|.+++......   ...+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++
T Consensus       101 ~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A          101 TCEGGELLERIVSAQAR---GKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             CCSCCBHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             eCCCCcHHHHHHhhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            99999999999754211   156899999999999999999999987   9999999999999   45678999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.......   .....||+.|+|||.
T Consensus       175 ~~~~~~~~---~~~~~~t~~y~aPE~  197 (285)
T 3is5_A          175 ELFKSDEH---STNAAGTALYMAPEV  197 (285)
T ss_dssp             CC-------------CTTGGGCCHHH
T ss_pred             eecCCccc---CcCcccccCcCChHH
Confidence            87654432   245578999999775

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.96  E-value=6.9e-30  Score=254.80  Aligned_cols=169  Identities=26%  Similarity=0.352  Sum_probs=136.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      ..++|...+.||+|+||.||+|.+..+++.||||++.+..        ......+.+|+.+|++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4579999999999999999999999999999999987531        1222357899999999999999999998753 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---Cc
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KI  328 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~  328 (372)
                      + ..++||||+++|+|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.+   +.
T Consensus       212 ~-~~~lv~e~~~~g~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          212 E-DYYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             S-EEEEEEECCTTCBGGGGTSSS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCC
T ss_pred             C-ceEEEEEcCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcce
Confidence            3 479999999999999888643       56899999999999999999999987   9999999999999754   45


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+++......   ......||++|+|||.
T Consensus       281 ~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  312 (419)
T 3i6u_A          281 IKITDFGHSKILGETS---LMRTLCGTPTYLAPEV  312 (419)
T ss_dssp             EEECCSSTTTSCC--------------CTTCCTTT
T ss_pred             EEEeecccceecCCCc---cccccCCCCCccCcee
Confidence            9999999998875433   2345679999999886

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=1.5e-29  Score=243.61  Aligned_cols=161  Identities=25%  Similarity=0.323  Sum_probs=125.7

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEeccCCCC
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGS  266 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~Ey~~~gs  266 (372)
                      +.||+|+||.||+|.+..+++.||||++.+.   ....+.+|+.+++.+. ||||+++++++.+ +...++||||+++|+
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGGE   92 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSCB
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCCc
Confidence            7899999999999999989999999999753   3456789999999997 9999999999876 455899999999999


Q ss_pred             HHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC---cEEEEecccccccCCC
Q 017411          267 LERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAP  343 (372)
Q Consensus       267 L~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~---~~KL~DFGla~~~~~~  343 (372)
                      |.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++   .+||+|||+++.....
T Consensus        93 L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           93 LFERIKKK-------KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             HHHHHHHC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             HHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999864       46899999999999999999999988   99999999999998765   8999999999876544


Q ss_pred             CCCccccccccCCCccCcccc
Q 017411          344 SVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..  ......||+.|+|||.-
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~  181 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELL  181 (325)
T ss_dssp             ---------------------
T ss_pred             CC--cccccCCCcCccCHHHh
Confidence            33  23456789999998764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=5.7e-30  Score=239.94  Aligned_cols=175  Identities=23%  Similarity=0.362  Sum_probs=143.1

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .+....++|+..+.||+|+||.||++.+. ++..||||++..... ..+.+.+|++++++++||||+++++++.+. ...
T Consensus        18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   94 (283)
T 3gen_A           18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPI   94 (283)
T ss_dssp             TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSE
T ss_pred             CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecC-CCe
Confidence            33445679999999999999999999887 467899999976532 346789999999999999999999998664 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg  165 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFG  165 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTT
T ss_pred             EEEEeccCCCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccc
Confidence            99999999999999997643      45899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++........ ......||+.|+|||.
T Consensus       166 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~  192 (283)
T 3gen_A          166 LSRYVLDDEYT-SSVGSKFPVRWSPPEV  192 (283)
T ss_dssp             GGGGBCCHHHH-STTSTTSCGGGCCHHH
T ss_pred             ccccccccccc-cccCCccCcccCCHHH
Confidence            99876543211 1223456777888764

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=1e-29  Score=236.75  Aligned_cols=173  Identities=27%  Similarity=0.356  Sum_probs=148.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.+. ...++|||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e   85 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLE   85 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEEE
Confidence            5899999999999999999999988999999998754 334557889999999999999999999998764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           86 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ecCCCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            99999999988643       46899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .............||+.|+|||.-.
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~  180 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLK  180 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGT
T ss_pred             CCCcchhcccCCccccCccChHHHh
Confidence            5333222334567899999987643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=3.6e-30  Score=249.25  Aligned_cols=170  Identities=24%  Similarity=0.306  Sum_probs=147.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh--------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK--------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~--------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||+++....        ...+.+.+|+.++++++||||+++++++.+ .
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-~  101 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-Q  101 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC-S
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee-C
Confidence            4589999999999999999999999999999999976421        133457789999999999999999999876 4


Q ss_pred             CeEEEEEeccCCC-CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          253 QGLFLIYKYVSGG-SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       253 ~~~~lV~Ey~~~g-sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      ...++||||+.+| +|.+++...       ..+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEE
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEE
Confidence            5589999999776 999999764       46899999999999999999999987   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++.......   .....||+.|+|||.-
T Consensus       172 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~  201 (335)
T 3dls_A          172 IDFGSAAYLERGKL---FYTFCGTIEYCAPEVL  201 (335)
T ss_dssp             CCCTTCEECCTTCC---BCEECSCGGGCCHHHH
T ss_pred             eecccceECCCCCc---eeccCCCccccChhhh
Confidence            99999988765432   3456799999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.96  E-value=2.6e-29  Score=240.60  Aligned_cols=170  Identities=29%  Similarity=0.338  Sum_probs=147.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||.+.....      ...+.+.+|+.++++++||||+++++++.+ ...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   89 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTD   89 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCE
Confidence            3579999999999999999999998999999999975421      135679999999999999999999999876 455


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC----cEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPK  330 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~----~~K  330 (372)
                      .++||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++    .+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK-------ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC-------SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEEEcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEE
Confidence            89999999999999999753       46899999999999999999999987   99999999999999887    799


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+++.......   .....||+.|+|||.-
T Consensus       160 l~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~  190 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIV  190 (321)
T ss_dssp             ECCCTTCEECCTTCC---CCCCCSCGGGCCHHHH
T ss_pred             EccCccceecCcccc---ccccCCCCCccCcccc
Confidence            999999987765432   2345689999997754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.96  E-value=3.6e-29  Score=254.98  Aligned_cols=171  Identities=29%  Similarity=0.378  Sum_probs=145.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-------------hhHHHHHHHHHHHHhCCCCCeeceee
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------------ESSKAFCRELMIASSLHHPNIVPLVG  246 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------------~~~~~~~~Ev~iL~~l~HpnIv~l~g  246 (372)
                      ..++|.+.+.||+|+||.||+|.+..+++.||||++.+...             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            34689999999999999999999999999999999975421             23567899999999999999999999


Q ss_pred             eEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          247 FCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       247 ~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                      ++.+ ....++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus       114 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          114 VFED-KKYFYLVTEFYEGGELFEQIINR-------HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENK  182 (504)
T ss_dssp             EEEC-SSEEEEEEECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESST
T ss_pred             EEEc-CCEEEEEEecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecC
Confidence            9876 45589999999999999999765       46899999999999999999999988   9999999999999877


Q ss_pred             C---cEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          327 K---IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       327 ~---~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +   .+||+|||+++.......   .....||+.|+|||.-
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~  220 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVL  220 (504)
T ss_dssp             TCCSSEEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHH
T ss_pred             CCCccEEEEECCCCEEcCCCCc---cccccCCcCCCCHHHh
Confidence            6   699999999988765432   3455799999998753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=2.4e-29  Score=242.16  Aligned_cols=180  Identities=21%  Similarity=0.331  Sum_probs=146.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC-------CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG-------LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~-------~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      ..++|.+.+.||+|+||.||+|.+.       .++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3468999999999999999999975       34678999999764 345567899999999999 89999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      . ...++||||+++|+|.+++.......         .....+++..++.++.||+.||.|||+.+   |+||||||+||
T Consensus       113 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          113 D-GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             S-SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             C-CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            4 45899999999999999998653210         01135899999999999999999999987   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |++.++.+||+|||+++...............+|+.|+|||.
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  230 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEA  230 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHH
Confidence            999999999999999987765433222334567788988774

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=6.1e-30  Score=240.06  Aligned_cols=173  Identities=25%  Similarity=0.345  Sum_probs=134.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|.+... .....+.+.+|+.++++++||||+++++++.+  ...
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~   90 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPV   90 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--Ccc
Confidence            446899999999999999999998543   457999998764 44556789999999999999999999998743  347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  161 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG  161 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--
T ss_pred             EEEEecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccc
Confidence            89999999999999997643      46899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++........ ......+|+.|+|||.-
T Consensus       162 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~  189 (281)
T 1mp8_A          162 LSRYMEDSTYY-KASKGKLPIKWMAPESI  189 (281)
T ss_dssp             ------------------CCGGGCCHHHH
T ss_pred             cccccCccccc-ccccCCCcccccChhhc
Confidence            99877544321 22334567889987753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=2.7e-29  Score=235.85  Aligned_cols=169  Identities=32%  Similarity=0.523  Sum_probs=142.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh----h---HHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE----S---SKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~----~---~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      .++|+..+.||+|+||.||+|++..+++.||||++......    .   .+.+.+|+.++++++||||+++++++.+. .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP-P   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT-T
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC-C
Confidence            46899999999999999999999888999999998654221    1   16789999999999999999999987543 2


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc-----
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----  328 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~-----  328 (372)
                        ++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.     
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKA------HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             --eEEEEecCCCCHHHHHhccc------CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCcee
Confidence              69999999999999987543      46899999999999999999999765 44999999999999988776     


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+++.....     .....||+.|+|||.-
T Consensus       168 ~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~  198 (287)
T 4f0f_A          168 AKVADFGLSQQSVHS-----VSGLLGNFQWMAPETI  198 (287)
T ss_dssp             EEECCCTTCBCCSSC-----EECCCCCCTTSCGGGS
T ss_pred             EEeCCCCcccccccc-----ccccCCCccccCchhh
Confidence            999999999854432     2346789999998753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=5.9e-30  Score=244.21  Aligned_cols=188  Identities=20%  Similarity=0.226  Sum_probs=152.4

Q ss_pred             ccHHHHHHhhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeecee
Q 017411          172 LSYGEILAATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLV  245 (372)
Q Consensus       172 ~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~  245 (372)
                      +...++....++|...+.||+|+||.||+|.+.     .+++.||||.+... .......+.+|+.++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            344455667789999999999999999999875     34678999999764 344556799999999999999999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEE
Q 017411          246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKG---VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNIL  322 (372)
Q Consensus       246 g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NIL  322 (372)
                      +++.+.. ..++||||+++|+|.+++......   ......+++..++.++.||+.||.|||+.+   |+||||||+|||
T Consensus        95 ~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIl  170 (322)
T 1p4o_A           95 GVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM  170 (322)
T ss_dssp             EEECSSS-SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred             EEEccCC-ccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEE
Confidence            9987644 479999999999999999864311   011135789999999999999999999987   999999999999


Q ss_pred             EcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          323 LSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       323 ld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.++.+||+|||+++...............||+.|+|||.
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            99999999999999987654332223334567888999775

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.96  E-value=2.1e-29  Score=245.78  Aligned_cols=177  Identities=24%  Similarity=0.344  Sum_probs=149.0

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-  252 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-  252 (372)
                      +++.....+|+..+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++.... 
T Consensus        20 g~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           20 GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             -CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cEeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            34444557999999999999999999999989999999999754 3445578999999999999999999999886543 


Q ss_pred             ---CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcE
Q 017411          253 ---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       253 ---~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                         ...++||||+. |+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~  167 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDL  167 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCE
T ss_pred             cccceEEEEEcccC-cCHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCE
Confidence               35899999996 599999865        35899999999999999999999988   9999999999999999999


Q ss_pred             EEEecccccccCCCCCC-ccccccccCCCccCccc
Q 017411          330 KLCDFGLATWTSAPSVP-FLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~-~~~~~~~GT~gy~apea  363 (372)
                      ||+|||+++........ .......||+.|+|||.
T Consensus       168 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~  202 (364)
T 3qyz_A          168 KICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI  202 (364)
T ss_dssp             EECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHH
T ss_pred             EEEeCcceEecCCCCCccccccccccccCCCCCHH
Confidence            99999999876533221 12345679999999774

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.3e-29  Score=246.68  Aligned_cols=166  Identities=22%  Similarity=0.317  Sum_probs=138.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----C
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~  253 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46899999999999999999999989999999999653  4455678899999999999999999999986542     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..|+||||+ +++|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  171 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  171 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecC-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEe
Confidence            368999999 8899999975        35899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++......     ....||+.|+|||.
T Consensus       172 fg~a~~~~~~~-----~~~~~t~~y~aPE~  196 (367)
T 1cm8_A          172 FGLARQADSEM-----TGYVVTRWYRAPEV  196 (367)
T ss_dssp             CTTCEECCSSC-----CSSCSCGGGCCTHH
T ss_pred             eeccccccccc-----CcCcCCCCcCCHHH
Confidence            99998765332     34578999999875

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.96  E-value=6.5e-29  Score=234.19  Aligned_cols=169  Identities=30%  Similarity=0.358  Sum_probs=147.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---------hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEc
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---------KESSKAFCRELMIASSLH-HPNIVPLVGFCID  250 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---------~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~  250 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||+++...         ....+.+.+|+++++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            469999999999999999999999899999999997542         233467889999999996 9999999999866


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                       ....++||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+|
T Consensus        96 -~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           96 -NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred             -CCeEEEEEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEE
Confidence             45689999999999999999865       46899999999999999999999988   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+|||+++.......   .....||+.|+|||.
T Consensus       165 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~  194 (298)
T 1phk_A          165 LTDFGFSCQLDPGEK---LREVCGTPSYLAPEI  194 (298)
T ss_dssp             ECCCTTCEECCTTCC---BCCCCSCGGGCCHHH
T ss_pred             EecccchhhcCCCcc---cccccCCccccCHHH
Confidence            999999987754432   244578999999775

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.7e-29  Score=236.51  Aligned_cols=174  Identities=24%  Similarity=0.349  Sum_probs=144.7

Q ss_pred             CeeeceeEcccCceEEEEEEECCCC---eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLR---TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~---~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .|...+.||+|+||.||+|.+..++   ..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+...++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5677799999999999999875433   37999999764 4455678999999999999999999999987766655899


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+.+|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       102 ~e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~  172 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ------RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLAR  172 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSC
T ss_pred             EecccCCCHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcc
Confidence            99999999999997642      56899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCC--CccccccccCCCccCccccc
Q 017411          339 WTSAPSV--PFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~--~~~~~~~~GT~gy~apeaPE  365 (372)
                      .......  ........||+.|+|||.-.
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  201 (298)
T 3pls_A          173 DILDREYYSVQQHRHARLPVKWTALESLQ  201 (298)
T ss_dssp             TTTTGGGGCSCCSSCTTCGGGGSCHHHHT
T ss_pred             cccCCcccccccCcCCCCCccccChhhhc
Confidence            6643321  11223456788888877543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=2.2e-29  Score=239.77  Aligned_cols=179  Identities=22%  Similarity=0.286  Sum_probs=148.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc---CCCeEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGLF  256 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~~~~  256 (372)
                      ..++|+..+.||+|+||.||++....+++.||||++........+.+.+|+.++++++||||+++++++..   .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            34689999999999999999999988899999999987777777889999999999999999999999863   233578


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++......   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDK---GNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             EEEEeCCCCcHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            999999999999999874321   257899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCc-------cccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPF-------LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~-------~~~~~~GT~gy~apeaP  364 (372)
                      ++.........       ......||+.|+|||.-
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  215 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF  215 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGS
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHh
Confidence            87654221100       01234578999997753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.9e-29  Score=244.23  Aligned_cols=171  Identities=23%  Similarity=0.321  Sum_probs=139.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCC--CCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHH--PNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~~~~~~~~~  255 (372)
                      ..+.|++.+.||+|+||.||++.+. +++.||||++...  .....+.+.+|+.+|.+++|  |||+++++++.+ +...
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~   84 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYI   84 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEE
Confidence            3467999999999999999999885 4789999998754  44556789999999999986  999999999876 4568


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++|||+ .+++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||
T Consensus        85 ~lv~e~-~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG  152 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFG  152 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHS-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCS
T ss_pred             EEEEeC-CCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecc
Confidence            999995 588999999864       46899999999999999999999987   99999999999997 6789999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++...............||++|+|||.-
T Consensus       153 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  181 (343)
T 3dbq_A          153 IANQMQPDTTSVVKDSQVGTVNYMPPEAI  181 (343)
T ss_dssp             SSCCC------------CCCCSSCCHHHH
T ss_pred             cccccCcccccccCCCCcCCcCcCCHHHH
Confidence            99887655443334566899999998763

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.96  E-value=3e-29  Score=235.45  Aligned_cols=168  Identities=27%  Similarity=0.455  Sum_probs=146.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|++++++++||||+++++++.+ ....++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEE
Confidence            58999999999999999999999889999999986532   2234678999999999999999999999876 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        93 ~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~  162 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-------GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV  162 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             EEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccc
Confidence            9999999999999875       35899999999999999999999887   9999999999999999999999999997


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......    .....||+.|+|||.-
T Consensus       163 ~~~~~~----~~~~~~~~~y~aPE~~  184 (284)
T 2vgo_A          163 HAPSLR----RRTMCGTLDYLPPEMI  184 (284)
T ss_dssp             ECSSSC----BCCCCSCGGGCCHHHH
T ss_pred             cCcccc----cccccCCCCcCCHHHh
Confidence            665432    2345788999997753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=2.4e-29  Score=235.02  Aligned_cols=168  Identities=27%  Similarity=0.393  Sum_probs=144.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc-----------
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-----------  250 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-----------  250 (372)
                      .+|+..+.||+|+||.||+|.+..+++.||+|++....    +.+.+|++++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            47999999999999999999998889999999997654    246789999999999999999998743           


Q ss_pred             ----CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC
Q 017411          251 ----PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       251 ----~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~  326 (372)
                          .....++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-----EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDT  158 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEET
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCC
Confidence                12347899999999999999986532     46899999999999999999999987   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +.+||+|||+++.......   .....||+.|+|||.-
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~  193 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQI  193 (284)
T ss_dssp             TEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHH
T ss_pred             CCEEECcchhheecccccc---ccccCCcccccChhhh
Confidence            9999999999988765432   2345689999997753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=1.9e-29  Score=237.25  Aligned_cols=173  Identities=25%  Similarity=0.382  Sum_probs=141.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC---------
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---------  251 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---------  251 (372)
                      .++|+..+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.++++++||||+++++++.+.         
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            35899999999999999999999888999999999653 44557889999999999999999999987653         


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          252 ---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       252 ---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                         ....++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~  154 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN------LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRN  154 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC------GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc------cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCC
Confidence               345799999999999999998643      35788999999999999999999987   999999999999999999


Q ss_pred             EEEEecccccccCCCCC------------CccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSV------------PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~------------~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+++.......            ........||+.|+|||.
T Consensus       155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  201 (303)
T 1zy4_A          155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV  201 (303)
T ss_dssp             EEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred             EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence            99999999987643210            112234568899999775

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.96  E-value=1.9e-29  Score=245.18  Aligned_cols=167  Identities=27%  Similarity=0.350  Sum_probs=142.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++++...    .+.+|++++.++ +||||+++++++.+ ....|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEEE
Confidence            4589999999999999999999999999999999976532    235688888887 79999999999876 45689999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC----CcEEEEecc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK----KIPKLCDFG  335 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~----~~~KL~DFG  335 (372)
                      ||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||+..+    +.+||+|||
T Consensus        96 E~~~gg~L~~~i~~~-------~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg  165 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ-------KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG  165 (342)
T ss_dssp             CCCCSCBHHHHHHTC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred             eCCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence            999999999999764       46899999999999999999999988   9999999999998543    359999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++.......  ...+..||+.|+|||.-
T Consensus       166 ~a~~~~~~~~--~~~~~~gt~~y~aPE~~  192 (342)
T 2qr7_A          166 FAKQLRAENG--LLMTPCYTANFVAPEVL  192 (342)
T ss_dssp             TCEECBCTTC--CBCCSSCCSSCCCHHHH
T ss_pred             CcccCcCCCC--ceeccCCCccccCHHHh
Confidence            9987754432  23456789999998754

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.96  E-value=8.8e-30  Score=244.64  Aligned_cols=169  Identities=30%  Similarity=0.419  Sum_probs=136.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|...+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++++++||||+++++++.+. ...++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEec
Confidence            5799999999999999999999988999999999754322 122456899999999999999999998764 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |++ |+|.+++....      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  150 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCG------NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAK  150 (324)
T ss_dssp             CCS-EEHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC
T ss_pred             ccc-cCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccc
Confidence            997 59999987653      46899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ..+..  ......||+.|+|||.
T Consensus       151 ~~~~~--~~~~~~~t~~y~aPE~  171 (324)
T 3mtl_A          151 SIPTK--TYDNEVVTLWYRPPDI  171 (324)
T ss_dssp             --------------CGGGCCHHH
T ss_pred             cCCcc--ccccccCcccccChhh
Confidence            54432  2234578999999775

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.96  E-value=1.2e-29  Score=246.59  Aligned_cols=169  Identities=27%  Similarity=0.368  Sum_probs=146.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|+..+.||+|+||.||++.+..+++.||+|++... .....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEE
Confidence            35899999999999999999999989999999999765 455567899999999999999999999998774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||+++++|.+++...       ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++
T Consensus       111 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  180 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSG  180 (360)
T ss_dssp             CCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCH
T ss_pred             ECCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCc
Confidence            999999999999875       4689999999999999999999985 6   9999999999999999999999999997


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......    .....||+.|+|||.-
T Consensus       181 ~~~~~~----~~~~~gt~~y~aPE~~  202 (360)
T 3eqc_A          181 QLIDSM----ANSFVGTRSYMSPERL  202 (360)
T ss_dssp             HHHHHC--------CCCCTTCCHHHH
T ss_pred             cccccc----ccCCCCCCCeECHHHH
Confidence            654322    2345789999997753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.96  E-value=3.3e-29  Score=254.66  Aligned_cols=169  Identities=27%  Similarity=0.378  Sum_probs=142.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +.|+..+.||+|+||.||+|++..++..||||++.+..  ......+.+|+.+++.++||||+++++++.+ ....++||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEEE
Confidence            47999999999999999999999899999999997642  3335678999999999999999999999876 45589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~KL~DFGl  336 (372)
                      ||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++..   +.+||+|||+
T Consensus       116 e~~~~g~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          116 ECYKGGELFDEIIHR-------MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             ECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             ecCCCCcHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            999999999998765       46899999999999999999999988   9999999999999764   5599999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......   .....||+.|+|||.-
T Consensus       186 a~~~~~~~~---~~~~~gt~~y~aPE~l  210 (494)
T 3lij_A          186 SAVFENQKK---MKERLGTAYYIAPEVL  210 (494)
T ss_dssp             CEECBTTBC---BCCCCSCTTTCCHHHH
T ss_pred             CeECCCCcc---ccccCCCcCeeCHHHH
Confidence            988764432   3456799999997753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=3.2e-30  Score=252.92  Aligned_cols=175  Identities=17%  Similarity=0.200  Sum_probs=138.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHH---HHHHhCCCCCeecee-------e
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCREL---MIASSLHHPNIVPLV-------G  246 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev---~iL~~l~HpnIv~l~-------g  246 (372)
                      ..++|.+.+.||+|+||.||+|++..+++.||||++...   .....+.+.+|+   +++++++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            346899999999999999999999888999999999743   445567899999   555666899999998       5


Q ss_pred             eEEcCCC----------------eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 017411          247 FCIDPEQ----------------GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC  310 (372)
Q Consensus       247 ~~~~~~~----------------~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  310 (372)
                      ++.+.+.                ..++||||+ +|+|.+++............+++..++.|+.||+.||.|||+.+   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            5443321                278999999 68999999875321111123456888899999999999999988   


Q ss_pred             eEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       311 IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+||||||+|||++.++.+||+|||+|+....     ......| +.|+|||.-
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~  274 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELE  274 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhh
Confidence            99999999999999999999999999986432     2234567 888887753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.96  E-value=4.3e-29  Score=236.85  Aligned_cols=169  Identities=28%  Similarity=0.358  Sum_probs=144.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|...+.||+|+||.||++++..+++.||+|.+........+.+.+|+.++++++||||+++++++.+ ....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEEE
Confidence            3589999999999999999999998899999999987655555678999999999999999999999876 445899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEecccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DFGla  337 (372)
                      |+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++
T Consensus        87 ~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~  156 (304)
T 2jam_A           87 LVSGGELFDRILER-------GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLS  156 (304)
T ss_dssp             CCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred             cCCCccHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence            99999999999765       46899999999999999999999987   9999999999999   77899999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +......    .....||+.|+|||.-
T Consensus       157 ~~~~~~~----~~~~~~~~~y~aPE~~  179 (304)
T 2jam_A          157 KMEQNGI----MSTACGTPGYVAPEVL  179 (304)
T ss_dssp             CCCCCBT----THHHHSCCCBCCTTTB
T ss_pred             eecCCCc----cccccCCCCccChHHh
Confidence            7654332    2345689999998754

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.96  E-value=4.3e-29  Score=233.70  Aligned_cols=169  Identities=31%  Similarity=0.378  Sum_probs=143.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ++|...+.||+|+||.||++.+..+++.||+|.++....      ...+.+.+|+.++++++||||+++++++.+. ...
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDV   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeE
Confidence            479999999999999999999998899999999875421      2357899999999999999999999998764 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC----cEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  331 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~----~~KL  331 (372)
                      ++||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl  153 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK-------ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKL  153 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEeecCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEE
Confidence            9999999999999999764       46899999999999999999999987   99999999999998877    8999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++.......   .....||+.|+|||.-
T Consensus       154 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~  183 (283)
T 3bhy_A          154 IDFGIAHKIEAGNE---FKNIFGTPEFVAPEIV  183 (283)
T ss_dssp             CCCTTCEECC-----------CCCGGGCCHHHH
T ss_pred             EecccceeccCCCc---ccccCCCcCccCccee
Confidence            99999987754332   2345688999997753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.96  E-value=1.3e-29  Score=242.22  Aligned_cols=183  Identities=24%  Similarity=0.308  Sum_probs=146.8

Q ss_pred             ccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeE
Q 017411          170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFC  248 (372)
Q Consensus       170 ~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~  248 (372)
                      ..+++.++....++|++.+.||+|+||.||+|.+..+++.||||++..... ..+.+.+|+.+++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            344555566677899999999999999999999988899999999975432 346788999999998 799999999998


Q ss_pred             EcC-----CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          249 IDP-----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       249 ~~~-----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      ...     ....++||||+++++|.+++.....     ..+++..++.++.||+.||.|||..+   |+||||||+|||+
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~  162 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-----NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLL  162 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEE
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEE
Confidence            763     3468999999999999999986532     46899999999999999999999987   9999999999999


Q ss_pred             cCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          324 SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       324 d~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.++.+||+|||+++.......  ......||+.|+|||.
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~  200 (326)
T 2x7f_A          163 TENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEV  200 (326)
T ss_dssp             CTTCCEEECCCTTTC---------------CCGGGCCHHH
T ss_pred             cCCCCEEEeeCcCceecCcCcc--ccccccCCccccChhh
Confidence            9999999999999987654322  1234578999999775

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=1.8e-29  Score=243.25  Aligned_cols=172  Identities=27%  Similarity=0.392  Sum_probs=136.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeE----EEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~----vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .++|+..+.||+|+||.||+|.+..+++.    ||+|.+... .....+.+.+|+.++++++||||+++++++....  .
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~--~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST--V   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS--E
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC--c
Confidence            46899999999999999999998776665    477776543 3445678999999999999999999999987643  7


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++|+||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~v~~~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG  162 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFG  162 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTT
T ss_pred             eEEEEecCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCc
Confidence            89999999999999998753      46899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++...............||+.|+|||.
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~  190 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALES  190 (327)
T ss_dssp             C----------------CCCGGGSCHHH
T ss_pred             ceeEccCccccccccCCCccccccCHHH
Confidence            9998765544333344556778888764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.96  E-value=1.1e-29  Score=244.61  Aligned_cols=171  Identities=26%  Similarity=0.372  Sum_probs=136.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEE
Confidence            3468999999999999999999999999999999997543  23345678999999999999999999998764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-----CCCcEEEE
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-----SKKIPKLC  332 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-----~~~~~KL~  332 (372)
                      ||||++ |+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++     ..+.+||+
T Consensus       111 v~e~~~-~~L~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKN-------PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEECCS-EEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEecCC-CCHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999997 5999999765       45899999999999999999999988   99999999999994     45569999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++.......  ......||+.|+|||.-
T Consensus       180 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~  209 (329)
T 3gbz_A          180 DFGLARAFGIPIR--QFTHEIITLWYRPPEIL  209 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHH
T ss_pred             cCCCccccCCccc--ccCCCcCCccccCHHHh
Confidence            9999988754432  22445689999997753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.96  E-value=6.1e-29  Score=243.33  Aligned_cols=172  Identities=27%  Similarity=0.375  Sum_probs=148.6

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHHhC-CCCCeeceeeeE
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSL-HHPNIVPLVGFC  248 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~  248 (372)
                      ....++|.+.+.||+|+||.||+|.+..+++.||||++....        ....+.+.+|+.+++++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344568999999999999999999998889999999987542        12245688999999999 799999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      .. ....++||||+++++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       170 ~~-~~~~~lv~e~~~g~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          170 ES-SSFMFLVFDLMRKGELFDYLTEK-------VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EB-SSEEEEEECCCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             ee-CCEEEEEEEeCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            76 45589999999999999999865       46899999999999999999999987   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||++........   .....||+.|+|||.
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~  270 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEI  270 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHH
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhh
Confidence            99999999987764432   245679999999775

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=4.1e-29  Score=234.91  Aligned_cols=172  Identities=27%  Similarity=0.343  Sum_probs=143.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      +|.....||+|+||.||+|.+..+++.||||.+........+.+.+|+.+++.++||||+++++++.+. ...++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeC
Confidence            455556999999999999999888999999999877666677899999999999999999999998764 4589999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-CCcEEEEecccccccC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-KKIPKLCDFGLATWTS  341 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-~~~~KL~DFGla~~~~  341 (372)
                      ++++|.+++.....    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++. ++.+||+|||+++...
T Consensus       102 ~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A          102 PGGSLSALLRSKWG----PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             SEEEHHHHHHHTTC----CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             CCCCHHHHHHhhcc----CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999986532    145678899999999999999999987   999999999999987 8999999999998765


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....  ......||+.|+|||.-
T Consensus       175 ~~~~--~~~~~~~~~~y~aPE~~  195 (295)
T 2clq_A          175 GINP--CTETFTGTLQYMAPEII  195 (295)
T ss_dssp             C-------CCCCCCGGGCCHHHH
T ss_pred             CCCC--cccccCCCccccChhhh
Confidence            4322  22345789999997753

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.96  E-value=3.1e-29  Score=254.21  Aligned_cols=169  Identities=25%  Similarity=0.384  Sum_probs=144.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++.+.  .......+.+|++++++++||||+++++++.+ ....++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEEEE
Confidence            5899999999999999999999989999999998643  22345678999999999999999999999876 45589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc---CCCcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld---~~~~~KL~DFGl  336 (372)
                      ||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++   .++.+||+|||+
T Consensus       101 e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EcCCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            999999999999765       46899999999999999999999988   99999999999995   456799999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......   .....||+.|+|||+-
T Consensus       171 a~~~~~~~~---~~~~~gt~~y~aPE~~  195 (486)
T 3mwu_A          171 STCFQQNTK---MKDRIGTAYYIAPEVL  195 (486)
T ss_dssp             TTTBCCC-------CCTTGGGGCCGGGG
T ss_pred             CeECCCCCc---cCCCcCCCCCCCHHHh
Confidence            987754432   2445799999998753

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=9.2e-30  Score=240.46  Aligned_cols=172  Identities=23%  Similarity=0.321  Sum_probs=143.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..+.|++.+.||+|+||.||+|.+..+++.||+|++........+.+.+|+.++++++||||+++++++...+ ..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCC-eEEEEE
Confidence            3468999999999999999999999889999999998766666778999999999999999999999987754 589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        96 e~~~~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  166 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELD------RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK  166 (302)
T ss_dssp             ECCTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred             EeCCCCcHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence            9999999999987643      46899999999999999999999987   99999999999999999999999999864


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ......  ......||+.|+|||.
T Consensus       167 ~~~~~~--~~~~~~~~~~y~aPE~  188 (302)
T 2j7t_A          167 NLKTLQ--KRDSFIGTPYWMAPEV  188 (302)
T ss_dssp             HHHHHH--C-----CCGGGCCHHH
T ss_pred             cccccc--ccccccCChhhcCCee
Confidence            321111  1133468899999774

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=3.6e-29  Score=248.24  Aligned_cols=167  Identities=25%  Similarity=0.310  Sum_probs=133.7

Q ss_pred             CCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHH-hCCCCCeeceeeeEEc---CCCeEE
Q 017411          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIAS-SLHHPNIVPLVGFCID---PEQGLF  256 (372)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~-~l~HpnIv~l~g~~~~---~~~~~~  256 (372)
                      ++|... +.||+|+||.||++.+..+++.||||+++..     ..+.+|++++. ..+||||+++++++..   ....+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            467766 7899999999999999999999999999643     35678888874 5589999999998753   244589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEEEe
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL~D  333 (372)
                      +||||+++|+|.+++.....     ..+++..+..|+.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus       136 lv~E~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC--------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             EEEEeCCCCcHHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEe
Confidence            99999999999999976422     46899999999999999999999987   999999999999997   78999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++......   ......||+.|+|||.-
T Consensus       208 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~  235 (400)
T 1nxk_A          208 FGFAKETTSHN---SLTTPCYTPYYVAPEVL  235 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGS
T ss_pred             cccccccCCCC---ccccCCCCCCccCHhhc
Confidence            99998765432   22456789999998764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-29  Score=245.80  Aligned_cols=172  Identities=26%  Similarity=0.356  Sum_probs=139.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-----hhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-----ESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-----~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++.....     ...+.+.+|+.++++++||||+++++++.+. ..
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-Cc
Confidence            44689999999999999999999988899999999975321     1124688999999999999999999998764 44


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+++ +|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNS------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCC------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEEcCCC-CHHHHHHhcC------cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEec
Confidence            8999999975 8998886542      46888899999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++.......  ......||+.|+|||.-
T Consensus       157 g~a~~~~~~~~--~~~~~~~t~~y~aPE~~  184 (346)
T 1ua2_A          157 GLAKSFGSPNR--AYTHQVVTRWYRAPELL  184 (346)
T ss_dssp             GGGSTTTSCCC--CCCCSCCCCTTCCHHHH
T ss_pred             ccceeccCCcc--cCCcccccccccCchHh
Confidence            99987754432  23446789999998753

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.96  E-value=4.3e-29  Score=236.19  Aligned_cols=175  Identities=23%  Similarity=0.364  Sum_probs=147.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC----hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~  255 (372)
                      .++|.+.+.||+|+||.||++.+..+++.||+|++....    ....+.+.+|+.++++++||||+++++++... ....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            368999999999999999999998889999999997542    23457799999999999999999999988543 3458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||++++ |.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg  154 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPE-----KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALG  154 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTT-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEehhccCC-HHHHHHhCcc-----cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccc
Confidence            9999999876 8787766432     56899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++...............||+.|+|||.-
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  183 (305)
T 2wtk_C          155 VAEALHPFAADDTCRTSQGSPAFQPPEIA  183 (305)
T ss_dssp             TCEECCTTCSSCEECCCCSCGGGCCHHHH
T ss_pred             cccccCccccccccccCCCCCCCcChhhc
Confidence            99887644333344556789999997753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.96  E-value=5.5e-29  Score=237.35  Aligned_cols=172  Identities=24%  Similarity=0.330  Sum_probs=140.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.++++++||||+++++++.. +...++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEEE
Confidence            36899999999999999999999888999999999754   33445788999999999999999999999877 445899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       112 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ-------GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             EEECCCCEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             EEEecCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            99999999999999865       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +........ ......||+.|+|||.-
T Consensus       182 ~~~~~~~~~-~~~~~~~~~~y~aPE~~  207 (309)
T 2h34_A          182 SATTDEKLT-QLGNTVGTLYYMAPERF  207 (309)
T ss_dssp             ----------------CCGGGCCGGGT
T ss_pred             ccccccccc-cccccCCCcCccCHHHH
Confidence            876543321 22345689999997754

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.96  E-value=2.5e-29  Score=241.70  Aligned_cols=170  Identities=28%  Similarity=0.425  Sum_probs=141.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEE
Confidence            35899999999999999999999988999999998654  334456788999999999999999999998764 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       103 ~e~~~~~~l~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  172 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP-------NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFAR  172 (331)
T ss_dssp             EECCSEEHHHHHHHST-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EecCCcchHHHHHhhc-------cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCce
Confidence            9999999998886543       46899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  ......||+.|+|||.
T Consensus       173 ~~~~~~~--~~~~~~~t~~y~aPE~  195 (331)
T 4aaa_A          173 TLAAPGE--VYDDEVATRWYRAPEL  195 (331)
T ss_dssp             -------------CCCCCTTCCHHH
T ss_pred             eecCCcc--ccCCCcCCccccCccc
Confidence            7654432  2234578999999774

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.96  E-value=4.4e-29  Score=232.79  Aligned_cols=171  Identities=27%  Similarity=0.402  Sum_probs=140.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.++||||+++++++.+. ...++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEE
Confidence            368999999999999999999998889999999996532   23356789999999999999999999998764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++...       ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        89 v~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~  158 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH-------GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS  158 (276)
T ss_dssp             EEECCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGG
T ss_pred             EEeccCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccc
Confidence            99999999999999765       45899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +.......   .....||+.|+|||.-.
T Consensus       159 ~~~~~~~~---~~~~~~~~~y~aPE~~~  183 (276)
T 2h6d_A          159 NMMSDGEF---LRTSCGSPNYAAPEVIS  183 (276)
T ss_dssp             GCCCC----------------CCTGGGT
T ss_pred             cccCCCcc---eecccCCccccCHHHHc
Confidence            87754432   23456899999987643

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=1.8e-29  Score=235.78  Aligned_cols=178  Identities=25%  Similarity=0.323  Sum_probs=146.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc-CCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~~~~l  257 (372)
                      .++|+..+.||+|+||.||++....+++.||+|.+...  .....+.+.+|+.++++++||||+++++++.+ .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            35899999999999999999999988999999999754  34556789999999999999999999998754 3456899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ||||+++++|.+++......   ...+++..++.++.|++.||.|||+.+  ..+|+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhccc---CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999999865321   145899999999999999999999765  2349999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +++.......  ......||+.|+|||.
T Consensus       162 ~~~~~~~~~~--~~~~~~~~~~y~aPE~  187 (279)
T 2w5a_A          162 LARILNHDTS--FAKTFVGTPYYMSPEQ  187 (279)
T ss_dssp             HHHHC---CH--HHHHHHSCCTTCCHHH
T ss_pred             hheeeccccc--cccccCCCccccChHH
Confidence            9987754332  2234578999999775

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=3.3e-29  Score=242.62  Aligned_cols=172  Identities=25%  Similarity=0.378  Sum_probs=144.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-------C
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------E  252 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-------~  252 (372)
                      ++|+..+.||+|+||.||+|++..+++.||||++....  ......+.+|+.++++++||||+++++++...       .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            58999999999999999999999899999999986542  23345788999999999999999999998764       2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      +..++||||+++ +|.+.+....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEc
Confidence            357999999974 8888876543      46899999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccCCCCC--CccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSV--PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~--~~~~~~~~GT~gy~apea  363 (372)
                      |||+++.......  ........||+.|+|||.
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~  199 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL  199 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHH
T ss_pred             cchhcccccccccccccccCCcccccCccCchh
Confidence            9999987653322  112344578999999774

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=5.3e-29  Score=236.65  Aligned_cols=174  Identities=25%  Similarity=0.396  Sum_probs=136.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..+|++.+.||+|+||.||+|....+++.||||++...   .....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEE
Confidence            35899999999999999999999888999999999753   455667899999999999999999999998874 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++......   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       110 v~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQ---KRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             EEecCCCCCHHHHHHHhccc---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            99999999999999764321   156899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +.......  ......||+.|+|||.
T Consensus       184 ~~~~~~~~--~~~~~~~~~~y~aPE~  207 (310)
T 2wqm_A          184 RFFSSKTT--AAHSLVGTPYYMSPER  207 (310)
T ss_dssp             -----------------CCSSCCHHH
T ss_pred             eeecCCCc--cccccCCCeeEeChHH
Confidence            87654332  2234568899999774

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=2.1e-29  Score=241.72  Aligned_cols=179  Identities=27%  Similarity=0.343  Sum_probs=141.9

Q ss_pred             hCCeeeceeEcccCceEEEEEE-----ECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGK-----VGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~-----~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++|.+.+.||+|+||.||+|.     ...++..||||.+... .......+.+|+.++++++||||+++++++.+.. .
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL-P  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-S
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC-C
Confidence            4689999999999999999998     4456789999999754 4455678999999999999999999999987644 4


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKL  331 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL  331 (372)
                      .++||||+++++|.+++............+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            79999999999999999876433222346899999999999999999999987   999999999999984   446999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|||+++...............||+.|+|||.
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhH
Confidence            99999987644433223345568889999774

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=8.6e-30  Score=256.50  Aligned_cols=178  Identities=23%  Similarity=0.322  Sum_probs=147.1

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      ..++....++|...+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++.  ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CC
Confidence            34455567789999999999999999999864 6789999998643 34678999999999999999999999875  33


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~D  327 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEG-----SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIAD  327 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECS
T ss_pred             ccEEEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEee
Confidence            47999999999999999976432     35889999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++........ ......+|+.|+|||+-
T Consensus       328 FG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~  357 (454)
T 1qcf_A          328 FGLARVIEDNEYT-AREGAKFPIKWTAPEAI  357 (454)
T ss_dssp             TTGGGGBCCHHHH-TTCSSSSCGGGSCHHHH
T ss_pred             CCCceEcCCCcee-ccCCCcccccccCHHHh
Confidence            9999876532211 11223456778887653

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=8.9e-29  Score=232.96  Aligned_cols=171  Identities=23%  Similarity=0.268  Sum_probs=145.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.+++++ +|+|++++++++.+ ....++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEE
Confidence            468999999999999999999998889999999987543  224578899999999 79999999998866 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc-----EEEEec
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-----PKLCDF  334 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~-----~KL~DF  334 (372)
                      ||+ +++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.     +||+||
T Consensus        86 e~~-~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999 999999998653      46899999999999999999999887   999999999999987776     999999


Q ss_pred             ccccccCCCCCC-----ccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVP-----FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~-----~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........     .......||+.|+|||.-
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  190 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH  190 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhh
Confidence            999887654321     123456799999997753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.96  E-value=3.2e-29  Score=247.68  Aligned_cols=169  Identities=23%  Similarity=0.316  Sum_probs=140.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCC--CCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .+|++.+.||+|+||.||++.+.. ++.||||++...  .....+.+.+|+.+|++++  ||||+++++++... ..+++
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-~~~~l  133 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYM  133 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-CEEEE
Confidence            469999999999999999999865 889999998754  4556678999999999996  59999999988764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||| +.+++|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++
T Consensus       134 v~E-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a  201 (390)
T 2zmd_A          134 VME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIA  201 (390)
T ss_dssp             EEE-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSS
T ss_pred             EEe-cCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcc
Confidence            999 5688999999864       46889999999999999999999887   99999999999995 589999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +...............||+.|+|||.-
T Consensus       202 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  228 (390)
T 2zmd_A          202 NQMQPDTTSVVKDSQVGAVNYMPPEAI  228 (390)
T ss_dssp             CCC---------CCSCCCGGGCCHHHH
T ss_pred             ccccCCCccccCCCCCcCCCccChHHh
Confidence            887654433334456799999998764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=3.2e-29  Score=238.43  Aligned_cols=186  Identities=22%  Similarity=0.346  Sum_probs=139.3

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECC---CCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEE
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~  249 (372)
                      .++....++|...+.||+|+||.||+|....   ++..||||.++..  .....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            3444556789999999999999999998754   4568999998754  4455678999999999999999999999987


Q ss_pred             cCCC----eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC
Q 017411          250 DPEQ----GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       250 ~~~~----~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~  325 (372)
                      +...    ..++||||+++|+|.+++...... .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~  182 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE-TGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRD  182 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBT-TSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhh-cCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcC
Confidence            6443    358999999999999999654211 11257999999999999999999999887   999999999999999


Q ss_pred             CCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.+||+|||+++...............+++.|+|||.-
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  221 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESL  221 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHH
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhh
Confidence            999999999999877544332233345677888887653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.96  E-value=7.8e-29  Score=234.72  Aligned_cols=170  Identities=28%  Similarity=0.376  Sum_probs=147.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .+.|...+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEE
Confidence            357999999999999999999998889999999997543 34567899999999999999999999998774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++..        ..+++..+..++.|++.||.|||..+   |+||||||+||+++.++.+||+|||+++.
T Consensus       100 e~~~~~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  168 (303)
T 3a7i_A          100 EYLGGGSALDLLEP--------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQ  168 (303)
T ss_dssp             ECCTTEEHHHHHTT--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeCCCCcHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeeccccee
Confidence            99999999999864        45899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......  ......||+.|+|||.-
T Consensus       169 ~~~~~~--~~~~~~~~~~y~aPE~~  191 (303)
T 3a7i_A          169 LTDTQI--KRNTFVGTPFWMAPEVI  191 (303)
T ss_dssp             CBTTBC--CBCCCCSCGGGCCHHHH
T ss_pred             cCcccc--ccCccCCCcCccCHHHH
Confidence            754432  22445789999997753

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=3.8e-29  Score=232.65  Aligned_cols=168  Identities=27%  Similarity=0.449  Sum_probs=132.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC----hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED----KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|+..+.||+|+||.||+|.+.  ++.||||++....    ....+.+.+|+++++.++||||+++++++.+.+ ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP-NLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-ceE
Confidence            468999999999999999999975  7899999987542    233567899999999999999999999987644 479


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC--------CCc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--------KKI  328 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~--------~~~  328 (372)
                      +||||+++++|.+++..        ..+++..++.++.|++.||.|||+.+..+|+||||||+|||++.        ++.
T Consensus        83 lv~e~~~~~~L~~~~~~--------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSG--------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             EEEECCTTEEHHHHHTS--------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             EEEEcCCCCCHHHHhhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcc
Confidence            99999999999999853        46899999999999999999999987556899999999999986        678


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+++.......    ....||+.|+|||.
T Consensus       155 ~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~  185 (271)
T 3dtc_A          155 LKITDFGLAREWHRTTK----MSAAGAYAWMAPEV  185 (271)
T ss_dssp             EEECCCCC-----------------CCGGGSCHHH
T ss_pred             eEEccCCcccccccccc----cCCCCccceeCHHH
Confidence            99999999987654432    34578999999775

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=8.6e-30  Score=248.28  Aligned_cols=171  Identities=27%  Similarity=0.255  Sum_probs=145.1

Q ss_pred             CCeeeceeEcccCceEEEEEEEC---CCCeEEEEEEecCCC----hhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCC
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVG---LLRTSVAIKRLDKED----KESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~---~~~~~vAvK~l~~~~----~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~  253 (372)
                      ++|.+.+.||+|+||.||+++..   .+++.||||++++..    ....+.+.+|+++++++ +||||+++++++... .
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~  132 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-T  132 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-T
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-c
Confidence            58999999999999999999984   478999999987532    22335677899999999 699999999988764 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~D  202 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  202 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             eEEEEeecCCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEee
Confidence            589999999999999999865       46899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++........ ......||+.|+|||.-
T Consensus       203 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~  232 (355)
T 1vzo_A          203 FGLSKEFVADETE-RAYDFCGTIEYMAPDIV  232 (355)
T ss_dssp             SSEEEECCGGGGG-GGCGGGSCCTTCCHHHH
T ss_pred             CCCCeecccCCCC-cccCcccCcCccChhhh
Confidence            9999876533221 23456799999997764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=2.5e-29  Score=237.07  Aligned_cols=171  Identities=27%  Similarity=0.407  Sum_probs=133.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|++.+.||+|+||.||+|++..   .||||+++..  .....+.+.+|+.++++++||||+++++++..  ...++
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~l   96 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAI   96 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC--CccEE
Confidence            45689999999999999999998753   5999998754  45556789999999999999999999997533  34789


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        97 v~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  167 (289)
T 3og7_A           97 VTQWCEGSSLYHHLHASE------TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLA  167 (289)
T ss_dssp             EEECCCEEEHHHHHTTC---------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC--
T ss_pred             EEEecCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceec
Confidence            999999999999996543      46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +...............||+.|+|||.-
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~  194 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVI  194 (289)
T ss_dssp             ----------------CCCTTCCHHHH
T ss_pred             cccccccccccccccCCCccccCchhh
Confidence            876543333333456799999997753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=5.3e-29  Score=237.94  Aligned_cols=179  Identities=26%  Similarity=0.316  Sum_probs=137.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEE-------cC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCI-------DP  251 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~-------~~  251 (372)
                      ...+|++.+.||+|+||.||+|++..+++.||||++........+.+.+|+.++.++. ||||+++++++.       ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            4458999999999999999999998889999999997777777788999999999996 999999999884       23


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      ....++||||+. |+|.+++......    ..+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESR----GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTT----CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence            344789999995 7999998764321    46999999999999999999999764 34999999999999999999999


Q ss_pred             EecccccccCCCCCCc----------cccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPF----------LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~----------~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++.........          ......||+.|+|||.-
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~  222 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEII  222 (337)
T ss_dssp             CCCTTCBCCSSCC------------------------------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhh
Confidence            9999998775432210          11244689999998764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.96  E-value=2e-29  Score=255.22  Aligned_cols=169  Identities=27%  Similarity=0.421  Sum_probs=147.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  103 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFYL  103 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEE
Confidence            357999999999999999999999899999999996542   3456789999999999999999999999876 456899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEec
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDF  334 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DF  334 (372)
                      ||||+.+|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+||
T Consensus       104 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR-------KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             EECCCCSCBHHHHHHTC-------SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             EEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            99999999999999764       46899999999999999999999988   9999999999999   46789999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+++.......   .....||+.|+|||.
T Consensus       174 g~a~~~~~~~~---~~~~~gt~~y~aPE~  199 (484)
T 3nyv_A          174 GLSTHFEASKK---MKDKIGTAYYIAPEV  199 (484)
T ss_dssp             THHHHBCCCCS---HHHHTTGGGTCCHHH
T ss_pred             eeeEEcccccc---cccCCCCccccCcee
Confidence            99988765432   344579999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=5.9e-29  Score=238.66  Aligned_cols=174  Identities=25%  Similarity=0.334  Sum_probs=146.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEE----CCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~  255 (372)
                      .++|++.+.||+|+||.||+++.    ..+++.||||++........+.+.+|+.++++++||||+++++++...+ ...
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35799999999999999999984    5578999999998877777788999999999999999999999876543 247


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg  190 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFG  190 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST------TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             EEEEECCCCCCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCc
Confidence            89999999999999998653      45899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      +++......... ......++..|+|||.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  219 (326)
T 2w1i_A          191 LTKVLPQDKEYYKVKEPGESPIFWYAPES  219 (326)
T ss_dssp             TCEECCSSCSEEECSSCCSCCGGGCCHHH
T ss_pred             chhhccccccccccccCCCCceeEECchh
Confidence            998876543211 1223456777888764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2e-29  Score=248.00  Aligned_cols=173  Identities=23%  Similarity=0.345  Sum_probs=134.3

Q ss_pred             CeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      .|...+.||+|+||.||+|.+...   ...||||.++.. .....+.|.+|+.++++++||||++++++|.+.+...++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            577889999999999999987432   346899998754 4456678999999999999999999999987766668999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       170 ~e~~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             EECCTTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             EECCCCCCHHHHHhhcc------cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccc
Confidence            99999999999997543      46889999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCC--ccccccccCCCccCcccc
Q 017411          339 WTSAPSVP--FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~--~~~~~~~GT~gy~apeaP  364 (372)
                      ........  .......+|+.|+|||.-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~  268 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESL  268 (373)
T ss_dssp             -----------------CCGGGSCHHHH
T ss_pred             cccccccccccccCCCCCcccccChHHh
Confidence            76443221  112334567788887753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=5.4e-29  Score=244.73  Aligned_cols=172  Identities=24%  Similarity=0.340  Sum_probs=140.3

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC------
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP------  251 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~------  251 (372)
                      ....++|+..+.||+|+||.||+|.+..+++.||||++.....    ...+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            3456799999999999999999999998999999999875432    234799999999999999999988543      


Q ss_pred             -------------------------------CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 017411          252 -------------------------------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV  300 (372)
Q Consensus       252 -------------------------------~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL  300 (372)
                                                     ....++||||++ |+|.+.+......   ...+++..+..++.||+.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS---GRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHH
Confidence                                           223789999997 5888888753221   15799999999999999999


Q ss_pred             HHHHcCCCCceEEcCCCCCCEEEc-CCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          301 AYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       301 ~yLH~~~~~~IiHrDLKp~NILld-~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .|||+.+   |+||||||+|||++ .++.+||+|||+|+.......   .....||+.|+|||.
T Consensus       155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~  212 (383)
T 3eb0_A          155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPEL  212 (383)
T ss_dssp             HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHH
T ss_pred             HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHH
Confidence            9999887   99999999999998 688999999999987754432   234578999999774

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=2.8e-29  Score=244.90  Aligned_cols=175  Identities=18%  Similarity=0.258  Sum_probs=139.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCC-----CeEEEEEEecCCChhhH-----------HHHHHHHHHHHhCCCCCeec
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLL-----RTSVAIKRLDKEDKESS-----------KAFCRELMIASSLHHPNIVP  243 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~-----~~~vAvK~l~~~~~~~~-----------~~~~~Ev~iL~~l~HpnIv~  243 (372)
                      ..++|.+.+.||+|+||.||+|.+..+     ++.||||++........           ..+.+|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999998654     57899999876542211           12345666778889999999


Q ss_pred             eeeeEEcCC---CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCC
Q 017411          244 LVGFCIDPE---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (372)
Q Consensus       244 l~g~~~~~~---~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~N  320 (372)
                      +++++....   ...++||||+ +++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~------~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~N  182 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA------KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASN  182 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGG
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHH
Confidence            999987532   3479999999 999999998642      46999999999999999999999987   9999999999


Q ss_pred             EEEc--CCCcEEEEecccccccCCCCCC-----ccccccccCCCccCcccc
Q 017411          321 ILLS--SKKIPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       321 ILld--~~~~~KL~DFGla~~~~~~~~~-----~~~~~~~GT~gy~apeaP  364 (372)
                      ||++  .++.+||+|||+++.+......     .......||+.|+|||.-
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  233 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAH  233 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHH
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHh
Confidence            9999  8899999999999876433211     111345599999997754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.96  E-value=4.2e-29  Score=239.03  Aligned_cols=168  Identities=27%  Similarity=0.356  Sum_probs=141.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++....        ......+.+|++++++++||||+++++++.. +
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   87 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E   87 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-C
Confidence            358999999999999999999999899999999987532        1223458899999999999999999998765 3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc---E
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---P  329 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~---~  329 (372)
                      . .++||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.   +
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN-------KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCE
T ss_pred             c-eEEEEecCCCCcHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeE
Confidence            3 79999999999999998653       46899999999999999999999987   999999999999987654   9


Q ss_pred             EEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|||+++......   ......||+.|+|||.
T Consensus       157 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~  187 (322)
T 2ycf_A          157 KITDFGHSKILGETS---LMRTLCGTPTYLAPEV  187 (322)
T ss_dssp             EECCCTTCEECCCCH---HHHHHHSCCTTCCHHH
T ss_pred             EEccCccceeccccc---ccccccCCcCccCchh
Confidence            999999998775432   2234579999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=6e-29  Score=230.39  Aligned_cols=168  Identities=18%  Similarity=0.223  Sum_probs=143.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-CeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-QGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-~~~~lV  258 (372)
                      ++|+..+.||+|+||.||+|++.  ++.||||++...  .....+.+.+|+.++++++||||+++++++.+.. ...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            58999999999999999999986  789999999764  3455678999999999999999999999987652 457999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++.++|+|||++.
T Consensus        88 ~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGTN-----FVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EECCTTCBHHHHHHSCSS-----CCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             ecccCCCcHHHHHhhccc-----CCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEecccee
Confidence            999999999999976432     36899999999999999999999765 449999999999999999999999999876


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....       ....||+.|+|||.-
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~  180 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEAL  180 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHH
T ss_pred             eecc-------cCccCCccccChhhh
Confidence            5432       234688999997754

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.96  E-value=1.5e-28  Score=237.41  Aligned_cols=172  Identities=24%  Similarity=0.283  Sum_probs=143.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC----CCe
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP----EQG  254 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~~  254 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++... .......+.+|+.++++++||||+++++++...    ...
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            347999999999999999999999988999999999754 344566788999999999999999999987543    245


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+. ++|.+++..        ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        89 ~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST--------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEEeccC-ccHHHHHhh--------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEec
Confidence            899999996 699999875        35899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCCCc--------cccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPF--------LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~--------~~~~~~GT~gy~apea  363 (372)
                      |+++.........        ......||+.|+|||.
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  193 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEV  193 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCee
Confidence            9998765332110        1223578999999774

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=3e-29  Score=232.49  Aligned_cols=172  Identities=22%  Similarity=0.370  Sum_probs=144.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||++.+. ++..||+|.+..... ..+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~   82 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVT   82 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred             chhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CeEEEE
Confidence            3468999999999999999999986 467899999976532 3467899999999999999999999987644 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        83 e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~  153 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRF  153 (267)
T ss_dssp             CCCTTCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred             eCCCCCcHHHHHhhCc------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccc
Confidence            9999999999997653      46899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...... .......||+.|+|||.-
T Consensus       154 ~~~~~~-~~~~~~~~~~~y~aPE~~  177 (267)
T 3t9t_A          154 VLDDQY-TSSTGTKFPVKWASPEVF  177 (267)
T ss_dssp             BCCHHH-HSTTSTTCCGGGCCHHHH
T ss_pred             cccccc-cccccccccccccChhhh
Confidence            643221 112234567778887653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.96  E-value=3.7e-29  Score=234.66  Aligned_cols=173  Identities=21%  Similarity=0.311  Sum_probs=132.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-Chh-hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKE-SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~-~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++... ... ..+.+.++...++.++||||+++++++.+.+ ..++
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~-~~~l   83 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWI   83 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-SEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC-CEEE
Confidence            346899999999999999999999889999999999764 222 2333445555688889999999999988754 4899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||||++ |+|.+++......   ...+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+
T Consensus        84 v~e~~~-~~l~~~l~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDK---GQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             EEehhc-cchHHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCC
Confidence            999997 5898888653221   15799999999999999999999986 7   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.......   .....||+.|+|||.
T Consensus       157 ~~~~~~~~~---~~~~~~t~~y~aPE~  180 (290)
T 3fme_A          157 SGYLVDDVA---KDIDAGCKPYMAPER  180 (290)
T ss_dssp             ----------------CCCCCCSCHHH
T ss_pred             ccccccccc---ccccCCCccccChhh
Confidence            987754432   233468999999776

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=1.1e-28  Score=234.52  Aligned_cols=171  Identities=26%  Similarity=0.316  Sum_probs=142.5

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||.+....  ..+.+.+|+.++++++||||+++++++... ...++||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~  103 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVM  103 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEe
Confidence            4568999999999999999999999889999999997643  345788999999999999999999998774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++++|.+++....      ..+++..++.++.|++.||.|||..+   |+|+||||+||+++.++.+||+|||+++.
T Consensus       104 e~~~~~~L~~~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A          104 EYCGAGSVSDIIRLRN------KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             ECCTTEEHHHHHHHHT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ecCCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            9999999999997542      56899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ......  ......||+.|+|||.-
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~  197 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVI  197 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHH
T ss_pred             hhhhcc--ccCccCCCCCccChhhc
Confidence            654322  22345688999997753

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=5.1e-29  Score=234.89  Aligned_cols=174  Identities=22%  Similarity=0.303  Sum_probs=142.0

Q ss_pred             HhhCCeeece-eEcccCceEEEEEEE--CCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          179 AATHNFSKGR-VLGRGALSFVFKGKV--GLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       179 ~~t~~f~~~~-~LG~G~fG~Vy~~~~--~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      ...++|.+.+ .||+|+||.||+|.+  ..+++.||||+++..  .....+.+.+|+.++++++||||+++++++.  ..
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~   90 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AE   90 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CC
Confidence            3446888888 999999999999954  556789999999764  2344678999999999999999999999983  33


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECC
T ss_pred             CcEEEEEeCCCCCHHHHHHhC-------cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEcc
Confidence            489999999999999999764       45899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCCCc-cccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      ||+++......... ......||+.|+|||.-
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  192 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECI  192 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHH
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHh
Confidence            99998876543321 12233467788887653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.96  E-value=1.2e-28  Score=233.83  Aligned_cols=171  Identities=23%  Similarity=0.285  Sum_probs=138.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc----------
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID----------  250 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~----------  250 (372)
                      .++|...+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            3689999999999999999999998899999999988777778889999999999999999999998743          


Q ss_pred             ---CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-CC
Q 017411          251 ---PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SK  326 (372)
Q Consensus       251 ---~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-~~  326 (372)
                         .....++||||++ |+|.+++..        ..+++..++.++.|++.||.|||+.+   |+||||||+|||++ .+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~  157 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ--------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTED  157 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTT
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc--------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCC
Confidence               2345899999997 699999854        45899999999999999999999988   99999999999997 56


Q ss_pred             CcEEEEecccccccCCCCC-CccccccccCCCccCccc
Q 017411          327 KIPKLCDFGLATWTSAPSV-PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~-~~~~~~~~GT~gy~apea  363 (372)
                      +.+||+|||+++....... ........||..|+|||.
T Consensus       158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (320)
T 2i6l_A          158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRL  195 (320)
T ss_dssp             TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHH
T ss_pred             CeEEEccCccccccCCCcccccccccccccccccCcHH
Confidence            7999999999987653321 112234567888999774

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.1e-28  Score=236.33  Aligned_cols=172  Identities=26%  Similarity=0.311  Sum_probs=137.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC--CCCCeeceeeeEEcCC---Ce
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL--HHPNIVPLVGFCIDPE---QG  254 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l--~HpnIv~l~g~~~~~~---~~  254 (372)
                      ..++|++.+.||+|+||.||+|++.  ++.||||++....   ...+.+|.+++..+  +||||+++++++....   ..
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            3468999999999999999999986  7899999986532   23455666666554  8999999999987653   45


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCceEEcCCCCCCEEEcCCCcE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-----ERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~IiHrDLKp~NILld~~~~~  329 (372)
                      .++||||+++|+|.+++..        ..+++..++.++.|++.||.|||+..     .++|+||||||+|||++.++.+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKS--------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             eEEEEeccCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence            8999999999999999965        35899999999999999999999871     1239999999999999999999


Q ss_pred             EEEecccccccCCCCCCc--cccccccCCCccCcccc
Q 017411          330 KLCDFGLATWTSAPSVPF--LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~--~~~~~~GT~gy~apeaP  364 (372)
                      ||+|||+++.........  ......||+.|+|||.-
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  218 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL  218 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHH
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhc
Confidence            999999998765443211  12345799999997753

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=99.96  E-value=7.4e-29  Score=233.90  Aligned_cols=171  Identities=26%  Similarity=0.432  Sum_probs=143.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++... +..++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   81 (299)
T 2r3i_A            3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVF   81 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecC-CceEEEE
Confidence            58999999999999999999999889999999987542  22346788999999999999999999998764 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+. ++|.+++.....     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 e~~~-~~L~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~  152 (299)
T 2r3i_A           82 EFLH-QDLKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA  152 (299)
T ss_dssp             ECCS-EEHHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             Eccc-CCHHHHHHhhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhh
Confidence            9997 699999976532     45889999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...+..  ......||+.|+|||.-
T Consensus       153 ~~~~~~--~~~~~~~~~~y~aPE~~  175 (299)
T 2r3i_A          153 FGVPVR--TYTHEVVTLWYRAPEIL  175 (299)
T ss_dssp             HCCCSB--CTTSCBCCCTTCCHHHH
T ss_pred             ccCCcc--ccCcccccccccCcHHh
Confidence            754432  22345689999997753

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=2.5e-29  Score=253.05  Aligned_cols=177  Identities=25%  Similarity=0.328  Sum_probs=141.5

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      ..+....++|+..+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+.+|++++||||+++++++.+  ..
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~  252 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EP  252 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SS
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--Cc
Confidence            3444566789999999999999999999875 4679999997643 235679999999999999999999998765  34


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~Df  324 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADF  324 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eEEEehhhcCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCC
Confidence            7899999999999999976432     45899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++........ ......+++.|+|||+-
T Consensus       325 G~a~~~~~~~~~-~~~~~~~~~~y~aPE~~  353 (452)
T 1fmk_A          325 GLARLIEDNEYT-ARQGAKFPIKWTAPEAA  353 (452)
T ss_dssp             CTTC---------------CCGGGSCHHHH
T ss_pred             ccceecCCCcee-cccCCcccccccCHhHH
Confidence            999876543221 12234567788887753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=1.5e-28  Score=240.76  Aligned_cols=168  Identities=23%  Similarity=0.346  Sum_probs=135.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC-----C
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE-----Q  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~-----~  253 (372)
                      .++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46899999999999999999999989999999999753  4455677899999999999999999999986543     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+. ++|.+++.         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       104 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ceEEEEEcCC-CCHHHHHh---------hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEE
Confidence            5899999996 57888875         24889999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++......   ......||+.|+|||.-
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~  198 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVI  198 (371)
T ss_dssp             CCC-------------------CTTCCHHHH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHh
Confidence            99998765432   22345789999997753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.1e-28  Score=238.01  Aligned_cols=174  Identities=26%  Similarity=0.365  Sum_probs=137.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCC----CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLL----RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~----~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..+|...+.||+|+||.||+|.+..+    +..||||.++.. .......+.+|+.++++++||||+++++++.+. ...
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~  121 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPM  121 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-CCc
Confidence            35888999999999999999987543    346999999764 344556799999999999999999999998664 458


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg  192 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  192 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEeCCCCCcHHHHHHhCC------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCC
Confidence            99999999999999997643      46899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      +++........ .......+|+.|+|||.-
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  222 (333)
T 1mqb_A          193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAI  222 (333)
T ss_dssp             C-----------------CCCGGGSCHHHH
T ss_pred             cchhhccccccccccCCCCccccccCchhc
Confidence            99877543221 112233467778887653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=8.1e-29  Score=232.14  Aligned_cols=173  Identities=28%  Similarity=0.373  Sum_probs=141.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECC---CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..++|...+.||+|+||.||+|.+..   ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+ + ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E-PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S-SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C-CC
Confidence            34689999999999999999998643   3456999999765 44566789999999999999999999998754 3 36


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  158 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFG  158 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHT------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCC
T ss_pred             EEEEecCCCCCHHHHHHhcc------ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccC
Confidence            89999999999999997653      46899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++........ ......+|+.|+|||.-
T Consensus       159 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~  186 (281)
T 3cc6_A          159 LSRYIEDEDYY-KASVTRLPIKWMSPESI  186 (281)
T ss_dssp             GGGCC----------CCCCCGGGCCHHHH
T ss_pred             CCccccccccc-ccccCCCCcceeCchhh
Confidence            99877544321 22334577889987753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=1.7e-28  Score=234.93  Aligned_cols=164  Identities=24%  Similarity=0.314  Sum_probs=142.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcC-CCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP-EQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~-~~~~~lV~  259 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||+++...   .+.+.+|+.++++++ ||||+++++++.+. ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            58999999999999999999998889999999997543   357889999999997 99999999998763 34579999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGla~  338 (372)
                      ||+++++|.+++.          .+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+++
T Consensus       113 e~~~~~~l~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             ECCCCCCHHHHGG----------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eccCchhHHHHHH----------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            9999999999874          3788999999999999999999988   99999999999999776 89999999998


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .......   .....||..|+|||.-
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~  202 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELL  202 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHH
T ss_pred             EcCCCCc---cccccccccccChhhh
Confidence            7754432   2345788899997753

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.96  E-value=8.7e-29  Score=240.40  Aligned_cols=177  Identities=25%  Similarity=0.317  Sum_probs=140.2

Q ss_pred             cHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-----------ChhhHHHHHHHHHHHHhCCCCCe
Q 017411          173 SYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-----------DKESSKAFCRELMIASSLHHPNI  241 (372)
Q Consensus       173 s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-----------~~~~~~~~~~Ev~iL~~l~HpnI  241 (372)
                      ...++....++|...+.||+|+||.||+|.+.. ++.||||++...           .....+.+.+|++++++++||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            345667788999999999999999999999865 889999998542           22334789999999999999999


Q ss_pred             eceeeeEEcC----CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC
Q 017411          242 VPLVGFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (372)
Q Consensus       242 v~l~g~~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK  317 (372)
                      +++++++...    ....++||||++ |+|.+++....      ..+++..+..++.||+.||.|||+.+   |+|||||
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  161 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR------IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLH  161 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCC
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc------cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCC
Confidence            9999988542    235799999997 68888887542      46899999999999999999999988   9999999


Q ss_pred             CCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          318 PSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       318 p~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+|||++.++.+||+|||+++.......   .....||+.|+|||.
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~  204 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPEL  204 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHH
T ss_pred             hHHEEEcCCCCEEEEecCcccccccccc---cceecccceecCcHH
Confidence            9999999999999999999986544332   234578899999774

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=7.8e-29  Score=231.74  Aligned_cols=173  Identities=26%  Similarity=0.338  Sum_probs=144.0

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ....++|+..+.||+|+||.||+|... .+..||||.+.... ...+.+.+|++++++++||||+++++++.+ + ..++
T Consensus         9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-~~~~   84 (279)
T 1qpc_A            9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-PIYI   84 (279)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEE
T ss_pred             ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-C-CcEE
Confidence            344568999999999999999999986 46789999997643 235678999999999999999999998753 3 3789


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        85 v~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccc
Confidence            9999999999999975421     35899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +........ ......+++.|+|||.
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~y~aPE~  181 (279)
T 1qpc_A          157 RLIEDNEYT-AREGAKFPIKWTAPEA  181 (279)
T ss_dssp             EECSSSCEE-CCTTCCCCTTTSCHHH
T ss_pred             ccccCcccc-cccCCCCccCccChhh
Confidence            887644321 1233456777888764

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=1.3e-28  Score=236.28  Aligned_cols=171  Identities=24%  Similarity=0.360  Sum_probs=134.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHH--HHhCCCCCeeceeeeEE----cCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI--ASSLHHPNIVPLVGFCI----DPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~i--L~~l~HpnIv~l~g~~~----~~~~~  254 (372)
                      .++|++.+.||+|+||.||+|+.  +++.||||++....   ...+..|.++  +..++||||+++++.+.    .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            46899999999999999999987  47899999997543   2344455554  44589999999997543    22334


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCceEEcCCCCCCEEEcCCCc
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT------ERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~------~~~IiHrDLKp~NILld~~~~  328 (372)
                      .++||||+++|+|.+++...        ..++..++.++.||+.||.|||+..      .++|+||||||+|||++.++.
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~--------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH--------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC--------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             EEEEEecCCCCcHHHHHhhc--------ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence            68999999999999999763        4589999999999999999999871      113999999999999999999


Q ss_pred             EEEEecccccccCCCCC------CccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSV------PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~------~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+++.......      ........||+.|+|||.-
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL  200 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHH
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhh
Confidence            99999999987653321      1122345689999997753

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.96  E-value=5.6e-29  Score=232.86  Aligned_cols=166  Identities=27%  Similarity=0.460  Sum_probs=135.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||+|+||.||++.+.  ++.||||.++...  ..+.+.+|+.++++++||||+++++++.+.....++|||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   95 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   95 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence            468999999999999999999875  7899999997643  456789999999999999999999988766656899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++++|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           96 YMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CCTTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             cCCCCCHHHHHHhccc-----ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            9999999999986532     24789999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCCCccccccccCCCccCccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....     ....+++.|+|||.
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~  185 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEA  185 (278)
T ss_dssp             -------------CCTTTSCHHH
T ss_pred             cccc-----cCCCccccccCHHH
Confidence            5332     23357888998775

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.1e-28  Score=232.16  Aligned_cols=172  Identities=28%  Similarity=0.403  Sum_probs=143.2

Q ss_pred             hCCeeece-eEcccCceEEEEEEEC--CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGR-VLGRGALSFVFKGKVG--LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~-~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||||+++.. .....+.+.+|++++++++||||+++++++.. + ..+
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~-~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-ALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-SEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-C-CcE
Confidence            35677766 9999999999999864  45788999999864 44566789999999999999999999999843 3 489


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~  156 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  156 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEeCCCCCHHHHHHhCC------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccc
Confidence            9999999999999996532      46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCc-cccccccCCCccCccc
Q 017411          337 ATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      ++......... ......||+.|+|||.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPEC  184 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHH
T ss_pred             eeeeccCcceeeccccccccccccCHHH
Confidence            98875443211 1233456788998774

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.96  E-value=1.5e-28  Score=230.96  Aligned_cols=173  Identities=21%  Similarity=0.281  Sum_probs=142.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+.+++.++|++++..+.++.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            45789999999999999999999988999999998765322  2357889999999999998888887766677789999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DFGl  336 (372)
                      ||+ +++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||+   +.++.+||+|||+
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~  154 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             ECC-CCBHHHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred             Ecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence            999 999999997543      46899999999999999999999988   9999999999999   7889999999999


Q ss_pred             ccccCCCCCCc-----cccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPF-----LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~-----~~~~~~GT~gy~apeaP  364 (372)
                      ++.........     ......||+.|+|||.-
T Consensus       155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  187 (296)
T 4hgt_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTH  187 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHH
T ss_pred             ceeccCcccCccCCCCcccccCCCccccchHHh
Confidence            98876543211     22356789999997753

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=2e-28  Score=234.31  Aligned_cols=171  Identities=26%  Similarity=0.317  Sum_probs=142.6

Q ss_pred             CeeeceeEcccCceEEEEEEE----CCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLF  256 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~----~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~  256 (372)
                      .|+..+.||+|+||.||++..    ..+++.||||+++.. .....+.+.+|++++++++||||+++++++.+. ....+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            459999999999999988865    346789999999865 345567899999999999999999999998764 35589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++..        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       112 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~  180 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPR--------HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGL  180 (318)
T ss_dssp             EEECCCTTCBHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             EEEecccCCcHHHHHhh--------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccc
Confidence            99999999999999965        34899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCc-cccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      ++......... ......||..|+|||.-
T Consensus       181 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~  209 (318)
T 3lxp_A          181 AKAVPEGHEYYRVREDGDSPVFWYAPECL  209 (318)
T ss_dssp             CEECCTTCSEEEC---CCCCGGGCCHHHH
T ss_pred             cccccccccccccccCCCCCceeeChHHh
Confidence            99876543221 22345678889987653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.96  E-value=3.3e-29  Score=236.20  Aligned_cols=182  Identities=26%  Similarity=0.352  Sum_probs=129.5

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ...++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..++
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~l   90 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD-ELWL   90 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSS-CEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-CcEE
Confidence            34578999999999999999999988888999999987542 334567889999999999999999999987755 4899


Q ss_pred             EEeccCCCCHHHHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGV-RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~-~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||||+++++|.+++....... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            999999999999997532111 11256899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCC---CccccccccCCCccCcccc
Q 017411          337 ATWTSAPSV---PFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~---~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......   ........||+.|+|||.-
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  198 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVM  198 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHH
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHh
Confidence            987654321   1122345789999998754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.96  E-value=3.1e-28  Score=229.01  Aligned_cols=173  Identities=21%  Similarity=0.281  Sum_probs=146.2

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+.+++.++|++++..+.++.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            34689999999999999999999988899999999875432  2468899999999999998888877766667789999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DFGl  336 (372)
                      ||+ +++|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||+
T Consensus        85 e~~-~~~L~~~~~~~~------~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             Eec-CCCHHHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            999 999999997543      46899999999999999999999988   9999999999999   4788999999999


Q ss_pred             ccccCCCCCCc-----cccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPF-----LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~-----~~~~~~GT~gy~apeaP  364 (372)
                      ++.........     ......||+.|+|||.-
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  187 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTH  187 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHH
T ss_pred             cccccccccccccccccccccccccccCChhhh
Confidence            98876543211     12456799999997754

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.96  E-value=5e-28  Score=232.46  Aligned_cols=169  Identities=25%  Similarity=0.324  Sum_probs=142.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHh--CCCCCeeceeeeEEcCCC---e
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS--LHHPNIVPLVGFCIDPEQ---G  254 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~--l~HpnIv~l~g~~~~~~~---~  254 (372)
                      ..++|.+.+.||+|+||.||+|++.  ++.||||++...   ....+.+|++++..  ++||||+++++++.....   .
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            4468999999999999999999984  789999999653   34567889999887  789999999999877552   5


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCceEEcCCCCCCEEEcCC
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--------NGTERCVVHRDIKPSNILLSSK  326 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~~~~IiHrDLKp~NILld~~  326 (372)
                      .++||||+++|+|.+++..        ..+++..++.++.|++.||.|||        ..+   |+||||||+|||++.+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~  183 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKN  183 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTT
T ss_pred             eEEEEeecCCCcHHHHHhc--------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCC
Confidence            8999999999999999975        35899999999999999999999        555   9999999999999999


Q ss_pred             CcEEEEecccccccCCCCCCc--cccccccCCCccCcccc
Q 017411          327 KIPKLCDFGLATWTSAPSVPF--LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       327 ~~~KL~DFGla~~~~~~~~~~--~~~~~~GT~gy~apeaP  364 (372)
                      +.+||+|||+++.........  ......||+.|+|||.-
T Consensus       184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  223 (342)
T 1b6c_B          184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL  223 (342)
T ss_dssp             SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHH
T ss_pred             CCEEEEECCCceeccccccccccccccCCcCcccCCHhhh
Confidence            999999999998775443211  12345789999997753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=9.9e-29  Score=242.42  Aligned_cols=167  Identities=23%  Similarity=0.297  Sum_probs=127.6

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-----C
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----E  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-----~  252 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++...     .
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            347999999999999999999999999999999999753  445567889999999999999999999988643     1


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ...++|+||+ +++|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             CCCEEEEECC-CEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CeEEEEeccc-CCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEe
Confidence            3478999999 7899998864        35899999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |||+++.....     .....||+.|+|||.
T Consensus       175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~  200 (367)
T 2fst_X          175 DFGLARHTADE-----MTGYVATRWYRAPEI  200 (367)
T ss_dssp             C--------------------CCCTTCCHHH
T ss_pred             ecccccccccc-----CCCcCcCcCccChHH
Confidence            99999876533     234578999999775

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=8.7e-29  Score=237.99  Aligned_cols=179  Identities=23%  Similarity=0.278  Sum_probs=145.0

Q ss_pred             HHHHHhhCCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEc
Q 017411          175 GEILAATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH-HPNIVPLVGFCID  250 (372)
Q Consensus       175 ~ei~~~t~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~  250 (372)
                      .......+.|.+. +.||+|+||.||+|.+..+++.||||++...  .......+.+|+.++.+++ ||||+++++++.+
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~  100 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN  100 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence            3334445577776 8999999999999999989999999999764  2334578899999999995 6999999999876


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CC
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KK  327 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~  327 (372)
                       ....++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||..+   |+||||||+|||++.   ++
T Consensus       101 -~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A          101 -TSEIILILEYAAGGEIFSLCLPELA-----EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             -SSEEEEEEECCTTEEGGGGGSSCC------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred             -CCeEEEEEEecCCCcHHHHHHHhcc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence             4558999999999999999854322     56899999999999999999999987   999999999999988   78


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .+||+|||+++.......   .....||+.|+|||.-.
T Consensus       172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~  206 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILN  206 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHT
T ss_pred             cEEEeeCccccccCCccc---cccccCCcCccCCeeec
Confidence            999999999987754432   23457999999977543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.95  E-value=1.6e-28  Score=235.56  Aligned_cols=176  Identities=26%  Similarity=0.378  Sum_probs=140.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEE--EEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSV--AIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~v--AvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|+..+.||+|+||.||+|++..++..+  |+|.+... .....+.+.+|+++++++ +||||+++++++.+. ...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceEE
Confidence            58999999999999999999998777755  99998753 334456789999999999 899999999998764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          258 IYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ||||+++++|.+++......         ......+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence            99999999999999764200         001146899999999999999999999987   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+++......   ......+++.|+|||.-
T Consensus       181 ~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~  213 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESL  213 (327)
T ss_dssp             EEECCTTCEESSCEEC---CC----CCTTTCCHHHH
T ss_pred             EEEcccCcCccccccc---cccCCCCCccccChhhh
Confidence            9999999997543221   12334567889987743

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.95  E-value=1.9e-28  Score=233.54  Aligned_cols=167  Identities=34%  Similarity=0.498  Sum_probs=133.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||++++.  ++.||||++...  ...+.|.+|++++++++||||+++++++.+   ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEc
Confidence            57999999999999999999986  688999999754  345689999999999999999999998753   26899999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc-EEEEeccccccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI-PKLCDFGLATWT  340 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~-~KL~DFGla~~~  340 (372)
                      +++|+|.+++.....    ...+++..++.++.|+++||.|||+.+..+|+||||||+|||++.++. +||+|||+++..
T Consensus        81 ~~~~~L~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           81 AEGGSLYNVLHGAEP----LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             CTTCBHHHHHHCSSS----EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             CCCCCHHHHHhccCC----CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999976431    135788999999999999999999843344999999999999998886 799999999866


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....     ....||+.|+|||.-
T Consensus       157 ~~~~-----~~~~gt~~y~aPE~~  175 (307)
T 2eva_A          157 QTHM-----TNNKGSAAWMAPEVF  175 (307)
T ss_dssp             -------------CCTTSSCHHHH
T ss_pred             cccc-----ccCCCCCceEChhhh
Confidence            4332     234689999997754

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=4.9e-29  Score=256.32  Aligned_cols=178  Identities=25%  Similarity=0.318  Sum_probs=146.7

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      ..++....++|++.+.||+|+||.||+|.+.. +..||||+++... ...+.|.+|+++|++++||||+++++++.+  .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee--c
Confidence            34455566789999999999999999999875 4679999997643 235679999999999999999999998765  3


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+++|+|.++|.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~D  406 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVAD  406 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             cceEeeehhcCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcc
Confidence            47999999999999999976432     45899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+++....... .......++..|+|||+-
T Consensus       407 FG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~  436 (535)
T 2h8h_A          407 FGLARLIEDNEY-TARQGAKFPIKWTAPEAA  436 (535)
T ss_dssp             TTSTTTCCCHHH-HTTCSTTSCGGGSCHHHH
T ss_pred             cccceecCCCce-ecccCCcCcccccCHHHh
Confidence            999987653211 011223466778887653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=1.1e-28  Score=237.94  Aligned_cols=169  Identities=24%  Similarity=0.383  Sum_probs=144.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChh-----------------hHHHHHHHHHHHHhCCCCCeec
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----------------SSKAFCRELMIASSLHHPNIVP  243 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-----------------~~~~~~~Ev~iL~~l~HpnIv~  243 (372)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++......                 ..+.+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            46899999999999999999998  6899999998753211                 1178999999999999999999


Q ss_pred             eeeeEEcCCCeEEEEEeccCCCCHHHH------HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCC
Q 017411          244 LVGFCIDPEQGLFLIYKYVSGGSLERH------LHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDI  316 (372)
Q Consensus       244 l~g~~~~~~~~~~lV~Ey~~~gsL~~~------L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDL  316 (372)
                      +++++.+. ...++||||+++++|.++      +....     ...+++..++.++.|++.||.|||+ .+   |+||||
T Consensus       108 ~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl  178 (348)
T 2pml_X          108 CEGIITNY-DEVYIIYEYMENDSILKFDEYFFVLDKNY-----TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDV  178 (348)
T ss_dssp             CSEEEESS-SEEEEEEECCTTCBSSEESSSEESSCSSS-----CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCC
T ss_pred             EEEEEeeC-CeEEEEEeccCCCcHHHHHHHhhhhhhcc-----ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCC
Confidence            99998774 458999999999999998      43321     2579999999999999999999998 77   999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       317 Kp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|||++.++.+||+|||+++.....    ......||+.|+|||.-
T Consensus       179 ~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~  222 (348)
T 2pml_X          179 KPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFF  222 (348)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGG
T ss_pred             ChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhh
Confidence            999999999999999999999876543    22445789999997754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.4e-28  Score=255.24  Aligned_cols=174  Identities=27%  Similarity=0.388  Sum_probs=139.0

Q ss_pred             hhCCeeece-eEcccCceEEEEEEEC--CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          180 ATHNFSKGR-VLGRGALSFVFKGKVG--LLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       180 ~t~~f~~~~-~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ..+++...+ .||+|+||.||+|.+.  ..+..||||+++.. .....+.|.+|+++|++++|||||+++++|.. + ..
T Consensus       333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~-~~  410 (613)
T 2ozo_A          333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-AL  410 (613)
T ss_dssp             CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S-SE
T ss_pred             cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C-Ce
Confidence            344555555 8999999999999875  34567999999764 33456789999999999999999999999865 3 48


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFG  481 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFG  481 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCS
T ss_pred             EEEEEeCCCCcHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeecc
Confidence            99999999999999997542      46899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      +++......... ......+|+.|+|||+-
T Consensus       482 la~~~~~~~~~~~~~~~~~~~~~y~APE~~  511 (613)
T 2ozo_A          482 LSKALGADDSYYTARSAGKWPLKWYAPECI  511 (613)
T ss_dssp             TTTTCC--------------CCTTSCHHHH
T ss_pred             CcccccCCCceeeeccCCCCccceeCHhhh
Confidence            998875443211 12233466889997754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=8e-29  Score=240.41  Aligned_cols=170  Identities=16%  Similarity=0.229  Sum_probs=141.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC--------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeec---------
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP---------  243 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~---------  243 (372)
                      .++|.+.+.||+|+||.||+|.+..        .++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999976        3789999999754     35789999999999999988         


Q ss_pred             ------eeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC
Q 017411          244 ------LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (372)
Q Consensus       244 ------l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK  317 (372)
                            +++++...+...++||||+ +++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+|||||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik  186 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-----HVLSERSVLQVACRLLDALEFLHENE---YVHGNVT  186 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-----GCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence                  5667666566789999999 9999999986522     46999999999999999999999987   9999999


Q ss_pred             CCCEEEcCCC--cEEEEecccccccCCCCCC-----ccccccccCCCccCcccc
Q 017411          318 PSNILLSSKK--IPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       318 p~NILld~~~--~~KL~DFGla~~~~~~~~~-----~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||++.++  .+||+|||+++........     .......||+.|+|||.-
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  240 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH  240 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence            9999999998  9999999999876533211     112345789999997754

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=4.1e-28  Score=237.59  Aligned_cols=165  Identities=22%  Similarity=0.307  Sum_probs=138.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe----
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG----  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~----  254 (372)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46899999999999999999999999999999999764  444567889999999999999999999998764431    


Q ss_pred             -EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          255 -LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       255 -~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                       .++||||+. ++|.+++.         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       121 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~D  187 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG---------MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  187 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECS
T ss_pred             eEEEEEcccc-ccHHHHhh---------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEe
Confidence             389999996 68888763         34899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++......     ....||+.|+|||.
T Consensus       188 fg~a~~~~~~~-----~~~~~t~~y~aPE~  212 (371)
T 4exu_A          188 FGLARHADAEM-----TGYVVTRWYRAPEV  212 (371)
T ss_dssp             TTCC-------------CTTCCCTTSCHHH
T ss_pred             cCcccccccCc-----CCcccCccccCHHH
Confidence            99998765432     34578999999775

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=3.1e-28  Score=242.93  Aligned_cols=169  Identities=29%  Similarity=0.364  Sum_probs=137.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-----CCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-----~~~~~  256 (372)
                      .+|+..+.||+|+||.||+|++..+++.||||++.....    .+.+|+++|++++||||+++++++...     ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            479999999999999999999998899999999865422    234799999999999999999987542     12367


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEEEecc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFG  335 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL~DFG  335 (372)
                      +||||+++ +|.+.+......   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.+ +.+||+|||
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG  202 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRA---KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFG  202 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eehhcccc-cHHHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccch
Confidence            99999975 677776543211   157999999999999999999999887   9999999999999965 678999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +++.......   .....||+.|+|||.-
T Consensus       203 ~a~~~~~~~~---~~~~~~t~~y~aPE~~  228 (420)
T 1j1b_A          203 SAKQLVRGEP---NVSYICSRYYRAPELI  228 (420)
T ss_dssp             TCEECCTTCC---CCSCCSCTTSCCHHHH
T ss_pred             hhhhcccCCC---ceeeeeCCCcCCHHHH
Confidence            9997654432   2345789999997753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.95  E-value=1.4e-28  Score=238.19  Aligned_cols=173  Identities=18%  Similarity=0.255  Sum_probs=136.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC---CCeEEEEEEecCCChh-----------hHHHHHHHHHHHHhCCCCCeeceee
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKEDKE-----------SSKAFCRELMIASSLHHPNIVPLVG  246 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~~~~-----------~~~~~~~Ev~iL~~l~HpnIv~l~g  246 (372)
                      .++|.+.+.||+|+||.||+|.+..   ++..||||++......           ....+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            3689999999999999999999976   6789999998765321           1124668889999999999999999


Q ss_pred             eEEcC---CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE
Q 017411          247 FCIDP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL  323 (372)
Q Consensus       247 ~~~~~---~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl  323 (372)
                      ++...   ....++||||+ +++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||+
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  184 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-------GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL  184 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-------GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEE
Confidence            98762   45589999999 99999998764       36899999999999999999999987   9999999999999


Q ss_pred             cCCC--cEEEEecccccccCCCCCC-----ccccccccCCCccCcccc
Q 017411          324 SSKK--IPKLCDFGLATWTSAPSVP-----FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       324 d~~~--~~KL~DFGla~~~~~~~~~-----~~~~~~~GT~gy~apeaP  364 (372)
                      +.++  .+||+|||+++.+......     .......||+.|+|||.-
T Consensus       185 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  232 (345)
T 2v62_A          185 GYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAH  232 (345)
T ss_dssp             ESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHH
T ss_pred             ccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHh
Confidence            9887  9999999999876432211     112345789999997753

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=2e-28  Score=239.47  Aligned_cols=169  Identities=14%  Similarity=0.055  Sum_probs=125.4

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhC--CCCCeecee-------eeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSL--HHPNIVPLV-------GFC  248 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l--~HpnIv~l~-------g~~  248 (372)
                      ..+|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            446999999999999999999999899999999998753   23455677885444444  699988754       333


Q ss_pred             EcCC----------------CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHHcC
Q 017411          249 IDPE----------------QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR------YKVALGIAESVAYLHNG  306 (372)
Q Consensus       249 ~~~~----------------~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~------~~i~~qia~gL~yLH~~  306 (372)
                      ....                ...++||||++ |+|.+++.....      .+.+..+      +.++.||+.||.|||+.
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~------~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~  213 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF------VYVFRGDEGILALHILTAQLIRLAANLQSK  213 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH------SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc------ccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence            2211                23799999998 899999987532      3455555      67889999999999998


Q ss_pred             CCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       307 ~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +   |+||||||+|||++.++.+||+|||+|+......     ....||+.|+|||.-
T Consensus       214 ~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~  263 (371)
T 3q60_A          214 G---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFL  263 (371)
T ss_dssp             T---EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHH
T ss_pred             C---CccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhc
Confidence            8   9999999999999999999999999998764321     244577889987754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.95  E-value=8.2e-28  Score=240.61  Aligned_cols=168  Identities=21%  Similarity=0.267  Sum_probs=142.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC------CCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL------HHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l------~HpnIv~l~g~~~~~~~~  254 (372)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+++++.+      .|+||+++++++... ..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-Ce
Confidence            45799999999999999999999999999999999753 34456778888888876      577999999998764 45


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc--EEEE
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI--PKLC  332 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~--~KL~  332 (372)
                      .++||||+. ++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.  +||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~  244 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF-----QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI  244 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred             EEEEEeccC-CCHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence            899999995 699999987532     45899999999999999999999987   999999999999999987  9999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++......     .+..||+.|+|||.-
T Consensus       245 DFG~a~~~~~~~-----~~~~gt~~y~aPE~~  271 (429)
T 3kvw_A          245 DFGSSCYEHQRV-----YTYIQSRFYRAPEVI  271 (429)
T ss_dssp             CCTTCEETTCCC-----CSSCSCGGGCCHHHH
T ss_pred             ecccceecCCcc-----cccCCCCCccChHHH
Confidence            999998754332     345789999997753

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.95  E-value=5.5e-28  Score=236.30  Aligned_cols=169  Identities=22%  Similarity=0.288  Sum_probs=141.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC--------CCCeeceeeeEEc--
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH--------HPNIVPLVGFCID--  250 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~--------HpnIv~l~g~~~~--  250 (372)
                      .++|.+.+.||+|+||.||+|++..+++.||||++... ....+.+.+|+.+++.++        |+||+++++++..  
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36899999999999999999999989999999999754 445677899999999985        7889999998762  


Q ss_pred             -CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCC-
Q 017411          251 -PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKK-  327 (372)
Q Consensus       251 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~-  327 (372)
                       .....++||||+ +++|.+++.....     ..+++..++.++.||+.||.|||+. +   |+||||||+|||++.++ 
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~  185 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNY-----QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQ  185 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccch
Confidence             234589999999 6677777665422     4689999999999999999999987 7   99999999999999775 


Q ss_pred             ------------------------------------------------cEEEEecccccccCCCCCCccccccccCCCcc
Q 017411          328 ------------------------------------------------IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQN  359 (372)
Q Consensus       328 ------------------------------------------------~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~  359 (372)
                                                                      .+||+|||+++......     ....||+.|+
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~  260 (397)
T 1wak_A          186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYR  260 (397)
T ss_dssp             HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGC
T ss_pred             hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCccc
Confidence                                                            79999999998775432     3357899999


Q ss_pred             Ccccc
Q 017411          360 PFCIE  364 (372)
Q Consensus       360 apeaP  364 (372)
                      |||.-
T Consensus       261 aPE~~  265 (397)
T 1wak_A          261 SLEVL  265 (397)
T ss_dssp             CHHHH
T ss_pred             CChhh
Confidence            97753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=4e-28  Score=256.20  Aligned_cols=164  Identities=25%  Similarity=0.363  Sum_probs=140.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC-CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe----
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL-LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG----  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~----  254 (372)
                      .++|++.+.||+|+||.||+|.+.. +++.||||++... .......+.+|++++++++||||+++++++...+..    
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999975 6899999998654 445566789999999999999999999998764432    


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .|+||||+++++|.+++.         ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+ .+||+||
T Consensus       159 ~~lv~E~~~g~~L~~~~~---------~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF  225 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKG---------QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL  225 (681)
T ss_dssp             EEEEEECCCCEECC-------------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred             eEEEEEeCCCCcHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence            699999999999988764         25899999999999999999999988   9999999999999886 8999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+++.....      ....||++|+|||.
T Consensus       226 G~a~~~~~~------~~~~gt~~y~aPE~  248 (681)
T 2pzi_A          226 GAVSRINSF------GYLYGTPGFQAPEI  248 (681)
T ss_dssp             TTCEETTCC------SCCCCCTTTSCTTH
T ss_pred             ccchhcccC------CccCCCccccCHHH
Confidence            999877543      34579999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=2.9e-28  Score=255.60  Aligned_cols=165  Identities=24%  Similarity=0.336  Sum_probs=134.9

Q ss_pred             eeEcccCceEEEEEEE--CCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKV--GLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~--~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.+  ..+++.||||+++..  .....+.+.+|+++|++++|||||++++++.. + ..++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~-~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-E-SWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-SEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-C-CEEEEEEccC
Confidence            4799999999999965  455689999999764  33456789999999999999999999999864 3 3789999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus       453 ~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          453 LGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             TEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             CCCHHHHHhhC-------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            99999999754       46899999999999999999999988   999999999999999999999999999987654


Q ss_pred             CCCc-cccccccCCCccCcccc
Q 017411          344 SVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      .... ......||+.|+|||+-
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~  544 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECI  544 (635)
T ss_dssp             ------------CGGGSCHHHH
T ss_pred             ccccccccCCCCceeeeChhhh
Confidence            3221 22334567889997754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.95  E-value=7.3e-28  Score=226.53  Aligned_cols=168  Identities=26%  Similarity=0.402  Sum_probs=144.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++.+ ....++|+
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~  100 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYIVG  100 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEEEEE
Confidence            5899999999999999999999888999999998653  23445788999999999999999999999876 45589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC---CcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK---KIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~---~~~KL~DFGl  336 (372)
                      ||+++++|.+++...       ..+++..++.++.||+.||.|||..+   |+||||||+||+++.+   +.+||+|||+
T Consensus       101 e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A          101 ELYTGGELFDEIIKR-------KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             CCCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999998765       45899999999999999999999987   9999999999999764   4799999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.......   .....||+.|+|||.
T Consensus       171 ~~~~~~~~~---~~~~~~~~~y~aPE~  194 (287)
T 2wei_A          171 STCFQQNTK---MKDRIGTAYYIAPEV  194 (287)
T ss_dssp             GGTBCCCSS---CSCHHHHHTTCCHHH
T ss_pred             ceeecCCCc---cccccCcccccChHH
Confidence            987654432   233468889999774

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=6.1e-29  Score=257.68  Aligned_cols=161  Identities=14%  Similarity=0.120  Sum_probs=124.5

Q ss_pred             eEcccCceEEEEEEECCCCeEEEEEEecCC----------ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          189 VLGRGALSFVFKGKVGLLRTSVAIKRLDKE----------DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       189 ~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~----------~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..+.|++|.+..++....|+.||+|++.+.          .....++|.+|+++|+++ .|+||+++++++.+ ++..||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence            345666666666665556889999999754          134456799999999999 69999999998876 556999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||++|++|.++|...       ..++..   +|+.||+.||.|+|+++   ||||||||+|||++.+|++||+|||+|
T Consensus       320 VMEyv~G~~L~d~i~~~-------~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlA  386 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAG-------EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSI  386 (569)
T ss_dssp             EEECCCSEEHHHHHHTT-------CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTE
T ss_pred             EEecCCCCcHHHHHHhC-------CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccC
Confidence            99999999999999764       356553   58999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +.......  ...+.+||++|||||.-.
T Consensus       387 r~~~~~~~--~~~t~vGTp~YmAPE~l~  412 (569)
T 4azs_A          387 VTTPQDCS--WPTNLVQSFFVFVNELFA  412 (569)
T ss_dssp             ESCC---C--CSHHHHHHHHHHHHHHC-
T ss_pred             eeCCCCCc--cccCceechhhccHHHhC
Confidence            97765433  345678999999988643

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.95  E-value=3.4e-28  Score=228.22  Aligned_cols=172  Identities=25%  Similarity=0.381  Sum_probs=134.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECC-CC--eEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGL-LR--TSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~-~~--~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~  254 (372)
                      .++|+..+.||+|+||.||+|.+.. ++  ..||||+++..   .....+.+.+|++++++++||||+++++++.+..  
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP--   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS--
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC--
Confidence            3589999999999999999998632 23  36999998754   3345678999999999999999999999886543  


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .++|+||+++++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Df  165 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDF  165 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCC
T ss_pred             ceeeEecccCCCHHHHHHhcc------CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccc
Confidence            789999999999999998753      35899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCCCc-cccccccCCCccCccc
Q 017411          335 GLATWTSAPSVPF-LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       335 Gla~~~~~~~~~~-~~~~~~GT~gy~apea  363 (372)
                      |+++......... ......+|+.|+|||.
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  195 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPES  195 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHH
T ss_pred             cccccccccccchhhhccCCCCceeeCchh
Confidence            9998875443221 2234467778888764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.95  E-value=2.1e-28  Score=233.06  Aligned_cols=181  Identities=23%  Similarity=0.310  Sum_probs=141.8

Q ss_pred             ccccHHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCC--CCCeecee
Q 017411          170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLH--HPNIVPLV  245 (372)
Q Consensus       170 ~~~s~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~--HpnIv~l~  245 (372)
                      ..+.+..+....++|++.+.||+|+||.||++.+.. ++.||||++...  .....+.+.+|+.++.+++  ||||++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            344555555667789999999999999999999864 889999999754  4456678999999999997  59999999


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC
Q 017411          246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       246 g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~  325 (372)
                      +++.+ +...++||| +.+++|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.
T Consensus        95 ~~~~~-~~~~~lv~e-~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~  162 (313)
T 3cek_A           95 DYEIT-DQYIYMVME-CGNIDLNSWLKKK-------KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD  162 (313)
T ss_dssp             EEEEC-SSEEEEEEC-CCSEEHHHHHHHC-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET
T ss_pred             EEeec-CCEEEEEEe-cCCCcHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC
Confidence            99876 445899999 5588999999864       46899999999999999999999987   999999999999964


Q ss_pred             CCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                       +.+||+|||+++...............||+.|+|||.-
T Consensus       163 -~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  200 (313)
T 3cek_A          163 -GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI  200 (313)
T ss_dssp             -TEEEECCCSSSCC--------------CCGGGCCHHHH
T ss_pred             -CeEEEeeccccccccCccccccccCCCCCCCcCCHHHH
Confidence             89999999999877554432233455789999997764

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.1e-28  Score=232.68  Aligned_cols=171  Identities=26%  Similarity=0.323  Sum_probs=138.5

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHHhC----CCCCeeceeee
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSL----HHPNIVPLVGF  247 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l----~HpnIv~l~g~  247 (372)
                      ....++|++.+.||+|+||.||+|.+..+++.||||+++....      .....+.+|+.++.++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3445789999999999999999999988899999999976432      1233466799999988    89999999998


Q ss_pred             EEcCCCeEEEEEec-cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-C
Q 017411          248 CIDPEQGLFLIYKY-VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-S  325 (372)
Q Consensus       248 ~~~~~~~~~lV~Ey-~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-~  325 (372)
                      +...+ ..++|+|| +.+++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+||+++ .
T Consensus       107 ~~~~~-~~~~v~e~~~~~~~L~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          107 FETQE-GFMLVLERPLPAQDLFDYITEK-------GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLR  175 (312)
T ss_dssp             C------CEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETT
T ss_pred             EecCC-eEEEEEEecCCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCC
Confidence            87644 47899999 7899999999875       46899999999999999999999987   99999999999999 8


Q ss_pred             CCcEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          326 KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.+||+|||+++......    .....||..|+|||.
T Consensus       176 ~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~  209 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEW  209 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHH
T ss_pred             CCeEEEEEcchhhhcccCc----ccccCCcccccCcee
Confidence            8999999999998876443    234568999999774

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.95  E-value=1.4e-27  Score=227.96  Aligned_cols=168  Identities=22%  Similarity=0.270  Sum_probs=141.8

Q ss_pred             hCCeeeceeEcccCceEEEEEEE-CCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCC------CeeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKV-GLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP------NIVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~-~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp------nIv~l~g~~~~~~~  253 (372)
                      .++|++.+.||+|+||.||+|.+ ..+++.||||+++.. ....+.+.+|+.+++.++|+      +++++++++... .
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-G   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-T
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-C
Confidence            36899999999999999999998 557899999999754 34556788999999988765      499999988764 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC--------
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--------  325 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~--------  325 (372)
                      ..++||||+ +++|.+++.....     ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.        
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGF-----LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccC
Confidence            589999999 8899999976532     46899999999999999999999987   999999999999987        


Q ss_pred             -----------CCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          326 -----------KKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       326 -----------~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                                 ++.+||+|||+++......     ....||+.|+|||.-
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~  206 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVI  206 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHH
T ss_pred             CccccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHh
Confidence                       6689999999998754332     345789999997753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=5.2e-28  Score=234.22  Aligned_cols=176  Identities=26%  Similarity=0.302  Sum_probs=132.2

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---  253 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---  253 (372)
                      .....++|++.+.||+|+||.||+|.+..+++.||||++.... .....+.+|++.+..++||||+++++++.....   
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~   96 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR   96 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence            4456689999999999999999999999889999999986542 223456788888999999999999999865322   


Q ss_pred             ---eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCceEEcCCCCCCEEEcC-CC
Q 017411          254 ---GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH--NGTERCVVHRDIKPSNILLSS-KK  327 (372)
Q Consensus       254 ---~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~~~~IiHrDLKp~NILld~-~~  327 (372)
                         ..++||||+++ +|...+......   ...+++..+..++.|++.||.|||  ..+   |+||||||+|||++. ++
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           97 RDIYLNVVMEYVPD-TLHRCCRNYYRR---QVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             TCEEEEEEEECCSC-BHHHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             cceeEEEEeecccc-cHHHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence               27899999975 666555432211   157899999999999999999999  666   999999999999997 89


Q ss_pred             cEEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          328 IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .+||+|||+++.......   .....||+.|+|||.
T Consensus       170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~  202 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPEL  202 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHH
T ss_pred             cEEEeeCCCceecCCCCC---cccccCCcceeCHHH
Confidence            999999999987764432   234578999999775

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=7.4e-28  Score=233.49  Aligned_cols=165  Identities=22%  Similarity=0.315  Sum_probs=138.7

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-----
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-----  253 (372)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46899999999999999999999989999999999753  34456788999999999999999999999876433     


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+. ++|.+++.         ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~lv~e~~~-~~l~~~~~---------~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG---------LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECS
T ss_pred             eEEEEecccc-CCHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEee
Confidence            2489999997 68877763         34899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+++......     ....||+.|+|||.
T Consensus       170 fg~~~~~~~~~-----~~~~~t~~y~aPE~  194 (353)
T 3coi_A          170 FGLARHADAEM-----TGYVVTRWYRAPEV  194 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHH
T ss_pred             cccccCCCCCc-----cccccCcCcCCHHH
Confidence            99998764332     34578999999775

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=7.8e-28  Score=229.61  Aligned_cols=173  Identities=29%  Similarity=0.366  Sum_probs=140.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEEC-CCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhC---CCCCeeceeeeEEc---
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVG-LLRTSVAIKRLDKED--KESSKAFCRELMIASSL---HHPNIVPLVGFCID---  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~-~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~---  250 (372)
                      ..++|++.+.||+|+||.||+|.+. .+++.||||++....  ......+.+|+.+++.+   +||||+++++++..   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999985 678899999986432  12223466777776665   89999999998862   


Q ss_pred             -CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcE
Q 017411          251 -PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP  329 (372)
Q Consensus       251 -~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~  329 (372)
                       .....++||||+. |+|.+++.....     ..+++..++.++.||+.||.|||..+   |+||||||+|||++.++.+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE-----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT-----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCE
Confidence             3445899999997 699999986532     45899999999999999999999988   9999999999999999999


Q ss_pred             EEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|||+++......   ......||+.|+|||.-
T Consensus       160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~  191 (326)
T 1blx_A          160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVL  191 (326)
T ss_dssp             EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHH
T ss_pred             EEecCcccccccCCC---CccccccccceeCHHHH
Confidence            999999998765322   22445789999997753

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=7e-28  Score=238.46  Aligned_cols=176  Identities=26%  Similarity=0.428  Sum_probs=127.1

Q ss_pred             Ceee-ceeEcccCceEEEEEEEC--CCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc-CCCeEEEE
Q 017411          183 NFSK-GRVLGRGALSFVFKGKVG--LLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID-PEQGLFLI  258 (372)
Q Consensus       183 ~f~~-~~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-~~~~~~lV  258 (372)
                      .|.. +++||+|+||.||+|++.  .+++.||||++.....  ...+.+|+.+|++++||||+++++++.. .+...++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            4555 468999999999999976  4678999999975432  2468899999999999999999999864 35568999


Q ss_pred             EeccCCCCHHHHHHhhccC--CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE----cCCCcEEEE
Q 017411          259 YKYVSGGSLERHLHEKKKG--VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----SSKKIPKLC  332 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~--~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl----d~~~~~KL~  332 (372)
                      |||+. ++|.+++......  ......+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99996 5888888643211  011135899999999999999999999988   9999999999999    677899999


Q ss_pred             ecccccccCCCCCC-ccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      |||+|+........ .......||+.|+|||+-
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  207 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELL  207 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhh
Confidence            99999887543221 123456799999997753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.95  E-value=1.7e-27  Score=228.13  Aligned_cols=175  Identities=23%  Similarity=0.278  Sum_probs=128.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHH-HHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELM-IASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~-iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|...+.||+|+||.||+|.+..+++.||||++... .......+.+|+. +++.++||||+++++++.+. ...++
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~l   98 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWI   98 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEE
Confidence            346899999999999999999999988999999999764 3344455666666 67778999999999998774 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||||+++ +|.+++......  ....+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+
T Consensus        99 v~e~~~~-~l~~~~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSV--LDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHT--TCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             EEeecCC-ChHHHHHHHHhh--hcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCC
Confidence            9999975 888887643211  115789999999999999999999987 7   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......   .....||+.|+|||.-
T Consensus       173 ~~~~~~~~~---~~~~~gt~~y~aPE~~  197 (327)
T 3aln_A          173 SGQLVDSIA---KTRDAGCRPYMAPERI  197 (327)
T ss_dssp             SCC-------------------------
T ss_pred             ceecccccc---cccCCCCccccCceee
Confidence            987654322   2334689999998764

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.95  E-value=1.1e-27  Score=251.99  Aligned_cols=177  Identities=25%  Similarity=0.334  Sum_probs=143.8

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECC---CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGL---LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~---~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      +.....++|+..+.||+|+||.||+|.+..   .+..||||.++.. .....+.+.+|+.++++++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            344455689999999999999999999854   3467999998764 44555789999999999999999999998743 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                       +..++||||+++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL  532 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVRK------FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKL  532 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHTT------TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEE
T ss_pred             -CceEEEEEcCCCCcHHHHHHhcc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEE
Confidence             34789999999999999997643      46899999999999999999999987   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCcccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|||+++........ ......||+.|+|||.-
T Consensus       533 ~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~  564 (656)
T 2j0j_A          533 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESI  564 (656)
T ss_dssp             CCCCCCCSCCC-----------CCGGGCCHHHH
T ss_pred             EecCCCeecCCCcce-eccCCCCCcceeCHHHh
Confidence            999999877544321 22344577889997753

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.95  E-value=1.1e-27  Score=237.00  Aligned_cols=167  Identities=29%  Similarity=0.366  Sum_probs=133.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-----eEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----GLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-----~~~  256 (372)
                      .+|...+.||+|+||.||+|++..+++ ||+|++.....    ...+|+++++.++||||+++++++.....     ..+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            479999999999999999999976554 88888764322    22379999999999999999999864322     378


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-CCCcEEEEecc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFG  335 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-~~~~~KL~DFG  335 (372)
                      +||||++++ +.+.+......   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++ .++.+||+|||
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKL---KQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEeeccCcc-HHHHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence            999999764 44444322111   157899999999999999999999988   99999999999999 78999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|+.......   .....||+.|+|||.
T Consensus       188 ~a~~~~~~~~---~~~~~~t~~y~aPE~  212 (394)
T 4e7w_A          188 SAKILIAGEP---NVSYICSRYYRAPEL  212 (394)
T ss_dssp             TCEECCTTCC---CCSSCSCGGGCCHHH
T ss_pred             CcccccCCCC---CcccccCcCccCHHH
Confidence            9988754432   234578999999775

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=6.7e-28  Score=231.13  Aligned_cols=170  Identities=24%  Similarity=0.312  Sum_probs=144.5

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------hhHHHHHHHHHHHHhCC--CCCeeceeeeEEcC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------ESSKAFCRELMIASSLH--HPNIVPLVGFCIDP  251 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~  251 (372)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++.....      ...+.+.+|+.++++++  ||||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            45689999999999999999999988899999999975421      12245678999999996  59999999998764


Q ss_pred             CCeEEEEEeccCC-CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-CCCcE
Q 017411          252 EQGLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIP  329 (372)
Q Consensus       252 ~~~~~lV~Ey~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-~~~~~  329 (372)
                       ...++|+|++.+ ++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ .++.+
T Consensus       121 -~~~~lv~e~~~~~~~L~~~l~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~  189 (320)
T 3a99_A          121 -DSFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGEL  189 (320)
T ss_dssp             -SEEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEE
T ss_pred             -CcEEEEEEcCCCCccHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCE
Confidence             458999999976 8999999875       46899999999999999999999988   99999999999999 77999


Q ss_pred             EEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          330 KLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       330 KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|||+++......    .....||+.|+|||.-
T Consensus       190 kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~  220 (320)
T 3a99_A          190 KLIDFGSGALLKDTV----YTDFDGTRVYSPPEWI  220 (320)
T ss_dssp             EECCCTTCEECCSSC----BCCCCSCGGGSCHHHH
T ss_pred             EEeeCcccccccccc----ccCCCCCccCCChHHh
Confidence            999999998876432    2345689999997743

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.95  E-value=2.1e-27  Score=241.51  Aligned_cols=172  Identities=24%  Similarity=0.273  Sum_probs=141.5

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|.+.+.||+|+||.||+|.+..+++.||||++.....  ...+.+|+++++.++|++.+..+.++.......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            4689999999999999999999988899999998875432  23578999999999875555544444444566899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE---cCCCcEEEEecccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL---SSKKIPKLCDFGLA  337 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl---d~~~~~KL~DFGla  337 (372)
                      |+ +++|.+++....      ..+++..++.|+.||+.||.|||..+   |+||||||+||||   +.++.+||+|||++
T Consensus        84 ~~-g~sL~~ll~~~~------~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             CC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             CC-CCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99 999999997643      46999999999999999999999988   9999999999999   68899999999999


Q ss_pred             cccCCCCCCc-----cccccccCCCccCcccc
Q 017411          338 TWTSAPSVPF-----LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~-----~~~~~~GT~gy~apeaP  364 (372)
                      +.........     ......||+.|+|||.-
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  185 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTH  185 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHH
T ss_pred             eeccCCccccccccccccccCCCccccCHHHh
Confidence            8876543211     12356799999997764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=3e-27  Score=228.46  Aligned_cols=169  Identities=23%  Similarity=0.268  Sum_probs=123.4

Q ss_pred             hhCCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc---CCCeE
Q 017411          180 ATHNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCID---PEQGL  255 (372)
Q Consensus       180 ~t~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~---~~~~~  255 (372)
                      ..++|.+. +.||+|+||.||+|.+..+++.||||++.... .   ...+....++.++||||+++++++..   .....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            34689985 46999999999999999899999999997532 1   12223344677799999999998764   23347


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLC  332 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL~  332 (372)
                      ++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||..+   |+||||||+|||++.   ++.+||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGD-----QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-C-----CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             EEEEeccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEe
Confidence            899999999999999986532     46999999999999999999999987   999999999999976   4559999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCcccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |||+++......    .....||+.|+|||.-
T Consensus       174 Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~  201 (336)
T 3fhr_A          174 DFGFAKETTQNA----LQTPCYTPYYVAPEVL  201 (336)
T ss_dssp             CCTTCEEC------------------------
T ss_pred             ccccceeccccc----cccCCCCcCccChhhh
Confidence            999998765432    2345789999998753

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.95  E-value=6.2e-27  Score=225.17  Aligned_cols=168  Identities=19%  Similarity=0.266  Sum_probs=140.1

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC-eEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC------eeceeeeEEcCCC
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR-TSVAIKRLDKEDKESSKAFCRELMIASSLHHPN------IVPLVGFCIDPEQ  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~-~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn------Iv~l~g~~~~~~~  253 (372)
                      .++|++.+.||+|+||.||+|.+..++ +.||||+++.. ....+.+.+|+.++++++|++      ++.+++++... .
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-G   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-T
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-C
Confidence            468999999999999999999997666 78999999753 345567889999999987765      88888887664 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEE----------
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILL----------  323 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILl----------  323 (372)
                      ..++||||+ +++|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||+          
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~  166 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNF-----QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYN  166 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTT-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEEC
T ss_pred             eEEEEEecc-CCChHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccc
Confidence            589999999 6678777765432     46899999999999999999999887   9999999999999          


Q ss_pred             ---------cCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          324 ---------SSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       324 ---------d~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                               +.++.+||+|||+++......     ....||+.|+|||.-
T Consensus       167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~  211 (355)
T 2eu9_A          167 EHKSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVI  211 (355)
T ss_dssp             CC-CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHH
T ss_pred             ccccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeee
Confidence                     567899999999998754332     345789999997754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.95  E-value=3e-27  Score=229.68  Aligned_cols=169  Identities=20%  Similarity=0.282  Sum_probs=142.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-----------CCCeeceeeeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----------HPNIVPLVGFCI  249 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----------HpnIv~l~g~~~  249 (372)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36899999999999999999999888999999999753 344567889999998886           899999999887


Q ss_pred             cCC---CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEc-
Q 017411          250 DPE---QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLS-  324 (372)
Q Consensus       250 ~~~---~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld-  324 (372)
                      ...   ...++||||+ +++|.+++.....     ..+++..+..++.||+.||.|||+. +   |+||||||+|||++ 
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-----RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEI  167 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhc-----cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEec
Confidence            532   2578999999 8999999987532     4589999999999999999999997 7   99999999999994 


Q ss_pred             -----CCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          325 -----SKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       325 -----~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                           ..+.+||+|||+++......     ....||+.|+|||.-
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~  207 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVL  207 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHH
T ss_pred             cCCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHH
Confidence                 34589999999998775432     334789999997753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.94  E-value=3.9e-27  Score=223.74  Aligned_cols=171  Identities=23%  Similarity=0.349  Sum_probs=125.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhh-HHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KES-SKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~-~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++.... ... .+.+.++..+++.++||||+++++++.+. ...++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~l  101 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFI  101 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEE
Confidence            3468999999999999999999999889999999997643 222 33444555678888999999999998764 45899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||||+ ++.+..+.....      ..+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+
T Consensus       102 v~e~~-~~~~~~l~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~  171 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQ------GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGI  171 (318)
T ss_dssp             EECCC-SEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecc-CCcHHHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCC
Confidence            99999 556666655432      4689999999999999999999984 6   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ++.......   .....||+.|+|||.-
T Consensus       172 ~~~~~~~~~---~~~~~~~~~y~aPE~~  196 (318)
T 2dyl_A          172 SGRLVDDKA---KDRSAGCAAYMAPERI  196 (318)
T ss_dssp             C-----------------CCTTCCHHHH
T ss_pred             chhccCCcc---ccccCCCccccChhhc
Confidence            987654332   2345689999997753

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.94  E-value=1.1e-26  Score=228.12  Aligned_cols=172  Identities=20%  Similarity=0.222  Sum_probs=142.1

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CC-----CeeceeeeEEcCC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HP-----NIVPLVGFCIDPE  252 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-Hp-----nIv~l~g~~~~~~  252 (372)
                      ...++|++.+.||+|+||.||+|.+..+++.||||+++.. ......+.+|+.+++.++ |+     +|+++++++... 
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence            3457999999999999999999999989999999999753 344567788999988885 55     499999988764 


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc--CCCcEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPK  330 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld--~~~~~K  330 (372)
                      ...++||||++ ++|.+++.....     ..+++..+..++.|++.||.|||++. .+|+||||||+|||++  .++.+|
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNF-----RGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTT-----SCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEE
T ss_pred             CceEEEEecCC-CCHHHHHhhcCc-----CCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEE
Confidence            45899999995 599999987532     45899999999999999999999532 3499999999999995  478899


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+++......     ....||+.|+|||.-
T Consensus       202 L~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~  230 (382)
T 2vx3_A          202 IVDFGSSCQLGQRI-----YQYIQSRFYRSPEVL  230 (382)
T ss_dssp             ECCCTTCEETTCCC-----CSSCSCGGGCCHHHH
T ss_pred             EEeccCceeccccc-----ccccCCccccChHHH
Confidence            99999998875432     345789999997753

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.94  E-value=1.2e-27  Score=227.71  Aligned_cols=177  Identities=25%  Similarity=0.382  Sum_probs=139.9

Q ss_pred             HHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCC
Q 017411          175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPE  252 (372)
Q Consensus       175 ~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~  252 (372)
                      .++....++|+..+.||+|+||.||+|.+..   .||+|+++..  .....+.+.+|+.++++++||||+++++++.+..
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            3444456799999999999999999999864   4999998753  2233456788999999999999999999988754


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                       ..++||||+++++|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+
T Consensus       103 -~~~iv~e~~~~~~L~~~l~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~  171 (319)
T 2y4i_B          103 -HLAIITSLCKGRTLYSVVRDAK------IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVIT  171 (319)
T ss_dssp             -CEEEECBCCCSEEHHHHTTSSC------CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEEC
T ss_pred             -ceEEEeecccCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEe
Confidence             4899999999999999997542      46899999999999999999999987   99999999999998 6799999


Q ss_pred             ecccccccCCCCC---CccccccccCCCccCccccc
Q 017411          333 DFGLATWTSAPSV---PFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       333 DFGla~~~~~~~~---~~~~~~~~GT~gy~apeaPE  365 (372)
                      |||+++.......   ........||+.|+|||.-.
T Consensus       172 Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~  207 (319)
T 2y4i_B          172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR  207 (319)
T ss_dssp             CCSCCC----------CCSCBCCSGGGGTSCHHHHS
T ss_pred             ecCCccccccccccccccccccCCCcccccChHHhh
Confidence            9999876532211   11223446888899877643

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.94  E-value=9.1e-27  Score=233.22  Aligned_cols=174  Identities=22%  Similarity=0.237  Sum_probs=126.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      +.|...+.||+|+||+||.+.. .+++.||||++...   ..+.+.+|+.++.++ +||||+++++++.+ +...++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEe
Confidence            4566678999999999986544 45889999998653   235678999999876 89999999998765 456899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-------------C
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-------------K  327 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-------------~  327 (372)
                      |+. |+|.+++.............++..++.++.||+.||.|||+.+   |+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            995 6999999865321110011233456789999999999999987   9999999999999754             4


Q ss_pred             cEEEEecccccccCCCCCCc--cccccccCCCccCcccc
Q 017411          328 IPKLCDFGLATWTSAPSVPF--LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       328 ~~KL~DFGla~~~~~~~~~~--~~~~~~GT~gy~apeaP  364 (372)
                      .+||+|||+++.........  ......||++|+|||.-
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  204 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL  204 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence            89999999999876543221  12345799999998754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.94  E-value=9.9e-26  Score=213.59  Aligned_cols=148  Identities=26%  Similarity=0.412  Sum_probs=128.8

Q ss_pred             CCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHH-HhCCCCCeeceeeeEEc---CCCeEE
Q 017411          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIA-SSLHHPNIVPLVGFCID---PEQGLF  256 (372)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL-~~l~HpnIv~l~g~~~~---~~~~~~  256 (372)
                      ++|... +.||+|+||.||++.+..+++.||||+++..     ..+.+|+.++ +.++||||+++++++..   .....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            477776 7899999999999999988999999999653     3567888887 66699999999998764   244589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEEEe
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL~D  333 (372)
                      +||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTT-----CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEeecCCCcHHHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEec
Confidence            99999999999999987532     46999999999999999999999988   999999999999998   78999999


Q ss_pred             cccccccCC
Q 017411          334 FGLATWTSA  342 (372)
Q Consensus       334 FGla~~~~~  342 (372)
                      ||+++....
T Consensus       164 fg~a~~~~~  172 (299)
T 3m2w_A          164 FGFAKETTG  172 (299)
T ss_dssp             CTTCEECTT
T ss_pred             ccccccccc
Confidence            999987654

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.94  E-value=6.9e-26  Score=214.57  Aligned_cols=144  Identities=14%  Similarity=0.106  Sum_probs=127.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++...   .....+.+.+|+.++.+++||||+++++++.+. +..|+|
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv  109 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVV  109 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEE
Confidence            5799999999999999999999988999999999764   244567899999999999999999999998774 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++++|.+++..        . .....+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+++|...
T Consensus       110 ~e~~~g~~L~~~l~~--------~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~  177 (286)
T 3uqc_A          110 AEWIRGGSLQEVADT--------S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP  177 (286)
T ss_dssp             EECCCEEEHHHHHTT--------C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred             EEecCCCCHHHHHhc--------C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence            999999999999853        1 345567889999999999999988   9999999999999999999999887653

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.93  E-value=7.5e-27  Score=245.04  Aligned_cols=174  Identities=26%  Similarity=0.396  Sum_probs=146.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEc-----CCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCID-----PEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~-----~~~~~  255 (372)
                      ++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|++++++++||||+++++++..     .....
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6899999999999999999999888999999998764 45566789999999999999999999998643     14457


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc---EEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI---PKLC  332 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~---~KL~  332 (372)
                      ++||||+++|+|.+++.....    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~----~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~  166 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN----CCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII  166 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC----TTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhccc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence            899999999999999986432    135888999999999999999999987   999999999999997764   9999


Q ss_pred             ecccccccCCCCCCccccccccCCCccCccccc
Q 017411          333 DFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       333 DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |||+++.......   .....||++|+|||.-.
T Consensus       167 DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~  196 (676)
T 3qa8_A          167 DLGYAKELDQGEL---CTEFVGTLQYLAPELLE  196 (676)
T ss_dssp             SCCCCCBTTSCCC---CCCCCSCCTTCSSCSSC
T ss_pred             ccccccccccccc---cccccCCcccCChHHhc
Confidence            9999988765432   34567999999988644

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.93  E-value=2.1e-26  Score=230.78  Aligned_cols=170  Identities=25%  Similarity=0.249  Sum_probs=129.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ...+|...+.||+|+||+|+.... .+++.||||++.....   ..+.+|+.+|+++ +|||||++++++.+ ....|+|
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv   96 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIA   96 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEE
Confidence            345799999999999998654332 4578999999975432   2356899999999 79999999998876 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-----CCcEEEEe
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----KKIPKLCD  333 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-----~~~~KL~D  333 (372)
                      |||+. |+|.+++....      ..+.+..++.++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|
T Consensus        97 ~E~~~-g~L~~~l~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~D  166 (432)
T 3p23_A           97 IELCA-ATLQEYVEQKD------FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISD  166 (432)
T ss_dssp             EECCS-EEHHHHHHSSS------CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECC
T ss_pred             EECCC-CCHHHHHHhcC------CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEec
Confidence            99996 69999997653      23444556789999999999999988   999999999999953     23688999


Q ss_pred             cccccccCCCCCC-ccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|+........ .......||++|+|||.-
T Consensus       167 FG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l  198 (432)
T 3p23_A          167 FGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML  198 (432)
T ss_dssp             TTEEECC------------CCSCTTSCCGGGT
T ss_pred             ccceeeccCCCcceeeccccCCCcCccChhhh
Confidence            9999887644321 123456799999998764

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=3.5e-26  Score=235.54  Aligned_cols=158  Identities=22%  Similarity=0.233  Sum_probs=119.6

Q ss_pred             eeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          185 SKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       185 ~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ...+.||+|+||.||+|...  +..+++|+.....        ....+.+.+|++++++++||||+++..++...+. .+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KR  415 (540)
T ss_dssp             ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TE
T ss_pred             CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cE
Confidence            44578999999999999544  6789999864321        1124568999999999999999966555555444 68


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++++|.+++..               ++.++.|++.||.|||+.+   |+||||||+|||++.  .+||+|||+
T Consensus       416 lVmE~~~ggsL~~~l~~---------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGl  475 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGL  475 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTT
T ss_pred             EEEECCCCCCHHHHHHH---------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECcc
Confidence            99999999999999853               3479999999999999988   999999999999998  999999999


Q ss_pred             ccccCCCCCCc-----cccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPF-----LCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~-----~~~~~~GT~gy~apeaPE  365 (372)
                      |+.........     ...+..||+.|||||.-+
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~  509 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWE  509 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHH
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHH
Confidence            99886543211     124678999999977654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.92  E-value=1.1e-25  Score=224.08  Aligned_cols=175  Identities=17%  Similarity=0.166  Sum_probs=129.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCC-CCeecee----------
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHH-PNIVPLV----------  245 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~H-pnIv~l~----------  245 (372)
                      .+.+|...+.||+|+||.||+|.+..+++.||||++....   ....+.|.+|+.+++.++| +|...+.          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            4456888999999999999999999899999999987432   2235678999999999987 3221111          


Q ss_pred             -----------eeEEcC----CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 017411          246 -----------GFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERC  310 (372)
Q Consensus       246 -----------g~~~~~----~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  310 (372)
                                 .++...    ....+++|+++ +++|.+++............+++..++.++.||+.||.|||+.+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                       111110    11256777766 68999999633211111245788899999999999999999988   


Q ss_pred             eEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       311 IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+||||||+|||++.++.+||+|||+++.....     .....| ++|+|||.-
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~  279 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETT  279 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhh
Confidence            999999999999999999999999999875433     244567 888887653

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.1e-23  Score=196.49  Aligned_cols=142  Identities=18%  Similarity=0.161  Sum_probs=114.5

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCCh------------------hhHHHHHHHHHHHHhCC
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK------------------ESSKAFCRELMIASSLH  237 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~------------------~~~~~~~~Ev~iL~~l~  237 (372)
                      .+......|...+.||+|+||.||+|.+ .+++.||||.++....                  .....+.+|+.++++++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            4445566778889999999999999999 7799999999965321                  23567899999999999


Q ss_pred             CCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCC
Q 017411          238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIK  317 (372)
Q Consensus       238 HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLK  317 (372)
                        | +++.+++.. + ..++||||+++++|.+ +..             .....++.|++.||.|||..+   |+|||||
T Consensus       163 --~-~~v~~~~~~-~-~~~lvmE~~~g~~L~~-l~~-------------~~~~~i~~qi~~~l~~lH~~g---iiHrDlk  220 (282)
T 1zar_A          163 --G-LAVPKVYAW-E-GNAVLMELIDAKELYR-VRV-------------ENPDEVLDMILEEVAKFYHRG---IVHGDLS  220 (282)
T ss_dssp             --T-SSSCCEEEE-E-TTEEEEECCCCEEGGG-CCC-------------SCHHHHHHHHHHHHHHHHHTT---EECSCCS
T ss_pred             --C-CCcCeEEec-c-ceEEEEEecCCCcHHH-cch-------------hhHHHHHHHHHHHHHHHHHCC---CEeCCCC
Confidence              4 666665433 3 3689999999999987 421             123469999999999999888   9999999


Q ss_pred             CCCEEEcCCCcEEEEecccccccC
Q 017411          318 PSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       318 p~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |+|||++ ++.+||+|||+|+...
T Consensus       221 p~NILl~-~~~vkl~DFG~a~~~~  243 (282)
T 1zar_A          221 QYNVLVS-EEGIWIIDFPQSVEVG  243 (282)
T ss_dssp             TTSEEEE-TTEEEECCCTTCEETT
T ss_pred             HHHEEEE-CCcEEEEECCCCeECC
Confidence            9999999 9999999999997654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.86  E-value=8.7e-22  Score=183.83  Aligned_cols=144  Identities=17%  Similarity=0.112  Sum_probs=110.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeE--EEEEEecCCCh------------------------hhHHHHHHHHHHHH
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDK------------------------ESSKAFCRELMIAS  234 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~--vAvK~l~~~~~------------------------~~~~~~~~Ev~iL~  234 (372)
                      ..-|.+.+.||+|+||.||+|.+..+++.  ||||+++....                        .....+.+|+.+|.
T Consensus        46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            33477889999999999999998556888  99998754311                        11236789999999


Q ss_pred             hCCCCCe--eceeeeEEcCCCeEEEEEeccCC-C----CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHH-cC
Q 017411          235 SLHHPNI--VPLVGFCIDPEQGLFLIYKYVSG-G----SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLH-NG  306 (372)
Q Consensus       235 ~l~HpnI--v~l~g~~~~~~~~~~lV~Ey~~~-g----sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~  306 (372)
                      +++|+++  ..++.+  .   ..+|||||+.+ |    +|.++...          .++..+..++.|++.+|.||| ..
T Consensus       126 ~l~~~~i~~p~~~~~--~---~~~lVmE~~g~~g~~~~~L~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~  190 (258)
T 1zth_A          126 RAKEAGVSVPQPYTY--M---KNVLLMEFIGEDELPAPTLVELGRE----------LKELDVEGIFNDVVENVKRLYQEA  190 (258)
T ss_dssp             HHHHTTCCCCCEEEE--E---TTEEEEECCEETTEECCBHHHHGGG----------GGGSCHHHHHHHHHHHHHHHHHTS
T ss_pred             HHHhCCCCCCeEEEc--C---CCEEEEEecCCCCCccccHHHHhhc----------cChHHHHHHHHHHHHHHHHHHHHC
Confidence            9988764  333332  1   25899999942 4    67665432          123456789999999999999 87


Q ss_pred             CCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCCC
Q 017411          307 TERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       307 ~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~  344 (372)
                      +   |+||||||+|||++.  .++|+|||+|.....+.
T Consensus       191 g---ivHrDlkp~NILl~~--~~~liDFG~a~~~~~~~  223 (258)
T 1zth_A          191 E---LVHADLSEYNIMYID--KVYFIDMGQAVTLRHPM  223 (258)
T ss_dssp             C---EECSSCSTTSEEESS--SEEECCCTTCEETTSTT
T ss_pred             C---EEeCCCCHHHEEEcC--cEEEEECcccccCCCcc
Confidence            7   999999999999988  99999999998775543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.70  E-value=1.3e-17  Score=164.60  Aligned_cols=145  Identities=15%  Similarity=0.136  Sum_probs=101.2

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--------------hhhHH--------HHHHHHHHHHhC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--------------KESSK--------AFCRELMIASSL  236 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--------------~~~~~--------~~~~Ev~iL~~l  236 (372)
                      ....-|++...||+|+||.||+|... +|+.||||+++...              .....        ...+|...|.++
T Consensus        92 ~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL  170 (397)
T 4gyi_A           92 ARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL  170 (397)
T ss_dssp             HTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence            33345999999999999999999986 48899999875320              00011        123466666666


Q ss_pred             CCCCeeceeeeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCC
Q 017411          237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  316 (372)
Q Consensus       237 ~HpnIv~l~g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDL  316 (372)
                      .+.++....-+... .  .+|||||+++++|.++..           .  .....++.||+.+|.|||..+   ||||||
T Consensus       171 ~~~gv~vp~p~~~~-~--~~LVME~i~G~~L~~l~~-----------~--~~~~~l~~qll~~l~~lH~~g---IVHrDL  231 (397)
T 4gyi_A          171 YEEGFPVPEPIAQS-R--HTIVMSLVDALPMRQVSS-----------V--PDPASLYADLIALILRLAKHG---LIHGDF  231 (397)
T ss_dssp             HHTTCSCCCEEEEE-T--TEEEEECCSCEEGGGCCC-----------C--SCHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred             HhcCCCCCeeeecc-C--ceEEEEecCCccHhhhcc-----------c--HHHHHHHHHHHHHHHHHHHCC---CcCCCC
Confidence            54443222111111 2  369999999988865421           1  123467899999999999887   999999


Q ss_pred             CCCCEEEcCCC----------cEEEEecccccccCCC
Q 017411          317 KPSNILLSSKK----------IPKLCDFGLATWTSAP  343 (372)
Q Consensus       317 Kp~NILld~~~----------~~KL~DFGla~~~~~~  343 (372)
                      ||.|||+++++          .+.|+||+-+.....+
T Consensus       232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~hp  268 (397)
T 4gyi_A          232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDHP  268 (397)
T ss_dssp             STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTST
T ss_pred             CHHHEEEeCCCCcccccccccceEEEEeCCcccCCCC
Confidence            99999998876          3899999987655433

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.38  E-value=1.3e-12  Score=120.74  Aligned_cols=144  Identities=17%  Similarity=0.110  Sum_probs=109.6

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      -..|.....++.|+.+.||+....  +..+++|+...........+.+|+++++.+. +..+.++++++.+ .+..|+||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~   89 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNLLM   89 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEEEE
Confidence            357888888898999999998754  5789999987532122345889999999884 6778888888765 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--------------------------------  307 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------  307 (372)
                      ||++|.+|.+.+..            ......++.+++++|..||...                                
T Consensus        90 e~i~G~~l~~~~~~------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           90 SEADGVLCSEEYED------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             ECCSSEEHHHHCCT------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EecCCeehhhccCC------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            99999998876311            1123367889999999999811                                


Q ss_pred             ------------------------CCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          308 ------------------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       308 ------------------------~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                                              .+.++|+|++|.|||++.+..+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                    14489999999999998766667999998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.22  E-value=1.7e-11  Score=112.05  Aligned_cols=139  Identities=16%  Similarity=0.110  Sum_probs=96.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~~~~~~~~~lV~  259 (372)
                      .++......+.|..+.||+.... ++..+++|.....   ....+.+|+.+++.+.+.+  +.+++++.... +..++||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~   94 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLL   94 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEE
T ss_pred             CCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEE
Confidence            35555333345566999999753 4678999997653   2245778999998885444  45577776553 4479999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--------------------------------  307 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------  307 (372)
                      ||++|.+|.  ..          ...   ...++.+++..|..||...                                
T Consensus        95 e~i~G~~l~--~~----------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (264)
T 1nd4_A           95 GEVPGQDLL--SS----------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD  159 (264)
T ss_dssp             ECCSSEETT--TS----------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred             EecCCcccC--cC----------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence            999998874  11          111   1245667777777777643                                


Q ss_pred             -----------------------CCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          308 -----------------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       308 -----------------------~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                                             ...++|+|++|.|||++.++.+.|+||+.+...
T Consensus       160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                                   123999999999999987766779999998653

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.13  E-value=1.2e-10  Score=112.84  Aligned_cols=143  Identities=19%  Similarity=0.233  Sum_probs=104.8

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEec--CCC-hhhHHHHHHHHHHHHhCC--CCCeeceeeeEEcCC--CeEEEE
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLD--KED-KESSKAFCRELMIASSLH--HPNIVPLVGFCIDPE--QGLFLI  258 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~--~~~-~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~~--~~~~lV  258 (372)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+..  +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3578999999999998865  4578888876  322 122356788999999986  456788888775532  336899


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-------------------------------
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT-------------------------------  307 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-------------------------------  307 (372)
                      |||++|..+.+..         ...++...+..++.+++..|..||...                               
T Consensus       120 me~v~G~~l~~~~---------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (359)
T 3dxp_A          120 MEFVSGRVLWDQS---------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSE  190 (359)
T ss_dssp             EECCCCBCCCCTT---------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHC
T ss_pred             EEecCCeecCCCc---------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcC
Confidence            9999987764311         134678888889999999999999731                               


Q ss_pred             ------------------------CCceEEcCCCCCCEEEcCCCc--EEEEecccccc
Q 017411          308 ------------------------ERCVVHRDIKPSNILLSSKKI--PKLCDFGLATW  339 (372)
Q Consensus       308 ------------------------~~~IiHrDLKp~NILld~~~~--~KL~DFGla~~  339 (372)
                                              ...++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          191 TESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                    256999999999999987753  68999999864

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.5e-07  Score=89.25  Aligned_cols=138  Identities=20%  Similarity=0.244  Sum_probs=92.8

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCC---CeeceeeeEEcCCCeEEEEEeccC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHP---NIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hp---nIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      .+.++.|....||+.     +..+++|+..  .......+.+|.++|..+.+.   .+.+++.++....+..++|||+++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            356888988899987     3568888853  234456789999999998642   355666666544555789999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-------------------------------------
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-------------------------------------  306 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------------------------------------  306 (372)
                      |..|.....         ..++...+..++.+++..|..||..                                     
T Consensus        97 G~~l~~~~~---------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~  167 (306)
T 3tdw_A           97 GQILGEDGM---------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDES  167 (306)
T ss_dssp             SEECHHHHH---------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHH
T ss_pred             CeECchhhh---------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchh
Confidence            988766321         1123333333444444444444422                                     


Q ss_pred             --------------------CCCceEEcCCCCCCEEEcC---CCc-EEEEeccccccc
Q 017411          307 --------------------TERCVVHRDIKPSNILLSS---KKI-PKLCDFGLATWT  340 (372)
Q Consensus       307 --------------------~~~~IiHrDLKp~NILld~---~~~-~KL~DFGla~~~  340 (372)
                                          ..+.++|+|++|.|||++.   ++. +.|+||+.+..-
T Consensus       168 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          168 LRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             hHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                                2345799999999999987   455 489999988653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.73  E-value=3.2e-08  Score=93.40  Aligned_cols=138  Identities=22%  Similarity=0.286  Sum_probs=97.6

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCC--eeceeeeEEcCC--CeEEEEEec
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPN--IVPLVGFCIDPE--QGLFLIYKY  261 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-Hpn--Iv~l~g~~~~~~--~~~~lV~Ey  261 (372)
                      .+.++.|....||+..     ..+++|+....  .....+.+|+++|+.+. +..  +.+++.......  ...|+|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            3568999999999863     46889986532  44567889999998873 332  334444322222  124789999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-----------------------------------  306 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----------------------------------  306 (372)
                      ++|.+|......         .++..++..++.+++..|..||..                                   
T Consensus        98 i~G~~l~~~~~~---------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (304)
T 3sg8_A           98 IKGVPLTPLLLN---------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP  168 (304)
T ss_dssp             CCCEECCHHHHH---------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred             cCCeECCccccc---------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence            999888754321         356667777788888888888851                                   


Q ss_pred             --------------------CCCceEEcCCCCCCEEEcC--CCcEEEEeccccccc
Q 017411          307 --------------------TERCVVHRDIKPSNILLSS--KKIPKLCDFGLATWT  340 (372)
Q Consensus       307 --------------------~~~~IiHrDLKp~NILld~--~~~~KL~DFGla~~~  340 (372)
                                          ..+.++|+|++|.||+++.  ...+.|+||+.+..-
T Consensus       169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS  224 (304)
T ss_dssp             HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred             cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence                                1245899999999999998  456789999998654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.56  E-value=8.1e-07  Score=81.77  Aligned_cols=137  Identities=15%  Similarity=0.136  Sum_probs=95.6

Q ss_pred             eeEcccCce-EEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEEeccCCC
Q 017411          188 RVLGRGALS-FVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       188 ~~LG~G~fG-~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      +.+..|..| .||+......+..+.+|+-..   .....+.+|..+|+.+. +--+.++++++.+. +..++|||+++|.
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~  105 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGK  105 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCc
Confidence            345556555 699887766677899998654   23456888999998874 33466778877664 4579999999998


Q ss_pred             CHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 017411          266 SLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--------------------------------------  307 (372)
Q Consensus       266 sL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--------------------------------------  307 (372)
                      ++.+......           .....+..+++..|.-||...                                      
T Consensus       106 ~~~~~~~~~~-----------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (272)
T 4gkh_A          106 TAFQVLEEYP-----------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGW  174 (272)
T ss_dssp             EHHHHHHHCG-----------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTC
T ss_pred             cccccccCCH-----------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccch
Confidence            8877654311           112235555666666666321                                      


Q ss_pred             -----------------CCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          308 -----------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       308 -----------------~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                                       .+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       175 ~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          175 PVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             12379999999999999877778999998864

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.24  E-value=1.2e-06  Score=84.09  Aligned_cols=83  Identities=7%  Similarity=-0.005  Sum_probs=53.8

Q ss_pred             eceeE-cccCceEEEEEEEC---C---CCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCC-C--CCeeceeeeEEcCC
Q 017411          186 KGRVL-GRGALSFVFKGKVG---L---LRTSVAIKRLDKED---KESSKAFCRELMIASSLH-H--PNIVPLVGFCIDPE  252 (372)
Q Consensus       186 ~~~~L-G~G~fG~Vy~~~~~---~---~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~-H--pnIv~l~g~~~~~~  252 (372)
                      ..+.| +.|....+|+....   .   .+..+++|+.....   ......+.+|+.+++.+. +  ..+.+++.++.+..
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            34678 88889999987653   0   14678888765422   001235678888888774 2  34667777664432


Q ss_pred             --CeEEEEEeccCCCCHH
Q 017411          253 --QGLFLIYKYVSGGSLE  268 (372)
Q Consensus       253 --~~~~lV~Ey~~~gsL~  268 (372)
                        +..++||||++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              2358999999886543

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=6.5e-06  Score=80.39  Aligned_cols=76  Identities=17%  Similarity=0.076  Sum_probs=48.6

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCCh-------hhHHHHHHHHHHHHhCCC--CC-eeceeeeEEcCCCeEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDK-------ESSKAFCRELMIASSLHH--PN-IVPLVGFCIDPEQGLF  256 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~-------~~~~~~~~Ev~iL~~l~H--pn-Iv~l~g~~~~~~~~~~  256 (372)
                      .+.||.|.++.||++.....+..|+||.......       .....+..|.++|+.+..  |. +.+++.+  +.+. .+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc-cE
Confidence            4689999999999997655567899998653211       123456789988887732  33 3455543  3333 47


Q ss_pred             EEEeccCCC
Q 017411          257 LIYKYVSGG  265 (372)
Q Consensus       257 lV~Ey~~~g  265 (372)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.12  E-value=3.4e-05  Score=72.81  Aligned_cols=146  Identities=19%  Similarity=0.319  Sum_probs=78.8

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhC-----CCCCeecee-e-eEEcCCCeEEEEEe
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-----HHPNIVPLV-G-FCIDPEQGLFLIYK  260 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l-----~HpnIv~l~-g-~~~~~~~~~~lV~E  260 (372)
                      +.|+.|..+.||+....  +..+++|+.... .   ..+..|+.++..|     ..|.++... | .+....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            56766778899998764  345899998752 2   2233445444443     234444311 1 11111345789999


Q ss_pred             ccCCCCHH--------------HHHHhhccCC--CC-----CCCCCHHHHH-----------------------------
Q 017411          261 YVSGGSLE--------------RHLHEKKKGV--RG-----NSTLPWSVRY-----------------------------  290 (372)
Q Consensus       261 y~~~gsL~--------------~~L~~~~~~~--~~-----~~~l~~~~~~-----------------------------  290 (372)
                      |++|..+.              ..++......  ..     ...-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            99986542              1122211111  00     0112343211                             


Q ss_pred             --HHHHHHHHHHHHHHc----------CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          291 --KVALGIAESVAYLHN----------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       291 --~i~~qia~gL~yLH~----------~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                        .+...+..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence              011123345666653          1235599999999999998888999999998853

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.77  E-value=0.00031  Score=65.27  Aligned_cols=80  Identities=14%  Similarity=0.159  Sum_probs=56.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-C--CCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-H--PNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-H--pnIv~l~g~~~~~~~~~~lV  258 (372)
                      ......+.+|.|..+.||+.+.. +|+.|.+|+...........|.+|++.|+.|. .  --+.+++++  + .  .++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~-~--~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D-D--RTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E-T--TEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c-C--ceEE
Confidence            45666789999999999999876 47889999876544333446788999988874 2  234455543  2 2  2689


Q ss_pred             EeccCCCCH
Q 017411          259 YKYVSGGSL  267 (372)
Q Consensus       259 ~Ey~~~gsL  267 (372)
                      |||++++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999986543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.68  E-value=0.00017  Score=71.01  Aligned_cols=32  Identities=9%  Similarity=0.394  Sum_probs=27.6

Q ss_pred             CCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          308 ERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       308 ~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      .+.++|+|++|.|||++.++ ++|+||+.+..-
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            45699999999999998776 999999988643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.49  E-value=0.0011  Score=62.94  Aligned_cols=143  Identities=14%  Similarity=0.173  Sum_probs=90.4

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC---CCCeeceeeeEEcCCCeEEEEEecc
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH---HPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~---HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      ..+.|+.|.+..+|+....  +..+++|+....   ....+.+|.+.|+.|.   ...+.+++.++.. .+..++||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEec
Confidence            4578999999999998753  568889987643   3467888998888773   3567778877655 34589999999


Q ss_pred             CCCCHH--------HHH---Hhhcc-CC---CC-----------CCCCCHHHHH---HHHH----------------HHH
Q 017411          263 SGGSLE--------RHL---HEKKK-GV---RG-----------NSTLPWSVRY---KVAL----------------GIA  297 (372)
Q Consensus       263 ~~gsL~--------~~L---~~~~~-~~---~~-----------~~~l~~~~~~---~i~~----------------qia  297 (372)
                      ++..+.        ..|   +.... ..   ..           .-.-+|...+   ++..                .++
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            987541        222   22111 00   00           0012455332   1111                111


Q ss_pred             HHH-HHHHc-CCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          298 ESV-AYLHN-GTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       298 ~gL-~yLH~-~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ..+ ..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            122 23422 2346799999999999999887 8899984

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.37  E-value=0.00056  Score=63.96  Aligned_cols=142  Identities=11%  Similarity=0.114  Sum_probs=74.2

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeeEEcCCCeEEEEEecc-CC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYV-SG  264 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~~~~lV~Ey~-~~  264 (372)
                      .+.|+.|....+|+.      ..+++|+........ ....+|+.+++.+....+ .+++++  +.+. -++++||+ ++
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~-~~~v~e~i~~g   92 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPAT-GVMVTRYIAGA   92 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTT-CCEEEECCTTC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCC-CEEEEeecCCC
Confidence            578999999999998      358888876432111 122457777766632222 455543  3222 36899999 65


Q ss_pred             CCHHH---------------HHHhhccCCC-CCCCCC-HHHHHHHHH--------------HHHHHH----HHHHc-CCC
Q 017411          265 GSLER---------------HLHEKKKGVR-GNSTLP-WSVRYKVAL--------------GIAESV----AYLHN-GTE  308 (372)
Q Consensus       265 gsL~~---------------~L~~~~~~~~-~~~~l~-~~~~~~i~~--------------qia~gL----~yLH~-~~~  308 (372)
                      .+|..               .|.+-..... ...... +.....+..              .+...+    ..+.. ...
T Consensus        93 ~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~  172 (301)
T 3dxq_A           93 QTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLP  172 (301)
T ss_dssp             EECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             ccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCC
Confidence            44432               1111111000 000011 111111110              011111    12211 233


Q ss_pred             CceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            45899999999999 5667789999998764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.17  E-value=0.0018  Score=60.65  Aligned_cols=149  Identities=15%  Similarity=0.137  Sum_probs=78.4

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC--eeceeeeE-----EcCCCeEEEEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN--IVPLVGFC-----IDPEQGLFLIY  259 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn--Iv~l~g~~-----~~~~~~~~lV~  259 (372)
                      .+.|+.|....+|+.....  ..+++|+.....  ....+..|+.++..+....  +.+++...     ....+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~--g~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK--DPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESS--CCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC--ccEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4667788888999987653  368899886521  1224556777766653111  23333210     01123468999


Q ss_pred             eccCCCCHH-----------H---HHHhhccCCCCCC--C---CCHHHHHHH------------HHHHHHHHHHHHcC--
Q 017411          260 KYVSGGSLE-----------R---HLHEKKKGVRGNS--T---LPWSVRYKV------------ALGIAESVAYLHNG--  306 (372)
Q Consensus       260 Ey~~~gsL~-----------~---~L~~~~~~~~~~~--~---l~~~~~~~i------------~~qia~gL~yLH~~--  306 (372)
                      +|++|..+.           .   .++..........  .   ..|...+.-            ...+...+.++...  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999875431           1   1221111100000  0   123321110            01134455555531  


Q ss_pred             --CCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          307 --TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       307 --~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                        ....++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              234589999999999998876668999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.14  E-value=0.00074  Score=66.95  Aligned_cols=73  Identities=12%  Similarity=0.147  Sum_probs=48.1

Q ss_pred             ceeEcccCceEEEEEEECC-------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeeEEcCCCeEEEE
Q 017411          187 GRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~~~~lV  258 (372)
                      .+.|+.|-...||+.....       .+..+.+|+.....  ....+.+|..+++.+...++ .++++.+.  +   .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEE
Confidence            3678888889999998753       24678899884321  11455679888887743333 55666532  2   389


Q ss_pred             EeccCCCC
Q 017411          259 YKYVSGGS  266 (372)
Q Consensus       259 ~Ey~~~gs  266 (372)
                      +||++|.+
T Consensus       151 ~e~l~G~~  158 (429)
T 1nw1_A          151 EEYIPSRP  158 (429)
T ss_dssp             ECCCCEEE
T ss_pred             EEEeCCcc
Confidence            99997633

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.06  E-value=0.0016  Score=63.71  Aligned_cols=146  Identities=16%  Similarity=0.167  Sum_probs=81.5

Q ss_pred             eeEcccCceEEEEEEECC-------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEE
Q 017411          188 RVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +.|..|-...+|+.....       .+..|.+|+.... ......+.+|.++++.+. +.-..++++.+.  +   .+||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~---g~v~  129 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E---GRLE  129 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T---EEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C---ccEE
Confidence            567677778899987642       3467889886332 223455678999888774 322355666542  2   2899


Q ss_pred             eccCCCCHH--------------HHHHhhccC-CCCCCCC--CHHHHHHHHHHHHH-------------------HHHH-
Q 017411          260 KYVSGGSLE--------------RHLHEKKKG-VRGNSTL--PWSVRYKVALGIAE-------------------SVAY-  302 (372)
Q Consensus       260 Ey~~~gsL~--------------~~L~~~~~~-~~~~~~l--~~~~~~~i~~qia~-------------------gL~y-  302 (372)
                      ||++|..|.              +.|.+-... .......  -|.++.++..++..                   .+.. 
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999875442              112111111 0001112  24444444433321                   2233 


Q ss_pred             ---HHcC-CCCceEEcCCCCCCEEEcCC----CcEEEEecccccc
Q 017411          303 ---LHNG-TERCVVHRDIKPSNILLSSK----KIPKLCDFGLATW  339 (372)
Q Consensus       303 ---LH~~-~~~~IiHrDLKp~NILld~~----~~~KL~DFGla~~  339 (372)
                         |... ....++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               3222 23458999999999999876    7899999998864

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.02  E-value=0.0055  Score=57.86  Aligned_cols=33  Identities=27%  Similarity=0.343  Sum_probs=28.0

Q ss_pred             CCceEEcCCCCCCEEEcCC----CcEEEEeccccccc
Q 017411          308 ERCVVHRDIKPSNILLSSK----KIPKLCDFGLATWT  340 (372)
Q Consensus       308 ~~~IiHrDLKp~NILld~~----~~~KL~DFGla~~~  340 (372)
                      ...++|+|+.+.|||++.+    +.+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4569999999999999874    67999999988643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.97  E-value=0.0085  Score=56.19  Aligned_cols=147  Identities=18%  Similarity=0.170  Sum_probs=78.2

Q ss_pred             eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC--CCeeceeee----EEcCCCeEEEEEec
Q 017411          188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH--PNIVPLVGF----CIDPEQGLFLIYKY  261 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H--pnIv~l~g~----~~~~~~~~~lV~Ey  261 (372)
                      ..|+ |....||+.... .++.+++|...... .....+..|..++..+..  -.+++++..    ....++..+++|++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4576 777899987653 35679999986431 123456678877776632  123444432    00113346789999


Q ss_pred             cCCCCHH-----H------H---HHhhccCCC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHc-
Q 017411          262 VSGGSLE-----R------H---LHEKKKGVR--GNSTLPWSVR----YKV---------------ALGIAESVAYLHN-  305 (372)
Q Consensus       262 ~~~gsL~-----~------~---L~~~~~~~~--~~~~l~~~~~----~~i---------------~~qia~gL~yLH~-  305 (372)
                      ++|..+.     .      .   ++.......  .....++...    ..+               ...+...+..+.. 
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            9874431     1      1   111111000  0011222211    000               0011112222221 


Q ss_pred             ---CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          306 ---GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       306 ---~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                         .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               1234589999999999998 4 899999988754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.90  E-value=0.0033  Score=62.95  Aligned_cols=75  Identities=20%  Similarity=0.152  Sum_probs=47.2

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe-eceeeeEEcCCCeEEEEEeccCCC
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI-VPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI-v~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      .+.|+.|-...+|+......+..+.+|+........ -...+|..++..|...++ .++++.+ . +   .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCc
Confidence            467888888999999876444788899875432111 012478888888864444 4566654 2 2   2599999874


Q ss_pred             CH
Q 017411          266 SL  267 (372)
Q Consensus       266 sL  267 (372)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            43

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.62  E-value=0.0029  Score=60.79  Aligned_cols=73  Identities=15%  Similarity=0.134  Sum_probs=42.0

Q ss_pred             eeEcccCceEEEEEEECC--------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCC-eeceeeeEEcCCCeEEEE
Q 017411          188 RVLGRGALSFVFKGKVGL--------LRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPN-IVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~--------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~Hpn-Iv~l~g~~~~~~~~~~lV  258 (372)
                      +.|+.|....+|+.....        .+..+++|+....... ......|.++++.+...+ ..++++..   .+  ++|
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~---~~--~~v  112 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF---NG--GRI  112 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec---CC--cEE
Confidence            567788888999987653        1257888876543221 112356787777774223 34566543   22  589


Q ss_pred             EeccCCCC
Q 017411          259 YKYVSGGS  266 (372)
Q Consensus       259 ~Ey~~~gs  266 (372)
                      |||++|..
T Consensus       113 ~e~i~G~~  120 (369)
T 3c5i_A          113 EEWLYGDP  120 (369)
T ss_dssp             EECCCSEE
T ss_pred             EEEecCCc
Confidence            99998743

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.94  E-value=0.032  Score=53.10  Aligned_cols=32  Identities=19%  Similarity=0.341  Sum_probs=28.0

Q ss_pred             CceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      ..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            45999999999999998888999999887653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.74  E-value=0.099  Score=51.60  Aligned_cols=145  Identities=12%  Similarity=0.119  Sum_probs=81.7

Q ss_pred             eeEcccCceEEEEEEECCC-------CeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeEEEEE
Q 017411          188 RVLGRGALSFVFKGKVGLL-------RTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~~~-------~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      +.|..|-...+|+......       +..|.+|+....... .-...+|.++++.+. +.-..++++.+   .+  ++||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~---~~--~~I~  149 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF---PE--GRIE  149 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE---TT--EEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc---CC--CEEE
Confidence            5677777889999887521       467888886543211 112346888777774 22234555532   22  6899


Q ss_pred             eccCCCCHH--------------HHHHh---hcc---CCC---CCCCCCHHHHHHHHHHH-------------------H
Q 017411          260 KYVSGGSLE--------------RHLHE---KKK---GVR---GNSTLPWSVRYKVALGI-------------------A  297 (372)
Q Consensus       260 Ey~~~gsL~--------------~~L~~---~~~---~~~---~~~~l~~~~~~~i~~qi-------------------a  297 (372)
                      ||++|..|.              +.|.+   ...   ...   ...+..|.++..+..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            999885531              11111   100   000   11122344444333222                   2


Q ss_pred             HHHHHHHc---------------------CCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          298 ESVAYLHN---------------------GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       298 ~gL~yLH~---------------------~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ..+.+|..                     .....++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11235899999999999 7888999999998864

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=89.46  E-value=0.03  Score=55.91  Aligned_cols=60  Identities=8%  Similarity=0.104  Sum_probs=16.9

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEE------EEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAI------KRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCI  249 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAv------K~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~  249 (372)
                      .+.||   ||.||+|.+.....+|||      |..+..  ..+....|.+|..++..++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            35566   999999998754568888      665532  2333457889999999999999999988653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	372
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-45
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-41
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-40
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-39
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-39
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-39
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-39
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-38
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-38
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-37
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-37
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-36
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-36
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-36
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	5e-36
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	6e-36
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-35
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	7e-35
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-34
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-33
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-33
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	7e-33
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-32
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-32
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-32
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-31
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-31
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-30
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-30
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-30
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	5e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-30
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-29
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-28
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-27
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-26
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-26
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-26
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-26
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-25
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-25
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-25
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-25
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-24
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-24
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-23
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-23
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-22
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-22
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-18
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-45
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 16/177 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
             + G+ +G G+   V+KGK       VA+K L+      +  +AF  E+ +     H N
Sbjct: 9   QITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           I+  +G+   P+  L ++ ++  G SL  HLH  +                +A   A+ +
Sbjct: 66  ILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIET------KFEMIKLIDIARQTAQGM 117

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            YLH    + ++HRD+K +NI L      K+ DFGLAT  S  S     + + G+  
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 1e-41
 Identities = 47/176 (26%), Positives = 82/176 (46%), Gaps = 15/176 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNI 241
           +F K   LG G    VFK         +A K +  E K + +    REL +    + P I
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V   G      + + +  +++ GGSL++ L +  +       +P  +  KV++ + + + 
Sbjct: 67  VGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGR-------IPEQILGKVSIAVIKGLT 118

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           YL    +  ++HRD+KPSNIL++S+   KLCDFG++          +  +  GT  
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRS 168

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-40
 Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 10/161 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +     LG GA   V+K +        A K +D + +E  + +  E+ I +S  HPNIV
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+         L+++ ++ +GG+++  + E ++       L  S    V     +++ Y
Sbjct: 73  KLLDAFYYENN-LWILIEFCAGGAVDAVMLELER------PLTESQIQVVCKQTLDALNY 125

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           LH   +  ++HRD+K  NIL +     KL DFG++   +  
Sbjct: 126 LH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (350), Expect = 2e-39
 Identities = 45/159 (28%), Positives = 77/159 (48%), Gaps = 12/159 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
                + +G+G    V  G        VA+K +  +   +++AF  E  + + L H N+V
Sbjct: 8   ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLV 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G  ++ + GL+++ +Y++ GSL  +L       RG S L      K +L + E++ Y
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-----RGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
           L        VHRD+   N+L+S   + K+ DFGL    S
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  139 bits (352), Expect = 3e-39
 Identities = 46/177 (25%), Positives = 71/177 (40%), Gaps = 20/177 (11%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           FS  R +G G+   V+  +       VAIK++        E  +   +E+     L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
            +   G  +      +L+ +Y  G + +     KK        L       V  G  + +
Sbjct: 77  TIQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKP-------LQEVEIAAVTHGALQGL 128

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           AYLH      ++HRD+K  NILLS   + KL DFG A+  +         +  GT  
Sbjct: 129 AYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPY 176

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 6e-39
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 8/167 (4%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
           ++     +G G+     K +       +  K LD     +   +    E+ +   L HPN
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 241 IVPLVGFCIDPEQG-LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           IV      ID     L+++ +Y  GG L   +    KG +    L      +V   +  +
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT---KGTKERQYLDEEFVLRVMTQLTLA 121

Query: 300 VAYLH--NGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           +   H  +     V+HRD+KP+N+ L  K+  KL DFGLA   +  +
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT 168

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 7e-39
 Identities = 45/187 (24%), Positives = 69/187 (36%), Gaps = 13/187 (6%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
                   LG G    V+ G        VA+K L +    S  AF  E  +   L H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRL 70

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L          +++I +Y+  GSL   L            L  +    +A  IAE +A
Sbjct: 71  VRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGI-----KLTINKLLDMAAQIAEGMA 123

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPF 361
           ++    ER  +HRD++ +NIL+S     K+ DFGLA      +     +  K        
Sbjct: 124 FIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAP 179

Query: 362 CIEEWQR 368
               +  
Sbjct: 180 EAINYGT 186

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 46/176 (26%), Positives = 73/176 (41%), Gaps = 12/176 (6%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNI 241
           ++   + LG GA   V      +   +VA+K +D +   +  +   +E+ I   L+H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V   G   +     +L  +Y SGG L   +            +P     +    +   V 
Sbjct: 66  VKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIG-------MPEPDAQRFFHQLMAGVV 117

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           YLH      + HRDIKP N+LL  +   K+ DFGLAT     +   L   + GT  
Sbjct: 118 YLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 170

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 6e-38
 Identities = 52/172 (30%), Positives = 79/172 (45%), Gaps = 14/172 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---EDKESSKAFCRELMIASSLHHP 239
           +F  GR LG+G    V+  +    +  +A+K L K   E         RE+ I S L HP
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
           NI+ L G+  D  + ++LI +Y   G++ R L +  K                   +A +
Sbjct: 67  NILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSK-------FDEQRTATYITELANA 118

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
           ++Y H    + V+HRDIKP N+LL S    K+ DFG +    +     LC T
Sbjct: 119 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGT 167

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 1e-37
 Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 27/201 (13%)

Query: 183 NFSKGRVLGRGALSFVFKGK-VGLLRTS----VAIKRLDKE-DKESSKAFCRELMIASSL 236
           N   G+VLG GA   V      G+ +T     VA+K L ++ D    +A   EL + + L
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 237 -HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK----------------GVR 279
             H NIV L+G C      ++LI++Y   G L  +L  K++                   
Sbjct: 98  GSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
             + L +      A  +A+ + +L     +  VHRD+   N+L++  K+ K+CDFGLA  
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213

Query: 340 TSAPSVPFLCKTVKGTFGQNP 360
             + S   +    +       
Sbjct: 214 IMSDSNYVVRGNARLPVKWMA 234

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 3e-37
 Identities = 52/194 (26%), Positives = 78/194 (40%), Gaps = 22/194 (11%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS-KAFCRELMIASS 235
           +  S G+ LG GA   V +     L  S     VA+K L      +  +A   EL + S 
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 236 L-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST----------- 283
           L +H NIV L+G C        +I +Y   G L   L  K+     + T           
Sbjct: 83  LGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           L        +  +A+ +A+L     +  +HRD+   NILL+  +I K+CDFGLA      
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 344 SVPFLCKTVKGTFG 357
           S   +    +    
Sbjct: 199 SNYVVKGNARLPVK 212

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  131 bits (331), Expect = 2e-36
 Identities = 46/198 (23%), Positives = 77/198 (38%), Gaps = 23/198 (11%)

Query: 173 SYGEILAATHNFSK---------GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE-D 219
           ++ +   A   F+K          +V+G G    V  G +   G     VAIK L     
Sbjct: 8   TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67

Query: 220 KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVR 279
           ++  + F  E  I     HPN++ L G        + +I +++  GSL+  L +      
Sbjct: 68  EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDG--- 123

Query: 280 GNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
                       +  GIA  + YL +      VHRD+   NIL++S  + K+ DFGL+ +
Sbjct: 124 ---QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 340 TSAPSVPFLCKTVKGTFG 357
               +      +  G   
Sbjct: 178 LEDDTSDPTYTSALGGKI 195

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  132 bits (334), Expect = 3e-36
 Identities = 38/170 (22%), Positives = 73/170 (42%), Gaps = 15/170 (8%)

Query: 170 IRLSYGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRE 229
           + + +  +L    ++     LG GA   V +        + A K +    +   +   +E
Sbjct: 17  VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKE 73

Query: 230 LMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
           +   S L HP +V L     D  + + +IY+++SGG L   + ++         +     
Sbjct: 74  IQTMSVLRHPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNK------MSEDEA 126

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLA 337
            +    + + + ++H   E   VH D+KP NI+ ++K+    KL DFGL 
Sbjct: 127 VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 3e-36
 Identities = 48/187 (25%), Positives = 79/187 (42%), Gaps = 16/187 (8%)

Query: 176 EILAATHNFSKGRV-LGRGALSFVFKGKVGLLRTS--VAIKRLDKE-DKESSKAFCRELM 231
           ++     N     + LG G    V +G   + +    VAIK L +  +K  ++   RE  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 232 IASSLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYK 291
           I   L +P IV L+G C    + L L+ +   GG L + L  K++       +P S   +
Sbjct: 62  IMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKFLVGKRE------EIPVSNVAE 113

Query: 292 VALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP-SVPFLCK 350
           +   ++  + YL     +  VHRD+   N+LL ++   K+ DFGL+    A  S      
Sbjct: 114 LLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 170

Query: 351 TVKGTFG 357
             K    
Sbjct: 171 AGKWPLK 177

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 5e-36
 Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 14/178 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F  G++LG G+ S V   +        AIK L+K     +       RE  + S L HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
             V L     D E+ L+    Y   G L +++ +             +        I  +
Sbjct: 69  FFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGS-------FDETCTRFYTAEIVSA 120

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + YLH    + ++HRD+KP NILL+     ++ DFG A   S  S      +  GT  
Sbjct: 121 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (328), Expect = 5e-36
 Identities = 40/186 (21%), Positives = 79/186 (42%), Gaps = 10/186 (5%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            + +    LG G    V++G       +VA+K L + D    + F +E  +   + HPN+
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNL 75

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L+G C       ++I ++++ G+L  +L E  +       +   V   +A  I+ ++ 
Sbjct: 76  VQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQ-----EVSAVVLLYMATQISSAME 129

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPF 361
           YL    ++  +HRD+   N L+    + K+ DFGL+   +  +               P 
Sbjct: 130 YLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186

Query: 362 CIEEWQ 367
            +   +
Sbjct: 187 SLAYNK 192

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-36
 Identities = 46/177 (25%), Positives = 70/177 (39%), Gaps = 18/177 (10%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPL 244
              +GRG+   V+KG        VA   L      K   + F  E  +   L HPNIV  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 245 VGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
                   +G   + L+ + ++ G+L+ +L   K        +   V       I + + 
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQ 126

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           +LH  T   ++HRD+K  NI ++      K+ D GLAT   A       K V GT  
Sbjct: 127 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPE 178

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 6e-36
 Identities = 41/181 (22%), Positives = 67/181 (37%), Gaps = 21/181 (11%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVG 246
              +G+G    V++GK       VA+K     ++ S      E+     L H NI+  + 
Sbjct: 8   QESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 247 FCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
                      L+L+  Y   GSL  +L+           +      K+AL  A  +A+L
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--------VTVEGMIKLALSTASGLAHL 116

Query: 304 HN-----GTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKTVKGTF 356
           H        +  + HRD+K  NIL+       + D GLA    +   ++        GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176

Query: 357 G 357
            
Sbjct: 177 R 177

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (322), Expect = 5e-35
 Identities = 51/211 (24%), Positives = 81/211 (38%), Gaps = 27/211 (12%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASS 235
           +N    R +G GA   VF+ +   L      T VA+K L +E   +    F RE  + + 
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK-----------------GV 278
             +PNIV L+G C   +  + L+++Y++ G L   L                        
Sbjct: 73  FDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 279 RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT 338
            G   L  + +  +A  +A  +AYL    ER  VHRD+   N L+    + K+ DFGL+ 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR 188

Query: 339 WTSAPSVPFLCKTVKGTFGQNPFCIEEWQRL 369
              +                 P     + R 
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRY 219

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 6e-35
 Identities = 41/177 (23%), Positives = 72/177 (40%), Gaps = 17/177 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS--VAIKRLDKEDKESSKAFCRELMIASSLHHPN 240
           + +  + LG G    V  GK    R    VAIK + +    S   F  E  +  +L H  
Sbjct: 5   DLTFLKELGTGQFGVVKYGK---WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEK 60

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           +V L G C      +F+I +Y++ G L  +L E +               ++   + E++
Sbjct: 61  LVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRH------RFQTQQLLEMCKDVCEAM 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            YL +   +  +HRD+   N L++ + + K+ DFGL+ +             K    
Sbjct: 114 EYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVR 166

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 7e-35
 Identities = 37/162 (22%), Positives = 71/162 (43%), Gaps = 12/162 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +++   +G+GA   V+          VAI++++ + +   +    E+++     +PNIV
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
             +   +  ++ L+++ +Y++GGSL   + E                  V     +++ +
Sbjct: 81  NYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCM--------DEGQIAAVCRECLQALEF 131

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           LH      V+HRDIK  NILL      KL DFG     +   
Sbjct: 132 LH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  126 bits (318), Expect = 6e-34
 Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 12/161 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +     LG GA   V +            K ++            E+ I + LHHP ++
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L     D  + + LI +++SGG L   +  +         +  +          E + +
Sbjct: 90  NLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYK------MSEAEVINYMRQACEGLKH 142

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP--KLCDFGLATWTS 341
           +H   E  +VH DIKP NI+  +KK    K+ DFGLAT  +
Sbjct: 143 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 180

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 1e-33
 Identities = 43/188 (22%), Positives = 76/188 (40%), Gaps = 18/188 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSL 236
           +      LG G+   V +G+         SVA+K L  +     E+   F RE+    SL
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H N++ L G  + P   + ++ +    GSL   L + +               + A+ +
Sbjct: 69  DHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQG------HFLLGTLSRYAVQV 120

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGT 355
           AE + YL     +  +HRD+   N+LL+++ + K+ DFGL          ++ +   K  
Sbjct: 121 AEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 356 FGQNPFCI 363
           F       
Sbjct: 178 FAWCAPES 185

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 1e-33
 Identities = 43/183 (23%), Positives = 67/183 (36%), Gaps = 12/183 (6%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI 241
            +      LG+G    V+ G        VAIK L      S +AF +E  +   L H  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKL 74

Query: 242 VPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVA 301
           V L     +    ++++ +Y+S GSL   L  +                 +A  IA  +A
Sbjct: 75  VQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYL-----RLPQLVDMAAQIASGMA 127

Query: 302 YLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPF 361
           Y+        VHRD++ +NIL+    + K+ DFGLA                      P 
Sbjct: 128 YVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE 184

Query: 362 CIE 364
              
Sbjct: 185 AAL 187

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-33
 Identities = 41/175 (23%), Positives = 71/175 (40%), Gaps = 13/175 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
             +  + +G G    V  G   L +  VAIK + +    S + F  E  +   L HP +V
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L G C++    + L+++++  G L  +L  +                 + L + E +AY
Sbjct: 64  QLYGVCLEQAP-ICLVFEFMEHGCLSDYLRTQ------RGLFAAETLLGMCLDVCEGMAY 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           L    E CV+HRD+   N L+   ++ K+ DFG+  +             K    
Sbjct: 117 LE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST-GTKFPVK 167

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  124 bits (313), Expect = 3e-33
 Identities = 45/175 (25%), Positives = 71/175 (40%), Gaps = 17/175 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK------EDKESSKAFCRELMIASSL 236
           +FS  R++GRG    V+  +        A+K LDK      + +  +      L + S+ 
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
             P IV +      P++ L  I   ++GG L  HL +             +     A  I
Sbjct: 65  DCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVF-------SEADMRFYAAEI 116

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
              + ++H    R VV+RD+KP+NILL      ++ D GLA   S         T
Sbjct: 117 ILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGT 168

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 7e-33
 Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 17/175 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTS--VAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVP 243
           + LG G    V KG   + +    VA+K L  E  D         E  +   L +P IV 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
           ++G C        L+ +    G L ++L + +        +      ++   ++  + YL
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQQNRH-------VKDKNIIELVHQVSMGMKYL 123

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT-VKGTFG 357
                   VHRD+   N+LL ++   K+ DFGL+    A    +  +T  K    
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 49/189 (25%), Positives = 74/189 (39%), Gaps = 20/189 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKG--KVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-H 237
           ++     V+G G    V K   K   LR   AIKR+ +   K+  + F  EL +   L H
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEK---------KKGVRGNSTLPWSV 288
           HPNI+ L+G C      L+L  +Y   G+L   L +                 STL    
Sbjct: 70  HPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128

Query: 289 RYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFL 348
               A  +A  + YL    ++  +HRD+   NIL+    + K+ DFGL+           
Sbjct: 129 LLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--- 182

Query: 349 CKTVKGTFG 357
               +    
Sbjct: 183 KTMGRLPVR 191

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 49/197 (24%), Positives = 76/197 (38%), Gaps = 19/197 (9%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTS-----VAIKRLDKEDKESS-KAFCREL-MIAS 234
                G+ LGRGA   V +     +  +     VA+K L +    S  +A   EL ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 235 SLHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLP 285
             HH N+V L+G C  P   L +I ++   G+L  +L  K+                 L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 286 WSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSV 345
                  +  +A+ + +L     R  +HRD+   NILLS K + K+CDFGLA        
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 346 PFLCKTVKGTFGQNPFC 362
                  +         
Sbjct: 190 YVRKGDARLPLKWMAPE 206

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 3e-32
 Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 16/192 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLH 237
                GR +G G    V +G          +VAIK       +S +  F +E +      
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HP+IV L+G   +    +++I +  + G L   L  +K       +L  +     A  ++
Sbjct: 67  HPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKY------SLDLASLILYAYQLS 118

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            ++AYL     +  VHRDI   N+L+SS    KL DFGL+ +    S  +     K    
Sbjct: 119 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIK 174

Query: 358 QNPFCIEEWQRL 369
                   ++R 
Sbjct: 175 WMAPESINFRRF 186

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 5e-32
 Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 16/179 (8%)

Query: 184 FSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHH 238
           F K +VLG GA   V+KG        ++  VAIK L +    +++K    E  + +S+ +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P++  L+G C+     + LI + +  G L  ++ E K  +               + IA+
Sbjct: 71  PHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNI------GSQYLLNWCVQIAK 122

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
            + YL +   R +VHRD+   N+L+ + +  K+ DFGLA    A    +  +  K    
Sbjct: 123 GMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  118 bits (296), Expect = 2e-31
 Identities = 50/188 (26%), Positives = 73/188 (38%), Gaps = 24/188 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK---------EDKESSKAFCRELMIA 233
           N+    +LGRG  S V +          A+K +D          E +E  +A  +E+ I 
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 234 SSLH-HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKV 292
             +  HPNI+ L           FL++  +  G L  +L EK         L      K+
Sbjct: 64  RKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVT-------LSEKETRKI 115

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
              + E +  LH   +  +VHRD+KP NILL      KL DFG +            + V
Sbjct: 116 MRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREV 169

Query: 353 KGTFGQNP 360
            GT     
Sbjct: 170 CGTPSYLA 177

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 4e-31
 Identities = 51/187 (27%), Positives = 76/187 (40%), Gaps = 19/187 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           +++  +V+G G+   V++ K+      VAIK++ ++ +       REL I   L H NIV
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76

Query: 243 PLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
            L  F     +      L L+  YV         H      R   TLP          + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH----YSRAKQTLPVIYVKLYMYQLF 132

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTSAPSVPFLCKTVKGTF 356
            S+AY+H      + HRDIKP N+LL     + KLCDFG A              +   +
Sbjct: 133 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--VSYICSRY 187

Query: 357 GQNPFCI 363
            + P  I
Sbjct: 188 YRAPELI 194

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-30
 Identities = 49/182 (26%), Positives = 74/182 (40%), Gaps = 16/182 (8%)

Query: 182 HNFSKGRVLGRGALSFVFKGKV----GLLRTSVAIKRLDKEDKESSKA-FCRELMIASSL 236
              ++ +V+G G    V+KG +    G     VAIK L     E  +  F  E  I    
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
            H NI+ L G     +  + +I +Y+  G+L++ L EK                 +  GI
Sbjct: 67  SHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDG------EFSVLQLVGMLRGI 119

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW-TSAPSVPFLCKTVKGT 355
           A  + YL N      VHRD+   NIL++S  + K+ DFGL+      P   +     K  
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 356 FG 357
             
Sbjct: 177 IR 178

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  115 bits (290), Expect = 1e-30
 Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 17/181 (9%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPN 240
           +  G +LG G +S V   +   L   VA+K L  +   D      F RE   A++L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 241 IVPLVGFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           IV +              +++ +YV G +L   +H +         +      +V     
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-------MTPKRAIEVIADAC 121

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPF-LCKTVKGTF 356
           +++ + H   +  ++HRD+KP+NI++S+    K+ DFG+A   +           V GT 
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 357 G 357
            
Sbjct: 179 Q 179

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-30
 Identities = 41/190 (21%), Positives = 70/190 (36%), Gaps = 13/190 (6%)

Query: 187 GRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIV 242
             V+GRG    V+ G +      +   A+K L++  D      F  E +I     HPN++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+G C+  E    ++  Y+  G L   +  +      N T+   + + + +        
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKG----- 142

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFC 362
           +     +  VHRD+   N +L  K   K+ DFGLA          +              
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 363 IEEWQRLKSC 372
           +E  Q  K  
Sbjct: 203 LESLQTQKFT 212

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-30
 Identities = 44/185 (23%), Positives = 72/185 (38%), Gaps = 17/185 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH 238
           +F   ++LG+G+   VF  +        AIK L K+    D +       + +++ +  H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 239 PNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAE 298
           P +  +       E  LF + +Y++GG L  H+    K          S     A  I  
Sbjct: 63  PFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHK-------FDLSRATFYAAEIIL 114

Query: 299 SVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQ 358
            + +LH    + +V+RD+K  NILL      K+ DFG+              T  GT   
Sbjct: 115 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPDY 169

Query: 359 NPFCI 363
               I
Sbjct: 170 IAPEI 174

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-30
 Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 15/167 (8%)

Query: 175 GEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDK-EDKESSKAFCRELMIA 233
           G++      ++    +G GA   V      + +  VAIK++   E +   +   RE+ I 
Sbjct: 1   GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 234 SSLHHPNIVPLVGFCIDP---EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRY 290
               H NI+ +      P   +     +  ++ G  L + L  +         L      
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--------LSNDHIC 112

Query: 291 KVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA 337
                I   + Y+H      V+HRD+KPSN+LL++    K+CDFGLA
Sbjct: 113 YFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA 156

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 5e-30
 Identities = 31/157 (19%), Positives = 63/157 (40%), Gaps = 13/157 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
            +     LGRG    V +      + +   K +  +  +      +E+ I +   H NI+
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNIL 64

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L       E+ L +I++++SG  +   ++           L           + E++ +
Sbjct: 65  HLHESFESMEE-LVMIFEFISGLDIFERINTSAF------ELNEREIVSYVHQVCEALQF 117

Query: 303 LHNGTERCVVHRDIKPSNILLSSKK--IPKLCDFGLA 337
           LH      + H DI+P NI+  +++    K+ +FG A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  114 bits (287), Expect = 7e-30
 Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 19/178 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F   R LG G+   V   +        A+K L KE     +  +    E ++ S + HP
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            I+ + G   D +Q +F+I  Y+ GG L   L + ++        P  V    A  +  +
Sbjct: 65  FIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRF-------PNPVAKFYAAEVCLA 116

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           + YLH    + +++RD+KP NILL      K+ DFG A +     VP +  T+ GT  
Sbjct: 117 LEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTPD 166

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 37/185 (20%), Positives = 72/185 (38%), Gaps = 13/185 (7%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKEDKESSKA-FCRELMIASS 235
              +  R LG+G+   V++G    +      T VAIK +++      +  F  E  +   
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNST---LPWSVRYKV 292
            +  ++V L+G     +    +I + ++ G L+ +L   +  +  N        S   ++
Sbjct: 80  FNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 293 ALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTV 352
           A  IA+ +AYL+       VHRD+   N +++     K+ DFG+                
Sbjct: 139 AGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 353 KGTFG 357
                
Sbjct: 196 LLPVR 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 53/178 (29%), Positives = 76/178 (42%), Gaps = 18/178 (10%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA-FCRELMIASSLHHPNIV 242
           +    VLG GA S V   +    +  VAIK + K+  E  +     E+ +   + HPNIV
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L          L+LI + VSGG L   + EK                ++   + ++V Y
Sbjct: 71  ALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGF-------YTERDASRLIFQVLDAVKY 122

Query: 303 LHNGTERCVVHRDIKPSNILLSSKK---IPKLCDFGLATWTSAPSVPFLCKTVKGTFG 357
           LH   +  +VHRD+KP N+L  S        + DFGL+      SV     T  GT G
Sbjct: 123 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPG 174

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 43/162 (26%), Positives = 69/162 (42%), Gaps = 20/162 (12%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMI-ASSLHHPNIVPLV 245
            +VLG G    V +      +   A+K L    K       RE+ +   +   P+IV +V
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 246 GFCIDPEQG---LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
               +   G   L ++ + + GG L   + +     RG+         ++   I E++ Y
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQD-----RGDQAFTEREASEIMKSIGEAIQY 126

Query: 303 LHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLATWTS 341
           LH      + HRD+KP N+L +S     I KL DFG A  T+
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 4e-28
 Identities = 42/205 (20%), Positives = 72/205 (35%), Gaps = 22/205 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKE-DKESSKAFCRELMIA 233
                G+ LG GA   V   +   L        T VA+K L  +  ++       E+ + 
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 234 SSL-HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKK---------GVRGNST 283
             +  H NI+ L+G C      L++I +Y S G+L  +L  ++                 
Sbjct: 73  KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 284 LPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           L        A  +A  + YL     +  +HRD+   N+L++   + K+ DFGLA      
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 344 SVPFLCKTVKGTFGQNPFCIEEWQR 368
                    +             + 
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRI 213

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 2e-27
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 12/164 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
           NF K   +G G    V+K +  L    VA+K  RLD E +       RE+ +   L+HPN
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L+       + L+L+++++     +        G      +P  +       + + +
Sbjct: 63  IVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG------IPLPLIKSYLFQLLQGL 115

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
           A+ H      V+HRD+KP N+L++++   KL DFGLA     P 
Sbjct: 116 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 4e-27
 Identities = 43/197 (21%), Positives = 74/197 (37%), Gaps = 21/197 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            + K   +G+G    VFK +       VA+K++  E   +       RE+ I   L H N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 241 IVPLVGFCIDP-------EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVA 293
           +V L+  C          +  ++L++ +          +   K          S   +V 
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-------FTLSEIKRVM 123

Query: 294 LGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP--SVPFLCKT 351
             +      L+      ++HRD+K +N+L++   + KL DFGLA   S    S P     
Sbjct: 124 QMLLN---GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180

Query: 352 VKGTFGQNPFCIEEWQR 368
              T    P  +   +R
Sbjct: 181 RVVTLWYRPPELLLGER 197

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  106 bits (265), Expect = 1e-26
 Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 14/160 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
            F + + LG G+   V   K        A+K LDK+     +  +    E  I  +++ P
Sbjct: 42  QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +V L     D    L+++ +YV+GG +  HL    +                A  I  +
Sbjct: 102 FLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGR-------FSEPHARFYAAQIVLT 153

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW 339
             YLH      +++RD+KP N+L+  +   ++ DFG A  
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-26
 Identities = 43/189 (22%), Positives = 68/189 (35%), Gaps = 16/189 (8%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHP 239
           +F   ++LG+G    V   +        A+K L KE    K+       E  +  +  HP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 240 NIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAES 299
            +  L       ++ L  + +Y +GG L  HL  ++                    I  +
Sbjct: 66  FLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERV-------FTEERARFYGAEIVSA 117

Query: 300 VAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQN 359
           + YLH    R VV+RDIK  N++L      K+ DFGL     +           GT    
Sbjct: 118 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYL 172

Query: 360 PFCIEEWQR 368
              + E   
Sbjct: 173 APEVLEDND 181

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (260), Expect = 3e-26
 Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 16/161 (9%)

Query: 188 RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSK-----AFCRELMIASSLHHPNIV 242
             LG G  + V+K +       VAIK++    +  +K        RE+ +   L HPNI+
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
            L+         + L++ ++                     L  S      L   + + Y
Sbjct: 64  GLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSLV-------LTPSHIKAYMLMTLQGLEY 115

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
           LH   +  ++HRD+KP+N+LL    + KL DFGLA    +P
Sbjct: 116 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  104 bits (259), Expect = 3e-26
 Identities = 45/188 (23%), Positives = 79/188 (42%), Gaps = 15/188 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIK--RLDKEDKESSKAFCRELMIASSLHHPN 240
            +     +G G    V+K +     T  A+K  RL+KED+       RE+ I   L H N
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L       ++ L L+++++     +     +         L         L +   +
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHLDQDLKKLLDVCEGG-------LESVTAKSFLLQLLNGI 113

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNP 360
           AY H   +R V+HRD+KP N+L++ +   K+ DFGLA     P   +    +   + + P
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAP 169

Query: 361 FCIEEWQR 368
             +   ++
Sbjct: 170 DVLMGSKK 177

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 49/199 (24%), Positives = 79/199 (39%), Gaps = 23/199 (11%)

Query: 180 ATHNFSKGRVLGRGALSFVFKGK-VGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSL 236
           A   +     +G GA   VFK + +      VA+KR+  +  ++    +  RE+ +   L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 237 ---HHPNIVPLVGFCIDPEQG----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVR 289
               HPN+V L   C          L L++++V            + G      +P    
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG------VPTETI 118

Query: 290 YKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
             +   +   + +LH      VVHRD+KP NIL++S    KL DFGLA   S        
Sbjct: 119 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---L 172

Query: 350 KTVKGTFG-QNPFCIEEWQ 367
            +V  T   + P  + +  
Sbjct: 173 TSVVVTLWYRAPEVLLQSS 191

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  103 bits (257), Expect = 1e-25
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 19/162 (11%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSL-HHPNI 241
           ++   R LGRG  S VF+         V +K L    K+      RE+ I  +L   PNI
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKK---IKREIKILENLRGGPNI 92

Query: 242 VPLVGFCIDP-EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           + L     DP  +   L++++V+    ++             TL           I +++
Sbjct: 93  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----------TLTDYDIRFYMYEILKAL 142

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSK-KIPKLCDFGLATWTS 341
            Y H      ++HRD+KP N+++  + +  +L D+GLA +  
Sbjct: 143 DYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 2e-25
 Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 23/186 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE------DKESSKAFCRELMIASSLH 237
           +  G +LG G    V+ G        VAIK ++K+      +  +      E+++   + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 238 --HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
                ++ L+ +   P+    LI +             ++        L   +       
Sbjct: 66  SGFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGA------LQEELARSFFWQ 118

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLATWTSAPSVPFLCKTVKG 354
           + E+V + H      V+HRDIK  NIL+  ++   KL DFG                  G
Sbjct: 119 VLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDG 171

Query: 355 TFGQNP 360
           T   +P
Sbjct: 172 TRVYSP 177

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 3e-25
 Identities = 47/164 (28%), Positives = 69/164 (42%), Gaps = 21/164 (12%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESS------KAFCRELMIASSLH 237
           +  G  LG G  + V K +        A K + K   +SS      +   RE+ I   + 
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 238 HPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIA 297
           HPN++ L     +    + LI + V+GG L   L EK+        L      +    I 
Sbjct: 72  HPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKES-------LTEEEATEFLKQIL 123

Query: 298 ESVAYLHNGTERCVVHRDIKPSNILLSSKKIP----KLCDFGLA 337
             V YLH      + H D+KP NI+L  + +P    K+ DFGLA
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (251), Expect = 5e-25
 Identities = 36/182 (19%), Positives = 61/182 (33%), Gaps = 20/182 (10%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +  GR +G G+   ++ G        VAIK    + K        E  I   +     +P
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYL 303
            + +C        ++ + +     +      +K               +A  +   + Y+
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-------FSLKTVLLLADQMISRIEYI 119

Query: 304 HNGTERCVVHRDIKPSNILLSSKKIPKLC---DFGLATW-----TSAPSVPFLCKTVKGT 355
           H    +  +HRD+KP N L+   K   L    DFGLA       T         K + GT
Sbjct: 120 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176

Query: 356 FG 357
             
Sbjct: 177 AR 178

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.3 bits (246), Expect = 2e-24
 Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 13/164 (7%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            + K   +G G    VFK K       VA+KR+  +  D+    +  RE+ +   L H N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 241 IVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESV 300
           IV L       ++   +                KK     N  L   +       + + +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFC--------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114

Query: 301 AYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            + H+   R V+HRD+KP N+L++     KL +FGLA     P 
Sbjct: 115 GFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 6e-24
 Identities = 37/177 (20%), Positives = 71/177 (40%), Gaps = 19/177 (10%)

Query: 182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHP 239
             +   + +G GA   V     G     VAIK+L +    +  +K   REL +   + H 
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 240 NIVPLVGFCIDPEQG-----LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVAL 294
           N++ L+      E        +L+  ++  G+    L + +K       L       +  
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-------LGEDRIQFLVY 128

Query: 295 GIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKT 351
            + + + Y+H      ++HRD+KP N+ ++     K+ DFGLA    +    ++   
Sbjct: 129 QMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 182

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 97.2 bits (241), Expect = 1e-23
 Identities = 36/183 (19%), Positives = 59/183 (32%), Gaps = 22/183 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIV 242
           ++  GR +G G+   +F+G   L    VAIK   +           E      L     +
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGI 63

Query: 243 PLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAY 302
           P V +         L+   +     +      +K                A  +   V  
Sbjct: 64  PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK-------FSVKTVAMAAKQMLARVQS 116

Query: 303 LHNGTERCVVHRDIKPSNILLSSKKIP-----KLCDFGLATW-----TSAPSVPFLCKTV 352
           +H   E+ +V+RDIKP N L+            + DFG+  +     T         K +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173

Query: 353 KGT 355
            GT
Sbjct: 174 SGT 176

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 4e-23
 Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 17/174 (9%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTS---VAIKRLDK----EDKESSKAFCRELMIASS 235
           NF   +VLG GA   VF  +      +    A+K L K    +  ++++    E  +   
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 236 LHHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           +     +  + +    E  L LI  Y++GG L  HL ++++                   
Sbjct: 85  IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-------FTEHEVQIYVGE 137

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLC 349
           I  ++ +LH   +  +++RDIK  NILL S     L DFGL+    A       
Sbjct: 138 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 188

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 2e-22
 Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 17/167 (10%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            +     +G GA   V           VA+K+L +       +K   REL +   + H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 241 IVPLVGFCIDP----EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
           ++ L+          E     +  ++ G  L   +  +K        L       +   I
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--------LTDDHVQFLIYQI 130

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP 343
              + Y+H      ++HRD+KPSN+ ++     K+ DFGLA  T   
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.6 bits (234), Expect = 3e-22
 Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 20/166 (12%)

Query: 183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPN 240
            +   + +G GA   V      +L  +VAIK+L +   ++  +K   REL++   ++H N
Sbjct: 18  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 241 IVPLVGFCIDPE-----QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALG 295
           I+ L+      +     Q ++L+ + +     +    E                  +   
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----------DHERMSYLLYQ 127

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS 341
           +   + +LH      ++HRD+KPSNI++ S    K+ DFGLA    
Sbjct: 128 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 81.2 bits (199), Expect = 9e-18
 Identities = 32/194 (16%), Positives = 65/194 (33%), Gaps = 12/194 (6%)

Query: 184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVP 243
           +   R LG G  S V+  K  +  T VA+K +   DK  ++A   E+ +   ++  +   
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 244 LVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGV--------RGNSTLPWSVRYKVALG 295
                 +    L   + +     +   +  +  G           +  +P     +++  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 296 IAESVAYLHNGTERCVVHRDIKPSNILLSSKKIP-KLCDFGLATWTSAPSVPFLCKTVKG 354
           +   + Y+H      ++H DIKP N+L+     P  L    +A   +A            
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 355 TFGQNPFCIEEWQR 368
           T       +     
Sbjct: 192 TREYRSPEVLLGAP 205

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 74.0 bits (181), Expect = 3e-16
 Identities = 26/168 (15%), Positives = 48/168 (28%), Gaps = 26/168 (15%)

Query: 187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKA----------FCRELMIASSL 236
           G+++G G  S VF            +K          K           F    + ++  
Sbjct: 5   GKLMGEGKESAVFNCYSEKFGE-CVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63

Query: 237 HHPNIVPLVGFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGI 296
               +  L G  +                     +  +    +    +      +V   I
Sbjct: 64  EFRALQKLQGLAVPKVYAWE-----------GNAVLMELIDAKELYRVRVENPDEVLDMI 112

Query: 297 AESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPS 344
            E VA  +    R +VH D+   N+L+S + I  + DF  +       
Sbjct: 113 LEEVAKFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	372
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.98
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.98
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.98
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.52
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.8
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.79
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.44
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.65

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-39  Score=305.47  Aligned_cols=172  Identities=27%  Similarity=0.356  Sum_probs=149.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||+++... ....+.+.+|+++|++++|||||++++++.+. ...|+|||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmE   83 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLE   83 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEe
Confidence            58999999999999999999999999999999997653 33446789999999999999999999998874 45899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        84 y~~gg~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          84 YCSGGELFDRIEPD-------IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             CCTTEEGGGGSBTT-------TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheee
Confidence            99999999998653       46999999999999999999999988   999999999999999999999999999987


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ............+||+.|+|||.-
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~  177 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELL  177 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHH
T ss_pred             ccCCccccccceeeCcCccCHhHh
Confidence            655443345667899999998854

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-38  Score=298.65  Aligned_cols=170  Identities=24%  Similarity=0.355  Sum_probs=150.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||+||+|.+..+++.||||+++.......+.+.+|+++|++++|||||++++++.+.+ .+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT-EEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECC-EEEEEEEe
Confidence            47999999999999999999999999999999998765555678999999999999999999999988754 58999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |++|+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        99 ~~gg~L~~~~~~--------~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          99 LAGGSLTDVVTE--------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (293)
T ss_dssp             CTTCBHHHHHHH--------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cCCCcHHHHhhc--------cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeec
Confidence            999999998865        35899999999999999999999988   9999999999999999999999999999876


Q ss_pred             CCCCCccccccccCCCccCccccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ....  ......||+.|+|||.-.
T Consensus       168 ~~~~--~~~~~~gt~~Y~aPE~~~  189 (293)
T d1yhwa1         168 PEQS--KRSTMVGTPYWMAPEVVT  189 (293)
T ss_dssp             STTC--CBCCCCSCGGGCCHHHHS
T ss_pred             cccc--cccccccCCCccChhhhc
Confidence            4433  234567999999977543

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-38  Score=296.29  Aligned_cols=178  Identities=24%  Similarity=0.313  Sum_probs=139.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-CCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-EQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||.++..  .....+.+.+|+++|++++|||||++++++.+. +..+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5899999999999999999999999999999999764  345567799999999999999999999998753 3458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT--ERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      ||||++|+|.+++......   ...+++..++.++.||+.||.|||+.+  ..+||||||||+|||++.++.+||+|||+
T Consensus        84 mEy~~~g~L~~~i~~~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          84 MEYCEGGDLASVITKGTKE---RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EecCCCCcHHHHHHhcccc---CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999754321   157999999999999999999999754  23499999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+.......  ......||+.|+|||.-
T Consensus       161 a~~~~~~~~--~~~~~~gt~~Y~APE~l  186 (269)
T d2java1         161 ARILNHDTS--FAKAFVGTPYYMSPEQM  186 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHH
T ss_pred             eeecccCCC--ccccCCCCcccCCHHHH
Confidence            998765433  33567899999998764

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-38  Score=299.82  Aligned_cols=170  Identities=25%  Similarity=0.337  Sum_probs=150.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      +.|++.+.||+|+||.||+|++..+++.||||++++......+.+.+|+++|++++|||||++++++.+. +..++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEec
Confidence            4799999999999999999999999999999999877666677899999999999999999999998774 458999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      |++|+|.+++.+..      ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        91 ~~~g~L~~~~~~~~------~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          91 CAGGAVDAVMLELE------RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT  161 (288)
T ss_dssp             CTTEEHHHHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred             CCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence            99999999987653      46999999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCCCccccccccCCCccCccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....  ...+..||+.|+|||.
T Consensus       162 ~~~~--~~~~~~Gt~~y~APE~  181 (288)
T d2jfla1         162 RTIQ--RRDSFIGTPYWMAPEV  181 (288)
T ss_dssp             HHHH--HHTCCCSCCTTCCHHH
T ss_pred             CCcc--cccccccccccCCHHH
Confidence            3211  2345679999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-38  Score=293.56  Aligned_cols=169  Identities=31%  Similarity=0.469  Sum_probs=149.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|+++.+++.||||++.+.   .....+.+.+|+.++++++|||||++++++.+ +..+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence            4799999999999999999999999999999998753   22345678999999999999999999999876 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||||++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus        85 mEy~~~g~L~~~l~~~-------~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~  154 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL-------SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSV  154 (263)
T ss_dssp             EECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCS
T ss_pred             EeecCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceee
Confidence            9999999999999865       46999999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ......    .....||+.|+|||.-.
T Consensus       155 ~~~~~~----~~~~~Gt~~Y~APE~~~  177 (263)
T d2j4za1         155 HAPSSR----RTTLCGTLDYLPPEMIE  177 (263)
T ss_dssp             CCCCCC----CEETTEEGGGCCHHHHT
T ss_pred             ecCCCc----ccccCCCCcccCHHHHc
Confidence            765443    24567999999987644

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-38  Score=300.10  Aligned_cols=179  Identities=22%  Similarity=0.376  Sum_probs=151.3

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~  253 (372)
                      |++++...++|+..+.||+|+||.||+|.+..+++.||||+++... ...++|.+|+.+|++++|||||+++++|.+.+ 
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-   86 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP-   86 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCC-
Confidence            3445555678999999999999999999999889999999997643 34567999999999999999999999987754 


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+++|+|.+++.....     ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        87 ~~~iv~E~~~~g~l~~~l~~~~~-----~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          87 PFYIITEFMTYGNLLDYLRECNR-----QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             SCEEEEECCTTCBHHHHHHHSCT-----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             eeEEEeecccCcchHHHhhhccc-----cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcc
Confidence            48999999999999999976432     57899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|+........ ......||+.|+|||.
T Consensus       159 FG~a~~~~~~~~~-~~~~~~g~~~y~aPE~  187 (287)
T d1opja_         159 FGLSRLMTGDTYT-AHAGAKFPIKWTAPES  187 (287)
T ss_dssp             CCCTTTCCSSSSE-EETTEEECGGGCCHHH
T ss_pred             ccceeecCCCCce-eeccccccccccChHH
Confidence            9999987654332 2233456667777654

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=305.70  Aligned_cols=171  Identities=27%  Similarity=0.366  Sum_probs=148.9

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++.. .....+.+.+|+.+|++++|||||+++++|.+. ..+|+|
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEE
Confidence            356899999999999999999999999999999999764 344567899999999999999999999998874 458999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-TERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |||+++|+|.+++.+.       ..+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+|
T Consensus        83 mEy~~gg~L~~~l~~~-------~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla  152 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKA-------GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVS  152 (322)
T ss_dssp             EECCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred             EEcCCCCcHHHHHhhc-------CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCc
Confidence            9999999999999865       4689999999999999999999974 6   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +......    ..+.+||+.|+|||.-.
T Consensus       153 ~~~~~~~----~~~~~GT~~Y~APEvl~  176 (322)
T d1s9ja_         153 GQLIDSM----ANSFVGTRSYMSPERLQ  176 (322)
T ss_dssp             HHHHHHT----C---CCSSCCCCHHHHH
T ss_pred             cccCCCc----cccccCCccccCchHHc
Confidence            9764332    24568999999987543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-38  Score=296.84  Aligned_cols=172  Identities=27%  Similarity=0.349  Sum_probs=146.9

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||++++.   .....+.+.+|+++|++++|||||++++++.+ +..+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEE
Confidence            5799999999999999999999999999999999753   22345678999999999999999999999876 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|.+++...       ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus        87 mEy~~gg~L~~~~~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~  156 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI-------GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAK  156 (288)
T ss_dssp             ECCCTTEEHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEccCCCCHHHhhhcc-------CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccce
Confidence            9999999999998875       46999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .+..........+..||+.|+|||.-
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~  182 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELL  182 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHH
T ss_pred             ecccCCcccccccccCCccccCceee
Confidence            88655443344567899999998753

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-38  Score=297.82  Aligned_cols=172  Identities=27%  Similarity=0.397  Sum_probs=142.0

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      ...++|++.+.||+|+||.||+|+..   ..||||+++..  +....+.|.+|+.+|++++|||||++++++.+  ..++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEE
Confidence            34568999999999999999999865   35999999754  45567789999999999999999999998754  3478


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|||||++|+|.+++....      ..+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        80 lv~Ey~~~g~L~~~l~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGl  150 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIE------TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL  150 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred             EEEecCCCCCHHHHHhhcc------CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccc
Confidence            9999999999999997643      46999999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+............+..||+.|||||+-
T Consensus       151 a~~~~~~~~~~~~~~~~gt~~y~APE~l  178 (276)
T d1uwha_         151 ATVKSRWSGSHQFEQLSGSILWMAPEVI  178 (276)
T ss_dssp             SCC------------CCCCGGGCCHHHH
T ss_pred             eeeccccCCcccccccccCcccCCHHHH
Confidence            9887655444445667899999998764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-37  Score=287.38  Aligned_cols=169  Identities=26%  Similarity=0.329  Sum_probs=145.1

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC---CCeEEEE
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP---EQGLFLI  258 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~---~~~~~lV  258 (372)
                      |+..+.||+|+||+||+|.+..+++.||+|.+...  .....+.|.+|+++|++++|||||++++++.+.   +..+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            36667899999999999999999999999998754  445567899999999999999999999998642   3457999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc-CCCcEEEEecccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS-SKKIPKLCDFGLA  337 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld-~~~~~KL~DFGla  337 (372)
                      |||+++|+|.+++...       ..+++..++.++.||+.||.|||+.+ ++|+||||||+|||++ .++.+||+|||+|
T Consensus        91 mE~~~~g~L~~~l~~~-------~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF-------KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EeCCCCCcHHHHHhcc-------ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            9999999999999875       46899999999999999999999865 4599999999999996 5789999999999


Q ss_pred             cccCCCCCCccccccccCCCccCcccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +......    ..+..||+.|+|||.-
T Consensus       163 ~~~~~~~----~~~~~GT~~Y~aPE~~  185 (270)
T d1t4ha_         163 TLKRASF----AKAVIGTPEFMAPEMY  185 (270)
T ss_dssp             GGCCTTS----BEESCSSCCCCCGGGG
T ss_pred             eeccCCc----cCCcccCccccCHHHh
Confidence            8754432    3467899999998753

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-37  Score=295.69  Aligned_cols=171  Identities=26%  Similarity=0.289  Sum_probs=151.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++++.   .....+.+.+|+.+|++++|||||++++++.+ +..+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccccc
Confidence            5899999999999999999999999999999999764   22345678999999999999999999999877 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      ||||++|+|.+++...       ..+++..++.++.||+.||+|||+.+   ||||||||+|||++.+|.+||+|||+|+
T Consensus        84 ~ey~~gg~L~~~~~~~-------~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~  153 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-------RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK  153 (337)
T ss_dssp             EECCTTCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             eeccCCCchhhhhhcc-------cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccc
Confidence            9999999999999876       46899999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      .......  ...+.+||+.|+|||+-+
T Consensus       154 ~~~~~~~--~~~~~~GT~~Y~aPE~~~  178 (337)
T d1o6la_         154 EGISDGA--TMKTFCGTPEYLAPEVLE  178 (337)
T ss_dssp             CSCCTTC--CBCCCEECGGGCCGGGGS
T ss_pred             ccccCCc--ccccceeCHHHhhhhhcc
Confidence            7654433  345678999999988754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-37  Score=293.10  Aligned_cols=164  Identities=27%  Similarity=0.366  Sum_probs=145.4

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .|+..+.||+|+||.||+|++..+++.||||+++...   ....+.+.+|+.+|++++|||||++++++.+. ...|+||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEE
Confidence            5999999999999999999999999999999997643   34456789999999999999999999998774 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |||++|+|..++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.
T Consensus        95 E~~~~g~l~~~~~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK-------KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             ECCSEEHHHHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EecCCCchHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccc
Confidence            999999998776553       46999999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ....      ....||+.|+|||.
T Consensus       165 ~~~~------~~~~GT~~Y~APE~  182 (309)
T d1u5ra_         165 MAPA------NSFVGTPYWMAPEV  182 (309)
T ss_dssp             SSSB------CCCCSCGGGCCHHH
T ss_pred             cCCC------CccccCccccCHHH
Confidence            6432      34579999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-36  Score=294.99  Aligned_cols=171  Identities=23%  Similarity=0.361  Sum_probs=152.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+......+.+.+|+.+|++++|||||++++++.+ ++.+|+||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~  104 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYEF  104 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            489999999999999999999999999999999988777777889999999999999999999999877 4558999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC--CCcEEEEecccccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS--KKIPKLCDFGLATW  339 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~--~~~~KL~DFGla~~  339 (372)
                      |++|+|.+++....      ..+++..+..|+.||+.||.|||+.+   ||||||||+|||++.  ++.+||+|||+|+.
T Consensus       105 ~~gg~L~~~l~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         105 MSGGELFEKVADEH------NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             CCSCBHHHHHTCTT------SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999999996542      46999999999999999999999988   999999999999964  57899999999998


Q ss_pred             cCCCCCCccccccccCCCccCccccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +....   ...+..||+.|+|||.-+
T Consensus       176 ~~~~~---~~~~~~gT~~Y~aPEv~~  198 (350)
T d1koaa2         176 LDPKQ---SVKVTTGTAEFAAPEVAE  198 (350)
T ss_dssp             CCTTS---CEEEECSCTTTCCHHHHH
T ss_pred             ccccc---ccceecCcccccCHHHHc
Confidence            76543   235678999999988644

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-37  Score=288.64  Aligned_cols=172  Identities=26%  Similarity=0.340  Sum_probs=146.5

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|+..+.||+|+||.||+|.++ +++.||||+++... ...+.|.+|+++|++++|||||++++++.+ + ..++||
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~-~~~iv~   86 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E-PIYIIT   86 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEE
T ss_pred             CHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-C-CeEEEE
Confidence            4568999999999999999999986 46889999997643 344679999999999999999999998754 3 378999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|.+++.....     ..++|..++.|+.||++||.|||+.+   |+||||||+||||+.++.+||+|||+|+.
T Consensus        87 Ey~~~g~L~~~~~~~~~-----~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          87 EYMENGSLVDFLKTPSG-----IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             ECCTTCBHHHHTTSHHH-----HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EeCCCCcHHHHHhhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEE
Confidence            99999999998865432     46899999999999999999999987   99999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....... ......||+.|+|||.-
T Consensus       159 ~~~~~~~-~~~~~~gt~~y~APE~~  182 (272)
T d1qpca_         159 IEDNEYT-AREGAKFPIKWTAPEAI  182 (272)
T ss_dssp             CSSSCEE-CCTTCCCCTTTSCHHHH
T ss_pred             ccCCccc-cccccCCcccccChHHH
Confidence            7654322 23445788899997754

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-37  Score=284.63  Aligned_cols=171  Identities=22%  Similarity=0.393  Sum_probs=137.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||+|.+.. ++.||||+++... ...++|.+|++++++++|||||+++|+|.+.+. .++||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~lv~E~   81 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-ICLVFEF   81 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEEEEEC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCc-eEEEEEe
Confidence            589999999999999999999864 6789999997643 344679999999999999999999999887554 8999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|+|.+++....      ..++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        82 ~~~g~L~~~l~~~~------~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  152 (263)
T d1sm2a_          82 MEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL  152 (263)
T ss_dssp             CTTCBHHHHHHTTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred             cCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheecc
Confidence            99999999987653      56899999999999999999999987   9999999999999999999999999998875


Q ss_pred             CCCCCccccccccCCCccCccccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ..... ......||+.|+|||.-.
T Consensus       153 ~~~~~-~~~~~~gt~~y~aPE~l~  175 (263)
T d1sm2a_         153 DDQYT-SSTGTKFPVKWASPEVFS  175 (263)
T ss_dssp             -------------CTTSCCHHHHT
T ss_pred             CCCce-eecceecCcccCChHHhc
Confidence            44332 223457899999977543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-36  Score=290.44  Aligned_cols=168  Identities=29%  Similarity=0.386  Sum_probs=148.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|+++.+++.||||++++.   .....+.+.+|+.+|++++|||||++++++.+ +..+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeE
Confidence            4799999999999999999999999999999999753   23345678999999999999999999999876 4568999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+++|+|..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+
T Consensus        83 mE~~~gg~l~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~  152 (316)
T d1fota_          83 MDYIEGGELFSLLRKS-------QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAK  152 (316)
T ss_dssp             ECCCCSCBHHHHHHHT-------SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             eeecCCcccccccccc-------ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccce
Confidence            9999999999999875       46889999999999999999999887   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ......     .+..||+.|+|||.-.
T Consensus       153 ~~~~~~-----~~~~Gt~~Y~APE~l~  174 (316)
T d1fota_         153 YVPDVT-----YTLCGTPDYIAPEVVS  174 (316)
T ss_dssp             ECSSCB-----CCCCSCTTTCCHHHHT
T ss_pred             Eecccc-----ccccCcccccCHHHHc
Confidence            875432     4568999999987643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-36  Score=289.14  Aligned_cols=174  Identities=25%  Similarity=0.353  Sum_probs=134.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe---EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT---SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~---~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|+..+.||+|+||+||+|.+..+++   .||||.+... .....+.|.+|+++|++++|||||+++|+|.+.+ ..++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST-PVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS-SCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC-EEEE
Confidence            467788999999999999999875543   6899998754 4556678999999999999999999999987654 4899


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      |||||++|+|.+++....      ..++|..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+|
T Consensus       105 v~Ey~~~g~L~~~~~~~~------~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla  175 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQND------GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLS  175 (299)
T ss_dssp             EEECCTTEEHHHHHHTTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---
T ss_pred             EEEecCCCcceeeecccc------CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccc
Confidence            999999999999987643      46899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCCCcc---ccccccCCCccCccccc
Q 017411          338 TWTSAPSVPFL---CKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       338 ~~~~~~~~~~~---~~~~~GT~gy~apeaPE  365 (372)
                      +..........   .....||+.|+|||.-+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~  206 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ  206 (299)
T ss_dssp             --------------------CGGGSCHHHHH
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHh
Confidence            98754432211   12245788899977543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.4e-36  Score=292.43  Aligned_cols=170  Identities=24%  Similarity=0.294  Sum_probs=150.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|++.+.||+|+||.||+|.+..+++.||||++++......+.+.+|+++|++++|||||++++++.+ +..+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            479999999999999999999999999999999988766667789999999999999999999999876 5568999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc--CCCcEEEEecccccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS--SKKIPKLCDFGLATW  339 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld--~~~~~KL~DFGla~~  339 (372)
                      |++|+|.+++....      ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++  .++.+||+|||+|+.
T Consensus       108 ~~gg~L~~~~~~~~------~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         108 LSGGELFDRIAAED------YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             CCCCBHHHHTTCTT------CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             CCCChHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeeccccee
Confidence            99999998876542      46999999999999999999999988   99999999999998  568999999999998


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +....   ...+..||+.|+|||.-
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~  200 (352)
T d1koba_         179 LNPDE---IVKVTTATAEFAAPEIV  200 (352)
T ss_dssp             CCTTS---CEEEECSSGGGCCHHHH
T ss_pred             cCCCC---ceeeccCcccccCHHHH
Confidence            86543   23556899999997754

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-36  Score=289.49  Aligned_cols=171  Identities=30%  Similarity=0.387  Sum_probs=131.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC-hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED-KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .+.|++.+.||+|+||+||+|++..+++.||||++.+.. ......+.+|+.+|++++|||||++++++.+ +..+|+||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lvm   86 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLIM   86 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            357999999999999999999999999999999997653 2334568899999999999999999999876 45689999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEc---CCCcEEEEeccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLS---SKKIPKLCDFGL  336 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld---~~~~~KL~DFGl  336 (372)
                      |||++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||+.   .++.+||+|||+
T Consensus        87 E~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~  156 (307)
T d1a06a_          87 QLVSGGELFDRIVEK-------GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGL  156 (307)
T ss_dssp             CCCCSCBHHHHHHTC-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--
T ss_pred             eccCCCcHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccce
Confidence            999999999999764       46999999999999999999999988   99999999999995   578999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+.......   ..+..||+.|+|||.-.
T Consensus       157 a~~~~~~~~---~~~~~GT~~y~APE~~~  182 (307)
T d1a06a_         157 SKMEDPGSV---LSTACGTPGYVAPEVLA  182 (307)
T ss_dssp             -------------------CTTSCHHHHT
T ss_pred             eEEccCCCe---eeeeeeCccccCcHHHc
Confidence            987754432   34567999999987643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-36  Score=281.65  Aligned_cols=170  Identities=29%  Similarity=0.355  Sum_probs=148.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      +.|++.+.||+|+||+||+|++..+++.||||++++..      ....+.|.+|+.+|++++|||||++++++.+ +..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTDV   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEE
Confidence            57999999999999999999999999999999997532      2245789999999999999999999999876 4558


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC----cEEE
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK----IPKL  331 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~----~~KL  331 (372)
                      |+|||||++|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~-------~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK-------ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             EEEEEcCCCccccchhccc-------cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEe
Confidence            9999999999999999875       46999999999999999999999988   99999999999998776    5999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +|||+|+.......   ..+..||+.|+|||+-+
T Consensus       159 ~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~  189 (293)
T d1jksa_         159 IDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVN  189 (293)
T ss_dssp             CCCTTCEECTTSCB---CSCCCCCGGGCCHHHHT
T ss_pred             cchhhhhhcCCCcc---ccccCCCCcccCHHHHc
Confidence            99999988765432   34567899999987644

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-36  Score=281.67  Aligned_cols=173  Identities=27%  Similarity=0.373  Sum_probs=138.0

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCC----eEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLR----TSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      .+.|+..+.||+|+||.||+|.++.++    ..||||+++.. .......|.+|+.+|++++|||||+++|++.+.+. .
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~-~   84 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP-M   84 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-E
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc-e
Confidence            357999999999999999999986543    47999999764 44455679999999999999999999999877554 8


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+.++++.+++....      ..++|..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             EEEEEecccCcchhhhhccc------ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence            99999999999999887653      56999999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCC-CccccccccCCCccCccc
Q 017411          336 LATWTSAPSV-PFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       336 la~~~~~~~~-~~~~~~~~GT~gy~apea  363 (372)
                      +|+....... ........||+.|+|||.
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~  184 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEA  184 (283)
T ss_dssp             C-----------------CCCGGGSCHHH
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHH
Confidence            9998754332 222334568888999774

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=289.58  Aligned_cols=181  Identities=28%  Similarity=0.399  Sum_probs=147.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCC-----eEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLR-----TSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPE  252 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~-----~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~  252 (372)
                      ..++|++.+.||+|+||+||+|++..++     ..||+|.+... .......+.+|+.+|.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            3468999999999999999999986443     36999998654 334456789999999998 8999999999987755


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCC----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCC
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGV----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDI  316 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDL  316 (372)
                       .+++|||||++|+|.++|.......                .....+++..++.++.||+.||.|||+.+   ||||||
T Consensus       115 -~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDl  190 (325)
T d1rjba_         115 -PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL  190 (325)
T ss_dssp             -SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred             -eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccC
Confidence             4899999999999999998654211                11245899999999999999999999987   999999


Q ss_pred             CCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          317 KPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       317 Kp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|||++.++.+||+|||+|+............+..||+.|||||.-
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l  238 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESL  238 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHH
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHH
Confidence            999999999999999999999987655544444567789999998753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-36  Score=281.76  Aligned_cols=173  Identities=28%  Similarity=0.401  Sum_probs=145.3

Q ss_pred             hCCeeecee-EcccCceEEEEEEECC--CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRV-LGRGALSFVFKGKVGL--LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~-LG~G~fG~Vy~~~~~~--~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|...+. ||+|+||.||+|.++.  ++..||||+++.. .....+.|.+|+++|++++|||||+++|+|.+ + .+|
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~-~~~   84 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-ALM   84 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-SEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-eEE
Confidence            357777774 9999999999998753  3558999999764 45566789999999999999999999999864 3 389


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +|||||++|+|.+++...+      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        85 lvmE~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGl  155 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGL  155 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT------TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTT
T ss_pred             EEEEeCCCCcHHHHhhccc------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchh
Confidence            9999999999999986543      46999999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCC-ccccccccCCCccCcccc
Q 017411          337 ATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       337 a~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      |+........ .......||+.|+|||.-
T Consensus       156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~  184 (285)
T d1u59a_         156 SKALGADDSYYTARSAGKWPLKWYAPECI  184 (285)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHH
T ss_pred             hhcccccccccccccccccCccccChHHH
Confidence            9987654332 123345788999997753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.3e-35  Score=276.30  Aligned_cols=168  Identities=30%  Similarity=0.364  Sum_probs=147.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---------hhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcC
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---------KESSKAFCRELMIASSLH-HPNIVPLVGFCIDP  251 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---------~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~  251 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||++++..         ....+.+.+|+.+|++++ |||||++++++.+ 
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-   81 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET-   81 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence            68999999999999999999999899999999997642         123346889999999997 9999999999876 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      +..+|+|||||++|+|.++|...       ..+++..++.++.||+.||+|||..+   |+||||||+|||++.++.+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK-------VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             CcceEEEEEcCCCchHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEE
Confidence            55699999999999999999865       46999999999999999999999988   999999999999999999999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|||+++.+.....   .....||+.|+|||.
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~  180 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEI  180 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHH
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHH
Confidence            99999998765432   245679999999654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.2e-35  Score=288.25  Aligned_cols=167  Identities=26%  Similarity=0.320  Sum_probs=148.3

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLI  258 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV  258 (372)
                      ++|++.+.||+|+||.||+|+++.+++.||||++++.   .....+.+.+|+.+|+.++|||||++++++.+ ....++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccc
Confidence            4899999999999999999999999999999999753   22345678999999999999999999998876 4558999


Q ss_pred             EeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          259 YKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       259 ~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      |||+.+|+|.+++...       ..+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+
T Consensus       120 ~e~~~~g~l~~~l~~~-------~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~  189 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI-------GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAK  189 (350)
T ss_dssp             EECCTTCBHHHHHHHH-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             cccccccchhhhHhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeee
Confidence            9999999999999875       46899999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCCCccccccccCCCccCcccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....     ..+..||+.|||||.-
T Consensus       190 ~~~~~-----~~~~~Gt~~Y~APE~~  210 (350)
T d1rdqe_         190 RVKGR-----TWTLCGTPEALAPEII  210 (350)
T ss_dssp             ECSSC-----BCCCEECGGGCCHHHH
T ss_pred             ecccc-----cccccCccccCCHHHH
Confidence            87543     2356899999997754

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=282.80  Aligned_cols=171  Identities=27%  Similarity=0.393  Sum_probs=141.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe----EEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT----SVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~----~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .+|++.+.||+|+||+||+|.+..+++    .||+|.++.. .....+.|.+|+.+|++++|||||+++|+|.+.  ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--Cee
Confidence            479999999999999999999876665    5889988653 445567899999999999999999999999763  368


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +++||+.+|+|.+++....      ..+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+
T Consensus        87 ~v~e~~~~~~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGl  157 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGL  157 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTS------SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSH
T ss_pred             EEEEeccCCcccccccccc------cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccc
Confidence            9999999999999987753      57899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      |+...............||+.|+|||.
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~  184 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALES  184 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHH
T ss_pred             ceecccccccccccccccCccccChHH
Confidence            998876555444555678999999775

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=277.98  Aligned_cols=165  Identities=24%  Similarity=0.336  Sum_probs=137.4

Q ss_pred             eeEcccCceEEEEEEEC--CCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEeccC
Q 017411          188 RVLGRGALSFVFKGKVG--LLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYVS  263 (372)
Q Consensus       188 ~~LG~G~fG~Vy~~~~~--~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~~  263 (372)
                      +.||+|+||.||+|.++  .+++.||||+++..  +....+.|.+|+++|++++|||||+++++|.+ +. .++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~-~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES-WMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS-EEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC-EEEEEEcCC
Confidence            57999999999999864  34578999999753  34456789999999999999999999999864 33 789999999


Q ss_pred             CCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCCC
Q 017411          264 GGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSAP  343 (372)
Q Consensus       264 ~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~  343 (372)
                      +|+|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        91 ~g~L~~~l~~~-------~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          91 LGPLNKYLQQN-------RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  160 (277)
T ss_dssp             TEEHHHHHHHC-------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CCcHHHHHhhc-------cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccc
Confidence            99999999764       46999999999999999999999987   999999999999999999999999999987544


Q ss_pred             CCCc-cccccccCCCccCcccc
Q 017411          344 SVPF-LCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       344 ~~~~-~~~~~~GT~gy~apeaP  364 (372)
                      .... ......||+.|+|||.-
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l  182 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECI  182 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHH
T ss_pred             ccccccccccCCCceecCchhh
Confidence            3322 23346789999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-35  Score=287.72  Aligned_cols=168  Identities=29%  Similarity=0.320  Sum_probs=143.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHH---HHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFC---RELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~---~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++.+..   ......+.   +|+.+++.++|||||++++++.+. +.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEE
Confidence            68999999999999999999999999999999996531   11222333   446777888999999999998764 558


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      |+||||+++|+|.++|...       ..+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-------~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFG  152 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-------GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG  152 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCT
T ss_pred             EEEEEecCCCcHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeec
Confidence            9999999999999999875       46899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCCccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +|+.+....    .....||+.|+|||.-
T Consensus       153 la~~~~~~~----~~~~~GT~~y~APE~~  177 (364)
T d1omwa3         153 LACDFSKKK----PHASVGTHGYMAPEVL  177 (364)
T ss_dssp             TCEECSSSC----CCSCCSCGGGCCHHHH
T ss_pred             eeeecCCCc----ccccccccccchhHHh
Confidence            999776543    2456799999997753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-35  Score=273.78  Aligned_cols=170  Identities=24%  Similarity=0.376  Sum_probs=147.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|+..+.||+|+||.||+|+++ +++.||||++++... ..+.|++|+.++++++||||++++|+|.+.+ .+++||||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~-~~~iv~Ey   80 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR-PIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS-SEEEEEEC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC-ceEEEEEc
Confidence            68999999999999999999986 578999999987543 3468999999999999999999999987654 58999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccC
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTS  341 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~  341 (372)
                      +++|+|.+++....      ..+++..+.+++.|+++||.|||+.+   |+||||||+|||++.++.+||+|||+|+...
T Consensus        81 ~~~g~l~~~~~~~~------~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~  151 (258)
T d1k2pa_          81 MANGCLLNYLREMR------HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  151 (258)
T ss_dssp             CTTEEHHHHHHSGG------GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCS
T ss_pred             cCCCcHHHhhhccc------cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheecc
Confidence            99999999987654      46899999999999999999999887   9999999999999999999999999998776


Q ss_pred             CCCCCccccccccCCCccCcccc
Q 017411          342 APSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       342 ~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ..... ......||+.|+|||.-
T Consensus       152 ~~~~~-~~~~~~~t~~y~aPE~~  173 (258)
T d1k2pa_         152 DDEYT-SSVGSKFPVRWSPPEVL  173 (258)
T ss_dssp             SSSCC-CCCCSCCCGGGCCHHHH
T ss_pred             CCCce-eecccCCCCCcCCcHHh
Confidence            54332 23345688899997653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-35  Score=279.49  Aligned_cols=186  Identities=26%  Similarity=0.337  Sum_probs=145.0

Q ss_pred             HHHHhhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeE
Q 017411          176 EILAATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFC  248 (372)
Q Consensus       176 ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~  248 (372)
                      ++....++|+..+.||+|+||.||+|.+..     +++.||||+++.. .....+.+.+|+.++.++ +|+||+.+++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            344445789999999999999999999743     3468999999754 344566788888888776 689999999998


Q ss_pred             EcCCCeEEEEEeccCCCCHHHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCC
Q 017411          249 IDPEQGLFLIYKYVSGGSLERHLHEKKKGV---------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPS  319 (372)
Q Consensus       249 ~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~---------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~  319 (372)
                      .+.+...++|||||++|+|.+++.......         .....+++..++.++.||+.||.|||+.+   ||||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence            877767899999999999999998654211         01245899999999999999999999988   999999999


Q ss_pred             CEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          320 NILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       320 NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||||+.++.+||+|||+|+...............||+.|+|||.-
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l  208 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI  208 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHH
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHh
Confidence            999999999999999999987655544445667899999998754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-35  Score=280.94  Aligned_cols=188  Identities=25%  Similarity=0.327  Sum_probs=152.5

Q ss_pred             HHHHHHhhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeee
Q 017411          174 YGEILAATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGF  247 (372)
Q Consensus       174 ~~ei~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~  247 (372)
                      +.+++...++|++.+.||+|+||+||+|+.+.     +++.||||+++.. .....+.|.+|+++|++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            34455567899999999999999999998753     4578999999764 34456789999999999999999999999


Q ss_pred             EEcCCCeEEEEEeccCCCCHHHHHHhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCc
Q 017411          248 CIDPEQGLFLIYKYVSGGSLERHLHEKKKGV-----------------RGNSTLPWSVRYKVALGIAESVAYLHNGTERC  310 (372)
Q Consensus       248 ~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~-----------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~  310 (372)
                      |.+.. ..++||||+++|+|.+++.......                 .....+++..++.|+.||+.||.|||+.+   
T Consensus        85 ~~~~~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---  160 (301)
T d1lufa_          85 CAVGK-PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---  160 (301)
T ss_dssp             ECSSS-SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             eccCC-ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---
Confidence            87754 4899999999999999997643210                 11245899999999999999999999888   


Q ss_pred             eEEcCCCCCCEEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          311 VVHRDIKPSNILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       311 IiHrDLKp~NILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ||||||||+|||++.++.+||+|||+|+............+..||+.|+|||.-.
T Consensus       161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~  215 (301)
T d1lufa_         161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIF  215 (301)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHH
T ss_pred             eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHc
Confidence            9999999999999999999999999998776554444455677888899976543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.5e-35  Score=272.27  Aligned_cols=175  Identities=25%  Similarity=0.348  Sum_probs=142.9

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---e
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---G  254 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---~  254 (372)
                      .++|++.+.||+|+||.||+|++..+++.||||++++.   +....+.|.+|+++|++++|||||++++++...+.   .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999999999999999999764   34556679999999999999999999998875332   3


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      .|+||||+++++|.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++..+|+||
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-------~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~  155 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-------GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDF  155 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCC
T ss_pred             EEEEEECCCCCEehhhhccc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehh
Confidence            78999999999999998775       46999999999999999999999888   999999999999999999999999


Q ss_pred             ccccccCCCCC-CccccccccCCCccCccccc
Q 017411          335 GLATWTSAPSV-PFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~~~~-~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+++....... ........||+.|+|||.-+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             TTCEECC----------------TTCCHHHHT
T ss_pred             hhhhhhccccccccccccccCcccccCHHHHc
Confidence            99987644322 22345568999999987643

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-35  Score=279.03  Aligned_cols=171  Identities=25%  Similarity=0.317  Sum_probs=147.1

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC---hhhHHHHHHHHHHHH-hCCCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED---KESSKAFCRELMIAS-SLHHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~---~~~~~~~~~Ev~iL~-~l~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|.+.+.||+|+||+||+|++..+++.||||++++..   ....+.+.+|+.++. .++|||||++++++.+. ..+|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeE
Confidence            58999999999999999999999999999999997531   233456677777665 68999999999998774 45999


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLA  337 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla  337 (372)
                      ||||+++|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|
T Consensus        81 vmEy~~~g~L~~~i~~~-------~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a  150 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSC-------HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC  150 (320)
T ss_dssp             EEECCTTCBHHHHHHHH-------SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEeecCCCcHHHHhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchh
Confidence            99999999999999875       46899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCCccccccccCCCccCccccc
Q 017411          338 TWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       338 ~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      +.......  ......||+.|+|||.-.
T Consensus       151 ~~~~~~~~--~~~~~~gt~~y~aPE~~~  176 (320)
T d1xjda_         151 KENMLGDA--KTNTFCGTPDYIAPEILL  176 (320)
T ss_dssp             BCCCCTTC--CBCCCCSCGGGCCHHHHT
T ss_pred             hhcccccc--cccccCCCCCcCCHHHHc
Confidence            87654433  334568999999977543

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-35  Score=279.47  Aligned_cols=172  Identities=27%  Similarity=0.349  Sum_probs=140.1

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ..++|++.+.||+|+||.||+|+++.+ +.||||+++... ...+.|.+|+.++++++|||||+++++|.+ + ..++||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~-~~~lv~   90 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-PIYIVT   90 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-SCEEEE
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-C-CeEEEE
Confidence            346899999999999999999999764 679999997543 345689999999999999999999999854 3 378999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+++|+|..++.....     ..++|..++.++.||+.||.|||..+   |+||||||+||||+.++.+||+|||+|+.
T Consensus        91 Ey~~~g~l~~~~~~~~~-----~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~  162 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-----KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL  162 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EecCCCchhhhhhhccc-----ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhh
Confidence            99999999999876543     46999999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....... ......||+.|+|||.-
T Consensus       163 ~~~~~~~-~~~~~~gt~~y~aPE~~  186 (285)
T d1fmka3         163 IEDNEYT-ARQGAKFPIKWTAPEAA  186 (285)
T ss_dssp             --------------CCGGGSCHHHH
T ss_pred             ccCCCce-eeccccccccccChHHH
Confidence            7544322 23345789999997643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-34  Score=275.59  Aligned_cols=171  Identities=18%  Similarity=0.231  Sum_probs=148.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++++... ....+.+|+++|++++|||||++++++.+ ++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            4689999999999999999999999999999999987543 34568899999999999999999999876 455999999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC--CcEEEEeccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK--KIPKLCDFGLAT  338 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~--~~~KL~DFGla~  338 (372)
                      ||++|+|.+++....      ..+++.++..|+.||+.||.|||+.+   |+||||||+|||++.+  ..+||+|||+++
T Consensus        82 ~~~gg~L~~~i~~~~------~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          82 FISGLDIFERINTSA------FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             CCCCCBHHHHHTSSS------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             cCCCCcHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhh
Confidence            999999999997542      46899999999999999999999988   9999999999999854  589999999998


Q ss_pred             ccCCCCCCccccccccCCCccCccccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ......   ......||+.|+|||...
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~  176 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQ  176 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHT
T ss_pred             ccccCC---cccccccccccccchhcc
Confidence            875443   234567899999987543

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=274.68  Aligned_cols=171  Identities=26%  Similarity=0.432  Sum_probs=143.5

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|+++|++++|||||++++++.+. ..+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEE
Confidence            58999999999999999999999999999999996542  23356789999999999999999999998874 4589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+.+ ++.+++.....     ..+++..+..++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||+|+.
T Consensus        81 e~~~~-~~~~~~~~~~~-----~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~  151 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASAL-----TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARA  151 (298)
T ss_dssp             ECCSE-EHHHHHHHTTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHH
T ss_pred             eecCC-chhhhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCccee
Confidence            99965 55555544322     56999999999999999999999988   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...+..  ......||+.|+|||.-
T Consensus       152 ~~~~~~--~~~~~~gt~~y~apE~~  174 (298)
T d1gz8a_         152 FGVPVR--TYTHEVVTLWYRAPEIL  174 (298)
T ss_dssp             HCCCSB--CTTCCBCCCTTCCHHHH
T ss_pred             ccCCcc--cceeecccceeeehhhh
Confidence            765443  33455799999997753

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-35  Score=272.15  Aligned_cols=173  Identities=25%  Similarity=0.363  Sum_probs=135.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~  256 (372)
                      .++|++.+.||+|+||.||+|.+..+   +..||||.++.. .....+.|.+|+.+|++++|||||++++++.+  ...+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--NPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--SSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CeEE
Confidence            46899999999999999999998643   457999998754 44556789999999999999999999998854  3479


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccc
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGL  336 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGl  336 (372)
                      +||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        84 iv~E~~~~g~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~  154 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRK------YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  154 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTT------TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---
T ss_pred             EEEEeccCCcHHhhhhccC------CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchh
Confidence            9999999999999887643      46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      |+....... .......||+.|+|||.-.
T Consensus       155 a~~~~~~~~-~~~~~~~gt~~y~apE~l~  182 (273)
T d1mp8a_         155 SRYMEDSTY-YKASKGKLPIKWMAPESIN  182 (273)
T ss_dssp             -----------------CCGGGCCHHHHH
T ss_pred             heeccCCcc-eeccceecCcccchhhHhc
Confidence            987754332 2334567899999977643

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=274.57  Aligned_cols=166  Identities=25%  Similarity=0.312  Sum_probs=137.1

Q ss_pred             eceeEcccCceEEEEEEECCCCeEEEEEEecCCChh-----hHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          186 KGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKE-----SSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       186 ~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~-----~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      ..+.||+|+||+||+|++..+++.||||+++.....     ..+.+.+|+.+|++++|||||++++++.+.+ .+|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~-~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS-NISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT-CCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCC-ceeehhh
Confidence            457899999999999999999999999999754221     2346889999999999999999999987654 5899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+.++++..++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+|+..
T Consensus        81 ~~~~~~~~~~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~  150 (299)
T d1ua2a_          81 FMETDLEVIIKDNS-------LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  150 (299)
T ss_dssp             CCSEEHHHHHTTCC-------SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             hhcchHHhhhhhcc-------cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCcccccc
Confidence            99887766555322       46888999999999999999999988   999999999999999999999999999877


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      .....  ......||+.|+|||.-
T Consensus       151 ~~~~~--~~~~~~gt~~y~aPE~~  172 (299)
T d1ua2a_         151 GSPNR--AYTHQVVTRWYRAPELL  172 (299)
T ss_dssp             TSCCC--CCCCSCCCCTTCCHHHH
T ss_pred             CCCcc--cccceecChhhccHHHH
Confidence            65443  23445799999997753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-34  Score=274.96  Aligned_cols=168  Identities=24%  Similarity=0.306  Sum_probs=142.4

Q ss_pred             CCeeec-eeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHh-CCCCCeeceeeeEEc---CCCeEE
Q 017411          182 HNFSKG-RVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASS-LHHPNIVPLVGFCID---PEQGLF  256 (372)
Q Consensus       182 ~~f~~~-~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~-l~HpnIv~l~g~~~~---~~~~~~  256 (372)
                      ++|.+. +.||+|+||+||+|++..+++.||||+++..     ..+.+|++++.+ ++|||||++++++.+   .+..+|
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            589876 4699999999999999999999999999753     456789998765 589999999998754   234589


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEEEe
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCD  333 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL~D  333 (372)
                      +|||||++|+|.++|.....     ..+++..++.|+.||+.||.|||+.+   |+||||||+|||++.   .+.+||+|
T Consensus        86 ivmEy~~gg~L~~~i~~~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGD-----QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSC-----CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEECCCCCcHHHHHHhcCC-----CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccc
Confidence            99999999999999976421     46999999999999999999999988   999999999999985   46799999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ||+|+.......   .....||+.|+|||.-.
T Consensus       158 FG~a~~~~~~~~---~~~~~gt~~y~aPE~~~  186 (335)
T d2ozaa1         158 FGFAKETTSHNS---LTTPCYTPYYVAPEVLG  186 (335)
T ss_dssp             CTTCEECCCCCC---CCCCSCCCSSCCCCCCC
T ss_pred             cceeeeccCCCc---cccccCCcccCCcHHHc
Confidence            999998765443   34568999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-33  Score=269.55  Aligned_cols=169  Identities=24%  Similarity=0.366  Sum_probs=142.5

Q ss_pred             ceeEcccCceEEEEEEECCC---CeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEecc
Q 017411          187 GRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKYV  262 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey~  262 (372)
                      .++||+|+||+||+|++..+   ...||||++++. +....++|.+|+++|++++|||||+++|+|.+.+...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            47899999999999998543   346999999753 56667889999999999999999999999987777789999999


Q ss_pred             CCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccccCC
Q 017411          263 SGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWTSA  342 (372)
Q Consensus       263 ~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~~~  342 (372)
                      ++|+|.+++....      ..+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++....
T Consensus       112 ~~g~l~~~~~~~~------~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~  182 (311)
T d1r0pa_         112 KHGDLRNFIRNET------HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  182 (311)
T ss_dssp             TTCBHHHHHHCTT------CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred             ecCchhhhhcccc------ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence            9999999987653      46789999999999999999999887   99999999999999999999999999998754


Q ss_pred             CCCC--ccccccccCCCccCcccc
Q 017411          343 PSVP--FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       343 ~~~~--~~~~~~~GT~gy~apeaP  364 (372)
                      ....  .......||+.|+|||.-
T Consensus       183 ~~~~~~~~~~~~~gt~~y~aPE~~  206 (311)
T d1r0pa_         183 KEFDSVHNKTGAKLPVKWMALESL  206 (311)
T ss_dssp             TTCCCTTCTTCSSCCGGGSCHHHH
T ss_pred             cccccceecccccccccccChHHH
Confidence            4322  122345678888887643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-34  Score=268.13  Aligned_cols=167  Identities=27%  Similarity=0.452  Sum_probs=136.3

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEe
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYK  260 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~E  260 (372)
                      .++|+..+.||+|+||.||+|++.  ++.||||+++...  ..+.|.+|++++++++||||++++|+|.+....+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            357899999999999999999985  6799999997643  346799999999999999999999998776666899999


Q ss_pred             ccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEeccccccc
Q 017411          261 YVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATWT  340 (372)
Q Consensus       261 y~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~~  340 (372)
                      |+++|+|.++|.....     ..++|..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        82 y~~~g~L~~~l~~~~~-----~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~  153 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR-----SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  153 (262)
T ss_dssp             CCTTEEHHHHHHHHHH-----HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             ccCCCCHHHHHHhcCC-----CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceec
Confidence            9999999999976532     35899999999999999999999887   999999999999999999999999999876


Q ss_pred             CCCCCCccccccccCCCccCcccc
Q 017411          341 SAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       341 ~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ....     ....+|+.|+|||.-
T Consensus       154 ~~~~-----~~~~~~~~y~aPE~l  172 (262)
T d1byga_         154 SSTQ-----DTGKLPVKWTAPEAL  172 (262)
T ss_dssp             -------------CCTTTSCHHHH
T ss_pred             CCCC-----ccccccccCCChHHH
Confidence            5332     345678889987643

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-34  Score=269.49  Aligned_cols=171  Identities=25%  Similarity=0.322  Sum_probs=138.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHH--HHHHHHhCCCCCeeceeeeEEcCCC---eEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCR--ELMIASSLHHPNIVPLVGFCIDPEQ---GLF  256 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~--Ev~iL~~l~HpnIv~l~g~~~~~~~---~~~  256 (372)
                      ++|...+.||+|+||.||+|++.  ++.||||+++...   .+.+.+  |+..+.+++|||||+++++|.+.+.   .+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            46888899999999999999974  7899999996543   233444  4555567899999999999986442   478


Q ss_pred             EEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcC-----CCCceEEcCCCCCCEEEcCCCcEEE
Q 017411          257 LIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNG-----TERCVVHRDIKPSNILLSSKKIPKL  331 (372)
Q Consensus       257 lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-----~~~~IiHrDLKp~NILld~~~~~KL  331 (372)
                      +|||||++|+|.++|++        ..++|..++.++.|++.||.|||+.     ..++||||||||+||||+.++.+||
T Consensus        78 lv~Ey~~~g~L~~~l~~--------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl  149 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNR--------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             EEEECCTTCBHHHHHHH--------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             EEEecccCCCHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEE
Confidence            99999999999999976        3589999999999999999999974     2346999999999999999999999


Q ss_pred             EecccccccCCCCCCc--cccccccCCCccCccccc
Q 017411          332 CDFGLATWTSAPSVPF--LCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~--~~~~~~GT~gy~apeaPE  365 (372)
                      +|||+++.........  ......||++|+|||.-+
T Consensus       150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  185 (303)
T d1vjya_         150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLD  185 (303)
T ss_dssp             CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHT
T ss_pred             EecCccccccCCCcceeccccceecccCcCChhhcc
Confidence            9999999875543321  234568999999987643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-34  Score=273.30  Aligned_cols=182  Identities=20%  Similarity=0.235  Sum_probs=150.9

Q ss_pred             HHhhCCeeeceeEcccCceEEEEEEECC-----CCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC
Q 017411          178 LAATHNFSKGRVLGRGALSFVFKGKVGL-----LRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP  251 (372)
Q Consensus       178 ~~~t~~f~~~~~LG~G~fG~Vy~~~~~~-----~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~  251 (372)
                      ....++|+..+.||+|+||.||+|.+..     +++.||||++++. .......|.+|+.++++++|||||+++++|...
T Consensus        16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~   95 (308)
T d1p4oa_          16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   95 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS
T ss_pred             eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC
Confidence            3445789999999999999999998752     3578999999764 445556799999999999999999999998764


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKG---VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~---~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      + ..++||||+++|+|.+++......   ......+++..+..++.|+++||.|||+.+   |+||||||+|||++.+++
T Consensus        96 ~-~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          96 Q-PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             C-ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCce
Confidence            4 479999999999999998764321   112245799999999999999999999887   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +||+|||+|+...............||+.|+|||.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHH
Confidence            99999999998765544444455678999999775

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-34  Score=267.68  Aligned_cols=167  Identities=24%  Similarity=0.315  Sum_probs=142.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC------hhhHHHHHHHHHHHHhCC--CCCeeceeeeEEcCCC
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------KESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQ  253 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~~~  253 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++++..      ......+.+|+.+|++++  |||||++++++.+. +
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~   82 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-D   82 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-S
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-C
Confidence            58999999999999999999999999999999987531      112234678999999986  89999999998764 4


Q ss_pred             eEEEEEeccCC-CCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCC-CcEEE
Q 017411          254 GLFLIYKYVSG-GSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSK-KIPKL  331 (372)
Q Consensus       254 ~~~lV~Ey~~~-gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~-~~~KL  331 (372)
                      ..++||||+.+ +++.+++...       ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.+ +.+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~-------~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER-------GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH-------CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEE
T ss_pred             eEEEEEEeccCcchHHHHHhcc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEE
Confidence            58999999975 6888888765       46999999999999999999999988   9999999999999855 79999


Q ss_pred             EecccccccCCCCCCccccccccCCCccCccc
Q 017411          332 CDFGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       332 ~DFGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      +|||+|+......    ..+..||+.|+|||.
T Consensus       153 ~DFG~a~~~~~~~----~~~~~GT~~y~aPE~  180 (273)
T d1xwsa_         153 IDFGSGALLKDTV----YTDFDGTRVYSPPEW  180 (273)
T ss_dssp             CCCTTCEECCSSC----BCCCCSCGGGSCHHH
T ss_pred             Cccccceeccccc----ccccccCCCcCCHHH
Confidence            9999998765432    345689999999775

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-33  Score=269.53  Aligned_cols=183  Identities=27%  Similarity=0.334  Sum_probs=153.5

Q ss_pred             HhhCCeeeceeEcccCceEEEEEEEC-----CCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcC
Q 017411          179 AATHNFSKGRVLGRGALSFVFKGKVG-----LLRTSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDP  251 (372)
Q Consensus       179 ~~t~~f~~~~~LG~G~fG~Vy~~~~~-----~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~  251 (372)
                      ...++|++.+.||+|+||.||+|++.     .+++.||||++++. .......|.+|+.+++++ +|||||+++++|.+.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~   99 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence            34579999999999999999999863     35678999999764 445566799999999999 699999999998775


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCC
Q 017411          252 EQGLFLIYKYVSGGSLERHLHEKKKGV-----------RGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSN  320 (372)
Q Consensus       252 ~~~~~lV~Ey~~~gsL~~~L~~~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~N  320 (372)
                      +. .++|||||++|+|.+++.......           .....+++..+..++.||+.||.|||+++   |+||||||+|
T Consensus       100 ~~-~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N  175 (311)
T d1t46a_         100 GP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN  175 (311)
T ss_dssp             SS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             CE-EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccc
Confidence            44 899999999999999998754211           11246899999999999999999999988   9999999999


Q ss_pred             EEEcCCCcEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          321 ILLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       321 ILld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                      ||++.++.+||+|||+++...............||+.|+|||.-+
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  220 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIF  220 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhc
Confidence            999999999999999999887655544556678999999987644

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-34  Score=266.06  Aligned_cols=173  Identities=25%  Similarity=0.375  Sum_probs=135.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCC---CeEEEEEEecCC---ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLL---RTSVAIKRLDKE---DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~---~~~vAvK~l~~~---~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~  255 (372)
                      ++|++.+.||+|+||.||+|++...   ...||||++++.   .....+.|.+|+.+|++++|||||+++|+|.++  ..
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec--ch
Confidence            5799999999999999999987432   247999998754   345567899999999999999999999998653  36


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      ++||||+++|+|.+++....      ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        86 ~lv~e~~~~~~l~~~~~~~~------~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfG  156 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFG  156 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHHG------GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCT
T ss_pred             heeeeeecCcchhhhhhccc------CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccch
Confidence            89999999999999887654      46899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCCCc-cccccccCCCccCccccc
Q 017411          336 LATWTSAPSVPF-LCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       336 la~~~~~~~~~~-~~~~~~GT~gy~apeaPE  365 (372)
                      +++......... ......|++.|+|||.-.
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~  187 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLK  187 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHH
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHh
Confidence            999875543322 233456788899877543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-33  Score=267.84  Aligned_cols=176  Identities=26%  Similarity=0.387  Sum_probs=142.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCe--EEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEcCCCeEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRT--SVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCIDPEQGLFL  257 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~--~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~~~~~~~l  257 (372)
                      ++|+..+.||+|+||.||+|.++.++.  .||||+++.. .....+.|.+|+++|+++ +|||||+++++|.+. +..++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEE
Confidence            588999999999999999999987765  5788888653 344566899999999999 799999999999874 45899


Q ss_pred             EEeccCCCCHHHHHHhhcc---------CCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCc
Q 017411          258 IYKYVSGGSLERHLHEKKK---------GVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKI  328 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~---------~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~  328 (372)
                      ||||+++|+|.++|+....         .......++|..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            9999999999999975421         0011257999999999999999999999987   999999999999999999


Q ss_pred             EEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          329 PKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       329 ~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      +||+|||+|+.......   .....||..|+|||.-
T Consensus       166 ~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l  198 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESL  198 (309)
T ss_dssp             EEECCTTCEESSCEECC---C----CCTTTCCHHHH
T ss_pred             eEEcccccccccccccc---ccceecCCcccchHHh
Confidence            99999999987653332   2345689999997754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-33  Score=265.56  Aligned_cols=181  Identities=23%  Similarity=0.322  Sum_probs=145.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCC-------eEEEEEEecCC-ChhhHHHHHHHHHHHHhC-CCCCeeceeeeEEc
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLR-------TSVAIKRLDKE-DKESSKAFCRELMIASSL-HHPNIVPLVGFCID  250 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~-------~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l-~HpnIv~l~g~~~~  250 (372)
                      ..++|.+++.||+|+||.||+|+...++       ..||||++++. .......+.+|+..+.++ +|||||+++++|.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3468999999999999999999875433       47999999765 345567889999999888 89999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccC---------CCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKG---------VRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNI  321 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~---------~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NI  321 (372)
                      .+ ..++||||+++|+|.++|......         ......+++..++.++.||+.||.|||+.+   ||||||||+||
T Consensus        91 ~~-~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni  166 (299)
T d1fgka_          91 DG-PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  166 (299)
T ss_dssp             SS-SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CC-eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence            54 489999999999999999765321         112256899999999999999999999988   99999999999


Q ss_pred             EEcCCCcEEEEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          322 LLSSKKIPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       322 Lld~~~~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |++.++.+||+|||+++...............||+.|+|||.-
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l  209 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL  209 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHh
Confidence            9999999999999999988665554445567788999987643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-33  Score=266.80  Aligned_cols=174  Identities=24%  Similarity=0.291  Sum_probs=142.3

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC-ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC---eE
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ---GL  255 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~---~~  255 (372)
                      .+++|++.+.||+|+||+||+|.+..+++.||||++++. .....+.+++|+++|++++||||+++++++.....   ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            346899999999999999999999999999999999764 34556788999999999999999999999865321   12


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecc
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFG  335 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFG  335 (372)
                      +++++|+.+|+|.+++..        ..+++..++.++.||+.||.|||+.+   ||||||||+|||++.++.+||+|||
T Consensus        86 ~~l~~~~~~g~L~~~l~~--------~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKT--------QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             EEEEEECCCEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEEEEeecCCchhhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccC
Confidence            445566679999999975        35899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCCC-ccccccccCCCccCcccc
Q 017411          336 LATWTSAPSVP-FLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       336 la~~~~~~~~~-~~~~~~~GT~gy~apeaP  364 (372)
                      +|+........ .......||+.|+|||.-
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l  184 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIM  184 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGT
T ss_pred             ceeeccCCCccceeeccccccceechHHHh
Confidence            99876543221 123456789999998753

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.1e-33  Score=261.90  Aligned_cols=169  Identities=23%  Similarity=0.301  Sum_probs=139.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC--hhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED--KESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||+||+|++. +++.||||+++...  ....+.+.+|+.+|++++|||||++++++.+.+ ..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEE
Confidence            58999999999999999999986 67899999997643  333568999999999999999999999988754 489999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      ||+.++.+..+....       ..+++..+..++.||+.||+|||+.+   ||||||||+|||++.++.+||+|||+|..
T Consensus        80 e~~~~~~~~~~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~  149 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCE-------GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARA  149 (286)
T ss_dssp             ECCSEEHHHHHHTST-------TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHH
T ss_pred             EeehhhhHHHHHhhc-------CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEeccccccee
Confidence            999877666665433       57999999999999999999999987   99999999999999999999999999988


Q ss_pred             cCCCCCCccccccccCCCccCcccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ...+..  ......|++.|+|||.-
T Consensus       150 ~~~~~~--~~~~~~~~~~y~~pE~~  172 (286)
T d1ob3a_         150 FGIPVR--KYTHEIVTLWYRAPDVL  172 (286)
T ss_dssp             HCC-----------CCCTTCCHHHH
T ss_pred             cccCcc--ccceecccchhhhHHHH
Confidence            765433  23344688888887654

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.2e-32  Score=265.63  Aligned_cols=166  Identities=22%  Similarity=0.317  Sum_probs=139.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCC-----
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQ-----  253 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~-----  253 (372)
                      .++|++.+.||+|+||+||+|.+..+++.||||++++.  .....+.+.+|+.+|++++|||||+++++|...+.     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999999999999999999754  44556789999999999999999999999875432     


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      .+|+||||+ +.+|..++..        ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~--------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~D  164 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH--------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILD  164 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH--------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECC
T ss_pred             eEEEEEecc-cccHHHHHHh--------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccc
Confidence            368999999 6688887754        46999999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|+......     ....||+.|+|||.
T Consensus       165 fg~a~~~~~~~-----~~~~~t~~y~aPE~  189 (346)
T d1cm8a_         165 FGLARQADSEM-----TGYVVTRWYRAPEV  189 (346)
T ss_dssp             CTTCEECCSSC-----CSSCSCGGGCCTHH
T ss_pred             ccceeccCCcc-----ccccccccccCHHH
Confidence            99998775432     34578999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.98  E-value=1.8e-32  Score=262.29  Aligned_cols=163  Identities=25%  Similarity=0.320  Sum_probs=140.6

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcC-CCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDP-EQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~-~~~~~lV~  259 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||++++..   .+.+.+|+.+|++++ ||||+++++++... ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            58999999999999999999999999999999997643   357889999999995 99999999988643 34589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEeccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGLAT  338 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGla~  338 (372)
                      ||+.+++|..+.          ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++ .+||+|||+|+
T Consensus       112 e~~~~~~L~~~~----------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         112 EHVNNTDFKQLY----------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             ECCCSCBGGGTT----------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             eecCCCcHHHHh----------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccce
Confidence            999999997653          45899999999999999999999988   99999999999998655 69999999999


Q ss_pred             ccCCCCCCccccccccCCCccCccc
Q 017411          339 WTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       339 ~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......   .....||+.|+|||.
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~  200 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPEL  200 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHH
T ss_pred             eccCCCc---ccccccCccccCccc
Confidence            8765432   245578889998775

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=1.9e-32  Score=265.04  Aligned_cols=167  Identities=29%  Similarity=0.368  Sum_probs=136.5

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-----CCeEEE
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQGLFL  257 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-----~~~~~l  257 (372)
                      +|+..++||+|+||+||+|++..+++.||||++.+...    .+.+|+++|++++||||+++++++...     ...+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            68889999999999999999999999999999976532    234799999999999999999998643     234789


Q ss_pred             EEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCC-cEEEEeccc
Q 017411          258 IYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKK-IPKLCDFGL  336 (372)
Q Consensus       258 V~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~-~~KL~DFGl  336 (372)
                      |||||+++.+..+......    ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++ .+||+|||+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~----~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~  169 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRA----KQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS  169 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred             EEeccCCccHHHHHhhhhc----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence            9999976544443332211    157999999999999999999999887   99999999999999775 899999999


Q ss_pred             ccccCCCCCCccccccccCCCccCccc
Q 017411          337 ATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       337 a~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ++.......   ..+..||+.|+|||.
T Consensus       170 a~~~~~~~~---~~~~~gt~~y~aPE~  193 (350)
T d1q5ka_         170 AKQLVRGEP---NVSYICSRYYRAPEL  193 (350)
T ss_dssp             CEECCTTSC---CCSCCSCTTSCCHHH
T ss_pred             hhhccCCcc---cccccccccccChHH
Confidence            988754432   244578888988763

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6e-32  Score=253.60  Aligned_cols=169  Identities=24%  Similarity=0.329  Sum_probs=145.2

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEE
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~  259 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||+++..  .......+.+|+.+|+.++||||+++++++.+.. ..++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-KLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-EEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-ceeEEe
Confidence            5799999999999999999999999999999998654  3445678999999999999999999999987754 488999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                      |++.+++|..++...       ..+++..+..++.|++.||+|||..+   |+||||||+|||++.++.+||+|||.|+.
T Consensus        81 ~~~~~~~l~~~~~~~-------~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~  150 (292)
T d1unla_          81 EFCDQDLKKYFDSCN-------GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA  150 (292)
T ss_dssp             ECCSEEHHHHHHHTT-------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             eeccccccccccccc-------cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhc
Confidence            999999988887654       56899999999999999999999988   99999999999999999999999999998


Q ss_pred             cCCCCCCccccccccCCCccCccc
Q 017411          340 TSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       340 ~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      .......  .....+++.|+|||.
T Consensus       151 ~~~~~~~--~~~~~~~~~~~~pe~  172 (292)
T d1unla_         151 FGIPVRC--YSAEVVTLWYRPPDV  172 (292)
T ss_dssp             CCSCCSC--CCSCCSCGGGCCHHH
T ss_pred             ccCCCcc--ceeeccccchhhhhH
Confidence            7655432  233346666777653

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-32  Score=259.59  Aligned_cols=172  Identities=27%  Similarity=0.337  Sum_probs=138.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCC-CeEEEEEEecCC--ChhhHHHHHHHHHHHHhC---CCCCeeceeeeEEc----
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLL-RTSVAIKRLDKE--DKESSKAFCRELMIASSL---HHPNIVPLVGFCID----  250 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~-~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l---~HpnIv~l~g~~~~----  250 (372)
                      .++|++.+.||+|+||+||+|++..+ ++.||||+++..  .......+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999998654 678999998653  222233466777776655   89999999998853    


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEE
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPK  330 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~K  330 (372)
                      ....++++|||+.++.+........      ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~------~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPE------PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCT------TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             cCceEEEEEEeccCCchhhhhhccC------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCee
Confidence            2345799999998877665544332      56899999999999999999999988   99999999999999999999


Q ss_pred             EEecccccccCCCCCCccccccccCCCccCcccc
Q 017411          331 LCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       331 L~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+|||+++......   ......||+.|+|||.-
T Consensus       157 l~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~  187 (305)
T d1blxa_         157 LADFGLARIYSFQM---ALTSVVVTLWYRAPEVL  187 (305)
T ss_dssp             ECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHH
T ss_pred             ecchhhhhhhcccc---cCCCcccChhhcCcchh
Confidence            99999998654332   34567899999997753

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6e-32  Score=257.40  Aligned_cols=172  Identities=23%  Similarity=0.331  Sum_probs=139.0

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-------C
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-------E  252 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-------~  252 (372)
                      ++|++.+.||+|+||+||+|++..+++.||||++...  .....+.+.+|+.+|++++||||+++++++...       +
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5899999999999999999999989999999998654  333456789999999999999999999987542       2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEE
Q 017411          253 QGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLC  332 (372)
Q Consensus       253 ~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~  332 (372)
                      ..+++||||+.++.+.......       ..++...++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~-------~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL-------VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEEC
T ss_pred             ceEEEEEeccCCCccchhhhcc-------cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEee
Confidence            3479999999877665443322       56889999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccCCCCCCc--cccccccCCCccCccc
Q 017411          333 DFGLATWTSAPSVPF--LCKTVKGTFGQNPFCI  363 (372)
Q Consensus       333 DFGla~~~~~~~~~~--~~~~~~GT~gy~apea  363 (372)
                      |||+++.........  ......||+.|+|||.
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~  192 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL  192 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHH
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHH
Confidence            999998765432211  2233579999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.8e-31  Score=252.19  Aligned_cols=172  Identities=21%  Similarity=0.274  Sum_probs=141.4

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcCCCeEEEEEec
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNIVPLVGFCIDPEQGLFLIYKY  261 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~~~~~~lV~Ey  261 (372)
                      ++|++.+.||+|+||.||+|++..+++.||||++.....  .+.+.+|+++++.++|+|++..+..+.......++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            579999999999999999999998999999999876432  235789999999999888777766666666678999999


Q ss_pred             cCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC---CCcEEEEeccccc
Q 017411          262 VSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS---KKIPKLCDFGLAT  338 (372)
Q Consensus       262 ~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~---~~~~KL~DFGla~  338 (372)
                      + +++|.+.+....      ..+++..+..++.|++.||+|||+.+   ||||||||+|||++.   +..+||+|||+|+
T Consensus        85 ~-~~~l~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          85 L-GPSLEDLFNFCS------RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             C-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             c-CCchhhhhhhcc------CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcce
Confidence            9 567777765543      56899999999999999999999988   999999999999864   4579999999999


Q ss_pred             ccCCCCCC-----ccccccccCCCccCccccc
Q 017411          339 WTSAPSVP-----FLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       339 ~~~~~~~~-----~~~~~~~GT~gy~apeaPE  365 (372)
                      .+......     .......||+.|+|||+-.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  186 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHL  186 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHT
T ss_pred             eccccccccceeccccCCcCCCccccCHHHHh
Confidence            87544321     1234568999999987643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=2.7e-31  Score=250.88  Aligned_cols=172  Identities=23%  Similarity=0.271  Sum_probs=143.2

Q ss_pred             hCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCC-CCeeceeeeEEcCCCeEEEEE
Q 017411          181 THNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQGLFLIY  259 (372)
Q Consensus       181 t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~H-pnIv~l~g~~~~~~~~~~lV~  259 (372)
                      .++|++.+.||+|+||.||+|++..+++.||||+++....  ...+.+|+++++.++| +|++.+++++.+ +...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEE
Confidence            3689999999999999999999999999999999865422  2357789999999975 899999998766 44589999


Q ss_pred             eccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC-----CCcEEEEec
Q 017411          260 KYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS-----KKIPKLCDF  334 (372)
Q Consensus       260 Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~-----~~~~KL~DF  334 (372)
                      ||+ +++|.+++....      ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.     ++.+||+||
T Consensus        81 e~~-~~~l~~~~~~~~------~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DF  150 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG------RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDF  150 (293)
T ss_dssp             ECC-CCBHHHHHHHTT------TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             Eec-CCCHHHHHHhhc------cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEccc
Confidence            999 789999987653      46899999999999999999999888   999999999999974     578999999


Q ss_pred             ccccccCCCCCC-----ccccccccCCCccCccccc
Q 017411          335 GLATWTSAPSVP-----FLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       335 Gla~~~~~~~~~-----~~~~~~~GT~gy~apeaPE  365 (372)
                      |+|+........     .......||+.|+|||+-.
T Consensus       151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~  186 (293)
T d1csna_         151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL  186 (293)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHT
T ss_pred             ceeEEcccCccccceeecccCceEEchhhcCHHHhc
Confidence            999987543221     1234568999999987644

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.7e-31  Score=257.21  Aligned_cols=168  Identities=23%  Similarity=0.267  Sum_probs=139.8

Q ss_pred             hhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC----CC
Q 017411          180 ATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP----EQ  253 (372)
Q Consensus       180 ~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~----~~  253 (372)
                      .+++|++.+.||+|+||+||+|++..+++.||||++++.  +....+.+.+|+++|++++|||||++++++...    +.
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            357899999999999999999999999999999999764  345566789999999999999999999987532    12


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..+++++|+.+|+|.+++..        ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+|++|
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~--------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~d  164 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC--------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD  164 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             ceEEEEEeecCCchhhhccc--------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccc
Confidence            24567778889999999854        35999999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCI  363 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apea  363 (372)
                      ||+|......     ..+..||+.|+|||.
T Consensus       165 fg~a~~~~~~-----~~~~~g~~~y~apE~  189 (348)
T d2gfsa1         165 FGLARHTDDE-----MTGYVATRWYRAPEI  189 (348)
T ss_dssp             C----CCTGG-----GSSSCHHHHTSCHHH
T ss_pred             cchhcccCcc-----cccccccccccCchh
Confidence            9999765432     244578888888774

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=256.97  Aligned_cols=171  Identities=27%  Similarity=0.264  Sum_probs=145.5

Q ss_pred             CCeeeceeEcccCceEEEEEEE---CCCCeEEEEEEecCC----ChhhHHHHHHHHHHHHhCCC-CCeeceeeeEEcCCC
Q 017411          182 HNFSKGRVLGRGALSFVFKGKV---GLLRTSVAIKRLDKE----DKESSKAFCRELMIASSLHH-PNIVPLVGFCIDPEQ  253 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~---~~~~~~vAvK~l~~~----~~~~~~~~~~Ev~iL~~l~H-pnIv~l~g~~~~~~~  253 (372)
                      ++|++.+.||+|+||+||+|+.   ..+++.||||++++.    +....+.+.+|+++|++++| |||+++++++.+. .
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-T  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-T
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-C
Confidence            5799999999999999999987   346889999998653    22334568899999999976 8999999988764 4


Q ss_pred             eEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEe
Q 017411          254 GLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCD  333 (372)
Q Consensus       254 ~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~D  333 (372)
                      ..++||||+.+|+|.+++...       ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~-------~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~D  172 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR-------ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD  172 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESC
T ss_pred             ceeeeeecccccHHHHHHHhc-------ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEee
Confidence            589999999999999999876       45788899999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCCCccccccccCCCccCcccc
Q 017411          334 FGLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       334 FGla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      ||+|+........ ...+..||+.|++||..
T Consensus       173 FG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~  202 (322)
T d1vzoa_         173 FGLSKEFVADETE-RAYDFCGTIEYMAPDIV  202 (322)
T ss_dssp             SSEEEECCGGGGG-GGCGGGSCCTTCCHHHH
T ss_pred             ccchhhhcccccc-cccccccccccchhHHh
Confidence            9999877544322 34456799999998765

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.9e-31  Score=254.03  Aligned_cols=167  Identities=24%  Similarity=0.340  Sum_probs=131.7

Q ss_pred             CCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCC--ChhhHHHHHHHHHHHHhCCCCCeeceeeeEEcC-----CCe
Q 017411          182 HNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE--DKESSKAFCRELMIASSLHHPNIVPLVGFCIDP-----EQG  254 (372)
Q Consensus       182 ~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~Ev~iL~~l~HpnIv~l~g~~~~~-----~~~  254 (372)
                      ++|++.+.||+|+||+||+|.+..+++.||||++++.  .....+.+.+|+.+|++++|||||++++++...     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6899999999999999999999999999999999754  445566789999999999999999999998643     345


Q ss_pred             EEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcCCCcEEEEec
Q 017411          255 LFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSSKKIPKLCDF  334 (372)
Q Consensus       255 ~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~~~~~KL~DF  334 (372)
                      +|+||||+.++ +.+.+.         ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+|++||
T Consensus        97 ~~iv~Ey~~~~-l~~~~~---------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df  163 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ---------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC
T ss_pred             eEEEEeccchH-HHHhhh---------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeech
Confidence            89999999665 444442         45899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCCccccccccCCCccCcccc
Q 017411          335 GLATWTSAPSVPFLCKTVKGTFGQNPFCIE  364 (372)
Q Consensus       335 Gla~~~~~~~~~~~~~~~~GT~gy~apeaP  364 (372)
                      |+++.......   .....||+.|+|||.-
T Consensus       164 ~~~~~~~~~~~---~~~~~~t~~y~aPE~l  190 (355)
T d2b1pa1         164 GLARTAGTSFM---MTPYVVTRYYRAPEVI  190 (355)
T ss_dssp             CC------------------CCTTCCHHHH
T ss_pred             hhhhccccccc---cccccccccccChhhh
Confidence            99987655432   3455789999987754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=3.6e-26  Score=220.21  Aligned_cols=170  Identities=21%  Similarity=0.260  Sum_probs=133.0

Q ss_pred             CeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-----------CCCeeceeeeEEc-
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-----------HPNIVPLVGFCID-  250 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-----------HpnIv~l~g~~~~-  250 (372)
                      +|++++.||+|+||+||+|++..+++.||||++++. ....+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            599999999999999999999999999999999764 334567788999888775           5789999988753 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCceEEcCCCCCCEEEcCCC--
Q 017411          251 PEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHN-GTERCVVHRDIKPSNILLSSKK--  327 (372)
Q Consensus       251 ~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~IiHrDLKp~NILld~~~--  327 (372)
                      .....+++++++..+...........    ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++  
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYE----HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTT----TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             cccceeeeeeeccccccccccccccc----ccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence            23446677777655443333332221    2578999999999999999999997 55   99999999999998665  


Q ss_pred             ----cEEEEecccccccCCCCCCccccccccCCCccCccccc
Q 017411          328 ----IPKLCDFGLATWTSAPSVPFLCKTVKGTFGQNPFCIEE  365 (372)
Q Consensus       328 ----~~KL~DFGla~~~~~~~~~~~~~~~~GT~gy~apeaPE  365 (372)
                          .+|++|||.|+......     ....||+.|+|||.-.
T Consensus       166 ~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~  202 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLL  202 (362)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHH
T ss_pred             cccceeeEeeccccccccccc-----ccccccccccChhhcc
Confidence                49999999998765432     3457999999977543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=2.3e-23  Score=183.70  Aligned_cols=137  Identities=18%  Similarity=0.134  Sum_probs=107.0

Q ss_pred             eeeceeEcccCceEEEEEEECCCCeEEEEEEecCCC------------------hhhHHHHHHHHHHHHhCCCCCeecee
Q 017411          184 FSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKED------------------KESSKAFCRELMIASSLHHPNIVPLV  245 (372)
Q Consensus       184 f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~------------------~~~~~~~~~Ev~iL~~l~HpnIv~l~  245 (372)
                      +.+++.||+|+||.||+|.+. +++.||||+++...                  ........+|...+.++.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            356799999999999999986 58899999875320                  01123456788999999999999987


Q ss_pred             eeEEcCCCeEEEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCceEEcCCCCCCEEEcC
Q 017411          246 GFCIDPEQGLFLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGTERCVVHRDIKPSNILLSS  325 (372)
Q Consensus       246 g~~~~~~~~~~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~IiHrDLKp~NILld~  325 (372)
                      ++.   .  .+++|||+++..+.+              +++.....++.|++.+|.|||..+   |+||||||+|||+++
T Consensus        81 ~~~---~--~~lvme~~~~~~~~~--------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~  138 (191)
T d1zara2          81 AWE---G--NAVLMELIDAKELYR--------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE  138 (191)
T ss_dssp             EEE---T--TEEEEECCCCEEGGG--------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEET
T ss_pred             Eec---C--CEEEEEeeccccccc--------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeC
Confidence            652   2  269999998755422              333445678999999999999988   999999999999986


Q ss_pred             CCcEEEEecccccccCCCC
Q 017411          326 KKIPKLCDFGLATWTSAPS  344 (372)
Q Consensus       326 ~~~~KL~DFGla~~~~~~~  344 (372)
                      + .++|+|||+|+....+.
T Consensus       139 ~-~~~liDFG~a~~~~~~~  156 (191)
T d1zara2         139 E-GIWIIDFPQSVEVGEEG  156 (191)
T ss_dssp             T-EEEECCCTTCEETTSTT
T ss_pred             C-CEEEEECCCcccCCCCC
Confidence            5 58999999998775443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.52  E-value=2.5e-07  Score=82.58  Aligned_cols=148  Identities=16%  Similarity=0.112  Sum_probs=94.4

Q ss_pred             HHHhhCCeeeceeEcccCceEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCeE
Q 017411          177 ILAATHNFSKGRVLGRGALSFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQGL  255 (372)
Q Consensus       177 i~~~t~~f~~~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~~  255 (372)
                      +...-..|+..+..+.++.+.||+...  .+..+.+|+...........+.+|...+..+. +--+.+++.+..+ ++..
T Consensus         9 l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~   85 (263)
T d1j7la_           9 LKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWS   85 (263)
T ss_dssp             HHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEE
T ss_pred             HHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCce
Confidence            334445676655544444568998763  35678889886554334445678888877664 3335666666554 4457


Q ss_pred             EEEEeccCCCCHHHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------
Q 017411          256 FLIYKYVSGGSLERHLHEKKKGVRGNSTLPWSVRYKVALGIAESVAYLHNGT----------------------------  307 (372)
Q Consensus       256 ~lV~Ey~~~gsL~~~L~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~----------------------------  307 (372)
                      ++||+++++.++.+.....         ..   ...++.++++.+..||...                            
T Consensus        86 ~lv~~~l~G~~~~~~~~~~---------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE---------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC---------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             EEEEEeccccccccccccc---------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence            8999999998775543211         11   1223444555555555321                            


Q ss_pred             ----------------------------CCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          308 ----------------------------ERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       308 ----------------------------~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                                                  ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                        12379999999999999877677999998864

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.80  E-value=4.3e-05  Score=72.63  Aligned_cols=77  Identities=16%  Similarity=0.006  Sum_probs=47.6

Q ss_pred             ceeEcccCceEEEEEEECCCCeEEEEEEecCC-------ChhhHHHHHHHHHHHHhCC-C--CCeeceeeeEEcCCCeEE
Q 017411          187 GRVLGRGALSFVFKGKVGLLRTSVAIKRLDKE-------DKESSKAFCRELMIASSLH-H--PNIVPLVGFCIDPEQGLF  256 (372)
Q Consensus       187 ~~~LG~G~fG~Vy~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~Ev~iL~~l~-H--pnIv~l~g~~~~~~~~~~  256 (372)
                      .+.||.|....||+.....+++.|+||.-...       -+....+...|.+.|+.+. +  ..+.+++.+  +++. .+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~-~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCC-CE
Confidence            35789999999999988766788999975421       0112234456887777652 2  345556554  3344 36


Q ss_pred             EEEeccCCCC
Q 017411          257 LIYKYVSGGS  266 (372)
Q Consensus       257 lV~Ey~~~gs  266 (372)
                      +|||++++..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.79  E-value=4.5e-05  Score=67.02  Aligned_cols=146  Identities=18%  Similarity=0.107  Sum_probs=80.4

Q ss_pred             eEcccCc-eEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCC--CCCeeceeeeEEcCCCeEEEEEeccCCC
Q 017411          189 VLGRGAL-SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLH--HPNIVPLVGFCIDPEQGLFLIYKYVSGG  265 (372)
Q Consensus       189 ~LG~G~f-G~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~--HpnIv~l~g~~~~~~~~~~lV~Ey~~~g  265 (372)
                      .+..|.. +.||+.... .+..+.+|.-.....   ..+.+|...++.+.  .-.+.+++.++.+ ++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeecc
Confidence            4555554 578988764 355688897765432   24567777777663  2335667776655 44578999999875


Q ss_pred             CHHH--------------HHHhhccCCCCCCCC--CHHHHHHHH--------------------HHHHHHHHHHHcC---
Q 017411          266 SLER--------------HLHEKKKGVRGNSTL--PWSVRYKVA--------------------LGIAESVAYLHNG---  306 (372)
Q Consensus       266 sL~~--------------~L~~~~~~~~~~~~l--~~~~~~~i~--------------------~qia~gL~yLH~~---  306 (372)
                      ++.+              .+..-.........+  .+.....-.                    ......+..+...   
T Consensus        92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (255)
T d1nd4a_          92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD  171 (255)
T ss_dssp             ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred             ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence            5421              111111000000000  010000000                    0011122222221   


Q ss_pred             -CCCceEEcCCCCCCEEEcCCCcEEEEecccccc
Q 017411          307 -TERCVVHRDIKPSNILLSSKKIPKLCDFGLATW  339 (372)
Q Consensus       307 -~~~~IiHrDLKp~NILld~~~~~KL~DFGla~~  339 (372)
                       ..+.++|+|+.|.|||++.+..+-|+||+.+..
T Consensus       172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence             122379999999999999877778999998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.44  E-value=0.0039  Score=58.37  Aligned_cols=77  Identities=13%  Similarity=0.131  Sum_probs=47.9

Q ss_pred             CeeeceeEcccCceEEEEEEECC-------CCeEEEEEEecCCChhhHHHHHHHHHHHHhCC-CCCeeceeeeEEcCCCe
Q 017411          183 NFSKGRVLGRGALSFVFKGKVGL-------LRTSVAIKRLDKEDKESSKAFCRELMIASSLH-HPNIVPLVGFCIDPEQG  254 (372)
Q Consensus       183 ~f~~~~~LG~G~fG~Vy~~~~~~-------~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~-HpnIv~l~g~~~~~~~~  254 (372)
                      ++++ +.|+.|-.=.+|+.....       ..+.|.+++.-...  ......+|..+++.+. +.-..++++++.  +  
T Consensus        44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--  116 (395)
T d1nw1a_          44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS--G--  116 (395)
T ss_dssp             GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--
Confidence            3443 678878888999988643       23456676654322  2234557888888774 433346776642  2  


Q ss_pred             EEEEEeccCCCCH
Q 017411          255 LFLIYKYVSGGSL  267 (372)
Q Consensus       255 ~~lV~Ey~~~gsL  267 (372)
                       .+|+||+++..|
T Consensus       117 -g~I~efi~g~~l  128 (395)
T d1nw1a_         117 -GRLEEYIPSRPL  128 (395)
T ss_dssp             -EEEECCCCEEEC
T ss_pred             -ceEEEEeccccC
Confidence             588999986433

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.26  E-value=0.0071  Score=55.00  Aligned_cols=67  Identities=16%  Similarity=0.181  Sum_probs=40.7

Q ss_pred             eEEEEEEECCCCeEEEEEEecCCChhhHHHHHHHHHHHHhCCCCCe--eceee----eEEcCCCeEEEEEeccCC
Q 017411          196 SFVFKGKVGLLRTSVAIKRLDKEDKESSKAFCRELMIASSLHHPNI--VPLVG----FCIDPEQGLFLIYKYVSG  264 (372)
Q Consensus       196 G~Vy~~~~~~~~~~vAvK~l~~~~~~~~~~~~~Ev~iL~~l~HpnI--v~l~g----~~~~~~~~~~lV~Ey~~~  264 (372)
                      -.||+.... +|..|++|+.... ....+++..|...+..|....|  +..+.    .....+...+.++++++|
T Consensus        36 N~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          36 NRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             SEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             ceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            479999875 4778999998653 2234567788888777642222  11111    111223446889999876

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.65  E-value=0.04  Score=49.09  Aligned_cols=30  Identities=27%  Similarity=0.460  Sum_probs=27.0

Q ss_pred             CceEEcCCCCCCEEEcCCCcEEEEeccccc
Q 017411          309 RCVVHRDIKPSNILLSSKKIPKLCDFGLAT  338 (372)
Q Consensus       309 ~~IiHrDLKp~NILld~~~~~KL~DFGla~  338 (372)
                      .++||+|+.++||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            459999999999999988777899999885